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The daily lives of scientists are much less filled
with clever new ideas than the public must im-
agine. To be sure, we have largely been educated
with the best thoughts of the past, but as we all
learn in school, the reading of history does not let
us predict the future. It is not that we are much
too satisfied with the earlier triumphs of our
youths. Even the most profound leaps forward be-
come boring if lectured on too often. I remember
that after giving only some six lectures on the dou-
ble helix, I had gone stale and desperately needed
some new thought to emerge so as to regain the
feeling of being alive. But wanting to be clever
and achieving it are not the same. During those
post-DNA semi-blues, I had moved to Caltech and
become friendly with Dick Feynmann, then the
brightest star on its or any other physics scene.
Then he liked to tell others how hard it was for
him to develop a first-rate idea and that nothing
of value had come easily. There was always the
possibility that Dick was exaggerating his strug-
gles, to make those of us less intellectually en-
dowed more at ease with his brilliance. It seemed
wisest, however, to take his words at face value.
Success would not necessarily come with hard
work, but without its pain true advances were
unlikely to fall out. In the now almost 30 years
that have since elapsed, I have seen almost no ex-
ceptions to this generalization and find that I
quickly lose interest in a scientist if I discover that
he lacks virtual monomaniacal interest in his
work.
Most of our days are thus spent not being clever
about the future, but somehow hopefully posi-
tioning ourselves so as to be thought clever at
some later period. To start with we must know
what we want to solve. If we start out to conquer
a minor goal, then the odds are hopelessly stack-
ed against us. On the other hand, if we set our
sights on an important objective merely because
it is there, we should not assume that its intrinsic
importance in any way justifies inevitable failure.
We all know too many people who have set out to
crack the mysteries of the human brain and have
only invented new words to describe our continu-
ing deep ignorance of perception, memory, and
learning. It is therefore essential to gain somehow
a feeling as to whether a given problem might
now be solvable or whether we must await the re-
ception of some new facts that as yet do not exist.
Here we generally think ahead for a period of one
to several years, knowing we are likely to lose our
grants or potential for further fellowships if we
show no progress. Even more important, failure
itself is not pleasant to live with, and our very
sanity is likely to demand a move to a more realis-
tic objective.
The question thus should be asked as to
whether this past decade's massive preoccupation
with the nature of cancer cells was premature
given that even today we know so little about nor-
mal cells. Most fortunately, we had not bitten off
more than we could chew. Our apparent gamble
in pushing such large masses of federal monies in-
to research on cancer, as opposed to, say, into de-
velopmental biology, was never that far out a bet.
For already by the early 1960s unambiguous con-
nections between cancer and many different vi-
ruses had been established. It was not that viruses
were then thought to be the cause of most cancer.
What we liked best about them was that they
were the perfect tools to probe the molecular
genetics of higher vertebrate cells. Viruses gave
us a logical handle to use our brains, as opposed
to our emotions, in deciding what to do next.
I first became aware of the possibility of using
viruses to study cancer in the fall of 1947 when, as
a beginning graduate student at Indiana Universi-
ty, I took Salva Luria's course on viruses. Not until
1959, however, did I see any way to rationally
connect viruses and cancer. Then I first learned of
Seymour Cohen's recent research showing that
the DNA molecules of the T-even bacteriophages
coded for proteins involved in DNA synthesis.
This discovery opened my mind to the possibility
that animal viruses might have similar genes, and
soon I was telling everyone within reach that the
cancer-causing (oncogenic) capacity of the DNA
tumor viruses must arise through their possession
of genes that turn on DNA synthesis. But my idea
failed to excite anyone else, in large part because
there was no way to test it. After a politely cool
reception before a large audience at Massachu-
setts General Hospital, I returned to thinking
about protein synthesis. This was a wise move. In
contrast to cancer, there were hard facts to think
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about, and we would soon be searching success-
fully for messenger RNA.
Soon afterwards, the exciting molecular nature
of the newly discovered DNA tumor viruses, poly-
oma and SV40, became known. They were among
the smallest of any known viruses, having virtual-
ly no more genetic information than the smallest
bacteriophages. And they could be propagated in
cells growing in culture, thereby allowing the rou-
tine preparation of radioactively labeled virus.
Moreover, through the work of Dulbecco, Stoker,
and Sachs these tiny tumor viruses were shown to
be capable of converting cultured normal cells in-
to their cancerous ("transformed") equivalents.
The stage was thus set to test directly whether the
transformed cells contained new genetic informa-
tion acquired from their respective inducing
tumor viruses. These crucial experiments, first
done (1965-1968) in Dulbecco's lab at the Salk
Institute, revealed the presence of polyoma
(SV40)-specific DNA (genes) within the trans-
formed cells. There they had become inserted in
the host-cell chromosomal DNA and most likely
coded for cancer-inducing proteins.
By this time (the late 1960s) the basic features
of the genetic code had been worked out, and
with the isolation of the first bacterial repressors
there was a widespread feeling among molecular
biologists that the moment had arrived to tackle
the structure and functioning of higher eucaryotic
genes. And given that the most successful route
into the genetic essence of E. coil had been
through its viruses, the phages, the most sensible
way to approach the vastly more genetically com-
plex higher eucaryotic cells had to be through in-
tensive molecular characterizations of their
viruses. Here, because of their small sizes, the
most obvious viruses with which to start were
SV40 and polyoma. And so the Dulbecco and
Stoker labs began to receive an increasing number
of visiting scientists who wanted to learn the
essentials of animal virology as the first step in
their move into the field of eucaryotic gene
regulation.
The migration of so many leading molecular
biologists into the DNA tumor virus field between
1968 and 1972 thus in no way reflected the feeling
that the cancer problem in any sense was solvable
over the short term. Rather, it reflected, as now
perceived, a highly intelligent assessment of
where the next major advances in molecular gene-
tics would lie.
We did have the worry, however, that growing
animal cells in culture would be far more expen-
sive than equivalent work with bacteria, and that
barring some unexpected good luck, our molecu-
lar attack on tumor viruses would move much
more slowly than we would like. In addition, it
would consume massive sums of money. So in the
summer of 1970 I went to Washington to lobby in
favor of a great increase in monies for the NCI
(that was to be the War on Cancer), arguing that
our goal of identifying viral cancer genes and
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their functions was now feasible given sufficient
funding.
In retrospect, I was far more optimistic than I
should have been given the hard facts at my dis-
posal. Even then, almost 20 years after the dis-
covery of the double helix, our tools for directly
analyzing DNA were primitive, with most of our
past successes with E. co/i the result of sophisti-
cated genetic analyses that we saw little chance
of soon duplicating with higher cells like those of
the mouse or humans. On the other hand, I knew
well that a rash of unexpected new discoveries
had allowed the genetic code to be elucidated
much sooner than any of us thought possible
when we took on this objective after the dis-
covery of the double helix. And so I hoped that
during the 1970s many powerful new experimen-
tal procedures would become available if our
science continued to be well-funded.
But at first the SV40 work here, as in the other
labs that had gone into the DNA tumor virus field,
as expected went painfully slowly. Wisely, we did
not ask ourselves too often where we were likely
to have real answers that might excite us, much
less others. Then, almost without warning, the
restriction enzymes of Werner Arber were realiz-
ed to be the almost magical sequence-specific
DNA-cutting enzymes that we had so long dreamt
about but never seriously thought would exist.
And happily there turned out to be many, many
cutting enzymes, with Richard Roberts here quick-
ly changing the face of DNA chemistry through
his isolation, from a wide variety of bacteria, en-
zymes that cut at a very large number of unique
DNA sequences. Then came recombinant DNA
and the easy possibility of the cloning of the DNA
fragments made by the specific restriction en-
zyme cuts. With the development of these clon-
ing procedures, work with tumor virus genes now
could move almost as fast as that with bacterial
genes, and our initial speculations about the ex-
istence of viral cancer genes have turned into the
hardest of hard facts.
Now most exciting are powerful recombinant
DNA experiments here, at the MIT Cancer Center,
at the Sidney Farber Cancer Center of Harvard
Medical School, and at the NCI that have resulted
in the isolation of several human genes whose
misfunctionings lead to cancer. And the next
several months will most likely witness the isola-
tion of their respective oncogenic protein prod-
ucts. The pace of our research has thus changed
over the past 10 years from that of an impatient
snail to that of an almost uncontrolled tornado.
The odds nevertheless remain high that we still
have a very long way to go before we can honest-
ly say to the outside world that we understand the
chemical essences of many cancer cells. For up
till now most of our success has come from analy-
ses at the DNA level, with our knowledge of the
fundamental biochemistry of any cell, be it nor-
mal or cancerous, woefully incomplete. So while
we may soon clearly say that the overabundance
or mistimed appearance of a given protein has led
to this or that cancerous state, we shall likely still
be a very, very long way from understanding the
cellular consequences of this overproduction
(mistiming). In pursuing these facts, however, we
shall most probably be making one unanticipated
discovery after another as to how the vast
multitudes of chemical reactions within cells are
harmoniously regulated.
Happily the morale of scientists now looking to
spot the exact chemical changes that characterize
cancerous transformations is very high. They
know just enough about normal cells to come up
frequently with new hypotheses as to what has
gone wrong in cancer cells. And because they
now can run very precise 2-D gels and will soon
have monoclonal antibodies of ever-increasing
specificity, their new ideas can be more quickly
checked than ever before. The realization that
their latest brainstorm might well be wrong mat-
ters much less than the realization that hard facts
about cancer cells are rapidly accumulating and
that the next decade should witness a virtual
flood of relevant information.
As an example, many cancer cells move in
much-less-coordinated fashion than their normal
equivalents, and common sense tells us to look at
the musclelike proteins within cancer cells. Now
our Cell Biology group is very excited by changes
in amounts of the several tropomyosinlike mole-
cules that accompany cancerous transformations
induced by SV40 and adenovirus 2. The signifi-
cance, however, of these observations is impossi-
ble to assess as long as we remain so ignorant as
to why our cultured cells each possess several
types of tropomyosin. We need to learn more
about the tropomyosins themselves, an endeavor
that is likely to divert us, at least temporarily,
from the cancer cell itself.
The outside world should not, however, be un-
happy with the thought that the scientists who
now study cancer cells may still have so far to go.
For now when I am asked how the recent striking
successes of scientists in identifying cancer genes
might lead to ways of selectively killing cancer
cells, I can give no encouraging response. Without
further facts we must guess that most of those
proteins whose overproduction (mistiming) leads
to cancer are vital cellular constituents that can-
not be dispensed with. It thus may not be possible
to selectively block their action in cancer cells
without simultaneously adversely affecting their
respective vital functioning in normal cells.
When, however, we understand the proteins of
the cancer cell at the deep level at which they will
soon be able to characterize its genes, we may see
the cancer problem in a very different light. Now
there is no point in being inherently pessimistic on
the basis of still hopelessly inadequate informa-
tion. Instead, our only sensible course of action is
to continue to encourage the best scientists we
can find to work on the nature of cells both nor-
mal and cancerous, and to see that they have all
the resources that can be wisely utilized. In so
helping them, we should in no way try to plot their
course of action. That approach could only be
successful if we ourselves knew where the truths
of the future will lie.
We must, therefore, have the courage of contin-
uing to face the inherently unknown, trusting that
our best younger scientists have been so trained
that the unexpected will not disturb but instead
be seized for the opportunity to reveal the scien-
tific cleverness that they all hope so badly to
display. Only in this way will they have a fighting
chance to banish someday from the human condi-
tion the dread that the word cancer still brings to
the human heart.
HIGHLIGHTS OF THE YEAR
Renewal of Our Program Project Support for
Tumor Virus Research
The main financial backing for our tumor virus
research comes not from a multitude of relatively
small grants to individual scientists, but through a
large, single, program project grant from the NCI.
It not only provides supply and equipment
monies, but also the salaries of many key scien-
tists on our staff. Funds coming to a group as op-
posed to individuals give us much-needed salary
stability. If a given scientist leaves, the monies
that support him do not follow him, but remain
with us to let us appoint a replacement. Program
project grants generally run for five years, and our
first such grant commenced in January of 1972.
Through it we had the opportunity to start our
Nucleic Acid Chemistry Section and attract
Richard Roberts to lead it. The very large con-
tribution we made to tumor virus research by the
finding and use of new restriction enzymes was
possible only through our program project sup-
port, as was the development in James Lab of new
gel electrophoretic methods for separation of the
DNA fragments created by restriction enzyme
cuts. So we considered our initial program project
monies well spent, as did the Site Visitors who
reviewed us and recommended the second five
years of support that commenced in January of
1977. Soon afterwards we more than justified this
support through our many collective efforts that
resulted in our independent discovery of RNA
splicing. The many consequences of splicing dom-
inated our work over the next several years, with
the pace of this research increasing following the
introduction of recombinant DNA methodologies
when the NI H Guidelines were loosened to permit
work on tumor virus genomes (early 1979).
We thus had confidence that we would again
be judged well when our big grant came up for
formal renewal in the late fall of 1981. Given,
however, the increasingly tight federal funding
situation, we were necessarily worried as to
whether we would be given sufficient funds to let
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us work at our past pace. So, great efforts went in-
to the preparation of our grant proposal, as well
as into the way we would present our data to the
Site Visitors who looked us over in late May. Hap-
pily the final verdict was most favorable, and we
now have guaranteed, starting January 1, 1982,
the resources that should give us another five
years of productive DNA tumor virus research.
Supervising this grant application was Joe Sam-
brook, who deserves much credit for a job that
needed to be very well done and was so ac-
complished.
The Cloning of Human Cancer Genes
The capacity of purified DNA to transfer genetic
traits from one cell to another was first
demonstrated using bacteria almost 40 years ago.
Those experiments, done by O.T. Avery, Cohn
Macleod, and Macy In McCarty at the Rockefeller
Institute, provided the first hard proof that DNA is
the primary genetic material. Soon there were at-
tempts to transfer functional DNA into the cells
of higher organisms, but the first such experi-
ments were at best ambiguous. A French group
claimed to have transformed the plumes of ducks
by injecting DNA into their eggs, but when it
became known that the eggs had been acquired
from a local farmer's market and did not behave
reproducibly, the episode was regarded as an ex-
ample of hapless "transduction." Later, claims
were made by Al lex Fox that Drosophila DNA
could produce quasi-stable genetic changes, but
little attention was paid to his work. Only after
purified animal viral DNA (SV40, polyoma,
adenoviral) was shown to be infectious, and Ca+ +
shown to greatly enhance this infectivity, was the
transfer ("transfection") of eucaryotic genes
seriously sought for. By 1977, reproducible, high-
level success with the herpes thymidine kinase
gene by Michael Wig ler and Richard Axel of P & S
solidly established DNA transfection as a work-
able line of research. Particularly important was
their unexpected observation that those rare cells
that become transfected take up very large
numbers of DNA molecules that they quickly link
together in very long linear concatenates.
The characterization of the optimal circum-
stances for DNA transfection quickly led to ex-
periments to see whether DNA from cancer cells
could transform normal cells into their cancerous
equivalents. The first successful such research, us-
ing DNA from a chemically transformed mouse
cell, was done in Bob Weinberg's lab at the MIT
Cancer Center. Soon afterwards the phenomena
was extended to DNA obtained from cell lines
arising from several types of human tumors.
Among the first starting such experiments was
Michael Wig ler, who moved here from P & S late
in 1978 to head up our Mammalian Cell Genetics
Section. The cancer transfection experiments of
his group started in earnest some 18 months ago
and soon showed that several human tumor cell
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lines (lung, colon, bladder, and neuroblastoma)
yield DNA that transforms mouse NI H3T3 cells in-
to their cancerous equivalents. Given this result,
the next step obviously was to clone the respective
"cancer" gene(s) using recombinant DNA
methodologies. Instead of using the more conven-
tional brute force method of ponderously screen-
ing a very large library of human tumor cell DNA,
Wigler's group opted for cloning procedures that
select for a bacterial supressor tRNA gene that
they enzymatically linked to the tumor cell DNA
used to transform normal mouse cells. Already
this selective procedure has been used most suc-
cessfully by Wig ler and his most talented col-
laborators Kenji Shimizu and Mitch Goldfarb to
clone a putative human bladder cancer gene.
Final Stages in the Construction of the
Reginald Harris Building
The tiny "mouse house" next to McClintock Lab
that has served as our animal holding facility has
with each passing year become more and more in-
adequate. We have thus been anxiously awaiting
the arrival of the new and much larger modern
animal facilities that our new Reginald Harris
Building will provide. For reasons apparently only
clear to our outside contractor, the pace of con-
struction went very slowly until the middle of the
summer. The Harris Building, however, is not a
simple building, containing a multitude of devices
to save and reuse energy. So we were not surpris-
ed when by late fall it was clear that the newly
compromised finishing date of January 1982
would not be met. Then we guessed that only by
mid-April would we have the opportunity to begin
to expand the number of experimental mice, rats,
guinea pigs, and rabbits needed to meet our
research demands. Now we are at last in posses-
sion of an essentially complete building. The for-
mal dedication is scheduled for May 27th to coin-
cide with our annual RNA Tumor Virus Meeting.
Adjacent to the Harris Building are greatly ex-
panded parking facilities that can handle some
100 cars. This construction has momentarily
created a large treeless area which by late May
shall be transformed back to a sylvan appearance
through the planting of some 60 trees in addition
to masses of appropriate shrubs.
Our Symposium Centered on the Cytoplasm
The preoccupation of this lab with molecular
genetics has, not surprisingly, given a strong
genetic basis to many of our Symposia. In chosing
"The Organization of the Cytoplasm" for our June
1981 topic, we initially excluded any discussion of
matters relating to the inside of the nucleus. We
knew, for example, that if we discussed the mech-
anics of cell division, we would again be focusing
on chromosome structure, a topic that we come
back to over and over. We instead tried to play it
safe by emphasizing speakers working on the
Reginald Harris Building
structures of the filamentous systems that give
cells their shape and bring about their coor-
dinated movements. In choosing them we consult-
ed countless outside advisors, with the final pro-
gram a product of Guenter Albrecht-Buehler's and
my desire to emphasize the research directions
that seem likely to dominate cytoplasmic re-
search over the next several years. As the Sym-
posium drew near we found that many of our pro-
jected discussions would make sense only if we
learned the newly discovered facts about the
genes that code for the cytoskeletal proteins.
Recombinant DNA methodologies thus became
an unexpectedly important aspect of our meeting,
which represented the most complete overview of
the cytoplasm that has yet been attempted.
To set the framework for the Symposium, we
asked Ephraim Racker, Frank Solomon, Dan Bran-
ton, and Gunther Blobel to present opening night
overviews of cytoplasmic organization and func-
tion. These proved most incisive, as was the con-
cluding summary given so well by Bill Brinkley.
Schematic Drawings Are Now in Hand
for Our New Auditorium
Over the past year, our Building Committee head-
ed by Edward Pulling has had numerous discus-
sions with our architects Moore, Grover, and
Harper concerning the details of the new audito-
rium building that we have so long felt necessary
for the maintenance of our position as the leading
international meeting site for molecular biology.
We are very satisfied by the schematic plans now
in hand and hope to initiate soon a major fund
drive for the two million dollars that the building
will require. At the same time we are planning the
renovations that need to be made to Blackford
Hall to give it the kitchen facilities required for
serving the 300-400 people that we must feed
each day during our summer meeting season. Our
final objective is an integrated meetings complex
containing the new Auditorium, Blackford Hall,
and the Vannevar Bush building, which we intend
to connect directly to Blackford so that it can give
us additional indoor dining space and at long last
do away with the need for the large tents that we
must have on hand in case of rain.
Optimally, this complex will be ready for the
summer of 1985, when we shall be holding special
celebrations to mark our 50th Symposium on
Quantitative Biology.
Continued High-level Popularity of Our
Summer Courses
The number of applicants for our 14 summer
courses totaled 563, almost identical in number to
the 556 applicants for the 1980 courses. Of these,
200 (vs 193 in 1980) students applied for our eight
offerings in neurobiology. Particularly impressive
was the 31 applications for our new advanced
course on Single-channel Recording and we are
repeating this workshop-type effort in 1982. Key
to this offering and to our Brain Slice Course were
funds provided by the Klingenstein Fund. They
came to our aid at the last moment when expect-
ed federal funding fell victim to the preferential
utilization of NIH funds for research grants as op-
posed to short-term training.
The remaining 363 applicants were for our
courses in Cancer and Genetics, with again our
Molecular Cloning Course drawing the most ap-
plicants (159 vs 172 in 1979). Two new courses
were given, Plant Molecular Biology taught by
Fred Ausubel and John Bedbrook and Introduc-
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Architect's model of prosposed auditorium
tion of Macromolecules into Mammalian Cells
taught by Mario Cappechi and Geoffry Cooper.
Both were heavily oversubscribed and will be
given again in 1982.
The fact that the number of applicants effec-
tively remained the same despite severe de-
creases in the individual grant funds that pay for
so many of the stipends reflects well on the con-
tinued perceived high potential contribution of
these courses to our students' intellectual futures.
We award as much scholarship aid as our funds
permit, usually in the form of 1/2 stipends that re-
quire a corresponding vote of confidence from
our students' home institutions.
To Give Us the Proper Balance, the Scope of
Our Year-round Effort in Neurobiology Must
Be Increased
We now run the largest summer advanced train-
ing program in neurobiology in the world, a
remarkable achievement under any circum-
stances but one made more impressive consider-
ing the tiny size of our year-round neurobiology
program. Even if the outside funding for our
courses were easy to obtain, and now just the op-
posite situation holds, the major responsibility of
organizing these courses requires more time than
Bill Udry and I have to give, as well as a great
diversion from research of Birgit Zipser, who until
last year was our only resident neurobiologist. We
thus must develop here a significant year-round
neurobiology research program if we are to re-
main a potent factor in the summer training of
neurobiologists. Toward this end last year we ap-
pointed Susan Hockfield to our staff and strongly
encouraged Ron McKay to make the transition to
10
being a full-time neurobiologist. Our situation,
however, is still very metastable, with our house
of cards capable of falling down if one or more
members of our year-round staff leaves. We must
recruit more neurobiologists to our staff and help
them acquire the postdoctoral fellows who would
benefit by working here with them. Toward that
end I have approached a major foundation to see
whether they would give us the seed money to let
us make a modestly big neurobiological splash us-
ing our recombinant DNA and hybridoma
methodologies. A positive response would not
only be most welcomed news obviously to us, but
also we feel to the future of neurobiology on the
worldwide scene.
Dedication of the Max Delbruck Laboratory
The final touches to the new addition that trans-
formed our more than somewhat decrepit Daven-
port Lab into our marvelous new Delbruck
Laboratory occurred in mid-summer. The "post-
modern colonial" design of our architects Moore,
Grover, and Harper is universally thought a strik-
ing success, greatly enhancing the pleasure of a
walk along Bungtown Road. The waterside of Del-
briick Lab has been most imaginatively trans-
formed into an almost Japanese garden environ-
ment by Hans Triede and his most-competent
grounds staff, and the tiny bridge that cuts across
the little pond brings delight to the eye with each
passage. The new labs provided by Delbruck give
our Yeast Group for the first time a real home in
which to pursue the molecular details of their
cassette model for mating-type interconversions.
Also available now for the first time are growth
chambers for plant cells, giving the occupants of
Delbriick Laboratory, rear view
Delbriick the chance to try their hands at the
genetic engineering of higher plant cells.
The Dedication Ceremony for Delbru-ck, held
during our annual Phage Meeting in August, was a
most-splendid occasion, with Manny, Jonathan,
Nicola, and Tobby DelbrUck attending, as did
many of the scientists whose intellectual lives
Max helped form here in Cold Spring Harbor. The
memory-filled dedication booklet, most ably put
together by Susan Gensel, Ellen DeWeerdt, and
Tom Broker, has recently been expanded to in-
clude the highly personal dedicatory addresses
given by Rollin Hotchkiss, Gordon Sato, John
Cairns, and Al Hershey. Concluding the dedica-
tion day was a traditional square dance on the big
lawn below Davenport House (Carnegie Dorm)
that brought back memories of similar occasions
in the early days of phage.
High-level Employment of Our Banbury
Facilities
We now possess at the Banbury estate given to us
by Mr. Charles S. Robertson a uniquely wonderful
center for small conferences. This past year it
hosted a most intellectually diverse smorgasbord
of high-level meetings and courses. Particularly
important was the meeting arranged in late March
on the "Quantification of Occupational Cancer"
that brought together many of the leading
authorities on cancer causation to discuss
whether it is possible to assess correctly that frac-
tion of cancer that has an occupational origin.
This is a field not lacking in strongly held diverse
views, and the very fact of this meeting was an
achievement in itself. We collected together
speakers who were not prone to face each other,
and their opposing arguments are faithfully repro-
duced in the semi-massive 752-page Banbury Re-
port that was published eight months later.
Our late October meeting on the "Patenting of
Life Forms" was also a notable occasion, provid-
ing an intimate view of patent examiners, lawyers,
and judges, all enthusiastically displaying the
wares of their trades. We have also begun to use
Banbury for the holding of select, small scientific
meetings, with much praise marking the holding
of intellectually spirited gatherings on "Gene
Amplification and Aberrant Chromosomal Struc-
tures" in October and "Construction and Use of
Victor McElheny
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Mammalian Eukaryotic Viral Vectors" in
December.
The initial hopes that we had for the Banbury
Center have thus been more than achieved in the
now less than four years that Victor McElheny has
functioned as its director. It is thus with much
regret that I must report that as of May 1, 1982
Victor will leave the Banbury Center to become
the director of a new program for science jour-
nalists that he will organize at MIT under the
auspices of its Program on Science, Technology,
and Society.
Now we are searching for a new Banbury Direc-
tor, knowing that duplicating Victor's intelligence,
dedication, and infectious conversational charm
will not be easy. The Banbury Center will neces-
sarily have a different style when his replacement
arrives.
Sammis Hall Comes into Use
Sammis Hall, our new residence at the Banbury
Conference Center, was formally dedicated on
July 19,1981. Charles S. Robertson's mother was a
Sammis, a name associated with early Hunting-
ton, being one of its first settlers in the 1650s. For
many generations the Sammis family farmed the
land where the Banbury Center resides, and it was
this family association that led Charles and Marie
Robertson to build their home here in 1936.
Charles Moore, in designing Sammis Hall, drew on
the work of Palladio, in particular his Villa Poiana,
and Sammis Hall is appropriately covered with
stucco of the terra cotta hue that dominates the
northern Italian countryside.
Its first occupancy occurred in late March dur-
ing our meeting on "Quantification of Occupa-
tional Cancer," and from its initial use it has been
greatly praised by its residents. The dedication
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event itself was a most special event, with my
wife Liz preparing the handsome dedication book-
let and with Charles Moore present to give a talk
on the "Mind of the Architect" and Gunther Stent
speaking on the "Architecture of the Mind." Mr.
and Mrs. Robertson's children, Mimi, Ann, and
William, were on hand, as was his sister Mrs.
Charles Rose. It was an occasion of which we are
sure Charles Robertson would have been proud,
and we continue to miss him greatly
The Use of Davenport House for Musical
Concerts
In late April Davenport House became recipient
of a gift of a marvelous new Baldwin grand piano,
thus opening up the very real possibility of con-
certs in its newly renovated Music Room. The first
such concert was given on a mid-May evening
with the splendid duo-pianists Cosmo Buono and
David Bradshaw giving us their polished pyrotech-
nics. They also most kindly arranged with my wife
Liz a 1981-1982 series of Sunday afternoon con-
certs. Cosmo and David opened this series late in
September, followed by a splendid October
recital by the violinist Helen Armstrong accom-
panied by David and a mid-November concert by
the very talented younger pianist Garah Landes.
Our new Baldwin gives to our staff a wonderful
instrument to practice upon, and it will surely
enrich our cultural environment for many, many
years to come.
Our Publishing Program Continues
at a Brisk Pace
The activities of our publishing group in Nichols
steadily gained momentum as 1981 progressed.
Newly appearing this year were a second edition
Davenport House concert
of Bob Pollock's most successful Readings in
Mammalian Cell Culture, as well as two volumes
arising from our Neurobiology Program, Mono-
clonal Antibodies to Neural Antigens edited by
Ron McKay, Martin Raff, and Louis Reichardt and
The Neurobiology of the Leech edited by Ken
Muller, John Nicholls, and Gunther Stent. We also
published a new lab manual on Hybridoma Tech-
niques that came out of an EMBO course given by
George KOhler and his colleagues at the Basel In-
stitute of Immunology. It quickly proved in great
demand, and we are now in the third printing.
Our most major publishing effort continues to
be the proceedings of our annual Symposium.
Movable Genetic Elements, our 1980 Symposium
product, came off the presses in May, later than
we wanted, but nonetheless a notable achieve-
ment considering that it is a two-volume set con-
taining more than 1000 pages. It continues to sell
well, reflecting the great excitement that charac-
terizes this rapidly developing focal point of
modern genetics. The production of our eighth
volume in our Cell Proliferation series was also a
major event. Entitled Protein Phorsphorylation,
this two-volume set, edited by Ora Rosen and Ed-
win Krebs, contains more than 1400 pages that de-
tail the current widespread excitement about pro-
tein kinases and their roles in cellular metabolism.
Great efforts were also spent in preparing
books to appear in 1982. Scheduled for appear-
ance in the first half of 1982 are four titles in our
monograph series, The Molecular Biology of the
Yeast Saccharomyces, RNA Tumor Viruses, Mito-
chondrial Genes, and a revised paperback version
of DNA Tumor Viruses. We are also initiating a
new series of rapidly produced digests of the
small scientific meetings held at the Banbury
Center. The first such titles are Gene Amplifica-
tion and Eukaryotic Viral Vectors. Also scheduled
to appear before the mid-year is our new manual
Molecular Cloning, edited by Tom Maniatis, Ed
Fritsch, and Joe Sambrook. Already more than
3000 advance orders have been placed for what is
bound to be a best seller.
This year now makes the ninth that Nancy Ford
has directed our publication program, and she de-
serves great credit for seeing that our books are
now among the most handsome scientific books
produced anywhere in the world. During these
years she has been most ably assisted by Annette
Kirk, who has just received a most deserved pro-
motion to the newly created position of Assistant
Director of Publications.
The volumes sold during 1981 totalled 16,056, a
number very similar to sales in 1980 (16,041) and
in 1979 (16,300). In 1982 we shall witness a signifi-
cant increase in sales, reflecting the many fine
new books to be published over the next several
months.
Major Changes in Our Scientific Roster
The fact that our staff positions have no hard
monies behind them makes virtually inevitable
Guenter Albrecht-Buehler
the decisions by key scientists to move on to posi-
tions that offer more long-term security. We have
suffered a particularly major loss this year with
the departure of Keith Burridge, just following our
Symposium, to take up a position in the Cell
Biology Department of the University of North
Carolina Medical School at Chapel Hill. Keith
came to us in late 1973 as a postdoctoral fellow
from the MRC Laboratory of Molecular Biology in
Cambridge, later joining our staff and serving as a
focal point in the development of our Cell Biology
Group. A further major loss for our Cell Biology
effort is the impending (late May 1982) of Guenter
Albrecht-Buehler for a tenured professorship at
Northwestern University Medical School. For
eight years Guenter has generated many in-
novative ideas about cell motility and we shall
miss the deep intelligence that he brings to bear
on intelligent behavior at the cellular level.
Leaving us in November was John Smart, who
came here to most effectively set up our Protein
Chemistry Section. John's move was to the
genetic engineering firm Biogen, where he will be
in charge of the Protein Chemistry Section of their
new lab in Cambridge. An equally important loss
occurred with the departure of Kurt Drickamer in
September to the University of Chicago, where he
has been appointed Assistant Professor of
Biochemistry.
Leaving us during 1981 upon the completion of
their postdoctoral periods here were Fred Assel-
bergs, who has moved to Switzerland for a posi-
tion in the Biogen Geneva lab; Bob Blumenthal, to
be an Assistant Professor of Biochemistry at the
Toledo University Medical School; George
Chaconas, for an Assistant Professorship of Gene-
tics in the Cancer Research Laboratory at the
University of Western Ontario; Richard Frisque, to
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become an Assistant Professor of Virology at
Pennsylvania State University in University Park;
Shiu-lok Hu, to join Molecular Genetics, Inc. in
Minneapolis; Bing-dong Jiang, to return to Shang-
hai, China; Thomas Meyer, to return to Heidelberg
University in Germany; Kim Nasmyth, to take up a
staff position at the MRC Laboratory of Molecular
Biology in Cambridge; Keith Willison, to join the
staff of the Cancer Research Council in its London
Labs; and Clifford Yen, to help form a new
biotechnology firm here on Long Island.
Promoted to positions as Senior Staff Investiga-
tor are Fuyuhiko Tamanoi, to help start our new
DNA Synthesis Section in Demerec Lab; Mitchell
Goldfarb, who first came here from Bob Wein-
berg's MIT Lab to postdoc in Mike Wigler's Lab;
and Ron McKay, who after his degree at Edin-
burgh, was a postdoc in Walter Bodmer's Oxford
Lab before coming to James Lab. Rasika Harshey
and Bruce Stillman moved up from their postdoc
slots to Staff Investigator positions.
A New Addition to Our Senior
Scientist Ranks
Acting in their spring meeting, our Trustees ap-
proved the most well deserved promotion of
Michael Wigler to the rank of Senior Scientist
beginning January 1, 1982. This post carries a roll-
ing commitment of five years of salary support.
Given that we must largely live on short-term
federal funds, the "Rolling 5" position represents
the closest approximation to a tenured position
that we can offer and signifies our faith that the
scientist concerned has the capacity for sustain-
ed, self-motivated, creative research.
Awarding of the Lasker, Wolf, and MacArthur
Prizes to Barbara McClintock
Barbara McClintock was already a quiet legend
when I first met her here at Cold Spring Harbor
over the summer of 1948. Her mastery of cytoge-
netics and the clever, determined way she ana-
lyzed the mutations of corn, coupled with her
self-effacing, principled, Yankee behavior, made
her unlike any scientist I had or would ever see.
Only at the rare moment would she reveal her
thoughts, but when she did you knew exactly
where she stood and hoped that you would pass
her muster. But then you would never know, at
least not by direct communication. By 1951 she
began to talk of her experiments that told her that
genetic elements need not have fixed locations
but might jump from one chromosomal locus to
another. In doing so, gene function could cease or
suddenly be restored. Soon there was a steady
procession of the world's best geneticists to CSH
to hear Barbara tell her story, and afterwards they
would excitedly speak of what they had heard.
Already a member of the National Academy of
Sciences in 1944, Barbara rapidly began to receive
the peer recognition owed to her, culminating in
the award of National Medal of Science in 1970,
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the first woman to receive our country's highest
recognition for a scientist. And without our ever
noticing her momentary absences, she quietly col-
lected Honorary Degrees from a number of our
leading academic institutions (e.g., Harvard and
Rockefeller Universities).
In the midst of this last decade her concept of
movable genes has become extended to all forms
of living organisms, and the magnitude of her
achievement in reaching these ideas some 20
years ahead of others became even more widely
appreciated. The visible expressions that go along
with anointment as one of the greats now flow to
her, and within the past six months she has received
the prestigious Albert Lasker Award for Medical
Science, the Wolf Prize of Israel ($100,000) for
Biology jointly with Stanley Cohen, and most re-
cently the first prize fellowship of the John T. and
Catherine MacArthur Foundation, which chose
her for their first such yearly tax-free award of
$60,000. This latter award, the most munificent
prize so far given to any individual for academic
achievement was given expressly to let Barbara
continue to live exactly as she has in the past. She
thus need have no concern for the monetary prob-
lems that so beset today's academic world. Every-
one here is thrilled by Barbara's most deserved
good fortune, but in characteristic fashion she has
permitted no formal celebrations and continues
her daily walks along Bungtown as if nothing has
happened.
The Robertson Research Fund Strongly
Provides Our Capacity for the Novel
As the director, each year I enjoy the freedom
given to me through the existence of the Robert-
son Research Fund, the income from which is
available to support projects too new yet to have
support from conventional funding sources. Parti-
cularly important has been the availability of
funds for the starting expenses of new members of
our staff. This year the Robertson Fund allowed us
to give John Fiddes, Fred Heffron, and Maggie So
equipment and supply monies that let them com-
mence their work here at full speed. These funds
also provided support for two exceptionally tal-
ented Robertson Research postdoctoral fellows,
Kim Nasmyth and Kenji Shimizu, whose foreign
nationalities precluded them from federal fellow-
ship support. In addition, we have the means to
supplement the now more than tight Federal
grants in support of our summer meetings and
courses as well as help cover the cost of a new
DEC computer for handling our DNA sequence in-
formation.
We Need Soon to Add to Our Demerec and
James Facilities
That we have been so much at the moving edge of
modern biology owes much to our past decisions
as to when to seriously upgrade our facilities.
Now we see the need to make modest additions to
both Demerec and James Labs that will prepare us
for a concerted assault on the structures and func-
tions of the proteins coded by the cancer genes
that recombinant DNA tricks are allowing us to
isolate. To do so, we must soon have the newest
equipment for the microsequencing of proteins as
well as a capability for in vitro site-specific
mutagenesis. For the latter work we need a
modern organic chemistry laboratory in which to
synthesize needed polynucleotides and polypep-
tides. These new facilities are best obtained
through the building of a 5000 sq.ft. addition to
Demerec Lab. It will extend to the south, be two
stories in height, and connect to the lower two
floors of Demerec. It should be effectively invisi-
ble to visitors entering the lab grounds through
either the upper or lower entrances off 25A.
We must also give ourselves better and more
permanent facilities for the making of monoclo-
nal antibodies. The cell lab in McClintock Lab
already devoted to this purpose is totally commit-
ted to work on the cytoskeletal proteins. Our
other hybridoma facility, located on the upper
floor of James Lab, must close down during the
summer months when we give there several ad-
vanced training courses. Clearly, James Lab must
possess year-round hybridoma facilities. We are
planning an approximately 5500 sq.ft. addition
that will extend to the north and have three floors
connected by elevator. The basement floor shall
give to James its first adequate kitchen and
media-making facilities.
The total cost of building and equipping these
two new additions will be in the neighborhood of
two million dollars. Toward this, we hope to apply
a major construction grant that was awarded to us
last May by the Pew Trust of Philadelphia. They
pledged to give us $400,000 if we can obtain the
remaining $1,600,000. Already we can apply
toward the James addition the some $300,000 that
still remains in the Harris Building NCI construc-
tion grant and which we have received permission
to use towards our hybridoma facilities. This
leaves us effectively $1,300,000 still to raise to
qualify for full receipt of the Pew Grant. Of this
sum, we have an effective pledge of $400,000 and
now are actively pursuing the remaining sums.
Common sense tells us not to try to start both ad-
ditions simultaneously, and we propose to start,
first, with the Demerec addition, whose working
drawings are already more than half done. Now
we would like its construction initiated by mid-
year.
We Continue to Have a Super-effective and
Cooperative Buildings and Grounds Staff
In many, if not most, academic institutions, even
the simplest replacement of a lab bench is not a
simple task, with a wide gulf separating the scien-
tists from those support staff whose job it is to see
Jack Richards
that the facilities exist for the flourishing of
science. Just the opposite is true here, with our
Buildings and Grounds staff not only alert to the
needs of our experiments, but responsible in see-
ing that our scientific careers are not held up by
bureaucratic infighting over prestige and
privilege. That we live under such remarkably
good care owes very much to Jack Richards who
heads our Buildings and Grounds Department. As
a former contractor in the Huntington area, Jack
knows how buildings (labs) should be built and
maintained, and his high standards and good taste
are visibly expressed throughout our grounds.
With the steady increase in the level of our
research, Jack's tasks become more demanding
each year, but he handles them well, always
politely listening to each request for still another
renovation (maintenance) job.
We Benefit from a Superbly Run Library
While we learn many new key facts through the
scientific grapevine, our continued long-term ex-
istence demands that we maintain a first-rate
library filled with the latest ways to disseminate
the overpowering crush of new research facts. We
are most fortunate that we not only possess a
superb library, whose journals and books date
back to the start of the century, but that it is also
most professionally run by our super Librarian
Susan Gensel, who has just marked her tenth an-
niversary with us.
The display and housing in stacks of our ever-
increasing numbers of books and journals has be-
come increasingly difficult, so we are now system-
atically remodeling the library. The basement
floor is already sparkingly redone, and handsome
new paneling now graces our main reading rooms
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Susan Gensel
on the ground floor. By the end of 1982, the
Library will have a completely new look.
Our Nichols Building Can No Longer
Accommodate Our Administrative Needs
Nichols Memorial Building, the center of our ad-
ministrative and publishing activities, now is
bursting at its seams, having so many people and
file cabinets that its functioning existence is badly
threatened. This crowding does not arise from a
needless proliferation of administrative support
personnel. Compared to other research institu-
tions, we are badly under-administered, with given
individuals working beyond the call of civilized
duty to keep us going. The most obvious way to
relieve this situation is to move our Publications
Department elsewhere, and when the funds be-
come available we hope to move Publications in-
to a totally new Urey Cottage, rebuilt from the
foundation up to give them the space their grow-
ing activities demand. Meanwhile, we are most
fortunate that our Administrative Director
William Udry has not only assembled, but kept
together, a first-rate administrative staff that in-
cludes our Comptroller Bill Keen, our Personnel
Manager Pat Hickey, our Grants Manager Steve
Kron, and our Purchasing Agent John Maroney.
LIBA Through Its Role in Mobilizing
Community Support Remains a Vital Feature
for Our Well Being
Located as we are remote from any major aca-
demic center, our more than 90 years existence
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defies the usual odds against the small institution
whose inevitable ups and downs are bound to pro-
vide moments when the level of competence falls
below the critical mass. Clearly helping us is our
exceptionally beautiful site. Few institutions pro-
vide its occupants our "picture book" at-
mosphere. Equally important are our neighbors,
most of whom, like us, know what a marvelous
place Cold Spring Harbor is to live, and who have
so long fought to maintain the uniqueness of our
environment. Almost 60 years ago they banded
together to form the Long Island Biological Asso-
ciation as a means of providing the financial aid
and wise counsel that must lie behind every in-
stitution that aspires to carry out first-rate
science. We are exceptionally fortunate that Ed-
ward Pulling, LIBA's Chairman for now almost 15
years, continues to mobilize so well our communi-
ty behind us. As a distinguished educator and
founder of the Millbrook School, Ed knows how
high-quality institutions should be run and sees
that we do not deviate from this course.
Creation of the Cell Biology Corporation
This lab's major involvement with recombinant
DNA and hybridoma methodologies opens up the
very real possibility of one or more of our re-
search programs opening up commercial applica-
tions that should not be ignored. To help respond
to any such opportunities if they arise, we have
founded the "Cell Biology Corporation." To
manage its operation, last July Angus McIntyre
was appointed as its President. Angus is a long-
time local resident and strong backer of our ac-
tivities. His past experience includes membership
on our Board of Trustees and from 1974 to 1977
acting as our Treasurer. At present, Cell Biology is
100% owned by the Lab, but given the right op-
portunity, it will amost surely need to raise out-
side capital and dilute our ownership. Now our
mood is essentially one of caution. The financial
community is no longer wild about biotechnol-
ogy, and we see great danger in starting a new
venture without the capitalization needed to give
it a realistic chance of success. The opportunities
nonetheless remain very real, and we should not
miss them because of lack of a focused overview
of what our science can lead to.
A Very Active Year for Our Board of Trustees
The need to assess critical possible relations be-
tween industry and us has necessitated many
more meetings of our Board of Trustees and its Ex-
ecutive Committee than have been necessary in
the past. With our staff totally the product of
academic experience, the advice of our Trustees,
both those with business backgrounds and those
from institutions that have prior experience with
industry, has proved exceedingly helpful in pro-
viding us the long-term outlook that rises above
the crises of the minute. We are particularly for-
tunate to have at our helm Walter Page, whose
vast business experience and friendships give us
entre to the highest levels of American industry.
Retiring from our Board at the conclusion of
their statutory six-year terms were Arnold Levine,
whose presence on our Executive Committee
served us so well, and Norris Darrell, Jr., whose
acute legal talents have been invaluable to our
cause. And we accepted the resignation of Abe
Worcel as an Institutional Trustee upon his move
from Princeton to Rochester. Newly elected as an
Individual Trustee was John Humes, a resident of
neighboring Mill Neck, formerly of the law firm of
Humes, Andrew and Botzow, and recently our
Ambassador to Austria. Elected as the new Institu-
tional Trustee representing Stony Book was Tom
Shenk.
We Have Ended This Year Stronger
Than at Its Start
This year commenced with our worrying much
about the consequence of the darkening national
economic pictures and the contractions in federal
money for science that were bound to come. So
we have spent much time considering alternative
funding sources that might supplement dwindling
support from Washington. Simultaneously, we
have tried to run an even tighter ship and not take
on new employees who we might soon have to
disengage because of failure to gain new grants.
Now that 1981 is over and our accounts properly
audited, I can happily report that we are still in ex-
cellent financial health. More monies were spent
on new buildings, renovations, and equipment
than required to cover depreciation of previously
acquired plant and equipment. In addition, we set
aside in plant fund reserve modest sums to give us
head starts for building projects of the near
future.
We thus continue to pursue the highest of in-
tellectual objectives and note with satisfaction
our ongoing ability to attract here highly talented
younger scientists. We realize, however, that
good fortune can be very ephemeral and that we
shall need the continued strong support from both
our local community and our scientific peers else-
where. Knowing that our many friends are still be-
hind us should let us surmount the many moments
of future anxiety that are bound to come. Cold
Spring Harbor should thus remain an institution
where the doing of science is an open, exciting ex-
perience that we shall share, to the very best of
our abilities, with the outside world.
April 23, 1982 James D. Watson
With much pleasure I can now report the sign-
ing of an agreement between the Cold Spring Har-
bor Laboratory and the Exxon Research and
Engineering Company (ER&E) to do collaborative
fundamental research in molecular biology.
Under the terms of the agreement, ER& E will pro-
vide 1.5 million dollars per year for the next five
years to allow us to set up joint projects that will
include new programs in the genetics of anaero-
bic bacteria and site-specific mutagenesis. We
shall also be able to strengthen several preexisting
research programs, in particular our efforts in pro-
tein chemistry. This agreement, coming at a time
when the future of federal funding for science is
filled with dark doubts, should allow us to main-
tain the intellectual vigor that has let us play a
major, worldwide role in molecular biology over
the past decade. Before concluding this agree-
ment its exact terms were thoroughly gone over
by our scientific staff, and by our Board of
Trustees, both of which bodies enthusiastically
and unanimously gave their support. The detailed
legal papers were negotiated most effectively by
our Administrative Director, Bill Udry, and by
Norris Darrell, Jr., our counsel, a member of the
New York law firm, Sullivan and Cromwell.
May 26, 1982 J.D.W.
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YEAR-ROUND RESEARCH
TUMOR VIRUSES
Molecular Biology of Tumor Viruses
Nucleic Acid Chemistry
Electron Microscopy
Protein Synthesis
Protein Chemistry
MOVABLE GENETIC ELEMENTS
Insertion Elements and Plasmids
Yeast and Plant Genetics
Molecular Approaches to Microbial
Pathogenicity and Virulence
Mechanism of Transposition
VERTEBRATE GENE STRUCTURE
AND EXPRESSION
Mammalian Cell Genetics
Hormonal Control of Gene Expression
Genes for the Major Structural Proteins
Polypeptide Hormone Genes
Molecular Genetics
Molecular Genetics of the Mouse
CELL BIOLOGY
Cell Motility
Cell Biochemistry
Quest 2-D Gel Laboratory
NEUROBIOLOGY
Neurobiology Laboratories
Neurobiology Workshops:
Single-Channel Recording
Electrophysiology of the Mammalian Brain Slice
First row: Y. Gluzman; J. Engler, R. Guilfoyle; B. Stillman; T. Kost; G.P. Thomas
Second row: J. Fiddes, W. Boorstein; M. Wig ler, K. Shimizu, D. Levy, M. Goldfarb, C. Fraser; J. Lewis
Third row: T. Kamata; S. Silberstein, G. Penzi, C. Monaghan, M. Goradia, B. Vogel; L. Cascio; J. Carrels, J. Leibold
Fourth row: D. Kurtz; J. Lin, S. Blose, F. Matsumura; M. Mathews
Fifth row: M. Rossini; A. Klar, P. Creatura, J. Wood, J. Abraham, J.B. Hicks, R. Malmberg, J. Strathern, D. Prudente,
S. Dellaporta, C. McGill, J. Mclndoo, J. Ivy; L. Chow
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TUMOR VIRUSES
Although the work of the Tumor Virus Group remains almost totally concerned with the
adenoviruses and the papovaviruses, the last year has seen some major changes of em-
phasis. There have been no less than three separate approaches to developing adenoviruses
as vectors: Terri Grodzicker, in collaboration with colleagues at Berkeley, has concentrated
on the analysis of recombinants between SV40 and adenoviruses generated chiefly by in
vivo recombination; David Solnick has used almost exclusively in vitro recombinant DNA
techniques to construct specific hybrid viruses; and Yakov Gluzman and his colleagues
have taken an entirely different approach, concentrating on developing helper-free, non-
defective adenoviral vectors. In all three cases the aim has been to provide cloning
vehicles that can be used not just to propagate foreign DNA sequences, but also to syn-
thesize large quantities of foreign gene products in eucarybtic cells. There is now good
reason to believe that such gene products will be processed, modified, and transported
through the cell in an authentic manner. In collaboration with Mary-Jane Gething (ICRF,
London), Joe Sambrook has shown that influenza hemagglutinin, expressed in copious
quantities from a cloned copy of the gene inserted into SV40 vectors, appears on the cell
surface in a glycosylated form that is indistinguishable from hemagglutinin encoded by in-
fluenza virus itself. This result opens the way to study the signals governing the traffic pat-
terns of protein within cells (Janet Brandsma).
Finally, a considerable fraction of the group's efforts remains focused on the central
problem of tumor viruses-the mechanism of transformation. Jim Stringer has continued
studies of the mechanism by which tumor virus genes become installed into and excised
from the cellular genome; Ron McKay has further developed his antigenic and functional
analysis of SV40 T antigen; and a large group of people (Bill Topp, Marilyn Anderson, Dick
Frisque, Bruce Anderson, Margaret Hightower, and their associates) have continued to
follow a line of work aimed at defining the structure and function of transforming genes of
adenoviruses and papovaviruses and the contribution of particular viral gene products to
the phenotype of the malignant cell.
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TUMOR VIRUSES
J. Sambrook, T. Grodzicker, Y. Gluzman, R. McKay, W. Topp, J. Stringer, B. Anderson, M. Anderson, J.
Brandsma, R. Frisque, M. Hightower, S.-L. Hu, H. Reichl, D. Solnick, 0. Sundin, K. Willison, M. Yamada,
C. Adler, B. Ahrens, P. Barkley, J. Bier, R. Chisum, M. Costa, L. Garbarini, M. Goodwin, R. Greene, C.
Grzywacz, D. Hanahan, D. Holtzman, R. Kelch, L. Kleina, R. McGuirk, M. Ramundo, P. Rosman, D.
Smith, C. Stephens, L. Vander Wahl, K. Van Doren, J. Wiggins
Viral Vectors
Adenovirus-SV40 Hybrids
T. Grodzicker, M. Yamada, D. Solnick, M. Costa,
C. Stevens
Last year we reported the construction of adeno-
SV40 hybrid viruses that express SV40 T antigens
under the control of adenoviral promoters. These
and new hybrid viruses are being studied to (1)
produce large amounts of SV40 T antigens; (2)
analyze genetic controlling elements, such as pro-
moters, splice sites, and ribosome binding sites;
and (3) test viral genomes that are suitable for use
as cloning vectors.
One of us (Terri Grodzicker), in collaboration
with R. Tjian and C. Thummel (University of Cali-
fornia, Berkeley), has obtained several novel
adeno-SV40 recombinant viruses that express
wild-type SV40 large and small T antigens under
control of different adenoviral promoters.
To place the SV40 early region under adeno-
viral transcriptional control, the structural se-
quences that code for SV40 large and small T anti-
gens were separated from the viral early promo-
ter, purified, and amplified in E. coli. As recipients
for the SV40 early region, we used two Ad2/Ad5
hybrid viruses that each contain only two of the
three Bam sites present in the Ad2 genome. These
interserotypic viruses, designated 1x51 i and
4x225b, were formed in vivo as wild-type recom-
binants from crosses between temperature-
sensitive mutants of Ad5 and the nondefective
Ad2-SV40 hybrid virus Ad2±ND1. Neither of these
viruses contains SV40 DNA. The SV40 early region
was inserted at the Bam sites of these
adenoviruses to generate a population of defec-
tive recombinant viruses that contain SV40 inser-
tion(s) in place of essential internal adenoviral
genes. The recombinants were propagated in
monkey cells in the presence of helper adeno-
virus. Expression of SV40 large T antigen by the
recombinants provides a helper function for the
growth of adenovirus in monkey cells, and this in
turn provides a selection for recombinants that ex-
press SV40 T antigen. Analysis of four indepen-
dent hybrids indicates that they contain the SV40
early region inserted in different positions and
orientations within the adenoviral genome. (1) Ad-
SVR5 has a tandem insertion of SV40 inserted be-
tween the Bam sites at positions 42 and 60. The
SV40 DNA is oriented with its 5' end at position 42
and is transcribed from the same strand as the
adenoviral major late transcripts. (2) Ad-SVR15
has one copy of the SV40 early region inserted be-
tween positions 29 and 60 and oriented so that the
A gene is transcribed in the same direction as the
E2 and E4 that lie upstream from it. (3) Ad-SVR1
and R6, which were made by insertion of SV40 in-
to an Ad2/5 recombinant virus known as 1x51
have grossly rearranged genomes, although the
SV40 coding region is intact. We have cloned the
segment of R6 containing the SV40 insertion into
plasmid vectors. Mapping experiments using
these clones, as well as analyses of heterodu-
plexes of Ad-SVR6 and adenoviral helper DNAs (in
collaboration with Louise Chow, Electron Micro-
scopy Section) show that the SV40 early region is
inserted into the early region lb transcription unit
at the left end of the adenoviral genome. The
DNA is inserted at least 130 by past the site that
codes for the nucleotides corresponding to the 5'
cap site of the lb mRNAs. Downstream from the
SV40 insertion is a segment ( -- 3 kb) of calf
thymus DNA that was present in the original
transfection mixture. We do not know the mech-
anism of integration of this DNA, but it has been
carried for many passages of the hybrid virus.
Using a different approach, David Solnick has
also constructed a new adeno-SV40 hybrid virus
that holds promise as a vehicle for the expression
of cloned DNAs. This hybrid carries two copies of
the adenoviral late promoter. To construct this
virus, a plasmid containing the SV40 segment cod-
ing for T antigen was inserted next to a segment of
adenoviral DNA containing the late promoter.
The late-promoter-SV40 unit was then inserted in
the late region of the adenoviral genome.
Regardless of the arrangement and orientation
of the SV40 insertions in the different hybrids, all
produce wild-type SV40 early proteins. However,
the hybrid viruses produce different amounts of
large and small T antigens with different kinetics
of synthesis. Ad-SVR15-infected cells yield low
amounts of T antigen. Ad-SVR5-infected cells pro-
duce high amounts of T antigen as a late viral pro-
tein, as do cells infected with Ad-SVR1 or R6,
which make three to five times more T antigen
than is found in SV40-infected cells. Large and
small T antigens produced by all viruses have the
same mobility as the wild-type SV40 proteins, as
judged by immunoprecipitation with various T an-
tisera and analysis of antigens on SDS-polyacryla-
mide gels. The Ad-SVR6 T antigen has been shown
to be identical to SV40 T antigen by partial pro-
teolysis with Staphylococcus aureus V8 protease
and analysis of tryptic peptides. Using Ad-SVR6-
infected cells, it has been possible to purify about
2 mg of T antigen from 8 liters of infected cells.
The large amounts of T antigen produced at late
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times after infection of R6-infected cells are strik-
ing because the SV40 early region is inserted into
one of the adenoviral early transforming regions.
The SV40-containing RNAs made by the different
recombinants are transcribed from different posi-
tions on the genome, although in all cases they
contain intact SV40 early sequences and display
normal splice patterns. However, the ratio of
small-T-antigen mRNA to large-T-antigen mRNA
in cells infected with hybrid viruses is reduced
relative to the ratio found in mRNA extracted
from lytically infected cells. Some hybrid mRNAs
appear to be transcribed from the adenoviral late
promoter and to contain the tripartite leader se-
quence (Ad-SVR5). Others (Ad-SVR15) are pro-
bably transcribed from /-strand early promoters.
The SV40-containing mRNA in R6 is transcribed
from the early adenoviral lb promoter. This result
is striking in several respects. The adenoviral 1 b
region codes for several RNAs that share the same
5' and 3' ends but have different internal amounts
of RNA removed by splicing. Some of these early
RNAs are produced in very low amounts, whereas
one RNA (that codes for the 15K polypeptide; see
Protein Synthesis Section) is made in larger
amounts and at late as well as at early times after
infection. SV40 T antigen is made in large
amounts at late times after infection from
R6-infected cells. Thus, transcription from the ear-
ly adenoviral lb region is very efficient at early
and late times and some posttranscriptional event
must set the levels of the mRNAs. In addition, the
SV40 early region in R6 is inserted over 100 by
downstream from the site that codes for the ATG
of the 1 b 15K protein, although wild-type SV40 T
antigen is produced. Thus, initiation of translation
of T antigen can start at the T antigen AUG
codon, although the mRNA carries the 1B 15K in-
itiation codon and ribosome-binding site at its 5'
end. This may be similar to the pattern found with
the 1B 15K and 57K polypeptides (see Protein
Chemistry and Protein Synthesis Sections).
Because SV40 T antigen can be expressed from
different adenoviral promoters, we extended our
studies to use the SV40 early region as an inser-
tional mutagen and attempted to place it in re-
gions of interest in the adenoviral genome. The
first new hybrid we made, Ad-SVR26, contains
SV40 DNA close to (-150 bp) but downstream
from the major late promoter and the first seg-
ment of the tripartite leader. Because we did not
have an adenoviral vector that contained restric-
tion enzyme sites that could be used to insert the
SV40 segment directly into the desired position in
the genome, we used a combination of in vitro
and in vivo recombination to create the desired
hybrid virus (see Fig. 1). We hope this method will
be useful for the construction of a variety of vi-
ruses carrying different insertions.
Although the SV40 sequences transcribed in
R26 are located in a region of adenoviral primary
transcripts that are normally removed by splicing,
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substantial amounts of SV40 large T antigen are
in fact produced at late times in infected cells
(50-100-fold higher than in SV40-infected cells).
Two T antigen species, as judged by immunopre-
cipitation with monoclonal antibodies, are
detected. One is slightly larger than SV40 T an-
tigen, whereas the other has the same mobility as
T antigen; however, these proteins have not yet
been analyzed to determine their exact relation-
ship to wild-type T antigen.
Extremely high amounts of SV40-containing
mRNAs are produced in R26-infected cells. Analy-
sis of these transcripts by nuclease-S1 analysis,
sandwich hybridization, and analysis of glycosy-
lated RNAs gives us a picture of how they are pro-
duced. Two predominant T-antigen mRNAs with
different 5' ends are found in infected cells. The
larger species of T-antigen mRNAs contains all
190 bases of adenoviral sequences between the
adenoviral late 5' cap site and the beginning of
the SV40 A gene. Because there are two ATG co-
dons for the adenoviral intervening region in
frame with T-coding sequences, translation of this
mRNA would give rise to the large species of T an-
tigen. Thus, although all adenoviral late mRNAs
carry the tripartite leader, large amounts of R26
message in which the first donor splice site is not
used are produced. In the second species of R26
T-antigen mRNA, the first leader segment is pres-
ent but is spliced to an acceptor present either in
the adenoviral intervening region downstream
from it or at the very beginning of the SV40 por-
tion of the transcript. In this case cryptic splice
acceptor sites that normally are not used are very
efficient points of processing.
We are continuing these studies in several
ways. Shiu-Lok Hu has constructed a set of plas-
mids in which the sequences coding for T antigen
are joined to a segment of adenoviral DNA con-
taining the major late promoter and extending
downstream to various positions between the
three leader segments and the block of late genes.
These Ad2-SV40 segments are being excised from
the plasmids and inserted into adenoviral vectors
to yield viruses containing SV40 DNA in different
positions of interest in adenovirus. By studying
transcription of SV40 DNA in these hybrid viruses,
we hope to learn more about control of transcrip-
tion and processing.
We are also attempting to insert early
adenoviral genes that code for products involved
in replication or control of transcription into new
positions on the adenoviral genome in an effort to
overproduce the proteins of interest. Examples in-
clude the Bellett protein and the immediate early
52K polypeptide (in collaboration with Bruce
Stillman and Mike Mathews, Protein Synthesis
Section). We are also doing experiments to see
whether human genes can be inserted and ex-
pressed in adenovirus.
As we have reported previously, we (in col-
laboration with Dan Klessig, University of Utah)
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Figure 1
Construction of Ad-SVR26 which contains the SV40 early region downstream from the adenoviral major late pro-
moter and the first segment of the tripartite leader. (A) pALE is a derivative of pBR322 that contains adenoviral and
SV40 early sequences linked together. The thin white bar represents Ad2 DNA and the black bar represents SV40
DNA. The Ad2 sequences extend in a counterclockwise direction from a Barn site (B) at 11 map units to a Hindll I (H)
site at position 17 over 200 by from the major late promoter (131 ). The SV40 DNA, containing coding sequences for
large and small T antigens (T), is joined to Ad2 sequences at a site (H) 10 by upstream from the initiation codon for T
antigen and is transcribed ( ) in a counterclockwise direction. The Ad2-SV40 insert is excised with Barn and inserted
into Ad2/Ad5 1x5li:R:EcoRl. (B) The map of 1x5I i showing its two Barn restriction enzyme cleavage sites (1), Ad2 se-
quences (thin line), and Ad5 sequences (thick line). (C) The genome structure of Ad-SVR26. The upper diagram
represents the deduced precursor to the final R26 genome structure depicted in the lower diagram. The two boxed
arrows emphasize the duplicated adenoviral sequences from map position 11.6 to 17 present in both the vector and
insert DNA of the precursor. The other arrows show the Barn sites in the recombinant genome. In the R6 map, the
late promoter and direction of transcription are indicated.
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have obtained human cell lines that express the
left-hand early adenoviral genes and can be used
as permissive hosts for the propagation of condi-
tional mutants (Grodzicker and Klessig, Cell
21: 453 [1980]). We have used the procedure of
cotransformation to introduce unselected Ad2
genes, along with the HSV-1 tk gene, into per-
missive thymidine kinase (TK)-deficient human 143
cells. We shall use the cotransformation procedure
to introduce some of the late-promoter-early-gene
constructs, described above, into 143 cells to see
whether the early genes can be expressed. If so, we
shall use them as permissive hosts for propagating
viral mutants.
Construction of Helper-free Adenovirus-5
Vectors
Y. Gluzman, B. Ahrens, K. Van Doren, H. Reichl,
D. Solnick
The use of defective adenovirus as vectors has
proven to be a powerful tool for overproduction
of SV40 T antigen and related molecules (Hassell
et al., J. Mol. Biol. 120: 209 [1978]; see above). For
some purposes, however, it is preferable to have a
vector population that can grow in the absence of
helper. By and large, DNA tumor viruses and vec-
tors based on them have well-defined packaging
constraints, and it is rare that a DNA molecule
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Figure 2
(a) Ad 5 map of early transcriptional regions. Early regions 1 and 3 are labeled El and E3. Region El is shown on
larger scale and the following features of El are depicted: sites for Pvull (1.4%), Hindll I (8%), Bg/I I (9.1 %); transcrip-
tional unit 1A and 1 B; and mRNA for protein IX. (b) Construction of AE1/(11309. Adenoviral DNA insert in the pAC
plasmid consists of (left to right): EcoRl linkers, 0-1.4% Ad5 DNA (Pvull), Xba linker, 9.1 -17% Ad5 DNA
(BgIII-HindIII). Adenoviral DNA in pAC retains sequences encoding the structural polypeptide IX (Bel site is
located 250 by upstream from the 5' end of polypeptide-IX mRNA). In vivo recombination between pAC and Xbal A
fragment of d1309 resulted in production of vector virus AEl/d/309. (c) Structure of AE3/d/312. This vector is missing
Xbal fragment D (78.5-84.5%) from its right arm and contains the d1312 left arm with a deletion of - 2.5% in region 1A.
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more than 5% longer than the wild-type genome
can be packaged. For construction of helper-
independent vectors, therefore, it is necessary to
define regions that are nonessential for lytic
growth, and that therefore can be eliminated from
the virus, or regions that might be complemented
by viral DNA integrated in a permissive host. From
work with defective Ad2-SV40 viruses (Kelly and
Lewis, J. Virol. 12: 643 [1973]) and deletion
mutants of Ad5 (Jones and Shenk, Cell 13:181
[1978]), it is known that region E3 (about 6% of the
adenoviral genome) is not essential for lytic
growth of the virus. Furthermore, it is possible to
propagate deletion mutants in region El in a per-
missive line of human cells (293) (Graham et al., J.
Gen. Virol. 36: 59 [1977]) that expresses an in-
tegrated El gene. We therefore set out to con-
struct a viral genome that lacked both E3 and El
and contained a single Xbal site in a suitable posi-
tion for cloning.
The deletion of El sequences was carried out
by manipulation of bacterial plasm ids containing
viral DNA fragments. Because of the presence of
a covalently attached protein, the termini of the
adenoviral genome are refractory to ligation and
therefore to cloning. To overcome this problem,
the protein was removed by treatment with
piperidine and a left-terminal fragment was fitted
with an EcoRl linker. We constructed a plasmid
(pAC) with an insert of Ad5 DNA extending from
the EcoRI linker at the left end of the genome to
the Hindi!l site at map coordinate 17.0, with a
deletion between the Pvull site at 1.4 m.u. and
the Bglll site at 9.1 m.u. An Xba linker was in-
serted at the site of the deletion. pAC thus retains
the leftmost 454 nucleotides of the viral genome,
which harbor an origin of replication and prob-
ably the signal for packaging of DNA into virions.
Also, pAC retains sequences encoding the struc-
tural polypeptide IX. This protein, although not
essential for viral replication, is known to con-
tribute to the termostability of the virion (Colby
and Shenk, J. Virol. 39: 977 [1981]).
To construct a virus containing the El region
altered in the plasmid, we took advantage of the
efficiency with which adenoviral DNA recom-
bines in vivo. Line 293 cells were transfected with
a mixture of the insert from pAC and the large
Xbal fragment from d/309, which extends from 3.7
to 100 m.u. and thus shares about 8 m.u. of
homology with the pAC insert. The structure of
recombinant virus is shown in Figure 2b. This
virus, named El, thus contains a deletion of 8.8
m.u., or about 3.3 kb.
Because of the presence of useful restriction
sites, the deletion of region-3 sequences was per-
formed directly using viral DNA. Briefly, we con-
structed a recombinant genome (dl455) with a left
half from d/312, containing no Xbal sites, and a
right half from wild-type Ad5, which contains two
Xbal sites. dl455 DNA is therefore cleaved by Xbal
at only two sites, both in E3. E3/d/312 was then
constructed by ligation of the two terminal Xbal
fragments of d1455. It contains a unique Xbal site
in E3 and has a deletion of 2.5 m.u. from El and
6.8 m.u. from E3, a total deletion of 9.3% or about
3.4 kb (Fig. 2c).
As a preliminary test of the utility of these vec-
tors, we have used El as a recipient for a fragment
containing the adenoviral major late promoter
harnessed to the SV40 early region devoid of its
own promoter. This fragment was used previously
in the construction of a helper-dependent recom-
binant producing SV40 T antigens (Solnick, Cell
24: 135 [1981]). For our purpose, it was fitted with
Xbal linkers and ligated to the Xbal "arms" of El,
after treatment of the arms with alkaline phospha-
tase. Of the 20 plaques isolated after transfection
of line 293 cells, 19 contained the insert in either
of the two possible orientations. It was found that
following lytic infection of line 293 cells, both
recombinants produce large quantities of SV40 T
antigen 20 hr postinfection. We also have cloned
the rat /3
2
globulin gene into the nondefective El
vector and at the present time we are investigat-
ing if dexamethasone-dependent expression of
this gene is preserved in the cloned state.
Foreign Proteins Expressed on Eucaryotic
Cell Surfaces
J. Sambrook, J. Brandsma, in collaboration
with M.-J. Gething (Imperial Cancer Research
Fund Laboratories)
In recent years the hemagglutinin of influenza
virus has become a model for the synthesis and
structure of eucaryotic transmembrane proteins.
Analysis of the amino acid sequence of hemag-
glutinin reveals three functional domains
characteristic of membrane proteins. A short,
N-terminal "signal" sequence probably directs the
nascent polypeptide chain through the membrane
of the endoplasmic reticulum (McCauley et al.,
FEBS Lett. 108: 422 [1979]). A hydrophobic
C-terminal domain seems to anchor the com-
pleted protein in the lipid bilayer. Between these
two is the long sequence that carries the hemag-
glutinating activity and major antigenic deter-
minants (Hirst, J. Exp. Med. 76: 195 [1942]; Brand
and Skehel, Nature New Biol. 238: 145 [1972]).
The aims of this project are to obtain the ex-
pression of the viral hemagglutinin on idle outer
membranes of mammalian cells using recombi-
nant animal virus vectors to (1) study the rules
that govern the functioning of the "signal" and
"anchor" sequences and (2) develop a method
whereby foreign proteins not normally found in
membranes can be displayed on the surfaces of
eucaryotic cells.
The cloned copy of the Japan HA gene (Geth-
ing, Nature 287:301 [1980]) contains no intervening
sequences and is a convenient size for insertion
into the late or early region of the SV40 genome.
Because the HA gene contains no promoter of its
own, the vectors were designed so that HA was ex-
pressed under the control of the SV40 early or late
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promoters. (For details of the constructions and of
the analysis of the expressed HA see Gething and
Sambrook, Nature 293:620 [1981].)
Late Replacement Vector SVEHA3
To construct the late-replacement vector, the HA
gene was inserted into the late region of SV40 be-
tween the Hpall site at nucleotide 346 and the
BamHI site at nucleotide 2533. This recombinant
viral genome was cloned into the BamHl site of
PAT153 and propagated in E. coll. For transfection
into simian cells, the recombinant SV40-HA ge-
nome was excised from the plasmid by digestion
with BamHl and purified and ligated to yield the
structure SVEHA3 shown in Figure 3. This recom-
binant viral genome contains the SV40 origin of
DNA replication and an intact set of early genes.
The HA gene is joined to the noncoding se-
quences that would normally be transcribed into
the untranslated 5' region of SV40 late mRNAs.
Late in infection of permissive simian cells this re-
combinant should express a hybrid mRNA consist-
ing of untranslated SV40 sequences at its 5' end
and an intact set of HA-coding sequences. Poly-
adenylation could occur either at a site that has
been postulated to function during the synthesis
of HA mRNA from its natural influenza viral RNA
template (Robertson et al., J. Virol. 38:157 [1981])
or at the normal site for late SV40 mRNAs at nu-
cleotide 2674. Translation of this hybrid mRNA
should begin at the first AUG that marks the be-
ginning of the HA-coding sequences. Because the
vector SVEHA3 contains an intact copy of the
gene coding for SV40 large T antigen, its DNA will
replicate efficiently in permissive simian cells.
However, production of infectious virions con-
taining the recombinant genome requires comple-
mentation by a helper virus such as dI1055, an ear-
ly deletion mutant of SV40 that can supply SV40
capsid proteins for the assembly of virions.
Figure 3
Late replacement vector SVEHA3.
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SVEHA3 and c111055 DNAs were introduced to-
gether into CV-1 cells using DEAE-dextran. The vi-
rus produced by these cells was serially passaged
twice on fresh monolayers. At this stage a virus
stock was obtained that induced a total cyto-
pathic effect within 72 hr after infection of CV-1
cells.
Early Replacement Vectors SVLHA8 and SVLHA10
A segment of DNA was constructed that contained
the intron of the small-T-antigen gene of SV40
linked directly to the poly (A)-addition site derived
from the same gene. This segment was linked to
the HA gene and the composite fragment inserted
into the SV40 genome between the Hindi! I site at
nucleotide 5171 and the BamHl site at nucleotide
2533. The recombinant viral genome was cloned
into the BamHl site of pAT153 and propagated in
bacteria. For transfection into simian cells, the re-
A.
Figure 4
Early replacement vectors SVLHA8 and SVLHA10
combinant SV40-HA genome was excised from
the plasmid by digestion with BamHI and purified
and ligated to yield the structure SVLHA8 shown
in Figure 4. This recombinant viral genome con-
tains the SV40 origin of DNA replication and an
intact set of late genes. The HA gene lies down-
stream from the early promoter, within the un-
translated sequences that normally precede the
sequences coding for SV40 early gene products.
Transcription from this promoter should therefore
generate hybrid mRNAs that begin at the usual
major sites in SV40 DNA (nucleotides 5320 and
5326) and consist of 70 nucleotides of untrans-
lated SV40 sequences linked to the entire coding
sequence of HA. Polyadenylation could occur
either at the postulated site within the 3' untrans-
lated sequences of the HA gene or at the normal
site for early SV40 mRNAs at nucleotide 2587. In
the latter case there is an opportunity for a spliced
mRNA to be formed by removal of the SV40 small
T intron that is inserted into the construct down-
stream of the HA sequences and upstream from
the SV40 early poly (A)-addition site.
At the time when these vectors were construct-
ed there were indications from other workers that
foreign genes inserted into SV40 recombinant vec-
tors were expressed more efficiently when splice
donors and acceptors were provided (Mulligan,
Nature 277:108 [1979]; Hamer and Leder, Cell
18:1299 [1979]; Gruss and Khoury, Proc. Natl.
Acad. Sci. 78: 133 [1981]). To test whether the in-
tron sequence that had been built into SVLHA8
was necessary for the efficient expression of HA, a
derivative (SVLHA10) was constructed that was
identical to SVLHA8 except that it lacked the in-
tron.
Because the early replacement vectors lack the
gene coding for large T antigen, they cannot repli-
cate in simian cells unless functional T antigen is
supplied. This can be done by using as a permis-
sive host the COS-1 line of SV40-transformed
monkey cells, which endogenously expresses
large T antigen. SVLHA8 and SVLHA10 were in-
troduced (Gluzman, Cell 23:175 [1981]) without
helper into COS-1 cells using DEAE-dextran. The
viruses produced by these cells were serially
passaged twice on fresh monolayers to obtain
stocks that induced total cytopathic effect in
COS-1 cells within 72 hr after infection. The same
stocks produced no visible cytopathic effect in
CV-1 cells.
Radioimmunoassay of Vector-infected Cells
Following infection of CV-1 cells by the SVEHA3
(+d11055) virus stock, or of COS-1 cells by the
SVEHA8 or SVEHA10 virus stocks, cell extracts
were assayed by radioimmunoassay for HA pro-
duction. The results obtained 62 hr postinfection
are given in Table 1.
Thus, the late replacement vector SVEHA3 ex-
pressed extremely high levels of HA in CV-1 cells.
The amount is equivalent to 80 pig of HA per
90-mm dish of cells.
Similarly, the intron- early replacement vector
SVLHA10 expressed high levels of HA in COS-1
cells. The lower level of expression in the intron+
SVLHA8 was in part due to the low percentage of
cells that became infected.
Analysis of the recombinant DNA molecules
isolated by Hirt extraction of cells infected with
sequential passages of the SVLHA8 stock showed
a rapid increase in the proportion of rearranged
(and presumably defective) molecules. By the
fourth or fifth passage the stock became essen-
tially noninfectious and contained a preponder-
ance of deleted and rearranged molecules.
Similar experiments with the SVEHA3 and the in-
tron- SVLHA10 viruses showed no such altera-
tions in the infectivity or in the structure of the
recombinant genome.
These results show that the provision of splice
junctions is not required for efficient expression
of HA cloned within either SV40 early or late re-
placement vectors. It might be tempting to argue
that the presence of the intron in the early re-
placement vector is actually detrimental to the
expression of the HA gene. However, the rapid ac-
cumulation of rearrangements in the genome sug-
gests that any deleterious effects are mediated at
the level of DNA rather than RNA. Why genomic
instability should be correlated with the presence
of the intron remains to be elucidated.
Analysis of the HA Protein Product
To establish the structure and biological activity
of the HA product expressed by either the early or
late replacement vectors, the following assays
were performed: immunoprecipitation, cytoplas-
mic and cell surface immunofluorescence, red
cell binding and low-pH-induced cell-cell fusion.
Table 1
ng HA/
106 cells
Av. no. moles
HA/cell
percentage cells
infecteda
No. moles HA
/infected cell
SVEHA3:CV-1
SVLHA8:COS-1
SVLHA10:COS-1
6800
22
1700
5.7 x 108
1.5 x 106
1.4 x 108
95
5
95
6.0 x 108
3 x 107
1 5 x 108
a Estimated by red cell binding.
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By all these tests the protein was indistinguishable
from authentic HA produced in influenza-virus-
infected cells.
Immunoprecipitation
The cell extracts from vector-infected cells con-
tained a protein that was specifically precipitated
by a monospecific anti-HA antiserum and that is
indistinguishable in size (Mr =75,000) from
authentic glycosylated HA precipitated from ex-
tracts of influenza-virus-infected cells.
lmmunofluorescence
Vector-infected cells showed bright cytoplasmic
immunofluorescence, with an area that is prob-
ably the Golgi aparatus staining particularly
brightly. Surface staining showed more uniform
but dimmer fluorescence over the entire cell sur-
face. Influenza-infected cells showed a similar
but less-bright pattern of fluorescence, and mock-
infected cells were dark.
Red Cell Binding
Monolayers of cells infected with SVEHA3 or
SVLHA10 bound erythrocytes in a dense carpet
over the cells' surfaces. Approximately 5% of the
cells infected with SVLHA8 were covered in a
dense layer of erythrocytes. These results in-
dicated that the vector-expressed HA is displayed
at the cell surface in a biologically active form.
Transient Expression of HA in COS-1 Cells
The experiments described above were carried
out using high-titer virus stocks containing the
recombinant genome. Starting from transfection
of DNA, preparation of these stocks normally
takes 2-3 weeks. To screen the phenotypes of mu-
tant HA genomes, a faster expression assay is
clearly desirable. We have shown that it is pos-
sible to study the expression of HA in COS-1 cells
only 48 hr after transfection of the SVHA vectors.
Because the COS-1 cells contain endogenous
SV40 large T antigen and are permissive for SV40
replication, plasmids containing SV40 origins of
DNA synthesis are replicated to high copy
number. A large pool of recombinant genomes is
built up and transiently transcribed and trans-
lated. Transient expression of HA from both the
early and late replacement vectors can be ana-
lyzed in COS-1 cells, and we have detected large
amounts of HA in cell extracts 48 hr after trans-
fection using DEAE-dextran of SVEHA3 or
Table 2
SVLHA10 (75ikg DNA per 60-mm dish of COS-1
cells). Approximately 10-30% of the cells became
transformed with DNA, and the yield of HA is
1-10% of that obtained after infection with a re-
combinant virus stock. This transient assay will
provide a convenient method for screening the ex-
pression of mutant HA genomes.
Analysis of the Expression of Mutant HAs
As a first step in the analysis of the functions of
the N-terminal and C-terminal hydrophobic re-
gions of HA, deletion mutants were constructed
that lack the DNA sequences coding for these
peptides.
Preparation of the signal-deleted mutant utilized
plasmid pJHB29 in which all the 5' nucleotides
coding for the signal had been removed using
BaI31 exonuclease. This truncated HA gene re-
placed the wild-type HA gene in the late expres-
sion vector. It was ligated into the Ball site im-
mediately following the original HA AUG so that
the HA initiation codon was fused in phase to the
codon for the first amino acid of the HA1 poly-
peptide.
Virus stocks containing the signal- mutant are
just now being prepared, and analysis of pheno-
type will be carried out in the near future.
Plasmid p2G10 contains a copy of the HA gene
lacking sequences corresponding to the
C-terminal membrane anchor. This truncated HA
gene replaced the wild-type HA gene in the late
expression vector, and virus stocks containing the
mutant genome (SVEHA20-A-) were prepared.
A most exciting result has been obtained with
the C-terminal-deleted, anchor- mutant. Infec-
tion of CV-1 cells with this mutant recombinant
leads to the accumulation of large amounts of HA
in the tissue culture medium. The results of
radioimmunoassay of cell extracts and the super-
natant medium from one 10-cm culture dish at 60
hr postinfection is shown in Table 2.
To facilitate the purification of the secreted
protein, it was determined that serum-containing
medium was not necessary once the viral infec-
tion was established. Under serum-free conditions
the secreted HA was essentially the only protein
in the culture medium.
From these results we conclude that the C-ter-
minal anchor is not required for translocation of
HA to the cell surface. It now seems that the rules
for transport (if not for gylcosylation) may be sim-
ple. Furthermore, the possibility is raised of ob-
taining and easily purifying large amounts of the
HA (pg) in
cell extracts
HA (pg) in
culture medium
Mock-infected CV-1 cells
SVEHA3-infected CV-1 cells
SVENA20-A --infected CV-1 cells
0
200
28
0
0
300
28
tity of their members, and simple-sequence DNA
may be of general importance in the gene conver-
sion process. It may be that the TG repeat found in
rat DNA is one of many such repeats in the cellular
genome. It is also possible that integration of SV40
DNA is facilitated by enzymes that recognize
simple-sequence DNA. These possibilities are cur-
rently under investigation.
Excision of SV40 DNA. SV40 DNA insertions
are powerful probes with which to explore organi-
zational plasticity of the cellular genome. Inser-
tions of SV40 DNA provide physical and genetic
markers in the cellular genome, and such inser-
tions are physically accessible through nucleic
acid hybridization techniques; furthermore, mor-
phological transformation by SV40 is a well-
defined, selectable genetic marker. More impor-
tantly, SV40 DNA insertions can be induced to ex-
cise from the integrated state. This activity ap-
pears to be unique to integrated papovavirus ge-
nomes and has great potential utility for the study
of recombination and rearrangement of DNA in
the chromosomal milieu. SV40 excision results
from the interaction of four elements: (1) the
origin of SV40 DNA replication, (2) the viral large-
T antigen, (3) recombination between homologous
DNA sequences, and (4) a permissive cellular en-
vironment. The viral origin, T antigen, and the
degree of DNA sequence homology are accessible
to manipulation through in vitro recombinant
DNA techniques. It should be possible to con-
struct cell lines with DNA insertions that poten-
tiate rearrangements of chromosomal DNA and to
examine the influence of the elements listed
above in any such process.
In addition, it should be possible to study other
recombinational processes, such as sister chroma-
tid exchange and gene conversion, by using SV40
along with other selectable genetic markers to
construct lines of cultured mammalian cells that
contain in their genomes exogeneous genes whose
specific recombination will manifest itself in the
biochemical phenotype of the cell. It is hoped
that this approach will detect in mammalian cells
the action of genetic processes known to be im-
portant in lower eucaryotic organisms.
Transformation and Viral Tumor Induction
W.C. Topp, M. Hightower, M. Ramundo, D. Smith
Our work this year continued a trend, begun
several years ago, away from studies centered on
SV40 and towards projects related to transforma-
tion and tumor induction by the human adenovi-
ruses. Two broad project areas can be defined
within the group: alterations in cellular nutritional
requirements that accompany viral transforma-
tion and the mechanism of induction of breast
fibroadenomas and sarcomas by the human
adenovirus serotypes of group D.
It is well know that virus-transformed cells re-
quire a medium supplemented with significantly
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lower concentrations of whole serum than re-
quired by normal cells for the maintenance of op-
timal exponential growth. This past year, in col-
laboration with Don McClure (University of Cali-
fornia, San Diego), we began a series of studies
designed to characterize this alteration in the require-
ment for serum-supplied macromolecular
"growth factors." We have chosen REF 52 cells as
a parental line from which to isolate transfor-
mants. This line, isolated in our lab by serial pas-
sage of 15-day-gestation rat embryo cells in a
regimen similar to that used for 3T3 cells, is char-
acterized both by an unusually low saturation
density (104 cells/cm2) and a strong dependence
on serum. It was determined that with a basal medium
consisting of 75% DME and 25% Ham's F12, a
rate and efficiency of clonal proliferation iden-
tical to that observed in 10% FCS-supplemented
medium could be obtained for REF 52 cultures
with a mixture consisting of insulin, transferrin,
epidermal growth factor (EGF), vasopressin, dex-
amethasone, and the high-density lipoprotein
complex (HDL). The responsiveness of REF 52
cells to HDL and vasopressin suggests that these
cells may be derived from vascular endothelium.
Five independent SV40 transformants of REF 52
were isolated by selecting colonies with an
altered morphology following serial dilution of
virus-infected cells. These lines were cloned
through microwells and characterized both as to
nutritional requirements for optimal clonal
growth and as to possession (in 10% FCS) of a
variety of phenotypes commonly associated with
viral transformation. All the transformants pro-
liferate in low serum supplement, but only three
of five show marked alterations in cytoplasmic
actin networks. Of these three, two express
plasminogen activator; and of these two, one
grows well suspended in soft agar. All five
transformants no longer require either EGF or
vasopressin for optimal growth, although cellular
morphology is still affected by these factors. This
is similar to results from other laboratories. In ad-
dition, steroid hormones such as dexamethasone
appear to be toxic for the transformants. Insulin
and transferrin are still required to the same
degree as for REF 52, but the HDL complex is no
longer required by any of the transformants.
Perhaps the most exciting result from this study is
that although two of the transformants have ob-
viated the need for any part of the HDL complex,
three others still require the fatty acid component
(supplied by bovine serum albumin binding
aracadonic and oleic acids). These three lines are
those expressing the more transformed pheno-
type. Whether this phenomenon is related to the
altered lipid metabolism often observed in virus-
infected cells or to some other effect such as
cellular growth response to prostaglandins, for
which these fatty acids serve as precursors, re-
mains to be determined. Whatever the reason, it is
intriguing that a phenomenon related to lipid
metabolism appears to correlate with the degree
external domains of membrane proteins for
analysis and perhaps vaccine production.
Finally, we have begun experiments in which
the signal and anchor sequences of HA are at-
tached upstream and downstream, respectively,
of the coding sequences of another gene. In this
way we hope to be able to cause foreign proteins
to (1) display on the surfaces of cells or (2) be
secreted from them. For example, we are attempt-
ing to alter the localization of SV40 T antigen by
replacing the sequences normally used in the in-
itiation of its transcription with the sequences
coding for the signal peptide of hemagglutinin.
This recombinant was able to replicate its DNA in
COS-1 cells but not in CV-1 cells. When virus
stocks obtained from COS-1 cells were used to in-
fect CV-1 cells, expression of T antigen was not
detectable either by immunofluorescence or im-
munoprecipitation, and dot blots of cytoplasmic
RNA revealed only a very low level of transcrip-
tion of the SV40 A gene. Sequencing studies are in
progress to determine the precise structure of
genetic region spanning the modified N-terminus
of the T-antigen gene.
In another approach, cDNA copies of the he-
magglutinin gene were put into a newly construc-
ted helper-free adenoviral vector (Gluzman, see
above). As control elements, the late promoter of
adenovirus was placed upstream and the polyade-
nylation site for SV40 T antigen, downstream of
the HA gene. Cotransfection of live 293 cells with
the Xbal A fragment of adenovirus d/309 DNA
yielded eight plaques. Three of these contain the
hemagglutinin gene, as determined by Southern
blotting of Hirt DNAs. Two of the three express
hemagglutinin at 3-6 x 105 molecules per cell, as
detected by radioimmunoassay. Subcloning of
the hemagglutinin gene from these three recom-
binants is underway. In the near future we plan to
replace the central portion of the hemagglutinin
gene with A gene of SV40 and to study the expres-
sion of T antigen in this system.
Transformed Cells and
Transforming Genes
Integration and Excision of SV40 DNA
J. Stringer
Integration of SV40 DNA. Integration of SV40
Rat
SVRE 9
DNA probably reflects the action of a cellular
recombination system that can incorporate any
foreign DNA into the cellular genome, and analy-
sis of SV40 DNA insertions may therefore reveal
the action of cellular recombination enzymes.
The structure of SV40 DNA insertions is different
from those of retroviral proviruses and movable
genetic elements. No single DNA sequence in
either the cell or the SV40 genome serves as an
obligatory site of SV40 integrative recombination,
and SV40 DNA insertions are not bordered by the
repeat structures characteristic of transposons
and retroviral proviruses (Annual Report, 1980).
Integration of SV40 could involve the matching of
short stretches of homologous sequences present
in the otherwise heterologous SV40 and cellular
genomes. To explore this possibility, I have se-
quenced a rat DNA fragment that contains an un-
occupied site of SV40 DNA integration. Compari-
son of this sequence with that of SV40 and that at
the rat-SV40 recombinant junction (Fig. 5) showed
that SV40 DNA became linked to rat DNA at a
point where the two genomes shared 5 by of DNA
sequence homology.
This is the first direct demonstration that DNA
sequence homology may mediate integrative re-
combination between SV40 DNA and the cellular
chromosome. Although analysis of more unoccu-
pied sites of SV40 DNA insertion will be needed to
understand fully the role of base pairing in SV40
integration, it is now clear that cells are able to
use a short sequence homology to integrate an
otherwise heterologous SV40 DNA molecule. This
example of homologous recombination suggests
an additional difference between integration of
SV40 DNA and integration of retroviruses and
transposition of movable elements.
The DNA sequence of the unoccupied SV40 inte-
gration site shown in Figure 5 is striking in two
ways. It is repetitive, containing 12 TG pairs in tan-
dem, and it is composed almost entirely of G and T.
Thus, this DNA chain is simple in both its sequence
arrangement and its base composition. This TG
repeat is remarkably similar to the "simple-
sequence" DNA present in the second introns of
human -y-globin genes. There is evidence to suggest
(Slightom et al., Cell 27: 627 [1980]) that simple-
sequence DNA may act as hot spots for the initia-
tion of gene conversion between human -y-globin
genes. Gene conversion is one mechanism by
which multigene families may conserve the iden-
TGTGCCTGTGTGTGTGTGTGTGTGTGTGTGGTTG
11111111111111111111
GGTTGTGAAGACCTTGTGTGTGTGTGTGTGGTTGIIIIHIIIIIIIIIIIII
SV40 GGTIGTGAAGACCTIGTGICGTCACCTICCCIGA
Figure 5
SV40 and rat DNA share 5 by of homology at the point of their recombination. The three lines of DNA sequence are
those of the parental molecules, SV40 and rat DNAs, and that of the recombinant, SVRE9. Vertical lines indicate se-
quence homologies between parent and progeny DNAs.
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of transformation. We are currently extending
these studies to the characterization of REF 52
transformed by mutants of SV40 that do not en-
code the viral small-T protein (as well as to REF 52
cultures transformed by human adenoviruses) in
order to determine the individual roles of the two
viral gene products.
Our third area of interest is the mechanism of
induction in female rats of benign breast fibroade-
nomas by members of group-D of the human ade-
noviruses. We have confirmed the results first re-
ported by Ankerst and Jonsson (Int. J. Cancer
13:286 [1974]) that human Ad9 induces multiple
breast tumors within 3 to 4 months in virtually
100% of female Wistar/Furth rats injected at
birth. Tumors do not develop in male rats. We ex-
pect that fibroadenoma induction may be a
general feature of group-D viruses, and we know
that at least one other member of group D, Adl 0,
is similarly tumorigenic. However, tumor growth
is strongly dependent on the physiological en-
vironment provided by the host. Both Lewis and
Wistar/Furth rats are susceptible but Sprague-
Dawley, Fisher, AxI, Taconic Farms, and Buffalo
rats are not, nor are Syrian hamsters or BALB/c,
C57B6, or C3H mice. Moreover, tumor induction
is strongly hormone-dependent: Ovariectomiza-
tion at 4 weeks of age completely eliminates
tumor appearance, and preliminary data suggest
that ovariectomization after tumor appearance
leads to regression.
Although the fibroadenomas possess both an
epithelial and a mesynchymal component, we
have shown by double immunofluorescent stain-
ing of cryogenic tumor sections with both anti-
tumor serum and a serum directed against epi-
thelial keratins, that viral antigens are expressed
only in the mesynchymal cells. The tumors are
quite similar in this regard to other adenovirus-
induced tumors, which are almost universally of
mesynchymal origin. This is consistent with the
fact that when tumors are explanted to culture,
only cells with a fibroblastoid morphology give a
stain with anti-tumor sera. The pattern of staining
is virtually identical to that observed in cells
transformed in vitro by viruses of groups A and B.
Very little was known about the molecular bi-
ology of the group-D viruses when we began this
project. Consequently, in collaboration with
Louise Chow and Tom Broker (Electron Micros-
copy Section), we have recently completed an ex-
tensive comparative study relating these viruses
to the better-characterized members of groups A,
B, and C. The transcriptional map of Ad9 is vir-
tually identical to that of Ad2. However there are
some major differences in the patterns of viral
gene expression. Most notably, Ad9 early region
la is substantially underproduced as compared to
the same region in Ad2, whereas Ad9 early region
3 is greatly overproduced, becoming the most
common early message. E3 is also nearly twice as
large as in Ad2, resulting in a greatly foreshort-
ened fiber gene. By DNA/DNA heteroduplex
analysis, the members of group D are closely re-
lated to the viruses of groups A, B, C, and E as are
the members of these groups one to another. A
striking exception to this is that the inverted ter-
minal repeat sequences of the group-D viruses ap-
pears to be only distantly related to that of the
other groups, a fact confirmed by Jeff Engler
(Electron Microscopy Section) at the sequence le-
vel. Thus, although some differences exist, there is
very little here to suggest the source of the unique
oncogenic behavior of the group-D viruses.
Studies on this area are continuing and center
about the isolation of viral variants with potential-
ly altered oncongenicity. There are also in pro-
gress ongoing in vivo experiments to characterize
further the involvement of the host endocrine
system.
Transformation of Rat Cells by Mutants in
Early Region 1 of Adenovirus 2
M.A. Anderson, R. Frisque, M. Cahn
Early regions 1A and 1B of Ad2 (encompassing
map units 1.5 to 11.5) encode the genes required
for virus-induced transformation of rat cells. We
are interested in identifying among the several
genes within this region those that are involved in
the establishment and maintenance of the trans-
formed state.
The problem has been approached using a
series of plasmids constructed in this laboratory
by Nigel Stow and Dick Frisque. These molecules
contain 0-9% of the Ad2 genome inserted into
pBR322, with small deletions generated within the
E1A or El B region by site-directed mutagenesis
(see Fig. 6). These mutagenized fragments have
been reestablished in viral genomes by recom-
bination with d1309, a viable deletion mutant of
Ad5 (see N. Stow and P. Rosman, Annual Report
1980).
Both the viruses and the plasmids have been us-
ed in transformation studies with baby rat kidney
cells. One of the two deletion mutants at the Xba
site in E1A and one of two mutants at the Sst
site in El B fail to transform. Cell lines have been
established using the wild-type viruses and plas-
mids and the mutants with deletions at the other
sites. These cell lines differ from each other in
morphology, number of actin cables, fibronectin
production, and distribution of the 1B 57K pro-
tein. We are examining whether these variations
are correlated with changes in viral DNA or pro-
tein.
Hr 440 an Ad5 host-range mutant isolated by D.
Solnick (Nature 291: 508 [1981]) has also been us-
ed in transformation studies with baby rat kidney
cells. Hr 440 is a lA splicing mutant that produces
no 12S mRNA and a truncated protein from the
13S message yet is wild type in expression from
the 1B region. This mutant transforms at greatly
decreased efficiency as compared with wild type,
suggesting that the 1B products alone are not suf-
ficient to induce transformation in this system.
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Figure 6
Position of the deletions generated within early region 1 of Ad2 relative to the splice sites (----) and coding regions
(f=) on the 1A and 1B mRNAs.
Proteins of Transformed Cells:
Plasminogen Activator
B. Anderson, J. Sambrook, in collaboration with
D. Rifkin (New York University Medical School)
Many lines of virus-transformed and tumor cells
synthesize and secrete large quantities of proteases
or protease activators, and it has been suggested
that in some cases, at least, the secretion of these
enzymes leads to increased proteolysis of the cell's
surface, which in turn induces several of the
phenotypic changes that characterize malignancy.
Among the proteases secreted from transformed
cells are two that are capable of activating
plasminogen to plasmin. The more common of
these, urokinase, appears to be a fairly broad-
spectrum protease; by contrast, the so-called tissue
activator that is synthesized by a relatively small
number of cell types is highly specific for
plasminogen. The enzyme may be similar to one
that is synthesized by cells of the vascular en-
dothelium and that may be responsible for in-
itiating the dissolution of fibrin clots. Little is known
about plasminogen activator, and the aims of this
project are to analyze the enzyme in detail at the
molecular level and to clone and study the struc-
ture of its gene.
During the last year we have raised polyclonal
sera in both rabbits and mice against denatured
and native forms of the activator purified from
human melanoma cells. These sera immunopreci-
pitate a family of highly glycosylated molecules
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(-70,000 m.w.) from a variety of transformed cell
and tumor lines of human origin. The secreted
form of the activator is of slightly lower molecular
weight than the intracellular form. This result is
consistent with pulse-chase experiments that show
that the protein is synthesized as a precursor that is
cleaved as it is secreted from the cell.
A solid-phase radioimmunoassay for plasmino-
gen activator has been developed to screen sera for
anti-plasminogen-activator binding activity. The
assay has already been used to follow the progress
of the various animal immunization programs and
is currently being used to identify murine
hybridoma cell lines that secrete monoclonal an-
tibodies directed against plasminogen activator.
These sera also neutralize the activity of purified
plasminogen activator and appear to recognize
molecules synthesized in in vitro protein-
synthesizing systems using mRNA extracted from
human melanoma cells.
Monoclonal Antibodies to the Early Proteins
of SV40 and Adenovirus
R.D. McKay
A large number of monoclonal antibodies to SV40
T antigen have been generated both here and at
other laboratories. We have mapped the sites at
which ours bind to T antigen by using a set of
adeno-SV40 hybrid viruses that express different
extents of T antigen stretching from the C terminus.
We have anti-T antibodies that bind to the amino
terminal sequence shared by small T antigen and to
each of the regions of large T defined by the hybrid
viruses Ad2D2, Ad2ND2, and Ad2NDldp2. These
antibodies have been used to probe two functions
of SV40 large T antigen: (1) its ability to bind
specifically to DNA and (2) its ability to act as a
target for virus-specific cytotoxic T-cell killing (in
collaboration with Dr. L.R. Gooding, Emory
University).
DNA Binding
Using a simple modification of the standard
Staphylococcus immunoabsorbtion procedure, it
is possible to sensitively and quantitatively mea-
sure the affinity of the interaction between SV40
T antigen and DNA (McKay, J. Mol. Biol 145:471
[1981]). This technology has now been extended in
several ways. First, DNase protection and
"footprinting" assays on the specific binding of T
antigen in a crude cell lysate have been
developed. Second, the immunobinding assay was
shown to be sufficiently sensitive to detect the
binding behavior of T antigen from transformed
cell lines. Third, SV40 T antigen has been shown
to bind specifically to sites in polyoma and JC
viral DNAs.
This assay has been used to study the conse-
quences of mutations both in the regulatory DNA
sequnces of SV40 (McKay and Di Maio, Nature
289:810 [1981]) and in the structural gene of large
T antigen (see section above by ).R. Stringer).
Virus-specific Cytotoxic T-cell Killing
Animals immunized with purified T antigen reject
syngeneic SV40-transformed cells. It is presumed
that T antigen exposed on the transformed cells
acts as a target for the immune response. Al-
though immunoreactive material can be found on
the surfaces of transformed cells, there is no
direct proof that it is either the target for the im-
mune system or specifically oriented in the cell
membrane.
We have tried to block cytotoxic killing and
failed, even though a monoclonal anti H-2 anti-
body specifically and effectively blocks cell kill-
ing.
To pursue this question further, we have used
quantitative microfluorimetry to ask whether cer-
tain antigenic sites on T antigen are inaccessible
on the cell surface and whether we can specifical-
ly remove T antigen from the cell surface and
leave H-2 intact. Our current data indicate that
there are antibodies that recognize nuclear T an-
tigen and do not recognize cell-surface T antigen,
suggesting that T antigen is specifically oriented
on the cell surface. It is also possible enzymatical-
ly to remove T antigen from the surfaces of cells
and leave H-2 antigenically intact. This observa-
tion suggests a route to show directly that SV40 T
antigen is itself the target for virus-specific cell
lysis.
Antibodies to Adenoviral Early Proteins
Although we now know a great deal about the
number and structure of adenoviral early pro-
teins, we know little of their functions. As a first
step toward the purification and study of these
proteins, Bruce Stillman (Protein Synthesis Sec-
tion) and I have immunized mice with either the
cytoplasm or a nuclear extract of HeLa cells in-
fected with adenovirus. Hybridomas derived from
these mice have been screened by immunofluor-
escence against (1) hydroxyurea-blocked
adenovirus-infected HeLa cells and (2) adeno-
virus-transformed cells. Antibodies that directly
inhibit adenoviral DNA replication in vitro are
also being sought (see B. Stillman). In a recent fu-
sion we screened 300 hybridoma cell lines in this
way, several of which stain only adenovirus-
infected HeLa cells. In two cases antibodies have
been cloned in soft agar and shown by several
criteria to recognize a gene product of adenoviral
early region 1 b. A second class of specific
monoclonal antibody binds to particular regions
of the cytoplasm of infected HeLa cells. A third
class is characterized by diffuse cytoplasmic
fluorescence of infected cells. We have discarded
any antibodies that recognize determinants in un-
infected HeLa cells. We have shown, however,
that certain antibodies with a high affinity for
particular sites in adenovirus-infected cells
immunoprecipitate the same proteins from in-
fected and uninfected HeLa cells. A possible ex-
planation for this finding is that adenovirus infec-
tion induces a relocation of normal cellular pro-
teins.
Analysis of Regulatory Sequences of SV40
Y. Gluzman, R. Frisque
The region of the SV40 genome around the unique
BglI restriction site at .67 m.u. contains several
regulatory signals. Replication-deficient mutants
of SV40 were constructed by cloning SV40 DNA in
a plasmid vector and altering the sequences near
the BglI site by site-specific mutagenesis techni-
ques (Gluzman et al., Cold Spring Harbor Symp.
Quant. Biol. 44: 293 [1980]). Many of these
mutants have small deletions (4-241 nucleotides),
and some induce early viral proteins in permissive
and nonpermissive cells, complement early
temperature-sensitive mutants, and transform
cells as well as wild-type SV40 (Gluzman, 1980
[ibid]; Gluzman, Cell 23:175 [1981]). Analysis of
viral mRNAs isolated from these transformants
showed that, irrespective of the size or location of
the deletions, the 5' ends of the viral mRNAs were
located approximately the same distance from
the putative early promoter (i.e., the TATA box),
rather than at a specific site in the viral genome.
There are indications that a second region (a
tandem repeat of 72 bp) 90 nucleotides upstream
from the TATA box may be part of the SV40 early
promoter (Benoist and Chambon, Nature 290: 304
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[1981]; Gruss et al., Proc. Natl. Acad. Sci. 78: 943
[1981]). We have made deletion mutants within
this region using the restriction enzyme Sphl,
which cleaves once within each 72-bp repeat. The
resulting virus remains viable after removal of the
sequences between the Sphl sites (one complete
72-bp repeat), which is in agreement with earlier
studies. In contrast to recent reports, however,
deletion of additional sequences by limited
nuclease-S1 or BaI31 treatment still yields viable
(though impaired) virus. We are presently deter-
mining what effect these deletions have on early
and late transcription of the SV40 genome and on
transformation.
In a parallel approach, two clones have been
constructed that contain the entire early coding
region of SV40 but lack the sequences just
upstream from the initiation codon for the early
viral proteins large and small T. The pT6 clone (Y.
Gluzman, S.-L. Hu, and J. Sambrook, unpubl.) was
constructed by positioning the Ad2 major late
promoter 60 nucleotides upstream from the in-
itiating codon. The pBD1 clone (L. Ling and Y. Gluz-
man, unpubl.) was derived from the adeno-SV40
hybrid D1. This clone contains the adenovirus ear-
ly region 2 promoter, with the cap site of the
mRNA located 200 nucleotides upstream from the
AUG codon of SV40 T antigen. The transforma-
tion efficiencies of these DNAs were compared to
that of a clone containing wild-type SV40.
Although the SV40 clone transformed rat cells at
a frequency of 300-600 foci /µg DNA/106 cells, the
clones containing the adenoviral promoters were
a hundredfold less efficient. Furthermore, pT6
and pBD1 transformants took longer to appear
than wild-type transformants, were less trans-
formed morphologically, and contained fewer
viral early proteins. Expression of large-T and
small-T proteins could be enhanced fivefold by
superinfecting cells transformed with pBD1 with
Ad2. This result might be due to the ability of ear-
ly region 1A to turn on other adenoviral transcrip-
tion units, including the E2 promoter of pBD1,
which is now integrated into the cellular genome.
Transformation of Permissive Cells
with Origin-defective Mutants of SV40
Y. Gluzman, 0. Sundin
Isolation of simian cell lines transformed by ori-
SV40. Lines of simian cells transformed by
origin-defective SV40 have been isolated (COS-1,
COS-7) (Gluzman, Cell 23:175 [1981]). The in-
tegrated copy of SV40 in these cells directs the
synthesis of a wild-type T antigen in sufficient
quantity to drive the replication of sequences of
foreign DNA that are attached to the SV40 origin
of DNA replication. Several foreign gene se-
quences have been replicated to high copy
number in this way. Some of these genes are
transcribed into mRNA, and in one case (influenza
HA) large quantities of the foreign protein are syn-
thesized. Thus, this system provides an opportuni-
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ty to use the techniques site-directed mutagenesis
and recombinant DNA technology to analyze the
roles of various control sequences in the expres-
sion of particular genes. Experiments of this type
are being undertaken, in collaboration with
Pamela Mellon and Tom Maniatis, using the
human a-globin gene (see Mellon et al., Cell
27: 279 [1981]). Although this general approach
has been quite informative, the limitation of the
COS system lies in the fact that once viral DNA
replication begins, it continues for 2-3 days until
the cells die. To avoid this problem and to gain
more control over the replication of SV40 recom-
binants and their transcription, temperature-
sensitive and origin-defective SV40 mutants were
used in an attempt to isolate temperature-
sensitive COS cells. At the present time, several
T-antigen-positive colonies of CV-1 cells trans-
formed by either tsA58-ori- or tsA209-ori -
mutants have been isolated. We are currently in-
vestigating to see whether SV40-specific DNA
replication in these cells is temperature-sensitive.
Human cells (in collaboration with Harvey Ozer,
Hunter College). Establishment of human lines
in culture is a very difficult process. Primary
human cells, if they grow at all in vitro, have a
very short life time. When human cells are
transformed by 5V40, however, they can be
passaged for longer times, and lines can be
established with greater ease. Unfortunately,
transformation of human cells by SV40 virus or
viral DNA is an inefficient process. The resulting
transformed colonies very often contain free
SV40 DNA and produce infectious virus at low
levels (Girardi et al. J. Cell Comp. Physiol. 65: 69
[1965]). To bypass this problem, origin-defective
mutants of SV40 were used. The DNAs of such
mutants were three to ten times more efficient in
transforming human fibroblasts than wild-type
SV40 DNA extracted either from virions or cloned
into the plasmids. The further investigation of this
problem involves establishment of permanent
human lines transformed by origin-defective
mutants, as well as attempts to transform human
cells with origin-defective tsA mutants of SV40.
The latter project might be useful if the transform-
ed phenotype of human cells is extinguished at
40°C and the properties specific for differentiated
cells prior to transformation are reestablished.
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NUCLEIC ACID CHEMISTRY
R.J. Roberts, T.R. Gingeras, R.M. Blumenthal, J.E. Brooks, N. D'Anna, G. Freyer, B.-D. Jiang, Y. Katoh,
P.M. Lin, P.A. Myers, D. O'Loane, K. O'Neill, B. Parsons, P. Rice, M. Wallace, C. Yen
During the past year the Nucleic Acid Chemistry
group has continued to accumulate data toward
the elucidation of the Ad2 DNA sequence. Many
computer programs have been written to assist
both in the assembly and in the analysis of the
growing body of sequence data now available.
Our long-standing interest in restriction endonu-
cleases and methylases has been maintained, and
we have been successful in cloning a type-II
restriction system into E. coli.
Adenovirus-2 Genomic Sequence
T.R. Gingeras, C. Yen, Y. Katoh, B.-D. Jiang, R.J.
Roberts
At the present time two main blocks of sequence
have been collected. The first segment consists of
15,000 nucleotides located between 0% and 41%
on the genome, of which 0-33% is in final form
and two short stretches of sequence are missing
between 33% and 41%. The second main block
of sequence is located at the right end of the
genome and consists of 4000 nucleotides of com-
pleted sequence between genome coordinates
89% and 100%. As a result of the information
available from this laboratory and from others,
most notably the groups of F. Galibert (HOpital
St.-Louis, Paris) and U. Pettersson (University of
Uppsala, Sweden) a total of 22kb of sequence
from the two ends of the genome are now
available in final form. In addition, several large
stretches of contiguous sequence exist between
coordinates 41% and 70%.
During the course of the last year the strategy
employed for sequencing the Ad2 genome has
focused on the collection of data using the M13
cloning-sequencing system. Not only does this ap-
proach provide a simplified means of obtaining
second-strand sequence information within
segments already sequenced, but it has also
allowed us to establish an M13 clone bank which
consists of single-stranded segments from both
the I and r strands of the genome. These clones
have already proven useful for the purification
and characterization of specific Ad2 mRNAs and
will provide a valuable resource for the future.
Analysis of the sequence presently available
and its correlation with data gathered elsewhere
now gives a reasonably complete picture of the
organization of information at the left end of the
genome between coordinates 0% and 33%. By
comparison of our sequence data with informa-
tion obtained by J. Smart (Protein Chemistry Sec-
tion) and B. Stillman (Protein Synthesis Section)
concerning the tryptic peptides of the Ad2 ter-
minal protein, the gene for that polypeptide has
been localized between coordinates 23.5% and
29% and is transcribed from the viral I strand. Of
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considerable interest is the finding of an unex-
pected large open reading frame lying between
coordinates 23% and 14.2% on the I strand. This
open reading frame has a total capacity in excess
of 120K daltons. The N group mutants of Ad2,
which are defective in replication, map within this
gene. Recently, J. Hurwitz (Albert Einstein College
of Medicine) and his collaborators have described
a polypeptide of 140K that is associated with the
Ad2 terminal protein during purification and that
appears to be a DNA polymerase. It is possible
that this protein is the translation product of this
new open reading frame.
In addition to these two large open reading
frames in early region 2B, there are more than ten
other open reading frames within the left-end se-
quence, each of which has a coding capacity in
excess of 10K and which presently cannot be
assigned to any known polypeptides. Some of
these show extensive overlap with other reading
frames. It is becoming increasingly apparent that
the organization of information within the Ad2
genome is highly economical.
Computer Program Development
R.M. Blumenthal, T.R. Gingeras, P. Rice, R.I.
Roberts
From the start of the Ad2 sequencing project we
have been developing software designed to aid
both in the DNA sequencing and the subsequent
analysis of the data. Such programs have elicited
considerable interest due to the huge volume of
sequence data being generated worldwide and
because they are written in a language (FOR-
TRAN) that is relatively transportable to other
computers. Copies of these programs have been
widely distributed.
Among the new programs written during the
course of the last year, there have been two de-
signed specifically to handle data associated with
the M13 cloning-sequencing system. One of these,
called M13, provides a master data base in which
information about the various M13 clones is
stored. A second program, SEQ, provides comple-
mentary information about the sequencing reac-
tions that have been carried out on the various
M13 clones. Both data bases can be searched by a
third program, called FIND, which allows the
ready retrieval of sequence information obtained
from individual clones. The programs M13 and
SEQ, which are responsible for generating the
data bases, require a minimum of manual input
and efforts are underway to reduce this input
even further. During the next year we hope to con-
solidate these programs into a single package that
will simplify both input and retrieval of data.
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A number of small utility programs have also
been written that assist in the analysis of se-
quence data and that include routines for finding
repeated sequences, some specialized searching
routines, and a program that provides annotated
sequence information. This latter program, called
COMBINE, was specifically designed to provide a
means of annotating sequence files that are not
yet in completed form. Often a situation is en-
countered when some specific feature of a se-
quence is known to be associated with a par-
ticular biological property and yet its absolute
coordinate within the sequence is not known
because of uncertainties elsewhere in the se-
quence. Thus, it is not possible to associate an ab-
solute nucleotide number with a particular
feature. This problem has ben overcome in a sim-
ple fashion by using an information file that con-
tains a unique identifying sequence, which is
associated with a comment to be annotated. By
combining a main sequence file with this informa-
tion file, it is possible to produce an annotated
output on which all known significant features of
a particular sequence are indicated. The system is
quite versatile and time-saving.
Table 1
Restriction Endonucleases
I.E. Brooks, P.M. Lin, P.A. Myers
The list of restriction endonucleases has grown
dramatically during the last year, with 97 new en-
tries having been added, including 17 new specifi-
cities. We have been involved in a joint project
with D. Comb and I. Schildkraut (New England
Biolabs), and 87 new strains have been examined
during the year, yielding a total of 32 type-II
restriction enzymes. Among those enzymes iden-
tified, eight have been shown to possess new
specificities, although in several cases the specific
sequences recognized have not yet been deter-
mined. These results are summarized in Table 1.
Much of our work has focused on species from
two genera, Nocardia and Bacillus, both of which
have proved to be valuable sources of type-II
restriction enzymes.
Early Region 4 of Adenovirus 2
G. Freyer
Early region 4 of Ad2 maps between coordinates
91.3% and 100% on the viral genome and is ex-
Strain Enzyme Recognition sequence
Bacillus stearothermophilus
Bacillus stearothermophilus
Bacillus stearothermophilus
C1
C11
G3
Bacillus stearothermophilus G6
Bacillus stearothermophilus H1
Bacillus stearothermophilus H3
Bacillus
Bacillus
Bacillus
stearothermophilus
stearothermophilus
stearothermophilus
Bacillus stearothermophilus
Bacillus stearothermophilus
Bacillus stearothermophilus
Bacillus stearothermophilus
Bacillus stearothermophilus
H4
P1
P5
P6
P8
P9
T12
X1
Microbacterium thermosphactum
Nocardia aerocologenes
Nocardia amarae
Nocardia argentinensis
Nocardia blackwellii
Nocardia corallina
Nocardia erythropolis
Nocardia opaca
Nocardia otitidis-caviarum
Nocardia rubra
Nocardia uniform is
Staphylococcus saprophyticus
Streptomyces endus
Streptoverticillium flavopersicum
Thermoactinomyces species
BstCI (Haell1)
BssCI (Haell1)
BstGI (BclI)
BstG II (EcoRII)
BssGI (BstXl)
BssGII (Mbol)
BstHI (Xhol)
BssHI (Xhol)
BssHII (BsePI)
BsrHI (BsePl)
BssPl
BsrPI
BsrPII
BsePI
BsaPI
BsoPI (BsePI)
BstTl (BstXI)
BstXI
BstXII (Mbol)
Mthl (Mbol)
Nael
Naml
Narl
Nbll (Pvul)
Ncol
Nerl
Nopl (Sall)
Nopll (Sall!)
Notl
Nrul
Nunl
Nunll (Narl)
Ssal
Sent
Sfll (Pstl)
Tsp l
GGCC
GGCC
TGATCA
CC (A/T) GG
GATC
CTCGAG
CTCGAG
GATC
GATC
GCCIGGC
GGCGCC
GGICGCC
CGAT1CG
CCATGG
GITCGAC
TCGICGA
GG1CGCC
CTGCAIG
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pressed early in infection. Although the transcrip-
tion of this region has been studied extensively
and some of the polypeptides encoded by it have
been partially characterized, its role in the Ad2
life cycle is not well understood. With the recent
availability of the complete genomic sequence of
this region, an interesting observation has been
made. A large open reading frame has been found
located between coordinates 92.3% and 94.8%
and capable of coding for a protein of 34K. This
sequence is wholly contained within two E4
mRNAs. However, both of these mRNAs have
complete open reading frames available
upstream of this large one. Unless these mRNAs
are polycistronic or subject to true internal initia-
tion, they would not be expected to be used for
the translation of the 34K polypeptide. All other
mRNAs from E4 are missing these sequences
because of a splicing event that removes se-
quences from coordinates 92.2% to 94.2%.
However, one mRNA does exist that contains a
short exon located between coordinates 94.8%
and 94.2% and that is then spliced a second time
to coordinate 92.2%. If a precursor to this RNA
that is lacking the second splice exists, then this
precursor would be an ideal mRNA from which to
translate the 34K polypeptide. Such a situation
might be analogous to the box locus of yeast
mitochondria (Lazowska et al., Cell 22: 333.
[1980].)
We are examining this system in several ways. A
cDNA library of early Ad2 mRNAs has been con-
structed and is being screened for sequences from
E4. We hope that the putative mRNA from which
the 34K protein is made will be present. The
library will also allow us to determine the splice
points for the other E4 mRNAs, since in only one
case is there sequence information presently
available. We are also exploring an immunologi-
cal approach to identify the 34K polypeptide. Bas-
ed upon the DNA sequence, we have had two
short oligopeptides synthesized, containing 10
and 17 residues from the C terminus of the 34K
polypeptide. These will be used to prepare an-
tisera which we hope will cross-react with the in-
tact protein and will allow us to detect it both in
vivo and in vitro. This approach has proved suc-
cessful in several other systems. We are also pur-
suing a genetic approach to examine the effects
of specific deletions within this reading frame.
Restriction and Modification Genes
J.E. Brooks, T.R. Gingeras
We have been interested in the study of bacterial
restriction-modification (r-m) systems for several
years. Although restriction enzymes are widely us-
ed as research tools, few have been carefully
studied. As yet, little is known about the control,
organization, and expression of these systems in
their bacterial hosts. Although a few of the r-m
systems have been shown to "restrict" the entry
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of foreign DNA into bacterial cells, in most cases
there is no defined function for these r-m systems.
Since most restriction enzymes have been
isolated from obscure bacteria with little formal
genetics, we have begun to transfer the genes
coding for the r-m into E. co/i.
Our work in this area initially began with the
isolation and characterization of one of the better
understood bacterial methylases, the E. coli dam
gene (Brooks et al., J. Mol. Biol. [1982b] in press).
Concomitant with this work were efforts to iden-
tify and isolate several bacterial type-II r-m genes.
A plasmid-borne Type-II r-m system (Jacoby and
Sutton, Plasmid 1:115 [1977]) is present in
Pseudomonas aeruginosa. This PaeR7 system was
originally shown to be a type-II system by Hinkle
and Miller (Plasmid 2: 387 [1979]) and was later
determined to be an isoschizomer of Xhol (P.
Myers, pers. commun.) that recognized the se-
quence CTCGAG. BamHl fragments of this
plasmid (pMG7) were cloned into pBR322, and in-
dividual clones were tested for the presence of
the PaeR7 r-m system. A list of clones that express
the PAO r-m system is detailed in Table 2 and in-
cludes recombinant plasmids that overexpress
both the endonuclease and methylase genes. Of
interest is the fact that although the Pseudomonas
plasmid pMG7 carries four antibiotic resistance
genes, none are expressed in any of the new
recombinant plasmids, not even in PAO 9 (see
Table 2) which contains pMG7 in its entirety.
Our studies of the products derived from these
clones have proved somewhat interesting. The
PaeR7 endonuclease cleaves at the same position
within the recognition sequence as Xhol
(CITCGAG); however, it does not cleave all
legitimate Xhol sites. One such site mapping at
26% on the Ad2 genome is entirely refractory to
PaeR7 cleavage, whether present in native Ad2
DNA or present in cloned copies of this segment
of the genome. Although it has been observed for
a long time that the kinetics of DNA cleavage
varies considerably depending on the position of
the recognition site, this is the only known exam-
ple of a totally refractory site. We do not know
whether this is a failure in recognition or cleavage
or both. However, it is possible that failure is only
in cleavage, in which case this will prove a useful
system in which to study recognition. Towards
this goal, reconstructed versions of this Ad2 site
are being cloned and tested for inhibition of
cleavage. The methylase produced by these
clones modifies the adenine residue in the
recognition sequence (CTCGAG). Although the
PaeR7 methylase is encoded by a separate gene
from the endonuclease, the PaeR7 methylase
modifies the Ad2 site at 26% at a very low rate.
Again the reasons are unclear at present. These
features of the PaeR7 system should prove useful
for studying how these two separate enzymes in-
teract with the same site.
Aided by a clone that contains a 4-kb insert and
that overproduces both the methylase and en-
Table 2
Properties of the PAO Clones
Clone name Insert
Size
(kb)
PAO 4e Bam Barn 39
PAO 9 Barn Barn (partial) 43
PAO 10 Barn Barn 39
PAO H4 Barn HindlIl 6.5
PAO N4 Barn Nru 4
R-M phenotype
in vivo in vitro
Ra Mb Rc Md
no phage growth
a The clones were scored + for in vivo restriction if they produced 10-5 less 080 phage plaques than a host
bacterium containing pBR322.
b The clones were scored + for in vivo modification if, after one cycle of growth on the host clone, 080 phage were
able to grow equally well on restricting and control bacteria.
In vitro restriction activity was determined using a crude lysate of the bacterial clone to cleave Ad2 DNA.
d In vitro methylation activity was determined using a crude lysate of the bacterial clone to modify Ad2 DNA and
demonstrating the prevention of subsequent cleavage by the PaeR7 endonuclease.
e PAO 4 clones express a function that prevents the adsorption of both 080 and X phage.
f Both the restriction and methylation assays showed these extracts to be more than twice as active as their PAO 4
parental clone.
donuclease, isolation and purification of these en-
zymes is in progress. The availability of purified
products from these clones will aid in the iden-
tification and mapping of these genes.
There is mounting evidence that eucaryotic
DNA methylation is important for gene regula-
tion. This has prompted us to explore the possibili-
ty of transferring prokaryotic methylase.genes in-
to mammalian tissue culture cells. In collabora-
tion with Dave Kurtz (Hormonal Control of Gene
Expression Section), initial transformation ex-
periments have been carried out with the E. coli
dam gene and the results are now being analyzed.
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ELECTRON MICROSCOPY
T.R. Broker, L.T. Chow, J.A. Engler, M. Rossini, R.A. Guilfoyle, B. Urso, M. van Bree, M. Hoppe,
M. Halloran
We have used electron microscopy heteroduplex
techniques to study the genetic organization and
expression of a variety of systems such as adeno-
SV40 hybrids, human and bovine papilloma virus-
es, and human a- and /3- tubulin gene families, as
well as of the adenoviruses on which we have con-
centrated for six years. With the near completion
of the electron microscopic mapping of cytoplas-
mic RNAs specified by human Ad2, we have now
also applied a complementing group of additional
techniques-cloning, site-directed mutagenesis,
DNA sequencing, and microinjection of genes
isolated on plasmids-to investigate questions of
adenoviral gene regulation and the fine structure
of genes and their transcriptional signals. We
have also compiled a vast amount of technical
data on the human and animal adenoviruses and
adeno-SV40 hybrids-maps of RNA transcripts,
protein-coding regions, point mutants and dele-
tions, insertions and substitutions, and DNA
restriction cleavage sites; DNA, RNA, and protein
sequences; and alignments and comparisons of
homologous sequences-which are published as
Appendixes in DNA Tumor Viruses and in Genetic
Maps. (Broker 1981, 1982).
Adenoviral Early Gene Regulation
M. Rossini, R. Guilfoyle, J. Engler, L. Chow,
B. Urso, M. Hoppe
The sequential appearance of cytoplasmic viral
mRNAs at early times during infection (Neuwald
et al., I. Virol. 21: 1019 [1977]; Chow et al., J. Mol.
Biol. 134: 265 [1979]; Nevins et al., J. Virol. 32: 727
[1979]) suggested the existence of regulatory inter-
actions among the different early genes. Tran-
scriptional analyses using viruses mutated in de-
fined early regions have provided evidence for
such interactions (Jones and Shenk, Proc. Natl.
Acad. Sci. 76: 3665 [1979]; Berk et al., Cell 17: 935
[1979]; Car lock and Jones, J. Virol. 40: 657 [1981];
Montell et al., Nature 295: 380 [1982]). Recently,
the stimulation of early region 2A expression by
the products of early region 1A has been recre-
ated, in a microinjection system (Rossini et al., I.
Virol. 38: 982 [1981]). In our research, cloned seg-
ments of the viral genome containing genes of in-
terest have been introduced into mammalian cell
nuclei in a variety of combinations and analyzed
for the expression of encoded proteins by an im-
munofluorescence assay. This method allows us
to address detailed questions concerning the ex-
pression and functions of early regions 1 A and 2A:
(1) What are the effects with regard to the activa-
tion of early region 2A caused various region E1A
mutations located in different parts of the gene
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and affecting different spliced RNAs and their
products? (2) How do the wild-type and mutant
E1A plasmids affect expression of the late pro-
moter for E2A? (3) Will other adenoviral pro-
moters lead to transcription of region 2A if they
are substituted for the natural promoters, and
how will they respond to co-injection of E1A plas-
mids? (4) What are the roles of E1A and E2A gene
products in the activation of other early genes?
To investigate whether (and how) region E1A
products interact with the different E2A pro-
moters, three E2A clones in the vector pBR322
have been tested in the microinjection system.
The first (constructed by D. Klessig, University of
Utah) contains a DNA segment between coordi-
nates 59.5 and 76.0 that includes the DNA
(DBP)-coding sequence and both the early and
late promoters located at coordinates 75 and 72,
respectively. The second plasmid (constructed by
S.-L. Hu, Tumor Virus Section) contains an Ad2
Hindll I A fragment (50.1-73.2) in which is present
the DBP gene and only the late promoter. The
third, control clone (constructed by J. Engler) is an
Ad2 BamHl -EcoRl fragment (59.5-71.2) that in-
cludes only the DBP gene but none of its pro-
moters.
The E2A clone containing the DBP gene with
early and late promoters is poorly expressed after
microinjection into hamster or human cell nuclei,
but the presence of E1A in the microinjection
solution leads to a full expression of the DBP, as
determined on the basis of indirect immunofluor-
escent tagging of an antibody to DBP (Table 1).
Surprisingly, the E2A clone containing the DBP-
coding sequence and only the late promoter was
able to produce a detectable amount of 72-kD
protein after microinjection in the absence of
E1A. But when the E1A plasmid was coinjected
with the late DBP gene, expression was dramati-
cally reduced, suggesting that an E1A product
acts as a repressor of transcription initiated at the
late promoter (Table 1). The E2A clone containing
only the gene without early or late promoters was,
as expected, unable to produce the 72-kD protein
either in the absence or presence of E1A products.
Various cloned E1A mutants (Stow, J. Virol.
37:171 [1981]) containing small deletions were
tested for their abilities to activate or repress E2A
expression. By DNA sequence analysis, we have
learned that two of the E1A mutants have dele-
tions of 4 by and 7 by around the Xbal restriction
site. These deletions shift the translation frame
and introduce stop codons that truncate the car-
boxyterminal portions of the gene products speci-
fied in common by all E1A mRNAs. Phenotypical-
ly they eliminate the activation of the E2A clone
containing both the early and the late promoters
TABLE 1
Expression of Early Region E2A after Microinjection into Hamster Cell Nuclei
DBP plasmid:
DBP promoters:
Coordinates:
pBR730 pAd15.1 pAd207
early (+ late) late none
59.5-76.0 50.1-73.2 59.5-71.2
E1A
plasmid Coord. Mutation percentage nuclei fluorescent
15 55 0
BE5 0-9.1 wt 58 15 0
HE4 0-4.3 60 nd 0
M6 0-9.1 SmaR (2.8) 66 8 nd
M14 0-9.1 SmaR (2.8) 48 18 nd
Sx1 0-4.3 SmaR (2.8) 47 18 nd
BE5.1 0-9.1 SmaR (2.8) 2 nd nd
X4 0-9.1 XbaR (3.7) 17 53 nd
X18 0-9.1 XbaR (3.7) 16 52 nd
H22 0-9.1 Hpa R (4.3) 41 15 nd
hrl 0.7-5.7 (2.9) 15 nd
hr440 0.7-5.7 (2.7) 17 nd
* Sequence deleted beyond the Hpal restriction site.
In each experiment, thymidine-kinase-deficient BHK cells were grown for 3 days on 22 X 30-mm glass cover slips in
DME containing 1% calf serum and thymidine. (tk cells have larger nuclei, facilitating the microinjection.) Fresh
medium containing 10% calf serum was added to the cultures 5-6 hr before injection.
About 10-14 liters of the buffer solution containing plasmids was injected into each of 100-200 cell nuclei in up to
ten replicate experiments. Cells were fixed for 15 min with methanol at -20 °C 20-22 hr after microinjection.
The 72-kD DBP was visualized in microinjected cells by indirect immunofluorescence using hamster anti-DBP
serum as the first antibody and fluorescein isothiocyanate-labeled goat anti-hamster glubulin as the second antibody.
Numbers in parenthesis are adenoviral map coordinates where the mutations are located.
and the repression of the E2A clone with just the
late promoter. The Ad5 mutant hrl has a single
base deletion which results in the premature ter-
mination of proteins encoded by the 13S mRNA,
but those encoded by the 12S RNA are not af-
fected (Esche et al., J. Mo/. Biol. 142: 399 [1980];
Ricciardi et al., Proc. Natl. Acad. Sci. 78: 6121
[1981]). The two-base change observed in the Ad5
mutant hr440 inactivates the donor splice site of
the 12S RNA and also introduces a termination
codon in the utilized translation frame of the 13S
RNA, with the appearance of a truncated protein
(D. Solnick and M. Anderson, J. Virol., in press).
E1A plasmids constructed by D. Solnick from
H5hrl and hr440 both gave negative responses
when injected with the E2A clone that has the ear-
ly and late promoters (Table 1). This is in agree-
ment with in vivo results using whole viruses con-
taining these mutations (Berk et al., Cell 17: 935
[1979]; Solnick, Nature 291: 508 [1981]). The Smal
mutant M14 was sequenced and found to have a
six-base deletion. Although the resulting protein
has a deletion of two amino acids, M14 acted like
wild type in its effects on the E2A promoters.
Nonetheless, it has a host-range defect when rein-
troduced into a whole viral chromosome and can
only grow in adenovirus-transformed line 293
cells (which contain a wild-type copy of early
region 1) (M. Anderson, Tumor Virus Section).
Another Sma mutant, BE5.1 (constructed by J.
Engler) has eight-base insertion in the restriction
site. This E1A plasmid is not able to stimulate DBP
synthesis from the early promoter (cf. Carlock and
Jones, J. Virol. 40: 657 [1981]). The Hpal-resistant
clone H22 and the HE4 clone-completely
deleted beyond the Hpal cleavage site-also act
like wild type. The Hpal restriction site is beyond
the E1A protein-coding region but before the site
of RNA polyadenylation. Together these results
suggest that both the carboxyl half of the El A pro-
teins and the internal domain unique to the pro-
teins encoded by the 13S RNA are involved in the
regulatory control of early region 2A. Our data do
not rule out the involvement of the products of
the 12S mRNA generated from early region 1.
The availability of an early region 1B plasmid,
pXX6 (constructed by N. Stow, Institute of
Virology, Glasgow), and various antisera to El B
proteins (from R. Frisque, R. McKay, Tumor Virus
Section, and B. Stillman, Protein Synthesis Sec-
tion) opened the possibility for testing the effect
of E1A on their expression. El B proteins were pro-
duced in cells microinjected with high concentra-
tions of pXX6 by itself, a response that decreased
linearly with the concentration of the plasmid.
The fluorescence of the anti-El B-protein serum
was localized in a few perinuclear bodies. Coin-
jection of the E1A plasmid had no stimulatory ef-
fect. But when the early DBP gene was also coin-
jected, El B expression increased dramatically. If
the E1A plasmid was then omitted, no such stimu-
lation was observed. This response suggested that
the effect of E1A was to stimulate DBP synthesis,
which in turn increased El B expression. This con-
clusion was strengthened by the observation that
the late promoter clone of DBP was able by itself
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to stimulate El B. But when E1A was also added, it
depressed DBP synthesis from the late clone and
El B expression remained unstimulated. It ap-
pears, then, that the DBP plays a significant role
in the expression of El B proteins, and there
emerges the concept of a regulatory cascade: E1A
-E2A- El B. Whether this is a direct effect on the
El B promoter or, instead, on mRNA splicing or
stability is not yet known. Recently, Richardson
and Westphal (Cell 27:133 [1981]) demonstrated
that the DBP also stimulates expression of early
region 4 genes.
To learn about the spacial relations between
the sequences necessary for transcription and
those that interact with E1A products, Richard
Guilfoyle is creating and mapping nested sets of
deletions extending from the upstream (5') sides
of both the early and late promoters for the DBP
toward the gene. The deletions range from -135
to +18 around the early promoter and from
-308 to +7 around the late promoter. (+1 is the
capped 5' end of the RNA.) These will be tested by
in vitro transcription to determine whether RNA is
made and by microinjection to learn whether pri-
mary transcripts are properly processed to mes-
sages and to determine how RNA synthesis re-
sponds to the absence or the presence of early re-
gion 1A. As a necessary control, we have shown
that the early promoter for DBP works in a cell-
free transcription system.
Other preliminary experiments have demon-
strated that the DNA sequence containing the ma-
jor late r-strand promoter and encoding the com-
plete first leader segment and donor splice site,
when coupled in the proper orientation upstream
of the DBP gene and its internal leader, can lead
to the expression of the DBP gene. This suggests
that splicing successfully joined the first late
r-strand leader segment to the DBP gene in the
hybrid transcript. Other promoters, including
those for the IVa2 gene and for early region 3,
have also been placed before the DBP gene.
Several other clones have been made that contain
the early, but lack the late, promoter for DBP. All
will be tested for expression in the presence and
absence of various adenoviral gene products.
DNA Sequences of Adenovirus
Types 7 and 12
J. Engler, M. van Bree, M. Hoppe
The DNA sequence of group-B Ad3 was determin-
ed between coordinates 8.9 and 11.0, as reported
last year. The sequence of another group B-virus,
Ad7, was determined between coordinates 11 and
31 (linking to the sequence of Ad7 between coor-
dinates 0 and 11 determined by Dijkema, Dekker,
and van Ormondt [see Broker 1981]). Over much
of that same interval the group-A Ad12 was also
sequenced. As described by the Nucleic Acid
Chemistry Section, the group-C Ad2 was sequenc-
ed from coordinates 0 to 31. Thus, the data are
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available for detailed comparisons of transcrip-
tional signals, open reading frames, inferred pro-
tein sequences, and conservation and divergence
on an evolutionary scale. The IVa2 genes of the
several viruses are 80% homologous, with most
nucleotide changes being transitions or transver-
sions. There is a corresponding conservation of
amino acid sequences, in as much as most base
changes occur in the third position of the coding
triplets. The Ad7 IVa2 protein consists of 448
amino acids and has a molecular weight of
50,600. The positions of the 5' end and of the
donor and acceptor splice sites of the Ad7 and
Ad12 messages can be inferred by analogy to
those of Ad5 (Fig. 1) (van Beveren et al., Gene
16: 179 [1981]):
Between coordinates 29 and 30, the genes for
two virus-associated (VA) RNAs are evident. They
have somewhat limited homology to the cor-
responding VA I and II RNAs of Ad2, but are
rather more conserved at the 5' and 3' ends and
the internal promoter region for polymerase III
transcription, and also with respect to the exten-
sive secondary structure. The T1 oligonucleotides
previously determined for Ad7 VA RNA (Ohe et
al., J. Biol. Chem. 244: 5320 [1969]) match the com-
plete sequence of VA I. Between coordinates 29
and 23, the leftward-transcribed strand has an
open reading frame that, over most of its length, is
closely related to those of Ad2 and, where com-
pleted, Ad12. Studies of the trypic peptides of the
Ad2 DNA terminal protein (55 kD) and its 87 kD
precursor have recently identified this open frame
as the corresponding gene (J. Smart and B.
Stillman, submitted; T. Gingeras et al., submitted;
P. Alestrom et al., submitted). The sequences giv-
ing rise to the late RNA leader segments 1, 2, i,
and 3 have also been identified by their close
homology to those of Ad2 (Akusjarvi and Petter-
son, Cell 16: 841 [1979]; Zain et al., Cell 16: 851
[1979]; A. Virtanen et al., submitted). There is
more homology than would have been expected
from the failure to establish Ad7 RNA:Ad2 DNA
heteroduplexes (Kilpatrick et al., J. Virol. 30: 899
[1979]). This raises the probability that the scat-
tered mismatched bases lower the optimum an-
nealing temperatures more than predicted by
previous equations to the point where the propen-
sity for intrastrand RNA secondary structures
may, for all practical purposes, prevent efficient
RNA:DNA cross-annealing. This has a great bear-
ing on the general design of hybridization
analyses using RNA:DNA probe combinations.
In Ad7 DNA, a long open reading frame starts
to the right of coordinate 20 and overlaps the
coding region for the amino-terminal portion of
the IVa2 protein, but it is in a different reading
frame (Fig. 1). This second gene encodes the
105-kD protein specified by early region 2B
(Stillman et al., Cell 23: 497 [1981]); cf. T. Gingeras
et al., submitted; P. Alestrom et al., submitted).
Within the overlapping genetic regions, the car-
boxyterminus of the 105-kD protein is substantial-
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Figure 1
Potential open translation frames in the 1Va2 gene of Ad7. The scale length indicates map coordinate and base pairs
from the left end of Ad7. Frame 1 begins at nucleotide 5769. Vertical lines show the positions of stop codons (UAG,
UGA, UAA) in each potential translation frame. The arrow in frame 2 marks the most abundant 5' end of the 1Va2
mRNA at nucleotide 5691, determined analogy to Ad2 (Baker and Ziff, J. Mol. Biol. 149: 189 [1981]). The dotted line
marks the positions of the donor (nucleotide (nucleotide 5282) RNA splice sites determined by
analogy to Ad5 (van Beveren et al., Gene 16: 179 [1981]). The coding frame for the IVa2 polypeptide is shown by the
solid bar; the position of the first ATG (nucleotide 5573) downstream from the presumed 5' end of the 1Va2 mRNA of
Ad7 is marked by the open triangle. This position is probably also used in Ad5 and Ad12. The stippled bar represents
the early region 2B protein-coding frame, which overlaps the 5' end of the 1Va2 gene.
ly more conserved than the amino terminus of the
Iva protein, suggesting that the primary evolu-
tionary pressure was exerted on the 105-kD pro-
tein. On the basis of its position in a transcrip-
tional unit that encodes other DNA replication
functions (DBP and the precursor to the DNA ter-
minal protein), the 105-kD protein can be inferred
to play a role in replication.
Sequences of the Inverted Terminal Dupli-
cations of Adenovirus Types 4, 9, 10, and 31
J. Engler
Ad4, 9, 10, and 31 DNAs were isolated by Diane
Smith and Bill Topp. The DNA terminal proteins
covalently linked to the 5' ends were removed by
exhaustive digestion with pronase. The 3' ends
were labeled by [32P]dGMP incorporation using
the large fragment of E. coli DNA polymerase I.
The terminal fragments were clipped off with re-
striction nuclease Rsal, and the fragments were
isolated by digestion with Rsal followed by poly-
acrylamide gel electrophoresis, and then sequenc-
ed by the Maxam-Gilbert method. As with all
other adenoviruses, the ends are inverted duplica-
tions of one another. Those of Ad4 (a group-E
virus) are 116 nucleotides long; those of Ad9 (a
group-D virus), 158 nucleotides; and those of Ad31
(a group-A virus), 148 nucleotides. By way of com-
parison, the terminal duplications previously
determined for Ad2 and Ad5 (group-C viruses) are
103 nucleotides long, and those of Ad12 (another
group-A virus) are 165 nucleotides long. All the
human serotypes share some sequence homology,
particularly over the first 22 nucleotides. This un-
doubtedly reflects conservation of recognition se-
quences for the linking of the (highly conserved)
terminal proteins, which serve as primers for DNA
replication, and for the binding of other proteins
involved in the initiation of replication at the ter-
minal origins for DNA synthesis. Nucleotide-by-
nucleotide alignments and comparisons of the in-
verted terminal duplications of these and several
other human and animal adenoviruses indicate
those sequence elements that are most highly
conserved, those that are more free to diverge,
and the extent to which the various viruses are in-
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terrelated evolutionarily (see Broker 1981; T.
Broker and J. Engler, in prep.).
Electron Microscopic Studies of
Adenovirus Type 9
L. Chow, T. Broker
Human Ad9 is a representative of the group-D
adenoviruses. Although they have not been
studied extensively at the molecular level, but
have a number of unusual biological properties,
including the specific induction of breast tumors
in female Wistar/Furth rats, as described in more
detail by Bill Topp (Annual Report, 1981). In col-
laboration with Bill Topp and Diane Smith, we
have been analyzing the DNA homology relation-
ships among the group-D viruses Ad9, 10, and 26
and with representatives of group-A (Ad12), group-
B (Ad7) and group-C (Ad2). The primary dif-
ferences among the group-D viruses reside in ear-
ly region 3 and the fiber genes. Those differences
between Ad9 and viruses from other groups are in
early regions 1a, 1 b, 3, and 4, as well as in the fiber
gene (Fig. 2). Early region 2a, encoding the DBP, is
somewhat diverged, and E2B, encoding the DNA
terminal protein and the 105-kD protein, is quite
highly conserved, as are the genes for many of the
late proteins.
Studies of Ad9 RNA in heteroduplexes with Ad9
DNA showed rather typical spliced adenoviral
RNA structures, reflecting a conservation of
genome organization, except in early region 3,
which was nearly twice as long in Ad9 (coor-
dinates 74-88) as in Ad2 (coordinates 78-86). The
Ad9 fiber gene is shorter than its analog in Ad2.
Early region 3 RNAs exhibited a multitude of alter-
native splicing patterns, with one or two interven-
ing sequences and two possible 3' ends. Further-
more, E3 is notably overexpressed relative to
transcripts from other early regions, and E1A
RNAs are significantly underrepresented. The
possible significance of these qualitative and
quantitative differences with regard to the unique
behavior of Ad9 are not presently known.
Studies of Adeno-SVR6 Hybrid Viruses
L. Chow, T. Grodzicker
The genomic structure of the hybrid virus adeno-
SVR6 constructed by C. Thummel, R. Tjian, and T.
Grodzicker, Cell 23:825 (1981) and the SV40
T-antigen RNA transcript derived from it have
been studied by electron microscopy heterodu-
plex analysis (Fig. 3). The SV40 insertion was
shown to be at adenovirus map coordinate 5.0,
within early region 1B, instead of at the BamHl
restriction site at coordinate 29.2, as originally
constructed, indicating that a major rearrange-
ment took place. The SV40 sequences are in the
Figure 2
Heteroduplex between Ad9 and Ad2. Unpaired regions in the heteroduplex are shown by solid bars in the inter-
pretive graphic. Early regions 1A, 1 B, 3, and 4; the DBP gene (D, part of early region 2A), and the positions of the VA
RNAs, penton (P), and hexon (H) are labeled. The single-stranded circular molecule in the micrograph is adenoviral
DNA with the inverted terminal duplication paired together.
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correct orientation to be transcribed from the
adenoviral early region 1B promoter. A variable
length of DNA that does not share any homology
with either adenoviral or SV40 DNA is located
transcriptionally downstream from the SV40
specific-sequences. The adenoviral DNA between
coordinates 5.0 and 59.5 is entirely deleted. The
SV40 T-antigen mRNA is a hybrid transcript that
originates from the El B promoter and is process-
ed using the polyadenylation signal of the SV40
insertion. It contains a 490-nucleotide leader
separated from the main body of 2660 nucleo-
tides by a splice deletion of 365 nucleotides. The
hybrid RNA leader therefore consists of 160
nucleotides of adenoviral El B sequence linked to
330 nucleotides of SV40 sequence. Correlation of
A. SV40\ 2.7kb
B.
C.
R6
Ad2
5.05%
.48kb .36kb 1.97kb/
4.6
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Figure 3
Structure of pSVR6 and its RNA transcript. (A)
Schematic representation of a heteroduplex formed
from Ad2 DNA (solid thick strands), SV40 DNA (thin
strands), and pSVR6 hybrid virus (containing adenoviral
sequences from coordinates 0-5.05 and 60-100 m.u., the
SV40 early region, and a variable length of other DNA
(hatched line) (which turns out to be carrier calf thymus
DNA used during transfection (T. Grodzicker, Tumor
Virus Section). (B) Schematic representation of an R
loop formed with pSVR6 and hybrid RNA recovered
from infected cells. The 5' end of the RNA starts at the
early region 1B promoter (coordinate 4.6), the 3' end is
at the 5V40 early region polyadenylation site, and the
splice corresponds to that found in the RNA for the
SV40 large T antigen. (C) Comparison of RNAs encoding:
(i) SV40 large T antigen, (ii) pSVR6 large T antigens, (iii)
the 15kD protein of Ad2 El B, the 55-kD protein of Ad2
El B. As above, thick lines refer to adenoviral sequences
and thin lines to SV40 sequences. AUG initiation codons
are indicated by tick marks, and those utilized in the
four RNAs are shown with an asterisk(*). The 55K RNA
species from both pSVR6 and adenoviruses are
translated starting at the second AUG initiation codon.
this mRNA structure with the adenoviral DNA se-
quence shows that the adenoviral DNA contains a
potential AUG initiation codon. This AUG is very
likely out of phase with the SV40 T-antigen coding
frame and, in any case, is apparently not utilized
during translation. This conclusion may be drawn
because the T antigen of the hybrid virus is iden-
tical to the genuine T antigen encoded by wild-
type SV40 virus (Thummel et al., COI 23: 825
[1981]). This presents the unusual situation of an
internal AUG, rather than the 5'-proximal AUG, in-
itiating the synthesis of a eucaryotic protein. In-
terestingly, El B proteins of wild-type Ad5 can be
translated from either the 5'-proximal or an inter-
nal AUG (Bos et al., Cell 27: 121 [1981]).
Characterization of Human a and 0-Tubulin
Genes
L. Chow (in collaboration with N.J. Cowan, D.C.
Wilde, and F.C. Wefald, Princeton University)
Several lambda recombinant phage made from a
human genomic library have been identified to
contain either a- or f3- tubulin- specific sequences
by Cowan, Wilde, and Wefald using cloned
chicken tubulin cDNAs as probes. They have
shown that there are multiple copies of each of
the genes and that genes in either family are not
linked closely. The structures of one fi-tubulin and
two a-tubulin genes have been studied by elec-
tron microscopy after heteroduplex formation
with chicken cDNAs (Figs. 4 and 5). All three genes
are spliced, and their 5' and 3' ends as deciphered
from electron microscopy studies are consistent
with those determined by biochemical methods.
The sum of the lengths of human sequences that
hybridize to the chicken cDNAs accounts for es-
sentially the entire length of the cDNAs. Further-
more, the human and chicken sequences form
stable heteroduplexes under rather stringent con-
ditions, suggesting a high degree of homology in
sequences expressed as mRNAs. The /3- tubulin
gene in clone 5-beta and the a-tubulin gene in
clone 2-alpha both contain three intervening se-
quences (IVS). The a-tubulin gene in clone
19-alpha has only two IVS, corresponding in posi-
tion to the first two in clone 2-alpha. However, the
intervening sequences in 2-alpha and 19-alpha dif-
fer in both size and sequence. In addition, the 5'
and 3' ends of these two genes are somewhat
diverged. Several pairs of short inverted duplica-
tions, presumably of the Alu family of middle-
repetitive sequences, are found in the intervening
and flanking sequences in clones 5-beta and
2-alpha. Whether the sequences play any role in
the regulation of these genes is not yet clear.
Homology Relationships of Human and
Bovine Papilloma Viruses
L. Chow, T. Broker
Papilloma viruses cause numerous types of warts
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Figure 4
Structures of a-tubulin-specific sequences in clones 2-alpha and 19-alpha. (a) Heteroduplex between a Sacl fragment
of 2-alpha and EcoRl- linearized chicken a-tubulin cDNA, pT1 DNA. The inverted duplications in 2-alpha did not pair
and gave a well-laid-out heteroduplex. (b) Like A, except that the two pairs of inverted duplications in 2-alpha had
annealed. (c) Heteroduplex between EcoRl- linearized pT1 DNA and a 19-alpha in a fragment generated by digestion
with EcoRI/Smal. ( ) 2 -alpha or 19-alpha restriction fragment; (- - -) pT1 DNA; ("") inverted duplications.
C1-C4 are regions of hybridization; S1-S3 are intervening sequences. (d) Schematic representations of a-tubulin-
specif ic sequences. Raised bars are sequences specific for a-tubulin; equivalent regions of 2-alpha and 19-alpha are
indicated by dotted lines; the scale indicates kilobase pairs.
in humans and other mammals and birds. Most
are benign epithelial cell proliferations, but a few
types have been correlated with the eventual
development of invasive carcinomas. Thus the
papilloma viruses appear to be bona fide tumor
viruses. They have been little studied because
they cannot be propagated in cell culture
systems. They replicate slowly in infected basal
epithelial cells sufficient to maintain a low copy
number of free HPV plasm ids. Productive replica-
tion, late protein synthesis, and the assembly of
new virion particles take place in situ in differen-
tiated keratinocytes. But such cells do not divide
in situ or in culture, and therefore large quantities
sufficient for experimental work with the viruses
cannot be prepared conveniently. At best, it has
been necessary to recover virus particles or viral
DNA and proteins from wart specimens surgically
isolated from afflicted individuals, which has
made the standardization of viral materials most
difficult. Nevertheless, with the advent of DNA
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cloning technologies, it became possible to pro-
duce large amounts of homogeneous papilloma
virus DNA. One early finding was the variety of
human and bovine papilloma viral types, each
characteristically associated with specific epider-
mal sites and tissues and with different clinical
manifestations. The types were categorized on
the basis of extent of DNA homology, as scored
by mass hybridization (cf. Orth et al., Proc. Natl.
Acad. Sci. 75: 1537 [1978]; Heilman et al., J. Virol.
36: 395 [1980]; Ostrow et al., Virology 108:21
[1981]; Gross et al., J. Invest. Dermatol. 78: 160
[1982]). Human papilloma virus type 1 (HPV-1) and
HPV-4 are primarily associated with deep plantar
warts; HPV-2, with common warts of the hands
and face; HPV-7, with warts of meat handlers
(although there is no defined relation with animal
wart viruses); HPV-3, HPV-5, HPV-8, HPV-9, and
HPV-10 with flat warts and the pityriasislike le-
sions of rare individuals afflicted with epider-
modysplasia verruciformis, a most serious infec-
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Figure 5
Structure of the human 0-tubulin gene in clone 5-beta. (A) Heteroduplex formed between an EcoRl fragment of
5-beta DNA and a cloned chicken 13- tubulin cDNA, T2. (B) Heteroduplex formed between a Sma I fragment of 5-beta
DNA and a linearized T2 plasm id. Arrowheads point to intervening sequences; arrows indicate the ends of the
heteroduplexes. In both cases, the amino-terminal encoding regions of the genes are located at the left of the
heteroduplexes. ( ) Human DNA in 5-beta; (- - -) pT2 DNA. (C) Diagram of the human 0-tubul in gene in the
5-beta genomic DNA clone. Raised bars indicate sequences homologous to those in T2 DNA. The length of the DNA
in kilobase pairs is indicated below the line.
tion that shows distinct familial tendancies and a
propensity to develop into invasive carcinomas;
HPV-6 causes condyloma acuminata, a highly in-
fectious veneral disease that accounts now for
about 10% of all new VD cases and is incurable.
Some cervical dysplasias also seem to be due to
HPV-11. The various genital warts may, rather in-
frequently, progress to invasive carcinomas.
There also appears to be a significant correlation
between venereal warts and the infection of
newborns with (presumably) HPV-6 that, within
several years of birth, gives rise to juvenile
laryngeal papillomatosis. Left untreated, this can
cause hoarseness, loss of speech, then asphyxia-
tion. It was formerly treated with X-irradiation,
with the consequent induction of throat cancers;
now the lesions are burned back with lasers,
though the process must be repeated at regular in-
tervals. Adult laryngeal papillomatosis is on the
rise, an apparent consequence of oral-genital sex.
Last year, Maurice Green approached us with
HPV-1, 2, 3, and 4 DNAs he and Karl Brackmann
had cloned at St. Louis University using viral
DNAs isolated in Gerard Orth's laboratory
(Pasteur Institute); with an unknown pair of clon-
ed Barn restriction fragments-presumably of
HPV origin-from a patient having vulval cancer
and epidermodysplasia verruciformis that they
worked up in collaboration with Magdalena Eis-
inger (Memorial Sloan-Kettering); and with HPV-5
DNA cloned by Dina Kremsdorf and Moshe Yaniv
(Pasteur Institute). We prepared and analyzed all
possible pairwise heteroduplex combinations of
the viral DNAs (excised from the pBR322 vector
sequences). The results were, in several respects,
unexpected. HPV-1 and HPV-4 form only very li-
mited heteroduplexes, with short, widely separ-
ated, but reproducible pairing, in spite of the fact
they cause nearly identical lesions (Fig. 6a). Each
of these establishes similar limited heterodu-
plexes with HPV-5, an epidermodysplasia verruci-
formis virus. HPV-1, 4, and 5 have not yet been
found to form heteroduplexes with HPV-2 or 3.
But HPV-2 and 3, implicated in lesions of a quite
different nature and seriousness, establish hetero-
duplexes over much of their length, as shown in
the electron micrograph of Figure 6b and as sum-
marized in the histogram in Figure 7. When the
stringency of pairing is raised by increasing the
solvent concentration of formamide, the pairing is
diminished to about 10% to 15% of their length.
These results indicate that the HPV-2 and HPV-3
DNAs are approximately 45-62% homologous
over most of their length and more so in the re-
gions with the most persistent pairing. When the
two Barn restriction fragments of the unknown
DNAs were mixed with either HPV-2 or HPV-3
DNA, they formed extensive heteroduplexes and
lined up end to end to span the full length of the
complementary HPV-3 or HPV-2 DNA strand.
Thus, together, the two fragments represent an en-
tire papilloma virus chromosome. They are rather
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Figure 6
Electron micrographs of human papilloma virus DNA heteroduplexes. (Top) HPV-1 and HPV-4 DNAs were both
linearized at their single BamHl restriction site. Only limited (though reproducible) pairing occurs under nonstrin-
gent conditions of 30% formamide, 22°C; nonetheless, both viruses are associated with deep plantar warts. (Bottom)
HPV-2 (opened at its single EcoRI site) formed extensive heteroduplexes with HPV-3 (opened at its single Barn site) in
the presence of 30% formamide, as shown; pairing in certain regions persisted in 50% formamide, indicating
substantial homology. Despite this similarity, HPV-2 is associated with common warts and HPV-3 with the rare and
serious disease epidermodysplasia verrucif orm is.
Figure 7
Graphic summary of heteroduplexes found between papilloma virus DNAs (excised from their plasmid vector se-
quences). (a) HPV-2 was opened at the single EcoRI restriction site and HPV-3 at its single BamHl site.
Heteroduplexes were found in 30% formamide and prepared for electron microscopy in 50% formamide (spread
over a hypophase with 20% formamide). (b) The same heteroduplexes prepared for electron microscopy under less
stringent conditions of 30% formamide spread over 5%. (c) HPV-2 in heteroduplex with an HPV-3 variant that was
cloned as two separate but contiguous BamHl restriction fragments. Samples were prepared by spreading from 30%
over 5% formamide at 20°C. An inverted duplication near its midpoint is shown in the line representation of the
HPV-2 strand. (d) HPV-3 in heteroduplex with the HPV-3 variant used in c. Samples were spread from 60% over 30%
formamide at 27°C. (These samples spread at 22°C had substantially more duplex.) In all cases, the DNAs were
opened with restriction endonucleases at nonhomologous sites, hence the staggered ends. The partial homology pat-
terns have not been oriented with respect to the restriction maps.
48
a HPV 2: HPV 3 HETERODUPLEXES; 50%4 20% FORMAMIDE
HPV 2
HPV 3 I0
b
X40
a_
C0
- 30
U)
020
O
. 100
HPV 2
HPV 3 0
0
10 30 4'0 610 70 100
HPV 2 = HPV 3 HETERODUPLEXES; 30% -) 5 % FORMAMIDE
0 10 20 30 40 50 60 70 80
10 20 30 40 50 60 70 80 90
100 Lys
a_
.75
_J
50 D
0
-J0
25
0
90 190
100
C HPV 2: HPV "n" HETERODUPLEXES; 30 %-) 5% FORMAMIDE, 22° C
100.
80
60
40
20
HPV"n
HPV 2
o'
BamHI A
50
BamHI B
100
0 50
EcoRI
d HPV 3 = HPV ''n" HETERODUPLEXES ; 60% 30% FORMAMIDE , 27° C
LL, 100
O-D0
w
cr)
D 500
(Ai
02
0
HPV "n
HPV 3
A
Figure 7
BamHI A BamHI B V
50 100
50
BamHI
100
A
100
49
closely related to HPV-3, which is not too surpris-
ing since the patient had epidermodysplasia ver-
ruciformis, but the prominant differences from
the group type HPV-3 in several regions of the
chromosomes establish this new virus as a signifi-
cant variant. All the human papilloma viral DNAs
measure close to 7800 nucleotide pairs, based on
comparisons with cPX174 and colicin El DNA
length standards. Future heteroduplex studies will
test independent isolates of HPV types to search
for other variants and to define a protoypte col-
lection. We shall concentrate in particular on
cloning and comparing viruses associated with
epidermodysplasia verruciform is, condyloma acu-
minata, and laryngeal papillomas.
Law et al. Virol. 32: 199 ([1979]) had reported
that certain restriction fragments of bovine papil-
loma virus 1 (BPV-1) and HPV-1 shared a limited
amount of homology. We formed BPV-1:HPV-1
heteroduplexes and mapped the partial homology
region precisely. This information should allow
mapping data achieved with the two systems to
be cross-correlated rather accurately, assuming
that the rest of the genomes are organized similar-
ly. Studies are in progress now to determine the
RNA transcription map of HPV-1 so that the heter-
oduplex patterns and the DNA sequence can be
interpreted with respect to genetic expression. To
that end, we have cloned HPV-1 isolated from a
plantar wart in a shuttle vector (provided by R.
Tjian [University of California, Berkeley]) that con-
tains the pBR322 replication origin and ampicillin
resistance gene and the SV40 replication origin.
Following transfection of SV40-transformed
monkey COS-7 cells (from Y. Gluzman, Tumor
Virus Section), RNAs were recovered. Several
spliced mRNA species were observed after
heteroduplex formation and are presently being
mapped by electron microscopy.
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PROTEIN SYNTHESIS
M.B. Mathews, B.W. Stillman, F. Tamanoi, F.A.M. Asselbergs, L.L. Cascio, E. Cilibrasi, S. Danheiser,
A.M. Francoeur, S. Lemaster, P.A. Reichel, G.P. Thomas, L. Woodruff
The expression of adenovirus genes in virus-
infected and virus-transformed cells remains a
focus of the research interests in the Protein Syn-
thesis Section. In addition to continued progress
in investigating the functions of virus-coded pro-
teins, particularly those concerned with DNA
replication, this year has seen the rapid develop-
ment of new research projects. One of the new
areas concerns ribonucleoprotein-particle forma-
tion and represents an outgrowth from other
adenovirus-related studies that we have been pur-
suing. A second topic, the investigation of the
stress response or "heat shock" phenomenon in
human cells, now shows few traces of its origins
(as far as our studies are concerned) in adenovirus
work.
Control of the Productive Cycle
S. Lemaster, M.B. Mathews
In previous annual reports we have discussed the
sequential expression of classes of adenovirus
genes. The immediate early genes are autono-
mously active and do not require protein synthe-
sis for their expression; the El A region early gene,
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Figure 1
Expression of the adenovirus genome integrated into transformed cell DNA. The full set of early regions of the virus
expressed in productive infection is illustrated in the top part of the figure. The portions of the viral genome that
have been identified in six transformed lines are shown in the lower part of the figure. Arrows indicate the early
genes expressed. The extent to which the products of a given early gene in transformed cells approximate those
found in productive infection is suggested by the shading: stippled, full expression; hatched, intermediate; unshad-
ed, poor correspondence. (Reprinted, with permission, from Lewis and Mathews 1981.)
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itself sensitive to a rigorous blockade of protein
synthesis, is responsible for activating most, if not
all, of the other early genes-El B, E2A, E2B, E3,
and E4; the intermediate genes are transcribed, at
least to some extent, before viral DNA replication
commences; and finally, the true late genes are
only expressed following viral DNA replication,
an event that involves at least two of the early
genes.
The distribution of these genes along the adeno-
virus chromosome is shown on the top line of
Figure 1. We have taken several approaches to ex-
plore aspects of this complex set of regulatory in-
teractions. Some of these investigations are well
advanced and are described in their individual sec-
tions below. A novel approach that we have recent-
ly adopted involves the construction of chimeric
genes that place the expression of the herpes
simplex virus enzyme, thymidine kinase (TK), under
the control of adenoviral DNA sequences thought
to control transcription of early regions E4 and E1A
and the late gene block. These chimeric genes will
be introduced into the genomes of cultured mam-
malian cells by transfection and selection will be
for stable TK-positive lines. If we succeed in
isolating these lines, they will be used to examine
the effects on TK expression of normal and mutant
viral gene products introduced by infection.
Manipulation of the adenoviral sequences that
abut the tk gene will add an extra dimension to this
analysis. With these complementary approaches
we hope to examine the functions and interactions
of viral gene products independently of the pro-
gression of an infection.
As a continuation of our work on the early-to-
late switch in gene expression, we are also investi-
gating the abortive growth of human adenovirus
in Chinese hamster ovary (CHO) cells. In a produc-
tive infection of human cells, the activation of the
late genes depends principally on the replication
of the viral DNA that is to serve as template for
transcription. Therefore, it was intriguing to learn
that abortively infected hamster cells are compe-
tent for DNA synthesis but are deficient in late
protein synthesis (Longiaru and Horwitz, Mol.
Cell. Biol. 1: 208 [1981]), implying that replication
and transcription are not necessarily linked.
Closer examination of this point has revealed that
some late mRNAs are present, albeit in low con-
centration and in relative proportions that differ
from those observed in lytic infection of human
cells. Since the early genes seem to be fully ex-
pressed, this implies that factors other than viral
proteins are involved in the production of viral
late gene products and that viral DNA replication
per se is not sufficient to allow synthesis of all
viral genes expressed late after infection. In short,
the hamster cell situation may resemble, in a
more extreme form, the well-known restriction of
human adenovirus multiplication that occurs in
monkey cells. We are currently investigating
whether the block is at the level of RNA transcrip-
tion, processing, or translation and whether it can
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be overcome, as in monkey cells, by SV40 T anti-
gen or changes in the gene encoding the adenovi-
ral DNA binding protein (DBP).
Adenovirus Genes in Transformed Cells
M.B. Mathews
The study of the activity of adenovirus genes in-
tegrated into the host genome in transformed
cells offers insights into the regulation of the viral
genes as well as into their oncogenic role. A sur-
vey of six of the more common adenovirus-trans-
formed cell lines was carried out in collaboration
with Dr. Jim Lewis while he was a member of this
laboratory and completed at long range after his
departure for the Fred Hutchinson Cancer
Research Center in Seattle. In Figure 1, the thin
lines represent the viral DNA segments, usually
comprising less than the full genome, present in
each transformed cell type. Those portions that
are expressed as mRNA are indicated by thick ar-
rows. As expected from previous work, none of
the mRNAs present only at late times in produc-
tive infection was found in any line of transform-
ed cells. Furthermore, of those mRNAs that are
present in small amounts at early times and much
greater amounts at late times, such as those for
the intermediate products IVa2 and IX, only IX was
observed at all (in F4 cells), and then only in the
small amounts characteristic of early times. We
were unable find in any transformed cell line
the L1 52,55K protein mRNA, which, unlike the
other late mRNAs, is present at early times during
infection. This implies that the major late pro-
moter is inactive, but it remains to be shown that
its sequences are fully intact in the transformed
cell genome. The absence of this and of other im-
mediate early gene products implies that these
products are not needed for the expression of
other viral genes, at least in the transformed cell.
This exception apart, all of the early genes that
are present are generally expressed as mRNA. In
most cases, however, less than the full set of
mRNA species (known from productively infected
cells) is seen in the transformed lines. (This fact is
illustrated by the shading of the arrows in Fig. 1.)
As expected, the transforming genes E1A and El B
are expressed in all of the cell lines examined, and
these are the only genes that are invariably ex-
pressed. As in other cases, these genes are not ex-
pressed in their entirety. The E1A species that are
seen at early times in a productive infection, the
58K (58,000 dalton), 54K, 48K, and 42K species,
are present in all cases, but the additional 28K
species, which is characteristically found at late
times of infection, is absent. The major El B
mRNAs, encoding the 15K and 57K proteins, are
present in all the lines, with the notable exception
that no 57K could be detected in F17 cells. This re-
sult, which has been confirmed with a monoclo-
nal antibody (see below), implies that the El B 57K
protein does not play any important role in main-
taining the transformed phenotype.
What this study does not reveal is the basis for
the varying levels of tumorigenicity exhibited by
these lines of transformed cells. The differing
degrees of tumorigenicity show no obvious cor-
relation with the presence or absence of addi-
tional El gene products (detected in two of the
lines), nor with the amounts of El A and El B gene
products. On the other hand, the more tumorige-
nic lines generally contain and express more viral
genes outside of region El than do the less
tumorigenic lines. However, this variation does
not correlate with the expression of any small
number of viral genes but rather with a wide vari-
ety of early genes. Furthermore, several cell lines
that we have not yet studied are as tumorigenic as
T2C4 but have only the left 14% of the viral
genome. Thus, it seems that tumorigenicity is not
related in any simple way to the expression of in-
tegrated viral genes.
Monoclonal Antibodies
B. Stillman
In collaboration with Ron McKay (Tumor Virus
Section), we have embarked on a search for mo-
noclonal antibodies directed against proteins syn-
thesized during the early stage of adenovirus in-
fection of HeLa cells. Nuclear extracts from Ad2 -
infected cells were injected into mice, and after
various periods of time spleen cells were removed
and fused with myeloma cell lines. Hybridoma
cells secreting antibodies of interest were
selected by screening the supernatant medium for
its ability to stain adenovirus-infected cells but
not uninfected cells. In the approximately 25
monoclonal-antibody-producing cell lines that
have been obtained in this way, two types of im-
munofluorescent staining patterns have appeared
a number of times (Fig. 2), and we have prelimi-
nary descriptions of these.
Monoclonal antibodies of the first type are
directed against the adenoviral El B 57K protein, a
component of the adenovirus T antigen. Two in-
dependently derived hybridomas produce anti-
body that immunoprecipitate the El B 57K protein
from infected HeLa cells, from transformed rat
cells, and from the products of cell-free transla-
tion of E1B mRNA. Neither antibody recognizes
any of the smaller El B proteins (described in the
1980 Annual Report). By both immunofluores-
cence and immunoprecipitation tests, the El B
57K protein is present in the transformed cell lines
293, F4, F19, REM, and T2C4 but not in F17 -
which is in accord with the analysis of El B 57K
mRNA in these cell lines discussed above. By im-
munofluorescence, the El B 57K protein is located
predominantly in the nuclei of infected cells,
although in some transformed cells it exhibits a
perinuclear distribution with a concentration at
one site (Fig. 2A).
The second type of antibody also appears to
stain virus-infected cells but not uninfected cells.
The immunofluorescence can be detected in in-
fected cells as soon as 1 hr postinfection and by 4
hr is localized at the cell extremities (Fig. 2B). In
addition, nuclear fluorescence is seen late during
virus infection. Surprisingly, a set of proteins,
40,000-43,000 daltons, is immunoprecipitated
from both infected and uninfected cells. The rela-
tionship between these proteins and the immuno-
fluorescent antigen remains to be clarified.
We expect that these and other hybridoma spe-
cificities that we have detected will be useful pro-
bes in determining functions of viral and cellular
proteins, and further characterization of the anti-
bodies is in progress.
Figure 2
Immunofluorescence of Ad2-infected HeLa cells with monoclonal antibody to (A) the E1B 57K and (B) induced an-
tigen. Cells were infected with Ad2, and hydroxyurea was added to prevent DNA synthesis. Cells were fixed at 21 hr
post infection.
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The Role of Adenovirus Terminal Protein
Precursor in DNA Replication
B. Stillman, F. Tamanoi
The widely accepted model for adenovirus DNA
replication (see Annual Report 1980) entails at
least three virus-coded proteins in different stages
of the process: the terminal protein precursor in
initiation, the DBP in elongation, and a protease
(the ts1 protease) in terminal protein maturation.
Briefly, the 87,000-dalton terminal protein precur-
sor binds to the end of the template DNA mole-
cule and initiates replication. This occurs by a
strand-displacement mechanism starting at either
terminus and requires the presence of DBP. Syn-
thesis of the second strand follows a similar
course, and maturation of the terminal protein in-
volves a later proteolytic cleavage. Other en-
zymes of viral and host origin are probably also
involved but these are less clearly defined.
The role of the terminal protein precursor (pTP)
in the initiation of DNA synthesis is now quite well
established. It is present in extracts of nuclei from
adenovirus-infected cells, and during DNA repli-
cation in vitro it becomes covalently linked to the
dCMP residue at the 5' end of the nascent DNA
chain. The initiation step can be studied in isola-
tion by omitting three of the deoxynucleotide tri-
phosphates from the reaction. In the presence of
dCTP, a pTP-dCMP complex is formed in the pre-
sence of a suitable template (see below). No ana-
logous complex is formed when dCTP is replaced
with any of the other three deoxynucleoside tri-
phosphates. This finding, which has also been re-
ported by Lichy et al. (Proc. Natl. Acad. Sci.
76:2678 [1980]), provides further support for the
protein-priming model of adenovirus DNA replica-
tion (Robinson et al., Virology 56: 54 [1973]; Re-
kosh et al., COI 11: 283 [1977]) and affords an as-
say for initiation that underlies several of the ex-
periments described in the next section.
Last year we reported that the gene for pTP is
located between genome coordinates 29 and 11,
in a newly recognized leftwards-reading E2B re-
gion. Together with John Smart (Protein Chemistry
Section), we have now carried out partial se-
quence analysis of the protein using automatic se-
quential Edman degradation of tryptic peptides
separated by high-performance liquid chromato-
graphy. Data obtained by analysis of pTP labeled
with [35S]methionine by cell-free translation or
with 1251 by iodination of protein from Ad2 ts1
virions give the position of the labeled amino
acids relative to arginine or lysine residues (tryp-
sin cleavage points). Comparison with predictions
derived from the DNA sequence of this region,
recently completed by the Nucleic Acid Chemis-
try Section, makes it clear that the pTP maps be-
tween coordinates 23.4 and 28.9 on the viral ge-
nome, although it leaves open a strong possibility
that some coding sequences come from the lead-
er originating at 39 m.u. that is spliced onto the
body of E2B mRNAs. Analysis of peptides from
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the mature 55K terminal protein shows that it
derives from the C-terminal portion of the precur-
sor, and a potential ts1 protease cleavage site has
been recognized at the appropriate location in the
predicted sequence (corresponding to coordinate
26.0). The site at which the initiating dCMP resi-
due, and subsequently the daughter DNA chain, is
covalently attached to the protein (corresponding
to coordinate 24.2) has also been identified: This
marks the first definition of a functional site
within the protein.
A remarkable fact that emerged from this work
is that the coding region for pTP does not overlap
the region containing mutations of the class-N
complementation group (Gatos et al., Cell 17: 945
[1979]). Mutants in this group exhibit a tempera-
ture-sensitive defect in the initiation of DNA
replication and map within an open reading frame
that is capable of encoding a protein of 120,000
daltons. Thus, it is likely that an additional protein
encoded by region E2B, perhaps the 105K protein
described last year, functions in viral DNA
replication. This possibility is currently under in-
vestigation.
DNA Sequence Requirements for Initiation
F. Tamanoi, B. Stillman
The development of a cell-free system for replica-
tion of adenovirus DNA (Challberg and Kelly,
Proc. Natl. Acad. Sci. 76: 655 [1979]) made it
theoretically possible to examine the DNA se-
quences required for initiation by introducing
mutations into the DNA of the viral termini and
studying their effects on replication in vitro. In
practice, this approach was debarred by the ap-
parently absolute requirement for parental ter-
minal protein on the template DNA, rendering the
functional origin unsuitable for genetic manipula-
tion in bacteria. Until this difficulty was cir-
cumvented, we adopted a different approach, ex-
ploiting the diversity of DNA sequence available
in nature.
In collaboration with Bill Topp (Tumor Virus
Section) and Jeff Engler (Electron Microscopy
Section), DNA-protein complexes were isolated
from the virions of Ad4, 7, 9, and 31, and their
abilities to function as templates for initiation
(assayed by pTP-dCMP complex formation) and
for chain elongation were compared to the tem-
plate activity of Ad2 DNA-protein complex. In the
replication system derived from Ad2-infected
cells, the heterologous DNAs all functioned as
template for both initiation and elongation of
DNA chains but to varying degrees were less ac-
tive than homologous Ad2 template DNA. All
heterologous DNAs catalyzed the formation of
pTP-dCMP complex, but no complex was observ-
ed when alternative deoxynucleotide tripho-
sphates were used. DNA sequence studies showed
that all the serotypes have a 5'-terminal dC
residue and also revealed extended regions of
conserved sequence within the first 50 bases of
each DNA, particularly between bases 9 and 18.
Since all DNAs supported replication to some ex-
tent, this suggests that conserved DNA sequences
play an important role as recognition signals for
proteins involved in the initiation of DNA replica-
tion.
The key to a systematic study of the sequence
requirements at the origin of replication came
from experiments using plasmid DNA as template.
With partially purified enzymes, we found that
the initiation reaction can occur on the plasmid
pLA1, which contains the left terminus of the viral
DNA, provided that the origin is located at the
end of the DNA molecule. When the origin is
located internally in the linear DNA or the
plasmid DNA is circular, initiation is not observed.
This finding came as a surprise, since previous
work, using pronase-treated viral DNA, suggested
that the presence of terminal protein on the
template DNA is necessary for initiation. To
resolve this apparent contradiction, piperidine
was used to remove the protein residue complete-
ly from pronase-treated viral DNA, with the result
that activity was restored. Thus, the terminal pro-
tein on the template DNA is dispensable for initia-
tion, and a specific DNA sequence is required.
This sequence must be present at or very near the
terminus: If as few as 20 nucleotides (or a short
peptide) are interposed, as in the linear form of
the plasmid *8, template activity is abolished.
Further surprise came when the linearized pLA1
DNA was heat-denatured and then used as a tem-
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plate. The single-stranded DNA still supported the
initiation, again provided that the origin is located
at the end of the DNA molecule. The fact that
single-stranded DNA can act as a template sug-
gests that initiation might comprise a two-step
process; first, the unwinding of duplex DNA at its
ends, and second, complex formation using
single-stranded DNA as a template.
We are currently attempting to define the mini-
mum length of wild-type sequence that retains
template activity. To this end, we have created
derivatives of pLA1 that contain decreasing stret-
ches of adenovirus terminal sequence, and these
will be tested for their ability to support the initia-
tion of replication.
The DNA Binding Protein
F.A.M. Asselbergs, M.B. Mathews
The adenovirus DBP is a 72,000-dalton
phosphoprotein, encoded by the E2A gene, with
an important role in the elongation reactions of
DNA replication. It has also been implicated in
several other events in the virus life cycle related
to mRNA regulation. Last year we reported that
the DBP can be synthesized in Xenopus oocytes
injected with adenovirus DNA, or subclones there-
from, and that some shorter products from the
same gene are also made. We have now establish-
ed that some of these shorter proteins are also
present in extracts of virus-infected human cells
and are the authentic products of identifiable
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Figure 3
Functional map of the adenovirus DBP. The open bar depicts the 72K protein, and the vertical bars within it mark
the positions of methionine residues. Brackets indicate regions involved in DNA binding and antibody (IgG) binding,
as well as phosphorylation sites (black triangles). Proteolytic cleavage sites in HeLa cells (H), Xenopus ocytes (0),
and reticulocyte lysate (R) are shown. Short horizontal arrows correspond to the N termini of related minor proteins.
The bottom scale shows the positions to which two mutants have been mapped. (From F. Asselbergs et al., submit-
ted.)
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mRNA species that can be translated in the reticu-
locyte cell-free system. From a comprehensive
study of the full-size DBP and the shorter poly-
peptides, carried out together with John Smart
(Protein Chemistry Section), we have been able to
define the location of several important features
within the protein sequence. As described before
with reference to the pTP, proteins labeled with
[35S] methionine were digested with trypsin, and
the resultant peptides were separated by HPLC
and subjected to sequential degradation from
their N termini. Through a comparison of these
data with the nucleic acid sequence published by
Kruijer et al. (Nucleic Acids Res. 9: 4709 [1981]), in-
dividual peptides were identified, the sequence of
DBP was confirmed along much of its length, and
the structures of the shorter DBP-related proteins
were defined. To identify functional domains
within the molecule, these results were correlated
with experimental determinations of DNA bin-
ding, antibody reactivity, and phosphorylation
properties. The map in Fig. 3 depicts the DBP as a
bar, with the protein's N terminus on the right, and
summarizes the functional topography of the
molecule as presently understood. This informa-
tion will serve as a basis for future detailed in-
vestigations of the biochemistry of this key pro-
tein.
Adenovirus Genes in Frog Oocytes
F.A.M. Asselbergs, M.B. Mathews
Foreign genes can readily be introduced into the
nuclei of immature eggs (oocytes) of the frog
Xenopus laevis by microinjection, and in most
cases they are expressed as mRNA and protein. In
the case of adenovirus DNA, only three of the
many viral genes are so expressed, and these are
in several ways an unrepresentative subset. One is
the DBP gene discussed above and in the 1980 An-
nual Report; the second is the gene for virion
polypeptide IX, translated from an mRNA that
(unusually for adenovirus) is unspliced; the third is
the gene pair encoding the virus-associated (VA)
RNAs, dealt with more fully in the next section.
We cannot at present do more than speculate
upon the reasons why the other adenovirus genes
remain silent in the oocyte, but this has not deter-
red us from exploiting those genes that are active.
In one series of experiments we have examined
the sequence requirements for polyadenylation of
mRNA transcripts. The sequence AAUAAA is
usually found a short distance upstream from the
polyadenylation point, and deletion of this signal
from a cloned polypeptide-IX gene abolishes pro-
tein synthesis. On the other hand, replacement of
adenovirus sequences with plasmid sequences at
the site of poly(A) addition and beyond has no
measurable effect on polyadenylation and poly-
peptide IX synthesis. Although we have not prov-
ed that the poly(A) tail is still added onto the same
nucleotide in the mutants as in the wild type, our
results indicate that the functional downstream
boundary of the gene does not extend beyond its
polyadenylation site.
Ribonucleoprotein Complex Formation
A.M. Francoeur, M.B. Mathews
We have continued our investigations into the
structure and function of the two small, non-
coding, adenovirus VA RNAs. The VA RNAs have
been implicated in processing and/or transport of
adenovirus mRNA and were recently shown by
Lerner et al. (Science 211: 400 [1981]) to form ribo-
nucleoprotein complexes (RNPs) with cellular pro-
tein. These RNPs can be specifically precipitated
with a class of sera, called anti-La, from patients
with the autoimmune disease systemic lupus
erythematosus. We have determined that only
about 2% of VA RNA labeled in vivo is found in
precipitable RNPs and that VA RNA associated
with RNPs appears to be very similar to, if not
identical with, free VA RNA. Comparable results
have been obtained with VA RNA synthesized in
Xenopus oocytes injected with adenoviral DNA,
showing that the La antigen is phylogenetically
widespread.
As a first step toward analyzing the VA RNP
particle, we have demonstrated that VA RNA syn-
thesized in vitro, using an extract of HeLa cells as
source of RNA polymerase HI, is precipitable by
anti-La serum. Interestingly, approximately 50%
of the VA RNA, synthesized is found in precipi-
table form, and 70% of the VA RNA,, synthesized
is precipitable. Since deproteinized VA RNA does
not immunoprecipitate, this means that a large
fraction of the RNA combines with the antigen in
vitro to form a VA RNP complex. The complex is
stable and is formed during transcription or very
soon after. To examine the RNA requirements for
RNP formation, we have programmed the reac-
tion with cloned VA RNA, mutants that have inter-
Figure 4
The stress proteins of HeLa cells displayed on 2-dimensional gels. Polypeptides synthesized in normal HeLa cells
(lower panel) and cells in which the stress proteins had been induced by exposure to AzC (upper panel) were pulse-
labeled with [35S] methionine. The proteins were separated according to their isoelectric points (pl, horizontal
dimension) and sizes ("k" value, vertical dimension). The major stress proteins have been indicated with letters in
both panels to illustrate the degree to which they are induced under these circumstances. The stress proteins are
designated A, 110K/p1 -5.4; B,100K/p1 - 5.0; C, 90K/p1 5.2; D, 80K/p1 5.2; E, 73K/p1 -5.5; F, 73K/p1 -6.4; and G,
72K/p1 5.6. Synthesis of the 73K protein cannot be detected in normal HeLa cells, and lower-molecular-weight pro-
tein (H) is not induced in HeLa cells.
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nal deletions or sequences replaced with those of
pBR322. All the mutant RNAs were found compe-
tent to form precipitable RNPs in vitro, suggesting
that the La antigen is recognizing a feature com-
mon to all the VA RNAs-the RNA termini and/or
the intragenic control region sequences. These
results hinted that the antigen might be involved
in the transcription process itself, but this idea is
not supported by experiments demonstrating that
the transcription system depleted of La antigen by
immunoabsorption retains full synthetic activity.
Further definition of the RNA sequences involv-
ed in RNP formation required establishment of
the means to reconstruct the complex from naked
RNA and factors present in the He La cell extract.
Using partially digested VA RNA, in such a recon-
stitution experiment, we found that only a small
subset of the RNA fragments are able to bind to
the La antigen, and these are located at the two
termini of the RNA molecule. It is tempting to
speculate that the antigen recognizes the stem
structure containing the two base-paired ends of
the molecule. We are presently examining this
possibility and turning our attention increasingly
towards the nature and properties of the protein
antigen. The La antigen appears to be a cellular
protein of molecular weight about 45,000 and is
distinct from the antigens recognized by other
classes of lupus sera.
Analysis of the Stress Response of
Mammalian Cells
G.P. Thomas, M.B. Mathews
The term "stress response" covers the various
forms of a highly conserved response displayed
by many, if not all, organisms when subjected to
metabolic insults of diverse nature. The most
familiar and best characterized example is the
heat shock response displayed by Drosophila lar-
vae and cultured cells subjected to elevated
temperature. Similar responses can be induced in
bacteria, plants, yeasts, protozoa, birds, mam-
mals, and invertebrates by heat shock and by
other means. It seems likely that in each case
similar target functions, perhaps with central roles
in metabolism as a whole, are affected, leading to
generalized metabolic imbalances of greater or
lesser severity. The response is characterized by
the rapid and extensive induction of a small suite
of genes. Their polypeptide products soon domi-
nate preexisting cell proteins in synthesis (Fig. 4)
and in accumulation as a result of controls at
both transcriptional and translational levels. A
growing list of agents can induce the response.
They range from chelators and ionophores to thiol
ligands and respiratory inhibitors, and no unitary
explanation comes to mind. It is noteworthy that
some agents induce only a subset of the eight or
so proteins that represent the full set, so the re-
sponse is a linked but not fully coordinated induc-
tion.
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Most of our work has employed an amino acid
analog, L-azetidine-2-carboxylic acid (AzC), a par-
ticularly potent inducer. The proteins induced in
He La cells by AzC have been characterized by
2-dimensional gel electrophoresis, limited proteo-
lysis, and tryptic peptide analysis. Similar proteins
are found in stressed hamster and chick cells, and
they are all also present in (theoretically un-
stressed) normal cells. Each protein occurs in se-
veral forms differing in charge, and in at least one
case the variation appears to reside in a single
tryptic peptide. These studies have been carried
out in collaboration with Jim Garrels (Quest 2-D
Gel Laboratory) and John Smart (Protein Chemis-
try Section). Together with Bill Welch and Jim
Feramisco (Cell Biochemistry Section), we have
undertaken to purify the stress proteins and to
raise antibodies against them. So far, the 100K,
90K, 80K, and 72-73K proteins have been exten-
sively purified and in some cases are close to ho-
mogeneity. Based on their fractionation during
the initial stages of purification, it would seem
that the 100K and 80K stress proteins are associat-
ed with membraneous material, whereas the
others are largely cytosolic. Instead, the 100K
stress protein has been localized to the Golgi ap-
paratus, as described more fully in the Cell
Biochemistry Section.
A large body of experiments with the AzC/HeLa
cell system supports the following model for the
induction process. The analog is incorporated into
proteins, presumably resulting in the formation of
aberrant or inactive proteins, and to a
decrease in overall RNA synthesis but an increas-
ed production of the mRNAs coding for the stress
proteins. Simultaneously, regulation at the trans-
lational level augments the response by discrimi-
nating against the utilization of preexisting
mRNAs. These conclusions are based on data ob-
tained by treatment of cells with inhibitors of pro-
tein or RNA synthesis and by examination of
mRNA levels by cell-free translation as well as by
physical means. A remarkable feature is that
translational control seems to be exerted at the le-
vel of protein chain elongation.
Further analysis of the mechanism will be facili-
tated by cloned copies of the genes and of their
cDNAs. Bacteriophage clones carrying at least
parts of the gene for the 90K protein are in hand,
as are plasmid subclones, and we are exploiting
these to make direct measurements of mRNA
levels and synthesis. An immediate goal is to ob-
tain clones of the other stress-protein genes.
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PROTEIN CHEMISTRY
LE. Smart, K. Drickamer, G. Binns, P. Chow, H. Engeser M. Hallaran
During its second year of existence the Protein
Chemistry Section has continued to focus on two
main areas: (1) studies on the structure and func-
tion of the transforming proteins of tumor viruses:
adenovirus type 2 (Ad2), avian sarcoma viruses,
and simian virus 40 (SV40) and (2) structural and
functional work on receptors for glycoprotein en-
docytosis.
Ad2 Early Proteins
J.E. Smart
Early during lytic infection by Ad2, four regions of
the viral genome are transcribed into mRNA.
These mRNAs encode proteins known to be in-
volved in the initiation and maintenance of
transformation, as well as other proteins that
directly or indirectly affect DNA replication and
the regulatory processes necessary for the switch
from early- to late-gene replication. The main ap-
proach that we have used to analyze the Ad2 ear-
ly proteins has involved the characterization of
peptides produced by selective proteolysis and/or
chemical cleavages of the polypeptides labeled
both in vivo and in vitro with various amino acids
([35S]methionine, [35S]cysteine, [3H]leucine, etc.).
The resulting peptides separated by high-
performance liquid chromatography (HPLC) on
reverse-phase or cation-exchange columns and
analyzed individually by sequential Edman
degradation to locate the positions of the in-
dividual labeled amino acids. By correlating this
partial amino acid sequence information with the
DNA-sequence and mRNA-splicing data, the
coding location of these polypeptides can be
assigned unambiguously. This approach also per-
mits deduction and confirmation of the complete
amino acid sequence of these proteins.
During the past year our primary research ef-
forts involving Ad2 have been directed towards a
more detailed understanding of the structures and
functions of early regions 2A and 2B. Both of
these regions are involved in viral DNA replica-
tion. Studies initiated in 1980 allowed us to iden-
tify the gene and the mRNA encoding the
adenoviral terminal protein (region 2B). These
studies, which were published early last year,
have been extended in collaboration with Bruce
Stillman and Mike Mathews of the Protein Syn-
thesis Section. Likewise, in collaboration with
Fred Asselbergs and Mike Mathews (Protein Syn-
thesis Section), an exhaustive study on region 2A
(Ad2 DNA-binding protein) was completed.
Adenoviral Terminal Protein
(Early Region 2B)
The adenoviral terminal protein functions as a
primer for the initiation of viral DNA replication
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by covalently binding the first nucleotide in the
viral DNA chain. It remains covalently attached
to the 5' ends of the viral DNA and is cleaved to
the terminal protein during viron maturation. The
gene encoding the terminal-protein precursor
maps within a 7-kb region of the viral genome that
specifies multiple mRNA and protein species. We
have determined the location within this region of
the coding sequences for the terminal protein by
aligning partial amino acid sequence data with
the amino acid sequence predicted from the DNA
sequence (see Nucleic Acid Chemistry Section).
The open translational reading frame between
coordinates 23.4 and 28.9 on the genome contains
the majority of the coding sequences for the
precursor protein. The mature virion terminal pro-
tein derives from the C terminus of the precursor
protein. Using this information, the site of
covalent attachment of the terminal protein to
the viral DNA has been established. This site also
corresponds to the site that covalently binds
dCMP. The coding region for terminal-protein
precursor does not overlap with the region to
which the N group of adenoviral mutants has
been mapped. We conclude that these mutants
define a protein, other than terminal protein, that
also functions in the initiation of viral DNA
replication. (See Protein Synthesis Section for a
more detailed report.)
Adenoviral DNA-binding Protein
(Early Region 2A)
The major early region 2A translation product is a
72K single-stranded DNA-binding protein. This
protein is involved in the initiation and
maintenance of viral DNA replication and ap-
pears to be involved in the downward modulation
of the rate of synthesis of the gene products from
the other early regions of the viral genome. We
have analyzed the major DNA-binding proteins
from Ad2 and Ad5 by peptide mapping and partial
amino acid sequencing. The major E2A products,
as well as several minor species, have been ob-
tained from infected He La cells or from transla-
tion of E2A-specific mRNA in a reticulocyte lysate
or in Xenopus oocytes. The results identify a con-
tinuous open reading frame of 1587 nucleotides
between 62 and 65 m.u. on the I strand of the viral
DNA as the region encoding the major 72K DNA-
binding protein. Minor related proteins probably
originate from partial proteolysis of the major
protein as well as from independent translation of
minor mRNA species that coterminate with the
major species. (See Protein Synthesis Section for
more details.) Detailed analysis of the minor
region 2A products has permitted determination
of those domains of the major protein that (1) are
involved in DNA binding, (2) are the major an-
tigenic sites in the native molecule, and (3) are the
major sites of serine and threonine phosphoryla-
tion in vivo.
Sites of Tyrosine and Serine Phosphoryl-
ation on the Transformation-specific Gene
Products of Distinct Avian Sarcoma Viruses
I.E. Smart
Transformation of cells by Rous sarcoma virus
(RSV) is initiated and maintained by the produc-
tion of a virus-encoded 60-kD transforming pro-
tein, pp6O5rc. One of the functions of pp6O5rc is to
catalyze the transfer of phosphate from ATP to
acceptor tyrosine(s) of various polypeptides. Fur-
thermore, when ATP is added to the immunopreci-
pitated transformation-specific proteins of all
three classes of avian sarcoma viruses, some of
the phosphate is transferred to the transforma-
tion-specific proteins themselves. The trans-
forming activity of these proteins implies that
they may play an important role in metabolic
regulation. In fact, by analogy with other protein
kinases, the modification of a number of different
enzymes and/or nonenzymic proteins via phos-
phorylation provides an attractive model for the
pleotropic effects of the transformation event.
Classification of avian sarcoma viruses has
been based on relatedness of their cell-derived se-
quences, which are apparently the source of their
sarcomagenic properties. The viruses of class I are
RSV and B77; of class II, Fujinama sarcoma virus
(FSV), PRCII, and PRCIV (PRCI 1p); and of class III,
Y73 and Esh sarcoma virus (ESV). In the recently
proposed system of nomenclature for the cell-
derived sequences of RNA tumor viruses, classes I
to II would contain src, fps, and yes sequences,
respectively. Although avian sarcoma viruses of
classes II and III contain transformation-specific
sequences that by all criteria are apparently dif-
ferent from those of the class-I viruses, their im-
munoprecipitated transformation-specific gene
products still show an associated tyrosine kinase
activity. In earlier collaborative studies with J.C.
Neil and P.K. Vogt (University of Southern Califor-
nia, Los Angeles), we established that within the
class-I and class-III viruses the site of tyrosine
phosphorylation was identical. Recently, we have
extended these studies to show that a similar site
of tyrosine phosphorylation occurs within the
class-II viruses. These studies have employed
structural analysis by sequential protease
cleavage, a method of potential widespread ap-
plication. These data suggest that the occurrence
of acidic amino acids adjacent to the phospho-
acceptor tyrosine may be a general property of
the target sites for tyrosine-specific protein
kinases. The observation of the apparent conser-
vation of these target sites in the otherwise
distinct class-I, -II, and -III avian sarcoma viruses
supports the hypothesis that such sites may play a
central role in regulating the function(s) of the
viral transforming proteins as well as of their nor-
mal cellular homologs.
Although phosphorylation at the tyrosine
residue of pp605 c appears to be essential for its
transforming activity, the phosphorylation of a
serine residue also occurs at another site in the
molecule and appears to exert some control on
the rate of tyrosine phosphorylation, at least in
vitro. Collaborative studies with A. Purchio and R.
Erikson (University of Colorado, Denver) were
undertaken to determine the site of serine
phosphorylation in pp605c. Employing the same
methodology as that used to determine the site of
tyrosine phosphorylation, we have established
that the site of the cAMP-dependent serine
phosphorylation in pp6O5rc lies 17 amino acids
from the N terminus of the molecule. Other
workers have shown that in the case of most
cAMP-dependent protein kinases, the amino acid
sequences at the phosphorylation sites in
physiologically significant substrates fall into two
categories: (1) -Lys-Arg-X-X-Ser-X- and (2) -Arg-Arg-
X-Ser-X-, in which X stands for any amino acid (ex-
cept it should be noted that the amino acid resi-
dues immediately adjacent on either side of the
serine to be phosphorylated usually have hydro-
phobic side chains). Interestingly, the site of
serine phosphorylation on pp6O5rc has the se-
quence -Arg-Arg-Arg-Ser-, which differs from the
consensus sequence in that an arginine residue
appears in the position immediately preceeding
the serine that usually would be occupied by an
amino acid with a hydrophobic side chain. Our
studies have shown that the removal of the
phosphate from the serine of pp605c occurs only
at a very low rate with standard phosphatases,
whereas phosphatases extracted from more
specialized tissues exhibit a high level of activity
against the phosphorylation serine of pp6O5"
These combined data suggest that the level of
phosphoserine in pp6O5rc may be modulated by a
discrete subset of cellular phosphatases.
Hepatic Lectins
K. Drickamer, G. Binns
Cell-surface receptors mediate the interaction of
cells with their environment. Specific receptors
are believed to make cells responsive to external
signals such as hormones, to specify the uptake
and degradation of certain extracellular compo-
nents, and to facilitate cell-cell recognition. Aber-
rances in each of these receptor functions are
responsible for several disease states, including
malignancy. In an effort to understand the func-
tion and dysfunction of receptors, we have con-
centrated on one specific set of receptors, the
hepatic lectins. These proteins are responsible for
the recognition of partially deglycosylated serum
proteins, which are taken up by hepatocytes.
Previous work from this and other laboratories in-
dicates that the cell biology of the uptake process
has much in common with the uptake processes
of other ligands such as low-density lipoprotein
and insulin; it is now recognized as an example of
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receptor-mediated endocytosis. The glycoprotein-
recognition system provides a unique opportunity
to study receptor function, because this is the on-
ly system in which the receptors can be readily
isolated for detailed structural studies. The term
hepatic lectins.(HL) is used because these proteins
have sugar-recognizing capacity; the receptor
from chicken liver is designated CHL and the cor-
responding rat protein is designated RHL. Ongo-
ing studies are concentrated in two areas: (1)
understanding the previously determined primary
structure of CHL and (2) comparison of this struc-
ture with that of RHL.
Further Characterization of CHL
As reported last year, the first stage in the in-
vestigation of CHL was determination of the com-
plete amino acid sequence of CHL. Much of the
current work is directed toward understanding
and interpreting this sequence. The most out-
standing questions involved are how CHL binds
glycoprotein ligands and how it interacts with
various hepatocyte membranes. Progress on the
first question has been slow, but good data are
now available to indicate that at least one of the
seven sulfhydryl groups in CHL is located at or
near the glycoprotein binding site. As all of the
cysteine residues are found in the C-terminal two-
thirds of the sequence, this already indicates that
the binding site is located towards the C-terminus,
as designated in Figure 1. Efforts are presently be-
ing directed at limiting the binding site more
specifically.
The primary structure itself suggests how CHL
may interact with the hepatocyte plasma mem-
brane. As shown in Figure 1, a completely non-
charged, hydrophobic stretch of amino acids
(positions 25 through 48) is likely to be the site of
interaction with the membrane lipids. This type of
sequence is typical of that found in other mem-
brane proteins and suggests that CHL may in fact
span the membrane. Documentation of this fact
would fulfill a long-standing prediction about the
structure of membrane receptors. It was relatively
easy to show that the C-terminal protein of CHL is
extracellular, because this region of the polypep-
tide contains a site of glycosylation always found
at the extracellular face of the membrane and be-
cause the ligand binding site must be at the cell
surface and earlier evidence placed this site to-
ward the C-terminal. This conclusion was further
supported by direct labeling experiments in which
cultured hepatocytes were labeled with the mem-
brane-impermeant probe lactoperoxidase. The
tyrosine residues that could be labeled with the
reagent were all found in the C-terminal two-
thirds of CHL.
These results clearly indicate that if CHL does
in fact span the membrane, it must be oriented
with the N-terminal end of the polypeptide in the
cytoplasm. Evidence for this prediction was there-
fore sought. The clearest results to date have been
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obtained with phosphate-labeled cells. Cells
grown in the presence of radioactive inorganic
phosphate incorporate a small amount of the
radiolabel into polypeptides by specific phospho-
rylation of certain serine, threonine, and tyrosine
residues by cytoplasmically located protein
kinases. Fortunately, it appears that CHL is a phos-
phate-acceptor protein. The acceptor site prob-
ably can be assumed to be in the cytoplasm. Al-
though the incorporation of radioactivity is very
small, it has been possible to localize the phos-
phorylation site toward the N-terminus of CHL,
which is consistent with the postulate that this
end of the molecule is probably facing the
cytoplasm.
An alternative way of identifying cytoplasmi-
cally disposed portions of the CHL polypeptide is
to label the exterior surface of vesicles that have
the opposite orientation of the plasma membrane.
The endocytosis process in which CHL functions
requires that the receptor move into coated
vesicles during the uptake process. CHL in these
vesicles would have the reverse orientation to
that of CHL in intact cells: The cytoplasmic do-
main would be located at the outside of the vesi-
cle and should be accessible to impermeable pro-
bes such as lactoperoxidase. Coated vesicles were
therefore isolated from chicken hepatocytes by
modifications of available methods for other
tissues. These preparations were shown to contain
CHL by the immunological-gel-staining method of
K. Burridge (Cell Biochemistry Section).
Sequence Work on RI-IL
The carbohydrate binding protein from rat livers
has a binding specificity distinct from that of CHL;
although the chicken protein recognized terminal
N-acetylglucosamine residues, RHL binds ter-
minal galactose. This difference reflects
physiological differences between the car-
bohydrates of serum proteins in avian and mam-
malian species. In spite of the specificity dif-
ferences, the receptors share many features in
common, such as pH and ion requirements. The
route of ligand uptake is also similar in both
cases. It was therefore of interest to see whether
the receptors from these two species were evolu-
tionarily related to each other. As shown in Figure
1, the sequence of RHL has been partially estab-
lished, and it already reveals that two portions of
this protein are strikingly homologous (40% iden-
tity) to CHL. The presence of two homologous
regions is apparently due to a large internal
duplication that has been tentatively aligned as
shown in Fig. 1. This suggests that RHL contains
two binding domains, each homologous with the
CHL binding domain. This would explain the
larger size of RHL. The presence of two ligand bin-
ding sites would also explain some of the ap-
parently anomalous binding results previously ob-
tained by others working with this protein. The se-
quence work must now be pursued to completion
CHICKEN
RAT
Hydrophobic
Domain
Binding Domain
Binding Domain I Binding Domain 2
Figure 1
Summary of primary structures of chicken and rat hepatic lectins. Portions of RHL structure not yet determined are
indicated as dashed lines. Binding domains 1 and 2 refer to large duplicated sequence homologous to ligand binding
region of CHL.
to establish the full extent of the CHL-RHL
homology. It will be particularly interesting to see
whether the hydrophobic domain and
cytoplasmic tail show structural similarities with
the corresponding portions of CHL.
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Movable Genetic Elements
Unstable phenotypes and variegated phenotypes, ascribed to "unstable genes," have in-
trigued geneticists for more than half a century. A meticulous study of "variegation" in maize
by Barbara McClintock at Cold Spring Harbor led her to propose many interesting ideas
relating gene expression to DNA rearrangements. Her work has shown remarkable intellec-
tual durability. It seems that in many cases unstable phenotypes result from high-frequency
DNA rearrangements. Perhaps within the next few years many of these interesting genetic
mysteries will be explained in molecular terms.
The groups in the Movable Genetic Elements Section are supported by a genetics program
grant from the National Institutes of Health. This genetics program has led to an intellectual
cohesion among the various groups and has allowed us to broaden our work. It is hoped that
the work done by the various groups in this section will contribute to a general understanding
of the principles underlying genetic flexibility.
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INSERTION ELEMENTS AND PLASMIDS
A.I. Bukhari, R.M. Harshey, G. Chaconas, L. Dalessandro, D. Evans, D. Foster, M. George (Goradia),
G. McGuinness, K. Messina, C. Monaghan, G. Penzi, B. Vogel
Transposable genetic elements require two things
to function: (1) specific DNA sequences that
define the ends of the element and (2) proteins
that recognizes these sequence and thus bring
about DNA transposition and all of its attendant
DNA rearrangements. The sequences at the ends
are repetitious and are generally present in an in-
verted order. For example, the ampicillin
resistance transposon Tn3 has 38 by of perfect in-
verted repeats at the ends. The temperate
bacteriophage Mu appears to be an exception to
this rule. Mu is the most promiscuous transposon
know, and yet its two ends do not show
characteristic long inverted repeats. We know
that the A-gene protein of Mu can recognize the
two ends, since in the presence of A the Mu DNA
can be inserted or excised precisely. The A protein
in Mu is equivalent to transposases in other
systems, with one striking difference: The A pro-
tein in Mu is required for excision, whereas in
other procaryotic transposable elements, the
transposases are not believed to play a role in ex-
cision. Although the A protein in Mu is interesting,
there are other proteins, in particular the B pro-
tein, that play important roles in the processes by
which Mu brings about DNA rearrangements.
We are interested in understanding the DNA
features that are recognized by the A and B pro-
teins and the manner in which they are recognized.
To define more precisely the DNA sequences re-
quired for transposition, we have been deleting in-
creasing amounts of Mu DNA near the ends.
These experiments are being done by using the ex-
onuclease Ba131 to degrade the Mu DNA from a
point in Mu DNA close to the ends. By this
technique, we have isolated a large number of
deletions near the ends of Mu and are now
systematically examining them for their biological
properties and nucleotide sequences.
We have also been examining the expression
and functioning of the gin protein, which is re-
quired for flip-flop of the invertible G segment of
Mu, and of the mom protein, which causes an
unusual modification of DNA. Both the gin and
mom genes are located near the right end of Mu
DNA. Thus, the deletions that we have generated
in vitro also affect the functioning of these genes
in various very interesting ways. We are now
analyzing these effects.
DNA Intermediates in Transposition of Mu
R.M. Harshey
By a process that is closely coupled to its replica-
tion, Mu can transpose into DNA sites that may
have no homology to it. Upon induction of Mu
replication, "key" structures are generated. These
structures are circles of variable size attached to
tails of variable length. We had proposed that
these molecules arise as a result of an in-
trachromosomal event of transposition that links
replicating Mu DNA to different host sequences,
thus accounting for the variability in size of these
structures. We have now isolated thes.e structures
using the following technique.
We cloned the lac operator into mini-Mu DNA,
which can undergo transposition when supplied
with replication proteins in trans by means of a
helper Mu prophage. This plasmid was allowed to
undergo transposition. The transposing mini-Mu
DNA was then trapped on nitrocellulose filters by
using the lac operator-repressor interaction. This
procedure enriched for key structures, which were
eluted from the filters with IPTG. Mu sequences
within these structures were localized in the elec-
tron microscope by visualizing the lac operator-
repressor interaction after complexing the
repressor with antibody and ferritin-conjugated
anti-antibody. The location of the bound ferritin
cores was measured with respect to the junction
between the circle and the tail in the key struc-
ture. These studies have confirmed that key struc-
tures contain Mu DNA and that it is replicating.
Thus, these structures are intermediates in
transposition as hypothesized. The method we
have used to find these intermediates can be ap-
plied to many different systems.
Figure 1 shows four molecules that were
analyzed. The molecules in A, B, and C contain
ferritin cores at positions equidistant from the
junction of the circle and tail in the key structure.
Thus, replication of Mu sequences has occurred,
and the junction must be a replication fork. The
sizes of the circles in A and B are 12 kb and 20 kb,
respectively. Since the size of the mini-Mu is 16.5
kb and the lac operator sequence is located 5 kb
from the left end, the molecules in A and B could
have arisen only if replication had started at the
left end of Mu. The molecule in D, which has a
simple ferritin core located on the tail, has a circle
size of 8.9 kb and could have arisen only if
replication had started at the right end. Some
molecules, such as the one with a circle size of
35.5 kb shown in C, could have started replicating
at the left or the right end, and their origin of
replication could not be identified. Thus, replica-
tion can begin at either the left or the right end of
Mu. Restriction enzyme analysis of these struc-
tures was also carried out, which again showed
that replication could begin at either one of the
ends of Mu. These results rule out schemes that
propose diffusible copies or single-stranded in-
termediates in transposition and lend support to
those in which double-stranded ends of transposa-
ble elements invade nonhomologous DNA sites to
insert copies of themselves.
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Figure 1
Analysis of key structures showing lac operator sequences. The ferritin cores (ferritin-conjugated anti-antibody-/ac
repressor antibody-/ac repressor complexes) are indicated by arrows. The drawings show schematically the disposi-
tion of the ferritin cores. The locations of the /ac operator sequences (contained in Mu) correspond to the predic-
tions of Harshey and Bukhari (1981).
Packaging of Host Sequences Attached to
the Ends of Mu DNA
M. George
A characteristic feature if Mu DNA is the
presence of host DNA at itsends; the host DNA is
heterogeneous in length and in sequences. These
sequences result from packaging of Mu DNA,
linked to different host sequences during the Mu
growth cycle. We previously showed that the left-
end host sequences vary from 56 by to 150 by and
fall into discrete blocks of 6 bp, with a 5-bp spac-
ing. Thus, cutting of DNA during packaging oc-
curs with a spacing of 5 by between each block.
We have now found that the cutting of DNA
during packaging is staggered. The experiment
was done as follows: (1) The 3' end of the host
DNA was labeled with a single [a- 32P]triphosphate
and Klenow polymerase. (2) The 5' end of the host
DNA was labeled with [-y-3211ATP and
polynucleotide kinase. (3) We used all four
[a-32P]triphosphates, and Klenow polymerase, to
fill in the ends. We then isolated the left end of
the Hindll I fragment, which is 1000 by cut it with
Hinf, which makes a cut 7 by away from the left
end of Mu, and ran the digest on an 8% sequenc-
ing gel to size the fragments from the three reac-
tions.
The results of the experiment indicated that the
5' end of host DNA at the left of Mu is 2 by longer
than its complementary strand.
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Transmid: A Vector for Shotgunning
Bacterial Chromosomes without
Restriction Enzymes
Bacteriophage Mu has many uses in molecular
genetics because of its remarkable genetic prop-
erties. When Mu transposition functions are fully
active, it can fuse two DNA molecules or it can
dissociate a DNA molecule into smaller mole-
cules at a high frequency. If a circular DNA mole-
cule undergoes dissociation, it results in the for-
mation of two smaller circles, each containing Mu
DNA. These circles normally do not have a repli-
cation origin (other than Mu DNA, which repli-
cates by a special mechanism). Thus, the hetero-
geneous circles formed after Mu induction in
bacterial cells are lost and cannot be rescued. We
have now cloned a ColEl replication origin within
Mu, which allows the circles to replicate as plas-
mids. Since the circles contain random host se-
quences, isolation of the circles amounts to clon-
ing of host-DNA segments into a plasmid. These
"plasmids" can be isolated by merely inducing
Mu in the presence of a "transmid," a mini-Mu se-
quence containing a replication origin. A Mu
transmid can replicate by transposition and can
also be packaged in Mu phage particles. Various
aspects of this system are currently being ana-
lyzed.
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YEAST AND PLANT GENETICS
J. Hicks, A.J.S. Klar, J.N. Strathern, J. Abraham, P.
Creatura, S. Dellaporta, L. Haas, J. Ivy,
G. LoFranco, C. McGill, J. Mclndoo, R. Malmberg, K.
Nasmyth, D. Prudente, S. Weisbrod, 1. Wood
The past year has been marked by two important
developments in the growth of what has been
known as the "Davenport Yeast Group." First, we
are no longer residents of Davenport Laboratory.
With the completion of our year-round laboratory
and office addition in the summer of 1981, the en-
tire complex was renamed in honor of the late
Professor Max Delbru-ck. Second, our yeast
genetics research has been expanded to include
new research on the genetics and molecular
biology of higher plants. This progress has been
made possible both by the increased space
available in Delbruck Laboratory and the addition
to our group of plant biologists Russell Malmberg
and Steven Dellaporta. We have also enjoyed the
presence of Visiting Scientists Jeremy Thorner
from the University of California at Berkeley and
George Sorger from McMaster University in
Hamilton, Ontario. Dr. Thorner continued his
work on the regulation of genes in the mating
pathways of yeast, and Dr. Sorger has pursued a
search for DNA clones of the nitrate-inducible
genes of Neurospora crassa.
As in the past most of our work this year has
centered on the structure of the mating-type
H
W X
HMLo
Ya Z I Z2
genes in the yeast Saccharomyces cerevisiae and
the mechanism by which mating types are alter-
nated in dividing yeast cells. The general layout of
the mating-type genes has been described inprevious reports and is diagrammed in Figure 1.The important features of this scheme can be
summarized as follows. Mating behavior is deter-
mined by the MATa and MATa cassettes that
alternatively occupy the MAT locus on
chromosome III. These alleles are identical in
DNA sequence with the exception of an internal
segment of 642 by in MATa and 747 by in MATa
(see Fig. 1). Mating-type switching involves the
replacement of the MATa sequence with the
MA Ta sequence (or vice versa) and is the result of
transposition of information to MAT from either
of two additional cassette sites, HML and HMR,
on the left and right ends of the same chromo-
some. The transposition event is catalyzed by the
product(s) of the HO (homothallism) gene located
on chromosome I. The HMLa and HMRa storage
cassettes are not normally expressed but are
under the negative transcriptional control of four
genes known as MARI, SIR1, SIRS, and SIR4. In
strains defective in any one of these MAR/SIR
MARI
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Figure 1
Diagram of the mating-type cassettes on chromosome III of Saccharomyces cerevisiae. See text for genetic descrip-
tion of MAT, HML, and HMR. W, X, Y, Z1, and Z2 represent regions defined by homology between MAT and the
HML or HMR locus: The W region is 723 bases in length and is found at MA T and HML; the X region is 704 bases in
length and is found at MAT, HML, and HMR; MAT, HML, and HMR can have either the a-specific sequence Ya (642
bases) or the a-specific sequence Ya (747 bases); Z1 is 239 bases in length and is found at MAT, HML, and HMR;finally , Z2 is 88 bases in length and is found only at MAT and HML. The HML and HMR copies of the mating-type
genes are normally kept silent by the MAR and SIR genes (see text). I nterconversion of MATa and MATa involves aunidirectional transposition-substitution event from HML or HMR to MAT and is regulated and/or catalyzed by theHO-gene product.
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genes, all three cassette-containing loci are fully
expressed. Our work this year has centered on the
mechanism of mating-type transposition and the
regulaton of the silent cassettes.
Switching Intermediates
Last year we demonstrated that DNA from a
population of cells that is switching efficiently
contains a significant portion that is cut in the
MAT DNA. The cut is at the boundary of the Y and
Z regions (see Fig. 1). The YZ boundaries at HML
and HMR are not cut, although the DNA se-
quences at these boundaries are identical to that
found at MAT. These results suggest questions
about the role of this cut in the homothallic
switching process and about the mechanism that
defines MAT as the recipient and HML or HMR as
the cassette donor.
We also demonstrated that switching could oc-
cur at MAT on a replicating plasmid. For example,
mats- on the 2p, based plasm id YEp13 is stable in
heterothallic cells but is efficientially switched to
MATa or MATa in homothallic strains. The
double-strand cut at the YZ boundary on the plas-
MAT a
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Figure 2
Deletion analysis of a cloned MAT cassette showing
that the region of the double-strand cut is required for
switching onto the plasmid from the chromosomal HML
or HMR locus. The Southern blot lanes at the bottom of
the figure show the assay for switching. The apparance
of the "MATa Bgl" band indicates that the plasmid
MAT sequence has been replaced by the MATa Bgl
cassette containing an extra Bg111 restriction site.
mid is also readily observed in homothallic cells.
These results suggested that in vitro
mutagenesis of the MAT DNA could be used to
identify sequences essential for switching. A set
of deletions was made by Ba131 digestion from
the Bg/II site in Ya followed by religation in the
presence of Xho linkers. YEp13:mata plasmids
with these deletions were tested for the ability to
undergo homothallic switching by transformation
into HO HMLcx MATa HMRa cells. Switching was
indicated by the production of YEp13:MA Ta.
Deletions entirely contained within Ya were effi-
ciently switched. In contrast, the deletions that
extended into Z were stable as mata- . For exam-
ple, deletion a125, which leaves 30 bases of Ya to
the left of Z, can be converted to MATa, whereas
deletion a147, which deletes 9 bases into Z, is not
switched at all. The site defined by these experi-
ments is diagrammed in Figure 2.
The coincidence of the site of the double-
strand cut with the site at the YZ boundary
defined by the deletion analysis as essential for
switching suggests that the double-strand cut is an
intermediate in the switching process.
We performed similar deletion analyses of the
W and X regions of MAT (both from the left of
MAT and from a site within Ya) and found no
single site required for homothallic switching. As
long as the YZ boundary was intact and there was
homology between the plasm id and sequences to
the left of Yu, the deletions bearing plasmids
could switch efficiently.
In a related set of experiments we tested the ef-
fect of the double-strand cut in strains unable to
complete the switching process because the
storage loci had been deleted. If the double-
strand cut were the initiating event in switching,
then cells lacking a donor locus might be unable
to repair the break and would therefore die.
Spores of genotype hmI. MATa (or MATa) hmrA
HO were observed microscopically to produce
such dead cells with a frequency and pattern
predicted by the established rules of mating-type
switching (Fig. 3). Thus, in these strains, the MAT
locus is cut in vivo, but in the absence of the
donor loci, the resulting broken chromosome
Mother Daughter
A
Dead Dead
Dead Dead 0<
HO
Figure 3
Appearance of dead cells in the pedigree of a
homothallic strain deleted for the HML and HMR
cassettes.
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leads to lethality. On the basis of this result we
suggest that the double-strand cut is not only an
intermediate but is in fact the initiating event in
transposition.
The deletion strains that yield dead cells essen-
tially grow in a linear rather than logarhythmic
fashion. This slow growth pattern provides a novel
genetic screening scheme for selecting mutations
in the switching pathway. Any mutant that blocks
the initiation of switching would grow
logarithmically and therefore could be easily
spotted on solid media. Thus far we have
obtained two classes of "fast growers." One class
results from mutations mapping at MAT
(substrate mutations) and the other class results
from mutations at HO. Whether the HO gene
itself codes for the cutting activity is now being
tested.
a
Control of the Silent Cassettes
One of the most novel aspects of the mating-type
regulatory scheme is the mechanism by which the
normally silent storage cassettes at the HML and
HMR loci are controlled (see Fig. 1). Each silent
cassette contains fully functional mating-type
genes that are kept under negative transcriptional
control through the action of the MAR- and SIR-
gene products. This implies that there are
negative control sites at HML and HMR that are
not present at the expressed MAT locus. All
mating-type cassettes are transcribed divergently
from a region of DNA that is identical in sequence
whether it is located at MAT, HML, or HMR. From
this result it was inferred that the required control
sites lie outside the cassettes themselves, in se-
quence unique to HML and HMR.
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Deletion and insertion mutagenesis of HMRa (a) and HMLcr (b) cassettes. The stippled areas indicate the regions
defined as necessary for the action of the MAR /SIR genes. The E site is on the left in both cases, and the I site on the
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To define the location and function of the con-
trol sites, we performed in vitro mutagenesis on
cloned plasmids containing the HML and HMR
cassettes. The most detailed studies were per-
formed by Judy Abraham on the HMRa locus.
Random deletions followed by insertion of syn-
thetic DNA sequences containing Xhol restriction
endonuclease cleavage sites were introduced into
the region surrounding the HMRa gene, thus
disrupting the normal coding and control se-
quences. The effects of these mutations were
assayed by reintroduction of the altered plasmids
into suitable yeast strains. The results of this work
are summarized in Figure 4a. Two sites, one on
each side of the cassette homology, were found to
be required for normal MAR /SIR control. The two
sites are not equivalent. Deletion of the E (Essen-
tial) site leads to full expression of the adjacent
cassette, whereas deletion of the I (Important) site
yields only a slight increase in expression. Dele-
tions bringing E or I closer to the promoter region
in HMR do not disrupt regulation, indicating that
the control mechanism does not depend on the
exact distance between E, I, and the transcription
start site. The E and I sequences thus define a do-
main of negative transcriptional control at HMR
that extends a distance of 2000 bp.
Sites analogous to E and I were also located
near the HMLa cassette by John Feldman, in col-
laboration with Dr. James Broach (State Universi-
ty of New York, Stony Brook). The series of dele-
tions generated by these experiments are shown in
Figure 4b. At HML, the domain of negative con-
trol between the E and I sequences extends
roughly 3300 bp.
The role of chromatin structure in the regula-
tion of the HML and HMR cassettes was explored
by Kim Nasmyth using nuclease digestion of
chromatin in intact nuclei. It is well known that
chromatin structure can cause certain sites in and
around genes to become "hypersensitive" to
nuclease digestion. When assayed by gel elec-
trophoresis and Southern blotting, these sites
show up as dark bands, which are not present
when the experiment is performed on purified
DNA. The appearance of such hypersensitive sites
can often be correlated with gene expression and
provides a probe for changes in chromatin struc-
ture that affect regulation. Under normal
MAR /SIR regulation, the silent cassettes yield
nuclease digestion patterns distinct from those
found at these loci when they are transcribed in
Mar- strains. The digestion patterns of the silent
loci under MAR /SIR regulation also differ from
those found at the MAT locus, indicating that the
action of the MAR /SIR products on the silent
cassettes causes a specific alteration in chromatin
structure. An example of these results is shown in
Figure 5.
In related experiments, Kim also compared the
topology of plasmids carrying regulated (HML
and HMR) and expressed (MAT) cassettes
replicating in Mar+ and Mar- yeast strains. This
was accomplished by separating the various
forms of the plasmid population on the basis of
DNA supercoil density by gel electrophoresis in
the presence of an intercalating dye. These ex-
periments showed that plasmids carrying either
HML or HMR are more negatively supercoiled
when isolated from Mar+ cells than when isolated
from Mar- cells. At HMR the sequences required
for generation of the supercoil difference are the
same as those required for transcriptional regula-
tion: The supercoil difference is completely lost if
the E site is deleted and is almost completely lost
if the I site is removed. The supercoil difference
can be observed in plasmids lacking the promoter
region and is thus independent of transcription.
N1AR and SIR Genes
The results mentioned above clearly affirm the
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Figure 5
Partial DNase-I digestion of chromatin in and around the HML cassette showing two sites near the 5' ends of the
transcripts that do not respond to MAR /SIR control and a pair of sites at the Y-Z boundary that only appear when the
cassette is in the expressed condition, either at MAT or at HML in a Mar- background.
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necessity for characterizing the products of the
MAR and SIR genes and their interactions with
one another before we can
understand how they
mediate control at HML and HMR. This work is
following several different paths. Cloned
molecules capable of complementing defects in
the MAR and SIR genes have been isolated and,
through the work of Lisa Haas and John Ivy, have
been shown to correspond to the appropriate
genetic loci. Preliminary results indicate that the
actions of certain loci are dependent on the
others. For example, raising the copy number of
the SIR3 gene on a plasmid can compensate for
complete lack of activity of the SIR4 gene,
possibly indicating that expression of S/R3 may
normally be dependent on SIR4. Furthermore, a
subfragment of the SIR4 clone lacking SIR4 activi-
ty can exercise a dominant effect on the MAR/SIR
regulatory system in wild-type cells, possibly by
interfering with formation of the normal
regulatory complex. Complete construction of the
MAR/SIR regulatory mechanism will, of course,
depend on isolation of proteins encoded by these
genes. To that end, Stu Weisbrod has identified a
cell line carrying a highly amplified version of the
HML cassette in its normal regulated form carried
on a plasmid. Partial purification of this
"minichromosome" may yield amplified amounts
of the presumed control protein complex bound
to the E and I control sites.
Directionality of Switching
Homothallic yeast strains carrying storage cas-
settes in the "normal" arrangement (HMLa
HMRa) switch the cassette at MAT to the opposite
allele in 90% of the cell divisions where switching
can occur. Strains in which the storage cassettes
are reversed (HMLa HMRa), however, switch at a
greatly reduced frequency (<6%). In last year's
report we proposed that a control mechanism ex-
ists to direct the switching process and that the
storage cassette chosen depends on the mating
type of the cell. That is, cells expressing MATa
preferentially transpose information from HMR to
MAT, and cells expressing MATa preferentially
transpose information from HML, irrespective of
the genetic information carried at the silent locus.
In the normal cassette arrangement this prefer-
ence leads to efficient switching. However, in
cells with reversed cassettes this directional bias
leads to "futile" switching events in which the
MATa allele, for example, is replaced by an iden-
tical a cassette from HMRa.
This hypothesis was confirmed through obser-
vation of switching behavior in strains carrying ge-
netically marked alleles at HML and HMR. Fur-
thermore, in strains where the preferred donor
locus has been deleted, the inefficient donor
becomes capable of donating efficiently. Thus,
the directional control mechanism apparently in-
volves a competition between the two storage
loci for pairing with the MAT locus and donating
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genetic information. The exact nature of this con-trol is still under study.
Plant Genetics
The overall direction of our newly initiated
research in plant systems is to use the unique
ability of some plants to regenerate from cell
culture to study gene expression during develop-
ment. In cell culture plants behave essentially
as
microorganisms and can be manipulated geneti-
cally in the same ways as yeast or bacteria. The
cells retain the capacity for development, how-
ever, and can be stimulated to regenerate into
whole plants in the laboratory. This feature allows
exploitation of genetic techniques at the cell cul-ture level on petri plates, followed by analysis
ofthe results in the developing organism. We
aretherefore attempting to identify developmental
mutants and to achieve genetic transformation
ofplant cells for the purpose of modifying and
manipulating the genes of interest.
An immediate goal of Russell Malmberg's
re-
search is the selection and characterization
of
cell culture mutants. Since moving to Cold Spring
Harbor Laboratory in May, he has made progress
in two areas: (1) analyzing a temperature-sensitive
mutant of tobacco and (2) improving the ability of
peas to regenerate whole plants from cell culture.
Previously, he had isolated the cell line ts4 and
had shown that it is defective in polyamine syn-
thesis, although probably not in any of the struc-
tural genes of the enzymatic pathway. Gel elec-
trophoresis studies showed that a 25,000-kD
polypeptide was being overproduced in the mu-
tant cell line. Recently, he discovered that grow-
ing wild-type cells on the polyamine synthesis in-
hibitor methylglyoxal Bis(guanylhydrazone)
(MGBG, a sperm idine analog) induces a similar
polypeptide. In collaboration with the Protein
Chemistry Section here, the polypeptides were
shown to have identical tryptic digestion patterns.
Thus, this tobacco cell line exhibits a polypeptide
for which there exists a constitutive mutation (ts4)
and a gratuitous inducer. In vitro translation
studies have shown that the message for this poly-
peptide is present in both induced and uninduced
cells, indicating that control of its expression is at
the posttranscriptional level. cDNA cloning of this
gene is now under way to further study its regula-
tion.
In contrast to tobacco, peas (Pisum sativum) are
an important food crop and have excellent whole-
plant genetics but they are very difficult to work
with in cell culture. Before coming to Cold Spring
Harbor, Russell had shown that one particular
primitive pea variety is capable of regeneration
from cell culture, whereas standard peas are not.
By Mendelian crosses he has now shown that the
ability to regenerate is a recessive character with
a fairly simple inheritance pattern, possibly coded
by a single gene. The implication of this work is
that it may be possible to cross the regeneration
trait into cultivated peas of agronomic and
genetic interest. He is currently trying to map the
genetic factors responsible and to determine the
number of genetic loci.
Vectors for the genetic transformation of plant
cells with cloned DNA are being constructed by
Steve Dellaporta. This field has been limited by
the lack of selectable markers in plant cells. In his
previous work Steve had selected tobacco cells
capable of growing without plant hormones after
introduction of the tumor-inducing plasmid Ti
from Agrobacterium tumefaciens. Refinements of
this selection are being carried out with cloned
portions of the Ti plasmid in the hope of finding
an easily selectable DNA sequence, the presence
of which will identify cells that have received new
genes. Steve is also constructing hybrid vectors
that will employ drug resistance genes isolated
from bacteria as selectable markers in the hope
that these genes will cause plant cells to become
resistant to the same drugs and thus allow the
identification of transformants. Additional com-
ponents of these vectors, such as origins of DNA
replication and promoters of gene transcription,
are being isolated from the tobacco genome by
assaying their functions in yeast, where transfor-
mation is easy and efficient. We believe that by
combining yeast genetics and plant genetics, pro-
gress toward our goal of understanding the
genetic control of cell differentiation will be
made easier and much more interesting.
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MOLECULAR APPROACHES TO MICROBIAL
PATHOGENICITY AND VIRULENCE
M. So, C.H. Lee, T. Mlawer, K. Messina, T.F. Meyer
The emphasis of this group is the study of the
genetic and molecular basis of microbial patho-
genesis. The approach is to understand the basic
mechanisms underlying the acquisition of patho-
genicity and virulence by the microorganism with
the hope that what is learned will lead to a solu-
tion for curing the disease in question.
There are two projects within the lab at the mo-
ment. One involves enterotoxigenic E. coil, which
produces diarrhea in man and in several agricul-
turally important animals. The E. coil must pro-
duce colonization factors that enable them to at-
tach to and establish a niche within the host and
toxins that elicit the clinical symptoms of diar-
rhea. We are examining the genes encoding the
heat-stable toxins produced by these enterotox-
igenic E. coil as well as the toxins themselves. In
this vein, we have shown that the genes coding for
one of the heat-stable toxins, STI, lies within a
transposon flanked by inverted repeats of Si.I We
have been able to get some important informa-
tion regarding the toxin from the sequence of the
gene and are in the process of establishing a
system for studying the mode of action of the tox-
in itself. Colonization is an important facet of the
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disease process, and we are currently studying the
genetics of the colonization factors specific for
human intestines, CFAI and CFAII, in collabora-
tion with D.G. Evans (University of Texas,
Houston). These projects are being carried out by
Chao-Hung Lee.
The second project in the laboratory also in-
volves colonization factors. One of the major
virulence factors in Neisseria gonorrhoeae is the
pili. We are examining the genetic regulation of
expression of the pilus antigen as well as the basis
for its antigenic variability. We have recently
shown that expression of the antigen involves
chromosomal rearrangement.
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MECHANISM OF TRANSPOSITION
F. Heffron, R. Kostriken, M. Wong, C. Moomaw
Genetic rearrangements take place in many
organisms and have important biological conse-
quences, for example, in the expression of a
diverse number of immunologlobin genes, in
genetic rearrangements in corn thought to be
linked with their development, and in bacteria
and lower eucaryotes genetic rearrangements are
used as parts of pathogenetic mechanisms. The
focus of this group is the study of the bacterial
transposable element Tn3. Procaryotic
transposable elements appear to transpose by two
different mechanisms. IS sequences and com-
posite transposons such as Tn5, Tn9, and Tn10 all
appear to transpose by a mechanism that yields
one of two possible end products-either a
cointegrate is generated or a precise transposition
of the transposable element occurs-whereas
Tn3, and others of its class, appears to transpose
by a mechanism in which cointegrates are
obligate intermediates. Most of our current
research involves testing the hypothesis that
cointegrates are intermediates in Tn3 transposi-
tion and determining the precise molecular
mechanism for its transposition. In the last year
we have shown that Tn3 encodes a site-specific
recombination system and that mutations in that
system "invariably" transpose to form
cointegrates (Kostriken et al., Proc. Natl. Acad.
Sci. 78: 4041 [1981]). We have shown that during
transposition, first, a cointegrate is formed in a
reaction requiring the transposase and both ends
of Tn3, and second, the cointegrate is resolved by
the site-specific recombination system it encodes.
The reason the word "invariably" is in quotation
marks is that no careful search has ever been
made to determine whether precise transposition
can take place with a Tn3 derivative containing a
defective site-specific recombination system.
As one test of the mechanism of transposition,
we have constructed a plasmid that allows us to
assay end-deletion frequency and inversion fre-
quency from Tn3 and to determine the frequency
of transposition in the same experiment. The
plasmid contains the galactokinase gene, a gene
for alkaline phosphatase, a temperature-sensitive
origin of replication, as well as complete or mu-
tant copies of Tn3. Using this plasmid we have
determined that the frequency of precise
transposition in a tnpR-minus Tn3 derivative is
much lower than cointegration and may be zero.
End-deletion frequency is low in this plasmid,
lower than the frequency of transposition but
equal to the frequency of inversion formation.
Neither end deletions nor inversions require the
product of the site-specific recombination system
(M. Wong et al., in prep.).
As another test of the mechanism of transposi-
tion we have contructed a heteroduplex transpo-
son containing different restriction sites on the
two strands. This hybrid transposon has allowed
us to test the strandedness of transposition. We
first constructed two Tn3 derivatives that contain
different restriction sites but differ by only a few
base pairs. A heteroduplex of the two was con-
structed on bacteriophage X. We can infect a cell
and force the hybrid transposon to transpose onto
a plasmid in the recipient cell without X replica-
tion. The products we observe are all cointegrates
(which was expected since we have not supplied
tnpR) in which one copy of the transposon con-
tains restriction sites exclusively from one strand
of the heteroduplex and the other copy contains
restriction sites exclusively from the other strand
(R. Kostriken et al., in prep.).
The second general area of work is focused on
the biochemistry of mating-type interconversion.
In collaboration with the Yeast and Plant Genetics
Section, we have established a system to study
mating-type interconversion in vitro. Mating-type
interconversion is thought to be initiated by a
double-strand break made by the product of the
HO gene at the MAT locus. In our in vitro system
we have identified HO-dependent cutting within
the mating-type locus. A number of mutant
plasm ids (constructed by Jeff Strathern, Yeast and
Plant Genetics Section) containing genetic lesions
near the HO cut site have been tested in vitro.
Those plasmids that can undergo switching in
vivo are cut in vitro and those that do not work in
the cell also do not work in vitro. We have also
observed that linear DNA is a substrate and that
normally silent copies are cut in this in vitro
system, although we are investigating what fac-
tors might keep these copies silent (R. Kostriken
and F. Heffron, in prep.).
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Vertebrate Gene Structure and Expression
The development of recombinant DNA techniques over the past few years has allowed
molecular biologists to investigate a considerable number of eucaryotic gene systems that
were previously unapproachable. Problems relating to the control of gene expression in
both normal and transformed cells can now be studied by recombinant DNA methods. In
response to the rapid progress in this area, a new research division whose aim was to study
several different gene systems in higher eucaryotes was formed at Cold Spring Harbor in
1980.
The study of the structure and expression of vertebrate genes has continued to expand in
1981. A Program Project Grant from the National Cancer Institute was funded starting April
1, 1981. This program comprises four distinct Sections: Mammalian Cell Genetics, Hor-
monal Control of Gene Expression, Genes for Major Structural Proteins, and Structure and
Expression of Polypeptide Hormone Genes. These four Sections are headed by Michael
Wig ler, David Kurtz, Stephen Hughes, and John Fiddes, respectively.
In addition, two other Sections with related interests are within the Vertebrate Gene
Structure and Expression Division. These are the Molecular Genetics Section headed by
David Zipser and the Molecular Genetics of the Mouse Section headed by Lee Silver. To
further the strength and unity that the program envisions, regular meetings are held at
which members of the Division present and discuss their work and ideas.
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MAMMALIAN CELL GENETICS
M. Wig ler, M. Perucho, K. Shimizu, M. Goldfarb, I. Kwoh, D. Levy, C. Lama, C. Fraser
The DNA-mediated gene-transfer method is play-
ing a critical role in our understanding of the
genetics of animal cells, and nowhere is this more
evident than in the study of cancer. This year
marks the first cloning of "tumor" genes from
human cells. The cloning and characterization of
these genes has become a major focus of our lab.
Projects on the inheritance and function of DNA
methylation and the characterization of the
cellular thymidine kinase (tk) gene continue from
previous years.
Screening Human Tumor Cell Lines for
Transforming Genes
M. Perucho, M. Goldfarb, K. Shimizu, C. Lama,
M. Wig ler
Work from two laboratories (R. Weinberg's at MIT
and G. Cooper's at Sidney Farber Cancer Institute)
has demonstrated the growth transformation of
normal-growth-controlled mouse cells (NIH 3T3)
with DNA from certain chemically transformed
rodent cell lines (Shih et al., Proc. Natl. Acad. Sci.
76: 5714 [1979]) lines (Shih et al., Nature 290: 261
[1981]; Krontiris and Cooper, Proc. Natl. Acad. Sci.
78: 1181 [1981]). These experiments suggested the
existence of dominant-acting transforming genes
of cellular origin. Such genes are of obvious in-
terest. Since, as our success with the cloning of
the chicken tk gene demonstrated, any gene can
be cloned given a means to detect its transfer, we
set about to clone transforming genes of human
origin.
As a first step, we screened various human
tumor cell lines for the presence of dominant-
acting transforming genes by using the NIH 3T3
DNA-transfer assay system. Twenty-one human
cell lines provided by Jorgen Fogh (Sloan-Ketter-
ing Institute) were screened, and five were found
positive: one bladder carcinoma cell line, T24;
two lung carcinoma cell lines, SK-LU-1 and Ca lu-1;
one colon carcinoma cell line, SK-CO-1; and one
neuroblastoma cell line, SK-N-SH. The trans-
forming gene or genes contained in these cells
were partially characterized by the technique of
"Alu blotting" (Shih et al., Nature 290: 261 [1981];
Perucho et al., Cell 27: 467 [1981]). This technique
exploits the ubiquitous presence of the repeated
sequence within the human genome known as the
Alu family (Jelinek et al., Proc. Natl. Acad. Sci.
77: 1398 [1980]). The presence of these human se-
quences within a transformed mouse cell are
readily detected by blot hybridization. The pat-
tern one sees in transformants is characteristic for
a given gene. Using this method, as well as char-
acterization by restriction endonuclease sensitivi-
ty, we established that three distinct transforming
genes were present in our five cell lines: one
unique to T24, one unique to SK-N-SH, and one
common to the colon and two lung carcinomas
(Perucho et al., Cell 27: 467 [1981]). After analyz-
ing samples exchanged with R. Weinberg's labora-
tory, another human colon carcinoma cell line
was found also to contain this last gene. Finding a
human transforming gene common to several in-
dependently derived human tumor cell lines may
indicate the existence of common or overlapping
pathways for carcinogenesis in humans.
We have also screened DNAs extracted from
surgical specimens of human tumors and from
human tumors grown in nude mice. No DNAs
from human tumors have been found positive.
However, DNA from one human lung tumor,
maintained in nude mice, efficiently transformed
NIH 3T3 cells. These cells contained the gene
common to the lung 'and colon carcinoma cell
lines. We are continuing our screening of DNAs
from human tumors both to study the distribution
and frequency of occurrence of the recently iden-
tified genes and to identify new sources of novel
genes.
Characterization of the Transforming Gene
from T24 Bladder Carcinoma Cells
M. Goldfarb, K. Shimizu, M. Wig ler
Screening studies indicate that T24 cells contain a
dominant-acting transforming gene. In previous
years we developed a method for isolating genes
from animal cells by utilizing an essentially gene-
tic approach ("plasmid rescue") and in this way
cloned the chicken tk gene. An improved tech-
nique ("suppressor rescue") recently developed in
our laboratory also utilizes genetic selection in E.
co/i, based on the ability of a cloned tRNA sup-
pressor gene to complement amber mutant bac-
teriophage. This method has been successfully ap-
plied to the isolation of the transforming gene
from T24 bladder carcinoma cells (Goldfarb et al.,
Nature [In press]). A DNA sequence of less than
5.0 kb was obtained and found to be active in
transforming NIH 3T3 cells. Hybridization studies
indicate that these sequences are found in all NIH
3T3 cells transformed with T24 DNA and in all
normal and tumor human tissue tested. No se-
quences were found in NIH 3T3 cells or in NIH
3T3 cells transformed with DNA from neuroblas-
toma or colon and lung carcinoma cells. The lo-
cus that encodes the transforming gene of T24 is
highly polymorphic in the human population with
respect to restriction fragment length polymor-
phisms. Our best work to date indicates that this
gene is not grossly rearranged in T24 cells. The
T24 gene encodes an mRNA of 1100 by that has
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been found expressed in every tumor cell line ex-
amined to date, but not in human placenta or in
human fibroblasts cultured in vitro.
Isolating the Transforming Genes from
Lung and Colon Carcinoma Cells
K. Shimizu, M. Perucho, M. Goldfarb, M. Wig ler
We have adopted a different strategy to clone the
common transforming genes of lung and colon
carcinoma cells. From the number and sizes of
gene-associated restriction fragments hybridizing
with human repetitive DNA, we have estimated
this gene to be in excess of 30 kb. Cloning it by
purely genetic means would therefore be very dif-
ficult. We have used an alternative method based
on screening genomic libraries constructed in
phage X from mouse cells transformed by these
human genes and using human repetitive DNA as
our hybridization probe. We obtained one phage
with a 12-kb human DNA insert. This insert con-
tained sequences that are present in all NIH 3T3
cells transformed with the common lung/colon
gene but not in NIH 3T3 cells transformed with
other human genes. Using the "left most" and
"right most" parts of the insert, we are attempting
to clone additional parts of the gene by "chromo-
some walking." We have not yet detected a
transcript of this gene in transformed mouse cells.
Characterization of the Cellular tk Gene
J. Kwoh, K. Shimizu, M. Goldfarb, M. Wig ler
Efforts to understand the control of the cellular tk
gene are continuing. Jesse Kwoh has now precise-
ly mapped the more than 80 linker insertion mu-
tants of the cloned chicken tk gene and correlated
these with their transformation efficiencies. Re-
sults of combined physical/genetic mapping and
nuclease-S1 heteroduplex mapping suggest that
the 3' noncoding region is encompassed in an
800-base unspliced region of transcript and that
the 5' coding region consists of at least three ex-
ons (the largest no greater than 400 bases) totaling
about 1000 bases. John Lewis (Molecular Genetics
Section) has shown that expression of tk is cell-
cycle-regulated in mouse cells transformed with
the 3.0-kb clone of chicken tk, pchtk-5. This sug-
gests that (1) the control sequences for cell-cycle
regulation of tk expression are contained on that
3.0-kb fragment and (2) that the regulatory me-
chanisms have been conserved from chicken to
mouse. In related work, Kenji Shimizu is isolating
the human tk gene and John Lewis is isolating the
Chinese hamster tk gene. Both are utilizing the
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technique of suppressor rescue. These genes will
be useful in identifying and studying the regula-
tory control sequences. The isolation of the hu-
man tk gene will further enable us to study muta-
tional events in the various disorders involving
DNA repair that afflict humans.
The Inheritance and Function of DNA
Methylation in Mammalian Cells
D. Levy, M. Wigler
In previous years we had begun work on the study
of DNA methylation in mammalian cells. These
studies involved methylating cloned genes in vitro
with Hpal I methylase, a bacterial enzyme that
modifies DNA at a subset of sites (CCGG) that are
normally found methylated in the genomic DNA
of vertebrates. We demonstrated two things: first,
that methylated genes do not transform as well as
the unmethylated controls; and second, that DNA
methylation patterns are heritable. The first point
confirmed the findings of others that methylation
was roughly associated with gene activity, and the
second point suggested, as had been hypothesized,
that methylation might play a role in somatic in-
heritance. Current work has centered about these
two points. First, we have established that the
reduced transformation efficiency of methylated
tk genes is likely to be the result of an effect on
the expression of those genes, since methylation
does not affect the efficiency of their transfer. Se-
cond, we have established that methylation of the
coding regions of the herpes simplex virus (HSV)
tk gene is sufficient to inhibit transformation, and
methylation of the 5' untranscribed region is with-
out effect. Third, treatment with azacytidine, a cy-
tidine analog that inhibits DNA methylation, can
induce reactivation of unexpressed methylated tk
genes. Fourth, the inheritance of methylation can
be very faithful, approaching greater than 99%
per cell generation in rat fibroblast cells. Our pre-
vious estimate was 95% per generation on the ba-
sis of studies in mouse L cells.
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HORMONAL CONTROL OF GENE EXPRESSION
D.T. Kurtz, D. Bishop, M.M. Manos, L. McCullough, C. Nicodemus
For the last several years our laboratory has been
investigating the regulation of the synthesis of a
male rat liver protein called a2u-globulin. This
protein is synthesized in the liver of adult male
rats under the control of sex steroids, insulin, thy-
roid hormone, and glucocorticoids.
a2u-Globulin Gene Structure
We have found that a2u-globulin is encoded by a
multigene family comprising 18-20 genes per
haploid complement. Twelve different genes
have thus far been isolated from a library of rat
genomic DNA cloned in Charon 4A. All the genes
are -3.5 kb in length and contain six introns.
Three of the twelve genes have been found to be
variants (possibly pseudogenes). From their 5'
ends through their last introns, these variants are
quite similar to the "normal" genes, but from that
point on the 3' sequences in these variants are
completely different from those in the normal
genes and different from each other. This region
corresponds to the 3' untranslated region of a2u-
globulin mRNA. Specific fragments from these
variant 3' ends were cloned and used as probes
versus mRNA from several rat tissues. No hybridi-
zation was detected, indicating that within these
limits of detection, these genes are not tran-
scribed in vivo. Electron microscopy studies of
heteroduplexes formed between one of the vari-
ant genes and a normal gene showed that in addi-
tion to the lack of homology at the 3' end, there is
a small (-100) deletion in this variant, which has
been mapped to the protein-coding region, be-
tween the fifth and sixth introns. Finally, all three
variant genes contain several Mspl sites (CCGG),
whereas the normal genes contain one, or at most
two, Mspl site in an 8-kb region surrounding the
genes.
a2u-Globulin Synthesis in the Salivary Gland
A cloned a2u-globulin cDNA was used to screen
several rat tissues for the presence of a2u-globulin
mRNA. It was found that in addition to the liver,
a2u-globulin mRNA is found in the salivary glands
of both male and female rats at a level of -100
copies/cell. This is 1/200 the level found in the
liver. However, the synthesis of a2u-globulin in sa-
livary gland was found to be constitutive and not
under hormonal modulation. Thyroid hormones, an-
drogen, glucocorticoids, or estrogens had no ef-
fect on the a2u-globulin mRNA level in the sali-
vary gland.
Hormonal Modulation of a2u-Globulin
Gene Expression
The approach we have used to investigate the hor-
monal control of a2u-globulin gene expression is a
simple one: If the information necessary for hor-
monal response is encoded in the DNA sequences
in or immediately around the a2u-globulin gene,
then when an isolated gene is put into a cell with
the appropriate hormone receptor, it should be
able to respond to the hormone. We have found
that this indeed is the case: Purified a2u-globulin
genes introduced into mouse L cells, rat R2 cells,
or rat XC cells respond to glucocorticoids,
resulting in the induction of cytoplasmic a2u-
globulin mRNA. The extent of induction varies
from clone to clone but it is generally eight- to
tenfold. Using cloned a2u-gene fragments contain-
ing progressively smaller amounts of flanking
DNA sequence, we have found that a cloned gene
fragment containing 275 bases of 5' flanking se-
quence and -400 bases of 3' flanking DNA still
responds to glucocorticoids, although the fold in-
duction is somewhat less.
The different cloned a2u-globulin genes were
tested for hormone inducibility following transfer
into L cells. All of the genes that possess the "nor-
mal" 3' end were found to be inducible. The
variant genes above, however, showed
a markedly different behavior: When introduced
into L cells, all of these variant genes produce
mRNA constitutively at a relatively high level.
Hormone administration has no effect on the
level of message. The constitutive level of a2u
mRNA produced by these variants (200-300
copies per cell) corresponds to the fully induced
level found for the hormonally inducible genes.
Hybrid genes containing either the 5' or 3' half of
an inducible gene linked to the opposite half of a
constitutive gene have been constructed and will
be used to investigate this phenomenon.
Cloned fragments from the 5' end of an induci-
ble a2u-globulin gene were ligated to the struc-
tural gene for HSV thymidine kinase. These hy-
brids were used to transfect Ltk - cells to a TK+
phenotype. It was found the thymidine kinase en-
zymic activity in L cells containing this construc-
tion was induced two- to fivefold by glucocorti-
coids. Thymidine kinase activity in L cells contain-
ing an authentic HSV tk gene is unaffected by glu-
cocorticoids, and in fact usually decreases. The
induction of these hybrid constructs that contain
only the 5' promoter region of the a2u-globulin
gene is consistently less than that seen when the
entire a2u-gene is used. This could indicate that
DNA sequences that respond to the hormone are
found throughout the gene or that the induction
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of a2u-globulin by glucocorticoids is due both to
an induction of transcription and a concomitant
stabilization of a2u mRNA in the cytoplasm. (Spe-
cific stabilization of mRNA by steroid hormones
has been found in several systems.) Constructs
that contain only the 5' promoter region from the
a2u-globulin gene may be able to respond to
glucocorticoids at the transcriptional level, but
the HSV tk message produced would not be ex-
pected to be stabilized by glucocorticoids. To
determine whether there is a component of
mRNA stabilization in the induction of a2u-globu-
lin, we have constructed hybrids in which various
portions of the a2u structural gene have been
cloned into the 3' untranslated region of the HSV
tk gene. Such constructs should result in an artifi-
cially elongated tk mRNA that contains a2u infor-
mation at the 3' end. These clones have been
transfected into L cells and the effect of glucocor-
ticoids on the level of the hybrid mRNA is being
investigated.
Modulation of a2u-Globulin Expression
by Other Hormones
The studies outlined above have been restricted
to glucocorticoid hormones because the recipient
cells used in these studies do not possess recep-
tors for sex steroids or thyroid hormone. The in-
duction of a2u by thyroid hormone in vivo and the
repression of a2u by estrogens in vivo are much
greater than the in vivo effects of glucocorticoid
80
hormones. Several cell lines have been described
that contain receptors for thyroid hormone (C3H
10T 1/2 cells) or estrogen (MCF-7 cells). A domi-
nant-acting vector for eucaryotic gene transfer
has been constructed by Doug Hanahan (Tumor
Virus Section). It consists of the procaryotic neo-
mycin resistance gene from Tn5 linked to the
SV40 early promoter. If appropriate splice and po-
ly(A)-addition sites are added, this vector seems to
be highly efficient in transforming several differ-
ent tissue culture lines to resistance to the neomy-
cin analog G418. This vector will make possible
studies on the molecular mechanisms of action of
sex steroids and thyroid hormone and may allow
us to begin to study the genetics of the hormone-
response pathway.
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GENES FOR THE MAJOR STRUCTURAL PROTEINS:
ORGANIZATION AND CONTROL OF EXPRESSION
S.H. Hughes, J. Feramisco, D. Heitman, T. Kost, A. Mutschler, J. Sorge, G.P. Thomas
Nondefective Avian Retroviral Vectors
Retroviruses, alone among the viruses of higher
eucaryotes, act as vectors in nature. The highly
oncogenic retroviruses all contain genes captured
from host-cell chromosomes. The high level of on-
cogenicity of these viruses is a direct result of the
expression of the captured cellular gene. In addi-
tion to their natural qualifications as vectors,
retroviruses have a number of other features that
enhance their usefulness for eucaryotic gene ma-
nipulation and expression. Retroviruses are nonly-
tic, and when not carrying an oncogene, they have
little or no effect on the growth properties or mor-
phology of cells in vitro. There are even a few
strains of retroviruses available that replicate in
animals but do not cause any disease. Retrovi-
ruses associate stably with the host cells; a copy
of the viral genome is inserted into host DNA as a
normal part of the virus life cycle. The efficiency
of infection is high: In vitro it is possible to infect
essentially every cell on a dish. The infection is
self-limiting, however, and the number of pro-
viruses inserted into the host genome is usually
less than four. Replication-competent viruses con-
taining only viral genes are usually about 7.5 kb in
length, making manipulations with restriction en-
zymes manageable. Additional genetic informa-
tion can be accommodated; the parental virus,
Rous sarcoma virus (RSV) is 9.5 kb in length. Of all
the known retroviruses that carry oncogenes of
cellular origin, only RSV has retained a full com-
plement of viral genes. In all other cases the ac-
quisition of the cellular gene is accompanied by
the loss of part or all of one or more viral genes.
Finally, the unique alternation between RNA and
DNA forms as the virus replicates poses the ques-
tion of how retroviruses regulate RNA splicing so
that genes containing essential genetic informa-
tion are not lost. The question of how newly in-
troduced genes containing introns are handled is
especially relevant, since in all of the cases
studied so far, the viral copy of the acquired
proto-oncogene is without intervening sequences,
despite the fact that in most cases the cellular
antecedent of the gene has intervening se-
quences.
For these reasons we have initiated a project to
use retroviruses as vectors. RSV was chosen as the
prototype because it should be possible to re-
place the oncogene (src) with other genes and still
maintain the full complement of viral genes.
Since src is expressed, precise replacement of src
should lead to expression of the inserted gene.
The advantages of a helper-independent vector
are substantial: Most important is that there need
be no selection for genes inserted into the vector.
Since all the viruses present in the infection are
the same, the problems caused by recombination
with or overgrowth by the helper are eliminated.
The vector is viable whether or not DNA is in-
serted in place of the src gene, which permits di-
rect assessment of a vector construction without
the complication of an insert.
Replication-competent src deletion mutants oc-
cur naturally at relatively high frequency. The
first retrovirus vectors we constructed resembled
these natural src deletion mutants; cloned viral
DNA was manipulated in vitro to remove most or
all of src. To allow the easy insertion of new gene-
tic information in place of src, the endpoints of
the in vitro deletions were joined with a linker
containing a site for the restriction endonuclease
C/al, which does not normally cleave RSV DNA.
The choice of C/al has the additional advantage
that DNA cleaved by Taql, which has a 4-base re-
cognition site, may be ligated directly to DNA
cleaved by C/al without further manipulations.
In the wild-type SR-A strain of RSV, from which
the vectors were derived, src is flanked by direct
repeats approximately 120 by long. The majority
of the natural deletion events that remove src oc-
cur within these 120-bp repeats (J. Sorge, unpub-
lished), although it is not clear whether the dele-
tion events are strictly homologous. The first ge-
neration of vectors retain most or all of both re-
peats (see Fig.1), and in all cases deletion events
similar to those that remove src from RSV were
observed. The percentage of deleted virus present
at any time after the initial infection is a product
of the propensity for deletion of the starting virus
and the growth advantage, if any, of the deleted
form. There seems to be a general tendency for in-
fections initiated with viruses containing large in-
serts to accumulate a higher percentage of dele-
tions. One apparent exception to this rule was a
construction in which a small insert was intro-
duced together with a small piece of pBR322 (325
bases of pBR322 were present). This construction
deleted much more rapidly than did a very similar
construction that lacked the pBR322 sequences
(see Fig. 1). Nuclease-S1 mapping demonstrated
an apparent deletion endpoint within the pBR322
sequences.
In some sense the selective advantage of the
smaller viruses may reflect the fact that the life
cycle of these viruses is more rapid. Reverse
transcriptase takes several hours to copy viral
RNA, and the difference in the amount of time it
takes to copy the larger and smaller genomes may
make the replication cycle of a deleted virus
faster. There may, however, be more to the sys-
tem than this: We have not been able to grow any
virus containing a genome larger than about 10
kb; larger constructions all failed to show any
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growth (Fig. 1), suggesting that there may be some
absolute size constraint.
We wished to eliminate or vastly reduce the
tendency for the virus to delete inserted genetic
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Figure 1
A comparison of some of the retroviral vectors derived from RSV. At the top of the figure is a schematic drawing of
the parental virus (labeled ASV). For convenience, only the src region and the LTRs are drawn to scale; the gag, pol,
and env genes are vastly compressed. In the SR-A strain of RSV, the src gene (labeled v-src in the drawing) is flanked
by direct repeats. These are shown in the drawing as filled black boxes. The size of the src gene, approximately 1600
bases, is given above the v-src region. After passage of a pure stock of RSV, and several of the recombinant viruses
as well, the region between the direct repeats is lost. The approximate percentage of deletions is given at the right.
This is not an absolute value, since the proportion of deleted viruses increases with time, but the measurements were
made at approximately the same time (about 4 weeks) after the initiation of infection in each case.
Immediately below the parental virus are drawings of three recombinants, each of which contains a complete
cDNA copy of the a subunit of human chorionic gonadatropin (aCHCG). The uppermost of these contains, in addi-
tion, 325 bases of sequence from the bacterial vector pBR322, the lowest of the three has had removed essentially
all of the right-hand copy of the direct repeat that originally flanked src.
The fifth drawing from the top shows one of the viral vectors without an insert; the vertical line represents the Clal
used to introduce DNA into the vector.
Below the drawing of the vector are three constructions that contain the complete genomic copy of the a subunit
of the human chorionic gonadotropin gene. This form of thegene contains two intervening sequences; the exons are
shown as cross-hatched boxes and the introns by a single dark line. The construction depicted in the uppermost of
the three drawings contains a complete copy of genomic a-HCG; the lower two have had a portion of the first exon
removed.
The two drawings at the bottom are retroviral vectors with plasmid inserts, either pBR 322 or the small plasmid
pfx-1. We have called constructions of this sort RSVPs.
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lost during virus passage. Assuming that the pro-
pensity for deletion depends on the presence of
both direct repeats that originally flanked src, the
solution was to eliminate one or both repeats.
Since the splice acceptor site used in making the
src message (see Fig.1), which should be useful for
expression of inserted genes, lies between the up-
stream repeat and the beginning of src, we chose
to eliminate the downstream direct repeat. A
series of clones were prepared by BaI31 digestion
and ligation to C/al linkers. This created C/al sites
at varying distances from the U3 region of the
LTR. These fragments were combined with vari-
ous cloned viral DNAs with Cla sites upstream to
src to yield viral DNAs with deletions ending -10,
-30, -45, etc. bases from the LTR. The -10 de-
rivatives were not viable, but all derivatives with
30 or more bases upstream of the LTR were viable.
The derivatives with almost all of the downstream
direct repeat removed show a greatly reduced
deletion frequency (see Fig. 1).
The behavior of inserts containing intervening
sequences was tested. The initial experiments
were done with derivatives that contained geno-
mic clones of human chorionic gonadotropin
(HCG), which has two intervening sequences. The
original construction was about 11 kb in length
and did not grow (see Fig. 1), presumably because
it was too large. Removing 1000 by from one of
the intervening sequences in vitro permitted viral
replication. The experiments were done in two
sets of viral vectors, those that contained both re-
peats intact and those lacking almost all of the
downstream direct repeat. After the virus had
reached a high titer, virion RNA and whole-cell
RNA samples were analyzed by nuclease-S1 diges-
tion, and the genomic form of viral DNA was ana-
lyzed by the transfer procedure of Southern.
In two of the experiments, the virion RNA was a
mixture of forms that did and did not retain HCG
intervening sequences. Loss of the HCG interven-
ing sequences from the provirus was documented
by the transfer procedure of Southern. In the third
experiment the virion RNA contained only the ful-
ly spliced form of the HCG insert. The elimination
of the intervening sequences is precise, as judged
by nuclease-51 analysis. The ratio of spliced to un-
spliced HCG inserts in virion RNA is apparently af-
fected by the amount of viral DNA used in the
transfection. Following a high-efficiency transfor-
mation, the vast majority of the genomes that
were present a few weeks after transfection con-
tained completely spliced HCG inserts. Following
a low-efficiency transfection the percentage of vi-
ral genomes containing spliced HCG inserts is
nearer 50%.
It is clear that splicing is not the inevitable fate
of retroviral RNA. There are three reasons for this
statement: Wild-type genomic retroviral RNA is it-
self unspliced; there are unspliced HCG inserts
present in several of the infections with the vec-
tors; and finally, the construction with the full
HCG genomic insert (exceeding the apparent size
limitation) does not grow following a low-efficien-
cy transfection.
Taken together, these data suggest separate
pathways for the maturation of virion RNA and vi-
ral message. Virion RNA is apparently protected
from the normal splicing machinery, presumably
by a viral gene product. Such a mechanism would
function as feedback loop that would regulate the
ratio of spliced to unspliced RNA if the viral gene
product were derived from spliced RNA. Spliced
RNA is not absolutely excluded from virions;
some viral message is packaged in the course of a
normal infection. If the mispackaging of message
is the major pathway whereby introns are re-
moved from the genomic HCG inserts, we can ac-
count both for the fact that intervening sequences
can be lost from the HCG during the retrovirus life
cycle and for the fact that not all the viruses lose
the intervening sequences even after several
rounds of viral replication. These observations
have considerable significance for the acquisition
of oncogenes by retroviruses. A retrovirus with a
precise cDNA copy of a gene can potentially de-
rive from a DNA fusion event linking retroviral
genes to a cellular gene containing intervening se-
quences. The only question that remains is how
well this event works with genes that contain
large intervening sequences.
We plan to test the effects of high-efficiency
transformation on the growth of constructions
with the full HCG genomic inserts, which ap-
parently are too large to replicate unless some of
the insert is removed either by deletion or by
splicing.
Retrovirus Recombinants Capable of
Replication in E. coli
It is now clear that retroviral genomes can act as
insertional mutagens in certain specific circum-
stances and can in either activate or inactivate
particular genes. It is also clear that retroviral
DNA can insert at a great many sites in the host
genome. It is not yet known whether retroviral
DNAs insert essentially at random in the host ge-
nome. This is of considerable interest for two rea-
sons: First, specificity of integration might play a
role in defining differences in oncogenic potential
among related viruses, some of which can acti-
vate oncogenes by integrating nearby. Second, re-
troviruses may be useful as general insertional
mutagens for both the identification and the isola-
tion of selectable markers. The general utility of
such a proposal depends crucially on whether or
not there is significant restriction on the number
of sites in the host genome that a retroviral ge-
nome can enter.
For these reasons, using the RSV-derived vec-
tors described in the previous section, we have
constructed recombinants (which we call RSVPs)
that have the src region of RSV replaced by a
small (2 kb) plasmid that carries the E. con origin
region and the tetracycline resistance gene (tet)
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from pBR322. Since the ultimate goal is to muta-
genize the host chromosome and then to rescue
retroviral genomes responsible for the mutagenic
events, it is valuable, if not essential, that the vec-
tor be helper-independent. This construction
grows on E. coil since there is an E. coil origin of
replication and a selectable marker in the small
plasmid, and it also grows in chicken cells since it
contains a full complement of uninterrupted viral
genes. The original RSVP construction retained
the direct repeats that flank src in RSV and, as a
consequence, deleted the plasmid sequence at
high frequency during passage in chicken cells.
Using a high-efficiency E. coil transformation pro-
tocol developed by D. Hanahan (Tumor Virus Sec-
tion), it was possible to rescue into E. coil RSVP
DNA directly from DNA isolated from RSVP-in-
fected chicken cells, despite the fact that 90% of
the RSVP viruses present in the chicken cells lack-
ed the plasmid insert. Based on the RSV vectors
described above we are now constructing a sec-
ond generation of RSVPs that have the down-
stream copy of the direct repeat removed (see Fig.
1). Since these have a vastly reduced deletion fre-
quency with other inserts, we hope to use them to
create RSVPs that delete their plasm ids only rare-
ly during passage on chicken cells.
Structure of the Endogenous Virus RAV-0
and the Construction of Defined Recom-
binants between Avian Leukosis Viruses
The avian leukosis viruses (ALVs) can cause leuko-
sis by activating the endogenous oncogene c-myc.
Insertion of an ALV provirus near c-myc can cause
greatly increased levels of c-myc transcription
and lead to cellular transformation. The endogen-
ous avian retrovirus RAV-0, which is closely re-
lated to the ALVs, does not cause leukosis in
chickens. The most obvious physiological differ-
ence between the ALVs and RAV-0 is their host
range, which is determined by the env gene. How-
ever, in vivo ALV/RAV-0 recombinants that have
acquired RAV-0 host range are still oncogenic in
birds, which argues strongly that the crucial dif-
ference(s) in oncogenic potential between RAV-0
and the ALVs does not lie in env. A physical com-
parison of the RAV-0 and ALV genomes by T1
oligonucleotide fingerprinting and hybridization
suggests that the most significant differences in
sequence between RAV-0 and the ALVs lie in a re-
gion corresponding to the 3' end of viral RNA. To
examine this more precisely, we have cloned a re-
plication-competent DNA copy of RAV-0 and se-
quenced the LTR and adjacent regions. The most
striking differences between the RAV-0 and ALV
sequences in the segment examined lie in the U3
portion of the LTR. Could these differences ac-
count for the differences in oncogenicity?
There are two obvious (as well as several less
likely) explanations for the lack of RAV-0 on-
cogenicity. Either the RAV-0 proviruses cannot in-
tegrate near the cellular oncogene c-myc, or if
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they do integrate near c-myc, they cannot ac-
tivate c-myc. If there are preferred integration
sites or regions in the host genome for the inser-
tion of retroviral DNA (which is not known),
models can be generated in which the LTR se-
quences are important determiners of this specifi-
city. Alternatively, RAV-0 may integrate next to
c-myc and fail to activate the endogenous onco-
gene. If this is the correct explanation, the crucial
difference between RAV-0 and the ALVs might
still reside in the LTR and, more specificially, in
the U3 region.
As a final test for the crucial region defining the
differences in oncogenic potential between the
ALVs and RAV-0, we are constructing in vitro de-
fined recombinants between an oncogenic ALV
parent, specifically the RSV-derived vectors de-
scribed above, and RAV-0. Because it is likely that
the crucial difference will reside in the LTR, the
first recombinants we have constructed have all
the genes, gag, poi, and env, from the ALV parent
and the LTR region from RAV-0. Dr. Lyman Crit-
tenden (USDA Poultry Laboratory) has agreed to
test the oncogenicity of these viruses in birds. If,
as we predict, such constructions are not oncoge-
nic in vivo, they would serve as the prototype for
an in vivo vector.
Since these recombinants have not been tested
in chickens as yet, our current conclusions must
rest on the sequence data alone. The sequence of
the RAV-0 LTR is very similar to that of the repli-
cation-defective endogenous virus EV-1. Like the
EV-1 LTR, the RAV-0 LTR is smaller (278 by in-
stead of 330 bp) than the LTRs of the oncogenic
members of the ASV/ALV group.
The U5 and R segments are quite similar; the
majority of the changes lie in the U, segment.
Although there is still obvious homology between
the U3 regions of RAV-0 and the oncogenic
ALV/ASV viruses, there are a series of small seg-
ments present in the oncogenic viruses that are
absent in RAV-0. It is possible that these missing
segments could account for the differences in on-
cogenic potential of RAV-0 and the ALVs. The
RAV-0 sequence outside the LTR region has also
been compared with the available ASV/ALV se-
quences (Czernilofsky et al 1980; D. Schwartz,
pers. commun.). The sequences between the LTR
and gag are very similar in the Pr-C strain of RSV
and RAV-0, and the region of env for which we
have sequence is similar in the SR-A and Pr-C
strains of ASV and RAV-0. The most obvious dif-
ference is at the extreme end of the env gene, at
the C terminus of gp37. The nucleic acid se-
quences are obviously related, but the predicted
amino acid sequence of the RAV-0 gp37 is signifi-
cantly longer than the sequence of the gp37 of Pr-
C, and very similar to the sequence of the gp37 of
SR-A. (We have made significant corrections in
the sequence of SR-A near the carboxy terminus
of gp37. [J. Sorg and S. Hughes, unpubl.].)The ma-
jor differences in this segment of gp37 suggest
that this region probably does not play a major
role in the function of the env protein.
The acquisition of src is of considerable in-
terest. Sarcoma viruses presumably are derived
from ALVs; however, src is also lost from RSVs at
high frquency, creating ALVs. When dealing with
an ALV, therefore, it is very difficult to know
whether or not the ALV previously contained src.
To understand the original acquisition of src, it is
essential to examine a viral genome that never
contained src. The most obvious candidate is
RAV-0, which is closely related to the other
ALV/ASV viruses, but almost certainly never con-
tained src.
The segment of RAV-0 that lies between the
end of the env gene and U3 is approximately 190
bases in length. Essentially this entire segment is
present between env and src in the SR-A strain of
RSV. Most of this segment is also present between
env and src in Pr-C; however, in Pr-C there is an ap-
parent deletion of 40 bases in the region adjacent
to env. In SR-A, but not in Pr-C, about half of this
segment is also present between src and the LTR.
This arrangement has implications for the mecha-
nism by which src was acquired. It suggests that
the src sequences were not merely inserted into
the region between env and src, but that at least
two viral genomes were involved. Through inte-
gration, or the actions of reverse transcriptase, or
both, src was apparently added to the end of the
viral genome, with the concomitant loss of the
LTR. To complete the virus, a second copy of the
sequence found between env and the LTR of
RAV-0 was also acquired, together with the LTR;
almost certainly a second viral genome was the
donor of this segment.
Isolation and Identification of Genes
Encoding Major Skeletal Proteins
We are working on protocols for rapidly identify-
ing individual recombinant clones. Our initial
strategy was to identify, from a complete geno-
mic library, clones that encoded abundant mes-
sages. Such clones were defined as those that re-
acted strongly with 32P- labeled cDNA prepared
from poly(A)+ RNA. Individual clones were identi-
fied by hybridization selection of mRNA followed
by translation. The translation products were
analyzed on one- and two-dimensional polyacry-
lamide gels. These methods allowed us to identify
clones ccrtaining genes from the actin, tubulin,
and 100-A-filament families. Although we have
been successful in identifying these highly ex-
Figure 2
Immunological identification of bacterial clones producing flu virus HA antigen. Two halves of a bacterial plate
were streaked with bacteria. Those containing a plasmid that expresses flu virus HA antigen were on the right; those
containing a related plasmid that did not contain flu virus HA antigen were on the left. A portion of the colonies was
transferred to an inert support, lysed, and cut in half, and one half of the filter was exposed first to a rabbit antibody
specific for flu virus HA antigen and then to a 1251-labeled goat anti-rabbit antibody. Excess antibody was washed
off, and the filter was exposed to X-ray film. An autoradiogram of the film is shown in the figure. The pattern of
streaks and spots on the right side of the figure corresponds precisely to the pattern of growth of the colonies pro-
ducing flu virus HA antigen. A similar pattern of colonies not producing flu virus HA antigen was present on the left
side of the figure; these are not deteCted in the assay.
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combinant X phage, each h of which contains d
pressed genes, the method is difficult and we
have had little success in identifying clones con-
complete copy of this gene. The message is about
taining genes expressed at lower levels. We are
2000 bases in length, of which about 1100 bases
now trying a new strategy for identification: clon- are required to
encode the 13-actin protein. There
ing cDNAs into plasmid expression vectors and is a long 3'
untranslated region, about 600-700
screening the individual colonies with labeled an-
bases in length; the 5' untranslated region is much
tibodies. Several groups have published protocols
shorter, about 120-130 bases in length.
of this sort, although only one of these has been
The gene itself contains four intervening se-
used to identify an unknown clone; the others
quences, all of which lie in the coding segment.
have been used only in reconstruction experi- All four are relatively small, the one nearest the
ments with defined cDNAs. The available proto- site of initiation of transcription is about 300 by in
cols are relatively laborious when compared with
length. The other three are, in order, about 550 by
200 bp, and 350 bp in length. Most of the gene has
the nucleic acid hybridization protocols normally
used to isolate clones.
now been sequenced. There is homology, as ex-
We are now testing a much simpler protocol, petted, to the yeast actin gene in the coding
based on the "western" protein transfer to nitro- regions both in the predicted amino acid se
cellulose, which is straightforward and, at least in quence and in the nucleic acid sequence. The
_reconstruction experiments, quite sensitive. In our amino acid sequence is much better preserved;
preliminary experiments, bacterial clones (kindly there has been considerable genetic drift at posi-
provided by M.-J. Gething, Imperial Cancer Re- tions in the gene that are unselected (usually third
search Fund) producing about 3000 molecules of base positions). Interestingly, there apparently has
flu virus HA antigen per cell were readily de- not been conservation of the position of interven-
tected, and colonies not producing HA that were ing sequences, suggesting that such sequences
present on the same filter were not detected (Fig. have been inserted into (and possibly lost from)
2). We are not constructing expression cDNA li- this gene during the course of evolution.
braries and will initially screen in parallel clones
for which both antibody and nucleic acid probes
are available. If a reasonable percentage of the
clones detected by the nucleic acid probes can be Publications
detected with the antibody probes, a purely anti-
genic screening will be initiated. Cleveland, D.W., S. Hughes, E. Stubblefield, M.W.
KIt is to be expected that only one cDNA clone in ischner, and H.E. Varmus. 1981. Multiple a- and
six has both the appropriate orientation and frame 0 -tubulin genes represent unlinked and dispersed
to express the same protein sequence that the gene families. I. Biol. Chem. 256: 3130.
parental message expresses. However, John Fid- Hughes, S. 1982. Sequence of the LTR and adjacentregions of the endogenous virus RAV-0. J. Virol. (indes (Human Polypeptide Hormone Genes Section) press).has developed a protocol for inserting, with Hughes, S., A. Mutschler, J.M. Bishop, and H.E. Varmus.
linkers, cDNAs in defined orientations, and with 1981. A Rous sarcoma virus provirus is flanked by
the high-efficiency transformation protocols of short direct repeats of cellular DNA which were pre-
Doug Hanahan (Tumor Virus Section), it is sent in only one copy prior to integration. Proc. Natl.
straightforward to manufacture an expression Acad. Sci. 78: 4299.
library large enough (about 105 members) to Hughes, S., J. Sorge, G.P. Thomas, J. Feramisco, L. Chow,
ascreen for clones of even relatively rare messages. nd J.Garrels. 1982. Approaches for isolating genes
encoding theantibodies are available at Cold Spring t  cytoskeletal proteins and for rein
Harbor for approximately twenty of the cytoskele- troducing the genes into cultured cells. Cold SpringHarbor Symp. Quant. Biol. 46: 507.tal proteins. Our initial efforts will be attempts to Sorge, J. and S. Hughes. 1982. The polypurine tract adja-
obtain vinculin clones. cent to the U3 region of the Rous sarcoma virus
genome provides a cis-acting function. J. Virol. (in
Analysis of the Chick [3-Actin Gene press).
. 1982. The splicing of intervening sequences in-There is only one /3 -actin gene in the chicken troduced into an infectious retrovirus vector. (Sub-genome. We have obtained two independent re- mitted.)
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STRUCTURE AND EXPRESSION OF HUMAN POLYPEPTIDE
HORMONE GENES
J.C. Fiddes, N. C. Vamvakopoulos, W.R. Boorstein
We have been interested in the structure and ex-
pression of two separate groups of mammalian
polypeptide hormones, the pituitary and placen-
tal glycoprotein hormones, and the hypothalamic
releasing hormones. Although structurally dis-
tinct, these two groups have a functional relation-
ship in that the hypothalamic releasing factors are
required for stimulating the synthesis and release
into the bloodstream of the pituitary hormones.
The Glycoprotein Hormones
There are three pituitary glycoprotein hormones,
luteinizing hormone (LH), follicle stimulating hor-
mone (FSH) and thyroid stimulating hormone
(TSH), and one placental glycoprotein hormone,
chorionic gonadotropin (CG). LH and FSH func-
tion synergistically in both the male and the
female to promote spermatogenesis or ovulation
by stimulating the synthesis of steroids by the
testes or ovaries. Following conception, the pla-
centa makes CG, which functions in a very similar
way to LH in that it stimulates the corpus luteum
of the ovary to produce the steroids essential for
the maintenance of pregnancy. Functionally,
therefore, the three hormones, LH, FSH, and CG,
are called the gonadotropins. The fourth member
of the group, TSH, although structurally related to
the gonadotropins, is functionally distinct in that
it causes the thyroid gland to make thyroxine and
tri-iodothyronine.
All four glycoprotein hormones are dimeric and
consist of dissimilar a and 13 subunits that are held
together noncovalently. The a-subunit amino acid
sequence appears to be common to all four hor-
mones, whereas the (3 subunits are unique and
confer biological specificity on the hormone. The
four 0 subunits all show sequence homology rang-
ing from about 80% between LH and CG to from
30% to 40% between all other pairs of 0 subunits.
It is therefore expected that the 0 subunits will be
encoded by a multigene family of sequences that
presumably had a common evolutionary ancestor.
Previously we had isolated and characterized
full-length cDNA clones for both the a and 0 sub-
units of CG by reverse transcribing human pla-
cental RNA. The cloned a-subunit gene was then
used as a hybridization probe to detect chromoso-
mal clone containing the region coding for the a
subunit. Analysis of this clone, and comparison of
it to the hybridizing fragments observed in total
human DNA, strongly indicates that there is a
single a-subunit gene that must be transcribed for
all four hormones.
Recently we have been analyzing genomic
clones isolated by hybridization to the OCG cDNA
and have found that the situation is much more
complex than with the single a gene. The 0
subunit of CG appears to be encoded by a family
of at least seven separate genes. A total of five of
these have been isolated on chromosomal clones,
and the presence of the other two is indicated by
Southern blotting of total human DNA.
The five genes isolated so far all appear to have
the same overall structure, with a small intron
close to the start of the signal peptide (between
amino acids -15 and -16) and another small in-
tron between amino acids 41 and 42 of the mature
protein. Several regions of slight sequence diver-
gence exist between the genes. For example, one
gene has a single nucleotide difference in the cod-
ing region so that the proline codon for amino
acid 126 is CCG and not the CCC that is present in
the other genes and the initial cDNA isolate. An
additional cDNA clone that has this altered codon
has now been isolated, proving that at least two of
the seven 0CG genes are expressed. The other re-
gion of sequence difference between the genes,
apart from in the intervening sequences, is in the
5' untranslated regions. Again, distinct types of
cDNA clones have been isolated, showing that
several of the OCG genes are probably functional.
We are presently characterizing the promoter se-
quences of the five genes and hope to study their
expression by in vitro transcription or reintroduc-
tion of the genes into cultured mammalian cells.
All five 0CG genes so far isolated are physically
linked on the chromosome and span a region of
about 45 kb. Southern blot analysis of human
DNA implies that the two uncloned genes are also
linked to this locus. Four of the five cloned genes
show a most unusual structure in that they are in
the form of two inverted symmetrical pairs. Tran-
scription of each inverted pair is convergent with
the two 3' ends of the genes, being separated by
about 2 kb of DNA.
Using human pituitary RNA, we are attempting
to isolate cDNA clones for the 0 subunits of LH,
FSH, and TSH to determine whether these are also
encoded by multigene families and whether they
are linked to the genes for the (3 subunit of CG.
The Hypothalamic Releasing Factors
The hypothalamus synthesizes several small pep-
tides which include gonadotropin releasing hor-
mone (gnRH) and thyroid-stimulating-hormone re-
leasing hormone (TRH). These peptides pass by a
direct vascular connection to the pituitary where
they stimulate the release of LH and FSH (gnRH)
and TSH (TRH). Although both of these peptides
are produced in very minute quantities, they have
been isolated and their primary structure deter-
mined. gnRH was thus shown to be a decapeptide,
and TRH is a tripeptide.
We assume that these small peptides are made
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in the hypothalamus as part of a larger precursor
didate for gnRH. We have now used the primer-ex-
that is processed in a way similar to the proopio-
tension clone to screen a complete oligo(dT)-
melanocortin and enkephalin precursors. To
primed cDNA library and are determining by DNA
understand the biosynthesis of these hormones, sequence analysis whether the positively hybridiz-
we are attempting to isolate cDNA clones encod-
ing clones code for the putative gnRH precursor.
ing the putative precursor to one of the hypotha-
The second approach involves the construction
lamic peptides, gnRH. This project is in collabora- of complete cDNA libraries by oligo(dT) priming
tion with M. Evinger and J. Roberts of Columbia and using either the oligonucleotides themselves
University and A. Markham of ICI, England. or the specifically primed cDNA they generate as
Synthetic oligonucleotides, 11-16 nucleotides
hybridization probes. We have been successful in
long, have been made to correspond to the known
creating cDNA libraries of greater than 105 recom
amino acid sequence of gnRH. Due to the degen- binants by using a double-linked cDNA cloning
eracy of the codons for the amino acids of gnRH,
technique and have screened these libraries as de-
a considerable number of oligonucleotides have
scribed above. Several positively hybridizing
been synthesized. We have been using these oli- clones have been isolated and these are being
gonucleotides in two ways.
analyzed by DNA sequencing to establish
First, the oligonucleotides have been used to whether they encode gnRH.
prime the synthesis of double-stranded cDNA
from mRNA prepared from a tissue that should be Publications
expressing gnRH. In addition to the hypothala- Boorstein, W.R., N.C. Vamvakopoulos, and J.C. Fiddes.
mus, there is evidence that gnRH is also made in Human chorionic gonadotropin ,(3 subunit is coded
the placenta, so this tissue has also been used. by a family of linked, symmetrically arranged genes.
When this specifically primed cDNA is analyzed (In preparation.)
by gel electrophoresis, a discrete set of bands is Fiddes, J.C. and H.M. Goodman. 1981. The gene
observed. The specifically primed cDNA from hu- encoding the common a subunit of the human
man placenta has been cloned in an attempt to glycoprotein hormones. 1. Mol. Appl. Genet. 1: 3.
isolate cDNA clones corresponding to the promi- -- 1981. The human gonadotropin genes. In
nent primer-dependent bands. Using this ap- Bioregulators of reproduction. P&S Biomedical
proach, a primer-extension cDNA clone has been Sciences Symposium. (ed. G. lagiello and H.J. Vogel),p. 279. Academic Press, New York.isolated that hybridizes to an mRNA species of Moore, D.D., J.C. Fiddes, R.A. Hallewell, M.A. Conkling,
the same size in the placenta and the hypothala- F.M. DeNoto, and H.M. Goodman. Multiple growth
mus and that is not found in other tissues. By hormone related sequences are linked in the human
these criteria, this short cDNA clone is a good can- genome. Proc. Natl. Acad. Sci. (in press).
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MOLECULAR GENETICS OF THE MOUSE
L.M. Silver, G. Blose, J.S. Danska, M.I. Harper, D. Lukralle, N. Sarvetnick, J. Uman, K.R. Willison
In our first year at Cold Spring Harbor we have set
up a new program that combines classical and
molecular approaches toward an understanding
of the organization and expression of the mouse
genome. We have an actively breeding colony of
approximately 1000 mice, and this colony pro-
vides the material used in almost all of the experi-
ments that we are conducting. A major long-term
emphasis of our research program is the use of de-
velopmental mutations to understand the molecu-
lar basis of mammalian embryogenesis. In parti-
cular, we have begun a comprehensive analysis of
the mouse t complex, which has intrigued geneti-
cists for more than 50 years with its striking and
unorthodox features.
The topics addressed in this report include: classi-
cal breeding studies of t-complex gene interactions;
identification and analysis of t-complex proteins;
discovery of a novel middle repetitive family of
DNA sequences that has been characterized as a
nomadic element within the mouse genome; efforts
directed toward an analysis of the DNA sequence
organization within the t complex; and molecular
studies of another region of the mouse genome de-
fined by the mutations albino and pink-eyed dilution.
Breeding Analysis of Developmental
Mutations in the Mouse
L.M. Silver, D. Lukralle, G. Blose
The t complex is a large region of mouse chromo-
some 17 that includes the major histocompatability
A.
B.
C.
T Tc17-16
(H-2) complex (see Silver, Cell 27: 239 [1981] for a
review). Variant forms of the t complex, know as t
haplotypes, are found at a high frequency in wild
populations. All naturally occurring t haplotypes
exhibit a series of effects on embryonic develop-
ment, sperm differentiation and maturation, and
meiotic recombination. A complete t haplotype is
operationally defined as one that suppresses re-
combination, in +/t heterozygotes, along the 12
centimorgan (cM) region of chromosome encom-
passing the locus T and the H-2 complex (Fig. 1);
all t haplotypes recovered from wild populations
have been complete. However, partial t haplo-
types can be obtained in the laboratory as the pro-
ducts of rare recombinant events in +/t animals
(Lyon et al., Nature 279: 38 [1979]). All partial t
haplotypes carry a subset of the genetic factors
responsible for the various t haplotype effects and
continue to suppress recombination only along
the length of t chromatin derived from the paren-
tal t haplotype. Only a complete t haplotype can
be transmitted at a very high ratio (greater than
95%) from +/t males, and it is this property that
allows the propagation of the t-H-2 complex
through wild populations as an indivisible unit.
In studies done in collaboration with K. Artzt
(Sloan-Kettering Institute), we demonstrated that
the basis for the suppression of recombination be-
tween normal and mutant t forms of chromosome
17 is a lack of homology in the DNA sequence or-
ganization of the two forms of the chromosome. A
basic homology in general DNA sequence does ex-
-t- CrcP- )
cti< Tcp-I
+ (Tce-1'
16
Tcr -
tf
Vtf
tf
H-2).
H-2t
[1_2t
1-{-26
618
----711C)
Figure 1
Genetic maps of the t-complex region of mouse chromosome 17. The wavy line represents t-haplotype
chromatin/DNA. (A) Representative genotype of a mouse carrying a complete t haplotype. (B) Representative
genotype of a mouse carrying a partial t haplotype opposite a complete t haplotype. Recombination occurs freely
only in the region of overlapping t DNA/chromatin. (C) Representative genotype of a mouse carrying two different
partial t haplotypes. Recombination occurs freely only in the isolated region of overlapping t DNA/chromatin.
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ist among all known t haplotypes, so that normal
recombination will occur in genotypic regions of
overlapping t DNA (see Fig. 1).
To perform any kind of molecular analysis of
the t complex, it is essential to breed animals that
are genetically identical except for defined dif-
ferences within the t complex region. Mouse
strains that differ in an isolated region of the
genome and are otherwise homogeneous are con-
sidered to be congenic. Congenic strains are pro-
duced by the repeated selection and backcrossing
of a particular mutation onto a highly inbred line.
We were fortunate to receive from J.L. Guenet of
the Pasteur Institute a series of already congenic
lines carrying different mutant t haplotypes (t°,
r12, tw2 tw5, and tw18) or the unilocal T mutation
on the highly inbred 129/Sy strain of mice. These
congenic lines were carried through at least 14
successive backcross generations prior to entering
our colony, where further rounds of backcrossing
have been pursued. We have begun the produc-
tion of ten novel congenic lines for other variant
forms of the t complex, such as partial t
haplotypes and deletions. In certain cases we
have reached the fourth backcross generation. A
continuation of this breeding program will pro-
vide a family of congenic strains to be used in all
of the molecular studies of the effects of
t-haplotype genes on development.
The studies of M. Lyon and her colleagues
(Lyon et al., Nature 279:38 [1979]) have demon-
strated the existence of three separable genetic
factors that interact within a complete t haplo-
type to cause transmission-ratio distortion. We
would like to understand more fully the interac-
tions among these genes in various cis and trans
combinations. Towards this goal, we are con-
structing a variety of genotypes for breeding
analysis. Our preliminary studies indicate that on-
ly one of the three factors is active within the
postmeiotic haploid genome, whereas the other
two factors appear to be expressed in the diploid
genome.
We are currently providing mice in a collabora-
tive effort with G. Martin of the University of
California, San Francisco, for the production of
embryonic stem cell lines that are homozygous
for the lethal 048 haplotype. Such cell lines could
provide a biochemical source for the purification
of t-haplotype-specified proteins present only in
embryonic cells. In another collaborative effort,
we are providing P. Olds-Clark (Temple Universi-
ty) with tw12 males for the isolation of ejaculated
sperm from the female reproductive tract.
Analysis of the proportion of different sperm pre-
sent from a +/t heterozygous male is possible
with an H-2 cDNA probe. This analysis will pro-
vide information on the physiological basis for
transmission-ratio distortion.
We are maintaining congenic strains for other
developmental mutations such as Steel and W,
which affect hematopoesis and spermatogenesis,s s,
and albino and pink eyed dilution, which have
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multiple effects. Molecular studies of these muta-
tions will be pursued in parallel with studies of the
t complex; some of these studies are discussed
below.
Identification and Characterization of
t-Complex Proteins by 2-D Gel
Electrophoresis
L. Silver, J. Uman, J. Carrels
We are using a computer-directed system of two-
dimensional gel electrophoresis (see QUEST 2-D
Gel Laboratory Section) for the identification and
genetic mapping of protein specified by the
mouse t complex. A comprehensive 2-D gel analy-
sis of the t complex could identify proteins critical
to development and differentiation, as well as
provide information on the extent of polymor-
phism associated with naturally occurring t haplo-
types and the relatedness of different wild t-hap-
lotype groups. In our initial analysis we chose to
study the testicular cell protein patterns ex-
pressed by six different lethal t haplotypes (five
complete and one partial) that are all congenic on
the 129/SvJ background. In control experiments,
the 2-D gel patterns of different 129/SYJ males
ranging in age from 8 weeks to 40 weeks and sacri-
ficed on different days, were observed to be high-
ly reproducible with no major qualitative differ-
ences. An analysis of the five complete t haplo-
types (t°, tw2, tw5, tw", and tw32) allowed the identi-
fication of nine t-haplotype-specific proteins
among the 1500 most prominent testicular cell
proteins observed (see Fig. 2). Eight of these
t-haplotype-specific proteins are expressed in an
identical form by mice carrying any one of the
five complete t haplotypes on a 129/SvJ back-
ground. All eight invariant t-specific proteins are
also synthesized by animals carrying a complete t
haplotype on a congenic inbred C3H background.
Six of these invariant t-specific proteins have ap-
parent wild-type counterparts that differ in charge
but are of comparable molecular weight and in-
tensity within the protein patterns of +/t hetero-
zygotes -all six "wild-type" proteins are missing
from the 2-D patterns of compound t°/tw12 ani-
mals. This last result suggests that at least six of
the nine t-specific proteins are direct gene pro-
ducts of the t complex. The level of polymor-
phism associated with t haplotypes (9/1500 is
0.6%) is much greater than expected for simply a
variant form of a region of chromosome 17 corre-
sponding to only 1% of the total mouse genome.
The accumulated data lead to the speculation
that all t haplotypes were derived from a common
ancestral pool of animals that were genetically
distinct from Mus musculus.
We have begun the process of mapping t-com-
plex-protein (Tcp) genes to subregions of the t
complex by utilizing the partial t-haplotype
strains. The preliminary results indicate that the
nine Tcp genes so far identified map to at least
three separable regions along chromosome 17.
Correlations between particular Tcp genes and
particular factors that affect spermatogenesis and
fertility have been made. Further studies along
this line are being pursued.
The p63/6.9 Protein and the Tcp-1 Gene
L. Silver
The most prominent t-specific protein to be ex-
pressed in the testes is called p63/6.9, and the
gene that specifies this protein is called Tcp -1. All
complete t haplotypes analyzed to date express
an acidic p63/6.9a, whereas all wild-type mouse
chromosomes 17 express a basic form of this pro-
tein called p63/6.9b. A comprehensive analysis of
Tcp-1 allelic association has been carried out with
over 20 different partial t haplotypes and other
variant forms of chromosome 17. The data in-
dicate that the Tcp-la locus is separable from all
of the identified t-haplotype factors except for
one; a complete correlation has been obtained
between Tcp-1a and a proximal t-haplotype factor
involved in effects on transmission-ratio distor-
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Figure 2
2-D gel map of labeled testicular proteins from an inbred 129/Sy mouse carrying a complete t haplotype and wild-
type alleles at C and P. Nine t-haplotype-specific proteins have been identified on the pattern. Other identified pro-
teins include actin (A), tubulin (T), and the two forms (A and B connected by arrows) of the CPR-1 protein that maps
to the albino-pink eyed dilution region of mouse chromosome 7. The acidic side of the gel is on the left, reversed
from previous work by Silver and colleagues.
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tion. An initial biochemical analysis of the p63/6.9
protein has been performed. The data provide
evidence that p63/6.9 is closely associated with
the external surface of testicular cells but not as
an integral membrane component. Chemical pro-
perties of the testicular form of this t-complex
gene product are similar to those reported for the
cell surface matrix proteins fibronectin and
laminin. The possibility is suggested that primary
effects of t haplotypes on sperm differentiation
could be exerted through the extracellular matrix.
p63/6.9 is also present (at a lower level) within the
cytoplasm and membranes of F9 teratocarcinoma
cells. It appears that the level of p63/6.9 synthesis
and the exact nature of p63/6.9 intra- and/or inter-
molecular interactions is under tissue-specific
control.
Identification of a 1-Complex Gene Product
Leads to Construction and Screening of a
Testis cDNA Library
K. Willison, J. Danska, L. Silver
The p63/6.9 proteins could represent primary gene
products of the t complex, or, alternatively, the
Tcp-1 gene could control the posttranslational
modification of a precursor form of p63/6.9 that is
encoded elsewhere in the genome. To determine
whether p63/6.9 is a direct gene product of the t
complex, testicular cytoplasmic RNA from mice
bearing the genotypes +/+, +/t, and t/t was
translated in a rabbit-reticulocyte-derived cell-
free system, and translated products were analyzed
by 2-D gel electrophoresis. The data indicate that
the difference between the allelic forms of p63/6.9
is encoded within mRNA transcribed from the t
complex. Thus, p63/6.9 is the first primary gene
product identified in the t complex. Results ob-
tained from both cell-free translation and pulse-
chase labeling experiments indicate that the
mature cell-surface associated form of p63/6.9
has not undergone detectable posttranslational
modification.
Because of our interest in obtaining a
molecular probe to study the organization of the t
complex, which is thought to be rearranged rela-
tive to the wild-type form of mouse chromosome
17, we have attempted to clone the Tcp -1 gene by
exploiting its relative prominence (0.5%) among
translatable testicular RNAs. A cDNA library was
constructed by oligo(dT)-primed reverse transcrip-
tion of testicular cell cytoplasmic poly(A)+ RNA
and ligation into the vector pBR322 using Ri/Hin-
dl I I linkers. To identify potential Tcp-1 clones,
testicular poly(A)+ RNA was fractionated by
agarose gel electrophoresis, and each fraction
was assayed for Tcp-1 mRNA enrichment by cell-
free translation and 2-D gel analysis of the result-
ing proteins. In the RNA fraction selected for
screening the testis cDNA library, actin and
p63/6.9 were the most prominent proteins among
the cell-free translation products. We selected 30
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of the most intensely hybridizing cDNA clones
and analyzed them further using positive mRNA
selection, cell-free translation, and SDS gel elec-
trophoresis. None of the 30 clones selected any
translatable RNA, nor did they hybridize to an ac-
tin cDNA clone (a gift from S. Hughes, Genes for
the Major Structural Proteins) despite the pre-
sence of the expected number of actin clones
(0.8 -1 %) within the complete testis library.
Therefore, we have found that within the testis,
poly(A)+ RNAs exist that are not translatable com-
mensurate with their abundance. This feature of
RNA populations must be considered when trying
to clone minor mRNAs by probing with RNA pop-
ulations characterized by their cell-free trans-
lation products. While cloning of the Tcp-1 gene
continued (see below), we became interested in
characterizing the poly(A)+ nontranslatable tran-
scripts so abundant in testicular cell RNA.
A Nomadic Middle Repetitive Element
in the Mouse
J. Danska, K. Willison, J. Uman, L. Silver
Much of the DNA in eucaryotes does not encode
protein and is organized in moderately repetitive
sequences (10-1000 copies/haploid genome) of
variable length interspersed with unique se-
quences. The precise function of such sequences
is unknown and subject to intense speculation.
Repetitive DNA has been most extensively cha-
racterized in Drosophila melanogaster, where ap-
proximately 40 groups of moderately repetitive
elements (MRE) comprise over 15% of the ge-
nome. copia and 412 exemplify families of MRE
that reside at many chromosomal locations
throughout the genome. Because different fami-
lies occupy variable chromosomal positions and
new arrangements have occurred within indivi-
dual members of a single strain of Drosophila,
these sequences are defined as nomadic. Another
example of a nomadic MRE is the Ty-1 family in
yeast. A striking number of structural characteris-
tics of copia, 412 and Ty-1 are shared by some in-
tegrated retroviruses. The MRE has persisted
throughout evolution perhaps as a persistent
genomic parasite or because of some conserved
advantageous function or the ease with which
such structures adopt new functions.
We have isolated several cDNA clones (e.g.
pKWT17, see above) that recognize a moderately
repetitive element in the mouse that is polymor-
phic among and within different inbred mouse
strains. From reconstruction experiments and
screening of genomic libraries (Mary Harper, see
below), we estimate that between 50 and 100
copies of the element reside within the mouse
genome. Restriction analysis of total genomic
DNA from nine inbred lines indicates that the
repeat length of greater than 16kb is highly con-
served among the multiple copies of this element.
Upon digestion of genomic DNA with any of the
A. BALB/c
B. C3H
C. 129 #1
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Figure 3
Comparative analysis of mouse genomic DNA with the
pKWT17 probe. DNA prepared from six different mice
was restricted with EcoRI and electrophoresed through a
0.7/ agarose gel. The 9 kb-20 kb region of the blot is
shown. Polymorphism within the 129/Sv strain is clearly
observed among the four 129/Sv patterns shown.
six cutter endonucleases used, the pKWT17 probe
detects a simple restriction pattern of one or two
major bands (see Fig. 3). In contrast, much more
complex restriction patterns, containing many
fragments, are obtained when the mouse genome
is probed with other repeated sequences such as
Alu, type-A intracisternal particle, mouse mam-
mary tumor virus, and murine leukemia virus se-
quences. Therefore, we have identified a novel
element with a longer repeat length than any
previously described mammalian moderately re-
petitive sequence. Analysis of human placental
DNA with pKWT17 demonstrates the existence of
a homologous moderately repetitive sequence in
the human genome.
While the restriction pattern produced by nine
of thirteen enzymes tested is identical among in-
bred strains, a polymorphic segment of the ele-
ment is revealed by EcoRI, Pvul I, BcII, Bg/I I diges-
tion. Most striking among these strain polymor-
phisms that are currently undergoing extensive
analysis is the unstable or nomadic arrangement
of this sequence within the highly inbred 129/Sv
strain. Despite sharing identical 2-D gel patterns
(as determined in collaboration with Jim Carrels,
Quest-2D Gel Laboratory), individual members of
the 129/Sv line can have one of two distinct re-
striction patterns with these four endonucleases.
Furthermore, new restriction patterns may occur
within a single generation. Thus far none of the
other inbred lines tested demonstrate multiple
MRE arrangements, but analyses of many more
animals are necessary before a conclusion can be
drawn. The mechanism of rearrangement in
129/Sv is unknown, but transposition through a
circular intermediate and illegitimate recombina-
tion are under consideration. Analysis of the DNA
sequence and the mapping of genomic clones cur-
rently underway are required before any of these
mechanisms can be tested.
Is it of interest to know the chromosomal locali-
zation of the MRE: Is it randomly dispersed over
50 to 100 sites or clustered in only a few loca-
tions? We are currently collaborating with D.
Wolgemuth (Columbia University) to determine
the distribution of the MRE by using in situ hy-
bridization of genomic clones to mouse chromo-
somes. By combining classical breeding analysis
with molecular approaches, we will attempt to
define the DNA structure, disposition within the
genome, and unorthodox inheritance of this mam-
malian MRE.
Transcription Products of a Mouse
Moderately Repetitive Element
J. Danska
The nomadic gene families copia and 412 were
first isolated because of their homology to ex-
tremely abundant poly(A)± RNA in Drosophila
tissue-culture lines. Several hundred slightly less
abundant poly(A)+ RNA species, collectively
composing 60% of the total cytoplasmic poly(A)+
RNA, are known to be homologous to several
other such gene families. These transcripts have
been characterized and are often found
associated with ribosomes, but they appear to be
nontranslatable in cell-free systems. The function
of these copious transcripts remains undefined.
Screening of the 30 cDNA clones from which
pKWT17 was selected for further study demon-
strated that the RNA transcripts homologous to
the MRE were more frequently represented in a
fraction of the poly(A)+ RNA population than
were any translatable mRNAs. It was of interest to
characterize the tissue and species distribution of
the transcripts detected by pKWT17. Dot blot
hybridizations of pKWT17 to equal amounts of
testis, liver, brain, heart, skeletal muscle, and
spleen poly(A)+-selected mouse RNA were per-
formed. The resulting equivalent signal intensity
indicated the widespread presence of MRE homo-
logous transcripts in the mouse. RNA from rat and
guinea pig testis and liver as well as human pla-
centa and HeLa RNA also hybridized to the probe,
but yeast RNA did not. To determine the size and
conservation of the transcripts, Northern blots
were performed using poly(A)+ and poly(A)-
RNAs from the cell types described above. A
primary transcript of about 1850 nucleotides was
common to the poly(A)+ RNA from all cell types
and species tested. No signal was detectable from
poly(A)- RNA under identical conditions. Addi-
tional, tissue-specific, higher-molecular-weight
transcripts that bear homology to the MRE were
observed in mouse myeloma and human HeLa
and placenta poly(A)+ RNA. We estimate that
these transcripts comprise 1-2% of the total
poly(A)+ RNA and suspect that they are RNA
polymerase II transcription products.
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Berk-Sharp nuclease-S1 analysis of the tran-
scripts using recently isolated genomic clones
(see section below) is in progress to determine the
size and intron-exon structure of the gene. Pro-
duction of a full-length cDNA clone and subse-
quent sequence analysis will also contribute to a
broader understanding of how these genes are
controlled and expressed.
Genomic Organization of a Murine
Middle Repetitive Element
M.I. Harper, L.M. Silver
We have started to characterize the MRE describ-
ed above by studying mouse genomic clones
derived from two sources. Total DNA from a
129/SvJ strain mouse (Fig. 3D) was digested to
completion with EcoRI and size fractionated by
sucrose gradient centrifugation. The fractions
containing the 13-kb and 16-kb hybridizing bands
were pooled and cloned into X Charon 4a arms.
The partial library obtained was hybridized
against pKWT17, and a number of positive clones
have been identified. However, even after plaque
purification, the DNA from each clone contains
more than one EcoRI band hybridizing to the
cDNA clone pKWT17. This suggests that the R1
mouse inserts contain some direct repeat(s) that
allow during virus propagation.
Nevertheless, the DNA of one such clone (XLS15)
only has a small ratio of a "secondary" R1 insert
and it has been serving as a useful probe because
its insert size (13,000 bp) makes it more sensitive
than pKWT17 (330 bp). XLS15 and the cDNA clone
pKWT17 give an almost identical pattern of
hybridization to R1-digested total mouse DNA
(129 /SvJ), except that XLS15 recognizes an addi-
tional repetitive band of 6 kb. The reason for this
is being investigated.
We have also probed a Balb/c mouse genomic
library (kindly provided by M. Davis, NIH) with the
cDNA clone pKWT17. Approximately I x 106
phage were initially plated out, of which 430 proved
to be positive. This gives an estimate of the copy
number as 50 to 60 per haploid genome. Plaque
purification and characterization of the mouse
genomic inserts is underway.
Our aim is now to find clones that extend in
either direction from the point of hybridization
with pKWT17 in order to find the length of the
MRE and the nature of the variable region(s). The
ends will be identified by isolating restriction
fragments from the various clones and using these
fragments as probes against genomic blots until
the pattern produced shows hybridization to
multiple flanking sequences. The ends will then
be subcloned into pBR322 and sequenced. It will
be of interest to find out whether this murine MRE
is flanked by direct repeats similar to those that
occur with transposible elements of lower
eucaryotes and procaryotes.
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Cloning of DNA
Encoding p63/6.9
N. Sarvetnick, G.P. Thomas
We intend to clone the DNA fragment encoding
p63/6.9 that has biochemical properties of an extra-
cellular matrix protein (see above). It is believed
that these proteins play a role in cell-cell recogni-
tion during development. Genetic evidence im-
plies that p63/6.9 might play a role specifically in
sperm differentiation. We have prepared a com-
plete cDNA library from isolated testis mRNA.
Total testis RNA was passed over an oligo(dT) col-
umn to obtain a polyadenylated fraction that was
used for the synthesis of cDNA. To maximize the
efficiency of cloning, EcoRI and Sal linkers were
sequentially ligated to each end of the cDNA
molecules. The utility of this cloning technique,
devised by David Kurtz and John Fiddes, is that a
large cDNA library can be made and the map
orientation with respect to each end of the mRNA
will be known. We will screen for potential Tcp-1
clones by making use of several previously estab-
lished facts. First, p63/6.9 has an abundance that
is at least 20 times higher in the testis than in the
liver. Second, previous cloning experiments (de-
scribed above) have produced a cDNA clone
pKWT17 that represents an abundant RNA spe-
cies in the same size fraction as the p63/6.9 mes-
sage. Testis poly(A)+ RNA will be size-fraction-
ated on a sucrose gradient, and cell-free transla-
tion will be used to identify a fraction enriched for
p63/6.9 message. A comparative screening of the
library between this fraction of testis RNA and an
analogous fraction of liver RNA should identify a
family of clones. To maximize this differential
screening, we have used liver RNA obtained from
a +/ThP mouse. The Th) form of chromosome 17
has been demonstrated both genetically and bio-
chemically to possess a deletion that includes
Tcp-1. pKWT17 and actin will be used as further
negative screens. Potential Tcp-1 clones can be
identified by their ability to select message that
can be translated into p63/6.9. Selected mRNA,
obtained by hybridization to each cDNA clone,
will be assayed in a cell-free translation system
and the resulting proteins analyzed by SDS gel
electrophoresis. Clones that select mRNA with
translation products in the molecular weight
range of p63/6.9 will be subjected to further analy-
sis by 2-D gel electrophoresis. Upon identification
of Tcp-1 cDNA clones, we will be able to analyze
the genomic organization of the t complex. We
will use the cDNA clone to select genomic clones
from t-homozygous libraries (see above) and com-
pare their structure with corresponding wild-type
genomic sequences. Subsequent analysis of Tcp-1
gene expression during spermatogenesis and
embryonic development may provide information
on the mechanism by which t haplotypes affect
these processes.
Genomic Analysis of the 1-1-2 Complex
Region Associated with Mutant I Haplotypes
L. Silver, S. Hughes, J. Uman
The H-2 complex is defined by a cluster of loci
(within the t complex) that codes for cell surface
antigens involved in the immune response. The
most remarkable feature of the H-2 loci is their ex-
treme polymorphism among wild mice, with as
many as 50 to 200 different alleles possible at
each locus. Any one particular combination of
alleles on a single chromosome defines a unique
H-2 haplotype. Surveys of large numbers of ani-
mals from around the world have demonstrated
that virtually all wild mice are heterozygous at
one or more H-2 loci and that the H-2 haplotypes
carried by almost all wild (non-t-carrying) mice are
unique. J. Klein (Max-Planck-Institut, Tubingen)
and H. McDevitt (Stanford University) have dis-
covered that in direct contrast to this situation is
the restricted polymorphism in H-2 haplotypes as-
sociated with all wild t haplotypes. To investigate
possible relationships between the different
t-defined H-2 haplotypes, we have used an H-2
cDNA clone (obtained from Lee Hood, California
Institute of Technology) to probe restriction
digests of total genomic DNA from mice with dif-
ferent t haplotypes on the inbred 129/Sv back-
ground. Fifteen t-specific, H-2-defined EcoRI frag-
ments were identified within the context of the
129/Sv background pattern. The surprising finding
of this study is the identity or near-identity in
H-2-defined restriction patterns from all complete
t haplotypes analyzed. The available data lead to
two major conclusions. First, it is clear that all t
haplotypes were derived from a small number of
closely related ancestors. Second, the H-2 com-
plex region associated with each primordial t
chromosome has been maintained within at least
the nine different present-day t haplotypes ana-
lyzed so far. Hence, the H-2 complex is an integral
component of naturally-occurring t haplotypes.
A recent report from the laboratory of K. Artzt
(Sloan-Kettering Institute) indicates that the lethal
genes of several t haplotypes are located in the
vicinity of the H-2 complex. This suggests the
possibility of using available H-2 clones as a
means toward the isolation of the lethal genes.
We are in the process of constructing genomic
libraries of DNA from several sources including
total liver DNA from a compound t°4"112 mouse.
The libraries will be constructed by partial diges-
tion of mouse DNA with the enzyme Sau3A and
ligation of an appropriately large size fraction to
arms of the bacteriophage vector L47.
Identification and Mapping of DNA and
Protein Markers for the alhin()(()-01/ik cljc(1
(111141"11 (P) Region of Mouse Chromosome 7
N. Sarvetnick, D. Lukralle, G. Blose, L. Silver
Albino (C) and pink eyed dilution (P) are linked
loci on mouse chromosome 7 that were among
the first used for classical studies of the mouse
genome during the early part of this century. A
large number of both spontaneous and induced
mutations have been identified at each of these
loci. Different recessive mutations have been
recognized by their distinctive effects on the coat
color and eye color of homozygous animals.
Studies with radiation-induced deletions at each
of these loci have demonstrated the existence of a
family of genes within the albino-pink eyed dilu-
tion (CP) region that have dramatic yet specific ef-
fects on development, tissue differentiation, and
fertility (see Gluecksohn-Waelsch, Cell 16:225
[1979] for a complete review of the albino region).
The nonpigmented 129/SvJ strain of mice is highly
inbred, with a selection for alternate recessive
alleles at the C locus and a recessive mutation at
the P locus for a final genotype of cchp/cp.
A pigmented congenic 129 strain has been con-
structed at the Jackson Laboratory by repeated
backcrossing of a segment of chromosome 7 from
the C3H strain, which carries wild-type alleles at
both the C and P loci, onto the 129/SvJ back-
ground. These congenic lines were analyzed for
protein polymorphisms by 2-D gel electrophore-
sis. A single prominent protein difference was ex-
pressed in all tissue types studied. Further breed-
ing analysis indicates the mapping of the gene
(tentatively called Cpr-1) specifying this protein to
the region encompassed by the C and P loci. The
129/SvJ-associated allele expresses an acidic
form, and the C3H-associated allele expresses a
basic form, of a 75-kD protein with an isoelectric
point of 6.7 (see Fig. 2).
All mammals carry endogenous proviral se-
quences homologous to different retroviral ge-
nomes. In recent years, it has become clear that al-
though the location of these proviruses within the
mouse genome is highly polymorphic, they are in-
herited in stable Mendelian manner over scores of
generations (Cohen and Varmus, Nature 278: 418
[1979]). In an attempt to map particular proviruses
to the CP region, total genomic DNA was pre-
pared from the congenic 129 lines described
above and analyzed for restriction site polymor-
phisms with a cloned mouse mammary tumor vi-
rus (MMTV) DNA probe. The results of these ex-
periments have allowed the identification of a
specific MMTV provirus (called MMTV-V by
Cohen and Varmus) that is stably integrated with-
in the albino-pink eyed dilution region of the C3H
genome.
To determine the relative map positions of both
MMTV-V and CPR-1, the following experiment is
in progress. Homozygous c
ch micep/c p  of the
129/SvJ strain have been mated to C3H mice
which have a + +/+ + genotype in the region of
interest. The Fl hybrid offspring (cchp/+ +) have
been crossed to homozygous cp/cp mice of the
129/SvJ strain. By observing coat and eye colors
of the offspring obtained from this second-
generation cross, it is possible to identify mice
carrying recombinant chromosomes obtained
from the Fl parent. Nonrecombinant animals will
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have a dark coat with black eyes (+ +/cp) or a
light chinchilla coat with pink eyes (c`hp/c/3)
Recombinant animals will have a dark coat with
pink eyes (+ p/cp) or a light chinchilla coat with
black eyes (c`h+/cp). Since C and P are separated
by 14 cm we expect one out of every seven
second-generation offspring to carry a recombi-
nant chromosome. All such animals will be used
for (1) protein analysis by 2-D gel electrophoresis
to determine alleles at CPR-1 and (2) DNA analysis
by Southern blot hybridization with an MMTV-V
probe to determine the presence or absence of
the MMTV-V provirus. The results obtained from
this four-point cross experiment will allow a deter-
mination of the relative map positions of four
closely linked genetic loci, two of which are de-
fined in gross morphological terms and two of
which are defined in molecular terms. Further
studies with radiation-induced deletions might
provide tools for the molecular analysis of certain
developmental genes identified within this in-
teresting region of the mouse genome.
Isolation of a Mouse Actin Gene
MI Harper, K.R. Willison
The study of early mammalian development at
the molecular level is only just beginning, one
great handicap being the limited amount of
material available. The mouse egg and preimplan-
tation embryo are only 80 -100µm in diameter and
contain approximately 25 ng of protein, 0.5 ng
RNA, and from 25 pg of DNA at the one-cell stage
to 500 pg at the blastocyst stage. We wish to study
the expression of the early embryonic mouse
genome by utilizing specific genetic probes, and it
is therefore a technical requirement that we in-
vestigate genes that are transcribed at high levels
during these stages. The ubiquitous structural pro-
tein actin appears an ideal candidate for such
studies since it is approximately 6% of the total
protein synthesized during preim plantation
stages. In mammals, a family of actin genes codes
for different forms of the protein in a tissue-
specific manner. There are at least four a actins
that are present in different muscle tissues and
two cytoplasmic actins, (3 and 7. All three forms
are synthesized in the preimplantation mouse em-
bryo, with (3 actin predominating. Problems to be
addressed are (1) whether all three forms are syn-
thesized from the embryonic genome during
cleavage stages or whether translation of specific
forms occurs on inherited maternal message, and
(2) what differentiation step first shows tissue
specificity in the actin genes being transcribed by
the embryo.
We have now isolated and partially characterized
a genomic clone of mouse actin. The clone was
first isolated from a mouse genomic X library
(kindly supplied by M. Davis, NIH) and was recog-
nized by its hybridization to a chick full-length
0-actin cDNA clone (kindly provided by D.W.
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Cleveland, University of California, San Francisco).
Hybridization was to a 10.5-kb EcoRI fragment of
the clone, and this fragment was subsequently
subcloned into the plasmid pBR322. We are now
studying two plasmid clones, pRT1 and pTR3, in
which the mouse DNA is inserted in opposite
orientations. A restriction map of the insert has
been constructed using the chick/3 cDNA clone to
probe Southern blots.
The pRT3 clone was used to select message
from poly(A)+ RNA isolated from mouse testes
that was subsequently translated in vitro in the
presence of [35S]methionine. The translation pro-
ducts were separated by 2-D electrophoresis (in
collaboration with Jim Carrels, Quest 2-D Gel
Laboratory). Only four protein spots were visible,
which correspond to the acetylated and nonacety-
lated forms of 3 and -y actin.
We now aim to find the direction of transcrip-
tion of the mouse actin gene and the position of
the promoter (assuming the clone does not con-
tain a pseudogene). This is being done by (1) elec-
tron microscopic visualization of R loops between
the actin clone and poly(A)+ RNA and (2) com-
parison of hybridization to 3'-primed and random-
ly primed cDNAs from poly(A)+ RNA. A cDNA
library has previously been constructed from
mouse testes poly(A)+ RNA (by KRW, see above).
As both and -y actins are synthesized by testes,
we plan to isolate the relevant cDNA clone for
comparison with our genomic one. Using the 3'
untranslated region of the cDNA clone for RNA
selection, followed by in vitro translation, we
hope to identify the genomic clone pRT1/3 as
either the (3- or -y-actin gene. We shall then be able
to probe the early embryo for specific transcripts.
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MOLECULAR GENETICS
D. Zipser, J. Lewis, L. Rodgers, L.Smith
The Bifunctional Promoter of IISV-1
Thymidine Kinase
D. Zipser, L. Rodgers, L. Smith
A large number of mutants have been generated
in the 5' flanking control region of cloned herpes
virus tk. Both deletion mutations and restriction
enzyme linker insertion mutations have been
made. In addition to analyzing these physically to
locate the site of mutation, we have also used
DNA plasmid carrying these mutations to trans-
form LTK - cells to a TK + phenotype. As a result
of analyzing a large number of transformants, we
have come to the following general conclusion:
The promoter region of the herpes virus tk gene is
bifunctional. One region of the promoter is used
by animal cells to express the herpes virus tk gene
in the absence of other herpes virus functions.
The second region of the promoter is used during
herpes virus infection to express herpes virus tk
under the conditions in which cellular messages
and proteins are no longer made. Expression from
this part of the promoter requires herpes-coded
functions. These two regions are distinct, and we
have obtained mutations that expunge each of
the functions without affecting the other.
We have transferred these mutations from cloned
herpes viruses tk genes back to herpes virus to test
their effect on the expression of the tk gene in
lytic infection. There is only an initial burst of tk
synthesis after infection with an HSV-1 with a
mutation in its "herpes virus-specific" promoter
region. This is expected since after shut off of cell
function, this part of the promoter cannot func-
tion. There is a delayed turn on of tk synthesis
after infection with virus with mutations in the
"cell-specific" part of the promoter. This in-
dicates that the herpes-virus-specific promoter se-
quences do not function until the cell functions
are shut off.
Another project is an attempt to identify the
herpes virus proteins that specifically interact
with the tk promoter region. Since we are in
possession of mutants that alter this region in a
variety of ways, we have strong controls for the
specificity of DNA interaction of either specified
herpes virus proteins or cellular proteins. We plan
to use the technique developed previously in this
lab to identify the specific DNA interaction of the
repressor protein of phage Mu.
In addition to the above projects we are also
following up some minor observations obtained in
the course of generating mutations in the herpes
virus tk gene. In particular, we found that muta-
tions in the 5' end of the structural protein region
did not completely obliterate tk expression. Our
preliminary analysis of this finding indicates that
there are two starts for herpes virus tk protein
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separated by about 140 bp. Both of these seem to
make functional tk proteins. When a mutation
disrupts the first protein start, the second one ap-
pears to suffice. To confirm this initial hypothesis,
we are constructing plasmids that will express the
tk gene from the /ac promoter using each of the
two different proposed starts. Using these
plasmids in bacteria, we should be able to deter-
mine whether both starts make active enzyme.
Regulation and Cloning of Cellular
Thymidine Kinase
J. Lewis
In the early 1950s autoradiographic analysis of
eucaryotic cells maintained in culture revealed
that cellular DNA synthesis was initiated several
hours after cell division and completed several
hours before the subsequent division. The recog-
nition that events of DNA synthesis occupied only
a minor fraction of the cell division time contrib-
uted to the development of the concept of a cell
division cycle. The pre-and post-DNA-synthesis
periods were proposed to be essential for the
preparations of DNA synthesis and cell division
and presumably were required for the activation
and repression of gene programs essential for
these dramatic cell routines. With the develop-
ment of methods for the induction of synchro-
nous cell division in in vitro eucaryotic cell cul-
tures, analysis of protein concentrations and en-
zyme-specific activities were made feasible. Such
studies confirmed suspiciouns that numerous
gene products were active in a cyclical fashion.
Not surprisingly, it was demonstrated that the
specific activities of many enzymes central to the
biosynthesis and metabolism of DNA nucleotide
precursors and enzymes important to DNA syn-
thesis were maximal during the S (synthetic) phase
of the cell cycle.
The enzyme thymidine kinase, which contrib-
utes to the metabolism of thymidylate, shows just
such an S-phase-specific activity maximum. The
specific activity, readily assayed, is regulated at
the nucleic acid level; the thymidine kinase en-
zyme is not apparently cyclically modified result-
ing in alterations of protein stability or function.
The cyclic expression of the tk gene locus pre-
sents, therefore, an interesting contrast to gene re-
gulation at other loci where expression is confined
to terminally differentiated cells, for example,
globins. We are interested in analyzing these con-
trols at the nucleotide sequence level.
Using in vitro cell cultures synchronized by
serum starvation and refeeding protocols, we
have confirmed the cell cycle dependence of tk
activity in TK ± mouse L cells. Furthermore, we
have demonstrated that tk specific activity is cell-
cycle-dependent as well as LTK- cells transformed
to TK+ by the introduction of the chicken tk gene
cloned by Mike Wig ler et al. (Mammalian Cell
Genetics) and in LTK - transformed to LTK ± by
high-molecular-weight DNA from Chinese
hamster cells. We interpret these results to sug-
gest that genetic elements governing cell cycle ex-
pression of the tk gene have been introduced into
the TK- cell along with the tk structural gene se-
quences. In contrast, we have observed that the tk
specific activity in LTK - cells transformed to TK+
by transfection with the tk gene of HSV is largely
invariant throughout the cell cycle. In an attempt
to establish a homologous genetic system in
which a cloned mammalian tk gene can be clonal-
ly isolated, mutagenized in vitro with recombi-
nant DNA techniques, and reintroduced into
homologous LTK - cells for the study of cell cycle
regulation, we have undertaken to isolate the
Chinese hamster tk gene.
We have analyzed the restriction enzyme sen-
sitivity profile of the hamster tk gene and iden-
tified BamHl and Bel as enzymes that leave the
tk activity of high-molecular-weight DNA intact.
Enzyme-cleaved DNAs enriched for tk gene activi-
ty by gradient centrifugation have been I igated to
cloned tRNA suppressor genes and applied as a
calcium phosphate precipitate to TK- cell
populations to derive TK ± mouse cell clones.
DNAs from multiple secondary transformants
derived from independent primary transformants
have been analyzed by Southern blot hybridiza-
tion for the presence of tRNA suppressor gene se-
quences. The presence of conserved tRNA sup-
pressor bands common to many or all secondary
2° from a given primary argue for the location of
tRNA suppressor gene sequences proximal to the
transfected Chinese hamster tk gene.
Genomic libraries of DNA from six secondary
transformants derived from six independent
primary transformants have been prepared with X
phage 1059 carrying an amber mutation introduc-
ed by Kenji Shimizu (Mammalian Cell Genetics).
These libraries have been screened for the
presence of tRNA gene sequences by growth on a
Sup- bacterial host. A fraction of these recombi-
nant phage that grow on such hosts might be ex-
pected to have incorporated hamster tk gene se-
quences in the recombinant insert. The DNA of
twelve recombinant phage isolates containing the
tRNA suppressor gene are currently being analyz-
ed for their ability to generate TK± cell transfor-
mants by transfection assay.
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CELL BIOLOGY
In 1981 the Cell Biology group expanded its efforts into several areas that may seem
peripheral to its main topic, cytoplasmic organization. These areas include "water in the
cytoplasmic matrix," "shock reaction," and "Golgi apparatus." In the detailed reports that
follow, some of the reasons will be explained that suggest a possibly quite central role
these areas may play in a deeper understanding of the dynamic behavior of the cytoplasm.
Along the main line of our interests, there were new findings about intermediate filaments
and vimentin-related proteins, as well as the raising of several monoclonal antibodies
against structural proteins. Many new stimuli came through this year's Symposium, which
focussed on the area of our main interests, namely "The Organization of the Cytoplasm".
We miss Keith Burridge, a friend and esteemed colleague of many years who left us in
spring to join the faculty of the Department of Anatomy at the University of North Carolina
at Chapel Hill. Two post-doctoral fellows, William J. Welch from the University of Califor-
nia at San Diego, and David Helfman from the Emory University at Atlanta, joined the
group to work on Cell Biochemistry. We were glad to welcome Nancy Hogg from the ICRF
Human Tumor Immunology Group, University College, London, as a guest in our group,
while she continued the studies of her finding of a peculiar fiber formation around certain
human monocytes. The group's photographer, Ted Lukralle, went into private business
after many years of most valuable help for us. His successor is Philip Renna.
Detailed reports are given below.
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CELL MOTILITY
G. Albrecht-Buehler, S. Blose, A Bushnell, A. Ca lasso, N. Hogg, T. Lukralle, D. Meltzer, P. Renna,
M. Schwartz, M. Szadkowski
Water Movement in the Cytoplasm:
Does Blebbing Reveal the Convulsive Flow
of Liquid and Solutes through
the Cytoplasmic Meshwork?
G. Albrecht-Buehler
Blebs, like lamellipodia and filopodia, belong to
the repertoire of surface projections that are
found on the surfaces of most animal cells. They
are hyaline, hemispherical extensions that expand
from the cell surface within 3 to 5 sec. Their ex-
pansion stops rather abruptly at a diameter of 2-5
Am, which is followed by a phase of slow shrink-
ing back into the cell surface (see Fig. 1, bleb 3).
The biological functions of belbs are not
known, although one function may be the storage
of surface materials. As to the mechanism of their
formation, it has been suggested that intracellular
hydrostatic pressure causes their expansion at
weakened spots of the cell surface. Although the
details of morphology and movement of blebs
support quite strongly the suggestion that
hydrostatic pressure is involved in their forma-
Figure 1
Blebbing microplast from a Swiss/3T3 cell.
(Bars indicate 2 gm.) (a-g) Time sequence
(interval 10/sec) showing that new blebs
(e.g., 3) form at the expense of existing ones
(e.g., 1 and 2). (h) Scanning electron
micrograph of a blebbing microplast.
tion, two fundamentally different mechanisms re-
main to be distinguished: Either the volume of a
newly forming bleb rushes in from another part of
the cell (i.e., cell volume is constant during bleb
expansion) or it is supplied by liquid pumped in
from the outside (i.e., cell volume increases dur-
ing bleb formation). If the first case is true, the
blebbing all over a cell surface indicates a rapid
"circulation" of liquid throughout the cytoplasm.
If the second case is true, the blebbing indicates a
"respiratory" action of the cell by which it rapidly
takes in large volumes of liquid from the outside,
and then, of course, "exhales" the liquid or else it
would eventually burst. Either possibility seems
important for our understanding of the transport
of messages, metabolites, ions, etc. through the
tightly organized cytoplasm of animal cells.
A whole cell is too large to allow detection of
any volume changes concommitant with the for-
mation of a new bleb. Therefore, we used our
recently found microplasts for the experiments.
Blebbing microplasts are small enough to allow
detection of volume changes upon bleb expan-
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sion. Indeed, we found that for every newly form-
ing bleb, the other existing blebs shrunk by the
same volume (Fig. 1). Studying the rapid gyrations
of particles inside blebs, we found that the blebs
are filled with a liquid of a viscosity between that
of water and serum.
The data suggest that the cell volume is con-
stant during blebbing. In other words, the
cytoplasm is able to push liquid through its
meshwork in convulsive ways and in changing
directions as blebs form on varying sites of the
cell surface. It is intriguing to speculate that the
well-known saltatory movement of cytoplasmic
organelles in non-blebbing, flat-ended cells may
be caused by the same convulsive mechanism, if
it meets a higher flow resistance than rounded
blebbing cells may offer.
Reversible Compression of Cytoplasm
One possible mechanism of the convulsive flow
of liquid through the cytoplasm is a rapid, local
compression inside the cytoplasm. Conceivably,
the "free" water is pushed out of these areas and
flows toward the cell surface. In this case, the
cytoplasm must be able to undergo rapid and
reversible local compression. It would be most in-
teresting to study condensed cytoplasm, provided
it can reversibly enter such states.
There have been earlier reports about the sur-
vival of cultured cells after the exposure to
hyperosmolar media, such as media containing up
to 1 NI sorbitol. Sorbitol is a poorly metabolized
glucose analog. Since such media can be ex-
pected to partially dehydrate, and thus condense,
cytoplasm, we examined the motile behavior and
ultrastructure of such treated cells.
We tested human fibroblasts, BHK cells, 3T3
cells, neuroblastoma cells, and PtK1 cells and
found an astonishing reversibility of the hyper-
tonic treatment. More than 60% of human
fibroblasts survived 60 min in 2 to sorbitol. We
chose a standard incubation of 3 min in medium
containing 1 to sorbitol. The following observa-
tions refer to this standard incubation and to one
or several of the above-mentioned cell types.
In less than 1 min the cells lost 50% to 75% of
their water content. Upon return to normal
medium, their ultrastructure and morphology
returned to normal within 3 min. Mitoses con-
tinued normally (Fig. 2a-f). Migration patterns and
growth curves also returned to normal. An intri-
guing aspect of irreversibility was observed when
blebbing microplasts switched to ruffling. They
would have continued to bleb without the prior
episode of dehydration in sorbitol.
During incubation with 1 rvt sorbitol, the
shrunken cells appear to store excess surface area
in numerous, rapidly forming microvilli. The
cytoplasm is also altered. Bundles of intermediate
filaments and microfilaments condense into
homogeneous streaks of materials that retain
birefringence. In contrast, microtubules display a
clearly visible exclusion zone around them (Fig. 2
g,h). Sharply outlined patches of tiny granules ap-
pear in the electron micrographs, as if ground
substance had condensed into unit packages (Fig.
2 g,h).
The ultrastructural data rest exclusively on
transmission electron microscopy and, therefore,
must be treated with caution, until an independ-
ent method of verification is found. Taking the
data at face value, however, it appears that the
cytoplasm is able to condense reversibly down to
one quarter of its former volume at a moments
notice. In view of the various interrupted func-
tions of the cytoplasm at the moment of partial
dehydration, this seems a quite remarkable quali-
ty of the cellular control systems.
The appearance of many outlined domains in
the condensed cytoplasm opens the possibility
that cytoplasm is, in fact, a mosaic of interlaced
domains of various shapes. This concept may
allow us a new understanding of the divisibility of
cytoplasm and the regeneration and replication of
cytoplasm as well as of its visco-elasticity.
Human Monocytes Have a Direct Role
in Coagulation
N. Hogg
Human monocytes belong to a class of cells that
originate in bone marrow, circulate in blood, and
then, under stimuli about which little is known,
migrate into tissues where they are termed
macrophages. These cells are collectively termed
mononuclear phagocytes. They are best known as
phagocytic or scavenger cells, arriving at sites of
inflammation and tissue damage to clear the
debris. They also play a crucial role early in the
immune response in processing foreign material,
presenting it in a suitable form to T lymphocytes.
Macrophages are found in many locations in the
body; the microglia of the brain, kupffer cells in
the liver, and alveolar cells in the lungs are
several unequivocal examples.
Figure 2
Response of mitotic BHK cells to incubation in 1 M sorbitol. (Bars indicate 10 gm.) (A-F) Reversibility of sorbitol
treatment. The metaphase cell in A was incubated in 1 M sorbitol for 3 min (B). Note the shrinkage of the cells'
outline and the disappearance of nucleoli in the phase-contrast image. After return to normal medium (C), the cell
proceeded through mitosis normally and the visibility of nucleoli reappeared (D-F). (G) Ultrastructure of spindle
microtubules and chromosomes 3 min after incubation in 1 M sorbitol. Note the while exclusion zones around
the
microtubules and the granular appearance of the ground substance. (H) One of the spindle poles (P). Centrioles are
not visible in any of the sections, although their visibility returns immediately upon return to normal medium or ex-
traction of the cytoplasm with Triton.
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There are hints that monocytes and tissue
macrophages may have other functions in the
body than those mentioned. I have been studying
a process in which macrophages have not been
previously implicated. In an effort to define
monoclonal antibodies specific for monocytes
and macrophages, a monoclonal antibody, named
UC45, was isolated which reacted with needlelike
projections or fibers that formed on the surfaces
of about 20% of monocytes from any particular
individual when the cells were adherent to a glass
or plastic surface (Fig. 3). In the presence of
plasma, these projections formed within 15 sec
and double-labeling experiments with UC45 and a
rabbit antibody to human fibrinogen suggested
the "needles" might be composed of fibrin. This
was confirmed when the needles were isolated
and biochemically analyzed. The monoclonal an-
tibody reacted with the a chain of the three-chain
fibrinogen molecule. The polymerization of
fibrinogen to fibrin by monocytes was prevented
by UC45, which suggests that plasma is the source
of fibrinogen composing the needles and that the
UC45 antigen may be crucial for polymerization.
I am now attempting to establish how
monocytes can accomplish this coagulation.
Studies with coagulation-factor-deficient plasmas
suggest that monocytes bear a prothrombinase on
their membranes. If this is so, they then have the
capability of short-circuiting the usual routes of
coagulation, which consist of about a dozen fac-
tors in the intrinsic pathway and about a half
dozen in the extrinsic pathway. The ability of
macrophages to coagulate fibrinogen suggests
that they may be hitherto unrecognized par-
ticipants in processes such as wound healing, they
may respond to inflammation in a manner not
previously appreciated, and the involvement of
macrophages in the coagulation associated with
metastasizing tumors would be worth in-
vestigating.
The monoclonal antibody UC45, which, as
stated above, has specificity for the a chain of
fibrin, a molecule of 66 kD, also reacts with the
mitochondria of all cell lines tested. UC45 ap-
pears not to react with internalized a chain but
with another molecule, the biochemical
characteristics of which have been difficult to
ascertain, as it seems to be easily degraded. A ma-
jor reactive entity is 200 kD. The reaction of UC45
with the a chain of fibrinogen and the mitochon-
dria) protein may be another example of the cross-
reactivity between different proteins which is be-
ing observed with increasing frequency as
monoclonal antibodies are being more widely
tested.
Figure 3
Fluorescent micrograph of a human monocyte bearing needles of fibrin which are labeled with the monoclonal an-
tibody UC45. (Bar indicates 10 Am.)
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Immunoelectron Microscopy of 10-nm
Filaments and Microfilaments Decorated
with a Monoclonal Antibody that Recognizes
Both vimentin and Tropomyosin
S. Blose, F. Matsumura, J. Lin
In recent years the molecular structure and func-
tion of the cytoskeleton have been under inten-
sive study. Using antibodies prepared against the
constituent proteins of the cytoskeleton, inn-
munofluorescence and immune electron
microscopy have revealed that many of these pro-
teins are organized into extensive filament arrays
found inside cells. The detailed structural
organization of vimentin and tropomyosin,
constituent proteins of the 10-nm filaments and
actin-containing microfilaments, respectively, are
currently under study. We have previously shown
that a mouse IgM monoclonal antibody, LCK-16,
can recognize a common antigenic determinant
on tropomyosin and vimentin (Blose et al., Cold
Spring Harbor Symp. Quant. Biol. 46: 455 [1982]).
This antibody has been used to probe the
molecular organization of these proteins in the
cytoskeleton at the ultrastructural level. Gerbil
fibroma cells (IMR-33) were grown in culture
dishes and then extracted with 0.2% Triton-X100
in stabilization buffer (0.1 M PIPES-KOH [pH 6.9],
5 mm MgCl2, 1 mm EGTA, 4% polyethelene
glycol-6000, and 1.5 mm GTP) at 37°C for 3 min.
This procedure leaves the cytoskeleton intact and
allows the antibody access to the filaments. The
LCK-16 antibody was supplied in stabilization buf-
fer and incubated at 37°C, 100% humidity. After
45 min the antibody was washed off, and the cells
were fixed in 2% glutaraldehyde and 2% tannic
acid. The cells were then processed by standard
methods (Blose and Chacko, J. Cell Biol. 70: 459
[1976]), and the thin sections were examined in a
Phillips 201E electron microscope. LCK-16
decorated the 10-nm filaments in a spiral fashion
(Fig. 4) as observed in thin section. The inclusion
of tannic acid in the fixation procedure greatly
enhanced the visualization of the antibody
decoration by acting primarily as a mordant be-
tween the osmium-treated structures and the lead
stain. Longitudinal profiles of the 10-nm filaments
revealed the antibody to decorate with a mean in-
terval spacing of approximately 31 nm (n=101,
30.9 ± 2.4 nm). The antibody-decorated filaments
cut in cross-section (section thickness 60-80 nm)
demonstrated triangular profiles. The triangular
profiles were reinforced by three 120°-angle
Markham rotations. The antibody in cross-
sectional profiles added on three projections (the
points of the triangle) that protruded -12.2/nm
off the 10-nm filament (diameter 9.9 ± 2.1 nm) sur-
face. In control experiments, extracted cells were
incubated with a mouse monoclonal IgM an-
tibody to actin, J LA-20 (Lin, Proc. Natl. Acad. Sci.
78: 2335 [1981]). The 10-nm filaments were not
decorated. Although the IgM molecule is large
(- 30 nm in diameter with a M of -900,000) and
could impose modest steric hindrance so that all
the antigenic sites on the vimentin filaments are
not bound, it is interesting that the sites that are
available cause the antibody to be bound in a
helical fashion with a 31-nm repeat. This repeat
appears to be smaller than the 140-nm repeat of
the 195K protein of neurofilaments reported by
Willard and Simon (J. Cell Biol. 89: 198 [1980]).
Small and Sobieszek (J. Cell Sci. 23: 243 [1977])
have shown a repeat of 31 nm of a major reflec-
tion obtained from optical diffraction patterns of
negatively stained 10-nm filaments of smooth
muscle. A comparison of these spacings cannot
be directly made because each study employed
different preparations and methods of fixation.
Although the significance of the finding of these
spacings has yet to be determined, it does imply
some fundamental repeat in the 10-nm-filament
structure. In cross-section the triangular profiles
suggest that three antibody molecules bind per
31-nm period. This seems plausible because each
section is -80-100 nm thick, representing two to
three period repeats, which results in the rein-
forcement of a triangular profile.
Based on the models of IgM binding to large an-
tigens by Feinstein (Feinstein and Beale, in Im-
munochemistry: An Advanced Textbook, p. 263,
Wiley, London [1977]; Feinstein, in The Immune
System, p. 24, Blackwell Scientific Publications,
London [1975]), it appears that LCK-16 binds to the
10-nm filament in the "table" or "staple" con-
figuration. That is, each molecule of LCK-16 IgM
has its Fab arms folded down from the central
(Fc)5 disc of the IgM to contact the 10-nm fila-
ment. The Fab arms then become the legs of the
table, with the table's top formed by the Fc cen-
tral disc. In this configuration, the monoclonal
IgM is clearly visualized in the electron
microscope, and because it is relatively easy to
use, monoclonal IgM gives distinct advantages
over primary antibody labeling or detection with a
second antibody.
When the ventral microfilament bundles of the
cells stained with LCK-16 were examined in thin
section, the microfilaments appeared more dense
than the controls, but no discernable periodicity
was observed. Therefore, reconstituted thin
filaments (F-actin tropomyosin) were employed
to assay at the ultrastructural level the LCK-16
binding to tropomyosin. In the negatively stained
specimens, LCK-16 caused the thin filaments to
laterally aggregate into large bundles as com-
pared with the control (Fig. 5). Furthermore,
LCK-16 produced a prominent periodicity of -38
nm (n-= 46, 37.5 ±1.18 nm) along the thin
filaments. In control experiments, JLA-20 (anti-
actin) decorated the thin filaments with a fuzzy
coat. J LA-20 appeared to cause fragmentation of
the thin filaments as compared with the control;
however, JLA-20 did not induce the lateral ag-
gregation of filaments observed with LCK-16. We
have interpreted the 38-nm period to correspond
to the spacing of the tropomyosin molecule on
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F-actin, on the basis of the model of Ebashi et al.
(Quart. Rev. Biophys. 2: 351 [1969]).
Several monoclonal antibodies (Lane and Hoef-
fer, Nature 288: 167 [1980]; Dulbecco et al., Nature
292: 772 [1981]; Pruss et al., Cell 27: 419 [1981];
Klymkowsky, Nature 291: 249 [1981]), including
LCK-16, have now been described that recognize
an antigenic determinant common to different
proteins. We have shown that LCK-16 recognizes
a common antigenic determinant on tropomyosin
and vimentin molecules. This is not surprising
since recently Geis ler and Weber (Proc. Natl.
Acad. Sci. 78: 4120 [1981]) have reported a stretch
of homologous sequence found in tropomyosin
and desmin (a major subunit of intermediate
filaments of muscle cells). The sequence they
have reported is located near the C terminus (from
the 220th to 228th amino acid) of the tropomyosin
molecule. By observing the negative staining
samples of tropomyosin paracrystals reacted with
LCK-16 antibody, we have been able to identify
the end of the tropomyosin molecule as the
antibody-binding site (F. Matsumura and J. Lin, in
prep.). Therefore, it is possible that LCK-16 an-
tibody may recognize this homologous sequence
in the tropomyosin and vimentin molecules.
By using LCK-16 antibody we have been able to
demonstrate, for the first time, the organization of
the tropomyosin molecule on reconstituted thin
filaments. The success of these experiments at the
ultrastructural level illustrates another advantage
of monoclonal antibodies; that is, one molecule
of monoclonal antibody recognizes only one an-
tigenic determinant (or one molecule of the an-
tigen).
Monoclonal Antibodies to a- and 0-Tubulin
S. B lose, D. Meltzer
Tubulin, a ubiquitous cytoskeletal protein, is found
in all eucaryotic cells. The protein is composed of
two monomer subunits, a- and 0-tubulin, that differ
to a small degree in molecular mass, isoelectric
point, and amino acid sequence. The a and
monomers associate to form u-1.3 heterodimers that
polymerize into 24-nm-diameter microtubules. Dur-
ing cell division the microtubules assemble into the
mitotic spindle, which guides the chromosomes
into daughter cells. In interphase cells, cytoplasmic
microtubules radiate from the cell center to the
cell's border. In interphase, microtubules influence
the generation of: (1) ansiometry in cell shape, (2)
cell movement, and (3) cell extensions such as cilia.
Microtubules operate in the directed shuttling of
intracellular organelles (i.e., mitochondria,
lysosomes, and phagosomes), and in transformed
cells the number and orientation of microtubules is
altered (Dustin, in Microtubules, p. 426, Springer-
Verlag, Berlin, [1978]). Other evidence suggests that
microtubules associate with 10-nm filaments to an-
chor the cell's nucleus and organelles in the
cytoplasmic matrix.
To probe the function of microtubules in cells,
we have generated monoclonal antibodies against
tubulin. Mice were immunized with native chick
brain tubulin that had been purified by two cycles
of reversible temperature-dependent assembly as
described before (Blose, Cell Motility 1:417
[1981]). The mice received four injections (250 itg
of tubulin each time) over one month. They were
then sacrificed and monoclonal antibodies were
made according to the method of Kohler and
Milstein (Nature 256: 495 [1975]), as modified by
Lin et al. (in Cell and Muscle Motility, (ed. R.M.
Dowben and J.W. Shay) Plenum Press, New York
[in press]). Five hybridomas were obtained that
produced monoclonal antibodies against
tubulin's subunits: DM1A (IgGi) and DM3A1 (IgGi)
were anti-a-tubulins; DM1 B (IgGi) and DM3B3
(IgGi) were anti-,3-tubulins; and DM3B2 (IgM)
recognized both a- and 0-tubulin. These an-
tibodies stain the extensive cytoplasmic arrays of
microtubules in interphase cells and can resolve
single microtubules near the cell border (Fig. 6, A
and B). Anti-tubulins stained cells entering mitosis
Figure 4
Electron micrographs of 10-nm filaments in gerbil fibroma cells decorated with mouse monoclonal antibody LCK-16.
All micrographs are of thin-sectioned (60-80 nm thick) specimens. (A) Two examples of single 10-nm filaments
decorated with LCK-16 in which tannic acid was excluded from the fixation protocol. The filaments were observed to
be decorated with a very fine lace of antibody, and in some regions a helix or period could be seen (arrowheads). (B)
Several examples of single 10-nm filaments decorated with LCK-16 and fixed with tannic acid. The antibody
decorated the filaments in a periodic-helical fashion (arrowheads) that was more clearly observed by the inclusion
of the tannic acid stain (cf. A). The antibody decorated the filaments with a period of -31 nm. (C) Control: 10-nm
filaments incubated with JLA-20 monoclonal antibody against actin and stained with tannic acid. As expected, the
10-nm filaments did not decorate with the actin antibody. (D-G) Electron micrographs of cross-sectional profiles of
10-nm filaments in gerbil fibroma cells decorated with mouse monoclonal antibody LCK-16 and stained with tannic
acid. (D) A cluster of 10-nm filaments decorated with LCK-16 revealed that the antibody imparted a triangular pro-
file to the individual filaments (arrowhead) when compared with the control (E). The antibody produced small sur-
face projections of the "points" of the triangle that appeared to link adjacent filaments. (E) Control: 10-nm filaments
incubated with monoclonal antibody to actin (I LA-20). No decoration was observed; instead, the filament profiles re-
mained round and individual filaments (arrowhead) measured -10 nm in diameter (9.922.1 nm). (F) A single 10-nm
filament decorated with LCK-16 shows the triangular profile. Arrowheads indicate the points of the triangle produc-
ed by antibody decoration. Each point protrudes -12.2 nm of the surface of the 10-nm filament. The filament in F
was used for Markham rotation in G. (G) The triangular profile of LCK-16-decorated 10-nm filament was reinforced
by three 120°-angle Markham rotations.
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Figure 6
Fluorescence (A) and phase-contrast (B) micrographs of an interphase gerbil fibroma cell (IMR-33) that has been in-
directly stained with DM1A, a monoclonal antibody to ce-tubulin. Cytoplasmic microtubules radiate from the cell
center located over the nucleus (Nu) (arrowhead) and extend to the cell's border (*). Fluorescence (C) and phase-
contrast (D) micrographs of a gerbil fibroma cell in early prophase that has been indirectly stained with DM3A1, a
monoclonal antibody to a-tubulin. The cell has begun to round up, and as compared with the cell in A and B, the
ctyoplasmic microtubules have broken down. Two asters of microtubules are observed (arrowheads) radiating into
the condensing chromosomes in the nucleus. Fragmented microtubules ( *) are seen in the cytoplasm. Fluorescence
(E) and phase-contrast (F) micrographs of a gerbil fibroma cell in metaphase stained with DM1 B, a monoclonal
against i3-tubulin. The chromosomes have migrated to the equatorial plate (dotted line), and the microtubules have
assembled into a complete mitotic spindle. Arrowheads indicate the spindle poles.
Figure 5
Electron micrographs of thin filaments incubated with monoclonal antibodies and negatively stained with 2%
aqueous uranyl acetate. LCK-16 caused the thin filaments to laterally aggregate into bundles (between arrowheads).
The LCK-16 antibody also decorated the thin filaments with a prominent -38-nm periodicity. The periodicity is in-
terpreted to correspond to the length of a tropomyosin molecule on the actin filament. When the thin filaments
were decorated with J LA-20, monoclonal antibody to actin, a fuzzy coat of antibody was observed on individual
filaments (between arrowheads). JLA-20 did not cause lateral aggregation of the thin filaments; it did cause some
fragmentation of the filaments. In the control, the reconstituted thin filaments (tropomyosin+ actin) observed bet-
ween the arrowheads are long and helical. LCK-16 and JLA-20 were reacted with the same preparation of thin
filaments seen in the control. All micrographs are at the same magnification.
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and showed that the cytoplasmic microtubule
pattern is replaced by the mitotic spindle (Fig.
6C-F). These antibodies are currently being
microinjected into cells to evaluate the effect on
organelle transport, cell shape, and mitosis.
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CELL BIOCHEMISTRY
K. Burridge, J. Feramisco, J. Lin, N. Haffner, D. Helfman, F. Matsumura, S. Matsumura, B. McLaughlin,
W. Welch
During the past year we have continued to in-
vestigate the structural and the functional roles of
the cytoskeletal elements in eucaryotic cell
motility and these efforts have evolved into new
directions concerning the cell biology of the
"stress response" and the disposition of the Golgi
apparatus in these cells. It is our aim to under-
stand the relationships among the structural pro-
teins and supramolecular systems in these cells
and their functions in the motility and
maintenance of the cell.
Ca+ +-sensitive Components of the Actin
Microfilament System of Nonmuscle Cells
K. Burridge, J. Feramisco, D. Helfman, W. Welch
Actin-containing microfilaments are believed to
provide at least a force-generation function in
many types of cell motility. Ca+ + is thought to
partake in the regulation of the force-generation
system. Thus, we have been investigating the
biochemistry of several of the components of the
microfilaments of nonmuscle cells and their
response to Ca +
a-Actinin
a-Actinin was first described as a protein compo-
nent of the Z line of striated muscle. It is in this
region of muscle that the actin filaments ter-
minate and presumably are cross-linked together
by the action of a-actinin. In nonmuscle cells,
a-actinin is localized primarily along the actin
microfilament bundles in densities that appear to
be related to the Z lines of striated muscle.
To compare the structural and biochemical
features of the muscle and nonmuscle forms of
a-actinin, we have purified these proteins from
muscle and from HeLa cells using a slight
modification of our original procedure developed
for the purification of the muscle form (Feramisco
and Burridge, J. Biol. Chem. 225: 1194 [1980]). Two
forms of a-actinin which are structurally similar to
smooth muscle a-actinin, have been purified from
HeLa cells (105,000 daltons and 100,000 daltons).
Peptide maps, amino acid compositions, S20,,,
values, Stokes' radii, immunological cross-
reactivity, and two-dimensional gel elec-
trophoresis have indicated that the HeLa proteins
are similar but not identical to the smooth muscle
protein. As reported last year, the HeLa forms of
a-actinin are capable of binding to actin and caus-
ing the gelation of actin, an activity similar to that
of the smooth muscle form of a-actinin. Upon
analysis of the ionic conditions of the gelation ac-
tivity, we have found that the activity of the non-
muscle forms of a-actinin, but not that of the
smooth muscle form of a-actinin, is regulated by
Ca+ +. Whereas the smooth muscle form is equal-
ly active under all Ca' concentrations tested,
the nonmuscle forms are active in the absence of
Ca' and totally inactive in the presence of 10'
NI Ca+ +
In terms of the several other Ca'-sensitive
actin-binding proteins isolated from nonmuscle
cells-such as actinogelin (Mimura and Asano,
Nature 272: 273 [1978]), platelet 105K protein
(Rosenberg et al. J. Biol. Chem. [in press]), Dic-
tyostelium 95K protein (Hellewell and Taylor, J.
Cell Biol. 83: 633 [1979]), Acanthemoeba 85K pro-
tein (Pollard et al. J. Cell Biol. 87: 223a [1980]),
gelsolin (Yin and Stossel, Nature 281: 583 [1979]),
villin (Bretscher and Weber, Cell 20: 839 [1980]),
and platelet 95K protein (Wang and Bryan, J. Cell
Biol. 87: 224a [1980])-our results indicating the
Ca+ + sensitivity of nonmuscle a-actinin lead us
to propose the following. In nonmuscle cells,
there are at least two classes of actin-binding pro-
teins- one corresponding to the nonmuscle
a-actinin class and the other to the villin/gelsolin
class. On the basis of their similarities in physical
and functional properties, the proteins ac-
tinogelin, platelet 105K protein, Dictyostelium
95K protein, and Acanthemoeba 85K protein
belong to the a-actinin class, whereas the others
belong to the villin/gelsolin class.
Vinculin, Myosin Light-chain Kinase, and a Higher-
molecular-weight Form of Vinculin
Other observations that seem relevant to cell
motility and to the finding that nonmuscle
a-actinin is inhibited by Ca' in its actin-gelating
activity are (1) that nonmuscle vinculin is
stimulated by Ca+ + in what appears to be its
binding to the ends of actin filaments, and (2) that
the myosin light-chain kinase, which is also
stimulated by Ca+ + in its activation of the con-
tractility of actomyosin, is also a component of
the actin microfilament system of nonmuscle
cells. These two observations are summarized
below.
First, vinculin is a component of both smooth
and nonmuscle cells, and a portion of it is local-
ized (at least in nonmuscle cells) at the ends of ac-
tin microfilaments where they terminate into the
plasma membrane. In vitro analysis of vinculin
has shown that it binds to the ends of actin
filaments (Burridge and Feramisco, Cold Spring
Harbor Symp. Quant. Biol. 46: 587 [1982];
jockusch and Isenberg, Cold Spring Harbor Symp.
Quant. Biol. 46: 613 [1982]; Lin et al., Cold Spring
Harbor Symp. Quant. Biol. 46: 769 [1982]) and thus
appears to block further elongation of the
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filaments. By isolating the protein from nonmus-
cle He La cells, we have found that it, too, appears
to bind to the ends of actin filaments. Unlike the
activity of vinculin from smooth muscle,
however, the nonmuscle protein is stimulated by
Ca+ + in this action.
Second, as we indicated in last year's report, by
immunofluorescence analysis, the Ca+ +-
dependent regulatory enzyme myosin light-chain
kinase was found to be localized along the actin
microfilaments of nonmuscle cells (in collabora-
tion with P. deLanerolle and R. Adelstein of NIH).
This finding is supportive of the idea that this pro-
tein kinase is in part reponsible for stimulation of
the actin-activated myosin ATPase of nonmuscle
actomyosin and thus for the stimulation of the
contractile force in these cells.
The summation of the Ca+ +-sensitive
biochemical activities of a-actinin, vinculin, and
the myosin light-chain kinase and their in-
tracellular locations lead us to several hypotheses
concerning the roles of these proteins and Ca'
in actin-based cell motility, some of which we are
testing currently. We hope that by altering the in-
tracellular Ca+ + concentration through microin-
jection, we will be able to follow alterations in the
distribution and activities of these potential
regulatory elements. Moreover, by utilizing affini-
ty chromatography and chemical crosslinking ex-
periments, we hope to identify the component(s)
in the plasma membrane that is reponsible for an-
choring actin filaments and vinculn to the adhe-
sion plaques at the membrane.
As we described in last year's report, smooth
muscle contains a protein with a M of 152kD that
is structurally related to vinculin of the same
tissue. Analysis of the biochemical activity of the
higher-molecular-weight form of vinculin shows
that it, too, is capable of inhibiting the
polymerization or reannealing of actin filaments.
Interestingly, this activity is stimulated by Cail,
as is the nonmuscle form of vinculin. To under-
stand the structural basis for the differences in
Ca+ +-sensitivities of the nonmuscle and muscle
forms of a-actinin, vinculin, and the 152kD pro-
tein, we have initiated experiments designed to
isolate the genes encoding these proteins (D.
Helfman, S. Hughes, P. Thomas, J. Fiddes, J.
Feramisco, in prep.; Major Structural Proteins Sec-
tion). Basically, we are using two techniques: (1)
protein sequencing combined with synthetic
oligonucleotides and (2) cDNA expression vectors
combined with a modification of Western blotting,
with both of which we hope to have success.
The Stress Response
W. Welch, J. Feramisco
Eucaryotic and procaryotic cells, when con-
fronted with environmental insults, elicit a com-
mon and seemingly highly conserved response:
"the stress response." Such a response in the cell
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is characterized by the dramatic accumulation of
a small number of polypeptides (the stress pro-
teins) concomitant with the decreased synthesis
of most other cellular polypeptides. A diverse col-
lection of treatments, including exposure to
drugs, to amino acid analogs, and growth at
elevated nonphysiological temperatures
(classically referred to as "heat shock"), all give
rise to the stress response. We and others have
described some of the mechanistic and
phenomenological aspects of the stress response
in a variety of eucaryotic cells. Once activated,
the stress response results in the induction of a
limited suite of stress proteins which eventually
become the major polypeptide products of the
stressed cell both in terms of their exclusive syn-
thesis and accumulation. The increases in the
amounts of these proteins in the stressed cell ap-
pear to result from the near exclusive synthesis of
mRNAs coding for these proteins as well as the
reduced translation of preexisting mRNAs coding
for other cellular polypeptides. The mechanisms
by which such transcriptional and translational
control are exerted in the stressed cell are not well
understood and constitute one aspect of our
research into the biology of the stressed cell (see
G.P. Thomas et al., Protein Synthesis Section).
The cellular response to stress appears to be
well conserved in both vertebrate and in-
vertebrate cells. The stress proteins induced in a
number of different cell types by a variety of in-
ducing agents have similar electrophoretic
mobilities in one-dimensional SDS-
polyacrylamide gels. In our particular system,
HeLa cells grown under stress accumulate signifi-
cant amounts of proteins with molecular weights
of 110,000 (110K), 100,000 (100K), 90,000 (90K),
80,000 (80K), 73,000 (73K), and 72,000 (72K) (see
Fig. 1, lanes E and F). Furthermore, in such stressed
cells synthesis of the normal complement of other
cellular proteins is dramatically reduced. All of
these stress proteins appear to be present in so-
called normal, unstressed cells grown in tissue
culture, although at much lower concentrations
(see Fig. 1, lane D). This may be indicative of nor-
mal cellular functions for these proteins or of
some degree of "stress" in the tissue culture pro-
cess.
Although the identity of the induced proteins in
stressed cells has been well-documented, their
function and location in the cell has not been
established. Therefore, as a first step in the
analysis of the function and location of these pro-
teins, we have purified four of the six stress pro-
teins, the 100K, 90K, 73K, and 72K proteins, from
stressed HeLa cells (see Fig. 1). Purification of the
remaining two proteins, the 110K and 80K pro-
teins, is now in progress. Interestingly, the 73K
and 72K proteins copurify throughout the
purification scheme and appear related, as deter-
mined by one-dimensional peptide mapping. The
100K and 90K proteins, like the 73K and 72K pro-
teins, copurify throughout their purification but
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Figure 1
Two-dimensional gel analysis of purified stress proteins. The protein synthesis patterns of normal HeLa cells (lane D)
and HeLa cells grown under stress for 16 hr (lane E) or for 24 hr (lane F) are shown. Numbers to the right indicate
molecular weights of the six major stress proteins.
(A) A two-dimensional gel of [ 5S]methionine-labeled polypeptides synthesized in vitro in a messenger-dependent
reticulocyte lysate system supplemented with mRNA isolated from stressed HeLa cells. (B,C) Coomassie-blue-
stained gels of our purified stress 100K and 90K proteins (B) and 73K and 72K proteins (C). Arrows in A indicate the
90K and 100K proteins, and arrowheads indicate the 72K and 73K proteins. Although not directly shown here, the
Coomassie-blue-stained 72K/73K proteins (B) as well as the 90K/100K proteins (C) coincided exactly on the gels with
their [35S]methionine-labeled counterparts (A).
appear unrelated on the basis of one-dimensional
peptide mapping. A number of physical proper-
ties, including the Stokes' radii, S values,
isoelectric points, and native molecurar weights,
have been determined for the purified stress pro-
teins (W. Welch et al., in prep.). Working in-
dependently from us, Jim Lin has obtained a
monolconal antibody that stains the Golgi region
of the cell. Much to our surprise, the antigen
recognized by this antibody appears to be the
100K stress protein. We have as yet to realize the
complete significance of this location of one of
the stress proteins. In addition, all of the other
purified proteins have been injected into rabbits,
and to date we have obtained specific antibodies
to 73K and 72K proteins. We have recently begun
immunizing mice with the purified stress proteins
and are in the process of generating monoclonal
antibodies to the stress proteins. Acquisition of
the purified stress proteins as well as the ap-
propriate antibodies should aid in the determina-
tion of the location and function(s) of the stress
proteins both in normal and in stressed cells and
thereby facilitate a more complete understanding
of the stress response.
Monoclonal Antibodies
J. Lin, F. Matsumura, S. Matsumura
We have continued our efforts to prepare more
monoclonal antibodies directed against contrac-
tile proteins of muscle cells and against structural
proteins of cultured cells. Two monoclonal an-
tibodies LK6 and ILK10) have been obtained and
characterized as anti-vinculin antibodies. Both an-
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tibodies reacted with both vinculin and vin-
culinlike 152K protein from chicken gizzard and
with vinculin from chicken embryo fibroblasts. In
fusion experiments using purified a-actinin as an-
tigen for immunization, we have obtained three
monoclonal antibodies (J LN1, JLN20, and J LN23)
that gave the typical a-actinin staining pattern in
cultured CEF cells. J LN1 and J LN23 antibodies ap-
peared to be chicken-specific. On the other hand,
JLN20 antibody gave the Z-line staining on
myofibrils from rabbit and rat skeletal muscle. In
addition, we have also obtained J LK13 antibody,
which gave the typical a-actinin staining pattern,
namely the periodic stress-fiber staining, and the
fluorescent patches terminated at the focal
,-Noints. This antibody appears to have broad
sp ,r_.ies specificity. These antibodies will be used
to isolate microfilaments from cultured cells.
Using skeletal muscle proteins, troponin T, and
crude myosin as antigens to immunize mice, we
have isolated several hybridoma clones. Among
them, the clones J LT7, J LT12, and J LT36 secreted
monospecific antibodies which gave I-doublet
staining on myofibrils by indirect im-
munofluorescence microscopy. The antigen
recognized by these antibodies has been iden-
tified as troponin T by using the Western blot
method. The antigen cannot be detected in
cultured fibroblasts. Clones FM10, FM20, and
FM21 secreted antibodies that gave A-doublet
staining pattern on myofibrils. According to
radioimmunoassay, these antibodies are directed
against C protein. The antibodies will be useful to
probe the detailed organization of C protein in the
myofibrils and to study myogenesis. We have also
obtained two antibodies that give the doublet
staining pattern at the A-I junction of myofibrils,
four antibodies that give the A-doublet staining
pattern, and one antibody that gives the M-line
stain. The identification of the antigens recognized
by these antibodies is currently in progress.
One of the advantages of the hybridoma
technique is that it may generate a monospecific
antibody against proteins that either exist in trace
amounts or that cannot be purified to homogenei-
ty. For example, in the fusion experiments with
vinculin as antigen for immunization, we have
also obtained four monoclonal antibodies (J LK3,
JLK7, JLK9 and JLK16) against a high-molecular-
weight (350K) protein that appears to be a trace
contaminant in the vinculin fraction. The im-
munofluorescent micrograph showed that 350K
protein is diffusely distributed throughout the
whole cell. The protein appeared not to be a sur-
face protein since iodination of intact cells did not
label this protein, Affinity column will be used to
purify this potein, and the biochemical properties
and functions of this protein will be determined.
In addition to the above-mentioned antibodies
against cytoarchitectural proteins, we have begun
to raise monoclonal antibodies against the com-
ponents of cytoplasmic organelles, such as Golgi
apparatus, endoplasmic reticulum, plasma mem
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brane, nucleus, and centrioles. One of the
monoclonal antibodies we have prepared, JL15a,
appears to recognize a Golgi-associated protein
(see below). In addition, preliminary screening by
indirect immunofluorescence shows many
hybridoma clones producing antibodies that
either give the nuclear staining pattern or give the
endoplasmic reticulum or mitochondrial staining
pattern. Characterization of these antibodies and
their antigens is now in progress. Our hope is to
produce specific tools capable of recognizing dif-
ferent organelles. These antibodies will be most
useful to dissect organelle composition and to
follow their fate inside cells.
Monoclonal Antibody to a Golgi-associated
Heat-Shock Protein
J. Lin, F. Matsumura. S. Matsumura
Golgi proteins can theoretically be divided into
three categories: (1) secretory proteins, such as
serum proteins, which are transiently passed
through the Golgi apparatus; (2) Golgi-specific
proteins, which are unique to the Golgi apparatus
and may play important roles in performing the
Golgi functions such as glycosylation, sulfation,
distilled fractionation, sorting, etc.; and (3) Golgi-
associated proteins that are derived from or also
localized in other organelles, such as NADPH-
cytochrome P450 reductase, NADH-cytochrome
b5 reductase. Proteins in the second and third
categories are most interesting but difficult to
identify and purify. However, monoclonal an-
tibody techniques may provide an opportunity to
identify Golgi-specific and Golgi-associated pro-
teins.
We have obtained a hybridoma clone, JLJ5a,
that secretes antibody directed against a 110K
protein from gerbil fibroma cells, Rat-1
fibroblasts, and L6 myoblasts. This protein is
mainly distributed at the perinuclear region,
which we have identified as a Golgi zone by
cytochemically staining for thiamine
pyrophosphatase (TPP, one of the enzyme
markers for Golgi apparatus). In monensin- and
colcemid-treated cells, the normal Golgi stacks
no longer exist and have become fragmented, as
revealed by both JLJ5a antibody and TPP stain-
ings. These results further support that the 110K
protein is localized at the Golgi apparatus.
Interestingly enough, the 110K protein is not
only found in the Golgi apparatus, but in the
nucleus of a subpopulation of interphase cells as
well. When cells were subjected to heat treat-
ment, the number of cells with nuclear staining by
JLJ5a antibody increased. It is striking that the
Golgi apparatus cannot be detected by JLJ5a an-
tibody in those cells with nuclear staining. Fur-
thermore, in collaboration with Jim Carrels (Quest
2-D Gel Laboratory Section), we have found that
110K protein prepared from immunoprecipitation
with JLJ5a antibody has electrophoretic mobility
in two-dimensional gels identical to that of one of
the heat-shock proteins in L6 myoblats. Thus,
110K protein recognized by JLJ5a antibody is a
Golgi-associated heat-shock protein. The ac-
cumulation of 110K protein in the nucleus in
response to heat shock may suggest some impor-
tant function for this Golgi-associated protein.
Microinjection of Monoclonal Antibodies into
Living Cells
S. Blose, J. Lin, J. Feramisco
With some degree of understanding as to the in-
tracellular locations and, in certain cases, the
biochemical activities of several cytoskeletal pro-
teins, we have turned our attention to the func-
tions of these proteins in the living cell. Through
the microinjection into fibroblasts of well-defined
monoclonal antibodies directed against specific
components of the cytoskeleton, we have been
able to perturb the intracellular location of the in-
termediate filament system, one cytoskeletal
system that has as yet unknown functions.
Preliminary experiments indicate that it may be
possible to alter the function of tubulin and/or the
microtubules as well.
As explained in last year's report, injection of a
monoclonal antibody directed against a compo-
nent of the intermediate filaments caused the
reorganization of these filaments into a tight cap
near the nucleus. Organelle movement, cell shape
and spreading, and blebbing and ruffling were
seemingly unaffected in these cells lacking the
normal distribution of intermediate filaments,
suggesting that these filaments are not involved in
these motility events.
Because of suggestions that there is a relation-
ship between the cytoskeleton and protein syn-
thesis (e.g., Zumbe and Trachsel, Eur. J. Cell Biol.
22: 376 [1980]), we have begun to examine the ef-
fects on protein synthesis of the alteration of
cytoskeleton elements. To carry out this analysis,
we have developed a method for confining 1-100
cells in a microwell, all of which are injected with
antibodies or control solutions. These cells are
then labeled for 1-5 hr with radioactive amino
acids, harvested, and subjected to two-dimensional
gel electrophoresis. Our first investigation was to
look at the protein synthesis patterns of cells lack-
ing the normal distribution of intermediate
filaments and compare these with control cell pat-
terns (Fig. 2). As can be seen, few detectable
changes in the protein synthesis occurred even
though the intermediate filament system had been
drastically altered by the injected antibody.
We are carrying out similar experimental
analysis of the distribution of the cytoskeletal
elements, organelle movement, cell shape, and
protein synthesis patterns in cells after the injec-
tion of monoclonal antibodies directed against
tubulin. In addition, we are examining the effects
of Ca+ + injection on the distribution of a-actinin,
vinculin, and actin to aid in the elucidation of the
mechanism of the putative Ca+ + control of func-
tion of the actin microfilament system of these
cells.
Calcium-dependent Mobility Changes
of Cytoskeletal Proteins
in SDS-Polyacrylamide Gels
F. Matsumura, S. Matsumura, J. Lin
It has been known that the calcium-binding pro-
tein calmodulin can be identified in the crude pro-
tein preparation by its mobility change in the SDS-
polyacrylamide gels that contain additional
calcium (Burgess et al., Biochim. Biophys. Acata
623: 257 [1980]). Since calcium appears to play a
regulatory role in the interaction between
cytoskeletal proteins, we have used our slab gel
system (low bisacrylamide content) to test
whether there is a similar calcium-dependent
mobility change for the cytoskeletal proteins such
as actin, myosin, tropomyosin, and troponin T, C,
and I from rabbit skeletal muscle and actin,
myosin, tropomyosin, a-actinin, filamin, and vin-
culin from chicken gizzard. The rationale was that
these or other muscle-related proteins may
qualify as calcium-binding proteins, suggesting
that their function in vivo may be regulated by
calcium concentration in cells.
In addition to troponin C (a known calcium-
binding protein in skeletal muscle), we have found
two proteins, gizzard a-actinin and slow compo-
nent of gizzard tropomyosin, that appear to
migrate faster in the Ca' gel. The mobility
change of these proteins in Ca" gels is rather
specific; in the Mg+ +-containing gels these pro-
teins do not show any mobility change and only a
small change can be noticed in the Sr+ +-
containing gel. Ca"-binding experiments show
that troponin C binds 4 moles of calcium, and
smooth muscle tropomyosin (dimer) binds 1 mole
Figure 2 (for figure, see p. 116)
Protein synthesis patterns in cells either containing or lacking a normal distribution of intermediate
filaments. Ap-
proximately 40 cells (gerbil fibroma) were microinjected with a sufficient amount of the monoclonal antibody
against a 95K protein to cause the aggregation of the intermediate filaments
(see Lin and Feramisco, 1981). Ten
hours postinjection the cells were labeled with [35S]methionine for 2 hr, harvested, and
analyzed by two-dimensional
gel electrophoresis (by the Quest 2-D Gel Laboratory). The top panel shows the
fluorogram of the proteins made by
control cells, and the bottom panel shows the proteins made by the cells injected
with the antibody. The arrow
points to the antigen against which the antibody is directed. Much of the pattern
is unchanged when compared with
that of control cells (except perhaps for the apparent reduction in synthesis of one
of the stress proteins!). (1) Actin
isotymes; (2,3) tubulins; (4) vimentin; (5) a-actinin.
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Figure 3
Ordered bundles of (A) thin filaments and (B-D) microfilaments formed by anti-tropomyosin monoclonal antibody 1LF15. (A) Thin filament bundles isolated from smooth muscle
(Taenia coli of guinea pig). (B-D) Microfilament bundles isolated from (B) BHK-21 fibroblasts, (C) L6 myoblasts, and (D) gerbil fibroma cells. The periodicity is indicated by
arrowheads.
of calcium in the native state. Surprisingly,
smooth muscle a-actinin does not bind calcium at
all. Therefore, the mobility change of a protein in
Ca+ + gels can be misleading if used to identify a
calcium-binding protein. Still, the observed
change of mobility may indicate that such a pro-
tein may undergo a conformational change after
the interaction with calcium ions. The conforma-
tional change may be important for the protein to
perform its regulatory function in cells.
Use of Monoclonal Antibodies to Isolate
Microfilaments from Cultured Cells
F. Matsumura, S. Matsumura, J. Lin
Microfilaments appear to play central roles in cell
motility and cell-shape changes. One of our goals
in studying the function of microfilaments is to
determine whether the protein composition or
ultrastructural organization of microfilaments
changes concomitantly with changes in biological
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Figure 4
SDS-polyacrylamide gel analysis of microfilament frac-
tions immunoprecipitated by monoclonal antibody
JLF15 from [35S]methionine-labeled L6 myoblasts (MB)
and myotubes (MT). (A) Coomassie blue stain; (B)
autoradiography. Asterisks indicate heavy and light
chains of IgM immunoglobulin. Note that 83K protein
found in the myoblast-microfilament fraction (lane MB
of B) appears to be missing in the myotube-
microfilament fraction and that tropomyosin changes
qualitatively and quantitatively during L6 differentia-
tion.
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activities such as spreading, mitosis, movement,
etc. For this purpose, it is quite essential to isolate
microfilaments in their intact form from cultured
cells. We have chosen anti-tropomyosin
monoclonal antibodies (JLF15, J LH2, and LCK16)
to isolate intact microfilaments for the following
reasons: (1) Since tropomyosin is one of the ubi-
quitous components of microfilaments, it is
suitable as an antigen for immunoprecipitation of
microfilaments; (2) monoclonal antibodies to
tropomyosin caused the aggregation of
microfilaments into ordered bundles, which can
be easily collected by low-speed centrifugation.
The procedure to isolate microfilaments is very
simple and rapid. Briefly, monolayer cells are first
extracted with Triton X-100 glycerol solution to
stabilize the cytoskeleton, and the residues are
homogenized in the presence of Mg-ATP. After
centrifugation, the supernatant is incubated with
monoclonal antibodies. Dispersed microfilaments
in the supernatant are aggregated by antibodies
into ordered bundles (Fig. 3), and the resultant
bundles are collected by low-speed centrifugation
and analyzed by electron microscopy and
biochemical methods such as SDS-
polyacrylamide gel analysis and actin-activated
myosin ATPase activity. Such isolated
microfilaments appear to be native with respect
to the following criteria: (1) they preserved the
typical filament morphology, namely, double
helical structure and periodic arrangement of
tropomyosin on actin filaments, and (2) the
microfilament fraction could activate myosin AT-
Pase activity to almost the same extent as skeletal
muscle F actin does.
We applied this method to examine changes in
the protein components of microfilaments from
L6 cells during myogenesis. As Figure 4 shows, the
composition is clearly different between these
two microfilament fractions. Tropomyosin
species changed from nonmuscle type to muscle
type during myogenesis. In addition, troponin ap-
peared in the microfilament fraction from
myotubes. More interestingly, an as yet uniden-
tified protein of 83K molecular weight found in
the myoblast-microfilament fraction was missing
from the myotube-microfilament fraction. The
characterization of this new protein, including
production of monoclonal antibody to this pro-
tein, is in progress.
The method assumes that Triton-glycerol ex-
traction immediately freezes the microfilaments
at the state identical to that occuring in in vivo
microfilament bundles. This is still to be proven
preferentially by demonstrating that the isolated
bundles express pronounced differences accord-
ing to the biological state of their source. Conse-
quently, we will use the monoclonal antibodies
that we have prepared (such as anti-actin, anti-
filamin, anti-a-actinin, and anti-vinculin) to isolate
other sets of microfilament fractions. Thus, the
protein composition, and perhaps organization,
along microfilaments can be analyzed in detail
and correlated to their functions. Two examples
of the usefulness of this technique are shown in
the next sections.
Analysis of Microfilament Components from
Cultured Normal and Virus-transformed Cells
S. Matsumura, F. Matsumura, J. Lin
Microfilament bundles in transformed cells have
been reported to be in a more dispersed state and
to have reduced thickness as judged by im-
munofluorescent microscopy. Recently, Hen-
dricks and Weintraub (Proc. Natl. Acad. Sci.
78: 5633 [1981]) reported that Rous sarcoma virus
(RSV)-transformed CEF contain a lesser amount of
tropomyosin. In collaboration with Margaret
Hightower and Bill Topp (Tumor Virus Section),
we have prepared microfilaments from normal
and two independent isolates of SV40-
transformed rat embryo fibroblasts using our new
method to isolate intact microfilaments from
cultured cells by immunoprecipitation with anti-
tropomyosin monoclonal antibody. Analysis by
SDS gel electrophoresis (Fig. 5) showed hardly any
difference between the amounts of tropomyosin
in the microfilaments of transformed cells versus
the normal cells. However, we could detect one
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Figure 5
SDS polyacrylamide gel analysis of microfilament frac-
tions immunoprecipitated by monoclonal antibody
JLF15 from normal rat embryo fibroblasts (REF52) and
its SV40-transformed lines (REF4A and REF10A). Gel
was stained with Coomassie blue. Asterisks indicate the
heavy and light chains of JLF15 IgM antibody.
protein band (37K) present only in the
microfilaments of transformed cells and two pro-
tein bands (250K and 32K) significantly increased
in the microfilaments of the transformed cells.
The further characterization of these proteins is in
progress.
Decoration of Microfilaments and Smooth
Muscle Thin Filaments with Monoclonal
Antibodies to Tropomyosin
F. Matsumura, S. Matsumura, J. Lin
Monoclonal antibodies have the advantage over
conventional antibodies in that they recognize on-
ly one antigenic determinant. Therefore, one can
expect to obtain higher resolution in localizing
that determinant within cytoskeletal filaments by
electron microscopy. We have used three dif-
ferent monoclonal antibodies (LCK16, J LH2, and
JLF15) against tropomyosin to localize this an-
tigen along smooth muscle thin filaments and
microfilaments from nonmuscle cells. As Figure 3
shows, monoclonal antibodies caused the ag-
gregation of smooth muscle thin filaments and
microfilaments from nonmuscle cultured cells
(BHK-21 fibroblasts, L6 myoblasts, gerbil fibroma
cells) into ordered bundles which displayed cross-
striations with a periodicity of 37±1 nm and
36 ±1 nm, respectively. In contrast, conventional
rabbit antiserum to tropomyosin distorted and ag-
gregated the thin filaments without generating
cross-striations. Therefore, monoclonal antibodies
to tropomyosin allow us, for the first time, to
observe directly the distribution of tropomyosin
molecules along thin filaments of smooth muscle
cells and microfilaments of cultured cells. A
similar approach using other monoclonal an-
tibodies that we have prepared will be applied to
show the ultrastructural arrangement of other
cytoskeletal proteins such as a-actinin, filamin,
and vinculin along microfilaments.
Publications
Blose, S.H. and J.J.C. Lin. 1981. Vimentin-10nm
filaments decorated with a monoclonal antibody that
recognizes a common determinant on vimentin and
tropomyosin. J. Cell Biol. 91: 239a.
Blose, S.H., F. Matsumura, and J.J.C. Lin. 1982. The
structure of vimentin 10-nm filaments probed with a
monoclonal antibody that recognizes a common an-
tigenic determinant on vimentin and tropomyosin.
Cold Spring Harbor Symp. Quant. Biol. 46: 455.
Burridge, K. and J.R. Feramisco. 1981. Non-muscle
a-actinins: Calcium-sensitive actin binding proteins.
Nature 294: 565.
--. 1982. a-Actinin and vinculin from nonmuscle
cells: Calcium-sensitive interactions with actin. Cold
Spring Harbor Symp. Quant. Biol. 46: 587.
-. Comparison of the muscle and nonmuscle forms
of vinculin. (In preparation.)
deLanerolle, P., R.S. Adelstein, J.R. Feramisco, and K.
119
Burridge. 1981. Localization of the myosin light chain
kinase in nonmuscle cells. Cold Spring Harbor Conf.
Cell Proliferation 8: 855.
Feramisco, J.R. and K. Burridge. Purification and
characterization of a-actinin from nonmuscle cells. (In
preparation.)
Feramisco, J.R., K. Burridge, P. deLanerolle, and R.S.
Adelstein. 1981. Characterization of antibodies to
smooth muscle myosin kinase and their use in localiz-
ing myosin kinase in nonmuscle cells. Proc. Natl.
Acad. Sci. 78: 4738.
Feramisco, J.R., J.E. Smart, K. Burridge, D.M. Helfman,
and G.P. Thomas. Co-existence of vinculin and a
vinculin-like protein of higher molecular weight in
smooth muscle. (Submitted.)
Hughes, S.H., J. Sorge, G.P. Thomas, J.R. Feramisco, L.
Chow, and J.I. Carrels. 1982. Approaches for isolating
genes encoding the cytoskeletal proteins and for rein-
troducing the genes into cultured cells. Cold Spring
Harbor Symp. Quant. Biol. 46: 507.
Kamiya, N., Y. Yoshimoto, and F. Matsumura. 1981.
Physiological aspects of actomyosin-based cell motili-
ty. In International cell biology 1980-1981 (ed. H.G.
Schweiger), p. 346. Springer-Verlag, Berlin.
. 1982. Contraction-relaxation cycle of Physarum
cytoplasm: Concomitant changes in intraplasmodial
ATP and Ca concentrations. Cold Spring Harbor
Symp. Quant. Biol. 46: 77.
Lin, J.J.C. 1981. Monoclonal antibodies against
myofibrillar components of rat skeletal muscle
decorate the intermediate filaments of cultured cells.
Proc. Natl. Acad. Sci. 78: 2335.
1982. Mapping structural proteins of cultured
cells by monoclonal antibodies. Cold Spring Harbor
Symp. Quant. Biol. 46: 769.
Lin, J.J.C. and J.R. Feramisco. 1981. Disruption of the in
vivo distribution of the intermediate filament network
in living fibroblasts through the microinjection of a
monoclonal antibody that binds to these filaments.
Cell 24: 185.
120
Lin, 1.1.C. and S.A. Queally. 1981. Monoclonal antibody
to Golgi-associated protein. J. Cell Biol. 91: 390a.
1982. A monoclonal antibody that recognizes
Golgi-associated protein of cultured fibroblast cells. J.
Cell Biol. 92: 108.
Lin, J.J.C., K. Burridge, S.H. Blose, A. Bushnell, S.A.
Queally, and J.R. Feramisco. 1981. Use of monoclonal
antibodies to study the cytoskeleton. In Current topics
of muscle and non-muscle motility (ed. J.W. Shay and
R.M. Dowben), vol. 2, p. 63.
Matsumura, F. and J.J.C. Lin. 1981. Monoclonal an-
tibodies to tropomyosin decorate native thin filaments
with 38nm periodicity. J. Cell Biol. 91: 290a.
Visualization of monoclonal antibody binding to
tropomyosin on native smooth muscle thin filaments
by electron microscopy. (Submitted.)
. Calcium-dependent mobility changes of
cytoskeletal proteins on SDS polyacrylamide gels. (In
preparation.)
Sugino, H. and F. Matsumura. Fragmin induces tension
reduction of actomyosipthreads in the presence of
micromolar levels of Ca . (Submitted.)
Thomas, G.P., W. Welch, M.B. Mathews, and J.R.
Feramisco. 1982. Molecular and cellular effects of
heat shock and related treatments of mammalian
tissue culture cells. Cold Spring Harbor Symp. Quant.
Biol. 46: 985.
Wang, K., J.R. Feramisco, and J.F. Ash. 1982.
Fluorescent localization of contractile proteins in
tissue culture cells. Methods Enzymol. (in press).
Welch, W., G.P. Thomas, and J.R. Feramisco.
Purification and properties of the major human heat-
shock proteins. (In preparation.)
Yoshimoto, Y., F. Matsumura, and N. Kamiya.
1981. Simultaneous oscillations of Ca2+ efflux and
tension generation in the permealized strand of
Physarum. Cell Motility 1: 433.
QUEST 2D-GEL LABORATORY
J.I. Garrels, F. Matsumura, S. Matsumura-Yamashiro, J. Leibold, T. Kelly, L. Cascio, S. Norris, J. Emanuele
Our work in the past year has focused heavily on
the improvement of our methods for computer
analysis of two-dimensional gels and on the
establishment of protein data bases for human,
rat, and mouse proteins. Although our laboratory
is routinely producing high-quality fluorograms to
resolve thousands of proteins from cells in dif-
ferent states of transformation and differentia-
tion, these studies will not be complete until we
can compare the images in detail and have a data-
base structure for storage and manipulation of the
data. Here we report our recent work in these
areas, as well as the status of several current pro-
jects and some new findings regarding proteins of
particular interest.
Towards Computerized Protein Data Bases
Our work prior to this year had given us a set of
programs for spot detection, integration, and pat-
tern matching. It had also given us many ideas for
improved speed, improved user interaction, and
more convenient data file structures. These
enhancements, we realized, would be necessary
to achieve the throughput and ease of use re-
quired to build a large protein data base accessi-
ble to many users. Since we had already set up a
successful system (the QST data management
system) that allows our laboratory technicians to
interact with their data (records of samples, gels,
exposures, etc.) and to run programs to manage
this data with no special computer knowledge, we
decided that this system should be extended to
control the image analysis programs and to
manage the protein data files.
These goals have been realized in the develop-
ment of a second-generation system of 2D-gel
analysis programs. These programs now give us
the speed, reliability, and ease of use that we
need for routine gel analysis. The operator can
begin a scan by entering data into a simple, self-
explanatory form (the SCAN form) on the screen
of an ADM42 terminal. The detection of spots,
conversion of density to dpm, and the integration
of spots is carried out by a series of programs that
are run automatically by the system. Each pro-
gram writes some summary information, such as
number of spots found, total dpm detected, total
execution time, and the input and output data file
numbers, into a permanent data record that can
be displayed on the SCAN form. The scanning pro-
cess, which puts a smoothed image of the film on-
to disk, requires only about 4 minutes. The series
of programs for spot detection and integration re-
quires about 30 minutes for an image of over 1000
spots. To scan many films during the day without
waiting for completion of the analysis programs,
we have written a queue manager utility. The
queue manager directs the flow of the programs
as time allows, and the unfinished processing for
the scans of the day is easily completed over-
night. The image, intermediate, and spot list files
are managed automatically by the system.
The spot integration programs generate a
sizable data record for each spot. In this data
record are stored such parameters as total densi-
ty, total dpm, and Gaussian curve-fitting
parameters (height, position, and half-width) and
codes to indicate unusual shapes, uneven
backgrounds, saturation, and degree of overlap.
When integration is complete, the list is sorted,
and for every spot a list of the ten nearest
neighbors is compiled. Finally, a synthetic image
is constructed from the spot list by computing the
density at each location in the image based on the
fitted Gaussian spot parameters. These
postintegration programs require only a few
minutes to run. At this stage, the synthetic image
can be displayed on the color monitor or plotted,
and the intensities of each spot can be read by the
user in terms of density, dpm, or fraction of
counts applied to the gel. If comparison to
another image or a standard image is desired, then
a matching program is run. The neighbors list, the
detailed spot records, and the synthetic image
provide the necessary input for the matching pro-
grams.
We have previously developed, and are just
completing the enhancement of a matching pro-
gram for comparison of two gel images. These im-
ages can be any two related spot patterns, but
usually one is a standard pattern representing a
compilation of spots from many previous gels.
Our approach requires only that the two images
be superimposable in local areas and that many
of the spots are common to the two images. Match-
ing is done primarily by neighbor relationships(positional information), but now consideration of
spot shapes, spot intensities, saturated spots, and
other flags in the data files is possible. One or
more landmark spots and their matches are initial-
ly selected by the operator. Then the computer
matches up to ten neighbors surrounding an initial
match. One of these new matches will then be
selected as the next reference match and ten
neighbors around it will be matched, as so on. In
the end, each spot has been matched based on its
position with respect to each of its neighbors. If
two or more spots are potential matches for a
standard spot, the ambiguity can often be resolved
by choosing the spot most similar in shape or in-
tensity.
There are, of course, cases in which a spot on
the new image could be one of two possible
standard spots that run very close together. Our
matching strategy allows these ambiguities to re-
main temporarily unresolved. Since most of our
samples are applied to several gels of different
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acrylamide concentrations in the second dimen-
sion, we can often use the data from a second gel
to resolve the ambiguity. In a gel of different com-
position, the spot pattern and the neighbor rela-
tionships will be somewhat different. The am-
biguities of matching found on a 10% gel in
general will not occur in a 12.5% gel. Therefore,
the last phase of our spot matching process is the
resolution of these ambiguities by comparison of
match lists from two different gels.
Our protein data-base structure has been worked
out in detail, and a standardized spot map of rat
proteins has been prepared. In our system, each
spot in the standard map is assigned a four-digit
number. As a convenience for users of the maps,
we let the first digit denote position along the pH
coordinate and the second digit denote position
along the molecular-weight coordinate. The
numbers have been assigned in proportion to the
spatial distribution of the proteins, and plenty of
unused numbers are available for newly
discovered proteins.
In the permanent data files, space is reserved to
enter the intensity of each of 10,000 spots for
each sample. We presently have enough space on
our disks to hold these lists for 500 samples for
each data base (human, rat, mouse). Knowing only
the sample number and the standard spot
number, the system will be able to obtain the in-
tensity of any spot in any sample very quickly.
Since cross-referenced data to describe all ex-
periments and samples is already in our
laboratory data base, it will be easy for us to set
up searches to find, for example, proteins present
only in muscle cells or proteins that increase in
transformed cells.
Another important aspect of the data base, in
addition to the master lists of protein intensity,
are records to hold textual information about
each protein. These records are handled by the
QST system and can be displayed on forms on the
terminal screen. We have created files called
HUMANSPOT, RATSPOT, and MOUSESPOT, and
a data record has been allocated for each of the
10,000 potential proteins. In these records we can
enter the pH and molecular-weight coordinates of
each spot, its name or attributes when known, and
pointers to a variety of other files to hold such in-
formation as literature references, amino acid
composition, posttranslational modification data,
tissue-specificity information, subcellular
localization data, etc. A user can obtain the
number for a spot of interest from standard maps
mounted on the wall and then call up the cor-
responding HUMANSPOT (or RATSPOT or
MOUSESPOT) record on the terminal to deter-
mine what is known about this spot. Entries are
now being made for known proteins and for pro-
teins of particular interest from our past ex-
periments.
Although not complete, our software for 2D-gel
analysis and data management is now a well-
structured, modular system that uses consistent
names and conventions throughout. We have
122
begun to distribute our software par k age, whir Ii
we call QUEST, to other scientific, laboratories
The software we have distributed includes the
QST record management system and the image-
processing programs for scanning, calibration,
spot detection, and integration. More programs
will be added to the distribution tapes as they are
completed.
studies of Inn-Ilan Disease
A major part of our effort in the gel lab in the past
year has been to prepare samples and resolve the
proteins from human fibroblast lines representing
normal individuals and patients with genetic
disease. A total of 16 normal lines, 17 lines from
patients either heterozygous or homozygous for
cystic fibrosis, and 11 lines from patients with
Huntington's disease have been examined. All
lines were obtained from either the American
Type Culture Collection or the Human Genetic
Mutant Cell Repository. The Hungtington's
disease study has been done with Dr. Irwin Fand
from Stony Brook. At least two samples have been
prepared from each line, representing high- and
low-density cultures, and most lines have been ex-
amined at two or more different passage levels.
Each sample has been run on gels of three dif-
ferent pH ranges (5-7, 6-8, and 3.5-10), and both
10% and 12.5% gels have been used in the se-
cond dimension. The images obtained from these
samples are very similar, but differences can be
found. Most of these differences are due to
polymorphisms in the human population. A full
analysis of the data from these samples is now be-
ing carried out by our new data analysis techni-
cian, Jane Emanuele.
Projects in Cell Biology
We are working closely with the other members of
the Cell Biology Section to identify and
characterize cytoskeletal and other abundant pro-
teins of cultured cells. In addition, we are
characterizing many of the less abundant proteins
of rat cells with regard to state of phosphoryla-
tion, kinetics of synthesis and turnover, and tissue
specificity.
The heat-shock proteins are a set of abundant
proteins with unknown functions. We have worked
in collaboration with Paul Thomas, Jim
Feramisco, and Bill Welch to study these proteins
in HeLa and chick cells (see Protein Synthesis Sec-
tion). In addition, we have examined the heat-
shock response in the rat muscle cell line L6. In
many cell types the major response occurs in a
90K and a 72-74K protein. In cultures of differen-
tiated L6 cells, however, the primary inductions
are in a 100K and a 80K protein. Each of these is
induced approximately 8-to 12-fold within 4 hours
of a mild (42°) heat shock. Both the 100K and 80K
proteins have phosphorylated components, and
the phosphorylated forms are induced to the
same extent as the major unphosphorylated
forms. Each of the heat-shock proteins is a major
component of cultured L6 cells under normal
culture conditions, and no dramatic changes of
synthesis occur during muscle differentiation,
although some decrease in the rate of synthesis of
the 100K protein is consistently observed. The 80K
heat-shock protein is apparently the same protein
that was reported by Wu et al. U. Biol. Chem.
256:5309 [1981]) to be induced by calcium
ionophores.
The 100K protein has been observed in other
stress response systems, although seldom as the
major response. We have made a fortunate obser-
vation through a separate project to identify pro-
teins immunoprecipated by monoclonal an-
tibodies produced by Jim Lin. One of these
monoclonal antibodies, J LJ5a, has high specificity
for the 100K "heat-shock" protein. Jim Lin has
already characterized this antibody and has
localized its antigen by immunofluorescence (see
Cell Biology Section). The localization of this pro-
tein in normal cells is coincident with the Golgi
apparatus, and its localization in shocked cells is
under investigation.
Protein phosphorylation has been studied
recently in the L6 and Rat-1 cell lines to determine
the phosphorylation patterns of particular pro-
teins and, more importantly, to determine the
overall extent of phosphorylation. We have found
in cultures of L6 cells, containing both differen-
tiated and undifferentiated cells, that about 13%
of most prominent contain
phosphate. Our detection is based on fluorograms
of gels containing 33P-labeled proteins, labeled by
growth of cells in phosphate-poor media contain-
ing the isotope for 24 hr. Phosphorylation could
be found on some of the relatively abundant pro-
teins, as well as on minor proteins, with no signifi-
cant preference for any abundance class. There
does seem to be more tissue specificity among
phosphoproteins than among other proteins.
About 14% of the phosphoproteins analyzed in
mixed myoblast/myotube cultures are not detect-
able in myoblast cultures, and 41% of the same
phosphoproteins are not detectable in Rat-1
fibroblasts.
These studies will be extended to many more
proteins and to other cell lines. In our L6 studies,
over 75% of the detected phosphoproteins did
not correspond to any 35S-labeled protein at the
level of exposure used. This indicates that the in-
corporation and sensitivity for detection of 33P
was much better than the detection of 355-labeled
proteins in this experiment and that large numbers
of minor phosphoproteins remain to be
characterized. Indeed, we have obtained high-
sensitivity phosphoprotein gels of Rat-1 cells in
which over 700 phosphoproteins can be detected.
To reliably match this many minor proteins to
their amino-acid-labeled counterparts is best done
by a double-label experiment in which proteins
labeled by each isotope are run in the same gel.
Detection will be by differential decay and com-
puter analysis.
Collaborative Experiments
Our laboratory has engaged in several major col-
laborations with other groups at the Cold Spring
Harbor Laboratory. These experiments include
studies of the stress response of HeLa and chick
cells (being done with Paul Thomas, Protein Syn-
thesis Section), identification of mouse proteins
specified by mutant haplotypes of the t complex
(being carried out with Lee Silver, Molecular
Genetics of the Mouse Section), and studies of
mouse cells transformed by DNA from human
tumor lines (being carried out with Mike Wigler,
Mammalian Cell Genetics Section). The progress
of these studies is reported in the corresponding
sections of this Annual Report.
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NEUROBIOLOGY
A new type of Neurobiology course which teaches state-of-the-art techniques that are in
obvious demand was introduced last year and is proving to be very effective. The topics
change every year or every second year and are a refreshing addition to our basic core pro-
gram. This past summer, for example, we taught Single-channel Recording and Elec-
trophysiology of the Mammalian Brain Slice. Likewise, our year-round program is in flux. It
is slowly growing in scope and promises to become more integrated into the laboratory's
scientific activity, where originally it had subserved a more peripheral function.
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LEECH NEUROBIOLOGY
B. Zipser, C. Schley
Our laboratory uses monoclonal antibodies to
probe into the molecular basis of neural recogni-
tion. We use the leech as an experimental
preparation because, in principle, in this limited-
size nervous system each individual neuron can
be identified. Thus, our strategy is to focus on
those antibodies that are specific for single kinds
or small sets of identifiable neurons. Our major
thrust has been and will continue to be directed at
generating large numbers of specific monoclonal
antibodies, since we consider it vitally important
to obtain a clear understanding of the different
kinds of sets of antigenically related neurons that
exist in the brain. Obvious questions that we are
beginning to address are, for example, how many
different specific molecular markers occur in a
given identified neuron? We need to know
whether a neuron has just a handful of markers,
such as those that exist to carry out the well-
understood phenomenon of synaptic transmission
and modulation, or whether there is a significant-
ly larger pool of specific molecules that might
specify synaptic connectivities. Thus, we pay at-
tention to the recurrence of individual neurons
that are part of different molecularly homologous
sets of neurons. The other approach is to analyze
a given set of antigenically related neurons in
detail by means of electrophysiological methods.
Here we search for a common functional
denominator that might be a coherent function,
such as, for example, reproductive behavior. Col-
laborative efforts are in progress with other
laboratories to intensify information on such a
particular antibody-labeled set of neurons by
characterizing the antigens biochemically and as
developmental markers. Although understanding
of neural connectivities will very likely be a long-
term effort, our monoclonal antibodies have
turned out to be a rich resource for shedding new
light on specific cell and neurobiological pro-
blems of long-standing interest in the leech.
Generation of New Monoclonal Antibodies
Our real hit among the new monoclonal an-
tibodies that were generated last year is an an-
tibody specific for a subset of mechanosensory
neurons that respond to noxious stimulation of
the skin. Our first antibody, Lan3-2, binds to full
sets of nociceptive neurons, whereas our new an-
tibody is a hyperfine immunochemical probe that
can distinguish between receptive fields. Other
antibodies were generated that (1) also bind to
neurons in segmental ganglia innervating the
animal's peripheral tissues or (2) bind only to
neurons in the head brain and are likely to exer-
cise a higher-order control over lower brain
centers through widespread antigenically related
processes.
Biochemical Characterization of Leech
Antigens
Much of last year was spent in collaboration with
Nancy Hogg in beginning the biochemical
analysis of leech antigens. Nancy introduced to
Cold Spring Harbor the technique of staining im-
munoblots from acrylamide gels through
horseradish peroxidase (HRP)-conjugated second
antibodies. Out of 17 antibodies tested, 7 stained
bands on immunoblots with molecular weights
ranging from 20,000 to 135,000. Many of these an-
tibodies give different staining patterns depend-
ing on whether the immunblots were prepared
with central nervous system tissue or with our
control tissues-the gut and penis. Correlative im-
munocytochemistry on the gut and penis showed
that in these peripheral tissues the antibodies bind
to neurons and often epithelial cells. The
highlight of this peripheral tissue histochemistry is
the discovery of a neuron just below the epithelial
gut surface that sends a thick neurite up to con-
tact the gut lumen. This neuron, densely packed
with intracellular antigen, is often surrounded by
a cloud of antigenically related granular material,
which may be the neuron's own neurosecretory
products.
The chemistry of the antigens identified by an-
tibodies binding to nociceptive neurons was
studied in more detail. Both antibodies, Lan3-2,
specific for the full set, and Laz2-369, specific for
a subset, bind to fuzzy, high-molecular-weight
bands. Both antibodies bind to surface antigens
and Felicia Henderson and John Smart have
already shown the Lan3-2 antigens to be a
glycoprotein.
Using Antibodies as Developmental Markers
I n collaboration with R. Stewart and E. Macagno(Columbia University), we started using antibodies
as markers to study the development of central
and peripheral nervous systems in the leech
species Haemopis against which the monoclonal
antibodies were generated. Since other leech
species are generally used for leech embryology,
Macagno and Stewart are characterizing early
development of Haemopis embryos.
Two of our monoclonal antibodies have
already provided interesting data on the develop-
ment of specific nerve cells. For example, Lan3-6,
the antibody that binds to about 40 neurons in the
adult ganglia during early development (10-11
days), first binds to only a single pair of nerve cells
(Fig. 1). At later stages, more cells begin to stain,
and by day 11-12 in ganglia 3, 11 cells stain; a day
later, there are already 18 stained cells. At all
ages, fewer neurons stain in the more posterior
ganglia, indicating an anterior-to-posterior gra-
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Figure 1
The monoclonal antibody Lan3-6 stains neuronal cell bodies in the 12-13-day-old embryo. (A-C) Three different
focal planes of ganglion 3 going from the doral to the ventral surface. (D) Composite drawing of all labeled cell
bodies, the dashed lines showing dorsal and the solid lines ventral cell bodies.
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Pressure
cells
Figure 2
The staining patterns of two antibodies, Lan3-6 (A) and Lan3-5 (8) that overlap in the pressure cells (arrows). Both an-
tibodies bind to four pressure cells in the standard 400-neuron ganglion.
HEAD I 2 3
4 5 6
L-(
)/(
.40)0 (.r
7 8 9
10 1 I
()6( (1( mrJyW
12 13
)y.11
f Ibb
. n
j).17L
Th7r
19
14 15
16
20 21 TAIL
V WULJ(j/
nr7r7n(\
Figure 3
Whole leech nerve cord diagram with pressure cells that jointly appear in the Lan3-5 and Lan3-6
patterns.
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dient of nervous system differentiation. An in-
teresting aspect of Lan3-6 is that it stains sensory
neurons in the leech central nervous system and
sensory receptors on the leech skin. Stewart and
Macagno have the first preliminary evidence that
there might be a gradient of sensory maturation in
the peripheral sensory organs as well.
Mapping Antigenically Homologous Neurons
Along the Entire Extent of the
Central Nervous System
Monoclonal antibodies are a new tool for study-
ing molecular neuroanatomy. In a simple
organism like the leech, monoclonal antibodies
can be used to map the whole central nervous
system distribution of sets of chemically
homologous neurons.
One cell type that was mapped along the entire
nerve cord is the primary mechanosensory cells
responding to pressure applied to the skin of the
leech. For this map, we used two monoclonal an-
tibodies, Lan3-5 and Lan3-6, whose staining pat-
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terns overlap in the pressure cells (Fig. 2). 1 igure
illustrates the pressure cell distribution for the
whole leech nerve cord.
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ANATOMICAL STUDIES WITH
MONOCOLONAL ANTIBODIES
S. Hockfield, E. Waldvogel
The large number of monoclonal antibodies that
recognize different subsets of nerve cells show us
that nerve cells have specific molecular markers.
Now we are impelled to determine what these
molecules mean to a functioning nervous system.
A primary goal of the anatomical studies is to
show the subcellular binding sites of antibodies.
These sites within a nerve cell can then suggest
possible functions of the antigen to which the an-
tibody binds. The antibodies have also been used
successfully to explore the organization of nerve
cell processes. These studies have shown us the
relationships among molecularly homogeneous
neural elements and also suggest possible func-
tions of neuron-specific molecules.
Electron Microscopic Localization of
Monoclonal Antibodies
We have now overcome the technical obstacles
to immuno-electron microscopy. We have deter-
mined the binding sites for a number of anti-
bodies; several have been shown to bind to sur-
face molecules and several to internal molecules.
The antibodies that bind to surface molecules
are particularly exciting because many hypothe-
ses for how the nervous system establishes and
maintains specific neuronal connections postu-
late surface markers that are involved in cell-to-
cell recognition. (Also, nerve cell membranes are
specialized to conduct electrical signals and re-
spond to neurotransmitters. Such specialized
functions may be mediated by membrane
molecules.) Lan3-2, an antibody that recognizes
the four neurons in each standard leech ganglion
that respond to noxious stimuli, recognizes a
molecule found on the surface of both neuron
cell bodies and axons (Fig. 1A). The axons stained
by Lan3-2 form bundles (fascicles) that are
delimited from neighboring axons by processes of
a glial cell. In well-preserved tissue, antibody
staining is more intense and consistent between
axonal and glial membranes than between axonal
and axonal membranes. These observations raise
several intriguing questions. Is the presence of the
antigen recognized by Lan3-2 a result of an axon
lying within a particular fascicle, or does the
presence of such an antigen direct an axon to
grow into a particular fascicle? Is the nerve cell
antigen recognized by the glial cell surrounding it,
and therefore, does this glial cell that enwraps
many different fascicles have specialized areas of
its surface to recognize particular neuronal
markers? Our current studies on axonal growth
and regeneration will address these questions.
Internal molecules are also intriguing since
they could be involved in nerve cell metabolism
or in the synthesis of neurotransmitters and other
neuron-specific products. Antibody Lan3-9 recog-
nizes ten neurons at the head of the leech and
nerve cell processes throughout the length of the
nervous system. These neurons could be involved
in modulating and/or coordinating segmental
neural activity. Our studies with Lan3-9 have
shown that it recognizes an internal antigen pre-
sent in the cytoplasm, but not the nucleus, of cell
bodies and axons. At the electron microscopic
level, antibody staining is associated with vesicu-
lar profiles in axons (Fig. 1 B). The staining charac-
teristics of Lan3-9 are similar to those shown for
neurotransmitters in other systems. These anatom-
ical observations suggest physiological studies
that could determine whether Lan3-9 is associated
with neurotransmitter function.
Monoclonal Antibodies Demonstrate
Organization of Axons in the Leech
One of the major reasons the leech has been a
popular organism for neurobiological research is
that its nervous system is composed of ganglia
containing only 400-neuron cell bodies. The rela-
tively small number of neurons their consis-
tent positions, sizes, and shapes, which can be re-
solved with the light microscope, allow one to
study the organization of the leech nervous sys-
tem. In contrast, the connective, a bundle of ax-
ons that connects each 400-neuron ganglion to its
neighbor, contains more than 5000 axons whose
sizes and positions can only be resolved at the
electron microscopic level, making it far more dif-
ficult to study. We have now used monoclonal an-
tibodies to explore the organization of axons in
the leech. The main goals of this study were to de-
termine whether (1) axons carry specific molecu-
lar markers, (2) axon position is as consistent as
neuron cell body position, and (3) similar mechan-
isms encode cell body and axon positions.
The initial stages of this study showed us that
each of the monoclonal antibodies has a charac-
teristic staining pattern among axons in the con-
nective (Fig. 2). The positions of stained axons are
essentially consistent in connectives from all the
segments of a single leech, from the head to the
tail. Also, these positions are consistent among
leeches of the same species and, in many cases, in
leeches of other species. These results demon-
strate that, like neuron cell body position, axonal
position is highly sterotypical and must be deter-
mined in a consistent way in all animals.
Although some antibodies stain bundles of ax-
ons (Lan3-2 and Lan3-6 in Fig. 2, for example),
others stain axons that run singly in the connec-
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Figure 1
I n electron micrographs of monoclonal antibody stained tissue one can recognize labeled axons. (A) Lan3-2 stains
the perimeter of small-diameter axons in the connective (41,000 x ). (B) Lan3-9-stained axons contain H RP-darkened
vesicles (10,500
B C
Figure 2
Cross sections of the connective demonstrate staining of different groups of axons (arrows) with each of three an-
tibodies. (A) Lan3-9 stains axons in the medial axon bundle of the connective and in the medial part of each lateral
bundle. (B) Lan3-6 stains axons in the lateral part of each lateral connective (171 x ). (C) Lan3-2 stains fascicles of ax-
ons in the ventral part of each lateral connective.
tive (Lan3-9 in Fig. 2, for example). We therefore
studied the relationship between grouping pat-
terns of cell bodies and axons stained with a given
antibody. Lan3-6 stains cell bodies that are
heterogeneous in location and size but stains a
distinct bundle of axons in the connective. Lan3-9
stains cell bodies that are homogeneous in loca-
tion and size but stains single axons in the connec-
tive. This shows that axon grouping does not
predict neuron cell body grouping. An antigen
common to all axons within a group may actually
be related to (by determining or as a result of) the
formation of that group. In embryological studies,
it has been shown that cell body position is deter-
mined before axonal outgrowth is complete. To-
gether these studies strongly suggest that dif-
ferent factors govern cell body and axon posi-
tions.
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CHARACTERIZING LEECH NEUROANTIGENS
R. McKay, J. Johansen, L. Kleina
Several immediate questions were raised by our
initial observation that many monoclonal an-
tibodies could be obtained that recognize subsets
of neurons in the leech nervous system. The leech
nervous system is composed of a chain of ganglia
containing 400 cell bodies. This structure is
bilaterally symmetrical so that the basic building
block can be considered to be a half ganglion of
200 cells. We found at least 30 different specific
staining patterns without finding a repeat. A
Poisson analysis using these numbers suggests
that there is at a minimum sufficient molecular
diversity in the leech ganglion for each of the 200
neurons in a half ganglion to be molecularly
distinct.
In the past year we have extended our informa-
tion on particularly interesting antibodies asking
questions as to the molecular nature of the an-
tigen, the distribution in the whole central ner-
vous systems of different species of leech, and the
appearance of these antigens in the development
of the nervous system. In addition, we have, of
course, been screening more hybridomas for in-
teresting antibodies against the adult nervous
system and, with the help of D. Weisblat (Univer-
sity of California, Berkeley), early embryos of the
leech.
A Molecule Present in All Neuron Cell Bodies
in the Central Nervous System of the Leech
In screening hybridoma cell lines for those
secreting specific antibodies, we found many an-
tibodies that bind to all neurons. One of these,
Lan3-8, recognizes all neuron cell bodies in the
midbody ganglia of Hemopis marmorata. This an-
tibody also recognizes all cell bodies in the
related species Hirudo medicinalis but fails to
bind to neurons in the more distantly related
species Helobdella triserialis. On Western blots
the antibody recognizes a single species of
molecule with a molecular mass of 62,000 in
Hemopis and Hirudo. To confirm that the antigen
recognized immunohistochemically is the same
as that recognized biochemically, we have shown
that the same 62K antigen is present in Retzius
cells, nociceptive cells, and anterior pagoda cells
microdissected from leech ganglia. This result is
technically encouraging since it shows that our
biochemical procedures are sensitive enough to
identify antigens in small numbers of specific cell
types, a very small mass of tissue.
Weisblat and his colleagues have shown that
the majority of the central nervous system is
derived from the expected ectodermal lineage.
The most anterior neural structure, the
supraesophageal ganglion, has a distinct
developmental origin, being derived from cells
that also give rise to the endoderm. We have
shown both immunohistochemically and
biochemically that the Lan3-8 antigen is also pre-
sent on neurons in the supraesophageal ganglion.
With the help of Steve Blose (Cell Biology Sec-
tion), we compared the proteins in these two dif-
ferently derived parts of the nervous system by
two-dimensional gel electrophoresis and silver
staining. We found that the majority of the pro-
teins in these differently derived parts of the leech
nervous system cannot be distinguished.
However, the silver-stained 2-D gels reveal some
quantitative differences between the supraesoph-
ageal and segmental ganglia consistent with
observations that some of our antibodies
recognize antigens present only in cell bodies in
the supraesophageal ganglion whereas others
recognize antigens present only in segmental
ganglia. It is interesting to note here that in
studies of neuronal lineages in the nematode
Caenorhabditis elegans, neurons have been found
as sisters of muscle cells in lineages that are
predominantly mesodermal (). Sulston, pers.
comm.). Why some neurons are derived from
lineages other than the standard ectodermal
lineage is a mystery. Antibodies such as Lan 3-8
that identify all central neurons should be useful
in the study of neuron differentiation and
development.
An Antigen Found Only in Nociceptive
Neurons
One of our antibodies, Lan3-2, recognizes the four
nociceptive neuron cell bodies in the midbody
ganglion of Hemopis marmorata. The ability of an-
tibodies such as this to bind specifically to the
cells responsive to noxious stimuli while failing to
bind to other characterized cells that respond to
touch and pressure has important implications.
How certain can we be that the antigen recognized
by this antibody is synthesized only by nociceptive
neurons and not in other neurons?
Although we consistently observe intense stain-
ing of nociceptive cell bodies with this antibody,
we can also sometimes see light and variable
staining of other cell bodies, including P cell
bodies, in H. marmorata. To ask whether the stain-
ing characteristics of these lightly stained cell
bodies was the same as the intense staining of N
cells, with Susan Hockfield we examined stained
ganglia at both the light and electron microscopic
levels. At the light microscopic level the N cells
were intensely stained while other cells were
much more lightly stained. At the electron
microscopic level it became apparent that in-
tensely stained cells had antibody bound along
the external surface of the cell. In lightly stained
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cells the stain was associated with cell processes
that were closely opposed to a cell body that was
otherwise unstained. These processes appear to
derive from other cells, probably those intensely
stained with this antibody. Although the cell
bodies in the leech are generally free of pro-
cesses, K. Muller, Carnegie Institution of
Washington (pers. commun.) has recently shown
by horseradish peroxidase filling that N cells do
sometimes have processes that encircle other cell
bodies, including P cells. These observations sug-
gest that the light staining of other cell bodies by
Lan3-2 may be due to processes of the N cell.
Although these results can account for light stain-
ing of some cell types, they do not prove that the
only cells to synthesize the antigen are N cells.
The antibody Lan3-2 recognizes three major
bands on Western blots of proteins extracted from
the nervous system of H. marmorata. The
molecular weights of the bands are similar in the
three species of leech we study. We will now be
able to ask directly whether all three proteins are
present in N cells since we have shown with
another antibody, Lan3-8, that we can detect the
antigen in small numbers of dissected cells of a
particular type.
Curiously, in the other two species of leech we
study, even though the molecular weights of the
antigens recognized by Lan3-2 are similar to those
of H. marmorata, no cell bodies normally bind the
monoclonal antibody in immunohistochemical
preparations. In all three species a subset of axons
bind Lan3-2. Since an antigen recognized by
Lan3-2 is only present in axons, the possibility ex-
ists that even in H. marmorata the fibers that bind
Lan3-2 are derived from cell bodies other than N
cells. We can address this question directly by
double-label studies, injecting a marker into
physiologically identified cell bodies and looking
at cross sections of the axon for coexistence of
the marker with the Lan3-2 antigen.
It is still too early to give a definitive answer to
the question we posed at the beginning of this sec-
tion, whether nociceptive neurons are the only
neurons that synthesize the Lan3-2 antigen.
However our ability to manipulate the simple ner-
vous system of the leech allows us to expect a
clear cut answer.
Physiological Studies of Nociceptive
Neurons Based on Antibody Staining
Patterns
An advantage in using monoclonal antibodies to
examine the nervous system is that they can rapid-
ly demonstrate the distribution of molecularly
homogeneous neurons and show differences in
neuron distributions between segmental ganglia.
For example, Lan3-2, the antibody that stains the
four nociceptive neurons in each standard
ganglion binds to only two neurons in the fifth
and sixth segmental ganglia. Physiological studies
which Susan Hockfield and I started during the
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1981 Leech neurophysiology course have shown
that the two neurons recognized by Lan3-2 in
these two ganglia are similar in many ways to
nociceptor neurons in other ganglia.
Intracellular electrophysiological studies con-
firmed the immunocytochemical observation that
only a single pair of N cells can be found in
ganglia 5 and 6. Physiologically, these cells are
similar to other N cells in action potential
characteristics and in their ability to be an-
tidromically activated by stimulating peripheral
roots. Intracellular injections of tracers showed
that anatomically they are also similar to other N
cells in their axonal projections into the connec-
tive and roots and in the shape and distribution of
axonal arbors. However, a major difference exists
in the peripheral fields of innervation of these
cells. Normally, each N cell innervates the skin of
an entire segment. Each N cell in ganglia 5 and 6
innervates only a very small area of skin within a
segment. The remaining areas are fully innervated
by N cells in the next two more-rostral and more-
caudal ganglia. These observations suggest that
molecular characteristics of N cells recongized by
antibody Lan3-2 may be independent of
receptive-field characteristics but could be
related to other features of N cells that distinguish
them from other neurons. These features might in-
clude mechanisms by which action potential size
and shape are determined (i.e., ionic channels), by
which neuron cell body or axon position is deter-
mined, or other features, as yet unexplored, such
as common neurotransmitter or embryological
origin.
Embryology
We have used the antibody Lan3-2, to determine
when in the development of the nervous system
crossreacting antigens are first expressed. In con-
trast to other monoclonal antibodies specifically
raised against leech embryos, Lan3-2 first binds to
leech embryos at stage 8. This stage, which is
equivalent to gastrulation, is the time at which
segmental organization of the animal first
becomes apparent. The antibody recognizes an
antigen in the ectodermal germinal bands that
will give raise to the nervous system and also in
the micromere cap which is of mesodermal origin.
Biochemical characterization will tell us how
similar the antigens present at this early stage in
development are to those found in the adult nerv-
ous system. Our preliminary observations already
show that antigenically related molecules occur
in cells that are mesodermally derived and not
destined to form part of the nervous system.
In addition to using the antibodies generated
against the adult nervous system to ask develop-
mental questions, with the collaboration of
D. Weisblat (University of California, Berkeley) we
are beginning to raise monoclonal antibodies
specifically against early embryonic stages of the
leech. In the first series of hybridoma cell lines to
be screened, most of the antibodies stained leech
embryos uniformly, but one line secreted an an-
tibody that recognizes an antigen that is apparent-
ly restricted to ectodermal and mesodermal
precursor cells. We hope to find more antibodies
that identify differentiation antigens of the neural
ectoderm. As with the adult nervous system, we
hope that a better understanding of the cellular
distribution of specific molecules will lead to an
insight into the mechanisms that first differentiate
neurons from other cells.
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Single-channel Recording Workshop, July 1 -lily 19
INSTRUCTORS
Patlak, Joseph, Ph.D, University of Vermont, Burlington
Horn, Richard, Ph.D., University of California, Los Angeles
Sigworth, Frederick, Ph.D., Max-Planck-Institute, Goettingen, Federal Republic of Germany
Corey, David, Ph.D., Yale University, New Haven, Connecticut
Jackson, Meyer, Ph.D., University of California, Los Angeles
The Single-channel Recording workshop gave the opportunity for 11 investigators with previous electro-
physiology experience to learn the patch-clamp technique for recording the currents through single-
membrane channels. Each of the five instructors set up a single-channel recording system for use during
the workshop. Students ranged in experience from the graduate to the established investigator level.
Lecture material presented by the instructors included extensive discussion of the techniques for ob-
taining high quality recordings, with special emphasis on minimizing the background noise and increas-
ing the frequency response of the patch-clamp circuit. The 'tricks' for making electrodes, establishing
gigohm seals, excising membrane, and recording from whole cells were demonstrated and practiced on
the five different recording set-ups. The technique was applied successfully to a variety of prepara-
tions, including neuroblastoma, photoreceptor, smooth muscle, pituitary cells, and neurons dissociated
from cortex, spinal cord, and sympathetic ganglion. Methods for the analysis of single-channel data
were also discussed and demonstrated.
PARTICIPANTS
Dani, John A., Ph.D., University of Washington, Seattle
Dubinsky, Janet, B.S., University of North Carolina, Chapel Hill
French, Robert J., Ph.D., University of Maryland, Baltimore
Hahin, Richard, Ph.D., University of Iowa, Iowa City
Horn, John P., Ph.D., Harvard Medical School, Boston, Massachusetts
Levis, Richard, M.S., Rush University, Chicago, Illinois
Nowak, Linda M., Ph.D., University of Michigan, Ann Arbor
Schwartz, Eric A., M.D., University of Chicago, Illinois
Serrano, Elba E., Ph.D., Stanford Medical School, California
Singer, Joshua J., Ph.D., University of Massachusetts, Worcester
Walsh, John V., Jr., M.D., University of Massachusetts, Worcester
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Electrophysiology of the Mammalian Brain Slice
August 12-August 25
INSTRUCTORS
Kelly, John S., Ph.D., St. George's Medical School, University of London, England
Andersen, Per, M.D., University of Oslo, Norway
Wilson, Wilkie A., Ph.D., Duke University, Durham, North Carolina
Alger, Bradley E., Ph.D., University of Maryland, College Park
ASSISTANTS
Crunelli, Vincenzo, Ph.D., St. George's Medical School, University of London, England
ladarole, Michael, Ph.D., Duke University, Durham, North Carolina
In this course students were acquainted with a variety of approaches to the electrophysiological study
of the in vitro mammalian brain slice, with emphasis on the hippocampal slice. Five experimental set-
ups were operated. In addition to a general focus on intracellular recording techniques, special pro-
cedures represented were: (1) extracellular methods for analysis of synaptic pathways and response
plasticity (Andersen); (2) analysis of drug and neurotransmitter actions using iontophoretic (Kelly and
Crunelli) or constant perfusion bath application (Alger) methods; (3) single-electrode voltage-clamp
recording (Wilson and ladarola).
After an orientation period with one instructor in which pairs of students gained practice preparing
and then stimulating and recording hippocampal slices, students rotated through all of the other
laboratories. By the end of the course every student had successfully demonstrated an ability to
prepare slices and to record intracellularly from cells in the hippocampal slice. In the evenings
seminars were given by the instructors and on weekends students presented summaries of their own
previous work. During the second week of the course students were encouraged to pursue individual
projects with a minimum of supervision from the instructors. These projects included studies of the
pharmacological effects of norepinephrine as well as extensions of the slice technique to other brain
areas, including the lateral geniculate nucleus.
PARTICIPANTS
Jackson, Meyer B., of California, Los Angeles
Martin, Michael R., Ph.D., National Institutes of Health, Bethesda, Maryland
Moore, Scott D., B.A., University of Virginia, Charlottesville
Neuman, Richard S., Ph.D., Memorial University, St. John's, Newfoundland, Canada
Rogawski, Michael A., Ph.D., National Institutes of Health, Bethesda, Maryland
Sanders, David J., Ph.D., University of Newcastle-upon-Tyne, England
Seifert, Wilfried, Ph.D., Max-Planck-Institute, Tubingen, Federal Republic of Germany
Smock, Timothy K., B.A., University of California, San Francisco
Vallano, Mary Lou, Ph.D., Sloan-Kettering Institute, New York, New York
SEMINARS
Andersen, P., University of Oslo. Anatomy of the hippocampal slice.
. Physiology of the hippocampal slice.
Kelly, J.S., University of London. Analysis of neurotransmitter actions-Classical neurotransmitters.
Analysis of neurotransmitter actions- Neuropeptides.
Alger, B.E., University of Maryland. Somatic and dendritic inhibition in the hippocampus.
Wilson, W.A., Duke University. Time-sharing single-electrode voltage clamp-Theory and practice.
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46th Cold Spring Harbor
Symposium onQuantitative Biology
Organization of the Cytoplasm, May 27-June 3
Any serious scientist working with cells must of necessity view them with awe. Even the relatively
simple cells of E. coli have the potential to make as many as 2000 different proteins and at least this
number must be found at a given time in any eukaryotic cell. While we now know the main
biochemical pathways through which cells utilize the energy of food (the sun) first to make cellular
building blocks and later to polymerize them into macromolecules, it is highly probable that for any
given cell the majority of its molecules have not yet been named, much less ascribed functional
roles. Of necessity, we have largely concentrated on molecules present in relatively large numbers
per cell, always attempting to understand vital cell functions (e.g., cell motility) in terms of their
properties. We know, however, that even the best of our hypotheses are likely to be incomplete and
that the understanding of the cell at the molecular level will have many many surprises to offer.
Until very recently the most fruitful approach for cell biologists has been to use microscopes to
probe directly the morphology of cells, and with the advent of the electron microscope in the 1950s,
our better cell biologists have had their field days. Happily, one after another of the objects (orga-
nelles) they have discovered (e.g., microtubules) have been dissected at the molecular level, and by
now the distinction between the cell biologist and the biochemist is fading fast. The younger
generation of cell biologists, in particular, know that they themselves must do much of the necessary
biochemistry, with their careers in jeopardy were they to depend upon help from card-carrying
biochemists. At the same time, many of our most astute biochemists know that most of their
traditional goals are near complete solutions and that only by taking on the complexities of cell
movement, cell differentiation, and cell division will their future lives remain exciting.
The time had thus arrived to hold our annual Symposium on cells, focusing it on "The Organiza-
tion of the Cytoplasm," knowing that we had to exclude the nucleus or we would be holding
another Symposium on the gene. In organizing this Symposium, we sought the advice of many
experts and, in particular, we wish to thank Gunter Blobel, Daniel Branton, Bill Brinkley, Werner
Franke, Howard Green, Robert D. Goldman, Marc Kirschner, Keith Porter, Peter Satir, John Singer,
Frank Solomon, Klaus Weber, and K. Wolfarth-Bottermann. The formal program contained 93
presentations to which the reports of several last minute presentations have been added. The total
attendance was 234, a smaller number than usual, but one dictated by our desire to have virtually
everyone view the meeting in person as opposed to looking at electron micrographs imperfectly
through closed-circuit T.V.
The most necessary financial support that let us invite so many participants was again provided by
the National Institutes of Health, the National Science Foundation, and the Department of Energy.
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Welcoming Remarks: J. D. Watson, Cold Spring Harbor Laboratory
Session 1: Principles of Organization: Functional and Spatial Order in the Cytoplasm
Chairperson: H. Huxley, MRC Laboratory of Molecular Biology, Cambridge, England
E. Racker, Section of Biochemistry, Molecular and Cell Biology, Cornell University, Ithaca, New
York: A protein kinase cascade activated by transformation.
D. Branton, Dept. of Cell and Developmental Biology, The Biological Laboratories, Harvard Univer-
sity, Cambridge, Massachusetts: Evaluating cytoskeleton-membrane interactions.
G. Blobel, Laboratory of Cell Biology, Rockefeller University, New York, New York: Regulation of
intracellular protein traffic.
F. Solomon, Dept. of Biology and Center for Cancer Research, Massachusetts Institute of Technol-
ogy, Cambridge: Organization of the cytoplasm for motility.
Session 2A: Principles of Organization: Water and the Cytoplasmic Architecture
Chairperson: R. Allen, Dartmouth College, Hanover, New Hampshire
J. S. Clegg, Laboratory for Quantitative Biology, University of Miami, Coral Gables, Florida: Interre-
lationships between water and cell metabolism in Artemia cysts. IX. Further metabolic studies and
D20 substitution.
J. W. Wojcieszyn,1 R. A. Schlegel,2 and K. A. Jacobson,"Dept. of Anatomy, University of North
Carolina, Chapel Hill; 2Molecular and Cell Biology Program, Pennsylvania State University, Uni-
versity Park: Measurements of the diffusion of macromolecules injected into the cytoplasm of
living cells.
G. Albrecht-Buehler, Cold Spring Harbor Laboratory, New York: Is blebbing of the cell surface
caused by liquid streams inside cells?
K. R. Porter and K. Anderson, Dept. of Molecular, Cellular, and Developmental Biology, University
of Colorado, Boulder: The cytoplasmic matrix of frozen-dried cells shows the same morphology
as that in glutaraldehyde fixed cells.
M. Schliwa and J. van Blerkom, Dept. of Molecular, Cellular, and Developmental Biology, University
of Colorado, Boulder: Structural organization of the cytoplasm.
Session 2B: Elements of Organization: Microtubules I
C. Silflow, J. Schloss, T. McKeithan, L. Keller, and J. Rosenbaum, Dept. of Biology, Yale University,
New Haven, Connecticut: Expression of flagellar protein genes during flagellar regeneration in
Chlamydomonas.
D. W. Cleveland, Dept. of Physiological Chemistry, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Examination of the genes coding for a and /3 tubulin.
P. Wensink and L. Kalfayan, Dept. of Biology, Rosenstiel Basic Medical Sciences Research Center,
Brandeis University, Waltham, Massachusetts: The structure and expression of the Drosophila
-tubulin gene family.
Session 3: Cell Surface: Surface Organization
Chairperson: J.-P. Revel, California Institute of Technology, Pasadena
J. P. Revel, B. N. Nicholson, S. B. Yancey, and D. J. Meyer, California Institute of Technology, Pasad-
ena: The hepatic gap junction.
E. L. Hertzberg and N. B. Gilula, Rockefeller University, New York, New York: Studies on mammal-
ian gap junctions.
V. Bennett, Dept. of Cell Biology and Anatomy, Johns Hopkins University School of Medicine,
Baltimore, Maryland: The molecular basis for membrane-cytoskeleton associations in human
erythrocytes.
R. O. Hynes, A. T. Destree, and D. D. Wagner, Center for Cancer Research, Massachusetts Institute
of Technology, Cambridge: Relationships between microfilaments, cell-substratum adhesion,
and fibronectin.
B. Geiger, Dept. of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel:
Substrate-attached membranes of cultured cells.
R. A. Bloodgood, Dept. of Anatomy, University of Virginia School of Medicine, Charlottesville: The
flagellum as a model system for studying dynamic cell surface events.
T. Roberts' and S. Ward,' 'Dept. of Biological Science, Florida State University, Tallahassee; 'Dept. of
Embryology, Carnegie Institution of Washington, Baltimore, Maryland: Directed membrane flow
on the pseudopods of C. elegans spermatozoa.
Session 4: Mechanisms of Organization: Cytoplasmic and Axonal Flow
Chairperson: N. Kamiya, National Institute for Basic Biology, Okazabi, Japan
S. Higashi-Fujime, Institute of Molecular Biology, Nagoya University, Japan: Active movement of
bundles composed of muscle F-actin and myosin filaments-A simple model system for nonmus-
cle cell motility.
N. Kamiya, Y. Yoshimoto, and F. Matsumura, Dept. of Cell Biology, National Institute for Basic
Biology, Okazaki, Japan: Contraction-relaxation cycle of Physarum cytoplasm-Concomitant
changes in intraplasmodial ATP and Ca' concentrations.
R. D. Allen," J. L. Travis,' J. Hayden,' N. S. Allen,' and A. C. Breuer,' 'Dartmouth College, Hanover,
New Hampshire; 'Cleveland Clinic, Ohio: Cytoplasmic transport systems in eukaryotic cells.
K. E. Wohlfarth-Bottermann and I. Block, Institute of Cytology, University of Bonn, Federal Republic
of Germany: The function of cytoplasmic flow in photosensory transduction and phase regulation
of contractile activities in Physarum.
D. Taylor, J. Heiple, Y.-L. Wang, E. Luna, L. Tanasugarn, J. Brier, J. Swanson, M. Fechheimer, P.
Amato, and M. Rockwell, Dept. of Cell and Developmental Biology, Harvard University, Cam-
bridge, Massachusetts: Cellular and molecular aspects of amoeboid movement.
R. J. Lasek and S. T. Brady, Dept. of Anatomy and Neurobiology Center, Case Western Reserve,
Cleveland, Ohio: The Axon-A prototype for studying expressional. cytoplasm.
H. Thoenen, M. Schwab, and R. Neumann, Dept. of Neurochemistry, Max-Planck-Institute of Psy-
chiatry, Martinsried, Federal Republic of Germany: Physiological importance and site of action of
nerve growth factor (NGF) reaching the perikaryon of adrenergic neurons by retrograde axonal
transport.
L. B. Chen, I. C. Summerhayes, L. V. Johnson, M. L. Walsh, S. D. Bernal, and T. J. Lampidis, Sidney
Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts: Probing mitochondria
in living cells with Rhodamine 123.
Session 5: Poster Session
R. D. Allan,' J. L. Travis,' J. Hayden,' N. S. Allen,' and A. C. Breuer,' 'Dartmouth College, Hanover,
New Hampshire; 'Cleveland Clinic, Ohio: Cytoplasmic transport systems in eukaryotic cells.
J. Avila, A. Villasante, and M. M. Valdivia, CSIC-UAM, Universidad Autonoma de Madrid, Spain:
Binding of microtubule associated protein MAP, to chromosome components.
S.T. Brady and R.J. Lasek, Dept. of Anatomy, Case Western Reserve University, Cleveland, Ohio:
Axonal microtubules-A special class of brain microtubules.
D. J. Goldberg,' D. Harris,' and J. H. Schwartz,' 'Dept. of Pharmocology and 'Dept. of Physiology,
Columbia University College of Physicians and Surgeons, New York, New York: Studies on the
mechanism of fast axonal transport using microinjection into single giant neurons.
S. B. Horowitz, Dept. of Biology, Michigan Cancer Foundation, Detroit, Michigan: Reference phase
analysis of cytoplasm.
E.-M. Mandelkow,1 E. Mandelkow,1 and J. Bordas,2 1Max-Planck-Institute for Medical Research,
Heidelberg; 'European Molecular Biology Laboratory, Hamburg, Federal Republic of Germany:
Structural transitions during microtubule assembly studied by time-resolved X-ray scattering.
F. Matsumura and J. J.-C. Lin, Cold Spring Harbor Laboratory, New York: Monoclonal antibodies to
tropomyosin decorate native thin filaments with 38NM periodicity.
J. R. Morris and R.J. Lasek, Dept. of Anatomy, Case Western Reserve University, Cleveland, Ohio
and Marine Biological Laboratory, Woods Hole, Massachusetts: Measurements of the concentra-
tions of tubulin and actin as monomer and polymer in the axon.
J. Parness and S. B. Horwitz, Depts. of Molecular Pharmacology and Cell Biology, Albert Einstein
College of Medicine, Bronx, New York: Taxol binds to polymerized tubulin.
D. Paulin, C. Babinet, H. Jakob, and F. Jacob, Service de Genetique cellulaire du College de France
and de l'Institut Pasteur, Paris: Intermediate-filaments as markers of mouse early development
and teratocarcinoma cell differentiation.
H. Ponstingl, M. Little, E. Krauhs, T. Kempf, W. Ade, and R. Hofer-Warbinek, Institute of Cell and
Tumor Biology, German Cancer Research Center, Heidelberg, Federal Republic of Germany:
Amino acid sequence of a- and/3- tubulin from pig brain.
F. C. S. Ramaekers,1 I. Dunia,2 E. L. Benedetti,' and H. Bloemenda1,1 'Dept. of Biochemistry, Univer-
sity of Nijmegen, The Netherlands; 'Institut de Biologie Moleculaire CNRS, University of Paris,
France: Lenticular intermediate-sized filament protein, its identification, biosynthesis, and inter-
action with the plasma membrane.
F. C. S. Ramaekers,1 P. H. K. Jap,2 and G. P. Vooijs,1 'Dept. of Pathology and 'Dept. of Cytology and
Histology, University of Nijmegen, The Netherlands: The use of antibodies directed against inter-
mediate filaments in the characterization of human malignant tumors.
D. D. Sabatini, M. A. Adesnik, G. Kreibich, T. Morimoto, D. Colman, J. Sherman, and E. Sabban,
Dept. of Cell Biology, New York University School of Medicine, New York: Biosynthesis of plasma
membrane proteins.
J. L. Salisbury, J. S. Condeelis, N. J. Maihle, and P. Satir, Dept. of Anatomy, Albert Einstein College of
Medicine, Bronx, New York: Calmodulin redistributes during capping of cell surface receptors.
I. V. Sandoval' and J. Vanderkerckhove,2 'California Institute of Technology, Pasadena; 'Laboratory
of Histology and Genetics, Gent, Belgium: A comparative study on the capacity of MAP2 and Tau
to promote microtubule polymerization and to bind to microtubules.
E. Schulze' and S. Blose ,2 1 Dept. of Molecular Biology, University of California, Berkeley; 'Cold
Spring Harbor Laboratory, New York: Maintenance of cytoplasmic continuity to small molecules
between daughter cells after mitosis.
R. Singer and J. Pudney, Dept. of Anatomy, University of Massachusetts Medical School, Worcester:
Morphomolecular basis of muscle differentiation.
R. W. Tucker,' L.-H. Liawa,2 and M. W. Berns,' 'Johns Hopkins Oncology Center, Baltimore, Mary-
land; 'University of California, Irvine: DNA synthesis and centriole duplication in PTK2 cells.
J. A. Weatherbee,1 P. Sherline,2 R. N. Mascardo,2 J. G. Izant,3 R. B. Luftig,4 and R. R. Weihing, 1
'Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts; 'University of Con-
necticut Health Center, Farmington; 3University of Colorado, Boulder; 4University of South
Carolina School of Medicine, Columbia: Microtubule-associated protein of HeLa cells.
Session 6: Elements of Organization: Intermediate Filaments I
Chairperson: H. Green, Massachusetts Institute of Technology, Cambridge
H. Green, Dept. of Biology, Massachusetts Institute of Technology, Cambridge: Differentiated
structural elements in the keratinocyte.
E. H. Ball and S. J. Singer, Dept. of Biology, University of California, La Jolla: Correlations of the
distributions of microtubules and intermediate filaments, and of microtubules and mitochondria,
in cultured cells as determined by double immunofluorescence microscopy.
R. Goldman,1 A. Goldman,' J. Jones," J. Talian,1 P. Steinert,2 M. Whitman-Aynardi,1 S. Yuspa,2 and R.
Zackroff," 1Dept. of Cell Biology and Anatomy, Northwestern University, Chicago, Illinois; 'NCI,
National Institutes of Health, Bethesda, Maryland: Organization and functions of intermediate
filaments (IF).
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H. Holtzer, G. Bennett, S. Tapscott, and J. Croop, Dept. of Anatomy, University of Pennsylvania
Medical School, Philadelphia: Variations in the protein subunits of the intermediate-sited fila-
ments associated with differentiation.
M. Shelanski, R. Liem, and J.-F. Leterrier, Dept. of Pharmacology, New York University School of
Medicine, New York: Neurofilament chemistry and interactions with microtubules.
E. Lazarides, B. L. Granger, D. L. Gard, R. H. Gomer, and J. Breckler, Division of Biology, California
Institute of Technology, Pasadena: Steps in the assembly of the Z-disc in muscle cells.
J. E. Celis,1 R. Bravo,' J. V. Small,2 J. Fey; and P.M. Larsen,' 'Dept. of Chemistry, Aarhus University,
Denmark;2 Institute of Molecular Biology, Austrian Academy of Sciences, Salzburg: Modification
of vimentin polypeptides during mitosis.
Session 7: Elements of Organization: Microfilaments I
Chairperson: K. Wohlfarth-Bottermann, University of Bonn, Federal Republic of Germany
E. A. Fyrberg; B. J. Bond,2 N.D. Hershey,' K. S. Mixter,2 and N. Davidson,' 'Dept. of Chemistry,
2Division of Biology, California Institute of Technology, Pasadena: The actin genes of Drosophila-
Protein coding regions are highly conserved but intron positions are not.
M. McKeown and R. A. Firtel, Dept. of Biology, University of California, San Diego, La Jolla: The
actin multigene family of Dictyostelium.
S. H. Hughes, J. Sorge, J. P. Thomas, J. Feramisco, L. Chow, and J. Garrels, Cold Spring Harbor
Laboratory, New York: Approaches for isolating genes encoding the cytoskeletal proteins and for
reintroducing the genes into cultured cells.
T. D. Pollard, U. Aebi, J. A. Cooper, W. E. Fowler, and P. Tseng, Dept. of Cell Biology and Anatomy,
Johns Hopkins Medical School, Baltimore, Maryland: Actin structure, polymerization, and
gelation.
L. Tilney" and D. DeRosier,2 'Dept. of Biology, University of Pennsylvania, Philadelphia; 2Brandeis
University, Rosenstiel Center, Waltham, Massachusetts: How actin filaments pack into bundles.
K. Weber and J. R. Glenney, Jr., Max-Planck-Institute for Biological Chemistry, Gottingen, Federal
Republic of Germany: Calcium control of microfilament assembly and turnover.
J. A. Spudich, P.A. Simpson, J. Pardee, L. Stryer, S. S. Brown, K. Yamamoto, A. Weeds, and E. R.
Kuczmarski, Dept. of Structural Biology, Fairchild Center, Stanford University, California: Control
of assembly of Dictyostelium actin and myosin
Session 8: Cell Surface: Clathrin
Chairperson: M. Brown, University of Texas Health Science Center, Dallas
M.S. Bretscher, MRC Laboratory of Molecular Biology, Cambridge, England: Surface uptake by
fibroblasts and its consequences.
M.S. Brown and J. L. Goldstein, Dept. of Molecular Genetics, University of Texas Health Science
Center, Dallas: Genetic studies of the low density lipoprotein receptor.
E. Ungewickell, E. R. Unanue, and D. Branton, Dept. of Cell and Developmental Biology, The
Biological Laboratories, Harvard University, Cambridge, Massachusetts: An investigation of the
structure of clathrin and its membrane interaction.
J. Wehland, M. C. Willingham, R. Dickson, and I. Pastan, Laboratory of Molecular Biology, NCI,
National Institutes of Health, Bethesda, Maryland: Microinjection of anti-clathrin antibodies into
fibroblasts does not interfere with the receptor-mediated endocytosis of a2-macroglobulin.
T. A. Libermann, B.A. Imhof, and W. Birchmeier, Laboratorium fLir Biochemie, Federal Institute of
Technology (ETH), Zurich, Switzerland: Transport of newly synthesized cellular glycoproteins
(e.g. fibronectin) from the endoplasmic reticulum to the golgi to the plasma membrane via coated
vesicles.
Session 9: Elements of Organization: Microtubules II
Chairperson: P. Satir, Albert Einstein College of Medicine, Bronx, New York
M. W. Kirschner' and D. W. Cleveland,' 'Dept. of Biochemistry and Biophysics, University of Califor-
nia Medical Center, San Francisco; 2Dept. of Physiological Chemistry, Johns Hopkins University
School of Medicine, Baltimore, Maryland: The regulation of tubulin monomer levels in the
cell-Evidence for transcriptional control and implications for spatial organization of microtubules.
G.G. Borisy, University of Wisconsin, Madison: How microtubules lengthen, shorten, and also
treadmill in the steady-state.
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L. 'ilson," K. W. Farrell) M. A. Jordan,' and R. L. Margolis,2 1Dept. of Biological Sciences, University
California, Santa Barbara; 2Hutchinson Cancer Research Center, Seattle, Washington: Microtu-
bule treadmills-Possible molecular machinery.
L. T. Haim& and B. R. Telzer,2 1Dept. of Biology, University of California, Riverside; 2Dept. of Biol-
ogy, Pomona College, Claremont, California: Dynein binding to spindle microtubules.
M. de Brabander, G. Geuens, R. Nydens, R. Willebrords, and J. De Mey, Laboratory of Oncology,
Janssen Pharmaceutica Research Laboratories, Beerse, Belgium: Microtuble stability and assembly
in living cells-The influence of metabolic inhibitors, taxol and pH.
B. R. Brinkley,' S. L. Brenner,' D. A. Pepper,2 and R. L. Pardue,"Dept. of Cell Biology, Baylor College
of Medicine, Houston, Texas; 2Laboratory of Molecular Biology, University of Wisconsin, Madi-
son: Tubulin assembly sites and the organization of microtubule arrays in mammalian cells.
M. Chalfie and J. N. Thomson, MRC Laboratory of Molecular Biology, Cambridge, England: Microt-
ubule structure in C. elegans neurons.
A.S. Bajer and J. Mole-Bajer, Dept. of Biology, University of Oregon, Eugene: Microtubule (MT)
arrays in enucleated cell fragments and characteristics of asters in standard amphiastral (animal)
and anastral (higher plant) spindles.
Session 10: Mechanisms of Organization: Calcium-regulation and Phosphorylation of
Cytoplasmic Components
Chairperson: E. Racker, Cornell University, Ithaca, New York
R. W. Wallace, E. A. Tallant, and W. Y. Cheung, Dept. of Biochemistry, St. Jude Children's Research
Hospital, and University of Tennessee Center for the Health Sciences, Memphis: Calmodulin-A
multifunctional modulator protein of Ca'+-regulated cellular functions.
A. R. Means, J. G. Chafouleas, W. Bolton, and A. E. Boyd III, Dept. of Cell Biology, Baylor College of
Medicine, Houston, Texas: Calmodulin may regulate the GIS transition during the growth cycle
of mammalian cells.
A. H. Lockwood, D. Trivette, and M. Pendergast, Laboratories for Cell Biology, University of North
Carolina, Chapel Hill: Association of cAMP and calcium-dependent protein kinases with the
cytoskeleton-Implications for motility, transformation, and cytoplasmic organization.
R. S. Adelstein, M. D. Pato, P. de Lanerolle, J. R. Sellers, and M. A. Conti, NHLBI, National Institutes
of Health, Bethesda, Maryland: Regulation of contractile proteins by reversible phosphorylation.
J. M. Scholey and J. Kendrick-Jones, MRC Laboratory of Molecular Biology, Cambridge, England:
Regulation of myosin filament assembly by light chain phosphorylation.
B. Sefton,' T. Hunter,' and J. Singer,2 'Tumor Virology Laboratory, Salk Institute, San Diego, Califor-
nia; 2Dept. of Biology, University of California, San Diego: Cytoskeletal targets for viral transform-
ing proteins.
L. Rohrschneider, M. Rosok, and K. Shriver, Fred Hutchinson Cancer Research Center, Seattle,
Washington: On the mechanism of transformation by Rous sarcoma virus-Events within adhe-
sion plaques.
Session 11: Elements of Organization: Intermediate Filaments
Chairperson: M. Osborn, Max-Planck-Institute, Gottingen, Federal Republic of Germany
E. B. Lane, Imperial Cancer Research Fund, London, England: Variability in tonofilaments, with a
possible marker for squamous cell transformation.
B. S. Eckert and R. A. Daley, Dept. of Anatomical Sciences, State University of New York, Buffalo: In
vivo disruption of the cytokeratin cytoskeleton in cultured epithelial cells-Microinjection of
antikeratin.
M. Osborn, N. Geisler, G. Shaw, and K. Weber, Max-Planck-Institute for Biophysical Chemistry,
Gottingen, Federal Republic of Germany: Expression and regulation of intermediate filaments.
W. W. Franke, E. Schmid, E.-D. Jarasch, D. L. Schiller, J. Stadler, S. Winter, R. Moll, M. Williams, R.
Sommer, J. Kartenbeck, and G. Krohne, Institute of Cell and Tumor Biology, German Cancer
Research Center, Heidelberg, Federal Republic of Germany: Differentiation specificity of expres-
sion of protein constituents of "insoluble" cytoskeletal elements.
P. Steinert,1 W. Idler; M. Aynardi,2 R. Zackroff,2 and R. Goldman2 'Dermatology Branch, NCI,
National Institutes of Health, Bethesda, Maryland; 2Dept. of Biological Sciences, Carnegie-Mellon
University, Pittsburg, Pennsylvania: Heterogeneity of intermediate filaments assembled in vitro.
G. Wiche, M. Baker, and F. Leichtfried, Institute of Biochemistry, Universityof Vienna, Austria: Book
polypeptides are components of cultured cell cytoskeletons and interact with vimentin contain-
ing filaments in vitro.
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M.S. Runge and R. C. Williams, Jr., Dept. of Molecular
Biology, Vanderbilt University, Nashville,
Tennessee: Formation of a microtubule-neurofilament
complex in vitro.
Session 12: Cell Surface: Synthesis,
Exocytosis, Endocytosis
Chairperson: D. Sabatini, New York University School
of Medicine, New York
S.C. Silverstein, J. Michl, J. Loike, and J.
Unkeless, Laboratory of Cellular Physiology and Immunol-
ogy, Rockefeller University, New York: On the mechanism of phagocytosis.
A. Novikoff and P. Novikoff, Dept. of Pathology, Albert Einstein College of Medicine, Bronx, New
York: The Golgi-apparatus; Conventional wisdom.
H. F. Lodish, W. Braell, S. Fridovich, M. Porter, D. Rup, A. L. Schwartz, and A. Zilberstein, Dept. of
Biology, Massachusetts Institute of Technology, Cambridge: Synthesis and assembly of the VSV
glycoprotein, the erythrocyte anion transport protein, and the hepatic receptor for asialogly-
coproteins.
J. E. Rothman, E. Fries, and W. Dunphy, Dept. of Biochemistry, Stanford University, California:
Intracellular transport of the vesicular stomatitis viral glycoprotein in cells and in cell-free systems'
D. D. Sabatini, M. A. Adesnik, G. Kreibich, T. Morimoto, D. Colman, J. Sherman, and E. Sabban,
Dept. of Cell Biology, New York University School of Medicine, New York: Biosynthesis of plasma
membrane proteins.
H. Pollard, C. Creutz, C. Pazoles, J. Scott, and V. Fowler, NIAMDD, National Institutes of Health,
Bethesda, Maryland: Regulation of organelle movement, membrane fusion, and exocytosis in the
chromaffin cell.
A. Helenius, M. Marsh, K. Matlin, H. Reggio, K. Simons, and J. White, European Molecular Biology
Laboratory, Heidelberg, Federal Republic of Germany: Are lysosomes the site of virus entry?
Session 13: Elements of Organization: Microfilaments II
Chairperson: K. Weber, Max-Planck-Institute, Gottingen, Federal Republic of Germany
K. E. Wohlfarth-Bottermann and W. Stockem, Institute of Cytology, University of Bonn, Federal
Republic of Germany: Fine structure and organization of microfilaments in Physarum as revealed
by chemical fixation and freeze-etching.
T. Stossel, K. Zaner, J. Hartwig, H. Yin, and F. Southwick, Dept. of Medicine, Harvard Medical
School, Boston, Massachusetts: Effects of macrophage cytoplasmic proteins on actin consistency.
J. Condeelis, Albert Einstein Colllege of Medicine, Bronx, New York: Composition, structure, and
function of the cortical actin lattice.
A. Asano and N. Mimura, Institute for Protein Research, Osaka University, Japan: Actinogellin, a
calcium-sensitive microfilament regulatory protein.
K. Burridge and J. R. Feramisco, Cold Spring Harbor Laboratory, New York: Nonmuscle a-actinins-
Calcium sensitive actin-binding proteins.
J. V. Small, Institute of Molecular Biology, Austrian Academy of Sciences, Salzburg: Organization of
actin in the leading edge of cultured cells-Influence of osmium tetroxide and dehydration on
the ultra-structure of actin meshworks.
B. M. Jockuschl and G. Isenberg,2 1European Molecular Biology Laboratory, Heidelberg; 2Max-
Planck-Institute for Psychiatry, Munich, Federal Republic of Germany: Interaction of a-actinin
and vinculin with actin-Opposite effects on filament network formation.
S. Lin, D. C. Lin, M. Grumet, D. H. Cribbs, J. A. Wilkins, and W. W. Magargal, Dept. of Biophysics,
Johns Hopkins University, Baltimore, Maryland: Effects of actin-containing complexes and pro-
teins with cytochalasin-like activity on the assembly of actin filaments in vitro.
Session 14: Cell Surface: Microvilli
Chairperson: L. Tilney, University of Pennsylvania, Philadelphia
P. T. Matsudaira and D. R. Burgess, Dept. of Biology, Dartmouth College, Hanover, New Hampshire:
The organization of the brush border cytoskeleton.
M. Mooseker, T. Keller, C. Howe, K. Wharton, and B. Grimwade, Dept. of Biology, Yale University,
New Haven, Connecticut: Regulation of contractility, cytoskeletal structure, and filament assem-
bly in the brush border.
A. Bretscher, Dept. of Cell Biology, University of Texas Health Science Center, Dallas: Purification of
villin and fimbrin from brush borders and their interaction with F-actin in vitro.
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D. Louvard, E. Coudrier, and H. Reggio, European Molecular Biology Laboratory, Heidelberg,
Federal Republic of Germany: Occurence in skeletal muscle of antigens related to the 110K and
140K protein of intestinal microvilli.
Session 15: Nucleus and Cytoplasm
Chairperson: A. Novikoff, Albert Einstein College of Medicine, Bronx, New York
L. Gerace1 and G. Blobel,2 1Dept. of Cell Biology and Anatomy, Johns Hopkins University School of
Medicine, Baltimore, Maryland; 2Laboratory of Cell Biology, Rockefeller University, New York,
New York: The nuclear lamina as a framework for the structural organization of the nuclear
envelope.
J. E. Mullet, A. R. Grossman, and N.-H. Chua, Rockefeller University, New York, New York: Post-
translational transport and assembly of chloroplast polypeptides.
G. P. Thomas, W. J. Welch, M. B. Mathews, and J. R. Feramisco, Cold Spring Harbor Laboratory, New
York: Molecular and cellular effects of heat shock and related treatments of mammalian tissue
culture cells.
E. Wang, D. S. Roos, and P. W. Choppin, Rockefeller University, New York, New York: Function of
cytoplasmic fibers in syncytia.
S. Penman, A. Fulton, D. Capco, C. F. Tse, and M. Cervera, Dept. of Biology, Massachusetts Institute
of Technology, Cambridge: The cytoskeletal and nuclear architecture-Form, functions and
mode of assembly.
Summary: W. Brinkley, Baylor College of Medicine, Houston, Texas
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SUMMER MEETINGS
C. elegans, May 6-May 10
Arranged by Samuel Ward, Carnegie Institution of Washington, Robert Herman, University of
Minnesota, Robert Horvitz, Massachusetts Institute of Technology, Gunther von Ehrenstein, Max-
Planck-Institute for Experimental Medicine
143 participants
Opening Remarks: S. Ward, Carnegie Institution of Washington, Baltimore, Maryland
Session 1: Genes and Developmental Lineage
Chairperson: J. Sulston, MRC Laboratory of Molecular Biology, Cambridge, England
M. Chalfie, J. E. Sulston, E. Hedgecock, J. N. Thomson, and K. Buck, MRC Laboratory of Molecular
Biology, Cambridge, England: Touch-insensitive mutants.
C. Ferguson, I. Greenwald, P. Sternberg, N. Tsung, and R. Horvitz, Dept. of Biology, Massachusetts
Institute of Technology, Cambridge: Mutations affecting vulva development in C. elegans.
E. Hedgecock, A. Otsuka, and C. Coulondre, MRC Laboratory of Molecular Biology, Cambridge,
England: Direct isolation of cell lineage mutants.
P. Sternberg and R. Horvitz, Dept. of Biology, Massachusetts Institute of Technology, Cambridge:
Postembryonic cell lineages of Panagrellus redivivus.
Session 2: Muscles and Genes
Chairperson: R. H. Waterston, Washington University, St. Louis, Missouri
J. Karn, A. R. Macleod, and S. Brenner, MRC Laboratory of Molecular Biology, Cambridge, England:
Molecular studies of the unc-54 myosin heavy-chain gene.
P. Anderson, MRC Laboratory of Molecular Biology, Cambridge, England: The physical nature of
mutations affecting unc-54.
D. G. Moerman, T. R. Lane, and R. H. Waterston, Depts. of Genetics and of Anatomy and Neurobiol-
ogy, Washington University, St. Louis, Missouri: Studies on unc-54 I and its suppressor sup-3 V.
J. Files and D. Hirsh, Dept. of Molecular, Cellular and Developmental Biology, University of Colorado,
Boulder: The actin genes of C. elegans.
L. A. Gossett,' L. H. Bolton,' H. F. Epstein,' and R. M. Hecht," Dept. of Biophysical Sciences, University
of Houston Central Campus; 'Dept. of Neurology, Baylor College of Medicine, Houston, Texas:
The ontogeny of muscle proteins in the C. elegans embryo.
J. M. Mackenzie, D. M. Miller, L. H. Bolton, and H. F. Epstein, Dept. of Neurology, Baylor College of
Medicine, Houston, Texas: Structural studies of normal and mutant thick filaments.
D.M. Miller III, L. H. Bolton, and H. F. Epstein, Dept. of Neurology, Baylor College of Medicine,
Houston, Texas: Monoclonal antibodies as probes of muscle structure and development in C.
elegans.
F. H. Schachat,' D. D. Bronson,' G. A. Jamieson, Jr.,' and T. C. Vanaman,2 Depts. of 'Anatomy and
'Microbiology, Duke University Medical Center, Durham, North Carolina: Calcium regulation and
phosphorylation in C. elegans muscle contraction.
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Session 3: The Genetics Stock Center
Chairperson: M. M. Swanson, University of Missouri, Columbia
M. M. Swanson and D. L. Riddle, Division of Biological Sciences, University of Missouri, Columbia:
Caenorhabditis Genetics Center.
Session 4: Genetics
Chairperson: J. Hodgkin, MRC Laboratory of Molecular Biology, Cambridge, England
R. Francis, D. G. Moerman, S. Plurad, and R. H. Waterston, Depts. of Genetics and of Anatomy and
Neurobiology, Washington University School of Medicine, St. Louis, Missouri: Extragenic suppres-
sors of mutations affecting muscle structure in C. elegans.
I. Greenwald and R. Horvitz, Dept. of Biology, Massachusetts Institute of Technology, Cambridge:
Genetic studies of unc-93(e1500) Ill.
A.M. Rose) D. L. Bane,' K. A. Beckenbach,2 and E. P.M. Candido,"University of British Columbia,
Vancouver; 2Simon Fraser University, Burnaby, B. C., Canada: Genetic and biochemical analysis of
unc-15-The gene coding for paramyosin in C. elegans.
P. S. Hartman and R. K. Herman, Dept. of Genetics and Cell Biology, University of Minnesota, St. Paul:
Radiation-sensitive mutants of C. elegans.
S. Carr M. Krause, and D. Hirsh, Dept. of Molecular, Cellular and Developmental Biology, University
of Colorado, Boulder: Genetic mapping of DNA sequence.
D. G. Albertson and J. N. Thomson, MRC Laboratory of Molecular Biology, Cambridge, England:
Kinetochore structure in C. elegans.
Session 5: Embryology
Chairperson: D. Hirsh, University of Colorado, Boulder
E. Schierenberg) J. E. Sulston,2 C. Carlson) W. Sidio) and G. von Ehrenstein) 'Dept. of Molecular
Biology, Max-Planck-Institute for Experimental Medicine, Gottingen, Federal Republic of Ger-
many; 2MRC Laboratory of Molecular Biology, Cambridge, England: Computer-aided analysis of C.
elegans embryogenesis.
R. Cassada, E. Isnenghi, K. Denich, K. Radnia, E. Schierenberg, K. Smith, and G. von Ehrenstein, Dept.
of Molecular Biology, Max-Planck-Institute for Experimental Medicine, Gottingen, Federal Repub-
lic of Germany: Genetic dissection of embryogenesis in C. elegans.
K. Denich, R. Cassada, E. Isnenghi, K. Radnia, E. Schierenberg, and G. von Ehrenstein, Dept. of
Molecular Biology, Max-Planck-Institute for Experimental Medicine, G6ttingen, Federal Republic
of Germany: Cell lineages and developmental defects of temperature-sensitive embryonic arrest
mutants of C. elegans.
J. Priess and D. Hirsh, Dept. of Molecular, Cellular and Developmental Biology, University of
Colorado, Boulder: Digestive tract development in C. elegans.
R. G. Knowlton, M. K. Edwards, M. Lauth, L. M. Donahue, P. M. Meneely, and W. B. Wood, Dept. of
Molecular, Cellular and Developmental Biology, University of Colorado, Boulder: Gene expres-
sion in C. elegans embryos.
S. Strome, M. Hobbs, and W. B. Wood, Dept.
of Molecular, Cellular and Developmental Biology,
University of Colorado, Boulder: Monoclonal antibodies against tissue-specific antigens in C
elegans.
H. U. Certa, R. Cassada, and G. von Ehrenstein, Dept.
of Molecular Biology, Max-Planck-Institute for
Experimental Medicine, Gottingen, Federal Republic of Germany: Histones of C. elegans.
Session 6: Poster Session
P. F. Agris,' P. Schmidt,2 J. Golden,' and D. L. Riddle,' 'Division of Biological Sciences, University of
Missouri, Columbia; 2Dept. of Biochemistry, University of Oklahoma Health Sciences Center,
Oklahoma City: In vivo phosphorous-NMR spectroscopy of C. elegans.
C. J. Barinaga and J. D. Willett, Dept. of Bacteriology and Biochemistry, University of Idaho, Mos-
cow: An improved instrument for the rapid counting and simultaneous two parameter measure-
ment of small nematodes.
M. A. Bolanowski, L. A. Jacobson, and R. L. Russell, Dept. of Biological Sciences, University of Pitts-
burgh, Pennsylvania: Water efflux from C. elegans.
M. Chalfie and J. N. Thomson, MRC Laboratory of Molecular Biology, Cambridge, England: Micro-
tubule structure in C. elegans neurons.
V. K.-H. Chen' and W. F. Hieb,2 'Dept. of Biophysics and 2Division of Cell and Molecular Biology,
State University of New York, Buffalo: Behavioral studies of nematodes by dynamic laser light
scattering.
L.W. Cribbs, Dept. of Biological Sciences, University of Pittsburgh, Pennsylvania: Protease intercon-
version of acetylcholinesterase forms.
B.O. Davis, Jr.,' G. L. Anderson,' and D. B. Dusenbery,2 'Kennesaw College, Marietta, Georgia;
2School of Biology, Georgia Institute of Technology, Atlanta: Fluorescent pigment accumulation
in aging C. elegans.
D. B. Dusenbery and E. A. Anderson, School of Biology, Georgia Institute of Technology, Atlanta:
Cold-resistant mutants of the nematode C. elegans.
W. Fixsen and R. Horvitz, Dept. of Biology, Massachusetts Institute of Technology, Cambridge: A
cell lineage mutation that produces multiple ectopic postdeirids and ray groups.
A. Fodor,' P. Deak,1 I. Kiss,' and T. Timar,2 'Institute of Genetics BRC, Hungarian Academy of
Science, Szeged; 2Alkaloida, Tiszavasvari, Hungary: Effects of some insect junvenile hormone and
precocene analog on C. elegans.
P. D. Gardner, Dept. of Biological Sciences, University of Pittsburgh, Pennsylvania: Lectin-based
purification and separation of C. elegans acetylcholinesterase forms.
E. Hedgecock and N. Thomson, MRC Laboratory of Molecular Biology, Cambridge, England: Neur-
onal guidance mutants.
D. L. Kolson, Dept. of Biological Sciences, University of Pittsburgh, Pennsylvania: New alleles of
ace-1 X.
C. Link, R. L. Russell, and L. Jacobson, Dept. of Biological Sciences, University of Pittsburgh, Pennsyl-
vania: "Age pigments" of C. elegans- Quantitation and physical properties.
K. R. Luehrsen, S.M. Wall, R. M. Hecht, and G. E. Fox, Dept. of Biophysical Sciences, University of
Houston Central Campus, Texas: The 5S ribosomal RNA sequence of nematodes.
G. McCaffrey and T. E. Johnson, Dept. of Molecular, Cellular and Developmental Biology, Univer-
sity of Colorado, Boulder: Protein changes during lifespan-2-D gel analysis.
R. Ouazana,' D. Herbage,2 and J. Brun,' "Laboratoire de Genetique Physiologique et Nematologie,
C.N.R.S., Paris; 2Laboratoire de Chimie Macromoleculaire, Universite Claude Bernard, Lyon,
France: Further characterization of some components of the C. elegans adult cuticle collagen.
R. L. Russell, O. J. Bashor, and L. Cavalier, Dept. of Biological Sciences, University of Pittsburgh,
Pennsylvania: Structure of the pharyngeo-intestinal "valve."
S. S. Siddiqui," G. von Ehrenstein,' E. Schierenberg,' P. Sams,' and J. G. Culotti,2 'Dept. of Molecular
Biology, Max-Planck-Institute for Experimental Medicine, Gottingen, Federal Republic of Ger-
many; 2Dept. of Biological Sciences, Northwestern University, Evanston, Illinois: Expression of
acetylcholinesterase activity during the embryonic and postembryonic development of C.
elegans.
Y. Tabuse' and J. Miwa,' 2 'Dept. of Biology, Faculty of Science, Osaka City University; 2lnstitute for
Biomedical Research, Osaka, Japan: Mutants of C. elegans resistant to tumor promoters.
C. Trent, N. Tsung, and R. Horvitz, Dept. of Biology, Massachusetts Institute of Technology, Cam-
bridge: Mutants that affect egg-laying in C. elegans.
B. M. Zuckerman,' S. P. Huang,' T. A. Tattar,2 and R. A. Rohde,' 'Laboratory of Experimental Biology,University of Massachusetts, East Wareham; 2Dept. of Plant Pathology, University of Massachu-
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setts, Amherst: C. elegans-The effects of 5-hydroxytryptophan and dopamine on behavior and
development.
Session 7: Aging and the Life Cycle
Chairperson: D. L. Riddle, University of Missouri, Columbia
V. Ambros and R. Horvitz, Dept. of Biology, Massachusetts Institute of Technology, Cambridge:
Genes that control developmental stage.
J. W. Golden and D. L. Riddle, Division of Biological Sciences, University of Missouri, Columbia: A
dauerlarva pheronome.
T. P. Snutch and D. L. Bail lie, Dept. of Biological Sciences, Simon Fraser University, Burnaby, B. C.,
Canada: Inducible genes in the nematode C. elegans.
J. Miwa; 2 Y. Tabuse,2 M. Furusawa,2 and H. Yamasaki,3 'Institute for Biomedical Research, Osaka;
'Dept. of Biology, Faculty of Science, Osaka City University, Japan; 3International Agency for
Research on Cancer, Lyon, France: Specific effect of tumor promoters on C. elegans.
T. E. Johnson, C. H. Lashlee, and G. McCaffrey, Dept. of Molecular, Cellular and Developmental
Biology, University of Colorado, Boulder: Quantitative genetics of lifespan.
M. A. Bolanowski, C. Link, R. L. Russell, and L. A. Jacobson, Dept. of Biological Sciences, University
of Pittsburgh, Pennsylvania: Quantitative measures of aging in C. elegans.
Session 8: Sex Determination and Gametogenesis
Chairperson: W. B. Wood, University of Colorado, Boulder
J. Hodgkin, MRC Laboratory of Molecular Biology, Cambridge, England: A major sex-determining
gene in C. elegans.
J. E. Kimble and J. G. White, MRC Laboratory of Molecular Biology, Cambridge, England: Control of
germ cell development by distal tip cells in C. elegans.
L. Edgar and D. Hirsh, Dept. of Molecular, Cellular and Developmental Biology, University of
Colorado, Boulder: Control of spermatogenesis in hermaphrodites.
M. R. Klass, Dept. of Biology, University of Houston, Texas: Regulation of the major sperm-protein
gene in C. elegans.
S. Ward, G. Nelson, T. Roberts, and Y. Argon, Dept. of Embryology, Carnegie Institution of Washing-
ton, Baltimore, Maryland: Genetic dissection of C. elegans spermiogenesis.
T. Roberts' and S. Ward,21Dept. of Biological Science, Florida State University,Tallahassee; 'Dept. of
Embryology, Carnegie Institution of Washington, Baltimore, Maryland: Directed membrane flow
on the pseudopods of C. elegans spermatozoa.
Session 9: Poster Session
G. Anderson, School of Biology, Georgia Institute of Technology, Atlanta: Superoxide dismutase
activity in dauerlarva of C. elegans.
T. Blumenthal, MRC Laboratory of Molecular Biology, Cambridge, England: Novel polypeptides
encoded by RNA from suppressor-containing strains.
P. Deak and A. Fodor, Institute of Genetics, Biological Research Center, Hungarian Academy of
Sciences, Szeged: Genetics and cytology of chromosome rearrangement SzT1 expressing domi-
nant X-balancer and HIM phenotypes.
B. Dow and M. R. Klass, Dept. of Biology, University of Houston, Texas: Cloning of the 15K gene
from C. elegans.
W. Fixsen and R. Horvitz, Dept. of Biology, Massachusetts Institute of Technology, Cambridge: Two
loci involved in the migrations of the ventral cord precursor cells.
P. Goldstein, University of North Carolina, Charlotte: Synaptonemal complex analysis of wild-type
and him mutants of C. elegans.
R. M. Hecht, S. M. Wall, and J. Jackson, Dept. of Biophysical Sciences, University of Houston Central
Campus, Texas: Nuclear terminal phenotypes of the embryonic lethals of C. elegans.
R. K. Herman, C. K. Kari, and P. S. Hartman, Dept. of Genetics and Cell Biology, University of
Minnesota, St. Paul: Dominant male-throwing mutants of C. elegans.
E. Isnenghi, R. Cassada, K. Smith, K. Radnia, and G. von Ehrenstein, Dept. of Molecular Biology,
Max-Planck-Institute for Experimental Medicine, Gottingen, Federal Republic of Germany: Mat-
ernal and other modes of expression and time of temperature sensitivity of genes affecting
embryogenesis in C. elegans.
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S. Jameel and B.A. McFadden,
Dept. of Biochemistry and Institute of Biological Chemistry,
Washington State University, Pullman:
Decay of isocitrate lyase in C. elegans.
R. Jefferson; P. Bazzicalupo,2 and D.
Hirsh; 1Dept. of Molecular, Cellular and Developmental
Biology, University of Colorado, Boulder; 2lnstituto
Internazionale di Genetica e Biofisica, Naples,
Italy: Developmental regulation of /3-glucuronidase.
L. ten- Jacobson and L. Jacobson, Dept.
of Biological Sciences, University of Pittsburgh, Pennsylva-
nia: Acid endoproteases of C. elegans.
C. Landel and D. Hirsh, Dept. of
Molecular, Cellular and Developmental Biology, University of
Colorado, Boulder: Multiple actins in the worm.
J. S. Laufer and W. B. Wood, Dept. of Molecular, Cellular
and Developmental Biology, University of
Colorado, Boulder: Behavior of
cleavage-inhibited blastomeres in C. elegans.
R. Ouazana; N. Mounier,1 J. Brun,
C. Drevon,2 and H. Yamasaki,2 1Laboratoire de Genetique
Physiologique et Nematologie, Universite
Claude Bernard Lyon -I; 2Unit of Chemical Carcino-
genesis, International Agency for Research on
Cancer, Lyon, France: Effect of phorbol ester
tumor promoters on C. elegans. Isolation
and characterization of TPA-resistant mutant strains.
T.M. Rogalski,1 D.G. Moerman,2 and D. L.
Bail lie; 1Dept. of Biological Sciences, Simon Fraser
University, Burnaby, B.C., Canada; 2Dept.
of Genetics, Washington University School of Medi-
cine, St. Louis, Missouri: Deficiencies and lethal mutations
in the unc-22 region of linkage group
IV of C. elegans.
R. E. Rosenbluth and D. L. Bail lie, Dept.
of Biological Sciences, Simon Fraser University, Burnab
y,B.C., Canada: Localization of breakpoints and
demonstration of reciprocity for the C. elegans,
translocation, eT1(111,-V),e873.
S.S. Siddiqui; G. von Ehrenstein; and J.G. Culotti,2 1Dept. of Molecular Biology, Max-Planck-
Institute for Experimental Medicine, Gottingen, Federal Republic of Germany; 2Dept. of Biologi-
cal Sciences, Northwestern University, Evanston, Illinois: Acetylcholinesterase mosaics in the
nematode C. elegans.
J. Sulston; E. Schierenberg,2 and G. von Ehrenstein,2 1MRC Laboratory of Molecular Biology, Cam-
bridge, England; 2Max-Planck-Institute for Experimental Medicine, Gottingen, Federal Republic
of Germany: Embryonic cell lineage.
J. R. Vanfleteren, Laboratoria voor Morfologie en Systematiek der Dieren, Rijksuniversiteit Gent,
Belgium: The histones of C. elegans.
W. Sharrock and J. Kimble, MRC Laboratory of Molecular Biology, Cambridge, England: Adult
hermaphrodite-specific proteins of C. elegans.
Session 10: Neurobiology
Chairperson: M. Chalfie, MRC Laboratory of Molecular Biology, Cambridge, England
J.G. White, E. Southgate, and J. N. Thomson, MRC Laboratory of Molecular Biology, Cambridge,
England: The nervous system of C. elegans.
R. E. Davis and A. O.W. Stretton, Neurosciences Program and Dept. of Zoology, University of Wis-
consin, Madison: Intracellular recordings from identified motorneurons in the nematode Ascaris.
R. L. Russell, Dept. of Biological Sciences, University of Pittsburgh, Pennsylvania: Computer model-
ing C. elegans movement.
J. Rand, Dept. of Biological Sciences, University of Pittsburgh, Pennsylvania: Choline acetyl-
transferase-deficient mutants of C. elegans.
J. G. Culotti, W.M. James, and W. L. Klein, Dept. of Biological Sciences, Northwestern University,
Evanston, Illinois: Binding of muscarinic and nicotinic ligands to homogenates of wild type and
cholinergic mutants of C. elegans.
J. A. Lewis and J. T. Fleming, Dept. of Biological Sciences, Columbia University, New York, New
York: A binding assay for the levamisole receptor.
C.D. Johnson, S.M. Rotter, and A. 0.W. Stretton, Dept. of Zoology, University of Wisconsin, Madi-
son: Acetylcholine functions in Ascaris.
Summary: S. Ward, Carnegie Institution of Washington, Baltimore, Maryland
This meeting was supported in part by grants from the National Institutes of Health.
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is
Mitochondrial Genes, May 13-May 17
Arranged by P. Slonimski, Centre de Genetique Moleculaire du CNRS, P. Borst, University of
Amsterdam, G. Attardi, California Institute of Technology
165 participants
Introduction: H. Roman, University of Seattle, Washington: Boris Ephrussi and the early days of
cytoplasmic inheritance in yeast
Session 1: Mammalian Genes and Transcripts
Chairperson: M. Simpson, State University of New York, Stony Brook
S. Anderson, A. T. Ban kier, B. G. Barrell, M. H. L. de Bruijn, E. Chen, A. R. Coulson, J. Drouin, I. C.
Eperon, D. P. Nierlich, B. A. Roe, F. Sanger, P. H. Schereir, A. J. H. Smith, R. Staden, and I. G.
Young, MRC Laboratory of Molecular Biology, Cambridge, England: Sequence and structure of
mammalian mitochondrial genomes.
G. Attardi, P. Cantatore, A. Chomyn, S. Crews, R. Gelfand, C. Merkel, J. Montoya, and D. Ojala,
California Institute of Technology, Pasadena: A comprehensive view of mitochondrial gene
expression in human cells.
M. J. Bibb, A. Brennicke, J. N. Doda, D. P. Tapper, R. A. van Etten, M. W. Walberg, C. T. Wright, and
D. A. Clayton, Dept. of Pathology, Stanford University School of Medicine, California: Sequence
organization and functional properties of mouse mtDNA.
D. T. Dubin, K. D. Timko, C. C. Hsuchen, and T. Azzolina, Dept. of Microbiology, CMDNJ-Rutgers
Medical School, Piscataway, New Jersey: 3'-Termini of animal cell mtRNA.
Session 2: Yeast Genes and mRNA Formation I
Chairperson: P. Slonimski, Centre de Genetique Moleculaire du CNRS, Gif-sur-Yvette, France
A. Tzagoloff, Dept. of Biological Sciences, Columbia University, New York, New York: Cytochrome
oxidase genes in yeast.
C. Jacq, H. de la Salle, and P. P. Slonimski, Centre de Genetique Moleculaire du CNRS, Gif-sur-
Yvette, France: Role of the last two introns of cytochrome b gene in the expression of two mosaic
genes-Physical studies of mutations.
P. Pajot, M. L. Wambier-Kluppel, C. Grandchamp, 0. Groudinsky, M. Labouesse, and P. P. Slo-
nimski, Centre de Genetique Moleculaire du CNRS, Gif-sur-Yvette, France: Loss of the last two
introns in the yeast cytochrome b gene permits the synthesis of active cytochrome b but prevents
the formation of cytochrome oxidase.
L.A. Grivell" M. de Haan," J. B. A. Crusius,' N. van Harten-Loosbroek,1 and G. S. P. Groot,' 'Section
of Molecular Biology, 'Laboratory of Biochemistry, Free University, Amsterdam, The Netherlands:
Evolution and the introns in yeast mtDNA.
R. Schweyen, C. Schmelzer, H. Bruckner, B. Suchy, A. Gessner, and F. Kaudewitz, Genetisches
Institut der Universitat Munchen, Munich, Federal Republic of Germany: Processing of mito-
chondrial transcripts in Saccharomyces cerevisiae.
H. R. Mahler,' P. S. Perlman,' D. K. Hanson," and M. R. Lamb,' 'Chemistry Dept., Indiana University,
Bloomington; 'Genetics Dept., Ohio State University, Columbus: The role of exon sequences in
the processing of cob introns.
P. S. Perlman,' H. R. Mahler,' M. R. Lamb,' P. Q. Anziano,' and D. Hanson,' 'Genetics Dept., Ohio
State University, Columbus; 'Chemistry Dept., Indiana University, Bloomington: Definition of
functional domains of an intron.
Session 3: Poster Session
A. C, Arnberg,' J. B. A. Crusius,2 P. H. Boer,' and L. A. Grivell,2 "Biochemical Laboratory, State Univer-
sity, Groningen; 'Section for Molecular Biology, Laboratory of Biochemistry, Amsterdam, The
Netherlands: Localization of DNA sequences encoding the long 5' leader of the
mRNA for cytoch-
rome b in yeast mitochondria.
G. Baldacci,' and G. Bernardi,' 'Istituto di Fisiologica Generale, University di Roma, Italy;
2Labora-
toire de Genetique Moleculaire, Institut de Recherche en Biologie Moleculaire,
Paris, France:
Transcription of the mitochondrial genome of yeast.
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P. H. Boer, J. B. A. Crusius, and L. A. Grivell, Section of Molecular Biology, Laboratory of Biochem,s_
try, Amsterdam, The Netherlands:
Early events in the processing of cob transcripts in yeast
mitochondria.
L. Bonen, Dept. of Biochemistry, Dalhousie
University, Halifax, Canada: A "5S-like" sequence
within the 3' end of human mitochondria' 12S rRNA.
S. G. Bonitz and A. Tzagoloff, Dept. of Biological Sciences, Columbia University, New York, New
York: The structure and nucleotide sequence of the gene coding for subunit 1 of yeast cyto-
chrome oxidase.
H. Bruckner, A. R. Gessner, B. Sichy, and F. Kaudewitz, Genetisches Institut der Universitat
chen, Munich, Federal Republic of Germany: Characterization of an exceptional series of mit
deletions in oxi3 and their effect on transcript splicing.
E. Ching' and G. Attardi,2 1Dept. of Cell Biology, Rockefeller University, New York, New York;
2Division of Biology, California Institute of Technology, Pasadena: High resolution fractionation
and partial characterization of the mitochondrial translation products from HeLa cells.
M. L. Claisse, 0. Groudinsky, B. Guiard, A. Spyridakis, M. Dreyfus, and P. P. Slonimski, Centre de
Genetique Moleculaire du CNRS, Gif-sur-Yvette, France: New mitochondrial high-molecular-
weight translation products in cob-box and oxi3 mutants.
G. Coruzzi, S. Bonitz, B. Thalenfeld, and A. Tzagoloff, Dept. of Biological Sciences, Columbia
University, New York, New York: Analysis of the nucleotide sequence and transcripts in the oxi1
region of yeast mtDNA.
M. de Zamaroczy, R. Marotta, and G. Bernardi, Laboratoire de Genetique Moleculaire, Institut de
Recherche en Biologie Moleculaire, Paris, France: The primary structure of the origins of replica-
tion of the mitochondrial genome of yeast.
T. D. Fox and S. Stampfli, Biocenter, University of Basel, Switzerland: An ochre mutation in the yeast
oxi1 gene and its supression by a second site mitochondria' mutation.
R. Gelfand1 and G. Attardi,2 1Dept. of Biology, Purdue University, West Lafayette, Indiana; 2Division
of Biology, California Institute of Technology, Pasadena: Synthesis and turnover of mtRNA in
HeLa cells-The mature RNA and mRNA species are metabolically unstable.
A. Halbreich, C. Grandchamp, and M. Foucher, Centre de Genetique Moleculaire du CNRS, Gif-
sur-Yvette, France: A low-molecular-weight RNA species which may arise from a trimming of the
pre-mRNA of yeast mitochondrial cytochrome b at the 3' end.
D. K. Hanson; M. R. Lamb,1 H.R. Mahler,1 and P. S. Perlman,2 1Chemistry Dept., Indiana University,
Bloomington; 2Genetics Dept., Ohio State University, Columbus: Homologous
accumulate in mutants of two different mitochondrial genes.
B.C. Hyman, J. H. Cramer, and R. H. Rownd, Laboratory of Molecular Biology and Dept. of Bio-
chemistry, University of Wisconsin, Madison: Isolation of a yeast mtDNA segment conferring
autonomously replicating function.
C. Julou and M. Bolotin-Fukuhara, Laboratoire de Biologie Generale, University de Paris, Orsay,
France: Mitochondrial ribosomal genes in yeast-Mutations and their suppression.
R. Marotta, R. Goursot, M. Mangin, G. Faugeron-Fonty, R. Goursot, and G. Bernardi: Laboratoire de
Genetique Moleculaire, Institut de Recherche en Biologie Moleculaire, Paris, France: Suppres-
sivity-The effect of partial or total deletions of the origin of replication of the petite genome.
J. Montoya, D. Ojala, S. Crews, R. Gelfand, and G. Attardi, California Institute of Technology,
Pasadena: Mapping and structural properties of an mtDNA L-strand-coded polyadenylated RNA
(7S RNA), and synthesis and processing of mitochondria' rRNA in HeLa cells.
P. Netter, C. Jacq, L. Clavilier, and P. P. Slonimski, Centre de Genetique Moleculaire du CNRS,
Gif-sur-Yvette, France: Localization of mutations in the "cytochrome-b-homologous" intron of
the oxidase gene in yeast.
G. Rode! and W. Bandlow, Genetisches Institut der Universitat MUnchen, Munich, Federal Republic
of Germany: A cAMP-receptor protein in yeast mitochondria.
E. Schiavon, D. Frezza, and G. Carignani, Istituto di Chimica Biologica and Centro Studio Fisiologia
Mitocondriale del CNR, Padova, Italy: Localization of mit mutations along the oxi3 region of
mtDNA in "long" strains of Saccharomyces cerevisiae.
B. E. Thalenfeld and A. Tzagoloff, Columbia University, New York, New York: Transcription of theoxi2 gene of yeast mtDNA.
M. W. Walberg, J. Bird, and D. A. Clayton, Dept. of Pathology, Stanford University School of Medi-
cine, California: Precise mapping of sequences coding for precursors of mouse mitochondrial
rRNAs.
B. Weiss-Brummer, G. Rode', and F. Kaudewitz, Genetisches Institut der Universitat MUnchen,Munich, Federal Republic of Germany: Characterization of some splicing-defective mutants
mapping in the intron -y 6 of the cob gene of Saccharomyces cerevisiae mtDNA.
K. Wolf,' B. Lang,2 P. Anziano,2 and P. S. Perlman,2 1Genetisches Institut der Universitat Munchen,
Munich, Federal Republic of Germany; 2Genetics Dept., Ohio State University, Columbus: Struc-
ture and function of the mitochondrial genome in Schizosaccharomyces pombe.
Session 4: Yeast Genes and mRNA Formation II
Chairperson: H. Mahler, Indiana University, Bloomington
D. Levens, T. Christianson, J. Edwards, A. Lustig, B. Ticho, J. Locker, and M. Rabinowitz, Depts. of
Biochemistry, Biology, Medicine, and Pathology, University of Chicago, Illinois: Transcriptional
initiation of yeast mtRNA and characterization and synthesis of mtRNA polymerase.
R. A. Butow, H. P. Zassenhaus, and F. Farrelly, Dept. of Biochemistry, University of Texas Health
Science Center, Dallas: Analysis of the van determinant region on yeast mtDNA.
M. E. S. Hudspeth,' D. S. Shumard,' K. R. Glaus,2 P. S. Perlman,2 and L. I. Grossman,' 'Division of
Biological Sciences, University of Michigan, Ann Arbor; 2Dept. of Genetics, Ohio State University,
Columbus: Sequence variation in the van region of yeast mtDNA.
J. Lazowska, A. Gargouri, and P. P. Slonimski, Centre de Genetique Moleculaire du CNRS, Gif-sur-
Yvette, France: Role of the second intron of cytochrome b gene-Analysis of mRNA-maturase
mutations and of the 3' region of the intron.
R. W. Davies, C. Scazzocchio, R. B. Waring, S. Lee, E. Grisi, M. M. Berks, and T. A. Brown, Dept. of
Biology, University of Essex, Colchester, England: DNA sequence of mosaic genes in the mito-
chondrial genome of Aspergillus nidulans.
A. Kruszewska, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw:
Nuclear and mitochondrial informational suppressors of box3 intron mutations.
G. Dujardin, 0. Groudinsky, and P. P. Slonimski, Centre de Genetique Moleculaire du CNRS,
Gif-sur-Yvette, France: Further studies on phenotypic and genetic suppression of intron mutations.
A.M. Colson and C. Legrand, Laboratoire de Cytogenetique, Universite de Louvain, Belgium: Prop-
erties of mitochondrial diuron-resistant mutants of Saccharomyces cerevisiae selected on DL-
lactate.
L. A.M. Hensgens, L. A. Grivell, and G. van der Horst, Section of Molecular Biology, Laboratory of
Biochemistry, Amsterdam, The Netherlands: Processing of oxi3 RNAs is dependent on intron-
encoded functions.
R. Schroeder,12 M. Breitenbach,' and R. J. Schweyen,2 'Institut fur Allgemeine Biochemie and Lud-
wig Boltzmann Forschungsstelle fur Biochemie der Universitat Wien; 2Genetisches Institut der
Universitat MLinchen, Munich, Federal Republic of Germany: Mitochondrial transcription and
translation during yeast differentiation.
Session 5: Replication and Ribosomal Genes in Yeast
Chairpersons: D. Cummings, University of Colorado, Denver
C. Saccone, Istituto Chimica Biologica, Bari, Italy
G. Bernardi, G. Baldacci, G. Bernardi, G. Faugeron-Fonty, C. Gaillard, R. Goursot, R. Goursot, A.
Huyard, M. Mangin, R. Marotta, and M. de Zamaroczy, Institut de Recherches en Biologie
Moleculaire, Laboratoire de Genetique Moleculaire, Paris, France: The sequence organization of
the mitochondria' genome of yeast.
H. Blanc' and B. Dujon,2 'Dept. of Genetics, Stanford University School of Medicine, California;
2The Biological Laboratories, Harvard University, Cambridge, Massachusetts: Replicator regions
of yeast mtDNA.
S. F. Cottrell, J. Blamire, and L. H. Lee, Dept. of Biology, Brooklyn College, City University of New
York, New York: Evidence for the synchronous replication of mtDNA during the yeast cell cycle.
G. Faugeron-Fonty, R. Marotta, M. de Zamaroczy, and G. Bernardi, Laboratoire de Genetique
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Moleculaire, Institut de Recherche en
Biologie Moleculaire, Paris, 1 rance: The localization
orientation of the origins of replication of
the mitochondria' genome of yeast. i_., and
B. °Drui 'on, The Biological Laboratories,
Harvard University, Cambridge, Massachusetts: Polymorphic
mitochondrial 21S rRNA gene and their genetic implications.
variations of the yeast
H. F. Tabak, J.van der Laan,
K. A. Osinga, and J. P. Schouten, Section for o
Molecular Biology, University of Amsterdam,
The Netherlands: The precision of RNA splicing
yeast mitochondrial petite
mutant, as assayed with a synthetic DNA oligonucleotide. in a
R. L. Strausberg, D. E. Lorant,
and P. E. Hardin, Dept. of Biology, Southern
Dallas, Texas: Novel mutations in
the 21S rRNA region of yeast mtDNA.
C. J. Weeden, M.A. Conners,
and J. A. Knight, Dept. of Biological Sciences, Mount Holyoke
Col-
lege, South Hadley, Massachusetts:
The use of nuclear suppr,esors to generate unusual
c asses of
mitochondrial chloramphenicol-resistant mutants
in baker s yeast. '
mitochondria.
F. Sor and H. Fukuhara, Institut Curie,
Universite de Paris, Orsay, France: Nucleotide sequence
of
the mitochondrial 15S rRNA gene of yeast.
M. Li,1 L. Lyon,2 N. Martin,2 and A.
Tzagoloff,' 'Dept. of Biological Sciences, Columbia University,
Biology, University of
New York, New York; 2Dept. of Biochemistry, University of Texas Health Science Center
Characterization of the paromomycin resistance locus in the 15S rRNA gene of yeast mitoch alias:
and
K. A. Osinga and H. F. Tabak, Section for Medical Enzymology and Molecular
Amsterdam, The Netherldan s: The transcription-initiation signal for the synthesis of the precursor
for small rRNA in yeast mitochondria.
Session 6: Recombination, Nucleocytoplasmic Interactions and tRNA Genes in Yeast
Chairperson: F. Kaudewitz, Universitat Munchen, Federal Republic of Germany
A. W. Linnane, Dept. of Biochemistry, Monash University, Clayton, Victoria, Australia: Structure and
expression of the oli2 gene in yeast mtDNA.
C. W. Birky, Jr. and A.R. Acton, Dept. of Genetics, Ohio State University, Columbus: Yeast mito-
chondrial genes-Recombination, replication, and random changes in frequencies.
G. Michaelis,1 G. Mannhaupt,1 E. Pratje,1 E. Fischer,2 and E. Schweizer,21Fakultat fiir Biologie, Univer-
sitat Bielefeld; 2Lehrstuhl fur Biochemie der Universitat Erlangen-Nurnberg, Federal Republic of
Germany: Mitochondria' translation products of nuclear pet mutants in Saccharomyces cerevisiae.
C. Dieckmann and A. Tzagoloff, Dept. of Biological Sciences, Columbia University, New York, New
York: Saturation of the nuclear genome for mutations affecting mitochondrial respiration.
L. Frontali, M. Agostinelli, G. Baldacci, C. Falcone, S. Francisci, C. Palleschi, and E. Zennaro, Istituto
di Fisiologa Generale, Universita di Roma, Italy: Expression of the mitochondrial genes in Sacchar-
omyces cerevisiae-Influences of physiological conditions and of nuclear background.
N.C. Martin, D. L. Miller, D. R. Najarian, and K. Underbrink-Lyon, Dept. of Biochemistry, University
of Texas Health Science Center, Dallas: Yeast mitochondrial tRNAs-Genes, transcripts, and
a
tRNA synthesis locus.
R. P. Martin, A.-P. Sibler, R. Bordonne, and G. Dirheimer, Laboratoire de Biochimie, Institut de
Biologie Moleculaire et Cellulaire du CNRS, Strasbourg, France: Codon-reading patterns in yeast
mitochondria.
A. P. Hudson, I. C. Lopez, R. A. Butow, and J. C. Mounolou, Dept. of Biochemistry, University of
Texas Health Science Center, Dallas: A biochemical approach to yeast mtDNA recombination.
D.W. Deters and M. Ewing, Dept. of Microbiology, University of Texas, Austin: Mitochondria'
translation products of different yeasts are distinguishable.
G. D. Clark-Walker and K. S. Sriprakash, Dept. of Genetics, Australian National University, Canberra:
Mechanisms for sequence rearrangements and size diversity in mtDNAs from yeasts.
D. Wilkie and I. Bruce, Dept. of Botany and Microbiology, University College, London, England:Correlation between uptake of sugars and flocculation in yeast-Mitochondrial influence.
G. Orlowska and Z. Kotylak, Institute of Microbiology, Wroclaw, Poland: Genetic characterization
of op1-type mutants.
Session 7: Poster Session
E. Agsteribbe, J. Samallo, and P. van den Boogaart, Laboratory of Physiological Chemistry, StateUniversity, Groningen, The Netherlands: Structural and functional analysis of Neurospora crassamtDNA. II. Transcripts of the oli and oxi/ region.
G. Bernardi and G. Bernardi, Laboratoire de Genetique Moleculaire, Institute de Recherche enBiologie Moleculaire, Paris, France: Intergenic and intervening sequences of the mitochondrialgenome of yeast.
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M. Breitenbach and R. Schroeder, Institut fur Allgemeine Biochemie and Ludwig Boltzmann For-
schungsstelle fur Biochemie der Universitt Wien, Austria: Mitochondrially inherited germina-tion-deficient mutants of yeast.
A. Brunner, Centro de Investigaciones en Fisiologia Celular, Universidad Nacional Autonoma deMexico, Villa Obregon: Recombination of mitochondrial markers during protoplast fusion in the
"petite-negative" yeast Kluyveromyces lactis.
L. Del Giudice, Istituto Internazionale di Genetica e Biofisica, CNR, Napoli, Italy: Cloning of mtDNAfrom petite-negative yeast Schizosaccharomyces pombe in the bacterial plasmid pBR322.S. Ferris,1 A. Wilson,1 and W. Brown,2 1Dept. of Biochemistry, University of California, Berkeley;2Division of Biological Sciences, University of Michigan, Ann Arbor: Evolutionary tree for apes
and humans based on cleavage maps of mtDNA.
E. Finzi, M. Sperling, and D. S. Beattie, Dept. of Biochemistry, Mount Sinai School of Medicine, NewYork, New York: Isolation of cytosolic proteins which control yeast mitochondrial protein
synthesis.
R. Goursot, G. Faugeron-Fonty, M. Mangin, and G. Bernardi, Laboratoire de Genetique Molecu-
laire, Institut de Recherche en Biologie Moleculaire, Paris, France: Suppressivity-The effect of
the repeat unit length of the petite genome and of other factors.
S. L. Hajduk,1 J. H. J. Hoeijmakers,2 P. Borst,2 W. B. Cosgrove,3 and K. Vickerman,11Dept. of Zoology,
University of Glasgow, Scotland; 2Dept. of Medical Enzymology, University of Amsterdam, The
Netherlands; 3Dept. of Zoology, University of Georgia, Athens: Kinetoplast DNA structure and
mitochondrial activity in the trypanosomatid flagellate Herpetomonas.
J. F. Hare, R. Hodges, and G. Wilson, Dept. of Biochemistry, University of Oregon Health Sciences
Center, Portland: Synthesis and assembly of the cytochrome complexes in cultured rat liver cells.
W. W. Hauswirth1 and P. J. Laipis,2 Depts. of lImmunology and Medical Microbiology; 2J. Hillis Miller
Health Center, University of Florida, Gainesville: Variational processes in bovine mtDNA.
N. Howell, Division of Radiation Therapy, Sidney Farber Cancer Institute, Boston, Massachusetts:
Mitochondrial PYR-IND mutations-Cellular origin, genetics, and effects on energy metabolism.
M. E. S. Hudspeth, D. S. Shumard, and L. I. Grossman, Dept. of Cellular and Molecular Biology,
University of Michigan, Ann Arbor: Achlya mtDNA contains an inverted repeat of rRNA genes.
J. Jayaraman and J. Ashraf, Dept. of Biochemistry, Madurai Kamaraj University School of Biological
Sciences, India: A specific protease for processing proteins made in the mitochondria?
M. F. Jubier,1 B. Lejeune,2 and F. Quetier,2 'Rockefeller University, New York, New York; 2Universite
Paris, Orsay, France: Heterogeneity of wheat mtDNA.
E. Keyhani and J. Keyhani, Institute of Biochemistry and Biophysics, University of Tehran, Iran:
Subunit I as a binding site of copper in cytochrome c oxidase in oxi mutants of the yeast Saccharo-
myces cerevisiae.
N. A. Khan, Dept. of Biology, Brooklyn College, New York, New York: Suppression of maltose-
negative phenotype by a nuclear gene in rho cells of yeast.
G. Kidane,1 J. Scott,2 T. Spithill,1 and L. Simpson12 1Biology Dept.; 2Molecular Biology Institute,
University of California, Los Angeles: Kinetoplast DNA minicircles from Leishmania tarentolae
can serve as autonomous replicating sequences in yeast.
C. M. Lazarus and H. Kuntzel, Abt. Chemie, Max-Planck-Institut filir Experimentelle Medizin, Got-
tingen, Federal Republic of Germany: Amplified mtDNA of Aspergillus amstelodami ragged
mutants-Assignments on homologous and heterologous restriction maps.
A. Lustig, D. Levens, and M. Rabinowitz, Depts. of Medicine and Biochemistry, University of Chi-
cago, Illinois: The biogenesis and regulation of mtRNA polymerase.
M. Mangin, G. Faugeron-Fonty, and G. Bernardi, Laboratoire de Genetique Moleculaire, Institut de
Recherche en Biologie Moleculaire, Paris, France: An investigation on the instability of a rear-
ranged mitochondrial genome from a spontaneous petite mutant.
University
Dept. of Physiological Chemistry, Johns I iopkins Medicine
J. C. Marini and P. T. Englund,
Baltimore, Maryland: Anomalous
electrophoretic behavior of a kinetoplast DNA restriction
'
fragment.
E. E. McKee, S. D. Power, G.
Bellus, J. McEwen, and .R. O. Poyton. Dent. of Microbiology
E of Connecticut Health Center, Farmington:
In vitro synthesis and membrane insertion
of mito-
chondrial
y
gene products.
M. M. K. Nass and M. A. D'Agostino,
Dept. of Radiation Therapy, University of Pennsylvania School
of Medicine, Philadelphia: Regulation
of mtDNA replication-Differential structural constraint
11-11
of Essex,
Colchester, England;
on the mtDNA polymerase in normal
and malignant cells.
Y. Pollack, J. Kasir, and G. Glaser,
Dept. of Cellular Biochemistry, Hebrew University-Hada
ahMedical School, Jerusalem, Israel: Characterization of a plasmid containing mouse mtDNA origins s
of replication.
D. Rickwood,' J. A. A.
2 1Chambers,' L. Robson,' and M. Barat, Dept. of Biology, University
2Universite Paris, Orsay, France: Proteins associated with mtDNA.
B.A. Roe, P. W. Armstrong, J. F. H. Wong, E. Y. Chen, A. Stankiewicz, D. P. Ma, and J. McDonough
Chemistry Dept., Kent State University, Ohio: Studies on mammalian mitochondrial tRNA'
C. Schmelzer and R. J. Schweyen, Genetisch-Mikrobiologisches Institut der Universitat
Munich, Federal Republic of Germany: Inhibition of mitochondrial translation blocks processing
of transcripts in yeast mitochondria.
E. P. Sena, Biology Dept., Case Western Reserve University, Cleveland, Ohio: Cytoduction of petite
genomes in yeast-Effects on the suppressivity of specific mitochondria! genomes.
K. Wakabayashi and T. Mabuchi, Dept. of Biochemistry, University of Yamanashi, Japan: Cloning of
yeast mtDNA.
G.-A. Wild and S. Werner, Institut fur Physiologische Chemie, Physikalische Biochemie and Zellbi-
ologie der Universitat Miinchen, Munich, Federal Republic of Germany: Biogenesis of cyto-
chrome oxidase in Neurospora crassa-Evidence that the mitochondrially made subunit 1 is
synthesized as a larger precursor in vitro.
Session 8: Genes of Filamentous Fungi
Chairperson: A. Kroon, State Groningen, The Netherlands
S. Yin and U. L. RajBhandary, Dept. of Biology, Massachusetts Institute of Technology, Cambridge:
DNA sequence of a cluster of tRNA genes and the 3' end of the large rRNA gene in Neurospora
crassa mitochondria.
A.M. Lambowitz,' H. Bertrand,2 G. Garriga,' D. M. Grant,' R. Vincent,' and R. A. Collins,' Dept. of
Biochemistry, St. Louis University Medical School, Missouri; 2Dept. of Biology, University of
Regina, Saskatchewan, Canada: RNA splicing in Neurospora mitochondria.
H. G. Kochel and H. Kuntzel, Abt. Chemie, Max-Planck-Institut fur Experimentelle Medizin, Gottin-
gen, Federal Republic of Germany: Nucleotide sequence and evolution of Aspergillus nidulans
mitochondrial genes.
H. Bertrand,' A.M. Lambowitz,2 R. A. Collins,2 R. Vincent,2 and G. Garriga,2 'Biology Dept., Univer-
sity of Regina, Canada; 2St. Louis University School of Medicine, Missouri: Regulation of mito-
chondrial biogenesis and RNA splicing in Neurospora.
P. van den Boogaart, J. Samallo, S. van Dijk, and E. Agsteribbe, Laboratory of Physiological Chemis-
try, State University, Groningen, The Netherlands: Structural and functional analysis of Neuros-
pora crassa mtDNA. I. Fine-mapping and base sequence analysis of the o/i/ region.
G. Macino, G. Morelli, and M. Melissari, Istituto di Fisiologia Generale, University di Roma, Italy:Cloning and sequencing of Neurospora crassa mitochondria! structural genes.
L. Belcour, 0. Begel, A.M. Keller, and C. Vierny, Centre de Genetique Moleculaire du CNRS,
Gif-sur-Yvette, France: Does senescence in Podospora anserina result from instability of the
mitochondrial genome?
K. Esser, U. Kuck, U. Stahl, and P. Tudzynski, Lehrstuhl fur Allgemeine Botanik, Ruhr-Universitht,
Bochum, Federal Republic of Germany: The Podospora plasmid causing senescence originatesfrom mtDNA.
G. Turner, A. Earl, and D. R. Greaves, Dept. of Bacteriology, University of Bristol, England: Does the
nuclear background select for species-specific mtDNA sequences in interspecies hybrids ofAspergillus?
P. Van't Sant, J. F. C. Mak, J. C. de Jonge, and H. de Vries, Laboratory of Physiological Chemistry,State University, Groningen, The Netherlands: Processing and integration of mitochondrial trans-lation products in wild-type Neurospora crassa and in a mitochondrial "stopper" mutant.
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Session 9: Genes of Animals, Plants, and Trypanozomes
Chairperson: G. Attardi, California Institute of Technology, Pasadena
F. J. Castora, R. Sternglanz, and M. V. Simpson, Dept. of Biochemistry, State University of New York,
Stony Brook: A new mitochondrial topoisomerase that catenates DNA and preliminary compari-
son with its nuclear counterpart.
W. M. Brown, Division of Biological Sciences, University of Michigan, Ann Arbor: Evolution of
mitochondrial genes in humans and apes.
D.C. Wallace, H. Blanc, N. Oliver, and C. W. Adams, Dept. of Genetics, Stanford University School
of Medicine, California: Human mitochondrial genes-A system for genetic and molecular
analysis.
C. J. Leaver, L. K. Dixon, and B.G. Forde, Dept. of Botany, University of Edinburgh, Scotland: Mito-
chondria! gene products and cytoplasmically inherited variation in higher plants.
T. D. Fox" and C. J. Leaver,' "Biocenter, University of Basel, Switzerland; 'Dept. of Biology, University
of Edinburgh, Scotland: The Zea maize mitochondrial gene coding cytochrome oxidase subunit
P.T. Englund, Dept. of Physiological Chemistry, Johns Hopkins School of Medicine, Baltimore,
Maryland: The replication of kinetoplast DNA.
L. Simpson,12 A. Simpson,' T. Spithill,1 and L. Livingston,' 'Biology Dept.; 'Molecular Biology Insti-
tute, University of California, Los Angeles: Sequence organization of maxicircle kinetoplast DNA
from Leishmania tarentolae.
Session 10: Genes of Plants, Protozoa, and Mammals
Chairperson: P. Borst, University of Amsterdam, The Netherlands
D. Grant' and K.-S. Chiang,' 'Dept. of Biochemistry, St. Louis University School of Medicine, Mis-
souri; 'Dept. of Biophysics and Theoretical Biology, University of Chicago, Illinois: The 512 mtDNA
molecules of the green alga Chlamydomonas reinhardtii-Some unexpected novel properties.
R. M. K. Dale, Dept. of Biology, Yale University, New Haven, Connecticut: Sequence homologies
among plant mtDNAs.
A. J. Bendich, Depts. of Botany and Genetics, University of Washington, Seattle: The mitochondrial
genome in plants-Another C-value paradox.
M. W. Gray, L. Bonen, D. Falconet, T. Y. Huh, M. N. Schnare, and D. F. Spencer, Dept. of Biochemis-
try, Dalhousie University, Halifax, Canada: Sequences of plant mitochondrial rRNAs and organi-
zation of their genes.
E. Bartnik, M. Kozlowski, and P. P. Stepieri, Dept. of Genetics, Warsaw University, Poland: Evolution
of mtDNA in the genus Aspergillus.
A. E. Pritchard and D. J. Cummings, Dept. of Microbiology, University of Colorado Health Sciences
Center, Denver: Sequence analysis of the initiation region of mtDNA from Paramecium aurelia.
Y. Suyama, Dept. of Biology, University of Pennsylvania, Philadelphia: Mapping native and imported
tRNAs in Tetrahymena mitochondria by two-dimensional urea-polyacrylamide gel electrophoresis.
A. Tait, Dept. of Genetics, University of Edinburgh, Scotland: The genetic control of mitochondrial
ribosomal proteins in paramecium.
C. Saccone,1 P. Cantatore,' R. Gallerani,' A. de Benedetto,' G. Gadaleta,1 C. Quagliariello,2 G. Pepe,1
C. Lanave,' and A.M. Kroon,3 'Centro di Studio sui Mitocondri e Metabolismo Energetico presso
Istituto di Chimica Biologica, University di Bari; 'Dipartimento di Biologia Cellulare, University
della Calabria, Italy; 3Laboratory of Physiological Chemistry, State University, Groningen, The
Netherlands: Rat mtDNA-Evolutionary considerations based on the nucleotide sequence analysis.
K. Koike, M Kobayashi, K. Yaginuma, T. Seki, and M. Imai, Gene Research Laboratory, Cancer
Institute, Tokyo, Japan: Structural feature of rat mitochondrial genome.
R. Sager, Division of Cancer Genetics, Sidney Farber Cancer Institute, Harvard Medical School,
Boston, Massachusetts: Studies of methylation in mtDNAs.
J. Solus and J. Eisenstadt, Dept. of Human Genetics, Yale University, New Haven, Connecticut:
Segregation of mtDNA species within mouse-Chinese hamster hybrid cell lines in response to
chloramphenicol and antimycin.
CH. Doersen and E. J. Stanbridge, Dept. of Microbiology, College of Medicine, University of Califor-
nia, Irvine: Nuclear and cytoplasmic inheritance of erythromycin resistance in human cells.
Session 11: Evolutionary Comparisons
Chairperson: R. Sager, Sidney Farber Cancer Institute, Boston, Massachusetts
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ofi yN sur-
rounding
University
n
and J. E. Newbold,' 'Curriculum in Genetic s
B. Greenberg," A. Sugino,i
2
Carolina, Chapel Hill; 2Laboratory
of Molecular Genetics, National Institute of Environmental
Health Sciences, Research Triangle
Park, North Carolina: Nucleotide sequence variability
rounding the origin of replication in human placental mtDNA.
R. L. Cann," W.M. Brown,2
and A. C. Wilson,' 'Dept. of Biochemistry, University of California,
Berkeley; 2Division of Biological Sciences,
University of Michigan, Ann Arbor: A mitochondrial
, Salt Lake City: T
dri'la'
perspective on human origins2.1
M. George, Jr." and A. C. Wilson,
Research Dept., San Diego Zoo, California; 2Dept. of Bio
h .
try, University of California, Berkeley:
Genealogical behavior of mtDNA.
D. R. Wolstenholme and J. M. Goddard, Dept.
of Biology, University of Utah
distribution among genes of nucleotide differences found between mtDNA molecules of domes-
ticated
e
and wild Rattus norvegicus.
G. Brown and M. V. Simpson, Dept. of Biochemistry, State University of New York, Sto Brook:r :
Sequence variability of the rat mitochondrial genome.
R. A. Lansman and J. C. Avise, Dept. of Molecular and Population Genetics, University of Georgia,
Athens: Sequence diversity of mtDNA within a single mammalian species.
J. M. Goddard, C. M.-R. Fauron, and D. R. Wolstenholme, Dept. of Biology, University of Utah, Salt
Lake City: Mitochondrial genomes from Drosophila species-Sequence studies of the A+T -ri
region and adjacent genes. ch
S. E. Kearsey and I. W. Craig, Dept. of Biochemistry, Genetics Laboratory, Oxford,
tide substitutions in the mitochondrial large rRNA genes from chloramphenicol-resistant mam-
malian cell lines.
A. Myers," E. Harris,2 D. Grant," J. Boynton,2 and N. Gillham," Depts. of 'Zoology and 2E3
University, Durham, North Carolina: Genetics and cytogenetics of the chloro plast genome
Chlamydomonas reinhardtii.
This meeting was partially funded by grants from the National Institutes of Health and theNational
Science Foundation.
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RNA Tumor Viruses, May 20-May 24
Arranged by John M. Coffin, Tufts University School of Medicine, George F. Vande Woude,National Cancer Institute
410 participants
Session 1: Provirus Synthesis, Structure, and Expression
Chairperson: H. Temin, University of Wisconsin, Madison
S.W. Mitra, M. Chow, and D. Baltimore, Massachusetts Institute of Technology, Cambridge: Repli-
cation of M-MuLV-The 5'-terminal sequences of plus-strand DNA synthesized de novo.
J. M. Taylor and T. W. Hsu, Institute for Cancer Research, Philadelphia, Pennsylvania: Studies on the
integration of retroviral DNA.
L. DesGroseillers, E. Rassart, and P. Jolicoeur, Institut de Recherches Cliniques de Montreal, Univer-
site de Montreal, Quebec, Canada: Molecular cloning of B- and N-tropic endogenous BALB/c
MuLV circular DNA intermediates -Isolation of infectious recombinant clones.
J. Chinsky and R. Soeiro, Depts. of Medicine and Cell Biology, Albert Einstein College of Medicine,
Bronx, New York: Fv-1 host restriction of F-MuLV-Analysis of unintegrated proviral DNA.
T. M. Shinnick, R. A. Lerner, and J. G. Sutcliffe, Research Institute of Scripps Clinic, La Jolla, Califor-
nia: Nucleotide sequence of M-MuLV.
C. Van Beveren, J. A. Galleshaw, P. J. van Straaten, and I. M. Verma, Tumor Virology Laboratory, Salk
Institute, San Diego, California: Complete nucleotide sequence of cloned M-MuSV DNA.
P. E. Montandon,' Y.-C. Lin,' J. Price,' F. Montandon,1 L. T. Bacheler,2 and H. Fan,' 'Salk Institute, San
Diego, California; 2Fels Research Institute, Philadelphia, Pennsylvania: Expression of M-MuLV
proviral DNA in productively infected fibroblasts.
E. P. Reddy, M. J. Smith, and S. A. Aaronson, NCI, National Institutes of Health, Bethesda, Maryland:
Complete nucleotide sequence of the M-MuSV genome.
S. Broome, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: An RSV gag
gene product modulates mRNA levels in transfected cells.
J. Hoffmann,' D. Steffen,2 and R. A. Weinberg,' 'Massachusetts Institute of Technology, Dept. of
Biology and Center for Cancer Research, Cambridge; 2Worcester Foundation for Experimental
Biology, Massachusetts: Methylation affecting the expression and DNA infectivity of MuLV
proviruses.
C. M. Stoltzfus, R. Dane, and T. Ficht, Dept. of Microbiology, University of Iowa, Iowa City: Synthe-
sis and processing of avian retroviral RNA in normal and S-adenosylmethionine-depleted chicken
embryo fibroblasts.
R. Swanstrom,1 P. Hackett,2 J. M. Bishop,' J. Majors,' and H. E. Varmus,"Dept. of Microbiology and
Immunology, University of California, San Francisco; 2Dept. of Genetics and Cell Biology, Univer-
sity of Minnesota, St. Paul: Characterization of the spliced leader sequences of RSV and MMTV
mRNAs.
D. Schwartz,' R. Tizard,1 W. Gilbert,' J. Taylor,' and R. Guntaka,3 'Harvard University, Cambridge,
Massachusetts; 2lnstitute for Cancer Research, Fox Chase, Philadelphia, Pennsylvania; 3Columbia
University, New York, New York: Localization of the splice junctions in the subgenomic mRNAs
of RSV.
Session 2: Provirus Expression and Exploitation
Chairperson: J. Taylor, Institute for Cancer Research, Fox Chase, Pennsylvania
D. Bryant, G. Gilmartin, and J. T. Parsons, Dept. of Microbiology, University of Virginia Medical
School, Charlottesville: In vitro mutagenesis of the RSV genome.
T. Pugatsch, B. Cullen, and D. W. Stacey, Roche Institute of Molecular Biology, Nutley, New Jersey:
Localization of biological functions on cloned ALV DNAs using site-specific mutagenesis and
microinjection.
B. Mermer, M. H. Malamy, and J. M. Coffin, Dept. of Molecular Biology and Microbiology, Tufts
University School of Medicine, Boston, Massachusetts: Part of the avian tumor virus genome can
drive expression of the lac operon in E. coli in fusion vectors which require both transcriptional
and translational signals.
S. Fuhrman, F. Keppe1,1 C. Van Beveren, 2 E. P. Geiduschek," and I. M. Verma,2 "University of Califor-
nia, La Jolla; 2Salk Institute, San Diego, California: In vitro transcription of molecularly cloned
murine retroviral DNAs.
G. L. Hager and M. C. Ostrowski, Laboratory of Tumor Virus Genetics, NCI, National Institutes of
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University of
presence and
Maryland: Murine type-C renovituses miltain transcriptionHealth, Bethesda,
Biochemistry and Biophysics,function in vitro.
D. S. Ucker, G. L. Firestone, and K. R. Yamamoto, Dept. of Bloc
MMTV DNA.
California, San Francisco: Characterization of MuMIV RNAs produced in the
In vitro
absence of glucocorticoid-stimulated transcription.
F. Lee," B. Diecknnann,1 P. Berg,2 R. Mulligan,2 and G. Ringold,1 Depts. of 'Pharmacology and
2Biochemistry, Stanford Medical School, California: Glucocorticoid stimulated expression of
dihydrofolate reductase cDNA in CHO cells-Hormonal sensitivity is imparted by
MMTV LTR.
C. Dickson, R. Smith, and G. Peters, Imperial Cancer Research Fund, London, England: I
,
synthesis of proteins encoded by the LTR of MMTV DNA.
L.A. Donehower and G. L. Hager, Laboratory of Tumor Virus Genetics, NCI, National Institutes of
Health, Bethesda, Maryland: Further evidence for the protein-coding potential of the
promo'
ter
L. McClements,' D. G. Blair,2 M. L. McGeady,' and G. F. Vande Woude,' 'NCI, National Institut
2Laboratory of Viral Carcinogenesis, National Career Institute, Frederickesof Health, Bethesda;
Maryland: Use of a retroviral sequence as a cloning vehicle.
M. J. Murray, D. Cowing, and R. A. Weinberg, Dept. of Biology and Center for Cancer Research
Massachusetts Institute of Technology, Cambridge: The use of a retroviral transcriptional c '
t'
 to activate a dihydrofolate reductase cDNA in mammalian cells.
K. Shimotohno and H. Temin, McArdle Laboratory for Cancer Research, University of Wisconsi
n
Madison: Retroviral (SNV) DNA as a possible vector for delivery of foreign DNA (HSV tk gene) to
vertebrate cells.
C.-M. Wei,' M. L. Gilson,' P. Spear,' and E. M. Scolnick,3 Laboratories of 'Viral Carcinogenesis, and
'Tumor Virus Genetics, NCI, National Institutes of Health, Bethesda, Maryland; Department
o
fMicrobiology, University of Chicago, Illinois: Construction and isolation of a transmissible retr
virus containing the src gene of Ha-MuSV and the tk gene of HSV-1.
Session 3: Poster Session: Provirus Synthesis, Structure, and Function Transforming Genes
C. Omer, E. Retzel, K. Staskus, and A. Faras, Dept. of Microbiology, University of Minnesota,
Minneapolis: Nature of the early events during reverse transcription by the RSV polymerase in
vitro.
J. Hillova,' M. R. Mariage-Samson,' M. Marx,' J. Belehradek, and E. Puvion,3 'Equipe deRecherche du CNRS, Institut de Cancerologie et d'Immunogenetique; 2lnstitut Gustave-Roussy;
'Laboratoire de Microscopie Electronique, Institut de Recherches Scientifiques sur le Cancer,
Villejuif, France: Integration patterns of RSV provirus in RSV-transformed Chinese hamster cells
suggesting transpositions of the provirus.
A. Richter,' H. Ozer,' and P. Jolicoeur,"Institut de Recherches Cliniques de Montreal, Universite
de Montreal, Quebec, Canada; 'Dept. of Biological Sciences, Hunter College, CUNY, New York:
MuLV replication in mouse fibroblasts temperature sensitive for cellular DNA synthesis.
S. Duttagupta, S. Saltzman, and R. Soeiro, Depts. of Medicine and Cell Biology, Albert Einstein
College of Medicine, Bronx, New York: Fv-1 host restriction of F-MuLV-Origin of NB-tropic
host-range variants.
S.M. Molineaux and J. E. Clements, Johns Hopkins University, Baltimore, Maryland: Analysis of thegenetic organization of visna virus using cloned viral DNA.
M. S. Reitz, R. Wong-Staal, and C. D. Trainor, NCI, National Institutes of Health, Bethesda, Mary-
land: Comparative restriction nuclease mapping of unintegrated proviruses of gibbon ape and
woolly monkey type-C viruses.
M. L. Scott, K. Fry, and H. S. Kaplan, Cancer Biology Research Laboratory, Stanford University School
of Medicine, California: Molecular cloning and partial nucleotide sequence characterization ofGALV.
A. Habara, E. P. Reddy, T. Storch, and S. A. Aaronson, NCI, National Institutes of Health, Bethesda,
Maryland: Molecular cloning of integrated R-MuLV proviral DNA.
S. L. Voynow and J. M. Coffin, Dept. of Molecular Biology and Microbiology, Tufts University School
of Medicine, Boston, Massachusetts: Characterization of a highly deleted, rapidly replicating
variant of RSV.
J.J. O'Rear, K. Shimotohno, and H. Temin, McArdle Laboratory for Cancer Research, University ofWisconsin, Madison: High-frequency variation in retroviral DNA.
J. J. Kopchick, G. Ju, A.M. Skalka, and D. W. Stacey, Roche Institute of Molecular Biology, Nutley,New Jersey: Biological activity of cloned retroviral DNA in microinjected cells.B. R. Cullen, J. J. Kopchick, and D. W. Stacey, Roche Institute of Molecular Biology, Nutley, NewJersey: ALV genomes containing regions of exogenous nucleic acid are functional in chickenfibroblasts.
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N. Hynes," B. Groner,' N. Kennedy,' U. Rahmsdorf,' L. Fabiani,1 R. Michalides,2 and R. Nusse,2
'Kernforschungszentrum Karlsruhe, German Democratic Republic; 2Dutch Cancer Institute,
Amsterdam, The Netherlands: The expression of a molecularly cloned MMTV provirus is
hormone-dependent following its transfer into cultured cells.
E. Buetti, D. Owen, and H. Diggelmann, Swiss Institute for Experimental Cancer Research, Epalinges,
Switzerland: Biological activity of molecularly cloned MMTV DNA in transfected cells. a
L. D. Johnson, R. G. Wolford, D. S. Berard, and G. L. Hager, Laboratory of Tumor Virus Genetics, NCI,
National Institutes of Health, Bethesda, Maryland: Molecular clones of MuMTV endogenous unit
V are hormonally responsive.
P. Luciw,1 M. Capecchi,2 J. M. Bishop,' and H. Varmus," 'University of California, San Francisco;
2University of Utah, Salt Lake City: Needle microinjection of cloned ASV DNA into mammalian
cells-Analysis of retrovirus integration and gene expression.
J. Sorge and S. Hughes, Cold Spring Harbor Laboratory, New York: ASV vectors.
J. Doehmer,' M. Barinaga,2 D. Jolly,2 M. Gilmore-Hebert,' R. Evans,' T. Friedmann,2 and I. M.
Verma,1 'The Salk Institute, San Diego; 2University of California, La Jolla: Retroviral DNAs as
eukaryotic gene cloning vectors.
A. Bernstein, A. Joyner, and Y. Yamamoto, Ontario Cancer Institute, Toronto, Canada: The LTR of
Friend SFFV activates expression of the HSV-1 tk gene.
C. Tabin, S. Goff, M. Murray, D. Baltimore, and R. A. Weinberg, Center for Cancer Research and
Dept. of Biology, Massachusetts Institute of Technology, Cambridge: Transfection of cloned
retroviral DNAs and selectable markers.
G. W. Notani, Depts. of Oral and Medical Microbiology, University of Minnesota, Minneapolis:
Expression of RSV and MuMTV nucleotide sequences in E. coli.
D. Stehelin,1 S. Salle," M. B. Raes," C. Lagrou," H. Beug,2 and T. Graf,21INSERM, Institut Pasteur,Lille,
France; 2German Cancer Research Center, Heidelberg, Federal Republic of Germany:The avian
cell DLV-related oncogenes are transcribed in immature hematopoietic cells.
R. C. Parker, H. E. Varmus, and J. M. Bishop, Dept. of Microbiology and Immunology, University of
California, San Francisco: Isolation and characterization of the region of the chicken chromo-
some containing c-src, the endogenous homolog of the RSV transforming gene.
T. Takeya,1 R. Junghans,2 G. Ju,2 A.M. Skalka,2 and H. Hanafusa,1 'Rockefeller University, New York,
New York; 2Roche Institute of Molecular Biology, Nutley, New Jersey: Gene structure of cellular
src and viral src of RSV.
D. Shalloway, A. D. Zelenetz, and G. M. Cooper, Dept. of Pathology, Sidney Farber Cancer Institute,
Harvard Medical School, Boston, Massachusetts: Molecular cloning and characterization of the
chicken gene homologous to the transforming gene of RSV.
J. Lautenberger,1 R. Schulz,' C. Goron,2 P. Tsichlis,1 D. Spyropoulos,1 T. Pry,' K. Rushlow,1 and T.
Papas,' Laboratories of 'Tumor Virus Genetics, NCI, and 2Biology of Viruses, NIAID, National
Institutes of Health, Bethesda, Maryland: Molecular cloning of avian myelocytomatosis virus
(MC29) transforming sequences.
K. Bister,1 G. Ramsay,2 M. Hayman,2 and P. Duesberg,1 1Dept. of Molecular Biology, University of
California, Berkeley; 2lmperial Cancer Research Fund, London, England: Definition of the one
gene of MC29-subgroup viruses using deletion mutants and molecularly cloned fragments of
MC29 proviral DNA.
C. Pachl, M. Linial, R. Eisenman, and M. Groudine, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Analysis of the cellular gene related to the oncogene of avian myelocytoma-
tosis virus (MC29).
S. Pfeifer, R. Pettersson, A. Vaheri, and N. Oker-Blom, Dept. of Virology, University of Helsinki,
Finland: Acute ALV, OK10, has a large, 8.2-kb genome and a modified glycoprotein gp78.
S. Saule, A. Sergeant, G. Torpier, C. Lagrou, M. B. Raes, and D. Ste6helin, Molecular Oncology,
INSERM, Pasteur Institute, Lille, France: OK10-transformed cells contain subgenomic mRNAs
that
could code for a non-gag-related transforming protein.
C. Moscovici and M. Giovannella Moscovici, University of Florida, Gainesville: Isolation of a is
mutant from AMV.
L. H. Evans' and P. H. Duesberg,2 'National Institutes of Health, Laboratory of Persistent
Viral Dis-
eases, Rocky Mountain Laboratories, Hamilton, Montana; 2Dept. of
Molecular Biology, University
of California, Berkeley: Direct identification of M-MuSV transforming sequences by
deletion
analysis-A transformation-defective deletion mutant.
A. Terebal and M. M. C. Lai,2 'Division of Virology, St. Jude Children's Research
Hospital, Memphis,
Tennesee; 2Dept. of Microbiology, University of Southern California
Medical Center, Los
Angeles: Chromosomal localization of cell oncogenes in White Leghorn chickens.
M. M. C. Lai,' T. C. Wong,' R. S. Cohen," and S. S. F. Hu ,2 1 Dept. of Microbiology, University
of
Southern California School of Medicine, Los Angeles; 2Dept. of Pediatrics,
City of Hope Medical
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Center, Duarte, California: Avian REV contains a new
class of oncogene of unusual strut turd (Ind
origin.
I. S. Y. Chen,' T. Mak,2 J. J. O'Rear," and H.
M. Temin,' 1McArdle Laboratory for Cancer Research,
University of Wisconsin, Madison; 'Ontario Cancer Institute, Toronto, Canada: Molecular char-
acterization of REV strain T.
D. Blair, W. McClements, M. Oskarsson, and G.
Vande Woude, NCI, National Institutes of Health,
Frederick and Bethesda, Maryland: The efficient activation of M-MuSV provirus V-mos transfor-
mation by cotransfection with cloned LTR sequences.
M. Jones, M. H.-T. Lai, R. A. Bosselman, and I. M. Verma, Tumor Virology Laboratory, Salk Institute,
San Diego, California: Identification and characterization of mammalian and human cellular
sequences homologous to the transforming gene of M-MuSV.
P. R. Andersen, S. R. Tronick, and S.A. Aaronson, NCI, National Institutes ofBALE -MSV.
Bethesda,
Maryland: Molecular cloning and structural organization of an MSV,
K. Prakash, S. R. Tronick, A. Eva, S. Devare, E. P. Reddy, A. Srinivasan, and S. A. Aaronson, NCI,
National Institutes of Health, Bethesda, Maryland: Analysis of sequences in human DNA related
to the transforming genes of murine transforming viruses.
B. Dale, T. Wheeler, and B. Ozanne, University of Texas Health Science Center, Dallas: Characteri-
zation of mouse nucleic acid sequences homologous to Ab-MuLV.
A. Srinivasan, E. P. Reddy, C. Y. Dunn, and S. A. Aaronson, NCI, National Institutes of Health,
Bethesda, Maryland: Functional organization of Ab-MuLV genome.
T. Ryder," E. Ohtsubo," and N. Tsuchida,2 "Dept. of Microbiology, State University of New York,
Stony Brook; 2Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania: Localization
of the transforming gene of K-MuSV and nucleotide sequencing of the LTRs.
A. Hampe," I. Laprevotte," F. Galibert," J. Even,' L. A. Fedele,2 and C. J. Sherr,21Laboratoire d'Hema-
tologie Experimentale, Hospital Saint Louis, Paris, France; 'Viral Pathology Section, NCI, National
Institutes of Health, Bethesda, Maryland: Nucleotide sequence analysis of proviral DNA from ST
FeSV.
G. Franchini, F. Wong-Staal, R. Dalla Favera, and R. C. Gallo, Laboratory of Tumor Cell Biology, NCI,
National Institutes of Health, Bethesda, Maryland: Isolation and characterization of the human
one gene related to the transforming gene (v-fes) of the ST FeSV.
E. Gelmann, R. C. Gallo, and F. Wong-Staal, Laboratory of Tumor Cell Biology, NCI, National Insti-
tutes of Health, Bethesda, Maryland: Molecular cloning of the SiSV, its helper (SSAV) and
helper virus genomes.
R. Dalla Favera, E. Gelmann, F. Wong-Staal, and R. C. Gallo, Laboratory of Tumor Cell Biology, NCI,
National Institutes of Health, Bethesda, Maryland: Detection and genomic organization of the
human SiSV-related oncogene (c-sis).
B.G. Neel, L.-H. Wang, T. Hanafusa, B. Mathey-Prevot, H. Hanafusa, and W. S. Hayward, Rockefeller
University, New York, New York: Isolation of a new acute transforming virus from an ALV-
induced fibrosarcoma.
L.-H. Wang," R. Feldman,' M. Shibuya,1 H. Hanafusa," M. F. D. Notter,2 and P. C. Balduzzi,2 'Rocke-
feller University, New York, New York; 'Dept. of Microbiology, University of Rochester, New
York: ASVs UR1 and UR2. II. Genetic structure and gene products.
T. Curran and N. Teich, Dept. of Viral-mediated Differentiation, Imperial Cancer Research Fund,
London, England: Characterization of FBJ murine-osteosarcoma-virus-transformed nonproducer
cells and identification of transformation-specific 39,000 -Balton protein.
Session 4: Poster Session: Virion Structure and Assembly; Transforming Proteins
T. D. Copeland and S. Oroszlan, Biological Carcinogenesis Program, Frederick Cancer ResearchCenter, Frederick, Maryland: Synthetic peptide substrates for type-C-RNA-tumor-virus-associatedproteolytic enzyme.
L. I. Messer,' J. G. Levin,' and S. K. Chattopadhyay,2
'NICHD; 'NCI, National Institutes of Health,Bethesda, Maryland: Differential stability of viral message and virion precursor RNA in MuLV-infected cells.
Y. Yoshinaka and R. B. Luftig, Dept. of Microbiology and Immunology, University of South CarolinaSchool of Medicine, Columbia: In vitro processing of Gz-MSV-associated Pr65g"g by the partiallypurified M-MuLV proteolytic factor.
M. Satake and R. B. Luftig, Dept. of Microbiology and Immunology, University of South CarolinaSchool of Medicine, Columbia: Immunofluorescent localization of MuLV-derived gp70 as com-pared to p15E and Pr65"g antigens associated with the cell membrane of infected cells.D. Borchelt, R. Resnick, and M. L. Perdue, Division of Experimental Pathology, University of Ken-
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tucky Medical Center, Lexington: Translation products of ASV RNA as markers in hybrid-arrested
translation analyses.
S. A. Whiteley and R. B. Naso, Dept. of Tumor Virology, University of Texas, M. D. Anderson Hospital
and Tumor Institute, Houston: Intracellular precursor polyproteins of SiSV(SSAV), GALV, and
related human retroviruses.
J. Bradac, S. Chatterjee, and E. Hunter, Dept. of Microbiology, University of Alabama, Birmingham:
Virus-specific protein synthesis in cells infected with M-PMV.
S.A. Maxwell and R. B. Arlinghaus, Dept. of Tumor Virology, University of Texas, M. D. Anderson
Hospital and Tumor Institute, Houston: In vitro proteolytic cleavage of Gz-MuSV p65gag.
A. Tanaka and A. Kaji, University of Pennsylvania, Philadelphia: A transformation-defective RSV
mutant with altered p19 of the gag gene-Inhibitory effect of this mutant on host cell growth.
W. S. Kloetzer and R. B. Arlinghaus, Dept. of Tumor Virology, University of Texas, M. D. Anderson
Hospital and Tumor Institute, Houston: Purification of a p10-associated protein kinase from
M-Mu LV.
E. C. Murphy, Jr., University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston:
Cell-free translation and size analysis of intracellular virus-specific RNA in a polymerase-defective
variant of M-MuLV.
T. Lerner and H. Hanafusa, Rockefeller University, New York, New York: The natureof the polyme-
rase defect in BH-RSVa-Protein and nucleic acid studies.
J. H. Weiss and A. J. Faras, Dept. of Microbiology, University of Minnesota, Minneapolis: Analysis of
the avian retrovirus reverse transcriptase using monoclonal antibodies and molecular cloning
procedures.
J. A. Bilello and P. M. Pitha, Johns Hopkins Oncology Center, Baltimore, Maryland: Effect of mouse
fibroblast interferon on the synthesis, processing, glycosylation, and shed of Friend and AKR-MCF
viral proteins.
H. Niman and J. Elder, Research Institute of Scripps Clinic, La Jolla, California: Molecular dissection
of Rauscher gp70 with monoclonal antibodies-A progress report.
J. Elder,' T. Kawakami,2 and R. Smith,3 'Research Institute of Scripps Clinic, La Jolla, California:
2Comparative Oncology Laboratory, University of California, Davis; 3Laboratory of Tumor Cell
Biology, NCI, National Institutes of Health, Bethesda, Maryland: Peptide fingerprint comparisons
of the surface glycoproteins of gibbon ape and woolly monkey retroviruses.
L. O. Arthur, T. D. Copeland, S. Oroszlan, and G. Schochetman, Biological Carcinogenesis Program,
Frederick Cancer Research Center, Frederick, Maryland: Processing and amino acid sequence
analysis of the MMTV env gene product.
G. L. Firestone, F. Payvar, and K. R. Yamamoto, Dept. of Biochemistry and Biophysics, University of
California, San Francisco: MMTV-infected HTC cells with defects in steroid-hormone-dependent
viral gene transcription and viral glycoprotein processing.
A. Sen,' J. C. Nei1,2 J. Ghuysdael,2 P. K. Vogt,2 and R. A. Lerner,' 'Cellular Biology and Immunopathol-
ogy Departments, Research Institute of Scripps Clinic, La Jolla, California; 2Dept. of Microbiology,
University of Southern California School of Medicine, Los Angeles: A chemically synthesized
peptide fragment containing the active tyrosine of RSV pp60s" allows immunological studies on
the src gene activities in transformed cells.
M. Yoshida and N. Kitamura, Dept. of Viral Oncology, Cancer Institute, Tokyo, Japan: Novel dele-
tion mutants in src of RSV showing unique transformation activity.
D. J. Fujita, J. Bechberger, and I. Nedic, Cancer Research Laboratory and Dept. of Biochemistry,
University of Western Ontario, London, Canada: Mutants of RSV which affect transformed-cell
morphology and exhibit altered pp60'" molecules.
J. Ghysdael, J. C. Neil, and P. K. Vogt, Dept. of Microbiology, University of Southern
California, Los
Angeles: Structural properties of ASV transformation-specific proteins.
L. Rohrschneider, M. Rosok, and K. Shriver, Fred Hutchinson Cancer Research Center,
Seattle,
Washington: Transformation parameters associated with pp60 s" adhesion plaques.
A. Barnekow, C. B. Boschek, A. Ziemiecki, and H. Bauer, Institut fur Virologie, Fachbereich
Human-
medizin Giessen, Germany: Biochemical and functional aspects of
extracellular RSV pp60su.
E. A. Garber and A. R. Goldberg, Rockefeller University, New York, New York: Novel
localization of
pp6Os" in RSV-transformed rat and goat cells and in chicken cells transformed
by viruses rescued
from these mammalian cells.
K. Moelling, P. Donner, M. K. Owada, T. Bunte, and I. Greiser-Wilke, Max-Planck-Institut
fur
Molekulare Genetik, Berlin, Federal Republic of Germany:
Characterization of the ASV trans-
forming gene product.
Hawaii, Honolulu;
,"Dept. of Microbiology, Cancer Center, University ofA. Lau,' A. Faras,2 R. Mitche11,2 and C. Collins
2Dept. of Microbiology, University of Minnesota,
Minneapolis; 3University o
Virginia School of Medicine, Charlottesville: ASV-transformed and revertant
field vole cells-
pp60s", cellular protein substrates, and arrangement of the integrated
ASV genome.
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T. Gilmore and G. S. Martin, Dept. of Zoology, University of ( alifor Rid , Berkeley: I yrosine-spe, ifi(
phosphorylation of the 50K polypeptide associated hwith. jt)p6(L)j,
UniversityB. Gallis, P. Bornstein, and D. L. Brautigan, Dept. of loc mis.ry, rsi Washington, Seattle:
Specific inhibition of phosphotyrosyl-protein phosphatase in membrane vesicles by m. i ( romoldr
levels of Zn- .
S. Amini and A. Kaji, Dept. of Microbiology, University of Pennsylvania Sc hool of Medicine, Phila-delphia: Localization of PP 36K, the presumed target protein for the src protein kinase of RSV, tothe membrane of chicken cells transformed by RSV.
J. G. Burr, Dept. of Biology, Massachusetts Institute of Technology, Cambridge: Phosphorylation of
a 68,000-dalton protein in the cytoskeletal structures of RSV-transformed cells.
B. Sefton, T. Patschinsky, T. Hunter, J. Cooper, and F. Esch, Salk Institute, San Diego, California:
Tyrosine phosphorylation and cellular transformation.
K. Beemon and B. Adkins, Salk Institute, San Diego, California: Tyrosine phosphorylation of cellular
proteins implicated in transformation by four classes of retroviruses.
I. U. Ali,' S. Rasheed,' and T. Hunter,3 'Meloy Laboratories, Rockville, Maryland; 'Department
ofPathology, University of Southern California, Los Angeles; 'Salk Institute, San Diego, California:
Structural analysis of fibronectins from normal and transformed cells.
W.-H. Lee,' K. Bister,' C. Moscovici,2 and P. Duesberg,' 'Dept. of Molecular Biology, University
ofCalifornia, Berkeley; 'Virus Research Laboratory, Veterans Administration Hospital, Gainesville,
Florida: ts mutants of Fujinami sarcoma virus-Tumorigenicity and reversible phosphorylation
ofthe transforming protein.
B. Adkins, T. Hunter, and K. Beemon, Salk Institute, San Diego, California: PRCII ASV-Comparative
characterization of the in vivo and in vitro synthesized transforming protein.
G. Ramsay,' T. Graf,' and M. J. Hayman,' 'Imperial Cancer Research Fund, London, England;2Deutsches Krebsforshungszentrum, Heidelberg, Federal Republic of Germany: Tryptic peptide
mapping of the fusion proteins of MC29 virus mutants.
J. H. Chen' and S.M. Anderson,' 'Life Sciences Biomedical Research Institute, St. Petersburg, Flor-ida; 'Rockefeller University, New York, New York: In vitro translation of AMV RNA.S. Harmon,'" and S. Wright,13 'Dept. of Biology; 'Dept. of Medicine, and Cellular, Viral and Molec-
ular Biology, University of Utah, Salt Lake City; 'Viral Oncology Laboratory, Veterans Administra-tion Medical Center, Salt Lake City, Utah: In vitro translation of AMV genomic RNA yields a92,000 -Balton protein with gag determinants.
L. Privalsky," B. Vennstrom,2 and J.M. Bishop,' 'University of California Medical Center, SanFrancisco; 'University of Uppsala, Sweden: Polypeptides specified by the erb region of AEV.M.A. Boss, G. Dreyfuss, and D. Baltimore, Dept. of Biology, Center for Cancer Research, Massachu-
setts Institute of Technology, Cambridge: Localization of the Ab-MuLV protein in a detergent-insoluble matrix-Architecture of the protein.
C. Machida,12 and D. Kabat, Depts. of 'Microbiology and Immunology,
'Dept. of Biochemistry,University of Oregon Health Sciences Center, Portland: Identification of an Ab-MuLV encodedprotein related to p120 on the plasma membrane of transformed lymphoid cells.J. P. Horn,' T. G. Wood,' E. C. Murphy,' R. L. Brown,3 R. Junghans,4 D. G. Blair,' and R. B. Arlinghaus,'
'Dept. of Tumor Virology, University of Texas, M. D. Anderson Hospital and Tumor Institute,Houston; 'NCI, National Institutes of Health, Bethesda;
'Frederick Cancer Research Center, Fred-erick, Maryland; 4Roche Institute of Molecular Biology, Nutley, New Jersey: A selective ts defectin gag-src viral RNA expression in cells infected with a ts mutant of MuSV.A. Sen and A. Cresse, Cellular Biology Department, Research Institute of Scripps Clinic, La Jolla,California: Purified protein kinase from MSV particles catalyzes preferential phosphorylation ofcertain proteins present in MSV-transformed cells.
H. A. Young,' C.-C. Li,' R. W. Ellis,' and S. Rasheed,' 'Biological Carcinogenesis Program, FrederickCancer Research Center, Frederick Maryland; 'Laboratory of Tumor Virus Genetics, NCI,National Institutes of Health, Bethesda, Maryland; 'Dept. of Pathology, University of SouthernCalifornia School of Medicine, Los Angeles: Analysis of the transforming gene of Rasheed ratsarcoma virus.
M. E. Furth, J. Maryak, A. Papageorge, and E. M. Scolnick, Laboratory of Tumor Virus Genetics, NCI,National Institutes of Health, Bethesda, Maryland: Characterization of the p21 src protein of HaSVand related proteins using monoclonal antibodies.
H. W. Snyder, Jr. and M. Singhal, Memorial Sloan-Kettering Cancer Center, New York, New York:Characterization of protein kinase activity associated with transforming gene products of the STand GA strains of FeSV.
A. Chen,' M. Kelliher,' F. de Noronha,' and M. Essex,"Dept. of Microbiology, Harvard UniversitySchool of Public Health, Boston, Massachusetts;
'Dept. of Veterinary Pathology, Cornell Univer-sity, Ithaca, New York: Expression of FeSV "gag-fes" in cultivated cat tumor cells.M. Barbacid, NCI, National Institutes of Health, Bethesda, Maryland: The McDonough strain of
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FeSV-Another retrovirus whose transforming gene products possess an associated protein kinase
activity specific for tyrosine residues.
H.-1. Thiel, T. J. Matthews, and E. M. Broughton, Dept. of Surgery, Duke University Medicial Center,
Durham, North Carolina: Transformation by SiSV-Expression of antigens in non-producer cells.
Session 5: Virion Structure and Assembly
Chairperson: J. Elder, Research Institute of Scripps Clinic, La Jolla, California
E. Hunter,' A. Bhown,1 A. D. Schwartz,2 and R. Eisenman,3 'Dept. of Microbiology, University of
Alabama, Birmingham; 2The Biological Laboratories, Harvard University, Cambridge, Massachu-
setts; 3Hutchinson Cancer Center, Seattle, Washington: Organization and processing of the gag
gene product of RSV.
L. E. Henderson,' C. Van Beveren,2 T. D. Copeland; R. J. Versteegen,1 I. M. Verma,2 and S. Oroszlan;
'Biological Carcinogenesis Program, Frederick Cancer Research Center, Frederick, Maryland;
2Tumor Virology Laboratory, Salk Institute, San Diego, California: Primary structure of MuLV
Pr65g" determined by protein and nucleic acid sequencing.
W. N. Burnette, C. van Beveren, I. M. Verma, and H. Fan, Salk Institute, San Diego, California:
Biosynthesis of MuLV gag polyproteins-Implications from nucleic acid sequence studies.
J. Leis and G. Duyk, Dept. of Biochemistry, Case Western Reserve University, Cleveland, Ohio:
Nucleotide sequences of AMV p19-protein-binding sites on RSV (Pr-C) RNA.
S. Johnson,' M. Veigel,' T. Vanaman,' and J. Leis,' 'Dept. of Microbiology and Immunology, Duke
University Medical Center, Durham, North Carolina; 2Dept. of Biochemistry, Case Western
Reserve University, Cleveland, Ohio: Isolation of a cyanogen bromide peptide of AMV p19
protein that contains its RNA binding site.
Y. Yoshinaka and R. B. Luftig, Dept. of Microbiology and Immunology, Universityof South Carolina
School of Medicine, Columbia: Two MuLV protein kinase activities and their possible functions.
D. P. Grandgenett,1 T. K. Misra; and J. T. Parsons,2 1St. Louis University Medical Center, Missouri;
2University of Virginia, Charlottesville, Virginia: Avian retrovirus pp32 protein-Specific binding
sites on retroviral DNA terminal repeats.
E. Hunter,1 M. Hardwick,' G. Davis,' A. Brown,' and D. Schwartz,2 'Dept. ofMicrobiology, University
of Alabama, Birmingham; 2The Biological Laboratories, Harvard University, Cambridge, Massa-
chusetts: Organization and processing of the env gene product of RSV.
N. Green,' T. M. Shinnick; 0. Witte,2 A. Ponpicelli,2 J. G. Sutcliffe,' and R. A. Lerner; 'Research
Institute of Scripps Clinic, La Jolla; 2University of California, Los Angeles: Sequence-specific
antibodies reveal that the maturation of M-MuLV envelope polyprotein involves the removal of a
carboxyterminal peptide.
A. Schultz, T. Copeland, L. Henderson, and S. Oroszlan, Biological Carcinogenesis Program, Freder-
ick Cancer Research Center, Frederick, Maryland: Virion- and cell-associated proteins coded by
the 3' end of the env gene of MuLV.
R. Massey and G. Schochetman, Biological Carcinogenesis Program, Frederick Cancer Research
Center, Frederick, Maryland: Monoclonal antibodies define domains on an MMTV env gene
product involved in infectivity and oncogenicity.
N. A. Wivel,1 J. A. Bilello,2 and P. M. Pitha,2 "National Institutes of Health, Bethesda; 2Johns Hopkins
School of Medicine, Baltimore, Maryland: Changes in the pattern of assembly of MCF virus in
interferon-treated mouse cells.
R. Naso, Y.-H. Wu, and C. Edbauer, Dept. of Tumor Virology, University of Texas, M. D. Anderson
Hospital and Tumor Institute, Houston: Antiretroviral action of interferon.
S. Chatterjee,1 H. C. Cheung,2 and E. Hunter," Depts. of 'Microbiology, and 2Biomathematics, Uni-
versity of Alabama, Birmingham: Interferon inhibition of primate retroviral fusion and replication-
A common effect of membrane stiffening?
Session 6: Viral and Cellular one Genes
Chairperson: D. Stehelin, Institut Pasteur, Lille, France
D. Sheiness, T. Gonda, B. Vennstrom, G. Payne, and J. M. Bishop, Dept. of
Microbiology, University
of California, San Francisco: Structure and expression in various tissues
of cellular homologs of
viral oncogenes: c-myc, c-myb, c-erb, and c-src.
N1. Shibuya, L.-H. Wang, and H. Hanafusa, Rockefeller University, New York,
New York: Structure
and expression of Fujinami sarcoma virus unique sequence and related cellular sequences.
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Biosynthesis of the p21 src protein of Ha-MuSV.
Session 10: Viral Leukemogenesis
Chairperson: P. Neiman, Fred Hutchison Cancer Center, Seattle, Washington
B. G. Neel,' C. E. Rogler,2 G. P. Gasic," A. M. Skalka,3 S.M. Astrin,2 and W. S. Hayward,' "Rockefeller
University, New York, New York; 2lnstitute for Cancer Research, Philadelphia, Pennsylvania;
3Roche Institute of Molecular Biology, Nutley, New Jersey: Molecular cloning of virus-cell junc-
tions from ALV-induced lymphomas.G. P. Gasic; B. G. Neel,' C. E. Rogler,2 S. M. Astrin,2 and W. S. Hayward.' 'Rockefeller University, New
York, New York; 2lnstitute for Cancer Research, Philadelphia, Pennsylvania: Nucleotide sequence
analysis of molecularly cloned virus-cell j
' "unction
fragments from ALV-induced lymphomas.
S. .M. Astrin; B. G. Neel,2 C. Rogler; J. Fang; A. M. Skalka,3 and W. S. Hayward,I stitute for Cancer
Research Philadelphia, Pennsylvania; 2Rockefeller University, New York, New York; 3Roche Insti-
tute of Molecular Biology, Nutley, New Jersey: Viral oncogenesis by promoter insertion-ALV
DNA is integrated next to the cellular myc gene in 85% of virally induced lymphomas.
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G. Payne,' J. M. Bishop,2 and H. E.
Varmus,2 Depts. of 'Biochemistry and Biophysics, and 'Microbiol-
ogy, University of California, San
Francisco: Oncogenesis by ALV-Evidence for a mechanism
involving insertional mutagenesis.
H. Robinson,' B. Blais,1 G. Gagnon,'
P. Tsichlis,2 and J. Coffin,3 'Worcester Foundation for EmxPaerryi..-
mental Biology, Shrewsbury, Massachusetts;
2NCI, National Institutes of Health, Bethesda, Mary-
land; 'Tufts University School of Medicine,
Boston, Massachusetts: Sequences in U3 determine
the oncogenic potential of ALV-Sequences
immediately 5 of U3 target ALV toward lympho_
mogenesis.
M. R. Noori-Daloii,1 H. J. Kung," L. B.
Crittenden,2 and R. L. Witter,21Dept. of Biochemistry, Michigan
State University; 2Regional Poultry Laboratory,
United States Dept. of Agriculture, East Lansing,
Michigan: The REV proviruses in avian bursal lymphomas-Amplification
of the proviruses and
specific integration near the proto- oncMcv locus.
W. A. Haseltine,1 F. S. Pedersen,2 R.
Crowther,' and D. Tenney,' 'Sidney Farber Cancer Institute
,
Harvard Medical School, Boston, Massachusetts;
2Dept. of Molecular Biology, University of Aar-
hus, Denmark: Genomic determinants of virulence
in AKR retroviruses.
M. M. Kelly,' M. L. Lung,' C.A. Holland,' S. K.
Chattopadhyay,2 D. R. Lowy,2 and N. Hopkins,' 'Cen-
ter for Cancer Research, Massachusetts Institute of Technology,
Cambridge; 2NCI, National Insti-
tutes of Health, Bethesda, Maryland:
Nucleotide sequences of the LTR and p15E coding
sequences of MCF 247.
S. K. Chattopadhyay,12 M. W. Cloyd,4 D. L.
Linemeyer,3 M. R. Lander,2 E. Rands," and D. R. Lowy1
'Dermatology Branch; 2Pediatric Oncology Branch; 'Laboratory of Tumor Virus Genetics, NCI
National Institutes of Health, Bethesda, Maryland; 4Rocky Mountain Laboratory, Hamilton, Mon-
tana: MCF viral genomes-Their cellular origin and role in AKR thymic lymphomas.
W. Herr and W. Gilbert, The Biological Laboratories, Harvard University, Cambridge, Massachu-
setts: Structure and arrangement of recombinant
proviruses in leukemic thymuses of AKR mice
.M. S. McGrath and I. L. Weissman, Stanford University, California: Receptor-mediated leukemo-
genesis-The murine B cell lymphoma BCLI utilizes cell-surface immunoglobulin as an MuLV
receptor.
P. Fischinger,1 H. Thiel,2 J. Ihle,3 and N. Dunlop,' 'National Cancer Institute; 3Frederick Cancer
Research Center, Frederick, Maryland; 2Dept. of Surgery, Duke University, Chapel Hill, North
Carolina: Presence of a recombinant MuLV-like glycoprotein in virus-free mouse lymphomas.
J. I. Mullins, J. W. Casey, M. O. Nicolson, A. Roach, J. B. Santon, K. B. Burck, and N. Davidson, Dept.
of Chemistry, California Institute of Technology, Pasadena: Cat endogenous FeLV-related
sequences contain unique 3' regions in LTRs distinct from those in infectious FeLV.
Session 11: Endogenous Viruses
Chairperson: H. Robinson, Worcester Foundation, Shrewsbury, Massachusetts
L. B. Crittenden, E.). Smith, and A.M. Fadly, Regional Poultry Laboratory, United States Dept. of
Agriculture, East Lansing, Michigan: Influence of endogenous ALV gene expression on response
to RAV-1 and REV infection.
R. Eisenman," H. Weintraub,' K. Conklin,2 J. Coffin,2 H. Robinson,' and M. Groudine,1 'Hutchinson
Cancer Center, Seattle, Washington; 2Tufts Medical School, Boston; 3Worcester Foundation for
Experimental Biology, Shrewsbury, Massachusetts: Control of endogenous avian retrovirus gene
expression by DNA methylation.
K. F. Conklin,' R. N. Eisenman,2 H. L. Robinson,' and J. M. Coffin,' Tufts University School of Medi-
cine, Boston, Massachusetts; 2Fred Hutchinson Cancer Research Center, Seattle, Washington;
3Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts: Spontaneous
expression and phenotype of the common ev-1 endogenous provirus of chickens.
F. Hishinuma and A.M. Skalka, Roche Institute of Molecular Biology, Nutley, New Jersey: Sequence
analysis of the 3' end of the ev-1 provirus.
R. Mural," J. Young,' R. Roblin,' J. 'hie,' D. Steffen,2 and R. Weinberg,3 'Frederick Cancer Research
Center, Frederick, Maryland; 2Worcester Foundation for Experimental Biology, Shrewsbury, Mas-
sachusetts; 3Dept. of Biology, Massachusetts Institute of Technology, Cambridge: The major
MuLV-related sequences in mouse DNA represent a limited number of proviral classes.
A.S. Khan,' C. F. Garon,' S. P. Staal,2 C. Buckler,' W. P. Rowe,' and M. A. Martin,"NIAID, National
Institutes of Health, Bethesda; 2Dept. of Oncology, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Characterization of endogenous MuLV-related sequences in BALB/c and
AKR mice.
N. A. Jenkins, N.G. Copeland, B. A. Taylor, and B. K. Lee, Jackson Laboratory, Bar Harbor, Maine:
Mapping the chromosomal location of ecotropic DNA sequences in C57BL/6J, C3H/HeJ, and
DBA/2J inbred mouse strains.
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J. McCubrey and R. Risser, McArdle Laboratory for Cancer Research, University of Wisconsin,
Madison: Genetic interactions in the induction of ecotropic MuLV.
P. Roy-Burman,1.2 A. Mock,' B.G. Devi,' and M. B. Gardner,' Depts. of 'Pathology, and 'Biochemis-
try, University of Southern California School of Medicine, Los Angeles: Restricted transcription of
endogenous ecotropic provirus genes by the Akvr-1R allele in wild mice.
A. B. Vaidya, N. E. Taraschi, S. L. Tancin, and C. A. Long, Dept. of Microbiology, Hahnemann Medical
College, Philadelphia, Pennsylvania: Control of endogenous MuMTV gene expression in lactating
mammary glands of C57BL mice.
R. Jaenisch, K. Harbers, D. Jahner, P. Nobis, and H. Stuhlmann, Heinrich-Pette-Institut, Hamburg,
Federal Republic of Germany: Experimental insertion of retroviral genomes into the germ line of
mice.
G. G. Lovinger and G. Schochetman, Biological Carcinogenesis Program, Frederick Cancer Research
Center, Frederick, Maryland: 5'-terminal nucleotide noncoding sequences of retroviruses-A
model for evolutionary divergence.
G. E. Mark, E. H. Birkenmeier, and G. J. Todaro, National Cancer institute, Frederick, Maryland:
Structure and function of the promoter sequences of an endogenous C-type retrovirus.
P. Kirschmeier," S. Gattoni," I. B. Weinstein,' E. Athan,2 and D. Dina,' 'Institute of Cancer Research,
Columbia University, New York; 'Dept. of Genetics, Albert Einstein College of Medicine, Bronx,
New York: Transcription of sequences related to the LTRs of MSV in carcinogen-transformed
mouse cell lines.
Session 12: Viruses and Tumors
Chairperson: S. Aaronson, National Cancer Institute, Bethesda, Maryland
E. C. Ward and D. P. Bolognesi,2 Depts. of Microbiology and Immunology, and 'Surgery, Duke
University Medical Center, Durham, North Carolina: Approaches toward immunotherapy of
"nonantigenic" tumors.
B. Chesebro and W. J. Britt, NIAID, Rocky Mountain Laboratory Hamilton, Montana: Monoclonal
anti-gp70 antibodies cause in vivo reduction of Friend virus infectious centers in leukemic
spleens.
S. Ruscetti," A. Rein,' and R. Bassin,"NCI, National Institutes of Health, Bethesda; 'Frederick Cancer
Research Center, Frederick, Maryland: F-MuLV-induced leukemia is mediated by MCF viruses
and is blocked in strains endogenously expressing a novel MCF-related glycoprotein.
G. L. Waneck and N. Rosenberg, Cancer Research Center, Tufts University School of Medicine,
Boston, Massachusetts: Ab-MuLV induction of lymphoid and erythroid colonies in fetal liver cell
cultures.
F. Alt,' N. Rosenberg,2 E. Thomas," S. Lewis,' and D. Baltimore,' 'Massachusetts Institute of Technol-
ogy, Cambridge; Tufts University School of Medicine, Boston, Massachusetts: Abelson virus
transformants usually have rearranged heavy-chain genes but not light-chain genes.
L.-C. Chen, S. A. Courtneidge, and J. M. Bishop, Dept. of Microbiology and Immunology, University
of California, San Francisco: The immunological phenotype of tumors induced by ALV.
U.G. Rovigattil and R. A. Weiss,' Istituto Fisio logia Generale, University Roma, Italy; 'Chester
Beatty Cancer Research Institute, London, England: The integrated provirus is involved in the
reexpression of the transformed phenotype in revertant rat cells.
P. Sankar-Mistry, G. Lemay, and P. Jolicoeur, Dept. de Microbiologie et d'immunologie, Institut de
Recherches Cliniques, University de Montreal, Quebec, Canada: The presence of 8.0-and 5.6-kb
genomic RNA in MuLV isolated from primary X-ray-irradiation-induced thymomas.
M. Robert-Guroff, F. W. Ruscetti, V. S. Kalyanaraman, M. S. Reitz, and R. C. Gallo, NCI, National
Institutes of Health, Bethesda, Maryland: In vitro transmission of the human retrovirus HTLV to
cells of relatives of a patient with acute lymphoblastic leukemia.
V. S. Kalyanaraman," M. Robert-Guroff,1 M. G. Sarngadharan," P. Bunn,' J. Minna,' and R. C. Gallo,,
'Laboratory of Tumor Cell Biology, NCI, National Institutes of Health, Bethesda, Maryland; "NCI-
VA Clinical Oncology, Washington, DC: Natural antibodies in human sera reactive against the
human retrovirus HTLV.
M.-A. Lane, A. Sainten and G. M. Cooper, Dept. of Pathology, Sidney Farber Cancer Institute,
Harvard Medical School, Boston, Massachusetts: Activation of related transforming genes in
mouse and human mammary carcinomas.
A. Eva,' K. Robbins,' P. Andersen,' A. Srinivasan," T. Papas,' S. Tronick," E. P. Reddy," E. Westin,3 F.
Wong- Staal,3 R. Gallo,3 N. Ellmore,1 and S. Aaronson,' Laboratories of 'Cellular and Molecular
Biology, 'Tumor Virus Genetics, and 3Tumor Cell Biology, N.C.I., National Institutes of Health,
Bethesda, Maryland: Human tumor cells contain transcripts related to the transforming genes of
retroviruses.
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Session 1: Mating Type
Chairperson: G. Fink, Cornell University, Ithaca, New York
D. Beach and P. Nurse, School of Biological Sciences, University of Sussex, Brighton, England:
Isolation of mating-type and cell genes from S. pornbe.
A. Klar, J. Strathern, J. Abraham, K. Nasmyth, J. Ivy, and J. Hicks, Cold Spring Harbor Laboratory,
New York: Controls of directedness of switching, direction of transposition and characterization
of a site essential for mating-type switching.
J. Haber, D. Rogers, and S. Stewart, Rosenstiel Center of Brandeis University, Waltham, Massachu-
setts: Control of expression and transposition of tandem duplications of yeast mating-type genes.
V. L. MacKay12 and K. Nasmyth,2 1Waksman Institute of Microbiology, Rutgers University, New
Brunswick, New Jersey; 2Dept. of Genetics, University of Washington, Seattle: Complementation
of ste4 mutations by the cloned STE5 gene.
A. J. Brake,' H. H. Liao,' J. Thorner,1-2 and K. Nasmyth,2 'Dept. of Microbiology and Immunology,
University of California, Berkeley; 2Cold Spring Harbor Laboratory, New York: Analysis of the role
of the STE5-gene product in the yeast mating response using the cloned STE5 gene.
G. Sprague, Jr. and I. Herskowitz, Dept. of Biology, University of Oregon, Eugene: The MA Ta1-gene
product is a positive regulator of synthesis of RNA from the a-specific STE3 gene.
K. Nasmyth, Cold Spring Harbor Laboratory, New York: The regulation of mating type chromatin
structure by MAR.
S. Harashima, K. Tanaka, A. Takagi, and Y. Oshima, Dept. of Fermentation Technology, Osaka
University, Japan: Mating-potency-dependent homozygosity of sir3 mutation by allelic transposi-
tion in S. cerevisiae.
T. R. Manney, Dept. of Physics, Kansas State University, Lawrence: A nonsterile allele of MATa2 that
makes reduced levels of a-factor.
R. Jensen and I. Herskowitz, Institute of Molecular Biology, University of Oregon, Eugene: Control
of expression of HO by the mating-type locus.
Session 2: Regulation I
Chairperson: F. LaCroute, Centre National de la Recherche Scientifique, Strasbourg, France
J. Gafner, A. Stotz, H. Eibel, T. Giller, L. Panzeri, and P. Philippsen, Dept. of Microbiology, Biocenter,
University of Basel, Switzerland: Analysis of TY and 6 sequences.
R. T. Elder, Dept. of Biology, University of Chicago, Illinois: Both the 5' and 3' ends of Ty1 RNA are in
the 6 sequences.
D. W. Russell,' M. Smith,1 V. M. Williamson,' D. Cox,' and E. T. Young,2 'Dept. of Biochemistry,
University of British Columbia, Vancouver, Canada; 2Dept. of Biochemistry, University of
Washington, Seattle: DNA sequence analysis of transposable-element-induced mutations of the
ADHII gene.
A. Taguchi and E. Young, Dept. of Biochemistry, University of Washington, Seattle: a/0 suppression
of yeast alcohol dehydrogenase constitutive mutations.
B. Errede, T. Cardillo, and F. Sherman, Dept. of Radiation Biology and Biophysics, University of
Rochester Medical School, New York: Mapping functional regions of the CYC7-H2 Ty1 insertion
element.
F. G. Chumley and G. R. Fink, Section of Biochemistry, Molecular and Cell Biology, Cornell Univer-
sity, Ithaca, New York: Transposition of his4-912 can restore gene expression.
L. Guarente, Dept. of Biochemistry and Molecular Biology, The Biological Laboratories, Harvard
University, Cambridge, Massachusetts: Structure of the promoter of the iso-1-cytochrome c gene
of S. cerevisiae.
J. M. Boss and R. S. Zitomer, Dept. of Biological Sciences, State University of New York, Albany: The
sequences of the wild-type iso-2-cytochrome c mRNA and two overproducing mutants.
K. S. Zaret,1 J. Kotval,2 and F. Sherman,' 1Dept. of Radiation Biology and Biophysics, University of
Rochester; 2Albany Medical College of Union University, New York: DNA sequence required for
efficient transcription termination and polyadenylation of CYC1 mRNA.
K. Struhl, MRC Laboratory of Molecular Biology, Cambridge, England: his3 promoter and regula-
tory elements.
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A. W. Murray13 and J. W. Szostak23 'Committee on Cell and Developmental Biology;
'Dept. ofBiological Chemistry; 'Sidney Farber Cancer Institute, Harvard Medical School, Boston, Massa-
chusetts: Chromosomal location affects the activity of the HIS3 promoter.
Session 3: Poster Session
J. Margolskee and I. Herskowitz, Institute of Molecular Biology, University of Oregon, Eugene: The
effect of a translocation involving chromosome III on the efficiency of mating-type interconversion.J. Feldman,' J. R. Broach," and J. B. Hicks,' "Dept. of Microbiology, State University of New York,Stony Brook; 'Cold Spring Harbor Laboratory, New York: Mutations of a cloned silent mating-
type cassete, HMLa, that allow its constitutive expression.
B. Weiffenbach and J. E. Haber, Rosenstiel Center of Brandeis University, Waltham, Massachusetts:
Homothallic conversion of mating-type alleles produces a DNA break in the MATO cistron in
rad52 cells.
J. McCusker, B. Weiffenbach, P. Thorburn, and J. E. Haber, Rosenstiel Center of Brandeis University,
Waltham, Massachusetts: Stability of broken chromosomes and circular chromosomes of yeast.
A. Comeau, L. Davidow, and J. Haber, Rosenstiel Center of Brandeis University, Waltham, Massachu-
setts: Factors affecting the direction, efficiency, and pedigree of mating-type switching.
M. N. Jagadish, D. R. Fugit, and V. L. MacKay, Waksman Institute of Microbiology, Rutgers Univer-
sity, New Brunswick, New Jersey: Inhibition of MATa2 in a tupi mutants.
D. E. Cabin and B.-K. Tye, Section of Biochemistry, Molecular and Cell Biology, Cornell University,
Ithaca, New York: Cloning of a gene that complements a non-mating-type-specific sterility muta-
tion in yeast.
J. Strathern, A. Klar, J. Abraham, J. Ivy, K. Nasmyth, and J. Hicks, Cold Spring Harbor Laboratory,
New York: Studies on mating type gene expression and transposition.
S. Murakami and D. Livingston, Dept. of Biochemistry, University of Minnesota, Minneapolis: Yeast
spheroplasts exhibit cell-division-cycle-specific inhibition.
J. Wood, Dept. of Genetics, University of Washington, Seattle: Genetic and cell cycle characteriza-
tion of the mitotic block caused by methyl-benzimidazole carbamate.
T. A. Peterson and S. I. Reed, University of California, Santa Barbara: The isolation of the cell-cycle
start gene CDC36 and its relationship to STE7.
M. E. Katz, P. Kayne, and S. I. Reed, Dept. of Biological Sciences, University of California, Santa
Barbara: The isolation of suppressors of STE mutations conferring cell-division-cycle-defective
phenotypes.
S. Okamoto, Laboratory of Genetics, Dept. of Biology, Faculty of Science, University of Tokyo,
Japan: A positive regulator for the pre-second meiotic morphogeneses of outer plaques in S.
cerevisiae.
H. Boucherie and C. S. McLaughlin, Dept. of Biological Chemistry, University of California, Irvine:
Protein synthesis during transition and stationary phases under glucose limitation in S. cerevisiae.
L. Alberghina, L. Popolo, and M. Vanoni, Laboratory of Comparative Biochemistry, University of
Milan, Italy: Dissociation of ribosomal and protein synthesis on cell cycle controls in S. cerevisiae.
M. A. Resnick," S. Stasiewicz," J. C. Game,' and R. Roth,' 'National Institute of Environmental and
Health Sciences, Research Triangle Park, North Carolina; 'Dept. of Genetics, University of Califor-
nia, Berkeley; 'Illinois Institute of Technology, Chicago: Role of rad52 gene function in early
molecular events of meiosis.
M.J. Clancy, Microbiology and Public Health, Michigan State University, East Lansing: Purification
and properties of a sporulation-specific enzyme.
B. Marian, A. Linsbauer, and U. Wintersberger, Institute for Cancer Research, University of Vienna,
Austria: Sodium butyrate accelerates sporulation of S. cerevisiae.
P. Nurse and D. Beach, Dept. of Biological Sciences, University of Sussex, Brighton, England: Gene
transposition implicated in the transition between proliferation and conjugation/sporulation in S.
pombe.
J. C. Game,' D. Schild,2 and R. E. Esposito,"Dept. of Genetics, 2Dept. of Biophysics and Medical
Physics, University of California, Berkeley; 3Dept. of Biology, University of Chicago, Illinois: The
meiotic phenotype of the rad57-1 mutation.
P. R. Russell and B. D. Hall, Dept. of Genetics, University of Washington, Seattle: Structure of the S.
pombe cytochrome-c gene.
S.C. Cheng, P. Mirabito, and D. Ogrydziak, Institute of Marine Resources, University of California,
Davis: Are there multiple secretion pathways in Saccharomycopis lipolytica?
R. Schmidt,' M. Manolson,2 and R. J. Poole,2 'Institut fur Biophysik, Freie Universitat Berlin, Federal
Republic of Germany; 2Dept. of Biology, McGill University, Montreal, Canada: A specific pho-
toaffinity label for the purine transport system in S. cerevisiae.
K. O'Malley, J. Saltzgaber-Muller, and M. Douglas, Dept. of Biochemistry, Health Science Center,
University of Texas, San Antonio: Selection of nuclear genes coding for mitochondrial compo-
nents by genetic complementation.
M. R. Lamb,' H. R. Mahler,2 and P. S. Perlman,3 'Dept. of Biology; 2Dept. of Chemistry, Indiana
University, Bloomington; 3Dept. of Genetics, Ohio State University, Columbus: Transition of the
mosaic gene OX13 in intron mutants of the COB gene of S. cerevisiae.
A.M. Colson, J. Oberto, and C. Colson, Universite de Louvain, Laboratoire de Cytogenetique,
Belgium: A nuclear mutation conferring diuron-resistance to the NADH-cytochrome c reductase
in the mitochondrial respiratory chain of S. cerevisiae.
E. M. Dimock, D. J. Perry, and T. L. Mason, Dept. of Biochemistry, University of Massachusetts,
Amherst: The biosynthesis and assembly of mitoribosomal proteins in petite mutants with deleted
or amplified rRNA genes.
M. Suissa, Biocenter, University of Basel, Switzerland: mRNAs for imported mitochondrial proteins
are associated with both free and mitochondria-bound cytoplasmic polysomes.
M. A. Nicholas and P. S. Perlman, Dept. of Genetics, Ohio State University, Columbus: Protein
synthesis-defective mutants in the eryl -oxil region of mitochondrial DNA-protein synthesis
analysis and effects on RNA processing.
C. Low and B.G. Adams, Dept. of Microbiology, University of Hawaii, Honolulu: The Bertholet
reaction-An assay for ammonia nitrogen produced by urea amidolyase activity in S. cerevisiae.
C. L. Denis and E. T. Young, Dept. of Biochemistry, University of Washington, Seattle: Isolation and
characterization of a positive regulatory gene, ADR1.
C. L. Denis,' J. Ferguson,2 and E. T. Young,"Dept. of Biochemistry, University of Washington, Seat-
tle; 2Dept. of Biological Sciences, University of California, Santa Barbara: A decrease in the mRNA
levels for the fermentative alcohol dehydrogenase upon growth on a nonfermentable carbon
source.
L. Droll, K.-D. Entian, and D. Mecke, Physiologisch-chemisches Institut der Universitat, Tdbingen,
Federal Republic of Germany: Reversible and irreversible inactivation of gluconeogenetic
enzymes in glycolytic mutants of S. cerevisiae.
A. P. G. M. van Loon,' J. Kreike,1 B. Lang,2 B. V. D. Horst,' R. Vaessen,' F. Driehuis,' A. Dekker,' and
L. A. Grivell,1 'Section for Molecular Biology, Laboratory of Biochemistry, University of Amster-
dam, The Netherlands; 2Genetisches Institut, Munchen, Federal Republic of Germany: The
ubiquinol-cytochrome-c reductase complex-Regulation of the synthesis of the active enzyme
complex and attempts to clone nuclear genes coding for subunits.
J. Polaina, Solar Energy Research Institute, Golden, Colorado: STA10-A gene present in S. cerevi-
siae that inhibits the expression of the amylolytic capability.
J. A. Bossinger, Dept. of Biology, Massachusetts Institute of Technology, Cambridge: Regulation
NAD-dependent glutamate dehydrogenase in S. cerevisiae.
J. M. Sedivy and D. G. Fraenkel, Dept. of Microbiology and Molecular Genetics, Harvard Medical
School, Boston, Massachusetts: S. cerevisiae mutants defective in fructose bisphosphatase activity.
D. B. Finkelstein and S. Strausberg, Dept. of Biochemistry, University of Texas Health Science Cen-
ter, Dallas: Alternate inducers of the yeast heat-shock response.
M. N. Beremand and C. S. McLaughlin, Dept. of Biological Chemistry, University of California,
Irvine: Heat shock in C. albicans.
J. M. Boss,' S. Gillam," R. S. Zitomer,' and M. Smith,2 'Dept. of Biological Sciences, State University of
New York, Albany; 2Dept. of Biochemistry, University of British Columbia, Vancouver, Canada:Sequence of the iso-1-cytochrome c mRNA.
D. Beier and E. T. Young, Dept. of Biochemistry, University of Washington, Seattle: Deletions ofADC/ that alter the level of ADHI enzyme activity.
G. B. Callega,1 S. Levy-Rick,' A. Nasim,2 and F. Moranelli,2 1Bio Logicals, Toronto, Canada; 2National
Research Council of Canada, Ottawa: Development of extracellular amylolytic activity in Schwan-
niocyces alluvws-Temperature sensitivity and catabolite repression.
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M. Igo and H. Greer, The Biological Laboratories, Harvard University, Cambridge, Massachusetts:
The yeast his4 region and transposable elements.
J. Jackson and G. Fink, Section of Biochemistry, Molecular and Cell Biology, Cornell University,
Ithaca, New York: Meiotic recombination between duplicated genetic elements.
D. Morisato and H. Greer, The Biological Laboratories, Harvard University, Cambridge, Massachu-
setts: General control of yeast his4 transcription.
H. Stark and D. B. Mowshowitz, Dept. of Biological Sciences, Columbia University, New York: MAL6
constitutive alleles are dominant as predicted for a positive regulatory system.
M. I. Riley and R. C. Dickson, Dept. of Biochemistry, University of Kentucky, Lexington: Mutants
defective in the regulation of /3-galactosidase induction in Kluyveromyces lactis.
A. P. Mitchell and B. Magasanik, Dept. of Biology, Massachusetts Institute of Technology, Cam-
bridge: A reversible inactivation of glutamine synthetase in S. cerevisiae.
R. Roggenkamp and C. P. Hollenberg, Institut fur Mikrobiologie, Universitat DUsseldorf, Federal
Republic of Germany: Processing of bacterial /3-lactamase expressed in S. cerevisiae.
M. Schweizer, J. Holtke, C. Lebert, and L. M. Roberts, Institut fur Biochemie der Universitat
Erlangen-Nurnberg, Federal Republic of Germany: Identification of clones for the fatty acid
synthetase complex by transformation of yeast.
M. Greenberg, L. Klig, V. Letts, B. Shicker, and S. Henry, Depts. of Genetics and Molecular Biology,
Albert Einstein College of Medicine, Bronx, New York: Inositol-overproducing mutant (opi3)
defective in the synthesis of phosphatidylcholine.
V. A. Letts and I. W. Dawes, Microbiology Dept., Edinburgh University, Scotland; Characterization
of a temperature-sensitive mutant of yeast altered in lipid biosynthesis.
M. Rose and D. Botstein, Dept. of Biology, Massachusetts Institute of Technology, Cambridge:
Structure and regulation of the yeast URA3 gene studied with fusions to the E. coli lacZ gene.
R. Hitzeman,' F. Nagle,' A. Singh,' C. Chen,' D. Goeddel,' G. Ammerer,2 and B. Hal1,2 'Dept. of
Molecular Biology, Genentech, Inc., South San Francisco, California; 2Dept. of Genetics, Univer-
sity of Washington, Seattle: Expression of a human gene in yeast.
S. Silverman and G. Fink, Section of Biochemistry, Molecular and Cell Biology, Cornell University,
Ithaca, New York: Insertion mutations and regulation at the his4 locus of S. cerevisiae.
Session 4: Cell Cycle and Sporulation
Chairperson: J. Strathern, Cold Spring Harbor Laboratory, New York
J. Yarger," K. Bostian,' J. Lemire," H. Halvorson,' and J. Hopper,2 "Rosenstiel Center of Brandeis
University, Waltham, Massachusetts; 2Milton S. Hershey Medical Center, Pennsylvania: Regula-
tion of the acid phosphatase (PHO5) and galactokinase (GAL1) genes during the cell cycle in S.
cerevisiae.
A. Lorincz," M. Miller,' N.-H. Xuong," 23 and E. P. Geiduschek,"Depts. of Biology, 2Chemistry, and
3Physics, University of California, San Diego, La Jolla: Quantitative analysis of two-dimensional
gels reveals several cell-cycle-regulated proteins in S. cerevisiae.
J.R. Ludwig 11,1 J.J. Foy,2 and C. S. McLaughlin,2 "Dept. of Biochemistry, Institute of Science
and
Technology, University of Manchester, England; 2Dept. of Biological Chemistry, University
of
California, Irvine: Synthesis of periodic and nonperiodic proteins through the cell
cycle of S.
cerevisiae.
G. C. Johnston and R. A. Singer, Faculty of Medicine, Dalhousie University, Halifax, Nova
Scotia,
Canada: Overlapping cell cycles and the dispensable G' period.
S. I. Reed, J. C. Groppe, and J. Ferguson, Dept. of Biological Sciences, University
of California,
Santa Barbara: Preliminary characterization of the transcriptional and translational
products
of the cell-cycle start gene-cdc28.
J. R. Shuster, Dept. of Genetics, University of Washington, Seattle: Suppression
of mutants defective
in conjugation by cell-division-cycle mutants in S. cerevisiae.
S. Klapholz, J. Wagstaff, and R. E. Esposito, Dept. of Biologyand Committee on
Genetics, University
of Chicago, Illinois: Single division meiosis in SP013-1 haploids.
L. Smith, M. J. Clancy, and P. T. Magee, Microbiology and Public Health, Michigan
State University,
East Lansing: Regulation of a sporulation-specific gene product.
D. H. Williamson,' L. H. Johnston," D. J. Fennel," A. L. Johnson,' and G. Simchen,2
"National Institute
for Medical Research, London, England; 2Genetics Dept., Hebrew University
of Jerusalem, Israel:
Genomic organization and the control of origin activation in premeiotic
DNA synthesis in S.
cerevisiae.
E. Chlebowicz-Sledziewska and W. L. Fan
g
man, Dept. of Genetics, University of Washington, Seat-
tle: Phase lengths in the unequal cell cycles of yeast mother and daughter
cells.
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Session 5: Chromatin and Chromosome Structure
Chairperson: T. Petes, University of Chicago, Illinois
M. Fitzgerald-Hayes, L. Clarke, E. Yeh, and J. Carbon, Dept. of Biologic al Sciences, University of
California, Santa Barbara: Functional and sequence analysi, of the centromere regions from yeast
chromosomes III and XI.
K. Bloom and J. Carbon, Dept. of Biological Sciences, University of California, Santa Barbara:
Chromatin structure and DNA-protein interactions of yeast centromere DNA.
C. Mann, D. T. Stinchcomb, and R. W. Davis, Dept. of Biochemistry, Stanford University School of
Medicine, California: Structure and function analysis of yeast centromeres.
J.W. Szostak, Dept. of Biological Chemistry, Sidney Farber Cancer Institute, Harvard Medical
School, Boston Massachusetts: The ends of the rDNA linear plasmid of Tetrahymena can function
as telomeres on linear plasmids in yeast.
M. C. Rykowski, J.W. Wallis, J. Choe, and M. Grunstein, Molecular Biology Institute, University of
California, Los Angeles: A genetic analysis of yeast histone H2B subtype function.
J. B. Rattner,1 B. Hamkalo,' C. A. Saunders,' J. R. Davie,' R. Ludwig,' and C. S. McLaughlin,"Dept. ofMolecular Biology and Biochemistry, University of California, Irvine; 'Dept. of Biochemistry andBiophysics, Oregon State University, Eugene; 3Dept. of Biochemistry, Irvine School of Medicine,
University of California: The ultrastructural organization of yeast chromatin.
J. F. Scott and C. M. Brajkovich, Molecular Biology Institute, University of California, Los Angeles:
Chromatin organization of Trp1-RI-Circle-A high-copy-number yeast chromosomal DNA plasmid.
C.S.M. Chan and B.-K. Tye, Dept. of Biochemistry, Molecular and Cell Biology, Cornell University,
Ithaca, New York: Complexity and organization of autonomously replicating sequences in S.
cerevisiae.
J. M. Walsh, C. A. Saunders, J. R. Davie, and J. H. Proffitt, Dept. of Biochemistry and Biophysics,Oregon State University, Corvallis: Chromatin structure of the iso-2-cytochrome c and gall
regions in yeast.
A. Sledziewski and E. Young, Dept. of Biochemistry, University of Washington, Seattle: DNase-I
sensitivity of ADH genes in the yeast S. cerevisiae.
R. Rothstein and C. Helms, Dept. of Microbiology, CMDNJ, New Jersey Medical School, Newark;Rearrangements at the SUP4 locus.
Session 6: Poster Session
A. Stotz and P. Philippsen, Dept. of Microbiology, Biocenter, University of Basel, Switzerland:
Arrangement of mobile and stable sequences in yeast strains.
H. L. Klein and T. D. Petes, Dept. of Microbiology, University of Chicago, Illinois: Genetic mapping
of Ty sequences.
G. Maine and B.-K. Tye, Section of Biochemistry, Molecular and Cell Biology, Cornell University,Ithaca, New York: Cloning of a centromeric DNA sequence from yeast.
R. J. Devenish, L. Lipchitz, and C. S. Newlon, Dept. of Zoology, University of Iowa, Iowa City:Replication of a circular derivative of chromosome III.
M. V. Olson, T. Frank, and M. Y. Graham, Dept. of Genetics, Washington University School ofMedicine, St. Louis, Missouri: Restriction mapping of the yeast nuclear genome-A feasibilitystudy.
T. Nilsson-Tillgren,' J. G. L. Petersen,' S. Holmberg,' C. Gjermansen,2 and M. C. Kielland-Brandt,'1lnstitute of Genetics, University of Copenhagen;
- 'Dept. of Physiology, Carlsberg Laboratory,Copenhagen Valby, Denmark: Differences between functionally homologous chromosomesfrom S. carlsbergensis.
J. R. Davie, C. A. Saunders, J. M. Walsh, and S. C. Weber, Dept. of Biochemistry and Biophysics,Oregon State University, Corvallis: Histone modifications in the yeast S. cerevisiae.D. Kolodrubetz, J. Choe, M. Rykowski, and M. Grunstein, Dept. of Biology, Molecular BiologyInstitute, University of California, Los Angeles: Sequence and function of the histone H2A genesin S. cerevisiae.
G. A. Bitter, NIAMDD, National Institutes of Health, Bethesda, Maryland: Heterologous in vitrotranscription systems utilizing components from mammalian and yeast cells.J. W. Wallis, M. Rykowski, and M. Grunstein, Dept. of Biology, Molecular Biology Institute, Univer-sity of California, Los Angeles: An in vivo test for histone H2B function.G. J. Ide, Dept. of Biochemistry and Biophysics, Oregon State University, Corvallis: Nucleoside5'-[7-S] triphosphates will initiate transcription in isolated yeast nuclei.S. E. Celniker and J. L. Campbell, Dept. of Chemistry, California Institute of Technology, Pasadena:In vitro DNA replication in S. cerevisiae.
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H. Singh, J. J. Bieker, J. P. Lussky, and L. B. Dumas, Dept. of Biochemistry and Molecular Biology,
Northwestern University, Evanston, Illinois: Single-stranded recombinant DNA molecules as
probes of replication and recombination in yeast.
K. H. Scheitl and P. M. Bhargava,2 'Max-Planck-Institut fLir Biophysikalische Chemie, Gottingen,
Federal Republic of Germany; 2Centre for Cellular and Molecular Biology, Hyderabad, India: An
antimicrobial protein from bull semen inhibits transcription in yeast cells.
V. A. Zakian and D. M. Kupfer, Fred Hutchinson Cancer Research Center, Seattle, Washington:
Replication, copy-number, and segregation properties of a plasmid containing the origin of
replication from X. Iaevis mitochondrial DNA.
R. Hackett,' L. Dicaprio,2 K. Gross,2 and B.-K. Tye,' Section of Biochemistry, Molecular and Cell
Biology, Cornell University, Ithaca, New York; 2Molecular Biology Dept., Roswell Park Memorial
Institute, Buffalo, New York: Replication of heterologous DNA in S. cerevisiae.
E. M. McIntosh, B. J. Barclay, and R. H. Haynes, Dept. of Biology, York University, Toronto, Canada:
DNA synthesis in yeast is strongly inhibited by ara-CMP but not by ara-C.
0. Landman and J. G. Little, Dept. of Biology, York University, Toronto, Canada: Unusual DNA
precursor metabolism in yeast-3' dTMP and 3',5' cyclic dTMP as sources of DNA-thymine.
C. M. Gaillardin,' P. Fournier,' L. de Louvencourt,1 C. Gerbaud,2 F. Lang,3 and H. Heslot, 1Labora-
toire Genetique, Institut National Agronomique, Paris; 2Laboratoire Biologie Genetique et Mole-
culaire, Faculte des Sciences, Orsay, France; 3Genetisches Institut der Universitat Munchen,
Federal Republic of Germany: Behavior of various replicators in the yeast S. pombe.
C. Holm, Dept. of Genetics, University of Washington, Seattle: Lethal sectoring caused by 2/J DNA in
nib strains.
J. F. Lemontt and S. V. Lair, Biology Division, Oak Ridge National Laboratory, Tennessee: Hydrazine-
induced mutagenesis at CAN/ in S. cerevisiae requires both DNA replication and the RAD6
function.
A. K. Beck, J. F. Lemontt, F. W. Larimer, and E. G. Bernstine, Biology Division, Oak Ridge National
Laboratory, Tennessee: Gamma-ray-induced nonrevertible ade2 mutation in S. cerevisiae carries
a large insertion as revealed with cloned ADE2 probe.
M. L. Carbone, M. E. Bianchi, and G. Lucchini, Istituto di Genetica, University di Milano, Italy: Yeast
mutants resistant to manganese.
B. Rockmill, J. Game, and S. Fogel, Dept. of Genetics, University of California, Berkeley: Two
systems for the detection of meiotic aneuploidy.
N. Sugawara and J. Szostak, Dept. of Biological Chemistry, Sidney Farber Cancer
Institute, Harvard
Medical School, Boston, Massachusetts: Recombination events between homologous
sequences
on nonhomologus chromosomes.
T. D. Petes and H. L. Klein, Dept. of Microbiology, University of Chicago, Illinois:
Meiotic recombi-
nation within a tandem array of LEU2 genes.
T. S. Cardillo, B. Errede, and F. Sherman, Dept. of Radiation Biology and
Biophysics, University of
Rochester Medical School, New York: Integrative transformation of yeast
results in multiple
insertions of DNA segments.
C. Moore, Dept. of Radiation Biology and Biophysics, University of Rochester,
New York: DNA
ligase is required for medium-independent DNA rejoining in yeast.
S.M. Smolik-Utlaut and T. D. Petes, Dept. of Microbiology, University of Chicago, Illinois:
Small
amounts of heterogeneity affect recombination of the reiterated rRNA genes
in yeast.
D. B. Kaback, Dept. of Microbiology, CMDNJ, New Jersey Medical
School, Newark: Saturation
mapping of chromosome I.
S.C. Falco, M. Rose, and D. Botstein, Dept. of Biology, Massachusetts
Institute of Technology,
Cambridge: Characterization and applications of recombination between
plasmids and chromo-
somes in yeast.
M. L. Dixon and R. K. Mortimer, Dept. of Biophysics and Medical Physics,
University of California,
Berkeley: Chromosome loss, recombination, and mutation detection
in a yeast assay system.
I. L. Calderon, D. Schild, C. R. Contopoulou, and R. K. Mortimer, Dept. of
Biophysics and Medical
Physics, University of California, Berkeley: Cloning of yeast genes
involved in repair an
recombination.
D. Schild, R. K. Mortimer, and R. Contopoulou, University of California,
Berkeley: Chromosome
loss in radiation-sensitive diploids of yeast.
S. W. Ruby and J. W. Szostak, Dept. of Biological Chemistry, Harvard
Medical School, Sidney Farber
Cancer Institute, Boston, Massachusetts: Specific genes in yeast are
induced by DNA damage.
J. I. Stiles, Dept. of Life Sciences, Indiana State University, Terre
Haute: Physical structure of an
element involved in the production of deletions, transpositions, and
other chromosomal rearran-
gements of the COR region of S. cerevisiae.
P. Munz, H. Amstutz, J. Kohli, and U. Leupold, Institute of
General Microbiology, University of
Bern, Switzerland: Heterologous recombination between tRNA
genes in S. pombe.
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R. Hofbauer, B. Hamilton, F. Fessl, and II. Ruis, Institut fur Allgemeine Llioc hernie der Universitat
Wien and Ludwig Boltzmann-Forschcmgsstelle fur Bioc hencie, Vienna, Austria: Studies on transla-
tional control of yeast protein synthesis in a cell-free system from S. ccreviiae.
L. Bisson, Dept. of Microbiology and Molecular Genetics, Harvard Medic al School, Boston, Massa-
chusetts: Utilization of exogenous dTMP by dTMP-permeable yeast strains.
T. Huffaker and P. W. Robbins, Dept. of Biology and Center for Cancer Research, Massachusetts
Institute of Technology, Cambridge: Temperature-sensitive mutants deficient in protein gly-
cosylation.
G. Thill and R. A. Kramer, NCI, National Institutes of Health, Bethesda, Maryland: Mapping of the 5'
termini of yeast repressible acid phosphatase mRNA and sequence analysis of the 5'-flanking
region.
L. L. McAlister and M. J. Holland, Dept. of Biological Chemistry, University of California, Davis:
Expression of two yeast enolase genes.
G. McKnight and F. Sherman, Dept. of Radiation Biology and Biophysics, University of Rochester
Medical School, New York: Characterization of the CYC7-H3 mutation that causes overproduc-
tion of iso-2-cytochrome c.
D. L. Montgomery,' S. J. McAndrew,2 L. Marr,' P. Jackson,' A. Walthall,2 and R. S. Zitomer,2 'Dept. ofBiochemistry, University of Texas, Health Science Center, San Antonio; 2Dept. of Biological Scien-
ces, State University of New York, Albany: Molecular characterization of three mutations which
alter transcription of the ISO-2-cytochrome c gene.
V. M. Williamson,' D. W. Russe11,2 M. Smith,2 and E. T. Young,' 'Dept. of Biochemistry, University ofWashington, Seattle; 2Dept. of Biochemistry, University of British Columbia, Vancouver: Analysis
of ADR2 transcripts in wild-type yeast strains and constitutive mutants.
M. Goldenthal, Dept. of Biochemistry, Albert Einstein College of Medicine, Bronx, New York:Isolation of mutants affecting maltose uptake in S. cerevisiae.
L. L. Spielman and D. B. Mowshowitz, Dept. of Biological Sciences, Columbia University, New York:Use of a new staining procedure to examine regulation of a glucosidases.
D. B. Wilson, Section of Biochemistry, Nioletular and Cell Biology, Cornell University, Ithaca, NewYork: Regulation of yeast galactokinase.
R. G. Buckholz and B.G. Adams, Dept. of Microbiology, University of Hawaii, Honolulu: a-Galactosidase synthesis in S. cerevisiae.
A. Laughon and R. F. Gesteland, Howard Hughes Medical Institute, University of Utah, Salt LakeCity: Cloning of the yeast GAL4 gene.
S. A. Johnston and J. E. Hopper, Milton S. Hershey Medical Center, Pennsylvania State University,
Hershey: A gal4 S. cerevisiae transformed with a GAL4-bearing plasmid produces galactokinase
constitutively.
C. P. Hollenberg and E. Erhart, Institut fur Mikrobiologie, Universitat Dusseldorf, Federal Republic
of Germany: Curing of 2p DNA by transformation.
Session 7: Transcription/Replication
Chairperson: R. Davis, Stanford University, California
A. Toh-e, S. Tada, and Y. Oshima, Dept. of Fermentation Technology, Osaka University, Japan:2-DNA-like plasmid in the osmotophilic haploid yeast S. rouxii.
E. Di Mauro,' P. Ballario,2 M. Buongiorno-Nardelli,3 F. Carnevali,2 and F. Pedone,3 'Cattedra diBiologia Molecolare; 2C. S. per gli Acidi Nucleici, CNR, Roma; instituto di Istologia e Embriolo-gia, Facolta di Scienze, University di Roma, Italy: Selective in vitro transcription of cloned 2 DNAby purified yeast RNA polymerase II.
D. Lohr,' and G. Ide,2 'Chemistry Dept., Arizona State University, Tempe; 2Biochemistry and Bio-physics, Oregon State University, Corvallis: Ananysis of in vitro initiation of transcription ofribosomal genes.
R. Koski, M. Worthington, D. Allison, and B. Hall, Dept of Genetics, University of Washington,
Seattle: Transcription of mutant SUP4 tRNAhr genes with yeast cell-free extracts.
M. Klekamp and T. Weil, Dept. of Biochemistry, University of Iowa Medical School; Iowa City:
Selective and accurate transcription of eukaryotic class-III genes in yeast soluble nuclear extracts.
H. Van Keulen and D. Y. Thomas, Molecular Genetics Section, National Research Council, Ottawa,
Canada: Selective transcripts of 5S DNA in a yeast in vitro transcription system.
J. R. Broach, V. R. Guarascio, Y. Y. Li, J. Makuni, and M. McLeod, Dept. of Microbiology, State
University of New York, Stony Brook: Replication of and recombination within the yeast plasmid,
2,u circle.
A. Sugino,1 H. Kojo,1 B. D. Greenberg,' P. O. Brown,', and K. C. Kim," 'Laboratory of Molecular
Genetics, National Institute of Environmental Health Sciences, Research Triangle Park, North
Carolina, 'Dept. of Biochemistry, University of Chicago, Illinois: In vitro replication of yeast 2p
plasmid DNA.
C.-I. Kuo and J. L. Campbell, Dept. of Chemistry, California Institute of Technology, Pasadena:
Purification of the cdc8 protein of S. cerevisiae by complementation in an aphidicolin-sensitive in
vitro DNA replication system.
R. H. Hice and W. L. Fangman, Dept. of Genetics, University of Washington, Seattle: Cell-cycle
regulation of the replication of an autonomous chromosomal plasmid.
V. A. Zakian, Fred Hutchinson Cancer Research Center, Seattle, Washington: Replication of Trp1-R1
circle-A multiple-copy synthetic plasmid derived from yeast chromosomal DNA
M. N. Conrad and C. S. Newlon, Dept of Zoology, University of Iowa, Iowa City: DNA synthesis in
cdc2.
Session 8: Regulation ll
Chairperson: Y. Oshima, Osaka University, Japan
T. F. Donahue, P. J. Farabaugh, and G. R. Fink, Section of Biochemistry, Molecular and Cell Biology,
Cornell University, Ithaca, New York: Regulation of his4 expression in yeast.
H. Greer, J. Schwartz, and M. Greenberg, The Biological Laboratories, Harvard University, Cam-
bridge, Massachusetts: Regulatory mutations linked to the yeast his4 region.
G. S. Zubenko, F. J. Park, and E. W. Jones, Dept. of Biological Sciences, Carnegie-Mellon University,
Pittsburgh, Pennsylvania: PEP4 gene function is required for maturation of vacuolar hydrolases.
T. G. Cooper and R. Sumrada, University of Pittsburgh, Pennsylvania: Transcriptional control
of the
CAR1 gene from S. cerevisiae.
F. Messenguy and E. Dubois, Institit de Recherches du CERIA, Brussels, Belgium: A posttranscrip-
tional regulatory mechanism is involved in specific repression and induction of arginine metabo-
lism in S. cerevisiae.
D.G. Fraenkel and D. Clifton, Dept. of Microbiology and Molecular Genetics, Harvard Medical
School, Boston, Massachusetts: Yeast phosphofructokinase mutants.
T. Alber,1 G. Kawasaki,' and G. A. Petsko," 'Biology Dept., 3Chemistry Dept., Massachusetts
Institute
of Technology, Cambridge; 'Genetics Dept., Harvard Medical School,
Boston, Massachusetts:
Structural analysis of expression and function of triose phosphage isomerase.
B. G. Adams and B. D. L. Li, Dept. of Microbiology, University of Hawaii,
Honolulu: Detection and
characterization of a novel UDP-galactose pyrophosphorylase activity in
yeast.
M. Johnston, T. St. John, and R. Davis, Dept. of Biochemistry, Stanford
University School of Medi-
cine, California: Structural and genetic analysis of the GAL-gene cluster.
H.J. Federoff, T. R. Eccleshall, J. Giacalone, R. Silver, and J. Marmur,
Albert Einstein College of
Medicine, Bronx, New York: Demonstration of two functional genes at
the MALE locus.
C.A. Michels, K. M. Hanenberger, and Y. Sylvestre, Queens College, City
University of New York,
Flushing: Pleiotropic mutations regulating resistance to glucose
repression are allelic to hxk2.
Session 9: Poster Session
J. F. Ernst, J. W. Stewart, and F. Sherman, Dept. of Radiation Biology
and Biophysics, University of
Rochester School of Medicine, New York: The formation of composite
iso-cytochromes c by
recombination between nonallelic genes in yeast.
F. Messenguy, E. Dubois, Y. Cornelis, and N. Herickx, Institut du
Recherches du CERIA, Brussels,
Belgium: In vivo stability of arg3 and cart mRNAs in C. cerevisiae.
D. Perlman and H.O. Halvorson, Brandeis University Waltham, Massasuchetts:
Distinct mRNAs for
different cytoplasmic and presectretory invertase polypeptides are
encoded by a single sue gene.
S. Vissers, J.-C. Jauniaux, and J.-M. Wiame, Laboratoire de
Microbiologie, Universite Libre de
Bruxelles, Belgium: Arginase gene homology in relation to the regulatory
properties of arginase.
179
E. Dubois and F. Messenguy, Institut de Recherches
du CI RI A, Br ussels, Belgium: I f ,Insc rif)tional
control of nitrogen catabolite repression in S. cerevisiae.
L. M. Melnick and R. K. Chan, Dept. of Microbiology,
University of Cincinnati College of Medicine,
Ohio: Analysis of pheromone supersensitive mutations in
yeast-Suppressors of the ssr2 mutation,
K. D. Atkinson, B. A. Leish, and J. M. Wang, Dept. of Biology, University of California, Riverside:
Membrane assembly in yeast secretion-defective mutants.
W. E. Courchesne and B. Magasanik, Dept. of Biology,
Massachusetts Institute of Technology, Cam-
bridge: Nitrogen regulation of permeases in S. cerevisiae.
M. Nishizawa, M. N. Jagadish, and J. S. Tkacz, Waksman Institute of Microbiology, Rutgers Univer-
sity, Piscataway, New Jersey: A temperature-sensitive mutant of S. cerevisiae with depressed
production of extracellular enzymes.
A. Yasui, U. Zimny, and W. Laskowski, Institute of Biophysics, Freie Universitat Berlin, Federal
Republic of Germany: Photodynamic action of thiopyronine in yeast cells.
N.M. Fried and J. R. Warner, Albert Einstein College of Medicine, Bronx, New York: Cloning of
yeast gene for cycloheximide resistance and ribosomal protein L29.
L. Gritz1'2 M. Cannon,' B. Littlewood,' and J. Davies,12 'Biochemistry Dept., University of Wisconsin,
Madison; 2Biogen S.A., Geneva, Switzerland: Ribosomal protein alterations in mutants of S.
cerevisiae.
V. L. Larionov,' A. V. Grishin,' A. S. Krayev,2 K. G. Skryabin,' and A. A. Bayev," 'Dept. of Genetics and
Selection, Leningrad State University, Leningrad; 'Institute of Molecular Biology, Academy of
Sciences of USSR, Moscow: The comparison of chromosomal and extrachromosomal rDNA in S.
cerevisiae.
A. K. Hopper, S. L. Nolan, and A. Furukawa, Dept. of Biological Chemistry, Milton S. Hershey
Medical Center, Hershey, Pennsylvania: Loss of suppression as an assay for mutants defective in
tRNA biosynthesis.
C. Weeks-Levy and R. Rothstein, Dept. of Microbiology, CMDNJ, New Jersey Medical School,
Newark: Expression of a yeast tRNA gene in vivo.
H. Hottinger, D. Pearson, F. Yamao, L. Cooley, and D. Soil, Dept. of Molecular Biophysics and
Biochemistry, Yale University, New Haven, Connecticut: The isolation of UGA suppressor genes
of S. pombe by transformation of S. cerevisiae UGA mutant strains.
C. Ball,' C. Cummins,' T. Donahue,' I. Edelman,' R. Gaber,' L. Mathison,' M. Mendenhall,' and M.
Culbertson,' Laboratories of Molecular Biology and Genetics, University of Wisconsin, Madison;
'Section of Biochemistry, Molecular and Cell Biology, Cornell University, Ithaca, New York:
Nontriplet reading of the genetic code.
R. F. Gaber and M. R. Culbertson, Laboratories of Molecular Biology and Genetics, University of
Wisconsin, Madison: Genetic and molecular analysis of glycine-specific frameshift suppressors.
R. Y. C. Lo,1 J. B. Bell,' and K. L. Roy,' 'Dept. of Genetics, 'Dept. of Microbiology, University of
Alberta, Edmonton, Canada: Dihydrouridine-deficient tRNAs in S. cerevisiae.
G. Merkel' and T. L. Heiser,' 'Millersville State College, Pennsylvania; 'Chemistry Dept., State Uni-
versity College, Oneonta, New York: The effects of antibiotics on polyribosome structure by
composite gel electrophoresis.
N. J. Pearson, H. M. Fried, and J. R. Warner, Albert Einstein College of Medicine, Bronx, New York:
Expression of a ribosomal protein gene carried on an autonomously replicating plasmid.
F. del Rey, T. F. Donahue, and G. R. Fink, Section of Biochemistry, Molecular and Cell Biology,
Cornell University, Ithaca, New York: Organization and expression of tRNA His genes in yeast.
J. J. Clare and S. G. Oliver, Dept. of Biochemistry, University of Manchester, Institute of Science and
Technology, England: tRNA charging and the coordination of transcription with translation.
A.S. Man'kin,' A.M. Kopylov,' P.M. Rubtsov,' and K. G. Skryabin,2 'Laboratory of Molecular Biol-
ogy and Bioorganic Chemistry, Moscow State University; 'Institute of Molecular Biology,
Academy of Sciences of USSR: The secondary structure model of the 18S rRNA of S. cerevisiae.
F. Meussdoerffer and G. R. Fink, Section of Biochemistry, Molecular and Cell Biology, Cornell
University, Ithaca, New York: Isolation of genes for methionine- and isoleucine-tRNA synthetases.
K. Bostian, S. Jayachandran, and D. Tipper, Dept. of Molecular Genetics and Microbiology, Univer-
sity of Massachusetts Medical School, Worcester: In vivo transcripts of killer yeast DS RNAs-Size,
polyadenylation, and translation products.
J. D. Welsh and M.J. Leibowitz, Dept. of Microbiology, CMDNJ, Rutgers Medical School, Piscata-
way, New Jersey: Localization of genes on the dsRNA killer plasmid of yeast.S. S. Sommer and R. B. Wickner, NCI, National Institutes of Health, Bethesda, Maryland: [HOK] and[NEX] are related plasmids and further evidence that M1 requires L.S.S. Sommer and R. B. Wickner, NCI, National Institutes of Health, Bethesda, Maryland: kob-
Recessive chromosomal mutations that bypass kexl.
A.M. Newman,' M. F. Tuite,2 J. R. Ludwig II,3 P. A. Bower,' and C. S. McLaughlin,' 'Dept. of Biologi-
cal Chemistry, University of California, Irvine;
'Dept. of Biochemistry, University of Oxford;
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3Dept. of Biochemistry, Institute of Science and Technology, Universit
y
of Manchester, England:
Protein and dsRNA synthesis associated with the virus-like particles of yeast-In vivo and in vitro
studies.
F. Messenguy,1 M. Crabeel,2 C. Verschuren,2 R. Huygen,2 and N. Glansdorff,21Institut de Recherches
du CERIA; 'Dept. of Microbiologie, Vrije Universiteit Brussel, Belgium: Fine-structure analysis of
cis-dominant mutations leading to constitutive expression of the arg3 gene in S. cerevisiae
J. C. Jauniaux," E. Dubois,' M. Crabee1,3 and J. M. Wiame," laboratoire de Microbiologie, Univers.ite
Libre de Bruxelles; 'Institut de Recherches du CERIA; 3Laboratorium voor Microbiologie, Vrije
Universiteit Brussel, Belgium: DNA and RNA analysis of arginase regulatory mutants in S.
cerevisiae.
F. Genbauffe, H.-S. Yoo, and T. G. Cooper, University of Pittsburgh, Pennsylvania: Transcriptional
control of the allantoin degradative system in wild-type and mutant strains of S. cerevisiae.
R. Sumrada and T. G. Cooper, University of Pittsburgh, Pennsylvania. Posttranslational processing of
urea amidolyase in S. cerevisiae.
T. G. Cooper and R. Sumrada, University of Pittsburgh, Pennsylvania: What is the inducer of arginase
and ornithine transaminase?
B. C. Hyman, J. H. Cramer, and R. H. Rownd, Dept. of Biochemistry, Laboratory of Molecular Biol-
ogy, University of Wisconsin, Madison: Properties of a yeast mitochondrial DNA segment con-
ferring autonomously replicating function.
V. Turoscy, G. Chisholm, and T. G. Cooper, University of Pittsburgh, Pennsylvania: Pleiotropic con-
trol of five genes by both positive and negative control elements in S. cerevisiae.
T. D. Fox and S. Staempfli, Biocenter, University of Basel, Switzerland: Suppression of a mitochon-
drial ochre mutation by a second-site mitochondrial mutation in or near the 15S rRNA gene.
K. A. Bostian, J. M. Lemire, and D. T. Rogers, Rosenstiel Center of Brandeis University, Waltham,
Massachusetts: Physical identification of multiple genes coding for variant acid phosphatase poly-
peptides in S. cerevisiae.
R.A. Kramer, G. Thill, and N. Anderson, NCI, National Institutes of Health, Bethesda, Maryland:
Structural analysis of cloned restriction fragments carrying yeast repressible acid phosphatase
genes.
B. Meyhack and A. Hinnen, Friedrich Miescher-Institut, Basel, Switzerland: Cloning of two structu-
ral genes for yeast acid phosphatase.
G. Kawasaki, Dept. of Microbiology and Molecular Genetics, Harvard Medical School, Boston,
Massachusetts: Isolation of glycolytic genes in S. cerevisiae.
A.M. Musti and R.A. Kramer, NCI, National Institutes of Health, Bethesda, Maryland: The chicken
glyceraldehyde-3-phosphate dehydrogenase gene has detectable homology to the yeast gene.
E. Abrams, J. Cohen, B. Buchferer, A. Reichel, and J. Marmur, Albert Einstein College of Medicine,
Bronx, New York: Characterization of plasmid mutations resulting in increased expression
in
yeast of the E. coil camr gene.
M. Yamamoto,' J. Sakaguchi,' Y. Asakura,2 and M. Yanagida,"Institute of Medical Science, Univer-
sity of Tokyo; 'Dept. of Biophysics, Faculty of Science, Kyoto University, Japan: Cloning
of a gene
for aspartate transcarbamylase from S. pombe by complementation of pyrB mutations in E.
coli.
G. R. Taylor,' B. J. Barclay,' R. K. Storms,' and R. H. Haynes,' 'Dept. of Biology, York University,
Toronto; 'Dept. of Biology, Concordia University, Montreal, Canada: Isolation of the
thymidylate
synthetase gene (TMP1) by complementation in S. cerevisiae.
J. Ferguson, J. C. Groppe, and S. I. Reed, Dept. of Biological Sciences, University
of California, Santa
Barbara: Three new shuttle vectors that allow easy, rapid subcloning of yeast genes on
small DNA
fragments.
A.G. Hinnebusch and G. R. Fink, Section of Biochemistry, Molecular and Cell
Biology, Cornell
University, Ithaca, New York: Molecular cloning of the HIS1 gene in yeast.
F. Hagie and R. Hitzeman, Dept. of Molecular Biology, Genentech, Inc. South San
Francisco, Califor-
nia: Primary structure of the yeast 3-phosphoglycerate kinase gene.
M. A. Eldarov, V. E. Ivanov, and K. G. Skryabin, Institute of Molecular Biology,
Academy of Sciences
of USSR, Moscow: The structural organization of the ARG4 gene from
S. cerevisiae.
R. Losson and F. Lacroute, Institut de Biologie Moleculaire and Cellulaire,
Laboratoire de Genetique
Physiologique, Strasbourg, France: Cloning and expression of pprl the regulatory
gene acting on
URA1 and URA3 structural genes.
Q. Ju, Q. Gong, F. Huang, H. Rong, J. He, and D. Kuang, Shanghai Institute of
Cell Biology, Acade-
mia Sinica, China: Characterization and cloning of a yeast plasmid.
F. W. Larimer; A. K. Beck,' and F. H. Gaertner,1'2 'Biology Division, Oak Ridge
National Laboratory;
'University of Tennessee, Oak Ridge Graduate School of Biomedical
Sciences: Isolation o the
ARO1 gene of S. cerevisiae.
A. Martinez-Arias and M. J. Casadaban, Dept. of Biophysics and
Theoretical Biology, University of
Chicago, Illinois: Regulated expression of yeast Ieu2 -E. coli
0-galactosidase gene fusion in yeast.
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J. B. McNeil and J. D. Friesen, Dept. of
Biology, York University, Toronto, Canada: S. cerevisiae DNA
responsible for the expression of the herpes simplex virus
thymidine kinase gene in yeast.
G. Ammerer,' G. Faye,' A. Barta,2 J. Bennetzen,' and B. D.
lall,"Dept. of Genetics, University of
Washington, Seattle; 'Endocrine Research Division, University
of California, San Francisco: In vivo
function of genes fused to the yeast ADHI 5' flanking sequence.
Workshop on Cloning and Expression Vectors
Chairperson: D. Botstein, Massachusetts
Institute of Technology, Cambridge
Session 10: Recombination and Repair
Chairperson: F. Sherman, University of Rochester, New York
P. Brown and J. Szostak, Dept. of Biological Chemistry, Sidney Farber Cancer Institute, Harvard
iMedical School, Boston, Massachusetts: Isolation of mutations n mitotic recombination.
S. Klapholz and R. E. Esposito, Biology Dept., University of Chicago, Illinois: A new rapid mapping
procedure employing a meiotic Rec mutant.
M. S. Esposito,' C.V. Bruschi,' D. T. Maleas,' K. A. Bjornstad,' and J. E. Colin,' 'Lawrence Berkeley
Laboratory, Berkeley, California; 'University of Oregon, Eugene: Comparative analysis of mitotic
meiotic recombination.
M. D. Mikus and T. D. Petes, Dept. of Microbiology, University of Chicago, Illinois: Gene conversion
and excision of single-copy genes inserted within yeast rDNA.
G. S. Roeder,' and G. R. Fink,' 'Dept. of Biology, Yale University, New Haven, Connecticut; 'Dept. of
Biochemistry, Cornell University, Ithaca, New York: Recombination of yeast transposable
elements.
S. Fogel and D. B. Kilgore, Dept. of Genetics, University of California, Berkeley: Mitotic and meiotic
gene conversion in nontandem duplications.
R. E. Malone, Dept. of Microbiology, Stritch School of Medicine, Loyola University of Chicago,
Maywood, Illinois: Multiple mutant analysis of recombination during meiosis and mitosis in yeast.
M. Frankenberg-Schwager, D. Frankenberg, M. NUsse, D. Blocher, and R. Harbich, Gesellschaft fOr
Strahlenund Umweltforschung mbH, Biophysikalische Strahlenforschung, Frankfurt, Federal
Republic of Germany: Effect of the rad52 gene on the cell-cycle-dependent variation of radiosen-
sitivity in yeast.
M. A. Resnick,' S. Stasiewicz,1 and J. C. Game,' 'National Institute of Environmental Health Sciences,
Research Triangle Park, North Carolina; 'Dept. of Genetics, University of California, Berkeley:
DNA metabolism during meiosis in excision-deficient and normal yeast following UV exposure.
M. Budd and R. Mortimer, Dept. of Biophysics and Medical Physics, University of California, Berke-
ley: Inducible repair of X-ray damage.
L. Bell and B. Byers, Dept. of Genetics, University of Washington, Seattle: Homologous association
of chromosomal DNA in meiosis.
T. L. Orr-Weaver,' R. J. Rothstein,' and J. W. Szostak,"Dept. of Biological Chemistry, Sidney Farber
Cancer Institute, Harvard Medical School, Boston, Massachusetts; 'Dept. of Microbiology, New
Jersey Medical School, Newark: Plasmid integration as a model system for recombination-DNA
ends are recombinogenic.
Session 11: Cell Surface, Structure and Transport
Chairperson: R. Mortimer, University of California, Berkeley
R. K. Chan and C. A. Otte, Dept. of Microbiology, University of Cincinnati College of Medicine,
Ohio: Defect in yeast mutants supersensitive to GI arrest by a-factor and a-factor pheromones.
J. Kurjan and I. Herskowitz, Institute of Molecular Biology, University of Oregon, Eugene: A puta-
tive a-factor precursor containing four tandem repeats of mature a -factor.
L. C. Blair, A. J. Brake, D. J. Julius, J. M. Lugovoy, and J. Thorner, Dept. of Microbiology and Immu-
nology, University of California, Berkeley: Synthesis and processing of yeast pheromones-
Identification and characterization of mutants that produce altered a-factors.
P. N. Lipke and K. Terrance, Dept. of Biological Sciences, Hunter College, City University of New
York, New York: Evidence for a single interacting system in S. cerevisiae agglutination.
P. Novick, S. Ferro, B. Esmon, and R. Schekman, Dept. of Biochemistry, University of California,
Berkeley: Order of events in the yeast secretory pathway.
N. F. Neff, J. H. Thomas, and D. Botstein, Dept. of Biology, Massachusetts Institute of Technology,
Cambridge: Genetics of tubulin in yeast-A gene that mutates to benomyl resistance is tightlylinked to sequences homologous to a chick /3-butulin cDNA.
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D. Short le, N.F. Neff, and D. Botstein, Dept. of Biology, Massachusetts Institute of Technology,
Cambridge: Genetics of actin in yeast-Analysis of actin function by transformation of yeast with
actin genes modified in vitro.
Session 12: Killer
Chairperson: C. McLaughlin, University of California, Irvine
D. J. Thiele, R. W. Wang, and M. J. Leibowitz, Dept. of Microbiology, CMDNJ, Rutgers Medical
School, Piscataway, New Jersey: Structural analysis of killer dsRNA of yeast.
J. Bruenn," L. Bobek,' L. Field,' D. Reilly,' V. Brennan,' and K. Gross,' "Division of Cell and Molecular
Biology, State University of New York, Buffalo; 'Molecular Biology Dept., Roswell Park Memorial
Institute, Buffalo, New York: Structure and replication of yeast viral dsRNAs.
B. L. Brizzard and S. R. de Kloet, Institute of Molecular Biophysics, Florida State University, Tallahas-
see: Superkiller yeast strain exhibits additional species of dsRNA.
R. B. Wickner, NIAMDD, National Institutes of Health, Bethesda, Maryland: Three genetically dis-
tinct L dsRNA species.
K. Bostian, S. Jayachandran, V. Burn, and D. Tipper, Dept. of Molecular Genetics and Microbiology,
University of Massachusetts Medical School, Worcester: Functional sequence of the structural
gene of killer MI dsRNA and maturation of the product, a precursor of toxin.
Session 13: tRNA, Ribosomes and Translation
Chairperson: D. Hawthorne, University of Washington, Seattle
M. F. Tuite' and C. S. McLaughlin,' 'Dept. of Biochemistry, University of Oxford, England; 'Dept. of
Biological Chemistry, University of California, Irvine: Termination readthrough in [psil and [psi]
cell-free lysates of S. cerevisiae.
C. Cummins,' T. Donahue,' and M. Culbertson,' Laboratories of Molecular Biology and Genetics,
University of Wisconsin, Madison; 'Section of Biochemistry, Molecular and Cell Biology, Cornell
University, Ithaca, New York: The SUF2 frameshift suppressor gene encodes an altered prolyl-
tRNA with a nucleotide addition in the anticodon.
A. K. Hopper, A. Furukawa, L. Schultz, and J. Kurjan, Dept. of Biological Chemistry, Milton S.
Hershey Medical Center, Hershey, Pennsylvania: Genetic and biochemical approaches to study-
ing tRNA processing and modification in yeast.
P. Tekamp, D. N. Standring, and W. J. Rutter, Dept. of Biochemistry and Biophysics, University of
California, San Francisco: RNA-processing enzymes specific for yeast 5S and tRNA.
J. L. Teem, J. Rodriguez, and M. Rosbash, Dept. of Biology, Rosenstiel Center of Brandeis University,
Waltham, Massachusetts: Posttranscriptional regulation of yeast ribosomal protein gene expression.
C. H. Kim and J. R. Warner, Albert Einstein College of Medicine, Bronx, New York: The mRNAs for
ribosomal proteins.
T. J. Zamb and T. D. Petes, Dept. of Microbiology, University of Chicago, Illinois: Orientation of the
rRNA gene cluster-Polarity of transcription relative to other genes on chromosome XII.
K. G. Skryabin, Institute of Molecular Biology, Academy of Sciences of USSR, Moscow: rRNA genes
of S. cerevisiae.
J. T. Barnitz, J. H. Cramer, and R. H. Rownd, Laboratory of Molecular Biology and Dept. of Biochem-
istry, University of Wisconsin, Madison: Organization of S. pombe ribosomal DNA.
R. J. Planta, J. Klootwijk, and G. M. Veldman, Biochemisch Laboratorium, Vrije Universiteit, Amster-
dam, The Netherlands: Transcription and processing of yeast ribosomal precursor RNA.
Session 14: Regulation Ill
Chairperson: E. Jones, Carnegie-Mellon University, Pittsburgh, Pennsylvania
B. Shicker, V. Letts, and S. Henry, Dept. of Genetics and Molecular Biology, Albert Einstein
College
of Medicine, Bronx, New York: Regulation of phospholipid biosynthesis in yeast.
Y.-P. Hsu, M. Hampsey, and G. B. Kohlhaw, Dept. of Biochemistry, Purdue
University, West
Lafayette, Indiana: Regulation of leucine biosynthesis in S. cerevisiae.
L. M. Hereford, M. A. Osley, and S. E. Bromley, Rosenstiel Center of Brandeis
University, Waltham,
Massachusetts: Transcriptional regulation of yeast histone gene expression.
M. R. Chevallier, J. C. Hubert, and F. Lacroute, Laboratoire de Genetique Physiologique,
Institut de
Biologie Moleculaire and Cellulaire Strasbourg, France: Transcription of the
uracil permease
gene in the wild type and in a regulatory mutant.
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M. Carlson,12 B. Osmond,1
and D. Botstein,1 iDept. of Biology, Massachusetts Institute of Technol-
ogy,
h
Cambridge; 2Dept. of Human
Genetics and Development, College of Physicians Sur-
geons, Columbia University, New
York: Structure and regulation of the SVC genes.
n°1-
Session 15: Mitochondria
Chairperson: B. D. Hall,
University of Washington, Seattle
D. K. Hanson; H. R. Mahler,'
and P. S. Perlman,21Dept. Chemistry, Indiana University, Bloomingto
n;
a
2Dept. Genetics, Ohio State
University, Columbus: Intron 4 of the cytochrome b gene encodes
polypeptide necessary for RNA processing
of two mitochondrial genes.
P. Q. Anziano, K. R. Glaus, K.
Jarrel, and P. S. Perlman, Genetics Dept., Ohio State University
Columbus: Functional domains of a
mitochondrial intron-Intron 4 of the cytochrome b gene.
S.G sser,G. Daum, P. Bohni, and G. Schatz, Dept. of Biochemistry, Biocenter, University of BaselSwitzerland: In vitro import of proteins into mitochondria. ,
This meeting was supported in part
by the National Institutes of Health, Cetus Corporation, and the
Upjohn Company.
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Nucleases, August 19-August 23
Arranged by Stuart M. Linn, University of California, Berkeley, Richard J. Roberts, Cold Spring
Harbor Laboratory
101 participants
Opening Address: Tribute to M. Laskowski
D. Kowalski, Roswell Park Memorial Institute, Buffalo, New York
Session 1: Replication Nucleases
Chairperson: C. M. Radding, Yale University School of Medicine, New Haven, Connecticut
K. Geider, T. F. Meyer, I. Baumel, and G. Harth, Dept. of Molecular Biology, Max-Planck-Institut fur
Medizinscheforschung, Heidelberg, Federal Republic of Germany: Bacteriophage fd gene-2
protein-A specific endonuclease with DNA ligase activity in replication of phage viral strands.
H. S. Jansz,1 P. D. Baas,' A. D. M. van Mansfeld,' F. Heidekamp,1 G. H. Veeneman,2 and J. H. van
Boom,2 'Institute of Molecular Biology and Laboratory for Physiological Chemistry, State Univer-
sity of Utrecht; 2Dept. of Organic Chemistry, State University of Leiden, The Netherlands: Gene-A
protein, a site-specific nuclease involved in initiation and termination of bacteriophage OX174
DNA replication.
D. Reinberg, S. L. Zipursky, D. Brown, and J. Hurwitz, Albert Einstein College of Medicine, Bronx,
New York: Studies on the mechanism of initiation, elongation, and termination of c1)X RFI DNA
replication.
R. Low, P. Burgers, J. Kobori, K. Arai, N. Arai, L. Bertsch, and A. Kornberg, Dept. of Biochemistry,
Stanford University School of Medicine, California: Primosome in DNA replication.
R. J. Crouch, NICHH, National Institutes of Health, Bethesda, Maryland: Mechanism of E. coli RNase H.
Session 2: Repair Nucleases
Chairperson: P. Sadowski, University of Toronto, Canada
S. Linn, D. W. Mosbaugh, and M. LaBelle, Dept. of Biochemistry, University of California, Berkeley:
Studies of base-excision repair.
R. H. Grafstrom, L. P. Park, and L. Grossman, Dept. of Biochemistry, Johns Hopkins University, Balti-
more, Maryland: Incision mechanism of dimer-containing DNA in M. luteus.
G. L. Chan, L. K. Gordon, C. P. Lindan, and W. A. Haseltine, Dept. of Pathology, Harvard Medical
School, and Sidney Farber Cancer Institute, Boston, Massachusetts: Repair endonucleases for
UV- irradiated DNA studied by DNA sequencing gels.
R.S. Lloyd, P.C. Seawell, C. A. Smith, A. K. Ganesan, and P. C. Hanawalt, Dept. of Biological Scien-
ces, Stanford University, California: Properties of endonuclease V of bacteriophage T4.
W. D. Rupp, A. Sancer, and B. Kacinski, Yale University School of Medicine, New Haven, Connecti-
cut: Identification and characterization of the E. coli uvr gene products.
E. Seeberg, N. D. Clarke, G. B. Evensen, and M. Kvall, Toxicology Division, Norwegian Defense
Research Establishment, Kjeller, Norway: Genetic control, gene cloning, and properties of two
distinct 3-meA DNA glycosylase activities in E. coli.
Session 3: Poster Session
1. Arendes,1 P. L. Car1,2 K. C. Kim,' and A. Sugino,"Laboratory of Molecular Genetics, National
Institute of Environmental Health Sciences, Research Triangle Park, North Carolina; 2Dept.
of
Pharmacology, University of North Carolina School of Medicine, Chapel Hill: Studies of RNase
H
mutants-Comparison of the enzyme from E. coli PC 412 (wt) and FB 2 (rnh ).
S
. Benchimol, M. Sumner-Smith, and A. Becker, Dept. of Medical Genetics,
University of Toronto,
Canada: PBEN-A single-stranded-DNA-dependent, ATP-dependent endodeoxyribonuclease is
the product of gene bEa59 of phage lambda.
1. E. Brooks and R. J. Roberts, Cold Spring Harbor Laboratory, New York: Modification
profile of
bacterial genomes.
1. G. Chirikjian,i J. George,' Y. H. Hamada,' P. Hensley,' and R. Blakesley,2 'Dept. of Biochemistry,
G. eorgetown Medical Center, Washington, D.C.; 2Bethesda Research Laboratories Inc.,
Gaithers-
burg,r , Maryland: Studies on the sequence-specific endonuclease BamHI.
G. DasGupta, A. M. Wu, R. Kahn, R. P. Cunningham, and C. M.
Radding, Dept. of Human Genetics,
185
Yale University School of Medicine, New
Haven, Connecticut: Concerted strand exchange and
formation of Holliday structures by E. coli recA protein.
T. K. Dziegielewski and M. Laskowski, Sr.,
Laboratory of Enzymology, Roswell Park Memorial Insti-
tute, Buffalo, New York: Nucleosomes
prepared from chicken erythrocyte nuclei with the aid of
micrococcal nuclease contain poly(ADP-Rib).
A. Goldfarb and V. Daniel, Biochemistry Dept.,
Weizmann Institute of Science, Rehovot, Israel: An
E. coli endonuclease responsible for primary cleavage
of in vitro transcripts of bacteriophage T4
tRNA gene cluster.
N. Hasan and A. Landy, Division of Biology and Medicine, Brown University, Providence, Rhode
Island: Characterization of an Int fragment produced by limited proteolysis.
W. Hollomon, J. Rusche, T. Rowe, and M. Brougham, Dept. of Immunology and Medical Microbiol-
ogy, University of Florida, Gainesville: DNA enzymes from Usti lago.
S. lida, J. Meyer, S. Hadi, B. Bachi, T. Bickle, and W. Arber, Dept. of Microbiology, Biocenter, Basel
Switzerland: Organization of the type-III modification and restriction genes of phages P1 and
P1-15.
C. M. Joyce,' N. D. F. Grindley,' and J. M. Rosenberg,2 'Dept. of Molecular Biophysics and Biochem-
istry, Yale University Medical School, New Haven, Connecticut; 2Dept. of Biological Sciences
,University of Pittsburgh, Pennsylvania: Reduced site specificity of endonucleases EcoRI and Bstl.
A. E. Karin and M. Urbauer, Dept. of Biochemistry, University of California, Riverside: Alteration of
E. coli recBC enzyme activities by monoclonal antibodies.
D. Kowalski, J. P. Sanford, and T. J. Foels, Laboratory of Enzymology, Roswell Park Memorial Insti-
tute, Buffalo, New York: Mung bean and PI nucleases-Zn metalloenzyme properties and action
on supercoiled PM2 DNA.
J. Langdale, B. D. Jiang, P. Myers, and R. J. Roberts, Cold Spring Harbor Laboratory, New York:
Isolation and characterization of restriction endonucleases.
M. Lauth, R. Reed, and N. Grindley, Dept. of Molecular Biophysics and Biochemistry, Yale Univer-
sity Medical School, New Haven, Connecticut: Location of resolvase binding sites at the resolu-
tion site of
D. Lee and P. Sadowski, Dept. of Medical Genetics, University of Toronto, Canada: Site-specific
cutting of intracellular DNA of bacteriophage T7 in vivo.
A. D. B. Malcolm and J. R. Moffatt, Dept. of Biochemistry, St. Mary's Hospital Medical School,
London, England: Differential reactivities at restriction enzyme sites.
A. MarSchel, E. Hatt, S. Colvin, L. Markowitz, and D. Hendrick, Bethesda Research Laboratories Inc.,
Gaithersburg, Maryland: Strains of Caryophanon latum differ with respect to their expression of
restriction endonucleases.
H. Motamedi, L. Nichols, L. Kangryul, and F. J. Schmidt, Dept. of Biochemistry, University of Mis-
souri, Columbia: Molecular cloning of the E. coli rnpA gene.
S. Nishikawa, D. Soll, and D. Frendewey, Yale University, New Haven, Connecticut: Purification of
tRNA processing nucleases from S. pombe.
S. Riazuddin,' Z. Ahmed,' and L. Grossman,2 'Nuclear Institute for Agriculture and Biology, Faisa-
labad, Pakistan; 2School of Hygiene and Public Health, John Hopkins University, Baltimore, Mary-
land: Isolation, purification, and characterization of a gamma-radiation-damage-specific enzyme.
S. Riazuddin,' A. Ather,1 and L. Grossman,2 'Nuclear Institute for Agrigulture and Biology, Faisa-
labad, Pakistan; 2School of Hygiene and Public Health, Johns Hopkins University, Baltimore,
Maryland: Studies on mutants of M. luteus parent cell having increased resistance against the
damaging effects of alkylating chemicals.
J. Rosamond, Dept. of Chemistry, University of Oxford, England: An endonuclease from the mito-
chondrion of the yeast S. cerevisiae.
P. Sadowski,' H. Murialdo,' G. Wu,' and N. Hozumi,23 Depts. of 'Medical Genetics and 2Medical
Biophysics, University of Toronto; 3Ontario Cancer Institute, Canada: An immunoglobulin light-
chain gene with an abnormal V-J junction and a mutated donor RNA splicing site.
B. M. Sahai and D. Kowalski, Laboratory of Enzymology, Roswell Park Memorial Institute, Buffalo,
New York: Eukaryotic DNA topoisomerase II activity correlates with cell growth.
I. Schildkraut, L. Greenough, G. Wilson, R. Grandoni, R. Borsetti, D. Wise, and D. Comb, New
England Biolabs, Beverly, Massachusetts: Identification and characterization of restriction
endonucleases.
K. Shishido and T. Ando, Dept. of Microbiology, Institute of Physical and Chemical Research,
Wako-shi, Saitama, Japan: The use of prokaryotic topoisomerase activity for the study on tertiary
structure of superhelical DNA and for the screening of DNA-binding substance.
D. A. Stahl and N. R. Pace, National Jewish Hospital and Research Center and Dept. of Biophysics
and Genetics, University of Colorado School of Medicine, Denver: The purification and proper-
ties of the component of B. subtilis RNase M5.
J.G. K. Williams, T. Shibata, R. Kahn, and C. M. Radding, Dept. of Human Genetics, Yale University
School of Medicine, New Haven, Connecticut: E. coli recA protein protects single-stranded DNA
or gapped duplex DNA from degradation by recBC DNase.
J. L. Woodhead and A. D. B. Malcolm, Dept. of Biochemistry, St. Mary's Hospital Medical School,
London, England: The essential carboxyl group in restriction endonuclease Eco.
J. L. Woodhead and A. D. B. Malcolm, Dept. of Biochemistry, St. Mary's Hospital Medical School,
London, England: Nonspecific binding of restriction endonuclease EcoRI to DNA.
Session 4: Topoisomerases
Chairperson: P. Modrich, Duke University, Durham, North Carolina
T. Goto, Y.-C. Tse, I. S. Sigal, D. S. Horowitz, L. A. Zumstein, S. L. Swanberg, K. Kirkegaard, K.
Becherer, A. Shaw, and J. C. Wang, Harvard University, Cambridge, Massachusetts: Recent studies
on DNA topoisomerases of E. coli and S. cerevisiae.
K. N. Kreuzer, D. Coit, and B. M. Alberts, Dept. of Biochemistry and Biophysics, University of
California, San Francisco: DNA cleavage reactions of the bacteriophage-T4-induced topoisomerase.
L.M. Fisher, K. Mizuuchi, M. H. O'Dea, and M. Gellert, NIAMDD, National Institutes of Health,
Bethesda, Maryland: DNA protection and double-stranded DNA by E. coli DNA gyrase.
T.-S. Hsieh, Dept. of Biochemistry, Duke University Medical Center, Durham, North Carolina:
Mechanism of the type-2 DNA topoisomerase from D. melanogaster.
B. Halligan, J. L. Davis, and L. F. Liu, Dept. of Physiological Chemistry, Johns Hopkins Medical
School, Baltimore, Maryland: Intra-and interstrand transfer by eukaryotic DNA topoisomerase.
M. D. Been and J. J. Champoux, Dept. of Microbiology and Immunology, University of Washington,
Seattle: Breakage of single- and double-stranded DNA by eukaryotic type-1 topoisomerases.
Session 5: Restriction Endonucleases
Chairperson: R. J. Roberts, Cold Spring Harbor Laboratory, New York
J. Burckhardt, J. Weisemann, D. L. Hamilton, and R. Yuan, NCI, Frederick Cancer Research Center,
Frederick, Maryland: The mechanism of DNA methylation by the restriction endonuclease from
E. coli K.
T. A. Bickle, S. lida, S. Hadi, and B. Suri, Dept. of Microbiology, Biocenter,
University of Basel,
Switzerland: A comparison of the properties of type-I and type-Ill restriction endonucleases
with
their corresponding modification methylases.
Piekarowicz, Institute of Microbiology, Warsaw University, Poland: Cleavage and methylation
of
DNA by the Hinf III and Hinel restriction enzymes.
A. Kiss, E. Szomolanyi, W. Reichardt, and P. Venetianer, Institute of Biochemistry,
Biological
Research Center, Szeged, Hungary: Molecular cloning of the modification methylase genes
of B.
sphaericus and B. subtilis.
L. Agarwal, Depts. of Biochemistry and Chemistry, University of Chicago, Illinois: Sequence
recognition by Hpal, HpaII, and Mspl endonucleases.
W. E. Jack, A.-L. Lu, R. Rubin, S.-C. Cheng, A. Newman, and P. Modrich,
Duke University Medical
Center, Durham, North Carolina: DNA contacts, mode of specific sequence location,
and struc-
tures of EcoRI restriction and modification enzymes.
P Greene, H. W. Boyer, and J. Rosenberg, University of California, San Francisco:
Genetic and
molecular analysis of the EcoRI restriction enzyme.
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Session 6: Recombination Nucleases I
Chairperson: S.M. Linn, University of California, Berkeley
P. D. Sadowski, D. Lee, L. Roberts, and W. Bradley,
Dept. of Medical Genetics, University Of To ronto
Canada: Recombination of bacteriophage T7
DNA in vivo and in vitro.
R. Kolodner, K. Davies, M. I. Doherty, R. A. Fishel, A. A. James, J. Joseph,
and P. M. Morrison, Sidney
Farber Cancer Institute and Dept. of Biological
Chemistry, Harvard Medical School, Boston, mas"
sachusetts: Genetic recombination of plasmid DNA.
H. A. Nash, N. L. Craig, and T. J. Pollock, NIMH,
National Institutes of Health, Bethesda, Maryland:
Protein-DNA interactions in site-specific recombination of phage lambda.
R. Kahn, R. P. Cunningham, C. DasGupta, arid C. M. Radding, Dept. of Human Genetics, Yal
eUniversity School of Medicine, New Haven, Connecticut: The polarity of strand transfer pro-
moted by E. coli recA protein.
A. Taylor, D. W. Schultz, and G. R. Smith, Institute of Molecular Biology, University of Oregon,
Eugene: Exonuclease V, Chi sites and recombination.
R. R. Reed, N. D. F. Grindley, and J. A. Steitz, Dept. of Molecular Biophysics and Biochemistry, Yal
eUniversity, New Haven, Connecticut: In vitro site-specific recombination mediated by the trans
poson -yo.
Session 7: Recombination Nucleases II. RNA-processing Enzymes
Chairperson: U. L. RajBhandary, Massachusetts Institute of Technology, Cambridge
M. J. Fraser, T. Y.-K. Chow, and L. M. Hunt, Dept. of Biochemistry, McGill University, Montreal,
Canada: A putative recombinase of Neurospora, endo-exonuclease.
M. Gold, A. Becker, and W. Parris, Dept. of Medical Genetics, University of Toronto, Canada:
Bacteriophage lambda DNA terminase.
G. A. Alianell, C.-F. Wei, and H. B. Gray, Jr., Dept. of Biophysical Sciences, University of Houston,
Texas: The extracellular nuclease of Alteromonas espejiana as a tool in nucleic acid research.
S. Altman, M. Baer, C. Guerrier-Takada, and R. Kole, Dept. of Biology, Yale University, New Haven,
Connecticut: Properties of RNase P-An endoribonuclease essential for tRNA biosynthesis.
M. P. Deutscher, H. Cudny, R. Zaniewski, P. Roy, and A. Solari, Dept. of Biochemistry, University of
Connecticut Health Center, Farmington: Nucleases acting at the 3' terminus of tRNA precursors.
H. D. Robertson, Laboratory of Genetics, Rockefeller University, New York, New York: Enzymes and
mechanisms in mRNA processing.
R. J. Crouch, S. Kanaya, S. Seidman, R.J. Feldmann, and P. Earl, National Institutes of Health,
Bethesda, Maryland: Processing of chicken rRNA.
Session 8: Splicing Enzymes
Chairperson: S. Altman, Yale University, New Haven, Connecticut
C. L. Peebles and J. Albelson, Dept. of Chemistry, University of California, San Diego: Pre-tRNA
splicing in yeast.
P. Grabowski, A. Zaug, S. Brehm, and T. Cech, Dept. of Chemistry, University of Colorado, Boulder:
In vitro splicing of the ribosomal RNA precursor of Tetrahymena.
Session 9: Open Discussion
Summary: S.M. Linn, University of California, Berkeley
This meeting was supported in part by grants from the National Institutes of Health and the National
Science Foundation. Contributions from the following companies are gratefully acknowledged:
Enzo Biochem; Bethesda Research Laboratories; New England Biolabs; New England Nuclear; PL
Biochemicals.
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Bacteriophage, August 25-August 30
Arranged by Ahmad I. Bukhari, Cold Spring Harbor Laboratory
170 participants
Session 1: T4 Genes and Their Functions
B. Kemper; J. Hays,2 K. Mizuuchi,3 and R. Weisberg,3 1lnstitut fur Genetik, University of Cologne,
Federal Republic of Germany; 2University of Maryland, Catonsville; 3NICHHD, National Institutes
of Health, Bethesda, Maryland: Cleavage of branched DNA by purified T4 49k-enzyme.
G. Mosig and S. Bock, Dept. of Molecular Biology, Vanderbilt University, Nashville, Tennessee: On
the roles of topoisomerase genes and recombination genes in primary and secondary initiation of
T4 DNA replication.
B. Kemper, Institut fur Genetik, University of Cologne, Federal Republic of Germany: T4-induced
endonuclease VII resolves branched DNA molecules in vitro.
V. I. Tanyashin and A. A. Bayev, Institute of Biochemistry and Physiology of Microorganisms, USSR
Accademy of Sciences, Pushchino: T4 DNA structure and function-Gene regions 50-30; 31-38,
and 42-46.
M.A. Jabber, J. M. Runnels, and L. R. Snyder, Dept. of Microbiology and Public Health, Michigan
State University, East Lansing: Genetic mapping of a host gene whose product may substitute for
the T4-induced polynucleotide kinase and RNA ligase enzymes.
A. Baxter; and C. G. Goff,21Dept. of Cell and Molecular Biology, University of Michigan, Ann Arbor;
2Dept. of Biology, Haverford College, Pennsylvania: Cloning and mapping the T4 gene-60 region.
W. M. Huang and Lian S. Ngai, Dept. of Cellular, Viral, and Molecular Biology, University of Utah
Medical Center, Salt Lake City: Expression of cloned T4 gene 39 in E. coli cells.
K. Dharmalingam, H. R. Revel, and E. B. Goldberg, Dept. of Molecular Biology and Microbiology,
Tufts University School of Medicine, Boston, Massachusetts: Deletion mapping and cloning of the
T4 anti-restriction endonuclease gene, arn.
B. Pragai and D. Apirion, Dept. of Microbiology, Washington University, St. Louis, Missouri: Pro-
cessing of RNA from the T4 tRNA cluster by host enzymes.
N. J. Casna and D. A. Shub, State University of New York, Albany: Bacteriophage T4 as a generalized
cloning vector.
G. G. Wilson, Dept. of Molecular Biophysics and Biochemistry, Yale University Medical School, New
Haven, Connecticut: Plasmid transduction by phage T4.
Session 2: Regulation of Gene Expression: T Phages and N4
J. N. Bailey and W.T. McAllister, Dept. of Microbiology, CMDNJ-Rutgers Medical
School, Piscata-
way New Jersey: Promoter sequences for E. coli and T3 RNA
polymerases in T3 DNA.
A. D. Carter,1 L. K. Jolliffe,2 and W. T. McAllister,21National Institutes of Health,
Bethesda, Maryland;
Dept. of Microgiology, Rutgers Medical School, Piscataway, New Jersey:
Identification of a
region in T7 late promoters which may be involved in promoter
selection in vivo and in vitro.
C. E. Morris and W.T. McAllister, Dept. of Microbiology, CMDNJ-Rutgers Medical
School, Piscata-
way, New Jersey: Expression of foreign genes in recombinant plasmids
under the control of T7
and T3 late promoters.
S. Shanblatt and D. Nakada, Dept. of Biochemistry, University of Pittsburgh School
of Medicine,
Pennsylvania: T7 interactions with E. coli RNA polymerase.
J. R. Christensen and P. Ooi, Dept. of Microbiology, University of Rochester,
New York: The trans-
cription program of phage T1-A beginning study.
C. Malone, S. Spellman, and L. B. Rothman-Denes, Dept. of Biophysics and
Theoretical Biology,
University of Chicago, Illinois: Cloning and construction of a genetic map
of bacteriophage N4.
L. Haynes, D. Marchetti, and L. B. Rothman-Denes, Dept. of Biophysics and
Theoretical Biology,
University of Chicago, Illinois: Specificity of transcription of the N4
virion-associated RNA
polymerase.
D. Marchetti C. Malone, and L. B. Rothman-Denes, Dept. of Biophysics
and Theoretical Biology,
University of Chicago, Illinois: N4 virion RNA polymerase has an intrinsic
ATPase that is required
for transcription.
W. .Zehring and L. B. Rothman-Denes, Dept. of Microbiology and
of Biophysics and Theoretical
Biology, University of Chicago, Illinois: Extensive purification and
template properties of bacteri-
ophage N4 activity-II RNA polymerase and analysis of its in vitro
and in vivo products.
J. K. Rist,1 A. Sugino,2 and L. B. Rothman-Denes,1 1Dept. of Biochemistry
and of Biophysics and
Theoretical Biology, University of Chicago, Illinois; 2Laboratory of
Molecular Genetics, National
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Institute of Enviromental Health Sciences,
Research Triangle Park, North Carolina: N4 DNA
replication.
Session 3: Transposable Elements
D. Roberts and N. Kleckner, Dept. of
Biochemistry and Molecular Biology, Harvard University,
Cambridge, Massachusetts: Isolation of host mutants
affected for transposition of Tn10-
.
V. Lundblad and N. Kleckner, The Biological Laboratories, Harvard University, Cambrid ge, Massa
chusetts: Host mutants of E. coli K12 that affect excision of transposon Tn/O.
M. A. Davis and N. Kleckner, Dept. of Biochemistry and Molecular Biology, Harvard University,
Cambridge, Massachusetts: Mutants of Tn10 that are
increased for transposition.
R. Isderg and M. Syvanen, Dept. of Microbiology and Molecular Genetics, Harvard Medical School,
Boston, Massachusetts: A supercoiled substrate is required for transposition of Tn5.
D. Hinton, K. Bidwell, and R. Musso, Cancer Biology Program, Frederick Cancer Research C enter,
Frederick, Maryland: Transcription and translation of IS2.
M. P. van Bree and J. A. Engler, Cold Spring Harbor Laboratory, New York: The nucleotide seq uence
of the transposable element IS5.
R. M. Harshey and A. I. Bukhari, Cold Spring Harbor Laboratory, New York: Integration precursor of
Mu.
R. M. Harshey, G. McGuinness, and A. I. Bukhari, Cold Spring Harbor Laboratory, New York:
Expression of the mom gene of bacteriophage Mu.
Session 4: Site-specific Recombination
N. L. Craig and H. A. Nash, NIMH, National Institutes of Health, Bethesda, Maryland: Protein-DNA
interactions in A site-specific recombination.
K. Abremski and J. Davidson, Cancer Biology Program, Frederick Cancer Research Center, Freder-
ick, Maryland: E. coli host-factor requirements for bacteriophage A excisive recombination.
H. I. Miller, and H. Echols, Dept. of Molecular Biology, University of California, Berkeley: SOS
induction and autoregulation of the himA gene for site-specific recombination in E. coli.
L. C. Plantefaber,' M. Gellert,' and D. I. Friedman,' 'Dept. of Microbiology and Immunology, Uni-
versity of Michigan, Ann Arbor; 2NIAMDD, National Institutes of Health, Bethesda, Maryland:
Isolation of temperature-sensitive himB mutants.
A. Winoto, S. Chung, J. Abraham, H. Begusch, and H. Echols, Dept. of Molecular Biology, University
of California, Berkeley: Directional control of the intergration-excision reaction by phage A-A
point mutation in the P' region that blocks integration but not excision.
R. A. Weisberg,' C. Foeller,2 L. Enquist,' A. Landy,2 and M. E. Gottesman,' 'NICHHD, National Insti-
tutes of Health, Bethesda, Maryland; 'Brown University, Providence, Rhode Island: The role of
homology in site-specific recombination of phage A.
R. H. Hoess and N. Sternberg, Cancer Biology Program, Frederick Cancer Research Center, Freder-
ick, Maryland: P1 site-specific recombination-Analysis of the recombining sites.
K. Abremski and N. Sternberg, Cancer Biology Program, Frederick Cancer Research Center, Freder-
ick, Maryland: An in vitro system for the study of bacteriophage P1 site-specific recombination.
A. Abeles, S. Austin, D. Chattoraj, F. Hart, and M. Yarmolinsky, Cancer Biology Program, Frederick
Cancer Research Center, Maryland: Localization and characterization of elements involved in the
replication and partition of P1 plasmid prophage.
M. Better and D. Freifelder, Dept. of Biochemistry, Brandeis University, Waltham, Massachusetts:
Electron microscopic examination of the intracellular population of bacteriophage A DNA.
R. Calendar,' L. Liu,' J. C. Wang,3 J. L. Davis,' and L. Perkocha,' 'Molecular Biology Dept., University
of California, Berkeley; 'Physiological Chemistry Dept., Johns Hopkins Medical School, Balti-
more, Maryland; 3The Biological Laboratories, Harvard University, Cambridge, Massachusetts:
Knotted DNA from P2 and P4 capsids and its use in the assay of type-II topoisomerases.
M. Sumner-Smith, S. Benchimol, A. Becker, and H. Murialdo, Dept. of Medical Genetics, University
of Toronto, Canada: The A b-region gene bEa59 encodes a single-stranded-DNA-dependent,
ATP-dependent endodeoxyribonuclease.
Session 5: Poster Session
C. Bauer and J. Gardner, Dept. of Microbiology, University of Illinois, Urbana: The secondary A
attachement site in the threonine operon attenuator-Mutations in the OP' attachment site.
G. E. Christie and R. Calendar, Dept. of Molecular Biology, University of California, Berkeley:
Sequence analysis of a bacteriophage P2 late gene promoter region.
F. J. Grundy and M. M. Howe, Dept. of Bacteriology, University of Wisconsin, Madison: Mutants of
bacteriophage Mu defective in S or U make particles lacking tail fibers.
D. H. Hall and R. G. Sargent, School of Biology, Georgia Institute of Technology, Atlanta: Cloning
and characterization of the dihydrofolate reductase gene of bacteriophage T4.
K. Kaiser' and K. Cartwright,2 'European Molecular Biology Laboratory, Heidelberg, Federal Repub-
lic of Germany; 2Western General Hospital, Edinburgh, Scotland: The role of defective prophages
in phage evolution.
A. Liss and R. A. Heiland, Rocky Mountain Laboratories, NIAID, National Institutes of Health, Hamil-
ton, Montana: Carrier-state stability in SV1-infected spiroplasmas.
N. E. Murray, J. Gough, and H. Senior, European Molecular Biology Laboratory, Heidelberg, Federal
Republic of Germany: Host specificity genes of E. coli strains.
M. P. Ontell and D. Nakada, Dept. of Biochemistry, University of Pittsburgh School of Medicine,
Pennsylvania: T7 2- infection of E. coli K-Loss of concatemer processing specificity during
packaging.
M. M. Susskind, Dept. of Molecular Genetics and Microbiology, University of Massachusetts Medi-
cal School, Worcester: mys, another new gene in the P22 imml region.
M. Yarmolinsky, Cancer Biology Program, Frederick Cancer Research Center, Frederick, Maryland:
Antagonism between gpant of phage P1 and the SOS repressor, gplexA of E. colt.
Session 6: Regulation of Gene Expression in Temperate Phages I
R. T. Sauer,' W. Krovatin,1 A. Jeffrey,2 and C. 0. Pabo,2 'Dept. of Biology, Massachusetts Institute of
Technology, Cambridge; 2The Biological Laboratories, Harvard University, Cambridge, Massachu-
setts: Interaction of the A. repressor with operator DNA.
Y. Takeda, C. G. Caday, and D. David, Chemistry Dept., University of Maryland, Catonsville: Interac-
tion of A Cro repressor with operator DNA-Mapping functional groups of Cro repressor by
chemical modification.
M. A. Hoyt,' A. Das,2 and H. Echols," "Dept. of Molecular Biology, University of California,
Berkeley;
Dept. of Microbiology, University of Connecticut Health Center, Farmington: Regulation of
lysogenization by phage A-Host controls on the quantity of CII.
Y. Ho and M. Rosenberg, NCI, National Institutes of Health, Bethesda, Maryland: Characterization
of the phage A regulatory protein CII.
A. Rattray and G. Guarneros, Dept. of Genetics and Molecular Biology, Centro de
Investigacioon y
Estudios Avanzados del I.P.M., Mexico City, Mexico: Regulation of integrative recombination-
The role of the CIII function.
D. Schindler and H. Echols, Dept. of Molecular Biology, University of California, Berkeley:
Retro-
regulation of the int gene A-Control of translation completion.
A. Oppenheim, S. Gottesman, and M. Gottesman, NCI, National Institutes of Health,
Bethesda,
Maryland: The terminator of the A Pt' transcript participate in int gene regulation.
D. Court, T. F. Huang, and A. Oppenheim, NCI, National Institutes of Health, Bethesda,
Maryland:
Deletion analysis of a transcription termination site and RNase III processing
site within the sib
region of A.
U. Schmeissner, K. McKenney, D. Court, and M. Rosenberg, NCI, National
Institutes of Health,
Bethesda, Maryland: Removal of a terminator structure by RNase III regulates
int gene expression
of phage X.
C. Georgopoulosi and Harvey Eisen,2 1Dept. of Cellular, Viral and Molecular
Biology, University of
Utah, Salt Lake City; 2lnstitut Pasteur, Paris, France: The bacteriophage
Hyp phenotype.
Session 7: Regulation of Gene Expression II
D. Ward and M. Gottesman, NCI, National Institutes of Health, Bethesda,
Maryland: The role of
translation in transcription antitermination by the A N product. 191
N. C. Franklin, Howard Hughes Medical Institute, University of Utah, Salt Lake City: Comparison of
DNA sequence in the N-24 regions of A and P22.
A. Das, K. Wolska, J. Wardwell, and S. Han, Dept. of Microbiology, University of Connecticut Health
iCenter, Farmington: Transcription antitermination by N protein in well-defined plasmids requires
A nut locus and host nus ABDE proteins.
L.J. Mashni, L. C. Plantefaber, M. Baumann, and D. I. Friedman, Dept. of Microbiology and Immu-
nology, University of Michigan, Ann Arbor: Identification of the nusC -60 mutation in E.
J. Wardwell, D. Burnham, and A. Das, Dept. of Microbiology, University of Connecticut Health
Center, Farmington: Interaction of N and nus proteins with the nut locus in a multicopy plasmid is
lethal to E. coli.
E. J. Grayhack and J. W. Roberts, Dept. of Biochemistry, Cornell University, Ithaca, New York: The
Q protein promotes increased transcription of the A late genes in vitro.
C. Debouck and C. Dambly, Genetique, University Libre de Bruxelles, Rhode-Saint-Genese, Bel-gium: Transcription termination in the PR-tin region of bacteriophage A.
D. L. Daniels and F. R. Blattner, Dept. of Genetics, University of Wisconsin, Madison: Nucleotide
sequence of the Q gene and theQ to S intergenic region of bacteriophage A.
M. A. Mozola and D. I. Friedman, Dept. of Microbiology and Immunology, University of Michigan,
Ann Arbor: A 080 function inhibitory for phage growth in HimA mutants of E. coli.
J. Garrett and R. Young, Dept. of Medical Biochemistry, Texas A&M University, College Station:
Induction of the A S killing activity.
D. B. Wilson and A. Okabe, Section of Biochemistry, Molecular and Cell Biology, Cornell University,
Ithaca, New York: Identification of the active form of the S-gene product.
Session 8: Regulation of Gene Expression HI
S. -J. Lee, S. Mango, V. Cryns, and R. Goldstein, Dept. of Microbiology and Molecular Genetics,
Harvard Medical School, Boston, Massachusetts: A possible role for antitermination in the trans-
criptional control of plasmid maintenance by satellite phage P4.
S. -J. Lee, S. Mango, and R. Goldstein, Dept. of Microbiology and Molecular Genetics, Harvard
Medical School, Boston, Massachusetts: Kinetic analysis of gene products encoded by satellite
bacteriophage P4.
V. Cryns and R. Goldstein, Dept. of Microbiology and Molecular Genetics, Harvard Medical School,
Boston, Massachusetts: Mutants of helper bacteriophage P2 insensitive to morphogenic interfer-
ence by satellite phage P4.
E. W. Six, J. A. Williams, and M.G. Sunshine, Dept. of Microbiology, University of Iowa, Iowa City: Aphage P2 mutant insensitive to interference by its satellite P4.
L. Korsnes and B. H. Lindqvist, Institute of Medical Biology, University of Tromse3, Norway: The ogrgene and control of late transcription in bacteriophage P2.
U. Skreslett, L. Korsnes, and B. H. Lindqvist, Institute of Medical Biology, University of Troms6,
Norway: Purification and analysis of E. coli RNA polymerase from bacteriophage P2-and P4-infected cells.
E. Gulletta,' S. Garges,' A. Das,' and S. Adhya,' 'NCI, National Institutes of Health, Bethesda, Mary-land; 'University of Connecticut, Farmington: Characterization of the rho gene of E. coli.S. Gottesman,' M. Gottesman,' M. Pearson,' J. Shaw,3 and A. Das," 'NCI, National Institutes ofHealth, Bethesda, Maryland; 'NCI, Frederick Cancer Research Center, Frederick, Maryland;
3Dept. of Medical Genetics, University of Toronto, Canada; 'Dept. of Microbiology, University ofConnecticut Health Center, Farmington: Properties of Ai nus mutation in the rho gene-rhoHDF026.
J. L. Pinkham and T. Platt, Yale University, New Haven, Connecticut: Nucleotide sequence of the rhogene in E. coli K12.
J. I. Auerbach' and P. Howard-Flanders,'
"NCI, National Institutes of Health, Bethesda, Maryland;
'Dept. of Therapeutic Radiology, Yale University, New Haven, Connecticut: Physiological signifi-cance of the role of the lexA gene in the repression of the uvr genes of E. coli.H. Aiba and S. Fujimoto, Radioisotope Laboratory, Faculty of Medicine, Kyoto University, Japan:Cloning and DNA sequence of the cAMP receptor protein gene of E. coli.
Session 9: Regulation of Gene Expression IV Morphogensis I
P. Youderian and M. M. Susskind, Dept. of Molecular Genetics and Microbiology, University ofMassachusetts Medical School, Worcester: Genetic analysis of the P22 0""1 operator.P. Youderian, S. Bouvier, D. Grana, and M. M. Susskind, Dept. of Molecular Genetics and Microbi-ology, University of Massachusetts Medical School, Worcester: Fine-structure genetic analysis ofthe P22 Pa' promoter.
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M. M. Susskind, S. Bouvier, P. Youderian, and S. J. Chadwick, Dept. of Molecular Genetics and
Microbiology, University of Massachusetts Medical School, Worcester: Posttranscriptional con-
trol of P22 ant gene expression.
P. Riggs and D. Bostein, Dept. of Biology, Massachusetts Institute of Technology, Cambridge:
Regulation of the late operon of phage P22.
D. F. Cully and A. J. Garro, City College of New York and Mt. Sinai School of Medicine, City
University of New York, New York: Nucleotide sequence analysis of the B. subtilis phage 0105
immunity region.
S. H. Shore and M. M. Howe, Dept. of Bacteriology, University of Wisconsin, Madison: Gene T
encodes the major head polypeptide of bacteriophage Mu.
M. George and A. I. Bukhari, Cold Spring Harbor Laboratory, New York: Packaging of host sequen-
ces attached to the ends of bacteriophage Mu DNA.
S. Casjens and W. M. Huang, Dept. of Cellular, Viral and Molecular Biology, University of Utah
Medical Center, Salt Lake City: Initiation of P22 DNA packaging.
M. Feiss,' W. Widner,1 and I. Kobayashi,2 'Dept. of Microbiology, University of Iowa, Iowa City;
2lnstitute of Molecular Biology, University of Oregon, Eugene: terminase-cos interactions-
Evidence for separate binding and cutting sites.
S. Frackman, D. Siegele, and M. Feiss, Dept. of microbiology, University of Iowa, Iowa City: Direct
interaction of A terminase with proheads in complex II.
Session 10: Morphogensis II
E. Wyckoff and S. Casjens, Dept. of Cellular, Viral and Molecular Biology, University of Utah
Medical Center, Salt Lake City: Regulation of phage P22 scaffolding protein synthesis.
D. H. Smith, D. P. Goldenberg, and J. King, Massachusetts Institute of Technology, Cambridge:
Genetic analysis of protein folding in the tail spike protein of P22.
R. W. Hendrix and M. Popa, Dept. of Biological Sciences, University of Pittsburgh, Pennsylvania: Tail
length in lambdoid phages-Correlation with size of a minor tail protein.
K. Tilly and C. Georgopoulos, Dept. of Cellular, Viral and Molecular Biology, University of Utah, Salt
Lake City: Evidence that the two E. coli groE morphogenetic gene products interact in vivo.
J. L. Carrascosa,1 E. Vinuela,2 N. Garcia,2 and A. Santisteban,2 "Centro de Biologia Molecular
(CSIC-UAM), Madrid; 2Centro de Investigacion UAM-IBM, Madrid, Spain: Head-tail connecting
region of bacteriophage 029.
P. B. Berget, M. Chidambaram, and M. F. Plishker, Dept. of Biochemistry and Molecular Biology,
University of Texas Medical School, Houston: In vitro assembly and analysis of the
first assembly
intermediate in T4 baseplate morphogenesis.
B. Stitt and L. Mindich, Public Health Research Institute of the City of New York,
Inc., New York:
Membrane assembly in Pseudomanas bacteriophage 06.
L. Mindich, C. Goldthwaite, and T. McGraw, Dept. of Microbiology, Public Health
Research Insti-
tute of the City of New York, Inc., New York: Morphogenesis of the
lipid-containing bacterio-
phage PRD1.
Session 11: Replication and Recombination (general)
S. Rein berg, S. L. Zipursky, D. Brown, and J. Hurwitz, Albert Einstein
College of Medicine, Bronx,
New Yo k: Studies on the requirements for leading and lagging strand
DNA synthesis during A
protein-dependent RF-RF DNA replication in vitro.
I. S. B. Yen and R. E. Webster, Dept. of Biochemistry, Duke University,
Durham, North Carolina:
Control of the intracellular concentrations of Fl gene-II and gene-X proteins
by gene-V protein.
K. Gelder, T. F. Meyer, and I. Baumel, Dept. of Molecular Biology, Max-Planck-Institut
fur Medizini-
scheforschung, Heidelberg, Federal Republic of Germany: Strand unwinding
by phage fd gene-2
protein and E. coli rep protein.
I. F. Meyer and K. Geider, Dept. of Molecular Biology, Max-Planck-Institut
fur Medizinischefor-
schung, Heidelberg, Federal Republic of Germany: Maintenance
of a replicon with the phage fd
replication origin by cloned fd gene 2.
K. Horiuchi and G. P. Dotto, Rockefeller University, New York, New
York: Replication of a plasmid
that contains a duplicated origin of bacteriophage f1 DNA replication.
M. Lichten and M.S. Fox, Dept. of Biology, Massachusetts
Institute of Technology, Cambridge: The
effect of nonhomologies on bacteriophage recombination.
Grosz,L. .r , Dept. of Genetics, Attila Jozsef University, Szeged, Hungary:
Mismatch repair and recom-
bination pattern of temperate phage 16-3 of R. meliloti. 193
R. Maurer, B.C. Osmond, and D. Botstein, Massachusetts Institute of Technology, Cambridge
Complementation and pseudoreversion analysis of essential Salmonella genes cloned in A.
R. Mosesson, R. M. Harshey, and A. I. Bukhari, Cold Spring Harbor Laboratory, New York: Shotgun_
ning of E. coli chromosome without restriction enzymes.
This meeting was supported in part by a grant from the National Cancer Institute, National Institutes
of Health.
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9th Cold Spring Harbor Conference on Cell Proliferation
Growth of Cells in Hormonally Defined Media, September 1-September 6
Arranged by David A. Sirbasku, University of Texas Health Science Center, Gordon H. Sato, Univer-
sity of California, San Diego, Arthur B. Pardee, Sidney Farber Cancer Institute, Harvard Medical
School
173 participants
Welcoming Remarks: J. D. Watson, Cold Spring Harbor Laboratory
Opening Address: Jacob Furth Dedication
K. H. Clifton, Radiation Effects Research Foundation, Hiroshima, Japan
Session 1: Hormone-dependent Tumor Growth: History and Current Topics
Chairperson: G. H. Sato, University of California, San Diego
H. Kirkman, Dept. of Structural Biology, Stanford University School of Medicine, California:
Estrogen- and androgen/estrogen-induced and -dependent tumors in the Syrian hamster.
R. Ross, University of Washington School of Medicine, Seattle: Growth factors-Current concepts.
R. Holley, Salk Institute, San Diego, California: Control of cell growth.
S. Cohen, Dept. of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee:
Some recent and historical aspects of EGF and NGF.
G. H. Sato, Dept. of Biology, University of California, San Diego: Defined media.
Session 2: Nutrition and Cells in Defined Media
Chairperson: C. Waymouth, Jackson Laboratory, Bar Harbor, Maine
C. Waymouth, P. Ward, and S. Blake, Jackson Laboratory, Bar Harbor, Maine: Mouse prostatic
epithelial cells in defined culture media.
R.G. Ham, Dept. of Molecular, Cellular and Developmental Biology, University of Colorado,
Boulder: Importance of the basal nutrient medium in the design of hormonally defined media.
W. L. McKeehan, W. Alton Jones Cell Science Center, Lake Placid, New York: Growth factor-nut-
rient interrelationships in control of normal and transformed cell proliferation.
D. McClure,' G. Sato,' M. Hightower, p-2 12 and W. To p Dept. of Biology, University of California, San
Diego; 2Cold Spring Harbor Laboratory, New York: Development of a defined medium for the
growth and maintenance of the rat embryo cell line REF52 and its application to the study of SV40
transformation.
Session 3: Role of Cell Matrix
Chairperson: L. Reid, Albert Einstein College of Medicine, Bronx, New York
L. Reid, Dept. of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York:
_.Synergistic regulation of growth and differentiation by hormones and extracellular matrix.
D G ospodarowicz, Cancer Research Institute, University of Calfornia Medical Center, San Fran-
cisco: Extracellular matrices and the establishment in tissue culture of normal diploid cells.
Grotendorst, National Institutes of Health, Bethesda, Maryland: Role of attachment
factors.
K. Yamada, S. K. Adiyama, and M. Hiyashi, NCI, National Institutes of Health, Bethesda, Maryland:
Fibronectin.
Session 4: Differentiation in Defined Media
Chairperson:
J. E. Lever, Dept. of Biochemistry and Molecular Biology, University of Texas Medical
School, Hous-
ton: Cell differentiation and dome formafion in polarized epithelial monolayers.
P tranerner and M. H. Saier, Jr., Dept. of Biology, University of California, San
Diego: Nutrient
sport and growth regulation in kidney epithelial cells cultured in a defined
medium.
D Dept. of Physiology and Cell Biology, University of Texas
School of Medicine,
Houston: Basal lamina assembly by the dog kidney epithelial cell line MDCK. 195
J. E. Lever, University of Texas Medical School, Houston
N. Alavi, D. Livingston, and M. Taub, Dept. of Biochemistry,
School of Medicine, State University of
New York, Buffalo: Growth and functional
properties Of proximal tubule cells from the rabbit
kidney in defined medium.
G. Erickson, R. Casper, and C. Hofeditz, Dept.
of Reproductive Medic ine, University of California
San Diego: The obligatory role of defined medium
in the hormone-dependent differentiation oi
rat granulosa cells.
J. P. Mather,' J. M. Saez,2 F. Haour,2 'Population
Council, New York, New York; 1INSERM, Lyo
nFrance: Hormone-hormone and hormone-vitamin
interactions in the control of growth ancf
function of testicular cells in vitro.
A. Rizzino, NCI, National Institutes of Health,
Frederick, Maryland: The effect of the substratum on
the differentiation of embryonal carcinoma cells.
Session 5: Expression of Differentiated Function in Defined Media
Chairperson: N.G. Coon, NCI, National Institutes of Health, Bethesda, Maryland
H. L. Leffert and K. S. Koch, Dept. of Medicine, University of California, San Diego: Hepatocyte
growth regulation by hormones in chemically defined media-A two-signal hypothesis.
G. N. Gill, J. F. Crivello, P. J. Hornsby, and M. H. Simonian, Dept. of Medicine, University of Califor-
nia School of Medicine, San Diego: Cultured adrenocortical cells.
D. N. Carney, A. F. Gazdar, P. A. Bunn, H. Oie, and J. D. Minna, NCI, National Institutes of Health,
Bethesda, Maryland: Growth and cloning of human small-cell lung cancer in serum-free, defined
media.
J. Folkman,1 C. Haudenschild,2 and B. Zetter,2 'Dept. of Surgery, Children's Hospital Medical Cen-
ter; 2Depts. of Surgery, Anatomy, and Physiology, Harvard Medical School, Boston, Massachu-
setts: Capillary endothelial cells-Growth control and differentiation.
T. Maciag,' G. A. Hoover,2 M. B. Stemerman,2 and R. Weinstein,2 Depts. of Pathology and 2Medicine,
Harvard Medical School, Beth Israel Hospital, Boston, Massachusetts: Human umbilical vein
endothelial cell mitogens.
G. R. Serrero, Dept. of Biology, University of California, San Diego: Growth and differentiation of a
fibro-adipogenic cell line in serum-free medium.
R. Wu, Laboratory of Pulmonary Function and Toxicology, National Institute of Environmental
Health Sciences, Research Triangle Park, North Carolina: Effects of hormones on the multiplica-
tion and differentiation of tracheal epithelial cells cultured in defined media.
F. S. Ambesi-Impiombato and D. Tramontano, Centro di Endocrinologia ed Oncologia Sperimentale
del CNR, Naples, Italy: The influence of hormones and serum on growth and differentiation of
thyroid cell strain FRT1.
Session 6: Cell Attachment Factors and Melanocytes
Chairperson: D. Barnes, University of Pittsburgh, Pennsylvania
D. W. Barnes,' M. Darmon,2 and J. Orly,' 'Dept. of Biological Sciences, University of Pittsburgh,
Pennsylvania; 2Dept. of Molecular Biology, Pasteur Institute, Paris, France; 'Dept. of Biological
Chemistry, Hebrew University, Jerusalem, Israel: Serum spreading factor-Effects on RF1 rat ovary
cells and 1003 mouse embryonal carcinoma cells in serum-free media.
G. Brunner and R. Wieser, Institute for Immunology, University of Mainz, Federal Republic of
Germany: Importance of the "contact environment" on the behavior of mammalian cells.
J. M. Varga,' D. T. Lambert,' L. Airoldi,1 G. Moellmann,' J. C. Bartholomew,2 and A. B. Lerner,' 'Dept.
of Dermatology, Yale University School of Medicine, New Haven, Connecticut; 'Laboratory of
Chemical Biodynamics, University of California, Berkeley: Characterization of murine melanoma
cells grown in serum-containing and serum- and hormone-free media.
M. Murray, R. Fleischmann, and J. Pawelek, Dept. of Dermatology, Yale University School of Medi-
cine, New Haven, Connecticut: A genetic approach to studies of insulin action in Cloudman S91
melanoma cells.
Session 7: Receptor-mediated Effects on Cell Growth
Chairperson: S. Hauschka, University of Washington, Seattle
I. Hayashi, City of Hope National Medical Center, Duarte, California: Growth of myoblasts in
hormone-supplemented serum-free medium.
T. Linkhart, B. Lim, and S. Hauschka, Dept. of Biochemistry, University of Washington, Seattle:
Regulation of normal and variant mouse myoblast proliferation and differentiation by specific
growth factors.
H.R. Herschman, D. B. Cawley, and D. L. Simpson, University of California School of Medicine, Los
Angeles: Toxic conjugates of epidermal growth factor and the enzymic chains of ricin toxin or
diptheria toxin.
N. Savion and D. Gospodarowicz, Cancer Research Institute, University of California, San Francisco:
Role of hormones, growth factors, and lipoproteins in the control of proliferation and differentia-
tion of cultured bovine granulosa cells.
Session 8: Lymphocytes and Granulocytes in Defined Media
Chairperson: I. Hayashi, City of Hope National Medical Center, Duarte, California
J. Hayashi and I. Goldschneider, Dept. of Pathology, University of Connecticut Health Center,
Farmington: In vitro culture of terminal-deoxynucleotidyl-transferase-positive rat bone marrow
cells.
1. Mendelsohn, A. Caviles, Jr., and J. Castagnola, Dept. of Medicine and Cancer Center, University
of California, San Diego: Proliferation of normal human lymphocytes in hormonally defined,
serum-free medium.
H. Murakami," H. Masui,2 and G. Sato,2 'Food Science and Technology Institute, Kyushu University,
Fukuoka, Japan; 2Dept. of Biology, University of California, San Diego: Cultivation of hybridoma
cells in serum-free medium.
T. R. Breitman, NCI, National Institutes of Health, Bethesda, Maryland: Induction of terminal differ-
entiation of HL-60 and fresh leukemic cells by retinoic acid.
1.-1.Mermod, R. N. Newby, and S. Bourgeois, Regulatory Biology Laboratory, Salk Institute, San
Diego, California: Effect of glucocorticoids on the growth of lymphoid cell lines.
Session 9: Growth Control in 3T3 Cells
Chairperson: C. D. Scher, Sidney Farber Cancer Center, Harvard University, Boston, Massachusetts
1.C. Smith, B. J. Bockus, J. P. Singh, and C. D. Stiles, Sidney Farber Cancer Institute, and Harvard
Medical School, Boston, Massachusetts: Molecular action of platelet-derived growth factor-
by somatic cell fusion techniques.
C. D. Scher," S. L. Hendrickson,' A. P. Whipple; M. M. Gottesman,2 and W. J. Pledger,3 1Sidney
Farber Cancer Institute, Boston, Massachusetts; 2NCI, National Institutes of
Health, Bethesda,
Maryland; 3University of North Carolina, Chapel Hill: Platelet-derived-growth-factor-modulated
proteins-Constitutive synthesis by a transformed cell line.
1. L. Wang, P. A. Steck, and J. W. Kurtz, Dept. of Biochemistry, Michigan State University,
East Lans-
ing: Isolation and characterization of a growth regulatory factor from 3T3 cells.
Session 10: Poster Session: Cell Function and Defined Media
Chairperson: D. Sirbasku, University of Texas Medical School, Houston
B. B. Asch,
ial Institute
. F. Dvorak,2 and D. R. Senger,2 1
, Buffalo, New York;
Dept. of Experimental Pathology, Roswell
Park Memor-
Sch
I Boston
2Dept. of Pathology, Beth Israel Hospital
and Harvard Medical
,.f_ib.ro°:blasts and epithelial cells.
A major phosphoprotein marker for neoplastic
transformation of
rAo4w3t1h
D
medium
Barnes Dept. of Biological Sciences, University of Pittsburgh, Pennsylvania: A
serum-free
hfuarnctoan epidermoid carcinoma cells; inhibition of
growth in culture by mouse
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nutrients
'Dept. of Biochemistry, St. Louis University Medic al Sc hool, Missouri;
,, University
oun;
W. J. Bettger' and R. G. Ham'
'Dept. of Molecular, Cellular
and Developmental Biology, University of Colorado, Boulder:
FUredericl.c,
nal growth of human dip oi
fibroblasts in a defined medium-The critic al role of
D. Bowen-Pope, K. Glenn, E. Raines,
and R. Ross, Depts. of Pathology and Biochemistry,
of Washington School of Medicine,
Seattle: Binding of radiolabeled platelet-derived growth
i erences
factor to its receptor.
N. Brunet,' D. Gourdji,' A. Rizzino,2 and A. Tixier-Vidal,'
'College de France, Paris 2
proiac..Maryland: Role of attachment and spreading factors-Effect of
fetuin on proliferation and i
tin secretion by GH3 cells-An
adaptation to primary cultures of normal rat prolactin cells.
G. Brunner, G. Tschank, and P.
Stasiecki, Institute for Immunology, University of Mainz, Feder
l
cells -
Characterization
Republic of Germany: Are different
molecular pathways the reason for proliferation Of
caused by hormones used in serum-free media?
R. L. Buzard and D. Horn, Molecular Biology Division,
Unviersity of Southern California, Los
Angeles: Growth inhibition by dexamethasone
in clonal variants of hamster melanoma
r ct riz tion of biological response and role of medium components.
H. Chang and O.W. Jones, Dept. of Medicine,
University of California, San Diego: Human amniotic
fluid cells in a hormonal supplement-Importance in amniocentesis.
D. Chaproniere-Rickenberg and M. M. Webber, Division
of Urology, University of Colorado Health
Sciences Center, Denver: A chemically defined medium for the growth of adult human prostatic
epithelium.
D. L. Coppock and D. S. Straus, Division of
Biomedical Sciences, University of California, Riverside:
Growth response to insulin and MSA in mouse melanoma cells and fibroblast x melanoma
hybrids.
F. J. Darfler and P. A. Inset Pharmacology Dept., University of California, San Diego: Growth of
hybridomas and other lymphoid cells in defined medium.
G. Fischer, Institute of Neurobiology, University of Heidelberg, Federal Republic of G
Cultivation of mouse cerebella cells in defined media.
H. Fong,' W. L. Chick,' and G. H. Sato,' 'Dept. of Biology, University of California, San Diego;2Deptte.
of Biochemistry, Massachusetts Medical School, Worcester: Hormones and factors that stimulate
growth of rat islet tumor cell line in serum-free medium.
G. R. Grotendorst,' H. E.J. Seppa,' G. R. Martin,' H. K. Kleinman,' C. D. Stiles, and C.D. Scher,'
'NIDR, National Institutes of Health, Bethesda, Maryland; - 'Sidney Farber Cancer Institute, Boston,
Massachusetts: The platelet-derived growth factor is a chemoattractant for fibroblastic cells.
M. Ho' and D. A. Sirbasku,' 'Dept. of Life Sciences, Kumamoto Women's University, Japan; 'Dept. of
Biochemistry and Molecular Biology, University of Texas Medical School, Houston: Partial purifi-
cation of mammary tumor cell estromedins from pregnant sheep uterus.
M. J. Jackson and S. Shin, Albert Einstein College of Medicine, Bronx, New York: The role of inositol
in mammalian cell growth in culture.
F. E. Leland, D. Danielpour, and D. A. Sirbasku, Dept. of Biochemistry and Molecular Biology
University of Texas Medical School, Houston: Studies of the endocrine, paracrine, and autocrine
control of mammary tumor cell growth.
J. G. Liehr, B. B. DaGue, A.M. Ballatore, and D. A. Sirbasku, Dept. of Biochemistry and Molecular
Biology, University of Texas Medical School, Houston: The multiple roles of estrogen in estrogen-
dependent renal clear-cell carcinoma of Syrian hamster.
R. W. Lim and S. D. Hauschka, Dept. of Biochemistry, University of Washington, Seattle: Differential
epidermal growth factor (EGF) responsiveness and EGF receptor modulation in a clonal line of
mouse myoblasts and a differentiation-defective variant.
H. Masui and T. White, University of California, San Diego: Correlation between in vivo tumorige-
nicity and growth characteristics of tumor cell subpopulations in human astrocytoma.
H. K. Meissl and M. Marcus,' 'Dept. of Cell Biology, New York University Medical School, New
York; 'Dept. of Genetics, Hebrew University, Jerusalem, Israel: Cell-cycle arrest points in nontu-
morigenic and tumorigenic cell lines, dependency on growth factors.
K. Miyazaki, H. Masui, and G. Sato, Dept. of Biology, University of California, San Diego: Control
factors for keratinization of human bronchogenic epidermoid carcinoma cells.
J. B. Moo and D. A. Sirbasku, Dept. of Biochemistry and Molecular Biology, University of Texas
Medical School, Houston: Role of estrogens and growth factors in pituitary tumor cell growth.
J. H. Nielsen, Hagedorn Research Laboratory, Copenhagen, Denmark: Growth hormone as a
growth factor for normal pancreatic islet cells in primary culture.
A. Richmond,' D. H. Lawson,'' and D. W. Nixon,'' 'Clinical Research Facility and 'Division of
Hematology-Oncology Dept.pt. of Medicine, Emory University School of Medicine, Atlanta, Geor-
gia: Release of an autostimulatory growth activity by human malignant melanoma cells.
H. Rochefort,' D. Chalbos,' E. Coezy,' M. Garcia,' P. Vic,' F. Vignon,' and B. Westley,' 'INSERM;
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2Laboratoire d' Histologie, Faculte de Medecine, Montpellier, France: Effect of estrogen on cellproliferation, ultrastructure, and secretory proteins in human breast cancer cell lines.M. Salas-Prato, Dept. of Biology, University of California, San Diego: Growth of fetal mouse liverprimary cells in serum-free medium.
D.S. Salomon,' L. A. Liotta,1 J.-M. Foidart,2 and M. Yaar,2 'NCI and 2NIDR, National Institutes ofHealth, Bethesda, Maryland: Synthesis and turnover of basement membrane components by
mouse embryonal carcinoma cells in serum-free hormone-supplemented medium.
S. S. Seaver,' S.M. Baird,2 J. van der Bosch,3 and G. Sato,3 'Dept. of Molecular Biology, VanderbiltUniversity, Nashville, Tennessee; 2Dept. of Pathology, VA Medical Center,San Diego, California;
3Dept. of Biology, University of California, San Diego: The effects of hormones on the growth andgene expression of a primary chick oviduct tissue culture system.
N. Shimizu, W. K. Miskimins, S. Gamou, and Y. Shimizu, Dept. of Cellular and DevelopmentalBiology, University of Arizona, Tucson: Genetics of insulin receptors and differentiation of 3T3 -L1
preadipocytes.
C. E. Smart, R. S. Slaughter, and J. E. Lever, Dept. of Biochemistry and Molecular Biology, University
of Texas Medical School, Houston: Lysosomotropic compounds stimulate dome formation (a
differentiated characteristic of MDCK kidney epithelial cell cultures).
R. Weinstein,' G. A. Hoover,' M. B. Stemerman,1 and T. Maciag,2 Depts. of 'Medicine and 2Pathol-
ogy, Harvard Medical School, Beth Israel Hospital, Boston, Massachusetts: Fibronectin depend-
ence for attachment in vitro-Fibroblast vs smooth muscle cell.
W. Wharton, E. Leof, E. O'Keefe, and W. J. Pledger, Cancer Research Center, University of North
Carolina, Chapel Hill: Reevaluation of the role of cyclic AMP in the control of cell-cycle traverse.
L. Wilkins,' G. Szabo,' L. Connell,' R. Nemore,2 and T. Maciag,2 'Harvard School of Dental Medicine;
2Beth Israel Hospital, Boston, Massachusetts: Growth of enriched human melanocyte cultures.
E.L. Wilson, C. Dutlow, and E. B. Dowdle, Dept. of Clinical Science and Immunology, Medical
School, Cape Town, South Africa: Characterization ofa new hormonally responsive human breast
carcinoma cell line.
R. A. Wolfe' and G. H. Sato,2 'Dept. of Molecular Genetics, Hoffmann-La Roche Inc., Nutley, New
Jersey; 2Dept. of Biology, University of California, San Diego: Continuous serum-free culture of
the N18TG-2 neuroblastoma, the C6BU-1 glioma, and NG108-15 neuroblastoma X glioma hybrid
cell lines.
I. Yamane, M. Kan, Y. Minamoto, and Y. Amatsuji, Institute for TB and Cancer, Tohoku University,
Sendai, Japan: a-Cyclodextrin-A partial substitute for bovine albumin in serum-free culture of
mammalian cells.
Session 11: Normal vs. Cancer Cells in Defined Media
Chairperson: R. Sager, Harvard University Medical School, Boston, Massachusetts
A.B. Pardee and P. V. Cherington, Sidney Farber Cancer Institute and Harvard Medical School,
Boston, Massachusetts: On the basis for loss of epidermal growth factor requirement by trans-
formed cells in defined medium.
R. F. Bennett, and B. L. Smith, Sidney Farber Cancer Institute, Boston, Massachusetts: Serum -
freeree growth of CHEF/18 and mutant cell lines.
W. J. Pledger, B. Chou, E. Leof, N. Olashaw, E. O'Keefe, J. J. Van Wyk, and W. R. Wharton, University
of North Carolina School of Medicine, Chapel Hill: Platelet-derived growth factor-Cellular
responses and possible mode of action.
S. . ow ers D. Alcorta, N. Nicholson, S. Chen, and R. Pollack, Dept. of Biological Sciences, ColumbiaUniversity, New York, New York: Transformation to serum independence specifically leads to
reduced hormone requirements for colonial cell growth.
A. Roberts M. A. Anzano, C. A. Frolik, and M. B. Sporn, NCI, National Institutes of Health,Bethesda, Maryland: Transforming growth factors-Characterization of two classes of factorsfrom both neoplastic and nonneoplastic tissues.
Session 12:
Chairperson:
T. Kail
of Colorado,eoka and J. E. Errick, Dept. of Molecular, Cellular and Developmental
Biology, University
cell growth. Boulder: Role of phosphoethanolamine, ethanolamine,
and prolactin on mammary
"Dept. of Biochemistry and MolecularD.A. Sirbasku,1 J. B. Officer,' and F. E. Leland," and M. Iio,2Biol ogy, University of Texas Medical School, Houston; 2Dept. of Life Sciences, Kumamoto
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Mammary Cell Growth in Defined Media
T. Kano-Sueoka, University of Colorado, Boulder
Women's University, Japan: Evidence
for a new role of pituitary-derived hormones and growth
R".)wShthiuritn)av, javr(l)dtj'.nYdaning,vCit,r1(n)(.'er Research Laboratory,
National
S.
factors Wi n
W.
mammary yt Tmoomr ocoekl la
of California, Berkeley: Growth
requirements for mammary epithelial cells in primary culture 'ure in
the presence and absence of
serum-Effects of in vivo mammogenic hormones.
Maryland: Growth-factor effects on mammary epithelialW. R Kidwell, L. A. Liotta, D.
Salomon, and J. Zwiebel, Laboratory of Pathophysiology
Institutes of Health, Bethesda,
eration and basement membrane synthesis.
M. R. Banerjee, R. Ganguly, N. M. Mehta, N. Ganguly,
and P. Majumder, Tumor Biology Laboratory
University of Nebraska, Lincoln: Regulation
of selective gene expression during differenti
Laboratory,
an isolated whole mammary organ
in a hormonally defined medium.
M. R. Stampfer,' A.1. Hackett,' 1. Bartley,'
J. P. Leung,' T. S. Edgington,2 and H. S. Smith,' 'Lawrence
Berkeley Laboratory, Peralta Cancer Research
Institute, Berkeley; 2Scripps Clinic and Research
Center, La Jolla, California: Expression of tumor-specific properties by human mammary epithe-liuin culture.
M. Lippman,' H. Nawata,' D. Bronzert,'
F. Vignon,2 and H. Rochefort,' 'NCI, National Institut es of
Health, Bethesda, Maryland; 2Endocrinology Unit, INSERM, Montpellier, France: Anti- estrogen-
resistant variants of hormone responsive MCF-7 human breast cancer cells.
Session 13: Neuronal Tissue in Defined Media
Chairperson: J. E. Bottenstein, University of California, Los Angeles
A. Michler-Stuke and J. E. Bottenstein, Dept. of Pediatrics, University of California School of Medi-
cine, Los Angeles: Growth of human and rat glioma cell lines in defined medium.
R. S. Morrison and J. de Vellis, Dept. of Anatomy, University of California, Los Angeles: Regulation
of proliferation and differentiation of astrocytes in a defined medium.
H. A. Armelin, A.G. Gambarini, and M. C. S. Armelin, Instituto de Quimica, Universidade de Sao
Paulo, Brazil: Pituitary FGF's and the growth of rat C6 glial cell variants.
H. G. Coon and C. N. Sinback, NCI, National Institutes of Health, Bethesda, Maryland: Cultures of
rat neuroblasts that divide and differentiate in vitro.
M. Darmon" and G. Sato,' 'Institut Pasteur, Paris, France; 'Dept. of Biology, University of California,
San Diego: Control of cell differentiation by the extracaular environment in an embryonal
carcinoma cell line.
R. Bunge, M. Bunge, D. Carey, D. Higgins, L. lacovitti, D. Kleinschmidt, and F. Moya, Dept. of
Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri:
Functional expression in neural tissue cultured in defined medium.
A. Tixier-Vidal, A. Faivre-Bauman, C. Loudes, and J. Puymirat, College de France, Paris: Expression
of neuronal functions by mouse fetal hypothalamic cells cultured in hormonally defined medium.
R. Goodman, Dept. of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia:
Pheochromocytoma cell lines in hormonally defined medium.
Concluding Remarks: A. Pardee, Sidney Farber Cancer Institute, Harvard University, Boston,
Massachusetts
This meeting was supported in part by funds from the National Cancer Institute, National Institutes
of Health, and the American Cancer Society.
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Session 1: Proteins and Regulation
Chairperson: H. F. Epstein, Baylor College of Medicine, Houston, Texas
H. F. Epstein,' D. M. Miller 111,1 L. A. Gosset,2 and R. M. Hecht,' 'Dept. of Neurology, Baylor College
of Medicine, Houston; 'Dept. of Biophysical Sciences, University of Houston, Texas: Myosin and
paramyosin expression in normal and mutant nematode embryogenesis.
S. Lowey, P. A. Benfield, G. F. Gauthier, D. D. LeBlanc, and G. Waller, Rosenstiel Center, Brandeis
University, Waltham, Massachusetts: Characterization of myosins from embryonic and develop-
ing chicken pectoralis muscle.
R.G. Whalen, S.M. Sell, C. Pinset, and L. Bugaisky, Dept. of Molecular Biology, Pasteur Institute,
Paris, France: Biochemical characterization of myosin heavy chain isozymes in adult and develop-
ing muscles.
R. C. Strohman, E. Bandman, and R. Matsuda, Dept. of Zoology, University of California, Berkeley:
Stability of expression of myosin isozymes, heavy chains, and light chains in long-term cultures.
R. Zak, A. W. Everett, R. A. Chizzonite, and W. A. Clark, Depts. of Medicine and of Pharmacological
and Physiological Sciences, University of Chicago, Illinois: Analysis of molecular variants of
myosin heavy chains in rabbit ventricles during normal growth and after treatment with thyroid
hormone.
J. I. Garrels, J.J. -C. Lin, and F. Matsumura, Cold Spring Harbor Laboratory, New York: Protein
synthesis and phosphorylation in myogenic cell lines studied by computer-analyzed two-dimen-
sional gel electrophoresis.
Session 2:
Chairperson:
Gene Structure and Expression I
R. A. Firtel, University of California, San Diego
M. McKeown and R. A. Firtel, Dept. of Biology, University of California, San Diego: The actin
T.
m ultigene family of Dictyostelium.
 L. Thomas' R. H. Scheller,2 L. B. McAllister,' R. J. Britten,' and E. H. Davidson,' 'Division of Biology,
California Institute of Technology, Pasadena; 'Institute of Cancer Research, Columbia University
College of Physicians & Surgeons, New York, New York: Linkage and expression of sea urchin
actin genes.
131 Bond,' N. Davidson,' S. Falkenthal,' E. A. Fyrberg,2 W. Mattox,' and V. Parker,' 'California
ci
P. u
Studies of muscle enes of Drosophila.p rotein g
'Dept. of Biology, Johns Hopkins University, Baltimore, Mary-.annstditute of Technology, Pasadena;
Medical J. Fornwald, C. Ovitt, T. Cooper, and A. Calman, Dept. of Anatomy, Temple
University
medical School Philadelphia, Pennsylvania: Structure and developmental regulation of muscle-
regulated gene sets.P Gunning, J. Engel, and L. Kedes, Howard Hughes Medical Institute Laboratory and Dept. ofMedicine,
Characterization
iirle, Stanford Medical School, Veterans Administration Medical Center, Palo Alto, Cali or-
of the human actin gene family.D. Hirsh J
U. Nud y of Colorado, Boulder: The actin genes of C. elegans.
Biolo gy,
UniversityFiles, S. Carr, and M. Krause, Dept. of Molecular, Cellular and Developmental
for co n t rWa cet liziemparnonteIninsst.itute of Science, Rehovot, Israel:
Studies on the structure of genes co
fdCinegll
Biology,elM. Shani, R. Zakut, D. Katcoff, J. Calvo, Y. Carmon, M.
Finer, and D. Yaffe, Dept. o
Session 3: Gene Structure and Expression II
Chairperson: d
M. L. Pea 1
Frederick and M. m.
M. L. Pearson, Frederick Cancer Research Center, Frederick, Maryland
ick, Maryland; Crerar,2 'Cancer Biology Program,
Frederick Cancer Research Center,h t
m 0y genesis. "Biol I
Canada: RNA polymerase II mutants defective
in
ogica s, Toronto,
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( ssion
B. Nadal-Ginard, R. M. Medford, H.
Nguyen, R. Gubitsind I . Bekesi, Alhert I instem Colipo
of
Medicine, Bronx, New York: Regulation of myosin heavy chain gene expression, during in o
L(,E9 cell myogenesis.
vitro
of Cell
M. Caravatti,' B. Robert,' A Minty,' A.
Weydert," S. Alonso,' A. Cohen," P. Daubas,i and M.
Ingham,' 'Friedrich Miescher Institute, Basel,
Switzerland; 'Dept. de Biologie Mol6(uidire,
'e )1
Paris, France: The messengers coding for myosins arid (.1( tins-Their expressionteur Institute,
during terminal differentiation of a mouse muscle cell line.
myogenesis.
M. Shani, D. Zevin-Sonkin, 0. Saxel, Y. Carmon, D. Katcoff, U. Nude!, and D. Yaffe, Dept.
Biology, Weizmann Institute of Science, Rehovot, Israel: Control of biosynthesis of muscleUS( e_
specific myosin heavy chain, myosin light chain 2, and a-actin during
R. Schwartz and W. Zimmer, Dept. of Cell Biology, Baylor College of Medicine, Houston, T
Amplification of the skeletal a-actin gene during myogenesis.
g
J. C. Perriard," U. B. Rosenberg,' P. Gerschwiler,' A. Frischauf,2 H. Lehrach," and H. M. Eppenber e
rl'Institute for Cell Biology, Swiss Federal Institute of Technology, Zurich, Switzerland; 'European
Molecular Biology Laboratory, Heidelberg, Federal Republic of Germany: Isoprotein switches as
indicators of gene regulation during the myogenic differentiation.
R. V. Storti," V. Blautch,' A. Szwast,' D. Mischke,2 and M.-L. Pardue,' 'Dept. of Biological Chemistry
University of Illinois Medical Center, Chicago; 'Dept. of Biology, Massachusetts Institute of Tech'
nology, Cambridge: Molecular cloning, characterization, and organization of Drosophila muscle
genes.
M. Ballivet, J. Patrick, J. Lee, and S. Heinemann, Neurobiology Laboratory, Salk Institute, San Diego,
California: Progress on cloning of the nicotinic acetylcholine receptor genes. -
Session 4: Gene Structure and Expression III
Chairperson: C. P. Emerson, Jr., University of Virginia, Charlottesville
K. E. M. Hastings and C. P. Emerson, Jr., Dept. of Biology, University of Virginia, Charlottesville:
cDNA clone analysis of mRNA regulation during myogenesis.
D. Feldman and S. Benoff, Dept. of Anatomy and Cell Biology, Downstate Medical Center, State
University of New York, Brooklyn: Differential utilization of myosin heavy chain mRNA isoforms
during development in skeletal muscle cultures.
P. K. Umeda, C. Kavinsky, A. M. Sinha, H.-J. Hsu, S. Jakovcic, and M. Rabinowitz, Depts. of Medicine
and of Biochemistry, University of Chicago, Illinois: Molecular cloning of myosin heavy chain
cDNAs from chick embryo skeletal muscle.
J. Karn and A. D. McLachlan, Laboratory of Molecular Biology, Medical Research Council, Cam-
bridge, England: Nucleotide sequence of a myosin heavy chain gene-Genetical and protein
structural implications.
D. G. Moerman, S. Bolten, and R. H. Waterston, Dept. of Genetics, Washington University, St. Louis,
Missouri: Studies on mutationally altered myosins in C. elegans.
A. J. Minty,' S. Alonso,' M. Caravatti,' A. Cohen,' P. Daubas,' and M. Buckingham,"Dept. of
Molecular Biology, Pasteur Institute, Paris, France; 2Freidrich Miescher Institute, Basel, Switzer-
land: The number and structure of mouse actin genes.
A.S. Havaranis, P. Bragg, and S.M. Heywood, Genetics and Cell Biology Section, University of
Connecticut, Storrs: Cytoplasmic utilization of liposome encapsulated myosin heavy chain mRNP
during muscle cell differentiation.
Session 5: Poster Session
R. E. Allen,' K. C. Masak,2 P. K. McAllister,' and G. Robinson,' 'Depts. of Nutrition and Food Science
and Animal Sciences; 'Dept. of Food Science and Human Nutrition, Michigan State University,
East Lansing: Age-related changes in a-actin accumlation in satellite-cell-derived myotubes.
A.S. Baldwin, Jr., E. L. W. Kittler, and C. P. Emerson, Jr., Dept. of Biology, University of Virginia,
Charlottesville: A quail fast skeletal muscle troponin I gene is linked to other fast-type genes.
E. Bandman, R. Matsuda, and R. C. Strohman, Dept. of Zoology, University of California, Berkeley:
Myosin isozymes during chicken fast muscle development in vivo and in culture.
S. I. Bernstein,' A. W. Glenn,' C. P. Emerson, Jr.," and J. J. Donady,2 "Dept. of Biology, University of
Virginia, Charlottesville; 'Dept. of Biology, Wesleyan University, Middletown, Connecticut: Isola-
tion, identification, and chromosomal mapping of a Drosophila myosin heavy chain gene.
G. S. Butler-Browne,' S. Cuenoud,1 L. Bugaisky,' K. Schwartz,' and R. G. Whalen,' "Dept. of Molecu-
lar Biology, Pasteur Institute, Paris, France; 2INSERM, Unit 127, Paris, France: Immunocytochemi-
cal studies of transitions of myosin isozymes in development.
W. R. Crain and A. D. Cooper, Cell Biology Group, Worcester Foundation for Experimental Biology,
Shrewsbury, Massachusetts: Fine structure analysis of two sea urchin actin genes.
M.Y. Fiszman, D. Montarras, and F. Gros, Dept. of Molecular Biology, Pasteur Institute, Paris,
France: Characterization of tropomyosin in various types of chick embryo muscles and study of
their developmental changes.
G. A. Freyer, T. C. Gilliam, D. Chisolm, and J. Robbins, Dept. of Biochemistry, University of Missouri,
Columbia: Isolation of normal chicken myosin heavy chain (MHC) plasmids, dystrophic chicken
genomic MHC recombinants, and detection of MHC mRNA during development.
L. I. Garfinkel and B. Nadal-Ginard, Albert Einstein College of Medicine, Bronx, New York: Cloning
and characterization of muscle mRNAs.
C. S. Giometti,' M. J. Danon,2 and N. G. Anderson,' 'Division of Biological and Medical Research,
Argonne National Laboratory, Illinois; 'Dept. of Neurology, University of Illinois Medical Center,
Chicago: Analysis of human muscle biopsies by two-dimensional electrophoresis.
R. M. Gubits and B. Nadal-Ginard, Dept. of Cell Biology, Albert Einstein College of Medicine, Bronx,
New York: Changes in the chromatin structure of a myosin heavy chain gene during LEG9
myoblast differentiation.
D. Hornig and B. Nadal-Ginard, Dept. of Cell Biology, Albert Einstein College of Medicine, Bronx,
New York: Characterization of adult skeletal muscle myosin heavy chain (MHC) genes of rat.
S. B. Jakowlew," P. Khandekar,' K. Datta,' A. Ahmed,' A. M. Zarraga," H.-H. Arnold,' and M. A. Q.
Siddiqui," 'Roche Institute of Molecular Biology, Nutley, New Jersey; 'University of Hamburg,
Federal Republic of Germany: Regulation of expression of cardiac muscle specific genes in early
chick embryo.
V. Mandavi, M. Periasamy, and B. Nadal-Ginard, Dept. of Cell Biology, Albert Einstein College of
Medicine, Bronx, New York: Analysis of the cardiac myosin heavy chain genes in the adult rat.
R. Matsuda, E. Bandman, and R. C. Strohman, Dept. of Zoology, University of California, Berkeley:
Myosin isozymes during chicken slow muscle development in vivo and in culture.
P. A. Merrifield and I. R. Konigsberg, Dept. of Biology, University of Virginia, Charlottesville: Myosin
synthesis and the cell cycle during myogenesis in vitro.
D. Montarras, M. Y. Fiszman, and F. Gros, Dept. of Molecular Biology, Pasteur Institute, Paris,
France: Synthesis of myosin light chains and tropomyosin subunits by quail embryo myoblastsdifferentiated in vitro.
B.M. Paterson, J. D. Eldridge, Z. Zehner, and M. C. O'Neill, NCI, National Institutes of Health,
Bethesda, Maryland: Isolation and preliminary characterization of two different a-actin genes and
one /3 -actin gene in the chicken.
C. E. Rozek and N. Davidson, Dept. of Chemistry, California Institute of Technology, Pasadena:
Isolation and preliminary characterization of a myosin heavy chain gene from Drosophila
melanogaster.
S. Sarkar, A. K. Mukherjee, S. R. Chandrika, and R. K. Roy, Dept. of Muscle Research, Boston Bio-
medical Research Institute, and Dept. of Neurology, Harvard Medical School, Bo inhibitory
Massachu-
setts: Studies on regulatory processes of chick muscle development-A translation
i itory 10S
RNP; abundant class muscle-specific mRNA sequences; and isozymic changes of myosin light
chains and tropomyosin subunits.G. Silver and J. D. Etlinger, Dept. of Anatomy and Cell Biology, Downstate Medical Center, State
University of New York, Brooklyn: Calcium-dependent control of myosin light chain
synthesis
and accumulation in skeletal muscle cultures.D.W. Winkelmann and S. Lowey, Rosenstiel Center, Brandeis University, Waltham,
Massachusetts:
Immunoquantitation of an adult myosin during chicken pectorals muscle development.R. Wydro, T. Nguyen, R. Gubits, and B. Nadal-Ginard, Dept. of Cell
Biology, Albert Einstein
College of Medicine, Bronx, New York: Myosin heavy chain is coded by a multigene
family with
highly conserved domains.Z. E. Zehner, M. C. O'Neill, and B. M. Paterson, NCI, National Institutes of
Health, Bethesda, Mary-
land: Characterization of the chick cytoskeleton gene, vimentin. 203
Session 6: Membrane Events
Chairperson: S. J. Kaufman,
University of Illinois, Urbana
J. Prives, L. Hoffman, T. Ross, and N.
Serafin, Dept. of Anatomic al Sc ien« -,, State University of New
.
York, Brook: Interaction
of cell surface proteins with the c ytoskeletal framework of embry-
onic muscle cells in culture.
Si. Kaufman and D. M. Ehrbar,
Dept. of Microbiology and School of Basic Medical Sciences
University of Illinois, Urbana: Association
of myoblast cell surface determinants with submem'
branous components.
D. M. Fambrough,' A.G. Engel,' and T.
L. Rosenberry,1 'Dept. of Embryology, Carnegie Institution of
Washington, Baltimore, Maryland; 'Dept. of Neurology,
'
Mayo Clinic, Rochester, Minnesota;
3Dept. of Pharmacology, Case Western Reserve
University, Cleveland, Ohio: Neuromuscular
acetylcholinesterase explored with monoclonal
antibodies.
J. M. Gardner and D. Fambrough, Dept.
of Embryology, Carnegie Institution of Washington, Balti-
more, Maryland: The biosynthesis
and expression of fibronectin during myogenesis in vitro
A. F. Horwitz, N. Neff, A. Sessions, C. Lowrey,
C. Smalley, and A. Tovar, Dept. of Biochemistry and.
Biophysics, University of Pennsylvania School of Medicine, Philadelphia: Membrane events in
myoblast fusion.
W. J. Strittmatter;323 C. E. Bright,3 and S. B.
Elias,'' Dept. of 'Neurology, 'Biochemistry and 'Program
in Neuroscience, Baylor College of Medicine, Houston, Texas: Rat myoblast fusion requires
catalytically specific proteases.
S.M. Fernandez and B. A. Herman, Dept. of Physiology, University of Connecticut Health Center,
lsaseRoe Uni-
versity,
l-
Farmington: Membrane dynamics and lectin cell surface topography during m
R. J. Przybylskil and R. G. MacBride,1.2 'Developmental Biology Center, CaseT-Wetoklrn ehsmaeReserve
r on cell behavior andrsity, Cleveland, Ohio; 'Dept.
of Anatomy, Oral Roberts Universit
y,effect of lactose-lectin treatment of prelusion skeletal muscle cultures
myotube formation.
Session 7: Committment and Embryogenesis
Chairperson: F. E. Stockdale, Stanford University, California
F. E. Stockdale, M. Crow, P. Olson, G. Schwartz, and T. Hunt, Depts. of Medicine and Biology,
Stanford University, California: The developmental lineage of fast and slow muscles.
P. H. Bonner and T. H. Morgan, School of Biological Sciences, University of Kentucky, Lexington:
Neural induction of chick skeletal myoblast differentiation.
I. R. Konigsberg, Dept. of Biology, University of Virginia, Charlottesville: Differentiating quail myo-
cytes are in a true Go state.
S. Hauschka, R. Rutz, and C. Haney, Dept. of Biochemistry, University of Washington, Seattle:
Regional distribution and cell lineage states of myogenic cells during early stages of vertebrate
limb development.
T. Linkhart, C. Clegg, R. Lim, G. Merrill, J. Chamberlain, and S. Hauschka, Dept. of Biochemistry,
University of Washington, Seattle: Control of mouse myoblast commitment to terminal differenti-
ation by mitogens.
H. Holtzer, P. Antin, S. Forrey-Schaudies, T. Friedman, and S. Tapscott, Dept. of Anatomy, University
of Pennsylvania School of Medicine, Philadelphia: Taxol-treated postmitotic myoblasts form
interdigitating microtubule-myosin arrays lacking actin filaments.
Session 8: Poster Session
E. K. Bayne and D. M. Fambrough, Dept. of Embryology, Carnegie Institution of Washington, Balti-
more, Maryland: An extracellular matrix-plasma membrane interaction in skeletal muscle.
W. V. Bleisch and V. N. Luine, Rockefeller University, New York, New York: Effect of testosterone on
growth, cholinergic enzymes, and receptors in an androgen sensitive muscle.
B. W. Cherney and A. I. Caplan, Developmental Biology Center, Case Western Reserve University,
Cleveland, Ohio: Measurement of poly(ADP-ribose) synthetase activity during muscle develop-
ment.
G.A. Cates and P.C. Holland, Dept. of Biochemistry, University of Saskatchewan, Saskatoon, and
Montreal Neurological Institute, Canada: I mmunochemical characterization of myoblast cell sur-
face proteins.
W. C. Claycomb, Dept. of Biochemistry, Louisiana State University School of Medicine, New
Orleans: The terminally differentiated adult cardiac muscle cell in culture.
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C. H. Clegg and S. D. Hauschka, Dept. of Biochemistry, University of Washington, Seattle: Heteroka-
ryon analysis of myoblast commitment to terminal differentiation.
R. Ehrismann,I2 D. E. Roth,2 H. M. Eppenberger,1 and D. C. Turner,1'2 'Institute of Cell Biology, Swiss
Federal Institute of Technology, Zurich, Switzerland; 2Dept. of Biochemistry, Upstate Medical
Center, State University of New York, Syracuse: Fibronectin structure and myoblast attachment.
B. M. Gilfix and B. D. Sanwal, Dept. of Biochemistry, University of Western Ontario, London, Can-
ada: Lectin-resistant myoblasts.
J. S. Gordon,' E. Winter,2 D. Levy,2 and C. Tuminello," "Dept. of Anatomical Sciences and 2Cellular
and Developmental Biology Program, State University of New York, Stony Brook: Chromosomal
protein synthesis and the regulation of myogenesis.
S. J. Kaufman and D. M. Ehrbar, Dept. of Microbiology and School of Basic Medical Sciences,
University of Illinois, Urbana: Association of myoblast cell surface determinants with submem-
branous components.
S.F. Konieczny,1 J. McKay,2 and J. R. Coleman,2 "Biomedical Division and 2Division of Biology and
Medicine, Brown University, Providence, Rhode Island: Isolation and characterization of termi-
nally differentiated chicken and rat skeletal muscle myoblasts.
J. B. Lawrence,' S. F. Konieczny,2 and J. R. Coleman,' 'Division of Biology and Medicine and 2Bio-
medical Division, Brown University, Providence, Rhode Island: Extinction of myogenic properties
in somatic cell heterokaryons.
D.C. Linden" and M. S. Letinsky,2 'Dept. of Physiology, University of California School of Medicine;
2Jerry Lewis Neuromuscular Research Center, Los Angeles, California: Development of the
cutaneous pectoris muscle in Rana catesbeiana-A light and electron microscopic study.
G. E. Morris, School of Biological Sciences, University of Sussex, Brighton, England: Myoblast cell
culture studies of possible calcium and cyclic nucleotide involvement in physiological modulation
of muscle gene expression.
H. T. Nguyen and B. Nadal-Ginard, Dept. of Cell Biology, Albert Einstein College of Medicine,
Bronx, New York: Isolation and characterization of a mutant myoblast cell line temperature
sensitive for commitment.
C.A. Quinn and F. S. Walsh, Institute of Neurology, London, England: Characteristics of a myogenic
rat x human muscle cell hybrid.
L.S. Quinn and M. Nameroff, Dept. of Biological Structure, University of Washington, Seattle:
Quantitative analysis of clonal myogenesis in the chick embryo.
L.S. Quinn and M. Nameroff, Dept. of Biological Structure, University of Washington, Seattle:
Bromodeoxyuridine uncouples myosin synthesis from creatine phosphokinase synthesis at the
terminal division in the myogenic lineage.
PG. Pauwi and J. D. David,2 'Dept. of Genetics, Iowa State University, Ames; 2Division of Biological
Sciences, University of Missouri, Columbia: Accelerated degradation of low molecular weight
surface proteins during fusion in L6.
L. L. Richer and R. J. Schmaltz, United States Meat Animal Research Center, USDA, Clay Center,
Nebraska: Serum-borne factors affecting cell proliferation in serum-free, primary cultures of fetal
pig myoblasts.
S. Scarpa,1 B. w. uhiendorf,2 J. Chen,' and G. Cantoni,2 Istituto di Biochimica Applicata, Universita
di Roma, Istituto Superiore di Sanita, Rome, Italy; 2NIMH, National Institutes of Health, Bethesda,
Maryland: The effect of concanavalin A and other lectins on myoblast line L5 differentiation.
E. Siegel, B. Mroczkowski, T. McCarthy, and S. Heywood, Dept. of Genetics and Cell Biology,
University of Connecticut, Storrs: Characterization of translational control RNA isolated
from
muscle mRNP particles.
F. E. Stockdale, B. K. Grove, G. Schwartz, and M. Yaross, Depts. of Medicine and Biology,
Stanford
University, California: Quantitative characterization of cell surface determinants on myogenic
cells during differentiation.
D.C. Turner,I2 Chiquet," J. Lawton,2 P. Dollenmeier," and R. Ehrismann
Biology, Swiss Federal Institute of Technology, Zurich, Switzerland;
;1'2 "Institute of .Cell
2Dept. of Biochestnryc,
Upstate Medical Center, State University of New York, Syracuse: Contact guidance o
myoge nic
cells by fibrils of fibronectin.
Vandenburgh, Dept. of Pathology and Laboratory of Medicine, Miriam
Hospital and Brown
mUniversity, Providence, Rhode Island: Orientation of developing myotubes
by a moving substratum.
Wakelam and D. Pette, Faculty of Biology, University of Konstanz, Federa
epu o
Germany: Changes in the metabolism of inositol-phospholipids during myoblast
fusion.
W. E. Wright, Dept. of Cell Biolog University of Texas Health Science Center,
Dallas: Evidence for a
DNA -based mechanism for the inhibition of myogenesis by 5'-bromodeoxyuridine.
R.thZalin, Dept. of Anatomy, University College, London, England: Factors affecting
the response of
B. Zani,
myoblasts to their developmental signal (prostaglandin El).chick
Cossu, S. Adamo, M. Pacifici, and M. Molinaro, Institute of
Histology and General
Embryology, University of Rome, Italy:
Requirement of protein synthesis for the inhibition of
muscle-specific phenotype by tumor promoters
in culture.
Session 9: Morphogenesis of the
Cytoskeleton and the Contractile Apparatus
Chairperson: D. Fischman, Down State
Medical Center, State University of New York, Brooklyn
D. A. Fischman, Dept. of Anatomy and Cell Biology, Downstate Medical Center, State University of
New York, Brooklyn: Myofibrillar assembly-Current paradoxes to be resolved.
T. Masaki, D. Bader, T. Obinata, and D. A. Fischman, Dept. of Anatomy and Cell Biology, Downstate
Baylor
Medical Center, State University of New York, Brooklyn: Immunological analysis of myosin iso-
forms during chick myogenesis.
H. F. Epstein, J. M. MacKenzie, Jr., S. A. Berman, and D. M. Miller III, Dept. of Neurology
College of Medicine, Houston, Texas: Myosin synthesis and assembly in normal and mutant
nematode body-wall muscle.
E. Lazarides,' B. L. Granger,' D. L. Gard,' J. Breckler,' S. I. Danto,2 and D. A. Fischman,2 1Division of
Biology, California Institute of Technology, Pasadena; 2Dept. of Anatomy and Cell Biology, Down-
state Medical Center, State University of New York, Brooklyn: Steps in the assembly of the Z-disc
in muscle cells.
K. Wang, Clayton Foundation Biochemical Institute, University of Texas, Austin: Myofibrillar
connections-The role of titin, nebulin, and intermediate filaments.
H. M. Eppenberger, T. Doetschman, J. C. Perriard, E. Strehler, D. Studer, and T. Wallimann, Institute
of Cell Biology, Swiss Federal Institute of Technology, Zurich, Switzerland: Myomesin in cross-
striated muscle cells.
Session 10: Neuromuscular Junction Formation
Chairperson: Z. W. Hall, University of California Medical School, San Francisco
L. Silberstein and Z.W. Hall, Dept. of Physiology, University of California Medical School, San
Francisco: Association of acetylcholine receptor clusters with extracellular matrix in myotube
cultures.
M. W. Cohen, F. Moody-Corbett, and P. R. Weldon, Dept. of Physiology, McGill University, Mont-
real, Canada: Influence of nerve on the formation and survival of sites of acetylcholine receptor
and cholinesterase localization on muscle cells in culture.
M. M. Salpeter and T. R. Podleski, Section of Neurobiology and Behavior, Cornell University, Ithaca,
New York: ACh receptor on primary rat muscle cells redistribute to reach junctional site densities
after exposure to soluble CNS extracts.
U. J. McMahan, Dept. of Neurobiology, Stanford University School of Medicine, California: The
role of extracellular matrix in regeneration of the neuromuscular junction.
L. Rubin, Rockefeller University, New York: Basement lamina components affecting acetylcholine
receptor localization in cultured chick myotubes.
Session 11: Poster Session
D. S. Dhillon and A. L. Harvey, Dept. of Physiology and Pharmacology, University of Strathclyde
Glasgow, Scotland: Comparison of the development of myotubes cultured from thymus and
skeletal muscle tissue of neonatal rats.
G. K. Dhooti and S. V. Perry,2 Dept. of 'Immunology and 2Biochemistry, University of Birmingham,
England: Role of nerve activity on the development of muscle cell phenotypes.
M.S. Ecob, Muscular Dystrophy Research Laboratories, University of Newcastle-upon-Tyne, Eng- -
land: Nerve-muscle interaction studied in an organotypic culture system.
H. F. Elson, Dept. of Pathology, University of California, San Diego: An extracellular matrix defect in
dystrophic human skeletal muscle cell cultures.
M. R. Emmerling and R. L. Rotundo, Dept. of Embryology, Carnegie Institution of Washington,
Baltimore, Maryland: Synthesis and cellular distribution of acetylcholinesterase molecular forms
in quail muscle cell cultures.
Y. Kidokoro, P. Brehm, and R. Gruener, Salk Institute, San Diego, Calfornia: Developmental
changes in acetylocholine receptor density and channel properties in Xenopus nerve-muscle
culture.
J. B. Parent,' J. Baumgold,2 and I. Spector,3 'Howard University Cancer Center, Washington, DC;
2NIMH; 'Laboratory of Biochemical Genetics, National Institutes of Health, Bethesda, Maryland:
Development of the sodium channel during muscle differentiation in tissue culture.
R. Sebbane and J. P. Merlie, Dept. of Biological Sciences, University of Pittsburgh, Pennsylvania:
Studies of the biogenesis of the skeletal muscle ACh receptor.
G. R. Slater, Muscular Dystrophy Research Laboratories, University of Newcastle-upon-Tyne, Eng-
land: Post-natal maturation of acetylcholine receptor distribution at mouse nerve-muscle
junctions.
M.A. Smith' and C. R. Slater,2 "Dept. of Biology, University of California, San Diego; 2Muscular
Dystrophy Research Laboratories, Newcastle General Hospital, Newcastle-upon-Tyne, England:
Acetylcholine receptors at developing chick neuromuscular junctions.
B.A. Wolitzky, H. L. Segal, and M.S. Hudecki, Division of Cell and Molecular Biology, State Univer-
. sity of New York, Buffalo: Rates of protein synthesis and degradation in normal and dystrophic
primary muscle cultures.
R. Yasin, F. S. Walsh, D. N. Landon, and E. J. Thompson, Institute of Neurology, University of London,
England: Cellular, biochemical, and immunological characterization of two human myogenic cell
clones.
L. Ziskind-Conhaim, Dept. of Physiology, University of California Medical School, San Francisco:
Effects of denervation and electrical inactivity on the formation of acetylcholine receptor clusters
in embryonic rat muscles.
Session 12: Muscle Development and Human Disease
Chairperson: S. H. Appel, Baylor College of Medicine, Houston, Texas
S. H. Appel, R. G. Smith, K. Vaca, and K. Ojika, Dept. of Neurology, Baylor College of Medicine,
Houston, Texas: Motor neuron survival, neurite extension, and acetylcholine (ACH) synthesis are
enhanced by muscle-derived proteins.
H.. M
. Blau and C. Webster, Dept. of Pharmacology, Stanford University School of
Medicine, Califor-
nia: Isolation and characterization of pure populations of human normal and dystrophic muscle
cells.
S. Fuchs, Dept. of Chemical Immunology, Weizmann Institute of Science, Rehovot,
Israel: An
autoimmune response to acetylcholine receptor in myasthenia gravis.
A Miranda, S. Shanske, and S. DiMauro, H. Houston Merritt Clinical Research Center for
Muscu-
lar Dystrophy and Related Disorders, Columbia University, New York, New
York: Isoenzyme
transitions in human muscle development.
F . 5
, Walsh and S. Dhut, Institute of Neurology, London, England: Surface
antigens phenotypes of
human muscle cells.
This meeting was supported in part by funds from the National Science
Foundation, the Frederick
Cancer Research Center, and the Muscular Dystrophy Association.
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BANBURY CENTER
1981 Activities
Banbury Center's fourth year of small con-
ferences on environmental health risks, with the
addition of small meetings focused on emerging
areas of molecular biology and on the effects of
molecular biological advances on society at large,
took place as the national government rapidly
changed its policies toward environmental regula-
tion in particular and the support of science in
general. The new tax-cutting Reagan administra-
tion began at once to ease restrictions on industry
that had multiplied over a decade of mounting
concern about the impact of advanced
technology, particularly in the areas of mining
and chemicals, on the health of workers and the
general population. The changed political climate
created problems for Banbury Center in achieving
its goal of a reasonable balance of views in its
conferences. Previously, the need was to assure
adequate representation of scientific skepticism
about the size of the environmental health risk
problem. Now, the problem was assuring that
what might be called an alarmist view would be
heard, while continuing to concentrate on facts
rather than opinions or ethical issues.
Such pressures merely forced us to redouble ef-
forts to assure the objectivity of the spring con-
ference on "Quantification of Occupational
Cancer," whose proceedings came out in
December as Banbury Report 9, and of our fall
conference on "Environmental Effects on Matura-
tion." The proceedings of the latter meeting,
which considered possible special vulnerabilities
of children to environmental chemicals, will be
published in the spring of 1982 as Banbury
Report 11.
The success of these meetings, and the expan-
sion of the Banbury program to include such con-
ferences on molecular biology as those on "Gene
Amplification and Aberrant Chromosomal Struc-
tures" (October) and "Construction and Use of
Mammalian Viral Vectors" (December), and on
broader impacts of fundamental biology ("Paten-
ting of Life Forms," October), reinforced con-
fidence in the original view of the beautiful
Robertson estate as an ideal place for meetings on
urgent technical issues of biological science andpublic policy.
The establishment of the center, after the late
Charles S. Robertson's magnificent gifts to the
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Laboratory in 1973 and 1976, was dictated by
anincreasing awareness of the social importance
and usefulness of molecular biology. Recombi-
nant DNA techniques had been applied in an im-portant way to short-term testing of possible
dangers from chemicals in the environment. The
techniques themselves were the subject of years
of intense, and now largely resolved, debate
about the possibility of health risks. Meanwhile,
scientists became increasingly conscious of the
power of recombinant DNA techniques for
understanding mechanisms of cancer induction as
well as normal cellular development and of the
rapidly expanding opportunities for using the new
techniques in industrial microbiology. All of these
subjects are of intense interest to the scientists
at Cold Spring Laboratory.
Sammis Hall
The sense of fulfillment of earlier hopes sharpen-
ed feelings of loss at the death in Florida, on May
2, 1981, of Charles Robertson, who had maintain-
ed a lively interest in the new uses of what had
been his family home for 40 years. A few days
after his death, members of the Banbury Center
and Laboratory staff considered it an honor to at-
tend a beautiful service in memory of Mr. Robert-
son at St. John's Episcopal Church in Cold Spring
H arbor.
Not long after, on July 19, a muggy, overcast
Sunday, a landmark in the development of Ban-
bury Center was passed with the dedication of our
16-bedroom guest house, Sammis Hall. The
Palladian-style structure, designed in 1978-1979
by the architectural firm of Moore, Grover, and
Harper, was named for Mr. Robertson's mother's
family. Accompanied by occasional showers, the
ceremonies were held under a yellow-and-white-
striped tent on the lawn next to the deck of the
Banbury Meeting House. Among these attending
were Mr. Robertson's sister, Mrs. Donald Rose,
who has her summer home here, and such other
members of the family as Mr. and Mrs. William
Robertson and Dr. and Mrs. Walter Meier, who
also are neighbors.
Built with the aid of grants of $150,000 from the
Kresge Foundation and $225,000 from the Max
Fleischmann Foundation, Sammis Hall pleasingly
supplements the family comfort of Robertson
House. Now, a total of 37 overnight guests can be
accommodated on the Banbury estate, with our
extra guests (already a usual feature of Banbury
conferences) housed in Blackford Hall at the main
Laboratory grounds across Cold Spring Harbor.
Excavation for Sammis Hall began in the fall of
1979, and the structure began rising in March
1980. A year later its first guests participated in
the conference on "Quantification of Occupa-
tional Cancer." By the end of 1981, no less than 20
groups of conference and course participants had
stayed in Sammis Hall for periods of from two
days to three weeks, enjoying its charming views
of surrounding trees and a unique central hall,
stretching more than two stories up to a dozen
skylights.
Dissemination of Findings
Publication of conference proceedings has been
an integral part of the Banbury program from the
beginning. The small size of the Banbury con-
ference room necessarily limits attendance to be-
tween 40 and 50 people, most of them active
researchers. There is little room for observers,
such as members of the press, at our technical
conferences. Thus, maximizing the usefulness of
bringing together such groups of researchers, who
do not meet together often, demands swift publi-
cation. Hence, Banbury Center strives to publish a
Banbury Report six or seven months after each
conference.
Our first Banbury Report was published in April
1979. Another followed by the end of that year
and four more were published in 1980. In 1981 we
published another three. These were Banbury
Report 7 on Endogenous Factors in Gastrointestinal
Cancer, Banbury Report 8 on Hormones and Breast
Cancer, and Banbury Report 9 on Quantification of
Occupational Cancer. As always, we were grateful
for the splendid cooperation of the scientists,
organizers, and participants, who observed our
tight deadlines. Preparations began for publica-
tion of Banbury Reports 10 and 11, covering our
meetings on patenting and environmental risks for
children.
With the aid of a $25,000 purchase of copies of
Banbury Reports 7 and 8 by the National Cancer
Institute for distribution to grantees, total sales of
Banbury Reports exceeded $140,000 for the year
and $350,000 since the start of the publication
program. The sales met most of the costs of book
production and distribution.
Our second major informational program in-
volves seminars specifically designed for groups,
such as journalists and legislative aides, who have
a major role in setting policy. Supported by a
$100,000 grant from the Alfred P. Sloan Founda-
tion (which, along with the Esther A. and Joseph
Klingenstein Fund financed the initial operations
of Banbury Center), we began holding seminars
for journalists in 1981.
The first of these, for the editorial staff of
Newsday, the Long Island newspaper, covered
such environmental health issues as ground water
pollution, diet and cancer, and chemical waste
disposal. The second, for the editorial staffs of the
magazines of Time, Inc., covered the scientific
background of current advances in genetic
engineering and reviewed the initial steps in the
creation of a genetic engineering industry. The
aim of both seminars was to bring scientists
together with editorial staffs at all levels to hear
Sammis Hall, rear view
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informal presentations and ask many
questions,
so as to open the door to future
contacts on
specific news stories and allow managers
of news-
gathering efforts to confront sources usually seen
only by reporters. We were gratified that the
publisher and the president of Newsday, Mr.
David Laventhol and Mr. Donald Cr
and Mr.
Henry Anatole Grunwald, Editor-in-Chief
of Time,
inc., were able to attend.
Conferences and Courses
The variety of meetings held at Banbury increased
during 1981. Besides two informational seminars,
two environmental health risk conferences, two
conferences on emerging areas of molecular
biology, and a conference on the social impact of
molecular biology, Banbury also was the site of
two conferences on neurobiology (as in 1980), two
courses on neurobiology, and a workshop on
tumor and transplantation antigens and provided
housing for some of the participants in nine major
conferences held at Cold Spring Harbor
Laboratory.
The conference on "Neurobiology of the
Leech," from June 29 to July 2, was organized by
John Nicholls of Stanford University, Kenneth
Muller of the Carnegie Institution of Washington,
and Gunther Stent of the University of California
at Berkeley (who also spoke at the dedication of
Sammis Hall). The conference on "Methods for
Measuring Global Neural Activity," from August 2
to 8, was organized by David Zipser of Cold
Spring Harbor Laboratory and Peter Hand of the
University of Pennsylvania School of Veterinary
Medicine under a Sloan Foundation grant.
The workshop on "Tumor and Transplantation
Antigens," from July 2 to 8, was organized (for the
second year in a row) by Arnold Levine of the
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State University of New York at Stony Brook whocompleted a term as an Institutional Trustee ofthe Laboratory.
The conference on "Gene Amplification
edsupported
Aberrant Chromosomal Structures,
the National Institutes of Health and by a specialfund established by Bankers Life of Chicago, wasorganized by Robert T. Schimke of StanfordUniversity. It was held from October 4 to 7.Organizing our second annual conference
on"Construction and Use of Mammalian Viral Vec-tors," held from December 4 to 6, was YakovGluzman of the scientific staff of Cold Spring Har-bor Laboratory.
Representing divergent views on the problem
ofquantification of occupational cancer, theorganizers of the conference, held from
March 29to April 2, were Richard Peto of the University
ofOxford, who doubts that cancer mortality due toenvironmental chemicals is rising among middle-
aged persons where trends can be most accurate-
ly measured, and Marvin Schneiderman
of Cle-
ment Associates, who has analyzed studies in-dicating a rising trend of cancer incidence.
Although a regulatory problem underlay the in-terest of the United States Environmental Protec-
tion Agency and the U.S. Department of Labor in
a Banbury conference on special environmental
health risks for children, the conference focused
on scientific work related to immature humans
and animals in general. The conference, entitled
"Environmental Effects on Maturation," was heldfrom November 1 to 4 and was organized by
Vilma Hunt of Pennsylvania State University,
Kate Smith of EPA's Health Effects Research
Laboratory in Cincinnati, and Dorothy Worth ofTufts University School of Medicine. The
regulatory problem in the background is
estimating the degree of risk for farm children
entering fields that have been sprayed with
pesticides.
Banbury staffers Lynda Moran (left) and Beatrice To liver (right) with Banbury CenterDirector, Victor McElheny
The conference on "Patenting of Life Forms,"
held from October 18 to 21, grew out of the con-
siderable confusion among both patent lawyers
and scientists about the implications of the
Supreme Court's 1980 decision that life forms
themselves are patentable along with processes
for creating them or using them. The organizers
were Norton Zinder of Rockefeller University, an
Institutional Trustee of Cold Spring Harbor
Laboratory, Niels Reimers, Director of
Technology Licensing of Stanford University, and
David W. Plant, partner in the New York City
patent law firm of Fish & Neave.
Courses and conferences at Banbury Center
brought some 400 scientists, lawyers, and jour-
nalists to Banbury and Cold Spring Harbor
Laboratory. A further 300 scientists were guests at
Banbury during Laboratory conferences. Our
guests came from the United States and 18
foreign countries.
Support
A wholly new enterprise like Banbury Center has
to struggle for financing. During 1981 financial
support strengthened notably.
The Environmental Protection Agency and
Department of Labor joined in a cooperative
agreement to support the conference on "En-
vironmental Effects on Maturation." The National
Institutes of Health and Bankers Life, following
up their support of the International Symposium
on Aging and Cancer in Washington, D.C., in
September, 1980, sponsored the October con-
ference on "Gene Amplification and Aberrant
Chromosomal Structures."
Very gratifying was notification of the award by
the National Cancer Institute of funds to hold a
conference on the "Possible Role of Nitrosamines
in Human Cancer," April 4 to 7, 1982. The Kaiser
Family Foundation of Menlo Park, California,
made a very generous grant to support the
holding of the Banbury conference on "Prospects
for Gene Therapy: Fact and Fiction," February 5
to 7, 1982, and publication of its findings. The Bur-
roughs Wellcome Fund granted $15,000 for a con-
ference on hereditary factors in cancer, which will
focus on probing for specific genes, to be held in
October 1982.
Support from corporations, which had reached
$85,000 in 1980 (our first year of seeking such
assistance), virtually doubled to $169,500 in 1981.
Of great help were letters of appeal from Alex-
ander C. Tomlinson of our Board of Trustees
which accompanied the Banbury proposal. Sus-
taining support in 1981 came from ten corporate
sources: Bristol-Myers Fund, Dow Chemical, E.I.
duPont deNemours, Exxon Education Foundation,
Getty Oil, International Business Machines, Eli Lil-
ly, New York Life, Phillips Chemical, and Texaco
Philanthropic Foundation. Just after the turn of
the year, Conoco joined the ranks with a contribu-
tion to the overall program.
A total of 15 companies, including Dow, du-
Pont, and Lilly, contributed a total of $43,000
toward the October conference on "Patenting of
Life Forms." The other contributors were: Baxter
Travenol Laboratories, Chevron Research Com-
pany, Exxon Research and Engineering Company,
Hoffman LaRoche, Inc., Johnson and Johnson,
Merck Sharp and Dohme Research Laboratories,
Monsanto Company, National Distillers and
Chemical Corporation, Pfizer, Inc., Schering-
Plough Corporation, Smith Kline and French
Laboratories, and The Upjohn Company.
For the December conference on "Construction
and Use of Mammalian Viral Vectors," two com-
panies, Applied Molecular Genetics, Inc., and
Bethesda Research Laboratories, joined 10 others,
including duPont, Lilly, and Monsanto, which had
contributed to the first
mammalian vectors
meeting in 1980. The other repeating contributors
were Abbott Laboratories, Biogen
N.V., Cetus Cor-
poration, Collaborative Research,
Inc.,
Genentech, Inc., Molecular Genetics,
Inc., and
New England BioLabs, Inc.
The roster of corporations contributing
at least
once to Banbury Center in
the last two years has
reached 32. Many of these companies
have given
generously to Cold Spring Harbor Laboratory over
the last decade. It is a pleasure
to record our
gratitude to new and old contributors.
Journalists Workshop for Newsday: Environmental Health Risks
January 16-18
Water Resources and Human HealthSession 1
C.C. Johnson, C.C. Johnson and Associates,
Silver Spring, Maryland: The numerous unknowns in making
policy to assure water quality.
J. Cotruvo, Environmental Protection Agency, Washington, DC:
The Environmental Protection Agency's
priorities in assuring water quality.
M. Kavanaugh, Montgomery Engineers, Washington, DC: Engineering water treatment with a view to
reuse.
J. Tripp, Environmental Defense Fund, New York, New York: Legal struggles over watershed protection
in the Northeast.
Session 2 The Health Effects of Chemical Waste Disposal
J. Highland, Environmental Defense Fund, Washington, DC: Dimensions of the problem.
R. Albert, New York University Medical Center, New York: Difficulties of measurement.
Session 3 Diet and Cancer
C. Mettlin, Roswell Park Memorial Institute, Buffalo, New York
P. Newberne, Massachusetts Institute of Technology, Cambridge
Quantification of Occupational Cancer, March 29-April 2
Varying viewpoints concerning the extent of the contribution of occupation to overall cancer incidence
were presented against a background of epidemiological issues, study methods, statistical approaches,
and cancer and chemical production trends. Precise evaluations were made about the role of asbestos
exposure in lung cancer and mesothelioma incidence as well as radiation and lung cancer incidence,
and the confounding factors of cigarette smoking and the healthy worker effect were considered.
Industry-sponsored surveillance programs were discussed, as were classification systems, record
linkage, exposure-based case-control studies, population-based large cohorts, and the use of standar-
dized mortality ratios vs. proportional mortality ratios. A concluding roundtable explored the prospect
of identifying high-risk groups and reducing cancer in industrial countries.
Session 1 Asbestos and Other Mineral Fibers
Chairperson: E.D. Acheson, University of Southampton, England
I.J. Selikoff, Mount Sinai School of Medicine, New York, New York: Constraints in estimating occupa-tional contributions to current cancer mortality in the United States.
P.E. Enterline, University of Pittsburgh Graduate School of Public Health, Pennsylvania: Proportion of
cancer due to exposure to asbestos.
W.J. Blot, National Cancer Institute, NIH, Bethesda, Maryland: Cancer among shipyard workers.
Peto, Imperial Cancer Research Fund, Oxford, England: Trends in mesothelioma incidence in the
United States and the forecast epidemic due to asbestos exposure during World War II.
J.C. McDonald, London School of Hygiene and Tropical Medicine, England: Mesothelioma as an index
of asbestos impact.
W.). Nicholson, Mount Sinai School of Medicine, New York, New York: Cancer from occupational
asbestos exposure- Projections 1980-2000.
Session 2 Radiation Risks-Animal Experiments
Chairperson: M. Schneiderman, Clement Associates, Inc., Washington, DC
S. Darby, National Radiological Protection Board, Harwell, England: Exposure to ionizing radiation and
cancer mortality among workers.
A.M. Stewart and George W. Kneale, University of Birmingham, England: Analysis of Hanford
data-Delayed effects of small doses of radiation delivered at slow-dose rates.
E.P. Radford, University of Pittsburgh Graduate School of Public Health, Pennsylvania: Radon
daughters in the induction of lung cancer in underground miners.
R. Saracci, International Agency for Research on Cancer, Lyon, France: The IARC monograph program
on the evaluation of the carcinogenic risk of occupational carcinogens.
G.M. Paddle, ICI Central Medical Group, Wilmslow, Cheshire, England: A strategy for the identification
of carcinogens in a large, complex chemical company.
Session 3 Industry-wide Cancer Experience- Methodological Problems
Chairperson: M.A. Silverstein, International Union, United Auto Workers, Detroit, Michigan
M.S. Gottlieb, Tulane University School of Medicine, New Orleans, Louisiana: Mortality studies on
lung, pancreas, esophageal, and other cancers in Louisiana.
R.R. Monson, Harvard University School of Public Health, Boston, Massachusetts: An estimate of the
percentage of occupational cancer among a group of rubber workers.
M. Karstadt, Mount Sinai School of Medicine, New York, New York: A survey of
availability of
epidemiologic data on humans exposed to animal carcinogens.
M.E. Warshauer, Memorial Sloan-Kettering Cancer Center, New York, New York: A prospective
study of
morbidity and mortality in petroleum industry employees in the United States-A
preliminary
report.
Session 4 Cancer in the US- Recent Trends and Proportion Due to Occupation
Chairperson: M.H. Sloan, National Cancer Institute, NIH, Silver Spring, Maryland
D.L.
eto, University of Oxford, England: Trends in US cancer onset rates.
D Davis, Environmental Law Institute, Washington, DC: Estimating cancer
causes-Problems in
methodology, production, and trends.
H.M. Rosenberg, National Center for Health Statistics, Hyattsville, Maryland:
NCHS data resources for
studying occupational cancer mortality.
Session 5 Special Problems of Methodology
Chairperson: B.W. Karrh, E.I. duPont deNemours & Company, Wilmington,
Delaware
M.S. Legatot r, University of Texas Medical Branch, Houston: A holistic
approach to monitoring high-risk
,._130populations by short-term procedures.
(-isutAustin, Union Carbide Corporation, New York, New York: An
industry-sponsored mortality
Wong,
program.
potential)Biometric Research Institute,
Inc., Washington, DC: An epidemiologic
study of workers
R.J.
wentially exposed to brominated chemicals-With a discussion of
multifactor adjustment.
of
a,.x,w, eiler, National Institute for Occupational Safety and
Health, Cincinnati, Ohio: Quantification
proportionate mortality ratios and
standardized mortality ratios.
, National Institute for Occupational Safety and
Health, Cincinnati, Ohio: Occupational
Wen
appropriate for proportionate mortality ratio analysis.
Gulf Oil Corporation, Houston, Texas: A population-based
cohort study of brain tumor
mortality among oil refinery workers with a discussion of methodological
issues of SMR and PMR.
213
Session 6 Methodology
Chairperson: E. Bingham, University of Cincinnati Medical
Center, Ohio
F.D. Hoerger, Dow Chemical Company,
Midland, Michigan: Indicators of exposure trends.
S.K. Hoar, National Cancer Institute,
NIH, Bethesda, Maryland: Epidemiology and occupational
classification systems.
J. Siemiatycki, Institut Armand-Frappier,
Laval-des-Rapides, Quebec, Canada: Exposure-based
case con-
trol approach to discovering occupational
carcinogens- Preliminary findings.
O. Axelson, Linkoping University, Sweden:
Guiding experiences on the etiology of acute
myeloid
leukemia.
S.W. Samuels, Industrial Union Department,
AFL-CIO, Washington, DC: The international co ntext of
carcinogen regulation- Benzidine.
S. Milham, Jr., Washington State Department of Social and Health Services, Olym pia: Proportionon of
cancer due to occupation in Washington State.
H. Tulinius, Icelandic Cancer Registry, Reykjavik: Cancer incidence and occupations in an area of i
air pollution.
H. Falk, Center for Disease Control, Atlanta, Georgia: Hepatic angiosarcoma registries - Implications
for rare-tumor studies.
Session 7 Broad Approaches to Occupational Cancer Quantification
Chairperson: J. Cairns, Harvard School of Public Health, Boston, Massachusetts
J.B. Swartz and S. Epstein, University of Illinois Medical Center, Chicago: Problems in assessing risk
from occupational and environmental exposure to carcinogens.
A.J. McMichael, Commonwealth Scientific and Industrial Research Organization, Adelaide, SA,
Australia: Differentiating work from life-style in cancer causation.
E.D. Acheson, University of Southampton, England: Towards a strategy for the identification of occupa-
tional carcinogens in England and Wales-A preliminary report.
M.R. Alderson, Institute of Cancer Research, Royal Cancer Hospital, Sutton, Surrey, England: Occupa-
tional studies-The use of national and industrial comparisons or an internal analysis.
H.B. Demopoulos, New York University Medical Center, New York: The value of contemporary
demographic controls in evaluating cancer incidence and mortality rates in heavily industrialized ur-
ban areas in the United States.
T. Hirayama, National Cancer Research Institute, Tokyo, Japan: Proportion of cancer attributable to
occupation obtained from a census, population-based, large cohort study in Japan.
Session 8 Future Needs
Chairperson: G.W. Beebe, National Cancer Institute, NIH, Bethesda, Maryland
G.W. Beebe, National Cancer Institute, NIH, Bethesda, Maryland: Record linkage and needed im-
provements in existing data resources.
M.E. Smith, Health Division, Statistics Canada, Ottawa: Long-term medical follow-up in Canada.
Journalists Workshop for Time, Inc.: DNA
May 3-4
Session 1 Scientific Successes with Recombinant DNA
J.D. Watson, Cold Spring Harbor Laboratory, New York: Comments on the political and technical his-
tory of recombinant DNA.
R. Roberts, Cold Spring Harbor Laboratory, New York: General introduction to the scientific techniques
of working with DNA.
P. Leder, National Institute of Child Health and Human Development, NIH, Bethesda, Maryland: Jump-
ing genes.
M. Ptashne, Harvard University, Cambridge, Massachusetts: Bacteria as factories.
Session 2 Consequences of Damage to DNA
B.N. Ames, University of California, Berkeley: Mutagenesis.
M.S. Fox, Massachusetts Institute of Technology, Cambridge: DNA repair.
J.L. German III, New York Blood Center, New York: Chromsome damage.
W.S. Hayward, Rockefeller University, New York, New York: Viruses.
Session 3 Long Shots in Applications of DNA Technology
1. Schell, University of Cologne, Germany: Plants.
R. Jaenisch, Heinrich-Pette-Institut, Hamburg, Federal Republic of Germany: The introduction of DNA
into the germ lines of mice.
M. Wig ler, Cold Spring Harbor Laboratory, New York: Cancer genes.
Session 4 The Business of DNA
Chairperson: J. Tooze, European Molecular Biology Organization, Heidelberg, Federal Republic of
Germany
Discussants:
N. Zinder, Rockefeller University, New York, New York
R. Biogen, Inc., Cambridge, Massachusetts
E.G. Jaworski, Monsanto Company, St. Louis, Missouri
R.E. Cape, Cetus Corporation, Berkeley, California
F. Pass, Molecular Genetics, Inc., Edina, Minnesota
Neurobiology of the Leech, June 29-July 2
Crucial support for Cold Spring Harbor Laboratory's program of conferences, courses,
and year-round
established
in the neurosciences is provided by the Marie H. Robertson Fund for Neurobiology.
This fund,
ished in 1976 through the Banbury Foundation by the family of Mr. Charles S. Robertson,
honors
the memory of Mr. Robertson's wife, who died in 1972. At first the fund, which provides
$75,000 annual-
was
used largely to support the summer teaching program in neurobiology,
which includes
lab oratory courses given on the main Laboratory grounds in the village of
Laurel Hollow and lecture
courses given at Banbury Center in the village of Lloyd Harbor. But in 1979,
after receipt of a substan-
tial raining grant from the National Institutes of Health, and added support
from the National Science
Foundation, it was decided to use some of the Marie H. Robertson funds to support summer
workshops
and to o make possible one or two specialized meetings each year at Banbury
Center.
Opening Discussion: When is a neuronal
circuit complete?
Moderator: I. Parnas, Hebrew University of Jerusalem, Israel
Session 1
Chairperson: K.J. Muller, Carnegie
Institution of Washington, Baltimore, Maryland
S. Blackshaw, University of Glasgow,
Scotland: Sensory cells and motoneurones.
W.O. Friesen, University of Virginia,
Charlottesville: Physiology and anatomy of sensillar
ceptors.
Kuwada, University of California, San
Diego: Development of identified neurons in the leech CNS.
A.P. Kramer, University of California, Berkeley:
Development of morphological variation of
sensory cells in Haementerial ghilianii.
I. Parnas, Hebrew University of Jerusalem,
Israel: Expansion of the receptive fields of leech n
cells following deletion of single neurons.
Session 2
Chairperson: J.G. Nicholls, Stanford University School of Medicine, California
D.A. Weisblat, University of California, Berkeley: Cell
lineage in glossiphoniid neurogenesis.
S.S. Blair, University of California, Berkeley: Alteration of cell patterning through single cell ablation in
the early embryo of the leech.
G.S. Stent, University of California, Berkeley: Somite formation in the leech embryo.
J. Fernandez, University of Chile, Santiago: Organization of the germinal plate and formation of 32
body segments in embryos of Hirudo medicinalis.
J. Hernandez, University of Chile, Santiago: Formation of ganglionic primordia in embryos of Hirudo
medicinalis.
Evening Discussion: What use is the leech, if any?
Moderator: G.S. Stent, University of California, Berkeley
Session 3
Chairperson: K.J. Muller, Carnegie Institution of Washington, Baltimore, Maryland
K.J. Muller, Carnegie Institution of Washington, Baltimore, Maryland: Leech synapses.
E. Macagno, Columbia University, New York, New York: The close association of the intraganglionic
dendritic fields of T cells.
R. Stewart, Columbia University, New York, New York: Anatomy of leech segmental ganglia, with some
comments about segmental and species differences.
A. Mason, Carnegie Institution of Washington, Baltimore, Maryland: Modulatory effects of the retzius
cells on longitudinal muscle of the leech Hirudo medicinalis.
R.T. Sawyer, Penclawdd, West Glamorgan, South Wales: Leech biology and behavior.
Session 4
Chairperson: A.E. Stuart, University of North Carolina, Chapel Hill
G.S. Stent, University of California, Berkeley: Neuronal circuits.
R.L. Calabrese, Harvard University, Cambridge, Massachusetts: Metastable coordination of the heart-
beat in the leech Hirudo medicinalis.
E.L. Peterson, Harvard University, Cambridge, Massachusetts: Coordination and phase control in the
heartbeat timing oscillator of Hirudo.
M. Pelligrino, University of Pisa, Italy: Effects of destruction of single HE cells in the CNS of the leech.
C. Lent, Brown University, Providence, Rhode Island: Physiology and anatomy of the Leydig cells within
the leech nervous system.
B. Payton, Memorial University of Newfoundland, St. Johns, Canada: The giant leech of Newfoundland.
Evening Discussion: Development and Regeneration
Moderator: J. Jansen, University of Oslo, Norway
Session 5
Chairperson: G.S. Stent, University of California, Berkeley
B. Wallace, Stanford University, California: Neurochemistry.
D. Stuart, University of California, Berkeley: Fluorescent staining of monoamine neurons in embryonic
and adult leech.
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A.L. Kleinhaus, Yale University School of Medicine, New Haven, Connecticut: Variation of membrane
properties and pharmacological sensitivities among identified leech neurons.
W. Kristan, University of California, San Diego: Diversity of leech behavioral responses mediated by
identified mechanosensory and motor neurons.
J.C. Weeks, University of Washington, Seattle: Identified neurons mediating swim initiation and pattern
generation in the leech.
B.M. Salzberg, University of Pennsylvania, Philadelphia: Multiple-site optical recording of membrane
potential- Prospects for optical recording from a reconstructed leech "nervous system."
Session 6
Chairperson: W. Kristan, University of California, San Diego
B. Zipser, Cold Spring Harbor Laboratory, New York: Specific neuron labeling.
J.G. Nicholls, Stanford University School of Medicine, California: Regeneration and plasticity.
L.P. Henderson, Stanford University School of Medicine, California: Serotonergic transmission between
isolated leech neurones in culture.
E.J. Elliott, Carnegie Institution of Washington, Baltimore, Maryland: Axon and synapse regeneration in
the absence of glia.
Workshop on Tumor and Transplantation Antigens, July 2-8
The development of DNA cloning and monoclonal antibody technologies has provided new research
directions in the area of tumor and transplantation antigens. Both formal research presentations and ex-
tensive discussions were held with a group of scientists representing several disciplines: tumor virology,
immunology, cell biology, genetics, and biochemistry. This workshop provided the group with an op-
portunity to compare and contrast observations from different experimental systems and to synthesize
emerging general principles. The workshop was held at a time when new directions and ideas are
emerging from an expanded research effort in this area.
Session 1
B. Bloom, Johns Hopkins University, Baltimore, Maryland: Mechanisms of tumor
recognition and rejec-
tion.
Session 2
R. Herberman, National Institutes of Health, Bethesda, Maryland: NK cells
and tumor rejection.
tumor im-
R. North, Trudeau Institute, Inc., Saranac Lake, New York: T-cell mediated suppression
of
munity.
F. Lilly, Albert Einstein College, Bronx, New York: Genetic loci of the mouse
involved in tumor rejec-
tion.
S.-I. Shin, Albert Einstein College, Bronx, New York: Tumor growth
and rejection in nude mice.
W. Dove, University of Wisconsin, Madison: Teratocarcinoma
transplantation rejection.
T. Boon, Ludwig Institute for Cancer Research, Brussels, Belgium: New transplantation
antigens of
teratocarcinomas.
Session 3
E. Blankenhorn, University of
Pennsylvania, Philadelphia: MHL-Genetics and monoclonal antibodies.
S. Weissman, Yale University,
New Haven, Connecticut: H-2, HLA, DNA clones.
M. Steinmetz, California Institute
of Technology, Pasadena: H-2, HLA, DNA clones.
L. Silver, Cold Spring Harbor Laboratory,
New York: T-locus genetics and biochemistry.
Session 4
R. Weinberg, Massachusetts Institute
of Technology, Cambridge: Transformation antigens.
N. Hopkins, Massachusetts Institute of Technology,
Cambridge: DNA-mediated transfer of
chemically
transformed cell phenotype.
D. Herlyn and M. Herlyn, Wistar Institute,
Philadelphia, Pennsylvania: Melanoma antigens.
0. Witte and N. Rosenberg, University of
California, Los Angeles, and Tufts University Medical School,
Boston, Massachusetts: Abelson virus transformation.
M. Hayman, Imperial Cancer Research Fund Laboratories, London, England: Acute leukemia viruses.
W. S. Hayward, Rockefeller University, New York, New York: Slow developing leukemias.
Session 5
J. Brugge, State University of New York, Stony Brook: RSV src.
E. Racker, Cornell University, Ithaca, New York: Cellular sarc.
B. Sefton, Salk Institute, San Diego, California: Cellular substrates of src.
E. M. Scolnick, National Cancer Institute, Bethesda, Maryland: Rodent src.
T.V. Rajan, Albert Einstein College, Bronx, New York: Antibody immunoselection of cell surface an-
tigens.
A. Linnenbach, Wistar Institute, Philadelphia, Pennsylvania: Human monoclonals.
Session 6
D. Lane' and E. Tucker Gurney', 'Imperial College of Science and Technology, London England;
'University of Utah, Salk Lake City: Monoclonal antibodies to SV40 tumor antigens.
S. Tevethia, Pennsylvania State University, Hershey: SV40-T-transplantation antigens.
K. Choudhury and Y. Ito, National Institutes of Health, Bethesda, Maryland: Polyoma T-antigens.
A.J. Levine, State University of New York, Stony Brook: p50-54 cellular tumor antigen.
Session 7 Roundtable Discussion: New and Old Concepts of Tumor and Transplantation Antigens
Discussants:
I. Weissman, Yale University, New Haven, Connecticut
B. Sefton, Salk Institute, San Diego, California
T. August, Johns Hopkins University, Baltimore, Maryland
R. Weinberg, Massachusetts Institute of Technology, Cambridge
T.V. Rajan, Albert Einstein College, Bronx, New York
Methods for Measuring Global Neural Activity Workshop
August 2-6
The last of three workshops in the Sloan Foundation-supported series devoted to the interface between
neuro- and cognitive sciences was held this summer at Banbury Center. The workshop topic was moti-
vated by the growing realization that in order to better understand the functioning of the brain, infor-
mation must be obtained about the coherence of neural activity in many brain structures. Extraordinary
technical difficulties confront studies of this kind and the workshop was devoted to a variety of new ap-
proaches which have promise for overcoming these barriers. Among the topics discussed extensively
were the use of the deoxyglucose method for labeling active neurons; the use of arrays of multiple elec-
trodes for recording from many places simultaneously; the measurement of the microblood flow in the
brain which has been found to be indicative of the level of neural activity; and use of specialized dyes
and optical techniques to follow the functioning of large arrays of neurons. The general tenor of the
workshop was that a real beginning had been made on the problem of measuring global neural activity,
but that a large amount of technical innovation and developmental work still remains to be done.
Session 1
D. Zipser' and P. Hand', 'Cold Spring Harbor Laboratory, New York; 'University of Pennsylvania School
of Veterinary Medicine, Philadelphia: Welcoming and introductory remarks.
S. Kety, McLean Hospital, Belmont, Massachusetts: Estimation of circulation and metabolism of the
brain by means of inert diffusible tracers.
Session 2
C. Gerstein, University of Pennsylvania, Philadelphia: Simultaneous recording from many neurons-A
cost/benefit analysis.
L. Sokoloff, National Institutes of Health, Bethesda, Maryland: Metabolic mapping of local functional
activity in the central nervous system with radioactive deoxyglucose.
M. P. Stryker, University of California, San Francisco, School of Medicine: Measurements of the
relationship between glucose utilization and neural activity in the cat's visual cortex.
M. Mishkin, National Institutes of Health, Bethesda, Maryland: The visual system visualized with the
2-DC technique.
C. Kennedy, National Institutes of Health, Bethesda, Maryland: Local metabolic responses during
motor activity.
D. Flood, University of Rochester Medical Center, New York: Methods of examining the response
of
neural population applied to the modification of orientation preferences of cats reared in striped
cylinders.
P. Hand, University of Pennsylvania, Philadelphia: Functional plasticity produced by sensory disuse or
enrichment.
C.R. Gallistel, University of Pennsylvania, Philadelphia: Objective quantitative data reduction with
computer-assisted image analysis.
Session 3
M. Des Rosiers, University of Montreal, Quebec, Canada: An overview of the
various difficulties
(technical and biological) encountered in attempting to apply the DG method at the cellular
level
while respecting the physiological prerequisites of the method.
Kelley,ey, Princeton University, New Jersey: Measuring activity in single neurons
with [ H] 2-deoxy-D-
glucose.
C. Smith, Nationalational Institutes of Health, Bethesda, Maryland: A method for the
determination of local
rates of protein synthesis in the nervous system.B. Agra
, "if, University of Michigan, Ann Arbor: Regional brain protein
synthesis in rat brain after
.....H.Yrglossal axotomy.
`,.. .bia Cohen, Yale University, New Haven, Connecticut: Optimal
methods for measuring spike activity.
i Hmsedlogrove, University of Pennsylvania, Philadelphia: Spectroscopic analysis
of the metabolic inter-
mediates of living and freeze-trapped brains.I. Greenberg,mn. erg, University of Pennsylvania, Philadelphia: Flow-metabolism
couple in the bane
University of Penns lvania Philadelphia: Application
of PC] iodoantipyrine cerebral
II
flow method to a behavioral problem - The vasomotor
hypothesis for drinking to angiotensin
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Session 4
D. Ingvar, University Hospital, Lund, Sweden:
Normal and abnormal distribution of activity in the
human cerebral cortex.
P. Roland, Bispebjerg Hospital, Copenhagen,
Denmark: Macrophysiological dissection of the human
brain.
M. Reivich, University of Pennsylvania,
Philadelphia: FDG technique- Physiologic and clinical studies.
M. Phelps, University of California, Los Angeles,
School of Medicine: The measurement of local
cerebral glucose metabolism in man with positron computed tomography-Factors which effect the
accuracy of local estimates and applications in visual and auditory stimulations.Philadelphia: Abnormalities in cerebral glucose metabolism
inCobbs, University of Pennsylvania,
patients with visual field defects.
R. Bajcsy, University of Pennsylvania, Philadelphia: Perception and recognition of 3-D shapes-
puter science point of view.
J.A. Feldman, University of Rochester, New York: Global activity questions suggested by connectionist
theory.
C.J. Vierck, Jr., University of Florida College of Medicine, Gainesville: The spinal somatosensory
pathways as model systems for neural coding by convergent interactions.
Session 5
J.H. Kaas, Vanderbilt University, Nashville, Tennessee: Microelectrode mapping methods for sub-
dividing the somatosensory system.
E.L. Schwartz, New York University Medical Center, New York: Computational anatomy in striate and
extrastriate primate visual cortex-Spatial mapping as a structural basis for perceptual coding.
M. Gazzaniga, New York Hospital-Cornell Medical Center, New York: Cognitive testing of the
separate hemispheres-Split brain approaches to metabolic studies.
Gene Amplification and Aberrant Chromosomal Structures
October 4-7
During the past 5 years there has developed a body of literature and a group of investigators concerned
with chromosomal abnormalities in cultured animal cells and in human tumors. These abnormalities in-
clude the presence of extrachromosomal elements called double minute chromosomes as well as ex-
panded regions of chromosomes called homogeneously staining regions. Other investigators studying
mechanisms of resistance to various agents that kill cells, including cancer chemotherapeutic agents,
have found that one common mechanism of resistance involves selective amplification of specific
genes. The amplified genes can be present in homogeneously staining regions of chromosomes, or can
occur on double minute chromosomes. Thus, these two different areas of investigation-chromosomal
abnormalities and drug resistance resulting from gene amplification-appear to be converging.
In October 1981, approximately 50 investigators, including workers in such diverse fields as bacterial
genetics, DNA repair-replication, drug resistance, chromosome structure, and developmental biology
met at Banbury Center to share current results and concepts.
Session 1 Examples of Gene Amplification
Chairperson: G. R. Stark, Stanford University Medical Center, California
P. C. Brown, Stanford University, California: Gene amplification and methotrexate resistance in cul-
tured animal cells.
C. Bostock, University of Edinburgh, Scotland: Amplification of dhfr genes in mouse cells.
J.R. Bertino, Yale University School of Medicine, New Haven, Connecticut: Gene amplification in a
human leukemia line K-562.
M.C. Weiss, Centre National de la Recherche Scientifique, Gif-sur-Yvette, France: dhfr amplification in
rat hepatoma variants.
J.L. Biedler and P.W. Melera, Sloan-Kettering Institute for Cancer Research, Rye, New York: Antifolate
and vincristine resistance in animal cells.
M. Tien Kuo, University of Texas System Cancer Center, Houston: Vincristine-resistant Chinese hamster
ovary cells.
C.T. Caskey, Baylor College of Medicine, Houston, Texas: hprt variants and reversion resulting from
gene amplification.
K.E. Mayo, University of Washingotn, Seattle: Regulation of amplified and transfected mouse metallo-
thionein genes.
I. Andrulis, The Hospital for Sick Children, Toronto, Ontario, Canada: Amplification of asparagine syn-
thetase genes in CHO cells.
Session 2 Gene Amplification
Chairperson: J.L. Biedler, Sloan-Kettering Institute for Cancer Research, Rye, New York
G. Levan, University of Gothenburg, Sweden: Double minute chromosomes, C-minus chromosomes in
mouse cell lines.
J.M. Trent, University of Arizona Health Sciences Center, Tucson: Metothrexate treatment and chromo-
somal aberrations in human tumors.
J.D. Minna, National Naval Medical Center, Bethesda, Maryland: Chromosomal aberrations in
human
oat cell tumor cell lines.
S.A. Endow, Duke University Medical Center, Durham, North Carolina: Replication of ribosomal genes
in Drosophila.
A.C. Spradling, Carnegie Institution of Washington, Baltimore, Maryland: Gene amplification
during de-
velopment in Drosophila.
R.J. Schwartz, Baylor College of Medicine, Houston, Texas: Actin gene
amplification in muscle de-
velopment.
V. Walbot, Stanford University, California: Nuclear gene amplification in maize and B
chromosomes.
R.E. Kellems, Baylor College of Medicine, Houston, Texas: Control of dihydrofolate reductase
DNA re-
plication and mRNA production.
Session 3 Molecular Structures of Amplified DNA Sequences
Chairperson: C. Bostock, University of Edinburgh, Scotland
R.I. Schimke, Stanford University, California: dhfr gene structure and
structure of amplified DNA se-
quences in various mouse cell lines.
J. Hamlin, University of Virginia, Charlottesville:
Amplified DNA sequences in MTX-resistant CHO
cell
s.L.A. Chasin, Columbia University, New York, New
York: Dihydrofolate reductase gene structure in
amplified and dhfr-deficient CHO cells.
G.R. Stark, Stanford University Medical Center, California: On the structure of amplified DNA s e_
quences in PALA-resistant cells.
G.M. Wahl, Salk Institute for Biological Studies, San Diego, California: Analysis of CAD gene amplifI
tion using molecular cloning, gene transfer, and cytogenetics.
ca
F. Gilbert, University of Pennsylvania School of Medicine, Philadelphia: Chromosomal aberrations in
human neuroblastomas and retinoblastomas.
P.E. Barker, Yale University School of Medicine, New Haven, Connecticut: Structure of aberran t chro-
mosome structures in human tumor cell lines.
H. Hubbell, Hahnemann Medical College and Hospital, Philadelphia, Pennsylvania: Molecular struc-
ture of DMs from a human colon carcinoid cell line.
D.L. George, Johns Hopkins University School of Medicine, Baltimore, Maryland: Amplified D NA se-
quences in mouse tumor cells-Association with DMs and HSRs.
Session 4 Mechanisms of Gene Amplification
Chairperson: R.T. Schimke, Stanford University, California
S. Lavi, Weizmann Institute of Science, Rehovot, Israel: Carcinogen-mediated amplification of DNA se-
quences in CHO cells.
T.D. Tlsty, Stanford University, California: Enhanced generation of MTX resistance in cultured animal
cells.
A. Varshaysky, Massachusetts Institute of Technology, Cambridge: Phorbol esters and gene amplifica-
tion.
M. Botchan, University of California, Berkeley: Chromosome excision and/or amplification promoted
by viral origins of replication.
P.C. Hanawalt, Stanford University, California: DNA repair pathways in mammalian cells.
W.A. Haseltine, Sidney Farber Cancer Institute, Boston, Massachusetts: Studies on DNA repair in
bacteria.
R.H. Rownd, Northwestern University Medical School, Chicago, Illinois: Use and lack of use of insertion
sequences in amplification mechanisms of amplification in bacteria.
Session 5 Chromosomal Alterations
Chairperson: S.A. Latt, The Children's Hospital Medical Center, Boston, Massachusetts
S.A. Latt, The Children's Hospital Medical Center, Boston, Massachusetts: Use of flow sorting to study
amplified DNA sequences.
R. Kaufman, Massachusetts Institute of Technology, Cambridge: Transfection and amplification of dhfr
genes in animal cells.
J. Roberts, Columbia University College of Physicians and Surgeons, New York, New York: Amplifica-
tion and correction of transformed genes.
J.D. Rowley, University of Chicago, Illinois: Nonrandom chromosome changes in human leukemia.
J.L. German III, New York Blood Center, New York: Human chromosomes and the generation of
somatic cell diversity.
J. Yunis, University of Minnesota, Minneapolis: High-resolution chromosome banding in the study of
human neoplasia and birth defects.
G. Klein, Karolinska Institute, Stockholm, Sweden: Gene dosage, gene expression, and tumorigenesis.
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Patenting of Life Forms, October 18-21
The Supreme Court's 1980 decision that artificial strains of microorganisms themselves could be
patented, as well as processes for making or using these strains, symbolized for many people the grow-
ing commercialization of techniques of molecular biology which hitherto had been regarded as tools
for investigating the foundations of genetics. The decision brought two cultures, patent law and fun-
damental biology, into sudden contact. Each knew little of the other. Both biologists and lawyers began
asking to what extent patenting of inventions, so central to the pharmaceutical industry but with a
much more subtle impact on the electronics industry, would govern the commercialization of the new
recombinant DNA techniques. To remove some of the uncertainty, leading patent lawyers and scien-
tists heard reviews by scientists of some of the immense diversity inherent in manipulations of
microorganisms and by lawyers of the application of patent law to such organisms. The conference
concluded with a review of recent changes in American and European patent laws and practices and
the possibility of more change soon.
Session 1 Scientific Issues
J. Hicks, Cold Spring Harbor Laboratory, New York: The life cycle of the common microbial hosts, with
emphasis on yeast-the most complex.
M. Scharff, Albert Einstein College of Medicine, Bronx, New York: Monoclonal antibodies. What
defines a permanent cell line, differentiating what is novel or unique; what parameters distinguish
one hybridoma from another?
C.M. Croce, Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania: Monoclonal an-
tibody systems with potential for diagnosis of pancreatic and other forms of cancer.
H. Heyneker, Genentech, Inc., South San Francisco, California: Vector systems and expressions in E.
coll.
A. Ullrich, Genentech, Inc., South San Francisco, California: Gene transfer-Moving a human gene to a
mouse genome.
S. Brenner, Cambridge University Medical School, England: Recombinants that are the same but dif-
ferent.
Session 2 Open Forum on Scientific Issues
Chairperson: N.D. Zinder, Rockefeller University, New York, New York
Discussants:
N.H. Carey, Celltech, Slough, Berkshire, England
P.A. Sharp, Massachusetts Institute of Technology, Cambridge
J. Davies, Biogen, SA, Geneva, Switzerland
J. Sambrook, Cold Spring Harbor Laboratory, New York
Session 3 Legal Issues
D.W. Plant, Fish & Neave, New York, New York: Primer on law on patents and other
intellectual
property.
B.I. Rowland, Townsend and Townsend, Palo Alto, California: Should the fruits of
genetic engineering
be patentable?
V. Vossius, Vossius, Vossius, Tauchner, Heunemann,
Rauh, Munich, Germany: Discussion of itesI and
II as they relate to European and German patent law.
T.D. Kiley, Genentech, Inc., South San Francisco, California: Assuming patentability, what property
rights should accrue to workers in this field?
J.W. Schlicher, Genentech, Inc., South San Francisco, California: The extent to which antitrust and pat-
ent misuse law limits the manner in which patents are acquired, enforced, and licensed.
N.J. Reimers,' R.G. Ditzel,2 and W.P. O'Neill,' 'Stanford University, California; 2University of Califor-
nia, Berkeley; 3DNAX Research Institute, Palo Alto, California: Problems in enforcing patents and in
commercializing patented subject matter in the genetic engineering field.
A.H. MacPherson, Skjerven, Morrill, Jensen, MacPherson, & Drucker, Santa Clara, California: Surviving
in an industry that largely eschews patents-electronics.
Session 4 Open Forum on Legal Issues
Chairperson: Hon. G. Rich, United States Court of Customs and Patent Appeals, Washington, DC
Discussants:
G.M. Gould, Hoffmann-La Roche, Inc., Nutley, New Jersey
C. H. Herr, E.I. duPont deNemours & Company, Wilmington, Delaware
A.E. Tanenholtz, US Department of Commerce, Patent & Trademark Office, Washington, DC
Session 5 Revision in Patent Law and the Patent Court System Affecting the Patenting of Life Forms
Discussants:
N.E. Noonan, House Committee on Science and Technology, Washington, DC
E.L. Bernard, Bernard, Rothwell & Brown, Washington, DC
G.M. Karny, Office of Technology Assessment, US Congress, Washington, DC
Environmental Effects on Maturation, November 1-4
To what extent are such environmental factors as nutrition and chemicals, artificial or natural, having
such effects on children as stunting their physical growth or mental development, predisposing them to
such long-term effects as cancer, or increasing the chance that these children, when they become
adults, will have children of their own with birth defects? Experts on human, primate, and small animal
development, including biochemists, pediatricians, psychologists, and pharmacologists, considered
what is presently known about environmental risks for children, including risks to the developing brain,
liver, and reproductive organs. The issues were considered in order to help plan research for better
understanding of the risks faced by farm workers' children in an environment where pesticides are used
heavily. Among many issues, participants considered the paradox presented by young animals actually
showing increased resistance to some chemicals, even though, as rapidly growing organisms, the
animals may have been expected to show increased vulnerability.
Session 1 Routes of Exposure: Skin and Lung
Chairperson: V. Hunt, Pennsylvania State University, University Park
H.I. Maibach, University of California School of Medicine, San Francisco: Percutaneous absorption-
Neonate compared to the adult.
L. Frank, University of Miami School of Medicine, Florida: Maturational aspects of exidant-induced
lung injury.
R.C. Spear, University of California, Berkeley: Farmworker exposure to pesticide residues-Reflections
on differential risk.
Session 2 Routes of Exposure: Gastrointestinal Tract
Chairperson: D. Barltrop, Westminster Children's Hospital, London, England
D. Barltrop, Westminster Children's Hospital, London, England: Lead/nutrition.
C.M. Schiller, National Institute of Environmental Health Sciences, Research Triangle Park, North
Carolina: Effects of toxins on gastrointestinal function-Developing systems.
S.J. Henning, University of Houston, Texas: Development of feeding behavior and digestive function.
E.P. Savage, Colorado State University, Fort Collins: Pesticides in human breast milk.
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Session 3 Metabolism, Liver and Gastrointestinal
Chairperson: G.L. Lucier, National Institute of Environmental Health Sciences, Research Triangle Park,
North Carolina
H.P. Hoensch, University of Tubingen, Federal Republic of Germany: Absorption and metabolism of
xenobiotics in the intestine.
E.S. Vesell, Pennsylvania State University, Hershey: Dynamically interacting factors that affect the
response of developing individuals to toxicants.
S.D. Murphy, University of Texas Health Science Center, Houston: Toxicity and metabolism of
organophosphorus insecticides in developing rats.
G.L. Lucier, National Institute of Environmental Health Sciences, Research Triangle Park, North
Carolina: Imprinting of hepatic metabolism by neonatal hormone.
Session 4 Kidney and Immune Systems
Chairperson: L.I. Kleinman, University of Cincinnati College of Medicine, Ohio
L.I. Kleinman, University of Cincinnati College of Medicine, Ohio: The effect of lead on the maturing
kidney.
R.J. Kav lock, US Environmental Protection Agency, Research Triangle Park, North Carolina: The
ontogeny of the hydropenia response in neonatal rats and its application in developmental tox-
icology studies.
J.N. Udall, Massachusetts General Hospital, Boston: Macromolecular transport across the developing
intestine.
M.I. Luster, National Institute of Environmental Health Sciences, Research Triangle Park, North
Carolina: Altered immune functions in rodents perinatally treated with 2,3,7,8-tetrachlorodibenzo-p-
dioxin, phorbol-12-myristate-13-acetate and benzo(a)pyrene.
T. Kal land, University of Bergen, Norway: Long-term effects on the immune system of an early life ex-
posure to diethylstilbestrol.
Session 5 Central Nervous
Chairperson: R.J. Bull, US Environmental Protection Agency, Cincinnati, Ohio
K. Suzuki, Albert Einstein College of Medicine, Bronx, New York: Development of myelin.
. Kearsley, New England Medical Center Hospital, Boston, Massachusetts: Cognitive
assessment of
developing infants.
L.W. Reiter, US Environmental Protection Agency, Research Triangle Park, North Carolina: Organo-tin
exposure in developing rodents.
.E. Bowman, University of Wisconsin Primate Laboratory, Madison: Some behavioral sequelae of
toxicant exposure during development.
.C. Vannucci, Cornell University Medical College, New York, New York: Vulnerability of the immature
brain to hypoxia-ischemia.
Session 6 Maturation of the Reproductive System, Including Neuroendocrine Aspects
Chairperson: J.H. Clark, Baylor College of Medicine, Houston, Texas
B.S. Me cEwen, Rockefeller University, New York, New York: Estrogens-Influences
on brain deve op-y or College of Medicine, Houston, Texas: Sex steroids
and maturation in the  female.I.H. Clark, Ba I
C.W.
Bnt and neuroendocrine function.
tiveatrrdacint,.
The Population Council, New York, New York: The
differentiation of the male reproduc-
i e
Wisconsin Regional Primate Research Center, Madison: The
developmental actions or ef
R.W. G
D.R.
Pfer, Worcester Foundation for Experimental Biology, Shrewsbury,
Massachusetts: Xenobiotics.an rogens in Rhesus monkeys.
D.R. K Mattison, National Institute of Child Health and Human Development,
NIH, Bethesda, Maryland:
Prepubertal ovarian toxicity.
Walker, Le Centre Hospitalier de l'Universite Laval, Quebec,
Canada: Long-term susceptibility
resultingting from brief perinatal manipulation of thyroid function. 225
Session 7 Epidemiological Perspectives
Chairperson: H.W. Berendes, National Institute
of Child Health and Human Development, NIH,
Bethesda, Maryland
I.E. Norman, Jr., National Research Council, Washington,
DC: Breast cancer in women irradiated in ear-
ly life.
R. Illsley, Institute of Medical Sociology, Aberdeen,
Scotland: Impact of early-life factors on pregnancy
outcomes.
D. Snowdon, Loma Linda University School of Health, California: Age at baptism into the Seventh-Day
Adventist Church and risk of death due to ischemic heart disease-A preliminary report.
G.G. Nahas, College of Physicians & Surgeons of Columbia University, New York, New York: The
Ledermann model applied to the frequency of marihuana use among U.S. high school seniors.
Session 8 Lessons from Pharmacokinetics and Human Responses
Chairperson: C.M. Berlin, Jr., Pennsylvania State University, Hershey
L.K. Garrettson, Virginia Commonwealth University, Richmond: Age-related development of
theophylline-Pharmacokinetic responses of children.
B.R. Sonawane, University of Pennsylvania, Philadelphia: Developmental aspects of acetaminophen
hepatotoxicity- Influence of age and acute starvation.
J.S. Partin, State University of New York, Stony Brook: Reye's syndrome and its association with
salicylates.
A.H. Neims, University of Florida College of Medicine, Gainesville: Some drug host aspects of drug
therapy in pediatrics.
J.M. Tanner, University of London, England: Conference summary.
Construction and Use of Mammalian Viral Vectors, December 3-6
At this conference 49 DNA and RNA tumor virologists presented and discussed the most recent ad-
vances in the use of tumor viruses as cloning vectors. The progress in this field can be judged by com-
paring this conference with the 1980 Banbury meeting on Construction and Use of Mammalian Viral
Vectors. One year ago, the only viral vectors constructed and used were SV40 and adenovirus; papil-
loma and RNA tumor viruses were merely discussed as potential vectors. In contrast, during the 1981
meeting, work with a great variety of vectors, including both DNA tumor viruses (SV40, polyoma,
papilloma, adenoviruses, herpesvirus) and RNA tumor viruses (MoMLV, MoMSV, HaMSV, ASV, SNV,
MMTV) was presented.
Session 1 SV40
Chairperson: T. Shenk, State University of New York, Stony Brook
G.C. Fareed, University of California, Los Angeles: Expression of influenza virus hemagglutinin using
SV40 vectors.
M.J. Gething, Imperial Cancer Research Fund Laboratories, London, England: Cell-surface expression
and secretion of influenza hemagglutinin from simian cells infected with SV40-HA vectors.
P. Gruss, NCI, National Institutes of Health, Bethesda, Maryland: The expression of viral and cellular
p21 ras genes using SV40 as a vector.
D.H. Hamer, NCI, National Institutes of Health, Bethesda, Maryland: Regulation of a metallothionein
gene cloned in animal virus vectors.
M. Horowitz, Massachusetts Institute of Technology, Cambridge: SV40 as a vector for cloning
eukaryotic sequences and controlling elements.
R. Treisman, Harvard University, Cambridge, Massachusetts: Expression of human 0-globin genes in
Cos-7 and HeLa cells.
A. Levinson, Genentech, Inc., South San Francisco, California: Expression of hepatitis B surface antigen
using SV40-based vectors.
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Session 2 RNA Tumor Viruses
Chairperson: G. Vande Woude, NCI, National Institutes of Health, Bethesda, Maryland
E.M. Scolnick, NCI, National Institutes of Health, Bethesda, Maryland: Properties of transmissible retro-
viruses containing the thymidine kinase gene of HSV.
S. Watanabe, University of Wisconsin, Madison: Encapsidation sequence required for retrovirus vec-
tors.
C. Tabin, Massachusetts Institute of Technology, Cambridge: The utilization of a retrovirus as a euka-
ryotic vector for transmitting cloned DNA sequences.
J. Sorge, Cold Spring Harbor Laboratory, New York: Retrovirus vector independent of selectable
markers.
R. Mulligan, Massachusetts Institute of Technology, Cambridge: Construction of transmissible retrovi-
rus cloning vehicles carrying dominant-acting genetic markers.
Session 3 Papilloma, Polyoma, Simian Virus
Chairperson: J. Sambrook, Cold Spring Harbor Laboratory, New York
P.M. Howley, NCI, National Institutes of Health, Bethesda, Maryland: Expression of selective traits in
mouse cells transformed by a BPV69T-SV2gpt hybrid DNA.
R. Breathnach, Faculte de Medicine de Strasbourg, France: Bovine papilloma virus 1-pBR322 and poly-
oma-pBR322 recombinants as eukaryotic vectors.
D. Di Maio, Harvard University, Cambridge, Massachusetts: Intact bovine papilloma virus-human DNA
recombinant plasmids that propagate as episomes in mouse and bacterial cells.
M. Botchan, University of California, Berkeley: Enhanced transformation mediated by bovine papil-
loma virus.
M. Fried, Imperial Cancer Research Fund Laboratories, London, England: Use of a polyoma virus vector.
R. Contreras, Laboratorium voor Moleculaire Biologie, Gent, Belgium: Expression of human fibroblast
interferon /3-1 gene by transfection of monkey cells with an SV40 vector.
P.J. Southern, Scripps Clinic and Research Foundation, La Jolla, California: Mammalian cell transforma-
tion with SV40 hybrid plasmid vectors.
Session 4 RNA Tumor Viruses
Chairperson: E.M. Scolnick, NCI, National Institutes of Health, Bethesda, Maryland
S. Broome, Harvard University, Cambridge, Massachusetts: A Rous sarcoma virus gag gene
product
Gilboa,
on RNA levels in transfected cells.
il , Princeton University, New Jersey: Transduction and expression of nonselectable genes
using
retrovirus-derived vectors.
Vande Woude, NCI, National Institutes of Health, Bethesda, Maryland: Use of
retroviral sequences
in cotransfection, activation, and rescue of one genes.
I.M. erma, Salk Institute, San Diego, California: Expression and regulation of rat
growth hormone gene
in mouse cells.
G.L. Hager, NCI, National Institutes of Health; Bethesda, Maryland: Analysis
of glucocorticoid regula-
tion by linkage of the mouse mammary tumor virus promoter to a
viral oncogene.
riegler, University of California, Berkeley: A retroviral LTR contains a new type
of eukaryotic
regulatory element.
Session 5 Adenovirus, Herpes virus
Chairperson: T. Grodzicker, Cold Spring Harbor Laboratory, New York
C.S. Thummel, University of California, Berkeley: Precise positioning of
5V40 DNA in adenovirus ex-
y.
vectors by a combination of in vitro and in vivo recombination.
K.,
L bi
zman, Cold Spring Harbor Laboratory, New York: Helper-independent
adenovirus vector.
r k ner, Massachusetts Institute of Technology, Cambridge: Adaptation
of adenovirus as a cloning
vehicle.
N. Frenkel, University
lex virus
of Chicago, Illinois: A novel eukaryotic-virus
vector-The herpes simp
amplicon.
N.D. Stow
ces using
Howard,
,.
University of Glasgow, Scotland: Propagation of foreign
DNA sequences a
simplNationaex virus
esl Institu
vector.
of Health
novelt;, in-
tegration into the E. coli chromosome.
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Maryland: Vectors which may be
propagated by
Postgraduate
Training Program
SUMMER 1981
The Postgraduate Training Program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects which are either so new or so specialized that they are not
adequately treated by universities. Our aim is to provide intensive study in the most recent develop-
ments and techniques in these subjects and to prepare students to enter directly into research in a par-
ticular area. To ensure up-to-date coverage of current research work, we bring together a workshop
staff from many laboratories around the world and supplement this staff with a series of seminar
speakers.
Neurobiology of Behavior, June 5-June 18
INSTRUCTORS
Kandel, Eric R., M.D., Columbia University, New York, New York
Koester, John, Ph.D., Columbia University, New York, New York
Pearson, Kier, Ph.D., University of Alberta, Edmonton, Canada
Nottebohm, Fernando, Ph.D., Rockefeller University, Millbrook, New York
This course was designed to introduce students to cellular approaches to the study of behavior and
learning. The lectures provided an intensive coverage of four main areas: 1) general principles of be-
havior and cellular neurobiology; 2) simple forms of behavior, learning, and motivation; 3) initiation
and maintenance of complex locomotor sequences, including voluntary movement and motor learning;
4) communication. To illustrate general principles, suitable systems for study were selected from both
invertebrate and vertebrate behavior. To put the cellular work into perspective, selected examples were
also taken from human behavior and its abnormalities.
PARTICIPANTS
Belardetti, Francesco, M.D., University of Pisa, Italy
Ford, Paul M., B.S., National Jewish Hospital, Denver, Colorado
Garg, Ajay P., B.S., Schenectady, New York
Hofmann, Michael J., B.S., University of Connecticut, Storrs
Lane, Steven R., B.A., University of California, San Francisco
Miyashita, Yasushi, M.S., University of Tokyo, Japan
Mortin, Lawrence I., B.S., Washington University, St. Louis, Missouri
Nelson, Lorene M., B.S., University of Colorado, Denver
Norris, Brian J., Texas Technological University, Lubbock
Nye, Jeffrey Scott, B.A., Harvard Medical School, Boston, Massachusetts
Parpal, Leslie A., M.A., Temple University, Philadelphia, Pennsylvania
Rapaport, Ray, B.A., Wayne State University, Detroit, Michigan
Reichert, Heinrich, Ph.D., Stanford University, California
Richerson, George B., B.S., University of Iowa, Iowa City
Rosenheimer, Julie L., B.A., University of Wisconsin, Madison
Symonds, Laura L., B.S., University of Pennsylvania, Philadelphia
Zabala, Nelson A., M.D., IVIC, Caracas, Venezuela
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SEMINARS
Kandel, E.R., Columbia University. Introduction to the cellular study of behavior.
Koester, J., Columbia University. Introduction to the biophysics of behavior.
Kandel, E.R., Columbia University. Morphology and physiology of synaptic transmission.
Koester, J., Columbia University. Repetitive firing properties and the control of behavior.
Kandel, E.R., Columbia University. Learning I. Habituation.
.
Learning 11. Sensitization.
Wine, J. Stanford University. Nerve circuitry for simple behavioral acts and their control.
Baudry, M., University of California. Long-term plasticity in the vertebrate CNS.
Levine, R., University of Washington. Hormones and behavior.
Kupfermann, I., Columbia University. Motivation.
Wurtz, R., National Institutes of Health. Attention.
Pearson, K., University of Alberta. Introduction to motor sequences.
.
Central and reflex control of movements.
.
Walking in the cat.
Getting, P., University of Iowa. Rhythm generation in invertebrate motor systems.
Friesen, 0., University of Virginia. Neuronal control of leech swimming.
Ghez, C., Columbia University. Voluntary movements in mammals.
Evarts, E., National Institute of Mental Health. Cerebral control of voluntary movement.
Thach, W.T., Jr., Washington University. Does the cerebellum learn motor programs?
Fuchs, A., University of Washington. Adaptive regulation in the oculomotor system.
Nottebohm, F., Rockefeller University. Introduction to communication.
Brain pathways for vocal learning.
Suga, N., Washington University. Brain pathways for sound processing in bats.
Zaidel, E., University of California. Language processing by the right and left hemisphere.
Ojemann, G., University of Washington. A surgeon's view of language processing pathways.
Geschwind, N., Harvard Medical School. Apraxia.
Zigmond, R., Harvard Medical School. Use and disuse: Effects on neurotransmitter
synthesis.
The role of neurotransmitters in behavioral abnormalities.
Nervous System of the Leech, June 6-June 26
INSTRUCTORS
Nicholls, John, M.D., Ph.D., Stanford University Medical School, California
Parnas, Itzhak, Ph.D., Hebrew University, Jerusalem, Israel
Muller, Kenneth, Ph.D., Carnegie Institution of Washington, Baltimore,
Maryland
Zipser, Birgit, Ph.D., Cold Spring Harbor Laboratory, New York
The aim of this workshop was to provide students with an intensive
lab and seminar course that would
with
enable
for recording from leech cells, now considered
straightforward and relatively easy, that
took much time and effort to be refined. With this knowledge,
they might avoid many of the trivial
technical difficulties that bedevil anyone starting on the nervous system
of the leech or other animals.
The initial work was devoted mainly to recognizing the individual cells,
learning how to record from
them with intracellular and extracellular electrodes, getting familiar
with the equipment, and perform-
ing dissections. The students then progressed to more difficult experiments,
such as recording synaptic
potentials while changing the fluid, bathing the preparation, or injecting
individual cells with marker
substancesstances to study their geometry.
The final phase of the course consisted of devising and performing original experiments, some of
which proved to be of sufficient interest to be pursued in greater detail. For example, individual nerve
cells in the leech were stained with specific monoclonal antibodies. Techniques for dissecting and
maintaining individual indentified cells and keeping them alive in culture, as well as the use of Pronase
injection for killing single cells were listed by the students.
PARTICIPANTS
Dhanjal, Sukhvinder S., B.S., Institute of Neurology, London, England
French, Kathleen A., Ph.D., University of North Carolina, Chapel Hill
Hockfield, Susan, Ph.D., Cold Spring Harbor Laboratory, New York
Laiwand, Roni, M.S., Hebrew University, Jerusalem, Israel
Macdonald, Beth L., B.A., University of Connecticut, Farmington
McKay, Ronald, Ph.D., Cold Spring Harbor Laboratory, New York
Schwarz, Jurgen R., Ph.D., University of Hamburg, Federal Republic of Germany
Shank land, Martin S., Ph.D., University of California, Berkeley
Tolbert, Leslie P., Ph.D., Harvard Medical School, Boston, Massachusetts
Zhang, Ren-Ji, State University of New York, Plattsburgh
SEMINARS
Blackshaw, S., Stanford Medical School. Touch cells.
. Nociceptive cells.
Friesen, 0., University of Nigeria. Receptors to waves in the fluid.
Kristan, W., University of California, San Diego. Swimming.
. Development of reflexes.
Muller, K., Carnegie Institution of Washington. Electronics for intracellular recording.
. Motor cells.
. Abnormal sensory and motor cells.
. The S cell: An interneuron.
. Regeneration.
. Structure of synapses.
Nicholls, J., Stanford Medical School. Introduction: Why the leech?
. Sensory cells.
. After potentials and conduction block.
. Synaptic transmission.
. Cultured cells: Chemical and electrical connections.
. Presynaptic inhibition and modulation of transmitter release.
. Accumulation and glia.
Parnas, I., Hebrew University. Conduction block.
. Spread of receptive fields after killing single cells with Pronase.
Stent, G., University of California, Berkeley. Swimming and heartbeat.
. Development of receptive fields.
Weisblat, D., University of California, Berkeley. Development of the leech.
Zipser, B., Cold Spring Harbor Laboratory. Neural control of sexual function in the leech.
. Monoclonal antibodies to specific cells.
The Mammalian Central Nervous System, June 6-June 29
INSTRUCTORS
Burke, Robert, M.D., National Institutes of Health, Bethesda, Maryland
Hubel, David, M.D., Harvard Medical School, Boston, Massachusetts
Malpeli, Joseph, Ph.D., University of Illinois, Chicago
Rymer, William Z., M.D., Northwestern Medical School, Chicago, Illinois
Sherk, Helen, Ph.D., Harvard Medical School, Boston, Massachusetts
This workshop offered laboratories and lectures on the mammalian central nervous system. It began
with four days of lectures by Robert Burke and David Hubel on the spinal cord, motor control, and the
visual system. These were followed by a day of demonstrations of recording from cat spinal
motorneurons and muscle afferents and lateral geniculate neurons. The remaining 18 days were
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devoted to four series of laboratory experiments on the cat CNS, with the eight participants working in
pairs, spending four to five days on each series. In all labs, participants learned the appropriate surgical
techniques, the preparation of microelectrodes, and histological procedures for reconstructing
microelectrode tracks. In one lab participants studied the reflex activity of motorneurons in the spinal
cord using both intracellular and extracellular recording techniques. Functional properties of the
associated motor units were identified and synaptic connections from various cutaneous and muscle
afferent systems were examined. In another lab, the participants recorded extracellularly from auditory
cortex and used retrograde transport of horseradish peroxidase to look for evidence of a columnar
structure to interhemispheric auditory projections. The other two labs focused on extracellular record-
ing from visual cortex (areas 17, 18, 19, and the Clare-Bishop area) and subcortical visual structures (the
lateral geniculate nucleus and the superior colliculus). The single-cell responses to visual stimuli,
retinotopic organization, and functional cytoarchitecture of these structures were examined. A digital
computer was used to generate poststimulus histograms. In the subcortical vision labs the participants
studied orthodromic and antidromic shock-evoked driving, making use of the impulse collision tech-
nique. Retrograde transport of horseradish peroxidase was also used in the vision experiments to study
the connections between cortical and subcortical structures.
PARTICIPANTS
Atkeson, Christopher G., B.A., Harvard University, Cambridge, Massachusetts
Carman, George J., B.A., University of Texas, Austin
Demeter, Steven, M.D., University of Iowa, Iowa City
Illing, Robert-Ben, M.D., Max-Planck-Gesellschaft, Munich, Federal Republic of Germany
Matsubara, Joanne A., B.A., University of California, San Diego
McDonagh, Martin J., Ph.D., The Medical School, Nottingham, England
Orbach, Harry S., Ph.D., Yale University, New Haven, Connecticut
Schumer, Robert A., Ph.D., New York University, New York
SEMINARS
Gilbert, C., Harvard University. Functional morphology of visual cortex.
Fetz, E., University of Washington. New approaches to the evaluation of motor cortex function.
Robinson, D., Johns Hopkins Medical School. Application of control theory to the oculomotor
system.
Karten, H., State University of New York, Stony Brook. Histochemistry of vertebrate return.
Limas, R., New York University. Cellular biology of olivo-cerebellar circuits.
Molecular Biology of Plants, June 6-June 26
INSTRUCTORS
Ausubel, Frederick M., Ph.D., Harvard University, Cambridge, Massachusetts
Bedbrook, John, R., Ph.D., CSIRO, Canberra, Australia
Smith, Stephen, Ph.D., CSIRO, Canberra, Australia
Riedel, Gerard E., Ph.D., CSIRO, Canberra, Australia
ASSISTANTS
Brown, Susan E., Harvard University, Cambridge, Massachusetts
Dunn, Barbara, B.S., Harvard University, Cambridge, Massachusetts
The three week Plant Molecular Biology Course consists of a series
of lectures by the staff and by
distinguished invited speakers and a series of laboratory exercises designed to acquaint the students
with the fundamentals of current plant molecular biology research. The course assumes that most stu-
dents come with a good background in molecular genetic
techniques but with a poor understanding of
general botany, plant physiology, plant sexual reproduction, and plant development. Therefore, the
course begins with lectures to acquaint the students with some of the fundamental differences between
plants and animals. The introductory topics are tied together by considering plants from a developmen-
tal point of view. Laboratory experiments involving whole plant anatomy, embryo and meristem cul-
ture, and somatic cell tissue culture complement the introductory lectures.
The introductory section is followed by a series of detailed lectures covering topics which are rela-
tively unique to plants including photosynthesis, seed formation and germination, and regeneration of
intact plants from somatic cultures. Among the topics covered are classical transmission genetics in-
cluding transposable genetic elements, cytogenetics, plant viruses, plant-bacterial interactions, and the
molecular biology of the plant organelle and nuclear genomes. The laboratory projects parallel the lec-
tures and include experiments on (1) the mechanism of a-amylase induction in germinating seeds; (2)
the manipulation of plant tissue cultures; (3) the generation of plant mutants; (4) the isolation, charac-
terization and manipulation of plant DNAs and RNAs; and (5) cytogenetics.
GUEST INSTRUCTORS
Smith, Jane H., ARCO Plant Cell Research Institute, Dublin, California
Dellaporta, Stephen, Worcester Polytechnic Institute, Massachusetts
Sussex, Ian, Yale University, New Haven, Connecticut
Walbot, Virginia, Stanford University, California
Hanson, Maureen, University of Virginia, Charlottesville
Jones, Jonathan, Harvard University, Cambridge, Massachusetts
Varner, Joseph, Washington, University, St. Louis, Missouri
Miles, Donald, University of Missouri, Columbia
PARTICIPANTS
Boccara, Martine, Ph.D., Sloan-Kettering Institute, New York
Carbonero, Pilar, M.D., Universidad Politecnica de Madrid, Spain
Dion, Patrice, Ph.D., Universite Laval, Quebec, Canada
Dowling, Elizabeth L., B.S., University of California, Berkeley
Goodman, Howard M., Ph.D., University of California, San Francisco
Hofman, Jason D., Ph.D., Dalhousie University, Halifax, Nova Scotia
Klessig, Daniel F., Ph.D., University of Utah, Salt Lake City
Lica, Lorraine M., Ph.D., University of California, Irvine
Magnusson, Ronald P., Ph.D., NCI, National Institutes of Health, Bethesda, Maryland
Novak, Ulrike, B.S., Imperial Cancer Research Fund, London, England
Sanchez, Federico E., Ph.D., University of California, San Francisco
Scolnik, Pablo A., Ph.D., University of Chicago, Illinois
Selzer, Gerald B., Ph.D., National Institutes of Health, Bethesda, Maryland
Simpson, Robert B., Ph.D., University of Washington, Seattle
Woznyj, Manfred J., M.S., Universitt Bielefeld, Federal Republic of Germany
Zimmer, Elizabeth A., Ph.D., Washington University, Seattle
SEMINARS
Sussex, I., Yale University. Plant anatomy and development.
Bedbrook, J., CSIRO. Molecular cloning of plant nuclear genes.
Ausubel, F., Harvard University. Molecular biology of nitrogen fixation.
Riedel, G., CSIRO. Development of vectors for transforming plant cells.
Walbot, V., Stanford University. Plant development.
van Montagu, M., Rijksuniversitiet Gent. Molecular biology of crown gall tumorigenesis.
Flavell, R., Plant Breeding Institute. Organization of chromosomal DNA sequences in plants.
Hanson, M., University of Virginia. Plant tissue culture.
Jones, J., Harvard University. In situ hybridization in plant cytogenetics.
Varner, J., Washington University. Molecular biology of plant hormone action.
Smith, S., CSIRO. Uptake of nuclear coded proteins in chloroplasts.
Mets, L., Carnegie Institute. Organelle genetics.
McClintock, B., Cold Spring Harbor Laboratory. Controlling elements in maize.
Burr, B., Brookhaven Laboratory. Controlling elements in maize.
Miles, D., University of Missouri. Isolation and characterization of photosynthetic mutants.
Verma, D.P., McGill University. Molecular biology of legume root nodules.
Bogorad, L., Harvard University. Molecular biology of chloroplast gene expression.
Shepard, J., Kansas State University. Use of plant tissue culture techniques in crop improvement.
Dellaporta, S., Worcester Polytechnic Institute. Transformation of plant protoplasts.
Hal lick, R., University of Colorado. Molecular biology of chloroplasts.
Malmberg, R., Cold Spring Harbor Laboratory. Plant tissue culture techniques.
Animal Cell Culture, June 13-June 26
INSTRUCTORS
Sato, Gordon H., Ph.D., University of California, San Diego, La Jolla
Mather, Jennie P., Ph.D., The Population Council, Rockefeller University, New York, New York
ASSISTANT
Byer, Alicia, B.A., The Population Council, Rockefeller University, New York, York
Recent investigations into the role of serum in cell culture medium have shown that the serum require-
ment for many established cell lines can be replaced by specific mixtures of hormones and purified
serum factors. This approach has been used successfully to prolong viability and function of primary
cultures, specifically select for one cell type in primary cultures, and establish cell lines of cell types
not previously maintained in culture. Participants brought their own cell lines and/or selected one of
the established lines provided and designed and carried out experiments to define a serum-free medium
for these cells. Participants also prepared primary cultures of several cell types in serum-free media.
Laboratory exercises were supplemented by lectures and discussions with invited speakers expert
in
various aspects of cell culture and hormonal control of cell proliferation and differentiation. Special
thanks go to Dr. Coon, Dr. Taub, and Br. Barnes for arranging laboratory exercises in specialized
aspects of the use of serum-fee hormone-supplemented media.
PARTICIPANTS
Aprison, Barry S., M.S., Brandeis University, Waltham, Massachusetts
Billeter, Rudolf, Ph.D., National Institutes of Health, Bethesda, Maryland
Brock, Tommy, Ph.D., University of Alabama, Birmingham
Bullock, Phyllis, M.S., Rush University, Chicago, Illinois
Burczak, John, M.S., Michigan State University, East Lansing
Eschenbruch, Margaret, Ph.D., Friedrich Miescher Institute, Basel, Switzerland
Fisher, Gordon, Ph.D., University of Sherbrooke, Quebec, Canada
Friderici, Karen, M.S., Michigan State University, East Lansing
Furth, Mark E., Ph.D., NCI, National Institutes of Health, Bethesda, Maryland
Hill, Julian B., M.D., NCI, National Institutes of Health, Bethesda, Maryland
lemma, Cristina, Ph.D., Superiore Istituto di Sanita, Rome, Italy
Ron, Dina, M.S., Ben Gurion University, Beer Sheva, Israel
Schairer, Hans, Ph.D., Gesellschaft fur Biotechnologische, Braunschweig, Federal
Republic of Germany
Smith, Carole, Ph.D., NCI, National Institutes of Health, Bethesda, Maryland
Valentich, John, Ph.D., University of Texas, Houston
Van Eldik, Linda, Ph.D., Rockefeller University, New York, New York
VIgnon, Francoise, Ph.D., INSERM, Montpellier, France
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SEMINARS
Coon, H., National Institutes of Health. Serum-free
culture of thyroid.
Taub, M., State University of New York, Buffalo.
Growth of kidney cells in serum-free medium.
McKeehan, W., W. Alton Jones Cell Science Center. Optimizing
media for serum-free culture hormone
nutrient interactions.
Barnes, D., University of Pittsburgh. Role of attachment factors in serum-free culture.
Phillips, D., Rockefeller University. Use of scanning and
electron microscopy to study hormone action in
cell culture.
Lane, D., Johns Hopkins University. Role of insulin in differentiation of adipocytes.
Pawelek, J., Yale University. Regulation of growth and differentiation in melanoma cells in culture.
Yamada, K., National Institutes of Health. Structure and function of fibronectin.
Glass, J., Beth Israel Hospital. Transferrin and iron uptake.
Haour, F., INSERM, Hormonal control of gonadatropin receptors and response.
Sherman, M., Roche Institute. Embryonic development in culture.
The Synapse and Sensory Transductor, July 9-July 29
INSTRUCTORS
Rahamimoff, Rami, M.D., Hebrew Unversity Medical School, Jerusalem, Israel
McMahan, U.Jack, Ph.D., Stanford University, California
Stevens, Charles F., M.D., Ph.D., Yale University, New Haven, Connecticut
Yoshikami, Doju, Ph.D., University of Utah, Salt Lake City
This course was designed for graduate students and research workers interested in the structure and
function of synapses and sensory receptors. It consisted of lectures; readings of papers; group discus-
sions; presentations of selected topics by participants; seminars by instructors, faculty, and partici-
pants; and demonstrations. After the course ended, some of the participants stayed on for a workshop.
PARTICIPANTS
Antelman, Bruce M., B.A., Harvard Medical School, Boston, Massachusetts
Baker, Anthony J., B.A., University of Bristol, England
Behrens, Maria Isabel, M.D., Catholic University, Santiago, Chile
Bodmer, Rolf A., B.S., Friedrich Miescher Institute, Basel, Switzerland
Drotar, AnnaMarie, M.S., University of Colorado, Boulder
Dye, John C., B.A., University of California, San Diego
Fallon, Justin, R., Ph.D., University College London, England
Frair, Patricia M., Ph.D., McGill University, Montreal, Canada
Greene, Glenn J., M.S., California Institute of Technology, Pasadena
Krause, James E., Ph.D., University of Pittsburgh, Pennsylvania
Lechleiter, James D., B.S., University of Arizona, Tucson
Nunez, Ramon H., M.D., University of Connecticut, Storrs
Nussinovitch, Itzhak, Hadassah Medical School, Jerusalem, Israel
Oland, Lynne A., M.S., University of North Carolina, Chapel Hill
Paggi, Paola, B.S., University of Rome, Italy
Pfeiffer, Friedhelm, B.S., Max-Planck-Institut fur Psychiatrie, Munich, Federal Republic of Germany
Porter, Seth, B.A., Dartmouth Medical School, Hanover, New Hampshire
Sawyer, Carol E., University of Pennsylvania, Philadelphia
Sherman-Gold, Rivka, M.S., Weizmann Institute, Rehovot, Israel
Silberberg, Shai D., B.S., Hadassah Medical School, Jerusalem, Israel
Tempel, Bruce L., M.A., Princeton University, New Jersey
Vergara, Cecilia, B.S., Harvard University, Boston, Massachusetts
SEMINARS
McMahan, J., Stanford University. Structure of peripheral synapses.
. Structure of central synapses.
. Localization of acetylcholine receptors at the neuromuscular junction.
. Localization of acetylcholinesterase at the neuromuscular junction.
. The vesicle hypothesis.
. Degeneration of the neuromuscular junction.
. Regeneration of the neuromuscular junction.
Rahamimoff, R., Hebrew University. Principles of signaling in the nervous system.
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-. The ionic basis of membrane potentials: The forces.
-. Ionic fluxes through excitable membranes.
-. The resting membrane potential.
.
The action potential: Phenomenology.
.
Cable properties and conductance of the action potential.
.
The ionic basis of the action potential currents.
.
Ionic conductances and models for action potentials.
.
Quantal release of transmitter.
.
The role of calcium ions in transmitter release.
.
Sodium ions as secondary regulators of quantal liberation of acetylcholine.
.
Frequency modulation of transmitter liberation.
Yoshikami, D., University of Utah. The excitatory postsynaptic potential.
.
The ionic basis of the excitatory postsynaptic potential.
.
The inhibitory postsynaptic potential.
.
Electrical synapses.
.
Microphysiology of the neuromuscular junction.
. Slow synaptic potentials.
.
Synaptic activity visualized by autoradiography.
Stevens, C., Yale University. The voltage dependence of the acetylcholine channel.
.
Fluctuation analysis of postsynaptic membrane channels.
-. Relaxation techniques in the study of the acetylcholine channel.
.
Application of noise analysis and single-channel recording in the study of local anesthetic action
and desensitization: Evidence, predictions, and intuition.
Goodenough, D., Harvard Medical School. Gap junctions: Structure as revealed by x-ray diffraction
and electron microscopy.
Cell biology of gap junctions.
Sigworth, F., Max-Planck Institute. Properties of sodium channels from fluctuation analysis
and
single-channel recording.
Corey, D., Yale University. Techniques of single-channel recording.
Schwartz, E., University of Chicago. First events in vision: Generation of response in vertebrate
rods.
Horn, J., Harvard Medical School. Slow muscarinic inhibition in sympathetic ganglia.
Purves, D., Washington University School of Medicine. Specificity in neural development.
Synaptic rearrangements during development.
Patterson, P., Harvard Medical School. The neural crest.
. The role of environment in the development of neurons in tissue culture.
Jackson, M., University of California, Los Angeles. Applications of single-channel
recording tech-
niques in tissue-cultured muscle and nerve.
Nicholls, J., Stanford University School of Medicine. Regeneration in the leech nervous
system.
Jan, L., University of California, San Fransicso. Peptides in the nervous system.
. Peptidergic transmission in sympathetic ganglia.
Herbert, E., University of Oregon. Processing of polyprotein precursors of
endocrine ACTH and
enkephalens.
. Regulation of synthesis; processing and release of constituent
hormones of pro-
oPlomelanocortin and use of recombinant DNA techniques to study gene
expression.
Bowers, C., Harvard Medical School. Neural regulation of pineal biochemistry.
Frank, E., Harvard Medical School. Monosynaptic reflexes in the spinal cord.
. Synaptic transmission in the spinal cord.
Shapiro, E. and R. Kretz, Columbia University. Post-tetanic poteniation
of an identified
synapse in Aplysia is correlated with a Ca2+ dependent K+ current in the
presynaptic neuron: Direct
evidence for Ca' accumulation.
Kado, R., CNRS. Sodium channels in oocytes.
Lee Rubin, L., Rockefeller University. Neuromuscular junction development. 1 and 11.
. Neurotoxins.
Albrecht-Buehler, G., Cold Spring Harbor Laboratory. Control of tissue cell movement.
Fambrough, D., Carnegie Institution. Acetylcholinesterase forms and distribution.
.
Acetylcholine receptor structure.
.
Acetylcholine receptor turnover.
.
Myasthenia gravis.
.
Acetylcholine receptor biosynthesis.
.
Regulation of acetylcholine receptors.
Black, I., Cornell College of Medicine. The catecholamine synapse.
.
Postnatal and prenatal development of the catecholamine system.
.
Development of the peptidergic system.
Rahamimoff, H., Hebrew University. Properties, purification, and reconstitution of calcium transport
systems from isolated nerve terminals.
Raviola, E., Harvard Medical School. Cell biology of the retina.
.
Connectivity in the retina.
Baylor, D., Stanford University School of Medicine. Overview of signaling in the retina.
.
Visual transduction in rods and cones.
.
Electrical analysis of transduction in rods.
.
Cell interactions in the vertebrate retina.
Hudspeth, J., California Institute of Technology. Mechanical transduction in the acoustico-
lateralis systems.
.
Physiology of hair cells.
Chiarandini, D., New York University. Ca2+ electrical activity in mammalian skeletal muscle.
Stefani, E., Instituto Politecnico Nacional. Ca2+ currents in frog skeletal muscles.
Zipser, B., Cold Spring Harbor Laboratory. Studies with monoclonal antibodies to the leech
nervous system.
Ascher, P., Ecole Norma le Superieure. Potassium responses to neurotransmitters in Aplysia neurons.
Molecular Cloning of Eukaryotic Genes, June 30-July 30
INSTRUCTORS
Maniatis, Thomas, Ph.D., Harvard University, Cambridge, Massachusetts
Fritsch, Edward F., Ph.D., Michigan State University, East Lansing
Engel, Doug, Ph.D., Northwestern University, Chicago, Illinois
ASSISTANTS
Weiss, Michael A., B.S., Harvard University, Cambridge, Massachusetts
Van de Woude, Susan, Harvard University, Cambridge, Massachusetts
Bates, Paul F., B.S., Michigan State University, East Lansing
The course is designed to give "hands on" experience in the isolation and analysis of eukaryotic genes.
Experiments performed during the course include double-strand cDNA synthesis; poly(dG):poly(dC)
tailing; DNA fragment isolation from gels; 32P labeling of nucleic acids in vitro; preparation and isola-
tion of X arms and preparation of eukaryotic DNA inserts for X cloning; preparation of in vitro packag-
ing extracts; formation of eukaryotic X libraries; screening of the eukaryotic DNA libraries in X phage by
plaque hybridization screening and by recombinational screening; formation of libraries in cosmid vec-
tors; specific methods for subcloning fragments of eukaryotic DNA in plasmid vectors; screening of
plasmids for insert fragments by size and by filter colony hybridization screening; and Northern and
chromosomal Southern blotting analyses. Laboratory demonstrations, prepared by outside experts, de-
tail the identification of recombinants by RNA filter selection and subsequent in vitro translation.
Topics covered include the transient replication and expression of genes in SV40 subclones of chromo-
somal genes transfected into simian cells and the expression of isolated genes introduced into cultured
cells by microinjection. Through the seminar series, students are also introduced to a wide variety of
topics in which recombinant DNA studies have proven to be indispensable in the analysis of the
organization and expression of genes in a wide variety of organisms and eukaryotic viruses.
PARTICIPANTS
Allen, Deborah, B.S., Imperial Cancer Research Fund, London, England
Arai, Ken-ichi, Ph.D., University of Tokyo, Japan
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Batter, David K., B.S., Cornell University, New York, New York
Deikman, Jill, B.A., University of California, Berkeley
Diesseroth, Albert B., Ph.D., National Institutes of Health, Bethesda, Maryland
Gefter, Malcolm L., Ph.D., Massachusetts Institute of Technology, Cambridge
Goodbourn, Stephen, B.A., Medical Research Council, Oxford, England
Lusis, Aldons J., Ph.D., University of California, Los Angeles
Magun, Bruce E., Ph.D., University of Arizona, Tucson
Oliver, Noelynn, B.A., Stanford University, California
Petko, Lawrence J., B.A., University of Chicago, Illinois
Riley, Sylvia C., B.S., University of Virginia, Charlottesville
Schopf, Thomas J.M., Ph.D., University of Chicago, Illinois
Sly, William S., M.D., Washington University, St. Louis, Missouri
Van Ommen, Gert-J an, Ph.D., University of Amsterdam, The Netherlands
Vezza, Anne C., Ph.D., Rockefeller University, New York, New York
SEMINARS
Bishop, M., University of California, San Francisco. Molecular biology of RNA tumor viruses.
Davis, R., Stanford University Medical School. Electron microscopy of DNA.
. Molecular biology of yeast.
McKnight, S., Carnegie Institution. Structure and function of eukaryotic promoters.
Roberts, R., Cold Spring Harbor Laboratory. Restriction enzymes, DNA sequencing and computer
analysis of sequence information.
Bender, W., Harvard Medical School. Molecular biology of Drosophila melanogaster.
Wig ler, M., Cold Spring Harbor Laboratory. DNA mediated gene transfer.
Seed, B., Harvard University. Gene isolation by recombination in E. coli.
Sambrook, J., Cold Spring Harbor Laboratory. DNA tumor viruses.
Di Maio, D., Harvard University. Directed mutagenesis.
Rubin, G., Harvard Medical School. Transposable elements in Drosophila.
Mulligan, R., Massachusetts Institute of Technology. Eukaryotic cloning and expression vectors.
Roberts, B., Harvard Medical School. Identification of specific cDNA clones by hybrid-
selection/translation procedures.
Grodzicker, T., Cold Spring Harbor Laboratory. Molecular biology of adenoviruses.
Mellon, P., Harvard University. Transient expression of cloned genes in cells in culture.
Efstratiadis, A., Harvard Medical School. Eukaryotic gene structure and evolution.
Engel, D., Northwestern University. Chicken globin genes.
Maniatis, T., Harvard University. Molecular genetics of human globin genes.
Ptashne, M., Harvard University. Expression of eukaryotic genes in bacteria.
Ausubel, F., Harvard University. Molecular biology of plants.
Hood, L., California Institute of Technology. Molecular basis of antibody diversity.
Capecchi, M., University of Utah. Microinjection of cloned DNA into cells in culture.
Advanced Bacterial Genetics, June 30-July 20
INSTRUCTORS
Berman, Michael, Ph.D., Frederick Cancer Research Center, Frederick,
Maryland
,...nquist, Lynn W., Ph.D., NCI, National Institutes of Health, Bethesda,
Maryland
IlhavY, Thomas, Ph.D., Frederick Cancer Research Center, Frederick,
Maryland
ASSISTANTS
Bear, Susan, Ph.D., National Institutes of Health, Bethesda, Maryland
mr, Scott, Ph.D., Frederick Cancer Research Center, Frederick, Maryland
Jackson, Dolores, B.S., Frederick Cancer Research Center,
Frederick, Maryland
Students performed a variety of genetic manipulations in the bacterium
E. coli using the insertion ele-
ment Tn O. Insertions which prevent utilization of maltose,
ribose, and galactose were isolated and
characterized genetically. In addition, insertions in a positive regulatory
gene required for expression of
the major outer membrane porin proteins were isolated. Insertions
near and in the structural genes for
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these porin proteins were isolated as well. Certain
Tn10 insertions were used as a selective marker to
perform localized mutagenesis of particular regions of the chromosome. From such experiments, a
number of deletion and point mutations were obtained.
The genetic analysis of porin regulation relied on the use of fusions
between these genes and the /ac
operon. The students isolated additional gene fusions
in vivo and in vitro. Using a defective Mu phage,
fusions between /acZ and various target genes were constructed in vivo. The students isolated
specialized transducing phages carrying different operon
fusions and then used in vitro recombination
to clone these fusions on a plasmid vector. In other experiments random DNA restriction enzyme
fragments were cloned into a plasmid vector allowing the isolation of gene fusion encoding hybrid
/3-galactosidase proteins. The students analyzed the plasmid clones for the extent of inserted DNA and
the relative levels of 0-galactosidase production.
Phage X vectors carrying DNA fragments encoding either the porin regulatory gene, ompR or proline
biosynthetic genes were used in mutagenesis experiments. Students isolated deletion and point muta-
tions in these genes and characterized them by genetic crosses and restriction enzyme analysis. These
phages were used to map genetically various chromosomal mutations obtained by the students.
Gene libraries of E. con and several other gram-negative bacteria were constructed using phage X.
Pools of these hybrid phages were screened for phages carrying porin regulatory genes and
0-galactosidase genes. Students identified and characterized such phages using complementation
selection, plaque hybridization, and restriction analysis.
PARTICIPANTS
Baird, David G., Ph.D., Agricultural Research Council, Newbury, England
Be las, M. Robert, B.A., University of Maryland, College Park
Downs, Karen M., M.S., University of Illinois, Chicago
Fahnestock, Stephen R., Ph.D., University of Wisconsin, Madison
Goff, Stephen A., B.A., Harvard Medical School, Cambridge, Massachusetts
Hoiseth, Susan K., B.A., Stanford University, California
Hollstein, Monica C., Ph.D., University of California, Berkeley
Hove -Jensen, Bjarne, Institute of Biological Chemistry, Copenhagen, Denmark
Jones, Robin M., M.S., University of Western Ontario, London, Canada
Lohman, Timothy M., Ph.D., University of Oregon, Eugene
Maloy, Stanley R., Ph.D., University of California, Irvine
Masker, Warren E., Ph.D., Oak Ridge National Laboratory, Tennessee
Reha-Krantz, Linda, Ph.D., University of Alberta, Edmonton, Canada
Schweizer, Herbert P., B.A., University of Konstanz, Federal Republic of Germany
Shurvinton, Claire E., B.S., University of Nottingham, England
Vaisanen, Eino, B.S., University of Helsinki, Finland
SEMINARS
Stahl, F., University of Oregon. Update on Chi, and E. coli recombinator.
Heffron, F., Cold Spring Harbor Laboratory. Transposable elements.
Gottesman, M., NCI, National Institutes of Health. The bacteriophage lambda: An overview.
Problems of gene regulation in bacteriophage lambda.
Davis, R., Stanford University School of Medicine. Expression of heterologous genes in E. coli.
Weinstock, G., Frederick Cancer Research Center. Application of new techniques to new problems in
bacterial genetics.
Botstein, D., Massachusetts Institute of Technology. Applying new technology to old problems in
bacterial genetics.
Roth, J., University of Utah. Why the chromosome is organized the way it is.
Ptashne, M., Harvard University. How the X repressor and Cro work.
Sternberg, N., Frederick Cancer Research Center. Dissection and analysis of components that
regulate the replication and partitioning of the stringent plasmid replicon P1.
Messing, J., University of Minnesota. DNA template selection by cloning.
Basic Neuroanatomical Methods, July 5-July 25
INSTRUCTORS
Jones, Edward G., M.D., Ph.D., Washington University Medical School, St. Louis, Missouri
Hand, Peter, D.V.M., Ph.D., University of Pennsylvania, Philadelphia
Pickel, Virginia M., Ph.D., Cornell University Medical College, New York, New York
ASSISTANTS
Wise, Steven P., Ph.D., National Institutes of Mental Health, Bethesda, Maryland
Hendry, Stewart H.C., B.A., Washington University, St. Louis, Missouri
McClure, Bertha, Washington University, St. Louis, Missouri
Hand, Carol, B.A., University of Pennsylvania, Philadelphia
This was primarily a laboratory course designed for research workers interested in learning basic and
advanced neuroanatomical techniques. Participants carried out an extensive set of laboratory exercises
involving most of the commonly used methods and there were lectures and discussions by the instruc-
tors and visiting speakers.
Classical methods covered included: perfusion fixation; embedding in different media; frozen, paraf-
fin, celloidin, and plastic sectioning; conventional cell staining methods; lesion making; silver im-
pregnation of normal and degenerating nerve fibers; brightfield, darkfield, and fluorescence
microscopy, photomicrography, and electron microscopy.
Newly developed methods included histochemical, radiochemical, and immunocytochemical
methods for tracing neuronal pathways in terms of axoplasmically transported
material,
neurotransmitter-related compounds, or metabolic activity.
PARTICIPANTS
Commins, Deborah L., B.A., University of California, Irvine
Denaro, Frank J., M.A., State University of New York, Stony Brook
Dodd, Jane, Ph.D., Harvard Medical School, Boston, Massachusetts
Eckmiller, Marion, University of Dusseldorf, Federal Republic of Germany
Fujita Shinobu C., Ph.D., California Institute of Technology, Pasadena
Manning, Donald C., B.S., Johns Hopkins University, Baltimore, Maryland
McKay, Ronald, Ph.D., Cold Spring Harbor Laboratory, New York
Millington, William R., Ph.D., Johns Hopkins University, Baltimore, Maryland
Sclar, Gary, M.S., University of California, Berkeley
Wirsig, Celest, B.A., University of Florida, Gainesville
SEMINARS
Hendrickson, A., University of Washington. Autoradiographic methods.
Swanson, L., Salk Institute. Flourescent dye tracers.
uello, C. University of Oxford. Monoclonal antibodies.
Peters, A., Boston University. The golgi-EM method.
Kelly, D., Princeton University. The initiated 2 D-G method.
La Vail, J., University of California, San Francisco. Retrograde axonal
transport.
Raviola, A., Harvard University. Freeze fracture-etch methods.
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Electrophysiological Methods,
July 21-August 10
INSTRUCTORS
Kehoe, Jac Sue, Ph.D., Ecole Norma
le Superieure, Paris, France
Chiarandini, Dante, M.D., New York
University, New York
Stefani, Enrique, M.D., Institute
Politecnico Nacional, Mexico City, Mexico
GUEST LECTURER
Kado, Ray, Ph.D., Centre National de la Recherche Scientifique, Gif-sur-Yvette, France
In this neurobiology course the
neuromuscular junction of the frog and the central ganglia
of th
e
e
mollusk Aplysia were used as experimental preparations for training students in basic el
trophysiological methods for cellular neurobiology. Examination of certain characteristics of thec-
resting, action and synaptic potentials of these two preparations served as a basis for introducing the
following techniques: microdissection, fabrication
of single and multibarreled capillary
micro
-
electrodes;
ro
l tr des; intracellular recording of membrane voltage changes (in so-called current clamp) and
brane currents (using a slow voltage clamp); intracellular and extracellular application of ions aend
drugs (by ionophoresis and pressure injections); and intracellular staining of Aplysia neurons.
The first 3 days of the course were devoted to lectures and exercises on electronics for cellul
ar
en-
neurobiologists given by Ray Kado. The last 2 days of the course were devoted to individual experimen-
tal projects chosen by the students. These projects permitted them to try techniques not taught in the
course and to use biological preparations that they intended to study when they returned to their ow
laboratories.
n
PARTICIPANTS
Chapron, Yves, D.Sc., CENG, Grenoble, France
Chesler, Mitchell, M.A., New York University, New York
Corman, Bruno J., Ph.D., Centre d'Etudes Nucleaires, Saclay, France
Davis, Robin L., M.A., Stanford University, California
Evans, Michael G., B.S., University of Bristol, England
Gurney, Alison M., B.S., University College London, England
Ignatius, Michael J., B.S., Stanford University, California
Penit, Jacqueline, College de France, Paris
Rubin, Leona J., University of Colorado, Boulder
Tublitz, Nathan, B.A., University of Washington, Seattle
McClintock Laboratory
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Introduction of Macromolecules into Mammalian Cells
July 22-August 10
INSTRUCTORS
Capecchi, Mario, Ph.D., University of Utah, Salt Lake City
Cooper, Geoffrey, Ph.D., Sidney Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts
ASSISTANTS
Lane, Mary Ann, Ph.D., Sidney Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts
Fraser, Laurie, B.S., University of Utah, Salt Lake City
This laboratory course focused on methods of introducing biologically active macromolecules into liv-
ing cells. Emphasis was placed on transferring DNA into cultured cells by transfection and by nuclear
injection using glass micropipettes. Laboratory exercises included (1) transfection of DNA containing
viral and cellular transforming genes; (2) microinjection and transfection of DNAs containing selectable
biochemical markers; and (3) introduction of proteins into cells by fusion with loaded red cell ghosts
and liposomes.
These exercises were supplemented with group discussions and lectures by invited speakers who con-
sidered the application of these methods to the isolation and functional characterization of structural
genes and their regulatory sequences, evaluation of in vitro mutagenesis, and analysis of the biological
activity of proteins and messenger RNAs.
PARTICIPANTS
Bond, Beverely J., B.A., California Institute of Technology, Pasadena
Caboche, Michel C., Ph.D., INRA, Versailles, France
Carbone, David P., B.A., Johns Hopkins University, Baltimore, Maryland
Chaudry, Furzana, B.S., Imperial Cancer Research Fund, London, England
Chin, Daniel J., Ph.D., University of Texas, Dallas
Crews, Stephen T., B.A., California of Technology, Pasadena
Dyson, Julian, B.S., Imperial Cancer Research Fund, London, England
Glanville, Niall F., Ph.D., Fred Hutchinson Cancer Center, Seattle, Washington
Heinrich, Guenther F., Ph.D., Institute for Immunology, Basel, Switzerland
Jackson, Marian J., M.S., Albert Einstein College, Bronx, New York
lames, Robert J., B.S., Washington University, Seattle
Katinka, Michael D., Ph.D., Pasteur Institute, Paris, France
Maresca, Antonella, Ph.D., NCI, National Institutes of Health, Bethesda, Maryland
Nowak, Barbara M.S., University of Erlangen, Federal Republic of Germany
Santangelo, George M., B.A., Yale University, New Haven, Connecticut
Wang, Yuan, Max-Planck-Institut fi.jr Biochemie, Munich, Federal Republic of Germany
SEMINARS
Cooper, G., Sidney Farber Cancer Institute. Analysis of cellular transforming genes by transfection.
Capecchi, M., University of Utah. DNA transfer by microinjection.
Kurtz, D., Cold Spring Harbor Laboratory. Hormonal control of gene expression.
o nick, E.M., NCI, National Institutes of Health. Biogical activities of SFFV DNA.
Van de Woude, G., NCI, National Institutes of Health. Cellular mechanisms associated with the ex-
pression of the transforming phenotype of transfected DNA.
Weinberg, R., Massachusetts Institute of Technology. Transforming sequences and proteins of
Wigler, tumors.igler, M., Cold Spring Harbor Laboratory. DNA mediated gene transfer as a genetic tool.
McBride,
uddle, F. Yale University. Gene transfer by chromosomes, DNA, and microinjection.
Stacey,
W.W., National Institutes of Health. Chromosome-mediated gene transfer.
S_acey, D., Roche Institute. Biological activities of injected retroviral DNA molecules.
Crodzicker, T., Cold Spring Harbor LabOratory. Introduction of foreign genes into
mammalian cells
using adenovirus vectors.
eramisco, J., Cold Spring Harbor Laboratory. Microinjection of antibodies in living cells.
Hager, G., National Cancer Institute. Hormone-responsive regulatory sequences of mouse mammary
tumor virus DNA.
Livingston, D., Sidney Farber Cancer Institute. Biological activities of SV40 T antigens.
Mulligan, R., Massachusetts Institute of Technology. Animal cell cloning vehicles.
Fraley, R., Monsanto Company. Liposome-mediated DNA transfer.
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Yeast Genetics, July 22-August 10
INSTRUCTORS
Fink, Gerald, Ph.D., Cornell University, Ithaca, New York
Sherman, Fred, Ph.D., University of Rochester, New York
Hicks, James, Ph.D., Cold Spring Harbor Laboratory, New York
ASSISTANT
Kosiba, Bradley, University of Rochester, New York
This program emphasized the major techniques used in molecular biology and genetic analysis of
yeast, including the following: the isolation and characterization of chromosomal and mitochondrial
mutants; tetrad analysis; chromosomal assignment of unknown numbers; mitotic recombination; allelic
and complementation tests; and analysis of heterothallic and homothallic characters. Recombinant
DNA techniques including yeast transformation, filter hybridization, and gel electrophoresis were ap-
plied to cloning and genetic analysis of yeast DNA.
PARTICIPANTS
Arai, Naoko, Ph.D., University of Tokyo, Japan
Ballario, Paola, B.S., University of Rome, Italy
Engler, Michael J., Ph.D., Harvard Medical School, Boston, Massachusetts
Gonzalez, Alicia M., M.S., Universidad Nacional, Mexico City, Mexico
Gupta, Naba K., Ph.D., University of Nebraska, Lincoln
Hieter, Philip A., B.A., National Institutes of Health, Bethesda, Maryland
Hsu, Yun-Pung, Ph.D., Purdue University, West Lafayette, Indiana
Lindquist, Susan L., Ph.D., University of Chicago, Illinois
Locht, Camille, M.S., Catholic University of Louvain, Belgium
Proffitt, John H., B.S., Oregon State University, Cornvallis
Pulitzer, John F., Ph.D., International Institute of Genetics, Naples, Italy
Sadowski, Paul D., Ph.D., University of Toronto, Ontario, Canada
Schmeissner, Ursula M., Ph.D., NCI, National Institutes of Health, Bethesda, Maryland
Stahl, Franklin W., Ph.D., University of Oregon, Eugene
Waxman, Lloyd H., Ph.D., Harvard Medical School, Boston, Massachusetts
Yocum, Rogers, Ph.D., Harvard University, Cambridge, Massachusetts
SEMINARS
Dutcher, S.K., Rockefeller University, Pleiotrophic effects of cell-division cycle mutants.
Broach, J., State University of New York, Stony Brook. The yeast plasmid Scp1.
Petes, T.D., University of Chicago. Structure and replication of yeast DNA
. Genetic analysis of repeated genes.
Warner, J., Albert Einstein College of Medicine. Coordinate expression of ribosomal genes.
McLaughlin, C.S., University of California, Irvine. Protein synthesis.
Hicks, J., Cold Spring Harbor Laboratory. Regulation of mating types.
Thorner, J.W., University of California, Berkeley. Control of conjugation by pheromones.
Mortimer, R.K., University of California, Berkeley. Genetic mapping.
Fink, G.R., Cornell University. Transposable elements.
Homison, G., Columbia University Medical School. Nuclear genes controlling mitochondrial geneexpression.
Hereford, L.M., Brandeis University. Regulation of histone synthesis.
Rosbash, M., Brandeis University. Organization, expression, and splicing of ribosomal protein genes.
Sherman, F., University of Rochester. Controlling regions of the cytochrome c genes.
Esposito, R.E., University of Chicago. Meiosis and ascospore formation.
Szostak, J.W., Sidney Farber Cancer Institute. Telomeres, damaged-induced genes, and mitotic
recombination.
Saunders, C., Oregon State University. Chromatin structure in active and inactive genes.
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UNDERGRADUATE
SUMMER RESEARCH
PROGRAM
An important aspect of the summer program at the Laboratory
is the participation of college undergraduate students in active
research projects under the supervision of full-time laboratory
staff members. The program was initiated in 1959. Since that
year, 230 students have completed the course, and many have
gone on to creative careers in biological sciences.
The objectives of the program are to provide (1) a greater
understanding of the fundamental principals of biology, (2) an
increased awareness of major problem areas under investiga-
tion, (3) better understanding of the physical and intellectual
tools for modern research and the pertinence of this informa-
tion to future training, and (4) a personal acquaintance with
research, research workers, and centers for study.
The following students, selected from a large number of ap-
plicants, took part in the program, which was supported by The
Camille and Henry Dreyfus Foundation, Inc. They are listed
below with their laboratory sponsors and topics of research.
Kristen M. Clarke, University of Pennsylvania
Research Advisor: R. Roberts
Lindsey Ann Criswell, University of California,
Berkeley
Research Advisor: B. Stillman
Lisa Haas, University of California, Berkeley
Research Advisor: J. Hicks
Jonathan Miller, Yale University
Research Advisor: J. Stringer
Nancy Mills, Harvard University
Research Advisor: D. Zipser
Roger Mosesson, Columbia College
Research Advisor: R. Harshey
Craig Okada, University of Utah
Research Advisor: F. Heffron
Ron Sapolsky, University of Rochester
Research Advisor: J. Smart
Eric S. Schulze, University of California,
Berkeley
Research Advisor: S. Blose
Nick Theodorakis, Washington University
Research Advisor: S. Hughes
Olney Fellow
Mirjana Nesin, University of Belgrade
Research Advisor: M. Wig ler
M13 as a chimeric protein cloning system.
Characterization of temperature-sensitive
mutants of adenovirus 2.
Mapping of cloned pieces of yeast which
complement mutations in positve and negative
regulatory elements for the unexpressed mating
type loci.
Viral RNA levels in rat cells transformed by an
SV40 T-antigen mutant.
The promoter region of the herpes virus
thymidine kinase gene.
Construction of mini-Mu plasmid vectors that
can be used for cloning.
I. cis inhibition of transposition.
II. Construction of a plasmid to
study deletions
associated with transposons.
Tryptic peptide mapping and sequencing
analysis of proteins from adenovirus
serotype 2
early regions.
The midbody-A functional and
molecular
perspective.
Sequencing the chicken 13 -actin gene.
Searching for human and murine transposons.
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IN-HOUSE SEMINARS
Cold Spring Harbor In-House Seminars were
initiated to provide a semiformal avenue for communica-
tion between the various research groups at the
laboratory. They are particularly useful for research
personnel who have joined the laboratory during the summer. The seminars also afford a necessary op-
portunity for the graduate students and post-graduate staff
to develop their skills in defending, organiz-
ing, and presenting their research. In addition
to those listed below, seminars were given by many
others involved in research at this laboratory.
1980-1981
November
Steve Dellaporta, Worcester Polytechnic Institute, Massachusetts: Direct transformation of plant
protoplasts with Ti DNA.
Susumu Tonegawa, Basel Institute for Immunology, Switzerland: Isolation of the "D" region of an
immunoglobin gene.
December
Hal Weintraub, Hutchinson Cancer Center, Seattle, Washington: Regulation and chromatin structure
of hemoglobin genes during development.
Russell Malmberg, Michigan State University, Lansing: Biochemical, cellular, and developmental
characterization of tobacco mutants that alter polyamine metabolism.
James Shapiro, University of Chicago, Illinois: The role of cointegrate resolution in the mobilization
of unique DNA by transposable elements.
January
David Helfman, Emory University School of Medicine, Atlanta, Georgia: Cyclic CMP
phosphodiesterase: Occurence, biological involvement, purification and characterization.
Nick Cowan, Princeton University, New Jersey: The structure of human tubulin genes.
Richard Young, Swiss Institute for Experimental Cancer Research, Lausanne: A single mouse amylase
gene specifies two different tissue specific mRNAs.
February
Alice Fulton, Massachusetts Institute of Technology, Cambridge: The cytoskeletal network -
Developmental reorganization and assembly in vitro and in vivo.
K. Mizuuchi, National Institutes of Health, Bethesda, Maryland: Integration in vitro.
James Broach, State University of New York, Stony Brook: Replication and recombination of the
yeast 2p. plasm id.
C.J. Bostock, Medical Research Council Laboratories, University of Edinburgh, Scotland: Gene
amplification in methotrexate resistant cells.
Winship Herr, Harvard University, Cambridge, Massachusetts: Probing for recombinant RNA tumor
viruses in leukemic AKR mice.
March
Hugh Pelham, Carnegie Institution, Baltimore, Maryland: Control of 5S RNA synthesis.
Sara Lavi, Weizmann Institute, Rehovet, Israel: Carcinogen mediated amplification of specific DNA
sequence in Chinese hamster cells.
Francis Galibert, L'Hopital Saint-Louis, Paris, France: Comparison of the nucleotide sequence of the
genome of the human hepatitis B virus and the woodchuck virus.
James Haber, Brandeis University, Waltham, Massachusetts: Mechanism of yeast mating type genestransposition.
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S. Rosenblatt, Weizmann Institute, Rehovet, Israel: Molecular biology of measles.
Bill Hayward, Rockefeller University, New York: ALV induced lymphoid leukosis -Activation of acellular one gene by promoter instertion.
Walter Doerfler, University of Cologne, Germany: Integration expression, and methylation of viralDNA in adenovirus type 2 and type 12 transformed and tumor cells.
Merilyn Sleigh, CSIRO, Sidney, Australia: The influenza virus haemagglutinin gene-Cloning, se-quencing, and evolution.
April
Olof Sundin, Massachusetts Institute of Technology, Cambridge: Segregation leads to accumulation
of catenated dimers- Dissection of the final stages of SV40 replication.
Alex Goldfarb, Max-Planck Institute, Munich, Federal Republic of Germany: Modulation of RNA
polymerase activity by bacteriophage T4-induced modification of the alpha subunit.
Walter Keller, University of Heidelberg, Germany: Transcription and processing of adenoviral RNA
with extracts from He La cells.
Werner Gobel, University of Wurzburg, Federal Republic of Germany: Hemolysin production by
pathogenic E. coli.
May
Mark Van Montagu, Rijks University, Gent, Belgium: A little something about Agrobacterium.
June
Elizabeth Taparowski, Brown University, Providence, Rhode Island: Evolution of bovine satellite se-
quences.
Mike Krangel, Harvard Biological Laboratories, Cambridge, Massachusetts: Biosynthesis of
histocompatibility antigens in normal and mutant cell lines.
July
Rolf Kemler, Pasteur Institute, Paris, France: Teratocarcinoma differentiation and the cytoskeleton.
August
David White, University of Melbourne, Australia: Antigenic determinants of influenza virus haemag-
glutinin recognized by Th, Ts, Td and B lymphocytes.
Walter Schaffner, University of Zurich, Switzerland: Expression of a genomic rabbit beta-globin gene
is enhanced by a small segment of SV40 or polyoma DNA.
Karin Esami, University of Western Ontario, Canada: Aspect of the biogenesis of vaccinia virus.
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NATURE STUDY PROGRAM
The Nature Study Program gives elementary and high school students the opportunity to acquire a
greater understanding of their environment. Through a series of specialized field courses, students can
engage in such introductory programs as Nature Detective, Seashore Life, and Pebble Pups, as well as
more advanced programs such as Marine Biology and Nature Photography.
During the summer a total of 412 students participated in the Nature Study Program. Most classes
were held outdoors, when weather permitted, or at the Uplands Farm Nature Preserve of the Long
Island Chapter of the Nature Conservancy. The Laboratory has equipped and maintains a darkroom and
classroom-laboratories at Uplands Farm for the study of field specimens collected by the students.
In addition to the four-week courses, a series of one-day marine biology workshops was offered to
students, with a special workshop for adults. Studies on the marine ecology of Long Island Sound were
conducted aboard the 66-foot schooner J.N. Carter chartered from Schooner, Inc. of New Haven,
Connecticut. This vessel is equipped with the instrumentation necessary to study the Sound chemically,
physically, and biologically. Students participated in these studies and in the actual sailing of the
vessel.
PROGRAM DIRECTOR
Edward Tronolone, M.S., P.D., Science Curriculum Associate, East Williston Public Schools.
INSTRUCTORS
Rose Becker, M.S., Museum of Long Island Natural Sciences, State University of New York, Stony
Brook
Kathryn Bott, M.S., Science teacher, Friends Academy
Gail Claydon, B.S., teacher, United Methodist Church of Huntington-Cold Spring Harbor
Robert Jaeger, M.S., science teacher, Mineola High School
Katherine Jindra, M.S., naturalist, Nassau County BOCES
Fred Maasch, M.Ed., biology teacher, Islip High School
James Romansky, M.S., biology teacher, Bay Shore High School
Bernadette Voras, M.S., science teacher, Shoreham-Wading River High School
COURSES
Nature Bugs
Nature Detectives
Advanced Nature Study
Pebble Pups
Rock Hounds
They Swim, Crawl, and Walk
Marine Biology
Nature Photography I & II
Fresh Water Life
Adventure Education
Marine Biology Workshop
Bird Study
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LABORATORY STAFF
DIRECTOR
J. D. Watson
ADMINISTRATIVE
DIRECTOR
William R. Udry
RESEARCH SCIENTISTS
Guenter Albrecht-Beuhler
Stephen Blose
Thomas Broker
Ahmad Bukhari
Louise Chow
Jeffrey Engler
James Feramisco
John Fiddes
James Carrels
Thomas Gingeras
Yakov Gluzman
Terri Grodzicker
Rasika Harshey
Fred Heffron
James Hicks
Susan Hockfield
Stephen Hughes
Amar Klar
David Kurtz
Jim Lin
Michael Mathews
Ronald McKay
Manuel Perucho
Richard Roberts
Lee Silver
Magdalene So
Bruce Stillman
Jeffrey Strathern
James Stringer
Fuyuhiko Tamanoi
William Topp
Michael Wig ler
Birgit Zipser
David Zipser
VISITING
SCIENTSTS
Nancy Hogg
Jorgen Johansen
Yoshiki Katoh
Pei -Mao Lin
Michele Manos
Mara Rossini
Staff as of December 1981
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ASSISTANT DIRECTOR
FOR RESEARCH
Joseph Sambrook
POSTDOCTORAL FELLOWS
Judith Abraham
Bruce Anderson
Marilyn Anderson
Frederick Asselbergs
Janet Brandsma
Joan Brooks
Stephen Dellaporta
Hans Engeser
Michele Francoeur
Greg Freyer
Richard Frisque
Mitchell Goldfarb
Marie Goradia
Richard Guilfoyle
Mary Harper
David Helfman
Margaret Hightower
John Ivy
Tohru Kamata
Thomas Kost
Deborah Kwoh
Theodore Kwoh
Chao-Hung Lee
Saundra Lemaster
John Lewis
Russell Malmberg
Fumio Matsumura
Catherine Monaghan
Kim Nasmyth
Kenji Shimizu
Joseph Sorge
Olof Sundin
G. Paul Thomas
Nikos Vamvakopoulos
William Welch
Stuart Weisbrod
Masao Yamada
Clifford Yen
GRADUATE
STUDENTS
Jayne Danska
Douglas Hanahan
Richard Kostricken
Daniel Levy
Zarina Manzoor
Pamela Rosman
Nora Sarvetnick
Kevin Van Doren
DIRECTOR
BANBURY CENTER
Victor McElheny
RESEARCH ASSISTANTS
Barbara Ahrens
Georgia Binns
William Boorstein
Ann Bushnell
Michael Cahn
Angela Ca lasso
Lynn Cascio
Terrance Chisum
Elizabeth Chow
Elizabeth Cilibrasi
Mary Costa
Patricia Creatura
Susan Danheiser
Jane Emanuele
Deborah Foster
Cecilia Fraser
Laurel Garbarini
Ronni Greene
Catherine Grzywacz
Nancy Haffner
Marie Hallaran
Mark Hoppe
Stephen Humenick
Lynn Kleina
Elaine Kosik
Concepcion Lama
Jessica Leibold
Geraldine LoFranco
Lois McCullough
Carolyn McGill
Robert McGuirk
Jean Mclndoo
Barbara McLaughlin
Donna Meltzer
Karen Messina
Natania Mlawer
Carolyn Moomaw
Ann Mutschler
Phyllis Myers
Diana O'Loane
Kathy O'Neill
Barbara Parsons
Gina Penzi
Doris Prudente
Mary Ramundo
Patricia Reichel
William Ricci
Patricia Rice
Michael Riggs
Linda Rodgers
Jan Scal
Carol Schley
Diane Smith
Lynn Smith
Jane Uman
Linda Van der Wal
Bruce Vogel
Elizabeth Waldvogel
Margaret Wallace
Jeanne Wiggins
Mary Wong
Jonathan Wood
Elizabeth Woodruff
ADMINISTRATIVE
AND GENERAL STAFF
Charlaine Apsel
Deon Baker
Guy Cozza
Johanna Di Giovanni
Jeffrey Drum
Douglas Gensel
Patrick Hickey
Eric Kaufman
William Keen
Stephen Kron
Patricia Kurfess
John Maroney
Carlos Mendez
Joyce Noe
Susan Ostrowski
Florence Otto
James Sabin
Roberta Salant
Susan Schultz
Martin Spiegel
Jacqueline Terrence
GENETICS RESEARCH UNIT
CARNEGIE INSTITUTION
OF WASHINGTON
Alfred D. Hershey
Barbara McClintock
SUPPORTING STAFF BUILDINGS AND
GROUNDS DEPARTMENT
Patricia Barkley
Maureen Berejka
Gladys Blose
Robert Borruso
Louisa Dalessandro
Nancy D'Anna
August Dulis
Steven Eagels
Marilyn Goodwin
Gladys Kist
Eric Lockhart
Deborah Lukralle
Madlyn Nathanson
Michael Ockler
Herb Parsons
Philip Renna
Marlene Rubino
Andrea Stephenson
Madeline Szadkowski
Barbara Ward
PUBLICATIONS
DEPARTMENT
Dorothy Brown
Michaela Cooney
Judith Cuddihy
Nadine Dumser
Nancy Ford
Annette Kirk
Joan McPartlin
Douglas Owen
Elizabeth Ritcey
LIBRARY STAFF/
MARKETING
Carol Aznakian
Ellen DeWeerdt
Genemary Falvey
Susan Gensel
Amy Gibson
David Gibson
Karen Herrmann
Laura Hyman
Colleen Lanahan
Audrey Powers
Regina Schwarz
John Bach
Joseph Brodawchuk
Carol Caldarelli
Vincent Carey
Ronald Chambers
Barbara Cuff
Peter Dunn
Warren Eddy
Joseph Ellis
Bruce Fahlbusch
Willie Hall
Douglas Haskett
Mary Hill
Lance LaBella
Thomas Lyden
Charles Marshall
Justin McAvoy
Cristopher McEvoy
John Meyer
Frank Mullady
Alfred Nickel
Alfred Pfeiffer
Joseph Pirnak
Gerard Reichert
Jack Richards
Diamond Scarduzio
Charles Schneider
Lane Smith
Peter Stahl
Owen Stewart
Patrick Sullivan
Hans Trede
Dorothy Youngs
BANBURY CENTER
Christine Dacier
Katya Davey
Margaret McEvoy
Lynda Moran
Beatrice Toliver
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N FINANCIAL STATEMENT
BALANCE SHEET
year ended December 31, 1981
with comparative figures for year ended December 31, 1980
ASSETS
CURRENT FUNDS
Unrestricted
1981 1980
Cash and Short-term investments $ 1,062,039 1,343,002
Accounts Receivable 267,888 440,985
Prepaid expenses and other assets 349,506 82,112
Inventory of books 131,461 90,188
Due from Banbury Center 146,373 128,785
Total unrestricted 1,957,267 2,085,072
Restricted
Grants and contracts receivable 2,845,237 2,540,887
Due from unrestricted fund 110,702 221,538
Total restricted 2,955,939 2,762,425
Total current funds $ 4,913,206 4,847,497
ENDOWMENT FUNDS
Robertson Research Fund
Cash 395,840 (24,084)
Marketable securities
(quoted market 1981 -$11,111,405;
1980-$10,798,472) 10,507,785 9,016,253
Total Robertson Research Fund 10,903,625 8,992,169
LIABILITIES AND FUND BALANCES
CURRENT FUNDS
Unrestricted
1981 1980
Accounts payable $ 438,074 327,289
Mortgage payable 66,600 133,200
Due to plant fund 30,850 808,714
Due to restricted fund 110,702 221,538
Fund balance 1,311,041 594,331
Total unrestricted 1,957,267 2,085,072
Restricted
Fund balance 2,955,939 2,762,425
Total restricted 2,955,939 2,762,425
Total current funds $ 4,913,206 4,847,497
Olney Memorial Fund
Cash
Marketable Securities
(quoted market 1981 - $20,355;
90 517
1980-$19,341) 27,538 27,538
Total Olney Memorial Fund 27,628 28,055
Total endowment funds $ 10,931,253 9,020,224 Fund balance $10,931,253 9,020,224
PLANT FUNDS PLANT FUNDS
Investments 517,021 245,665
Due from unrestricted fund 30,850 808,714
Land and improvements 966,110 966,110
Buildings 6,513,210 6,006,958
Furniture, fixtures and equipment 1,408,503 1,255,429
Books and periodicals 365,630 365,630
Construction in progress 585,779 371,787
10,387,103 10,020,293
Less allowance for depreciation Fund balance $ 7,521,682 7,632,288
and amortization 2,865,421 2,388,005
Total plant funds 7,521,682 7,632,288
BANBURY CENTER BANBURY CENTER
Current funds Current funds
Unrestricted Unrestricted
Cash $ 700 600 Accounts payable $ 85,406 57,733
Accounts receivable 8,101 26,293 Due to CSHL unrestricted fund 146,373 128,785
Inventory of books 47,419 Fund balance (133,245) (159,625)
Due from Banbury restricted fund 42,314 Total unrestricted 98,354 26,893
Total unrestricted 98,354 26,893 Restricted
Due to Banbury unrestricted 42,314
Restricted Fund balance 71,126
Grants and contracts receivable 113,440 Total restricted 113,440
Total restricted 113,440 Total current funds 211,974 26,893
Total current funds 211,974 26,893
Endowment Funds Endowment funds
Robertson Maintenance Fund
Cash 21,660 (16,314)
Marketable securities
(quoted market 1981 -
$1,937,629; 1980-$1,895,985) 1,882,356 1,630,397
Total endowment funds 1,904,016 1,614,083 Endowment funds balance 1,904,016 1,614,083
N...) Plant fundsLn4, Land 772,500 772,500
Plant funds
Buildings 792,757 412,672
Furniture, fixtures and equipment 176,285 176,285
Construction in progress 1,386 368,149
1,742,928 1,729,606
Less allowance for depreciation 221,356 173,596
Total plant funds 1,521,572 1,556,010 Plant funds balance 1,521,572 1,556,010
Total Banbury Center $ 3,637,562 3,196,986 Total Banbury Center $ 3,637,562 3,196,986
Total-All funds $ 27,003,703 24,696,995 Total-All funds $ 27,003,703 24,696,995
CURRENT REVENUES, EXPENSES AND TRANSFERS
year ended December 31, 1981
with comparative figures for year ended December 31, 1980
COLD SPRING HARBOR LABORATORY
1981 1980
BANBURY CENTER
REVENUES
1981 1980
REVENUES Endowment income $ 90,000 80,000
Grants and contracts $ 5,691,966 4,066,773 Grants & contributions 277,003 87,800
Indirect cost allowances on grants and Rooms and apartments 40,196 23,027
contracts 2,402,569 1,910,098 Publications 139,455 176,575
Contributions Transfer from Cold
Unrestricted 51,273 74,334 Spring Harbor Laboratory 60,264 378,345
Restricted and capital
Long Island Biological Association
33,367
-
40,587
120,000 Total revenues 606,918 745,747
Robertson Research Fund Distribution 412,000 375,000
Summer programs 363,967 287,634 EXPENSES
Laboratory rental 20,732 20,732 Conferences 118,715 49,182
Marina rental 48,401 43,370 Publications 182,079 204,210
Investment income 266,752 181,050 Operation and maintenance of plant 109,199 99,564
Publications sales 838,687 896,245 Program administration 183,610 152,708
Dining hall 387,436 327,328 Depreciation 48,537 43,200
Rooms and apartments 235,798 215,686 Capital plant 13,315 330,500
Other sources 26,211 97 Total expenditures 655,455 879,364
Total revenues $10,779,148 8,558,934 Excess (deficit) of
revenues over expenses (48,537) (133,617)
EXPENSES
Research* 4,616,825 3,782,095
Summer programs* 747,519 631,402
Library 182,990 153,052
Operation and maintenance of plant 1,378,817 1,137,772
General and administrative 1,100,037 910,581
Depreciation 475,136 430,800
Publications sales* 655,911 656,142
Dining hall* 425,887 406,292
Total expenses $ 9,583,122 8,108,136
K., TRANSFERSLP
cr, Capital building projects 1,115,471 875,673
Banbury Center 60,264 378,345
Total transfers 1,175,735 1,254,018
Total expenses and transfers 10,758,857 9,362,154
Excess (deficit) of revenues
over expenses and transfers $ 20,291 (803,220)* *
*Reported exclusive of an allocation for operation and maintenance of plant,
general and administrative, library, and depreciation expenses.
* *1980 deficit primarily caused by conversion of current funds to plant funds for
capital building projects.
Note: Copies of our complete, audited financial statements, certified by our independent auditors, Peat, Marwick, Mitchell & Co., are available upon re-
quest from the Comptroller, Cold Spring Harbor Laboratory.
COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
Year End December, 31, 1981
Federal Grants and Contracts
66.5%
Endowments
4.4% Auxiliary Activities18.3%
Non-Federal Grants Private Contributions
7.4% .8%
Interest and Miscellaneous
2.6%
GRANTS
January 1-December 31, 1981
NEW GRANTS
COLD SPRING HARBOR LABORATORY
Grantor
Principal Investigator
and Program Total Award
Duration
of Grant
National Institutes of Health Dr. Watson-Gene Organization $5,626,997 4/1/81-3/31/86
Program Project
Dr. Watson-1981 Cell 36,350 8/15/81-8/14/82
Proliferation
Meeting
Dr. Watson-1981 & 1983 C.
elegans Meeting
57,750 4/1/81'-3/31/84
Dr. Watson-General Research 104,513 4/1/81-3/31/82
Support
Dr. Watson-1981 Mitrochon-
drial Genes
3,000 4/1/81-3/31/82
Meeting
Dr. Albrecht-Buehler-Research 525,529 5/1/81-4/30/84
Dr. Blose-Research 326,982 12/1/81-11/30/84
Dr. Hicks-Research 1,196,529 7/1/81-6/30/86
Dr. Ivy-Fellowship 38,776 1/27/82-1/26/84
Dr. Klar-Research 876,786 7/1/81-6/30/86
Dr. Lemaster-Fellowship 34,681 6/1/81-2/15/83
Dr. McKay-Research 288,546 7/1/81-6/30/84
Dr. Roberts-1981 Nucleases 10,000
Meeting
Dr. Sorge-Fellowship 63,744 6/1/81-5/31/84
Dr. Welch-Fellowship 57,156 9/14/82-9/13/85
Dr. B. Zipser-Research 299,219 12/1/81-11/30/84
National Science Foundation Dr. Heffron-Research 147,000 2/15/81-1/31/83
Dr. Hicks-Research 99,600 5/15/81-4/30/84
Dr. Strathern- Equipment 64,845 5/15/81-4/30/82
Dr. D. Zipser-Research 100,000 1 /1 /81 -12/31 /82
1981 Mitrochondrial Genes 7,500 2/15/81-7/31/81
Meeting
-Dr. Watson
1981 Muscle Meeting 5,000 7/1/81-12/31/81
-Dr. Watson
1981 Nucleases Meeting 5,000 8/1/81-1/31/82
-Dr. Roberts
Asian Molecular Biology Dr. Watson-travel funds 1,000
Biology Organization
American Cancer Society Dr. Rossini-Research
Dr. Topp-Research
1981 Cell Meeting
42,106
15,000
3,938
9/1/80-12/31/81
2/1/81-1/31/82
9/1/81-9/30/81
Rita Allen Foundation Dr. Hockfield-Research 30,000
7/1/81-6/30/82
Abbott Laboratories 1982 In Vitro Mutagenesis
Meeting 500
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NEW GRANTS
COLD SPRING HARBOR LABORATORY
Grantor
Principal Investigator
and Program Total Award
Duration
of Grant
Applied Molecular Genetics,
Inc.
1982 In Vitro Mutagenesis
Meeting
1,000
Bethesda Research Laboratory 1981 Nucleases Meeting1981 Cell Meeting
3,000
1,000
Boehringer Manheim 1981 Cell Meeting 300
Biochemicals
Central General Hospital Research 2,500
Cetus Corporation 1981 Cell Meeting 1,0001981 Molecular Biology of 1,000
Yeast Meeting
1982 In Vitro Mutagenesis 1,000
Meeting
Chevron Chemical Co. 1981 Plant Course 5,000
Collaborative Research Corp. 1981 Cell Meeting 1,000
The Camille and Henry
Dreyfus Foundation
Dr. D. Zipser-1982 Under-
graduate Research Participation
20,000 1/1/82-12/31/82
Department of Energy 1981 Symposium Support 9,000 5/1/81-4/30/82
Enzo Biochem, Inc. 1981 Nucleases Meeting 500
Foundation for Microbiology 1982 Phycomyces Meeting 5,000
Johnson and Johnson 1981 Cell Meeting 750
K.C. Biological, Inc. 1981 Cell Meeting 1,000
Esther A. and Joseph
Klingenstein Fund
1981 Mammalian Brain Slice
and Single Channel Recording
29,500
Workshop
1982 Advanced Neuro-Anatomical 45,000
Course and Single-Channel
Recording Workshop
Leukemia Society of Dr. Engler-Fellowship 37,000 7/1/81-6/30/83
America, Inc.
Litton Bionetics, Inc. 1981 Muscle Meeting 5,000
Merck & Co. 1981 Muscle Meeting 1,500
1982 In Vitro Mutagenesis 1,000
Meeting
Dr. So-Research 5,000
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NEW GRANTS
COLD SPRING HARBOR LABORATORY
Grantor
Muscular Dystrophy
Association
Principal Investigator
and Program
1981 Muscle Meeting
Dr. Blose-Research
Dr. Carrels- Research
Dr. Lin-Research
Dr. Matsumura-Fellowship
Dr. Welch-Fellowship
Dr. B. Zipser-Synapse and
Single-Channel Recording
Workshop Support
Total Award
15,000
16,242
20,000
29,750
36,000
32,000
12,000
Duration
of Grant
1/1/81-12/31/81
1/1/81-12/31/81
1/1/81-12/31/81
1 /1 /81 -12/31 /82
1/1/81-12/31/82
New England Biolabs, Inc. 1981 In Vitro Mutagenesis 2,000
Meeting
1981 Nucleases Meeting 5,000
New England Nuclear 1981 Nucleases Meeting 250
1981 In Vitro Mutagenesis 100
Meeting
Pabst Brewing Co. 1981 Nucleases Meeting 1,000
Schleicher & Schuell, Inc. 1981 In Vitro Mutagenesis 100
Meeting
Upjohn Company 1981 Molecular Biology of 500
Yeast Meeting
Damon Runyon-Walter Dr. Abraham-Fellowship 17,000 8/1/81-7/31/82
Winchell Cancer Fund Dr. Brandsma-Fellowship 17,000 9/1/81-8/31/82
Yamasa Shoyo Co., Ltd. Dr. Katoh-Research 33,000 10/1/81-9/30/83
BANBURY CENTER
Duration
Grantor Program Total Award
of Grant
National Institutes of Health 1981 Gene Amplification $31,120
9/1/81-8/31/82
Conference
1982 Nitrosamines Conference 32,320
9/30/81-8/31/82
Environmental Protection
Agency
1981 Meeting on Response of
the Developing Organism to
50,000 9/1/81-8/31/82
Environmental Risks
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CONTINUING GRANTS
COLD SPRING HARBOR LABORATORY
Grantor
Principal Investigator
and Program Total Award
Duration
of Grant
National Institutes of Health Dr. Watson-General Research
Support
$ 64,418 4/1 /80 -3/31 /81
Dr. Watson-Summer 470,340 4/1 /77-3/31/82
Workshops
Dr. Watson-Symposium 187,433 4/1 /79-3/31/84
Support
Dr. Watson-Herpes Virus 42,280 7/1/80-6/30/81
Meeting
Dr. Watson- Neurobiology 258,500 6/1 /79 -3/31 /82
Course Support
Mr. Udry-Cancer Research 1,411,011 9/1 5/77- indefinite
Facility
Dr. Blose- Research 167,702 12/1/78-11/30/81
Dr. Bukhari-Genetics Program 1,661,439 6/1/80-5/31/83
Project
Dr. Burridge- Research 131,039 4/1/80-3/31/81
Dr. Chaconas-Fellowship 13,215 8/1/79-4/22/81
Dr. Feramisco-Research 214,758 7/1/80-6/30/83
Dr. Garrels-Research 323,073 4/1 /79 -3/31 /82
Dr. Gingeras/Roberts-Research 408,085 3/1/80-2/28/83
Dr. Hicks-Advanced Bacterial 97,081 4/1 /80 -3/31 /83
Genetics Course
Dr. Hicks-Research 384,703 7/1/78-6/30/81
Dr. Klar-Research 253,000 7/1/78-6/30/81
Dr. Kurtz-Research 179,542 4/1 /80 -3/31 /83
Dr. Mathews-Research 266,570 4/1 /80 -3/31 /83
Dr. Sambrook-Cancer Research 13,500,000 1/1/77-12/31/81
Center
Dr. So- Research 124,370 9/1 /80 -8/31 /82
Dr. Stringer-Fellowship 15,690 2/1 /79 -1 /31 /81
Dr. Topp-Research 275,806 1/1/79-12/31/81
Dr. Topp-Research 303,452 8/1/80-6/30/83
Dr. D. Zipser-Fellowship 852,578 7/1/78-6/30/83
Training
National Science Foundation Dr. Bukhari-Research 330,000 6/1 5/79-5/30/82
Dr. Garrels-Research 140,000 9/1 /80 -8/31 /82
Dr. Roberts- Research 345,000 8/1 5/80-7/31/83
Dr. Roberts-Research 210,000 12/15/79-11/30/82
Dr. B. Zipser-Neurobiology 60,000 7/1/79-12/31/82
Course Support
Dr. B. Zipser-Research 120,000 11/1/78-10/31/81
Dr. D. Zipser-Research 136,000 2/1 5/78-1/31/81
Dr. D. Zipser-Research 157,000 5/1 5/80-4/30/83
Cystic Fibrosis Dr. Carrels-Research 87,230 7/1/80-6/30/82
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CONTINUING GRANTS
COLD SPRING HARBOR LABORATORY
Grantor
Grass Foundation
Esther A. and Joseph
Klingenstein Fund
New England Biolabs, Inc.
Alfred P. Sloan Foundation
Principal Investigator
and Program
Dr. B. Zipser-Neurobiology
Scholarship
Dr. Watson-Neurobiology
Course Support
Dr. Roberts-Research
Dr. D. Zipser-Computer
Workshops
Total Award
24,000
60,000
14,000
31,000
Duration
of Grant
1980-1982
5/1/79-4/30/82
6/1/79-12/31/82
Volkswagen Foundation Dr. Watson-Neurobiology 78,696 1980-1982
Scholarships
Whitehall Foundation Dr. B. Zipser-Research 135,000 10/1/80-9/30/83
Helen Hay Whitney Dr. Drickamer-Fellowship 24,125 9/1 /79 -5/31 /81
Foundation Dr. Frisque-Fellowship 29,000 9/1 /80 -8/31 /82
Damon Runyon-Walter Dr. B. Anderson-Fellowship 35,000 10/1/80-9/30/82
Winchell Cancer Fund Dr. Goldfarb-Fellowship 35,000 10/1/80-9/30/82
Dr. Lin-Fellowship 28,000 7/1/79-6/30/81
Dr. Stillman-Fellowship 28,000 4/1 /79- 3/31 /81
BANBURY CENTER
Duration
Grantor Program Total Award of Grant
Alfred P. Sloan Foundation Public Information Workshops $100,000 1/1/80-12/31/82
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FINANCIAL SUPPORT
OF THE LABORATORY
The Cold Spring Harbor Laboratory is a publicly supported educational institution chartered by the
University of the State of New York and may receive contributions which are tax exempt under the pro-
visions of the Internal Revenue Code, particularly Section 501C. In addition, the Laboratory has been
formally designated a "public charity" by the Internal Revenue Service. Accordingly, it is an acceptable
recipient of funds which would result from the termination of "private" foundations.
The Laboratory depends upon the generous contributions of its sponsors, participating institutions
and friends for central institutional needs and capital improvements. In addition, the development of
any new programs, such as year-round research in neurobiology or the marine sciences, can be under-
taken only with substantial support from private sources.
Methods of Contributing to Cold Spring Harbor Laboratory
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities
You can generally deduct the full amount of the gift on your income tax return, if the appreciation
would have been a long-term gain, to the extent of 50% of your adjusted gross income and you
need pay no capital gains tax on the stock's appreciation.
We recommend either of the following methods:
(1) Deliver the stock certificates to your broker with instructions to him to open an account for
Cold Spring Harbor Laboratory and hold the securities in that account pending instructions
from Cold Spring Harbor Laboratory.
(2) Send the unendorsed stock certificates directly to the Laboratory: Comptroller, Cold Spring
Harbor Laboratory, Box 100, Cold Spring Harbor, New York 11724. I n a separate envelope send
an executed stock power.
Bequests
Probably most wills need to be updated. Designating Cold Spring Harbor Laboratory as beneficiary
ensures that a bequest will be utilized as specified for continuing good.
Appreciated real estate or personal property
Sizable tax benefits can result from such donations; the Laboratory can use some in its program
and can sell others.
Life insurance and charitable remainder trusts can be structured to suit the donor's specific desires as to
extent, timing, and tax needs.
Conversion of private foundation to "public" status on termination
This may be done by creating a separate fund within Cold Spring Harbor Laboratory whereby the
assets of the private foundation could be accounted for as a separate fund and used for the pur-
poses specified by the donor. Alternatively, the private foundation can be established as a "sup-
porting organization of Cold Spring Harbor Laboratory."
For additional information, please contact the Administrative Director, Cold Spring Harbor
Laboratory, Box 100, Cold Spring Harbor, N.Y. 11724, or call 516-367-8300.
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SPONSORS
of the Cold Spring Harbor Laboratory
Abbott Laboratories
Ortho Pharmaceutical Corporation
SmithKline Corporation
CONTRIBUTORS
to the Cold Spring Harbor Laboratory
Benjamin H. Balkind
Mr. & Mrs. Charles Beach Barlow
Mr. & Mrs. E.C. Bench
Dr. & Mrs. Paul Berg
Harold Bloomfield
Mrs. Edwin M. Bulk ley, Jr.
Mr. & Mrs. W. Newton Burdick, Jr.
Clarence U. Carruth, Jr.
Patricia K. Casentini
Dr. Lan Bo Chen
Lawrence M. Clum
Columbia University
Barbara Cope
Mr. & Mrs. Eugene J. Curtis
Roderick H. Cushman
Arthur D. Dana, Jr.
Dr. Bernard D. Davis
Morse G. Dial, Jr.
Dr. Lester Dubnick
Duke University
Dr. Timothy P. Fitzharris
James Fitzmorris
Flower Hill Elementary School
Mrs. Edward E. Ford
Mr. & Mrs. Michael Foti
Walter N. Frank, Jr.
Mrs. James L. Garard
John 0. Giles
Dr. & Mrs. Bentley H. Glass
Mr. & Mrs. R.L. Golden
Janet W. Goodwillie
Mr. & Mrs. Robert Halligan
Dr. Alfred D. Hershey
Dr. Ira Herskowitz
Dr. Bernhard Hirt
Dr. Alexander Hollaender
Hon. John P. Humes
Laura J. Ingraham
International Symposium on Aging & CancerMr. & Mrs. Frederic R. KelloggDr. George Khoury
Townsend J. Knight
Forrest C. Lattner
Dr. & Mrs. Monroe Levin
Dr. & Mrs. Arnold Levine
Mr. & Mrs. George Lindsay
Robert V. Lindsay
Mrs. V.S. Littauer
Massachusetts Institute of Technology
Mr. & Mrs. Jerry Matero
Leila McKnight
Mr. & Mrs. Walter Meier
Norman E. Melechen
Agnes Meyer
Morgan Guaranty Trust
Dr. T. Morimoto
Dr. Gisela Mosig
New York University Medical Center
Mr. & Mrs. Walter H. Page
Dr. David B. Pall
Mr. & Mrs. Michael George Pfeifer
Anne Raker
Dr. & Mrs. Fred Rapp
Rockefeller University
Mr. & Mrs. Walter F. Rosenblith
Marjorie Robertson Rose
Louise H. Ross
Mark Sandler
Mr. & Mrs. Lawrence Schling
Mrs. Franz Schneider
Thomas Schopf
Staff of Security Trust Company
Dorothy Shinderman
Dr. & Mrs. W. Shropshire, Jr.
Mrs. H. Garrison Silleck
Martin B. Simpson
Daniel & Maxine Singer
Violet Skelly
Sloan-Kettering Institute for Cancer Research
Dr. & Mrs. Robert Smirnow
Mr. & Mrs. Joseph Sorrentino
Ina Sporecke
State University of New York, Stony Brook
Mr. & Mrs. Donald E. Stokes
Herbert Stoller
Mr. & Mrs. Frank Taylor
Dr. Charles A. Thomas, Jr.
Kevin Tremble
University of Wisconsin
Dr. James D. Watson
Wawepex Society
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THE LONG ISLAND
BIOLOGICAL ASSOCIATION
THE LONG ISLAND BIOLOGICAL ASSOCIATION (LIBA)
and Its Relation to the Cold Spring Harbor Laboratory
Biological research at Cold Spring Harbor began
in 1890 when the Brooklyn Institute of Arts and
Sciences was looking for a place to set up a sum-
mer laboratory as the headquarters of its Depart-
ment of Zoology. Representatives of the Institute
were invited by Eugene S. Blackford, at that time
the First Commissioner of the State of New York,
to inspect a site on Bungtown Road across Nor-
thern Boulevard (25A) from the Fish Hatchery. The
site was found to be ideal, and so the original
Laboratory was organized with Mr. Blackford as
president of the Board of Trustees. The land was
leased from Mr. John D. Jones, whose family since
1819 had operated various industries including
shipbuilding, coopering, and textile manufacture
(later whaling, also) at the head of Cold Spring
Harbor. Bungtown Road, which runs through the
Lab property, got its name from the factory that
specialized in making bungs-or stoppers-for
barrels.
In 1892 the Laboratory's land was leased for a
dollar a year from the Wawepex Society, which
Mr. Jones had organized as a corporation for hold-
ing real estate and for investing funds for the prop-
agation of fishes and for scientific research. In
1904 the Wawepex Society leased additional land
to the Carnegie Institution of Washington, which
wanted to locate a Department of Experimental
Evolution in the Cold Spring Harbor area. Charles
B. Davenport, who had been directing the Labora-
tory since 1896, assumed the additional duties of
director of the Carnegie Institution's experimental
station. It is interesting to note that Mr. Davenport
lived in what came to be known later as the
Carnegie Dormitory, the Victorian house on 25A
built by John D. Jones before the turn of the cen-
tury, and recently repainted in its original colors.
The Long Island Biological Association was es-
tablished in 1924 when the Brooklyn Institute de-
cided to discontinue its research at Cold Spring
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Harbor and offered its laboratory to two universi-
ties. Fortunately, a local group of interested
neighbors decided to assume responsibility for the
Lab, and thus LI BA came into being. For 38 years
LIBA actually operated the Laboratory in con-
junction with the Carnegie Institution, but in 1962
it seemed advisable for the Laboratory to be reor-
ganized as an independent unit. Therefore, the
property on which it now stands was conveyed to
it by LIBA, which, however, still retains rever-
sionary rights. Today LIBA is one of thirteen in-
stitutions participating in the support of the Lab-
oratory, each institution being represented on the
Laboratory's Board of Trustees.
What has happened, in effect, is that LIBA has
become an expanding group of local "Friends of
the Laboratory" who help support it through an-
nual contributions. Also, from time to time, the
Association undertakes campaigns to finance spe-
cial important projects for which the Lab cannot
obtain funds from the Federal Government or
from other sources. For instance, in 1974, LIBA
made possible building the James Laboratory An-
nex and the renovation of Blackford Hall; and in
1976 the re-building of Williams House.
The affairs of LI BA are handled by a board of
28 directors who are elected to office by the
membership at an annual meeting. At least twice
a year LIBA members are invited to bring their
friends to a lecture or an open house at the Lab.
Membership in LIBA requires a minimum an-
nual contribution (tax deductible) of $25 for a hus-
band and wife, $15 for a single adult, $5 for a
junior member (under 21). Further information
can be obtained from the Long Island Biological
Association, Box 100, Cold Spring Harbor, N.Y.
11724, or by telephoning the Laboratory's ad-
ministrative director, Mr. Wiliam R. Udry, at (516)
367-8300.
OFFICERS
Chairman
Vice-Chairman
Treasurer
Secretary
Asst. Secretary-Treasurer
EXECUTIVE COMMITTEE
The Officers, also
Mrs. Charles 0. Ames
Mrs. Henry U. Harris, Jr.
Mrs. Richardson Pratt
DIRECTORS
Mrs. Charles 0. Ames
Dr. Alfred A. Azzoni
Mr. Edmund Bartlett
Mr. Samuel R. Callaway
Mr. David C. Clark
Mrs. Miner D. Crary, Jr.
Mr. Roderick H. Cushman
Mr. Norris W. Darrell, Jr.
Mr. Joseph C. Dey, Jr.
Mr. Charles F. Dolan
Mr. Edward Pulling
Mr. George J. Hossfeld, Jr.
Mr. James A. Eisenman
Mrs. James J. Pirtle, Jr.
Mr. William R. Udry
Mr. James A. Eisenman
Mr. Walter N. Frank, Jr.
Mr. Clarence E. Galston
Mr. Charles S. Gay
Mrs. Henry U. Harris, Jr.
Mr. George J. Hossfeld, Jr.
Mr. James A. McCurdy
Mr. Walter H. Page
Mr. William Parsons, Jr.
Mrs. James J. Pirtle, Jr.
Mrs. Edward Everett Post
Mrs. Richardson Pratt
Mr. Edward Pulling
Mr. Stanley S. Trotman, Jr.
Mrs. Stephen Van R. Ulman
Dr. James D. Watson
Mr. Richard J. Weghorn
Mrs. Alex M. White
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REPORT OF THE CHAIRMAN FOR 1981
I am pleased to report that in 1981
LIBA's
membership was further expanded and that it con-
tinued to contribute generously to the Associa-
tion's funds. What our next major project for the
Laboratory is to be will be decided at the direc-
tors' meeting in May 1982.
As usual, members and their guests were in-
vited to two lectures during the year. At the first,
the annual Dorcas Cummings Memorial Lecture
on May 10th, we had the good fortune to secure
as our speaker Mr. Walter Sullivan, Science Editor
of The New York Times, who took us into Outer
Space in a fascinating talk about the search for
extra-terrestrial inhabitants, based on his well
known book on the subject entitled We Are Not
Alone.
Then at the winter annual meeting we heard an
exciting lecture by Dr. Thomas E. Lovejoy, vice-
president of the World Wildlife Fund-U.S. and
originator of a joint Brazilian-American long-term
study of the ecological dynamics of forest patches
in the Central Amazon. He illustrated his talk with
a series of exceptionally brilliant colored slides.
At both of the directors' meetings, on April 5th
and October 25th, talks were given by members
of the Lab's scientific staff. The first was by
Ronald McKay in which he described his research
on monoclonal antibodies, which hold out great
hope for the benefit of mankind in the areas of
both diagnosis and therapy.
The second talk was given by Michael Wig ler,
who, with his teammates, has recently achieved a
major breakthrough in cancer research: the isola-
tion of a gene which transforms a healthy cell into
a cancerous cell. The special purpose of these
talks is to keep LIBA's directors in close touch
with important developments at the Lab and to
give them the opportunity to get to know the
scientists involved in them.
The successful and greatly appreciated custom
of giving dinner parties for the visiting scientists at
the Lab's summer Symposium was continued in
1981. This year's hosts and hostesses were
Mrs. Jeannette S. Berman
Mr. & Mrs. Beverly C. Chew
Mr. & Mrs. Miner D. Crary, Jr.
Mr. & Mrs. Roderick H. Cushman
Mr. & Mrs. Norris W. Darrell, Jr.
Mr. & Mrs. George J. Hossfeld, Jr.
Mr. & Mrs. Robert P. Koenig
Mr. & Mrs. Samuel D. Parkinson
Mr. & Mrs. James J. Pirtle, Jr.
Mr. & Mrs. Edward Everett Post
Mr. & Mrs. Franz Schneider
Mr. & Mrs. Richard J. Weghorn
At the annual meeting regret was expressed
that Mr. Samuel D. Parkinson's term of office as a
director had expired and that Mr. Theodore
Wickersham had resigned because he has moved
away from Cold Spring Harbor. After giving
thanks to both men for their loyal service to LIBA,
Mr. Galston, as chairman of the nominating com-
mittee, placed in nomination to fill the vacant
places on the Board, Mr. Charles F. Dolan and
Mrs. Stephen Van R. Ulman, who were then duly
elected to office.
Edward Pulling, Chairman
Long Island Bilogical Assn.
February 15, 1982
Walter Sullivan
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Mr. & Mrs. Thomas Ackerman
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Mr. & Mrs. Amyas Ames
Mrs. Charles E. Ames
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Mr. & Mrs. T.C. Cattrall, Jr.
Mr. & Mrs. Lionel Chaikin
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Mr. & Mrs. David C. Clark
Dr. & Mrs. Bayard Clarkson
Mr. & Mrs. Thomas N. Cochran
Dr. & Mrs. Peter Cohn
Mrs. C. Payson Coleman
Mr. & Mrs. John H. Coleman
Mrs. John K. Colgate
Mr. & Mrs. Emilio G. Collado
Mr. Bradley Collins
Mr. & Mrs. Patrick Collins
Mrs. Ralph C. Colyer
Dr. & Mrs. Crispin Cooke
Mr. & Mrs. Howard Corning, Jr.
Mr. Duncan B. Cox
Mr. E. V. Cox, Jr.
Mr. & Mrs. Charles L. Craig
Mr. & Mrs. Miner D. Crary, Jr.
Mr. & Mrs. Arthur M. Crocker
Mr. Robert L. Cummings
Mr. Robert L. Cummings Ill
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Mr. & Mrs. Roderick H. Cushman
Mr. & Mrs. George W. Cutting, Jr.
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Mrs. Halsey S. Downer
Mr. Clark M. Drasher, Jr.
Dr. & Mrs. Arthur Drazan
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Mrs. Malcolm MacKay
Mr. & Mrs. Marshall MacLeod
Mrs. Henry R. Macy
Mrs. 1.R. Mahoney
Mr. & Mrs. John Mariani
Mrs. John B. Marsh
Mr. & Mrs. John M. Martin
Mr. & Mrs. William H. Mathers
Mr. & Mrs. John D. Maxwell
Dr. Ernst Mayr
Mr. & Mrs. J.A. McCurdy II
Mr. & Mrs. Richard McDaniel
Mr. & Mrs. Victor McElheny
Miss Diana Mcllvaine
Mr. & Mrs. Angus P. McIntyre
Mr. & Mrs. Randall P. McIntyre
Dr. & Mrs. Walter Meier
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Mr. & Mrs. George D. O'Neill
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Mr. & Mrs. R. Ray Weeks
Mrs. F. Carrington Weems
Mr. John C. Weghorn
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